data_2km8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2km8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.424 0.63 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.28 175.2 3.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.956 2.437 . . . . 0.0 111.827 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.36 -2.88 9.37 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.825 2.35 . . . . 0.0 113.117 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' B' ' 77' ' ' LEU . 60.0 p -156.77 136.98 12.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.908 -1.12 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -179.12 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.529 0.68 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' B' ' 100' ' ' GLY . 2.4 t -128.05 163.48 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.891 . . . . 0.0 109.953 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.44 136.63 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 108.404 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.424 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 10.3 m-30 -106.78 119.49 39.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.017 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.435 ' N ' ' CD2' ' B' ' 30' ' ' LEU . 1.7 mm? -106.61 105.45 15.48 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -107.03 -72.79 0.81 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.84 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.418 ' OG ' ' CB ' ' B' ' 94' ' ' SER . 7.8 t -69.2 82.71 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.929 -1.336 . . . . 0.0 110.014 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.94 121.29 6.09 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.59 ' C ' ' H ' ' B' ' 36' ' ' ASP . 30.0 Cg_endo -69.72 164.35 34.83 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.515 1.477 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -59.73 2.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.589 -0.694 . . . . 0.0 109.468 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.59 ' H ' ' C ' ' B' ' 34' ' ' PRO . 89.3 m-20 -63.99 -39.16 93.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.23 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.4 113.98 18.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.581 -0.699 . . . . 0.0 109.158 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.4 p -110.05 -139.88 0.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 111.2 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.43 ' C ' ' CD ' ' B' ' 39' ' ' GLU . 0.5 OUTLIER -63.02 -29.45 70.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.962 -1.086 . . . . 0.0 110.794 -178.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -71.18 -54.39 11.18 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.343 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -49.05 64.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' B' ' 44' ' ' ASP . 24.1 mm -55.33 -52.58 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 42' ' ' ILE . 42.0 tp -37.6 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.839 -0.538 . . . . 0.0 110.846 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.604 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 88.8 m-20 -123.5 -24.75 4.51 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.585 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.407 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.2 tm? -57.64 -39.44 76.98 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 119.905 -1.747 . . . . 0.0 106.612 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.623 ' O ' ' N ' ' B' ' 48' ' ' ASN . 0.8 OUTLIER -84.48 -63.68 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.801 . . . . 0.0 109.289 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.758 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.7 t -38.8 -21.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.797 -0.564 . . . . 0.0 109.798 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.623 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.36 68.9 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.893 0.854 . . . . 0.0 110.511 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.758 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.51 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.804 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.36 -155.7 19.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.75 159.83 38.24 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.325 2.016 . . . . 0.0 112.327 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.489 ' CG1' ' H ' ' B' ' 53' ' ' ILE . 3.0 t -120.92 -152.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.489 ' H ' ' CG1' ' B' ' 52' ' ' VAL . 31.8 mm -151.91 -64.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.827 -1.171 . . . . 0.0 109.577 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -126.65 146.56 50.14 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.645 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.37 130.69 26.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -137.08 144.59 43.2 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 108.827 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.91 135.24 39.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.5 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -158.39 166.88 31.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.416 -0.802 . . . . 0.0 109.202 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.442 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.1 OUTLIER -122.06 -168.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.559 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 25.2 p-10 -101.1 73.88 0.11 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 112.508 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.442 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 28.6 Cg_endo -67.68 -36.65 18.46 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.623 1.549 . . . . 0.0 111.222 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -101.99 -59.91 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.517 -0.74 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 75.5 p -48.7 -40.72 29.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.419 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.67 26.81 68.62 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.559 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 32.1 mtp180 -131.8 -68.01 0.66 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -1.115 . . . . 0.0 110.216 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' B' ' 60' ' ' ASP . 0.0 OUTLIER -50.01 120.39 4.36 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.832 0.825 . . . . 0.0 110.791 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.32 -74.61 0.43 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.066 -1.021 . . . . 0.0 108.699 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -115.69 94.7 0.67 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.52 130.49 55.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.039 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.41 138.86 31.41 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.356 -0.937 . . . . 0.0 109.574 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -105.68 122.98 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.617 ' N ' ' CD1' ' B' ' 72' ' ' ILE . 1.6 mp -118.17 98.81 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.294 -0.879 . . . . 0.0 111.485 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -83.11 133.14 35.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.495 -1.378 . . . . 0.0 110.91 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.39 174.87 6.92 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.629 0.728 . . . . 0.0 110.996 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 11.7 ttt-85 -53.2 -42.36 66.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.708 -0.62 . . . . 0.0 110.967 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.5 m-20 160.7 179.19 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.534 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 9.3 mt -38.09 -22.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.856 -0.528 . . . . 0.0 109.63 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.7 mt-10 -70.23 -73.3 0.17 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.215 1.007 . . . . 0.0 109.324 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m -61.73 -40.93 96.84 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.824 -1.173 . . . . 0.0 108.297 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.3 m -62.54 -35.67 80.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.193 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -59.64 -56.66 19.09 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.598 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 70.2 m -65.25 -35.95 82.61 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.955 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -80.43 -61.86 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 110.9 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.583 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 41.5 t -56.16 -40.61 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.03 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' B' ' 81' ' ' ALA . 0.0 OUTLIER -68.14 -51.55 44.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.021 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' B' ' 82' ' ' SER . 81.4 m-20 -67.52 -44.21 78.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' B' ' 83' ' ' ALA . 1.7 pp -139.98 121.45 15.1 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.129 -0.982 . . . . 0.0 110.15 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 84' ' ' VAL . 1.4 p30 -143.89 -56.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.11 104.35 0.77 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -138.11 146.39 42.81 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.537 -1.566 . . . . 0.0 108.255 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . 0.556 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.1 tp-100 -33.72 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.508 -0.745 . . . . 0.0 111.217 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 90' ' ' TYR . 62.5 tp -146.19 126.16 13.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.69 -147.62 48.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' SER . . . . . 0.418 ' CB ' ' OG ' ' B' ' 32' ' ' SER . 0.2 OUTLIER -92.36 -18.87 22.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.054 -1.263 . . . . 0.0 109.537 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' B' ' 92' ' ' LEU . 60.2 mtp180 -131.02 161.19 32.53 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.458 ' O ' ' C ' ' B' ' 97' ' ' LEU . 8.9 m-85 -94.57 137.41 33.73 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.2 -0.937 . . . . 0.0 110.072 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -40.44 145.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -109.74 151.98 26.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 11.0 p -77.37 108.46 10.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.471 -0.768 . . . . 0.0 109.214 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -87.0 173.17 44.6 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 54.8 p90 -152.15 -32.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -1.065 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' SER . . . . . 0.464 ' C ' ' O ' ' B' ' 101' ' ' TYR . 74.3 m -37.01 143.33 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.35 -0.844 . . . . 0.0 110.666 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.943 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 158' ' ' SER . . . . . 0.527 ' CB ' ' HE ' ' C' ' 232' ' ' ARG . 32.9 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.327 0.584 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.8 OUTLIER 170.36 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . 0.624 ' HZ3' ' HZ3' ' C' ' 189' ' ' LYS . 12.1 ttmm -83.7 140.22 32.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.036 -1.04 . . . . 0.0 108.275 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 2.4 ptm -125.78 169.92 12.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.952 -1.092 . . . . 0.0 109.323 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -121.5 80.8 1.72 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.567 -0.708 . . . . 0.0 109.693 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mm -50.29 131.98 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' C' ' 229' ' ' ASP . . . -133.88 156.36 22.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.39 28.42 61.78 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.41 142.32 53.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.52 -0.988 . . . . 0.0 109.768 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' C' ' 169' ' ' ASP . 47.5 t30 -69.27 140.89 54.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . 0.493 ' O ' ' OD1' ' C' ' 169' ' ' ASP . 7.5 m0 -63.63 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.069 -1.019 . . . . 0.0 110.307 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . 0.6 ' H ' ' C ' ' C' ' 167' ' ' ASN . 57.4 m-20 -157.66 64.95 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.938 -1.102 . . . . 0.0 109.825 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 34.0 m -134.16 153.3 51.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.133 -0.98 . . . . 0.0 110.688 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.97 167.71 11.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.495 -0.753 . . . . 0.0 109.117 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.69 -67.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.754 -1.216 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -47.23 -36.13 8.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.034 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . 0.444 ' OD1' ' C ' ' C' ' 174' ' ' ASN . 1.6 t30 -69.74 -52.21 27.44 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 12.4 tp -55.46 -41.84 73.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' C' ' 177' ' ' GLU . 25.4 ttp85 -66.12 -60.43 2.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.103 -0.998 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -44.76 -31.35 1.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.231 -0.918 . . . . 0.0 108.783 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' C' ' 178' ' ' TYR . 21.8 t80 -76.01 -49.58 17.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.739 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.781 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.4 m-85 -72.16 -49.37 36.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.309 -0.869 . . . . 0.0 111.664 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.21 23.91 0.01 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 119.568 -1.958 . . . . 0.0 112.405 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . 0.781 ' N ' ' O ' ' C' ' 179' ' ' PHE . 4.9 ttpm? -90.24 -13.85 34.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.89 -1.359 . . . . 0.0 107.614 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . 0.616 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 32.0 m-85 -91.08 -62.69 1.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.4 -125.22 2.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 27.4 m -122.89 145.61 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -1.0 . . . . 0.0 109.86 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.66 142.61 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 9.7 t -97.1 -37.47 10.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 110.337 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' C' ' 206' ' ' SER . 42.9 t0 -165.08 160.39 18.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.986 -1.071 . . . . 0.0 110.202 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.36 147.71 22.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . 0.624 ' HZ3' ' HZ3' ' C' ' 160' ' ' LYS . 23.6 mttp -114.86 90.85 3.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 110.175 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 10.3 tt -84.79 142.35 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 191' ' ' MET . . . . . 0.533 ' O ' ' C ' ' C' ' 192' ' ' LYS . 0.0 OUTLIER -98.85 -47.56 5.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.188 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' C' ' 191' ' ' MET . 0.1 OUTLIER -30.8 124.53 0.19 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.636 0.732 . . . . 0.0 110.214 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . 0.438 ' CG ' ' OG1' ' C' ' 196' ' ' THR . 15.7 t0 -134.45 87.16 33.13 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.13 -22.62 75.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.312 2.008 . . . . 0.0 111.389 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.41 -52.51 15.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.627 -0.67 . . . . 0.0 109.894 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 196' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' C' ' 193' ' ' ASP . 3.0 p -70.61 -35.9 73.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 109.78 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 153.9 -76.22 0.22 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -168.65 155.1 7.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -1.18 . . . . 0.0 110.171 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 199' ' ' SER . . . . . 0.428 ' O ' ' C ' ' C' ' 200' ' ' ARG . 23.0 t -151.68 168.73 24.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' C' ' 199' ' ' SER . 14.1 mmp_? -46.44 143.52 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.937 -1.102 . . . . 0.0 108.286 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.27 91.25 1.42 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.121 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' C' ' 202' ' ' PHE . 25.1 p90 -152.25 167.17 29.47 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.38 130.99 3.32 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 118.149 -1.977 . . . . 0.0 110.766 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.14 120.7 29.74 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 119.992 -1.887 . . . . 0.0 107.271 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.33 104.79 14.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 109.148 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 206' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.4 OUTLIER -80.44 73.08 7.35 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.543 0.687 . . . . 0.0 109.606 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -67.95 114.74 6.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.981 -1.074 . . . . 0.0 109.408 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.75 -48.03 83.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 108.947 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' C' ' 211' ' ' SER . 1.8 mtmp? -84.36 101.3 1.41 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.992 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -39.38 -23.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 121.871 1.714 . . . . 0.0 112.704 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.473 ' N ' ' O ' ' C' ' 209' ' ' LYS . 17.9 t -62.26 -57.1 12.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.013 -1.054 . . . . 0.0 110.585 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.545 ' O ' ' CG2' ' C' ' 216' ' ' VAL . 24.7 m -41.51 -34.91 0.62 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.29 -0.881 . . . . 0.0 109.53 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.97 -43.02 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' C' ' 211' ' ' SER . 61.8 t0 -60.83 -50.64 72.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 0.0 110.506 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . 0.478 ' O ' ' OG1' ' C' ' 219' ' ' THR . 19.7 pt-20 -73.63 -31.83 63.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.967 -1.083 . . . . 0.0 109.972 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' C' ' 212' ' ' SER . 22.6 t -61.48 -50.99 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.747 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.02 -29.9 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.511 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -85.01 17.48 2.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.495 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' C' ' 215' ' ' GLU . 32.0 m -136.43 147.3 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.921 -1.112 . . . . 0.0 109.46 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -102.63 136.33 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.248 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.705 ' CD2' ' N ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -139.82 167.65 21.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.858 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.0 107.2 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.825 . . . . 0.0 108.899 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . 0.408 ' CD1' ' CG ' ' C' ' 178' ' ' TYR . 1.0 OUTLIER -73.43 -71.96 0.29 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 109.796 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . 0.574 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 60.2 t0 -84.95 0.45 51.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.039 -1.038 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.03 13.23 72.21 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . 0.579 ' NZ ' ' O ' ' C' ' 278' ' ' LYS . 1.2 tpmt? -90.09 -78.76 0.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -1.019 . . . . 0.0 109.325 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 174.75 109.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.251 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 17.9 pt -113.96 148.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.706 -0.621 . . . . 0.0 110.132 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' C' ' 164' ' ' GLY . 0.7 OUTLIER -125.43 96.68 38.36 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . 0.4 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 46.8 Cg_endo -85.4 125.31 2.93 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.564 2.176 . . . . 0.0 112.028 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -141.18 143.05 34.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.699 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.527 ' HE ' ' CB ' ' C' ' 158' ' ' SER . 75.1 ttt-85 -57.45 153.96 11.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 108.591 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -44.31 137.57 3.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 108.856 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.92 135.99 22.51 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.406 -0.809 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.24 139.19 16.39 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.809 1.672 . . . . 0.0 112.125 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.25 -44.58 88.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.518 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 34.0 p-10 -63.31 -38.65 91.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 109.856 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . 0.589 ' N ' ' OD1' ' C' ' 237' ' ' ASP . 48.6 tp10 -66.0 -40.34 91.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.399 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . 0.467 ' O ' ' OG1' ' C' ' 242' ' ' THR . 14.3 tt0 -62.31 -43.91 97.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.1 -39.24 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.049 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -63.32 -39.53 94.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.936 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 242' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 66.9 p -50.76 141.65 12.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.851 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.09 160.5 14.74 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' C' ' 318' ' ' ALA . 22.9 tttt -136.37 133.39 36.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.243 . . . . 0.0 110.45 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.61 147.57 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.51 -0.744 . . . . 0.0 109.463 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 4.7 t80 -103.0 130.42 50.09 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 10.1 t -100.14 134.97 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.784 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 249' ' ' GLY . . . -105.89 155.85 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 248' ' ' GLY . . . 59.66 141.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 2.7 tp -162.5 164.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.427 -1.043 . . . . 0.0 109.158 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -54.82 155.03 8.86 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.81 -28.78 86.99 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.548 2.166 . . . . 0.0 112.119 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.69 73.98 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.05 134.58 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.638 0.732 . . . . 0.0 109.932 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -96.32 157.05 36.19 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -57.74 -21.75 49.49 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.593 2.196 . . . . 0.0 111.859 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -51.98 -63.66 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.605 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' C' ' 261' ' ' GLU . 76.0 mm-40 -58.21 -88.11 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . 0.619 ' C ' ' O ' ' C' ' 258' ' ' GLU . 36.9 t80 -9.59 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.309 0.576 . . . . 0.0 111.449 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' C' ' 258' ' ' GLU . 96.9 mt-10 -56.71 -44.29 81.43 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.07 -1.019 . . . . 0.0 109.404 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . 0.723 ' N ' ' O ' ' C' ' 258' ' ' GLU . 76.3 mm-40 -69.44 -40.28 77.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . 0.417 ' O ' ' CG ' ' C' ' 265' ' ' GLN . 70.3 t80 -49.37 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.505 -0.747 . . . . 0.0 109.363 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.471 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 93.5 m-85 -55.39 -32.12 62.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.576 -1.328 . . . . 0.0 110.465 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.423 ' C ' ' O ' ' C' ' 263' ' ' PHE . 13.0 t -38.29 -38.32 0.35 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.822 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' C' ' 264' ' ' SER . 0.2 OUTLIER -52.11 -95.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.322 -1.486 . . . . 0.0 109.9 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.471 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -63.56 152.55 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.29 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 52.96 103.2 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 60.5 m -49.9 138.47 15.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.245 . . . . 0.0 107.785 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -99.63 104.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.103 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.5 -50.29 35.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.8 -1.187 . . . . 0.0 109.189 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . 0.497 ' O ' ' OG1' ' C' ' 290' ' ' THR . 57.4 t0 -142.36 98.05 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 109.611 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -128.25 166.39 18.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 109.419 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.1 OUTLIER 167.26 162.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.214 1.007 . . . . 0.0 111.367 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 5.9 tp -99.82 144.24 29.1 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 275' ' ' MET . . . . . 0.556 ' SD ' ' OD2' ' C' ' 279' ' ' ASP . 23.0 mmm -92.01 160.02 15.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.195 -1.566 . . . . 0.0 108.304 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 153.3 42.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' C' ' 281' ' ' GLY . 0.0 OUTLIER -49.73 -31.89 12.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 108.619 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . 0.579 ' O ' ' NZ ' ' C' ' 226' ' ' LYS . 57.4 tttp -54.99 -40.46 70.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.366 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' C' ' 275' ' ' MET . 91.3 m-20 -60.9 -37.4 82.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.35 -39.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.777 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' C' ' 277' ' ' ASP . . . 125.63 30.64 0.88 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.597 ' O ' ' N ' ' C' ' 284' ' ' ARG . 60.8 mm-40 -119.4 42.72 2.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.352 -1.087 . . . . 0.0 110.13 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 283' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' C' ' 283' ' ' SER . 6.6 t -62.51 39.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.247 -0.908 . . . . 0.0 110.032 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' C' ' 282' ' ' GLN . 68.2 mtp85 -55.87 -34.17 65.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -0.974 . . . . 0.0 109.44 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.85 79.55 0.38 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' C' ' 282' ' ' GLN . 0.0 OUTLIER -146.75 -176.02 5.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.578 -1.542 . . . . 0.0 111.984 -178.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -157.89 164.65 33.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -138.06 151.02 47.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.951 -1.323 . . . . 0.0 108.55 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -146.29 141.97 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.433 -1.417 . . . . 0.0 108.389 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 290' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' C' ' 271' ' ' ASP . 23.9 m -130.12 129.24 43.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.044 -1.035 . . . . 0.0 109.988 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.98 156.0 27.04 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . 0.454 ' C ' ' OD1' ' C' ' 292' ' ' ASP . 54.2 p30 -79.95 15.54 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.733 -1.23 . . . . 0.0 109.714 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 22.7 t -158.76 168.57 26.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.195 -0.94 . . . . 0.0 108.985 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.05 -12.05 20.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -57.31 -48.32 79.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.469 -0.769 . . . . 0.0 109.162 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.22 88.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.047 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.08 -57.74 6.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.22 -30.23 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' C' ' 302' ' ' GLN . 59.2 ttm-85 -63.86 -64.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.44 -0.787 . . . . 0.0 109.325 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' C' ' 303' ' ' ASN . 9.0 p -65.54 -23.0 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.415 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . 0.498 ' SG ' ' NH1' ' C' ' 317' ' ' ARG . 45.0 t -48.24 -57.32 6.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.062 -1.024 . . . . 0.0 109.706 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' C' ' 299' ' ' ARG . 3.9 pt20 -49.45 -22.33 1.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.109 . . . . 0.0 108.515 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' C' ' 300' ' ' VAL . 92.4 m-20 -99.67 69.73 1.62 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.9 -82.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.672 -1.268 . . . . 0.0 108.869 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -69.63 126.6 30.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.162 -0.961 . . . . 0.0 109.493 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 59.6 mt -120.22 145.45 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.37 114.69 11.87 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' C' ' 309' ' ' LYS . 22.1 t80 -114.59 -178.08 3.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.578 ' C ' ' O ' ' C' ' 308' ' ' PHE . 73.8 mttt -19.75 -82.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 0.0 111.998 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' C' ' 311' ' ' ARG . 47.6 p30 -127.97 -16.41 4.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 110.201 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . 0.429 ' N ' ' OD1' ' C' ' 310' ' ' ASP . 40.1 mtp180 -121.2 125.81 48.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -52.77 164.96 0.31 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.43 -0.793 . . . . 0.0 109.398 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.59 122.85 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.83 103.79 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 0.0 109.68 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 5.6 mm -72.53 146.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.014 -1.054 . . . . 0.0 110.046 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -154.04 152.39 30.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . 0.625 ' H ' ' CD ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER -59.73 149.69 30.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 108.998 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' C' ' 244' ' ' LYS . . . -50.77 -25.32 4.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.899 -1.126 . . . . 0.0 108.921 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 179.232 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.57 ' O ' ' CG ' ' B' ' 101' ' ' TYR . 16.1 Cg_exo -63.05 -176.92 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.819 2.346 . . . . 0.0 111.84 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 23' ' ' PRO . 71.0 Cg_endo -86.9 25.79 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.91 2.407 . . . . 0.0 112.811 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.58 107.22 2.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.907 -1.121 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.526 ' N ' ' HG ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -162.74 -40.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' B' ' 28' ' ' VAL . 1.2 p -139.56 158.0 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.664 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.436 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.9 t -108.59 134.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.427 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 9.1 m-30 -99.51 117.08 33.12 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.603 0.716 . . . . 0.0 109.682 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' B' ' 30' ' ' LEU . 1.1 mm? -101.98 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.581 ' C ' ' H ' ' B' ' 33' ' ' ILE . . . -146.75 -53.84 0.02 OUTLIER Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.986 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 27.6 t -69.5 30.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -1.21 . . . . 0.0 109.981 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.581 ' H ' ' C ' ' B' ' 31' ' ' GLY . 4.9 mp -108.71 136.37 19.98 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' B' ' 36' ' ' ASP . 83.0 Cg_endo -87.64 -176.01 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.743 1.629 . . . . 0.0 111.444 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.606 ' OH ' ' CG ' ' B' ' 59' ' ' PHE . 3.0 m-30 -67.1 0.45 2.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.73 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.554 ' CB ' HE22 ' B' ' 37' ' ' GLN . 62.7 m-20 -67.08 -45.27 77.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.964 -1.085 . . . . 0.0 108.968 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.554 HE22 ' CB ' ' B' ' 36' ' ' ASP . 11.8 mp0 -107.25 100.32 9.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.236 -0.915 . . . . 0.0 109.09 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -98.57 -153.95 0.45 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.651 -0.656 . . . . 0.0 110.079 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 40.2 tt0 -57.22 -26.29 60.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.141 -0.974 . . . . 0.0 109.884 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.7 -56.84 6.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.507 -0.746 . . . . 0.0 110.997 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.27 -41.63 80.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.948 . . . . 0.0 111.479 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mm -63.19 -52.28 60.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' B' ' 47' ' ' SER . 32.4 tp -58.5 -36.63 74.08 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -55.34 -74.77 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.416 1.103 . . . . 0.0 109.979 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -45.63 90.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.089 -177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' B' ' 48' ' ' ASN . 96.6 m -61.59 -68.67 0.3 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.003 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 87.7 p -33.39 -31.41 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.0 OUTLIER -78.37 -43.35 27.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.976 -1.078 . . . . 0.0 109.431 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 46' ' ' CYS . 13.2 t -43.4 -56.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.564 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.9 -158.79 11.63 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.938 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' B' ' 52' ' ' VAL . 57.9 Cg_endo -79.9 82.08 2.59 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.798 2.332 . . . . 0.0 112.788 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.556 ' O ' ' O ' ' B' ' 51' ' ' PRO . 0.3 OUTLIER -51.08 -166.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.424 HG12 ' O ' ' B' ' 52' ' ' VAL . 0.7 OUTLIER -160.09 -57.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.594 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 78.6 m-20 -117.91 132.64 56.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.402 HD12 ' N ' ' B' ' 56' ' ' LYS . 16.9 tp -133.0 126.36 31.77 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.402 ' N ' HD12 ' B' ' 55' ' ' LEU . 59.4 mttp -138.7 138.0 37.33 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.068 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.426 ' SD ' ' CB ' ' B' ' 70' ' ' ALA . 1.8 tpt -127.9 134.32 49.35 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' MET . . . . . 0.599 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.1 OUTLIER -153.66 150.13 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 109.87 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.606 ' CG ' ' OH ' ' B' ' 35' ' ' TYR . 4.0 m-85 -106.33 -177.54 3.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.345 -0.847 . . . . 0.0 109.555 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.582 ' OD2' ' N ' ' B' ' 66' ' ' SER . 13.6 m-20 -103.98 71.89 0.17 Allowed Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.908 -1.12 . . . . 0.0 111.939 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 17.0 Cg_exo -49.22 -65.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.239 1.959 . . . . 0.0 112.88 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -85.2 -54.14 4.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.429 -0.794 . . . . 0.0 110.255 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.456 ' C ' ' H ' ' B' ' 65' ' ' ARG . 62.4 p -51.99 -38.4 56.6 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.224 -0.923 . . . . 0.0 108.751 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.73 3.24 3.05 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' B' ' 63' ' ' THR . 83.0 mtt85 -65.83 -37.8 87.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.387 -1.067 . . . . 0.0 111.138 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.582 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.8 OUTLIER -155.4 150.12 26.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.379 -1.451 . . . . 0.0 112.305 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -115.98 77.97 1.14 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.65 54.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.48 127.33 52.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 108.602 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.426 ' CB ' ' SD ' ' B' ' 57' ' ' MET . . . -144.35 145.85 32.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.441 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -124.77 129.63 50.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 109.775 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.49 108.67 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.701 -0.799 . . . . 0.0 111.701 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.594 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 31.9 tt0 -92.9 134.12 35.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.352 -1.468 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -96.66 171.63 8.41 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.858 0.837 . . . . 0.0 110.415 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' B' ' 76' ' ' ASP . 4.0 tpt180 -42.88 -40.84 3.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.785 -0.572 . . . . 0.0 112.322 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' B' ' 78' ' ' GLU . 17.8 t70 166.61 -177.73 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.35 0.595 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 2.0 mm? -39.58 -21.88 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.072 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.2 mm-40 -70.59 -74.42 0.14 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.753 -1.217 . . . . 0.0 109.096 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 29.8 m -60.87 -41.89 96.86 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.526 ' HG ' ' N ' ' B' ' 26' ' ' ARG . 0.1 OUTLIER -62.35 -29.93 70.81 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.076 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -67.23 -60.91 2.21 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.947 -1.095 . . . . 0.0 108.461 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.653 ' HG ' HH21 ' B' ' 85' ' ' ARG . 59.0 m -61.51 -45.77 92.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.452 -0.78 . . . . 0.0 110.792 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.449 ' HA ' ' OD1' ' B' ' 86' ' ' ASN . . . -68.46 -67.31 0.48 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' B' ' 88' ' ' ASN . 16.1 t -49.73 -31.77 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.8 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . 0.653 HH21 ' HG ' ' B' ' 82' ' ' SER . 76.2 mtm180 -65.0 -52.44 56.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 109.559 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.589 ' OD1' ' O ' ' B' ' 82' ' ' SER . 0.0 OUTLIER -75.08 -42.8 56.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 117.973 -1.491 . . . . 0.0 108.183 178.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' B' ' 88' ' ' ASN . 17.1 mt -79.63 -2.08 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 110.185 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' B' ' 84' ' ' VAL . 0.5 OUTLIER -48.51 -82.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.55 114.9 1.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.639 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -139.71 149.76 44.03 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 119.936 1.868 . . . . 0.0 110.821 -179.169 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -47.87 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.102 -1.624 . . . . 0.0 110.044 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -154.71 113.09 3.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.247 -0.908 . . . . 0.0 108.627 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.55 -171.83 36.86 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 44.9 m -79.44 -14.74 58.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.899 -1.353 . . . . 0.0 109.929 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.435 ' N ' ' OG ' ' B' ' 32' ' ' SER . 14.8 ttm180 -146.78 163.64 35.36 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.3 m-85 -93.41 127.36 39.0 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.867 -1.146 . . . . 0.0 110.502 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.636 ' N ' ' CD1' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -41.37 156.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.383 0.611 . . . . 0.0 109.482 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -111.27 149.23 31.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.568 -0.708 . . . . 0.0 110.124 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' OD1' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -75.07 113.69 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.777 -0.577 . . . . 0.0 109.64 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.427 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -111.21 161.81 12.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' B' ' 23' ' ' PRO . 5.2 p90 -148.37 108.46 4.07 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.479 -1.013 . . . . 0.0 109.21 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 29.6 t -144.72 128.56 17.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.274 -0.891 . . . . 0.0 109.272 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.1 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . 0.41 ' SG ' ' CG2' ' C' ' 213' ' ' VAL . 8.6 t -116.04 87.32 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.057 0.932 . . . . 0.0 109.527 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -94.63 148.88 21.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -115.72 170.7 8.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.998 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -128.81 68.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 8.2 mm -57.26 129.39 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.79 -173.9 13.26 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' C' ' 227' ' ' VAL . . . 53.94 27.23 36.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.73 161.93 5.76 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.353 -1.087 . . . . 0.0 108.559 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' C' ' 168' ' ' TRP . 3.2 p30 -68.2 -71.84 0.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . 0.549 ' CG ' ' O ' ' C' ' 167' ' ' ASN . 0.1 OUTLIER 178.56 -32.97 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.884 -1.135 . . . . 0.0 109.636 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.29 96.96 3.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 11.9 m -129.21 141.94 51.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.872 . . . . 0.0 108.958 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 171' ' ' THR . . . . . 0.613 ' HG1' HD21 ' C' ' 174' ' ' ASN . 0.2 OUTLIER -92.56 156.59 17.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 109.594 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.81 -63.92 1.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.275 -0.891 . . . . 0.0 110.526 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.55 -33.53 22.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.929 -1.107 . . . . 0.0 109.696 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . 0.613 HD21 ' HG1' ' C' ' 171' ' ' THR . 87.9 m-20 -70.45 -50.84 34.12 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.911 0.863 . . . . 0.0 108.68 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -37.76 79.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.655 -0.653 . . . . 0.0 110.011 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -69.4 -60.74 2.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.48 -28.1 4.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.329 -0.857 . . . . 0.0 108.816 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' C' ' 178' ' ' TYR . 18.6 t80 -70.08 -53.61 16.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.922 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.763 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.6 m-85 -72.87 -41.87 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.608 -0.683 . . . . 0.0 112.501 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.77 30.01 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 119.347 -2.096 . . . . 0.0 111.431 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . 0.763 ' N ' ' O ' ' C' ' 179' ' ' PHE . 28.5 ttmt -94.01 -12.27 29.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . 0.617 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 44.0 m-85 -99.77 -50.7 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.405 0.622 . . . . 0.0 109.744 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -143.66 -130.89 2.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 39.7 m -122.76 141.25 52.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -1.064 . . . . 0.0 109.567 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.96 135.34 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.409 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.19 -41.52 9.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.921 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -160.1 158.0 29.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 109.657 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' C' ' 189' ' ' LYS . 0.6 OUTLIER -139.97 140.38 36.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . 0.453 ' N ' ' CD1' ' C' ' 188' ' ' LEU . 0.2 OUTLIER -105.74 92.51 4.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.175 . . . . 0.0 110.2 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.8 tt -117.13 145.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 13.0 ptp -154.19 61.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 109.986 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -68.22 171.86 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.998 -1.064 . . . . 0.0 109.614 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . 0.507 ' OD2' ' OG ' ' C' ' 199' ' ' SER . 0.5 OUTLIER -52.51 124.71 34.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 108.962 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.98 -4.82 15.98 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.153 1.902 . . . . 0.0 112.706 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.67 -85.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 32.5 p -98.69 -12.57 20.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 110.018 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 79.84 18.96 71.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -96.13 74.72 2.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.298 . . . . 0.0 110.176 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 199' ' ' SER . . . . . 0.571 ' O ' ' O ' ' C' ' 200' ' ' ARG . 37.0 m -167.31 171.64 10.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.576 ' C ' ' NE ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -34.98 162.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 110.128 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.06 108.29 0.36 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . 0.53 ' CE2' ' NH2' ' C' ' 200' ' ' ARG . 7.8 p90 -130.41 158.1 40.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -1.097 . . . . 0.0 109.377 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.16 116.96 1.54 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.747 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.07 82.72 6.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.716 -1.461 . . . . 0.0 107.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.5 mt -70.59 104.14 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.935 . . . . 0.0 111.621 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.0 t -76.75 76.34 3.39 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.5 122.84 17.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.526 -0.734 . . . . 0.0 110.459 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.19 -47.12 71.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.163 -0.961 . . . . 0.0 109.397 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -93.96 118.5 67.27 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.802 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.14 -2.25 2.91 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.516 ' O ' ' N ' ' C' ' 213' ' ' VAL . 18.6 t -74.53 -70.44 0.4 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.707 -1.246 . . . . 0.0 109.877 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.432 ' C ' ' O ' ' C' ' 211' ' ' SER . 28.2 t -39.28 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.5 -0.75 . . . . 0.0 109.96 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' C' ' 211' ' ' SER . 0.5 OUTLIER -61.99 -20.18 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.765 -1.209 . . . . 0.0 110.106 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.97 -45.09 9.94 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.045 0.926 . . . . 0.0 108.863 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . 0.5 ' OE2' ' OG1' ' C' ' 219' ' ' THR . 48.7 tp10 -70.92 -27.85 64.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.79 -0.569 . . . . 0.0 109.849 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' C' ' 217' ' ' VAL . 3.3 p -61.41 -49.11 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . 0.532 ' N ' ' CG1' ' C' ' 216' ' ' VAL . 14.4 p -78.27 -40.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.94 -1.1 . . . . 0.0 109.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -59.4 -48.67 80.75 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.441 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.5 ' OG1' ' OE2' ' C' ' 215' ' ' GLU . 28.6 m -79.06 155.07 28.95 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.738 0.78 . . . . 0.0 110.898 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -112.07 138.45 48.71 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.674 ' CD2' ' N ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -136.44 163.19 31.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.26 119.47 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.51 -72.28 0.05 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -126.22 20.7 7.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 109.171 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.42 8.94 58.26 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . 0.716 ' NZ ' ' HZ2' ' C' ' 278' ' ' LYS . 2.1 tpmt? -87.58 -76.8 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.368 -1.077 . . . . 0.0 109.188 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' C' ' 165' ' ' GLY . 1.2 t 169.13 135.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.385 -0.822 . . . . 0.0 109.629 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 17.9 pt -139.62 159.18 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.625 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.79 98.05 12.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 109.088 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . 0.431 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 83.8 Cg_endo -87.94 123.33 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.964 2.442 . . . . 0.0 113.252 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -141.61 139.1 33.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.054 . . . . 0.0 109.6 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' C' ' 233' ' ' ALA . 70.7 ttt180 -66.54 151.46 47.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.081 . . . . 0.0 109.868 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.64 138.17 4.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' C' ' 232' ' ' ARG . 3.4 mt -134.74 119.09 13.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.924 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -45.94 156.03 0.51 Allowed 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.037 1.825 . . . . 0.0 111.551 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.411 ' CZ ' HE22 ' C' ' 239' ' ' GLN . 0.3 OUTLIER -60.16 -45.62 92.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 0.0 110.485 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.13 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -70.42 -39.51 74.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.89 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . 0.411 HE22 ' CZ ' ' C' ' 236' ' ' ARG . 6.7 tt0 -58.45 -39.46 79.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.06 -36.71 84.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.975 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . 0.515 ' O ' ' C ' ' C' ' 242' ' ' THR . 19.4 tttt -56.77 -65.71 0.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 242' ' ' THR . . . . . 0.515 ' C ' ' O ' ' C' ' 241' ' ' LYS . 39.9 p -33.04 145.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.779 -0.575 . . . . 0.0 110.074 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -131.38 147.32 18.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 130.58 27.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -1.205 . . . . 0.0 109.832 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.42 152.59 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.701 0.762 . . . . 0.0 109.679 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -108.16 136.09 48.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.675 -0.641 . . . . 0.0 109.329 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 9.7 t -109.6 144.26 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.551 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 168.1 14.45 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . 0.582 ' O ' ' NH1' ' C' ' 311' ' ' ARG . . . 88.65 17.54 56.53 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 121.107 -1.231 . . . . 0.0 110.349 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 4.6 mt -116.04 136.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -1.053 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -108.67 178.15 20.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.96 -20.41 38.68 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.623 2.215 . . . . 0.0 112.379 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -56.1 -35.7 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.906 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 2.8 p -76.78 148.01 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.161 -0.962 . . . . 0.0 109.584 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -106.18 158.31 32.85 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.51 -21.31 61.28 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.455 2.103 . . . . 0.0 111.276 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -62.71 -54.76 34.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.04 -43.24 95.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -56.29 -59.67 4.61 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 109.936 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' C' ' 264' ' ' SER . 84.5 tt0 -60.66 -49.16 78.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . 0.487 ' C ' ' HG ' ' C' ' 264' ' ' SER . 47.4 tp10 -57.98 -22.56 49.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 0.0 108.75 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . 0.476 ' O ' ' OE1' ' C' ' 265' ' ' GLN . 67.6 t80 -81.25 -79.73 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.537 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 91.4 m-85 -52.61 -33.61 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.023 -1.048 . . . . 0.0 110.162 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' C' ' 260' ' ' GLU . 2.7 p -35.59 -38.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 111.996 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.658 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 1.8 pt20 -57.09 -90.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.422 -1.424 . . . . 0.0 110.339 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.658 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.7 OUTLIER -67.47 150.93 48.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.548 -1.345 . . . . 0.0 110.203 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 59.43 95.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 47.6 m -48.05 137.11 10.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.878 -1.366 . . . . 0.0 108.232 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -94.65 96.93 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 111.059 -178.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 6.4 mm -67.93 -39.57 81.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.449 -1.407 . . . . 0.0 108.497 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . 0.427 ' O ' ' OG1' ' C' ' 290' ' ' THR . 59.9 t0 -160.59 92.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.439 -0.788 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -123.42 172.33 8.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 109.888 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.0 OUTLIER 169.29 160.11 0.05 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.167 0.984 . . . . 0.0 111.277 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' C' ' 275' ' ' MET . 0.1 OUTLIER -107.7 152.59 24.12 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 275' ' ' MET . . . . . 0.443 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 0.0 OUTLIER -87.78 -179.12 6.21 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.492 -1.38 . . . . 0.0 109.858 -178.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.619 ' N ' ' HG1' ' C' ' 280' ' ' THR . 0.9 OUTLIER -153.21 -160.47 1.13 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.999 -1.063 . . . . 0.0 110.259 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . 0.449 ' HA ' ' N ' ' C' ' 283' ' ' SER . 1.2 m-20 -61.79 -85.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.281 -0.887 . . . . 0.0 111.58 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . 0.716 ' HZ2' ' NZ ' ' C' ' 226' ' ' LYS . 11.3 tptp -103.69 -32.11 9.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 109.805 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.54 -39.03 75.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 280' ' ' THR . . . . . 0.619 ' HG1' ' N ' ' C' ' 276' ' ' LEU . 75.6 p -151.14 132.33 14.45 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.688 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.84 -127.95 28.72 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' C' ' 283' ' ' SER . 96.3 mt-30 -141.53 147.26 37.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -1.078 . . . . 0.0 110.987 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 283' ' ' SER . . . . . 0.604 ' C ' ' H ' ' C' ' 285' ' ' GLY . 0.0 OUTLIER -16.57 -52.22 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.106 -177.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' C' ' 282' ' ' GLN . 97.3 mtt180 -69.21 47.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' C' ' 283' ' ' SER . . . -40.36 102.46 0.02 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' C' ' 286' ' ' PHE . 0.0 OUTLIER -67.42 -163.73 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -130.21 149.92 19.03 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.923 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -139.39 151.61 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 2.3 t -147.77 143.24 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.735 -1.228 . . . . 0.0 108.501 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 290' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' C' ' 271' ' ' ASP . 24.4 m -129.7 125.32 35.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.106 -0.996 . . . . 0.0 108.974 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -115.94 144.79 43.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.17 -50.2 73.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.658 -1.276 . . . . 0.0 109.149 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 72.9 m -98.02 178.95 4.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.27 -11.73 14.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -51.18 -44.38 61.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.0 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.85 . . . . 0.0 109.088 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . 0.566 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 59.4 t -60.16 -60.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -57.48 -28.18 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -64.29 -62.93 1.3 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.79 -28.17 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.798 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 67.5 m -45.78 -55.78 6.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 0.0 108.853 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' C' ' 301' ' ' CYS . 15.8 mm100 -47.63 -25.05 1.04 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' C' ' 300' ' ' VAL . 82.7 m-20 -98.98 72.66 1.91 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -65.74 -12.29 52.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.821 -1.174 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -132.0 122.75 26.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.831 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 46.7 mt -119.93 147.41 23.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . 0.448 ' C ' ' OD1' ' C' ' 307' ' ' ASP . 47.3 p30 -69.79 159.43 33.6 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 109.012 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.745 ' O ' ' O ' ' C' ' 309' ' ' LYS . 13.9 t80 -167.31 -171.46 1.72 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.745 ' O ' ' O ' ' C' ' 308' ' ' PHE . 68.2 mttt -42.27 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.107 0.956 . . . . 0.0 110.937 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . 0.448 ' C ' ' OD1' ' C' ' 310' ' ' ASP . 44.6 p30 -61.14 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.375 -1.453 . . . . 0.0 110.912 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' C' ' 309' ' ' LYS . 0.3 OUTLIER -166.75 112.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.979 -1.075 . . . . 0.0 109.641 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.49 168.94 0.5 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 48.4 pt -133.25 157.21 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 109.937 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -112.2 157.0 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.352 -0.842 . . . . 0.0 109.133 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.6 142.48 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -156.52 155.14 31.45 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -60.72 143.45 54.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.026 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.58 61.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.322 -0.862 . . . . 0.0 109.383 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 109.774 -179.473 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.411 ' HD2' HH21 ' B' ' 26' ' ' ARG . 30.5 Cg_endo -67.78 157.15 63.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.715 2.277 . . . . 0.0 112.067 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.86 -5.67 16.14 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.927 2.418 . . . . 0.0 112.832 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 75.5 m -148.5 130.23 15.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 109.669 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.717 HH12 ' HG ' ' B' ' 103' ' ' SER . 23.3 ttp85 179.05 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.07 151.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.592 -0.693 . . . . 0.0 109.637 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 10.8 t -103.49 131.84 51.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.565 ' HH ' ' H ' ' B' ' 102' ' ' SER . 3.2 m-85 -102.2 116.93 33.68 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.816 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 mp -102.71 129.19 49.25 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -106.12 -112.15 3.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.456 ' OG ' ' CG ' ' B' ' 95' ' ' ARG . 10.4 p -70.08 131.0 43.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -1.219 . . . . 0.0 109.331 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -163.42 132.88 3.08 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.572 ' C ' ' H ' ' B' ' 36' ' ' ASP . 14.8 Cg_endo -60.74 146.6 97.04 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.259 1.306 . . . . 0.0 112.162 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -62.98 3.66 0.22 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' B' ' 34' ' ' PRO . 93.0 m-20 -57.65 -37.77 73.92 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.362 -0.836 . . . . 0.0 108.913 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.429 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -119.27 113.23 20.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.769 . . . . 0.0 110.176 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.508 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 67.4 p -106.76 -141.18 0.37 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 0.0 109.88 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.79 -31.39 71.59 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.798 -1.189 . . . . 0.0 111.092 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -73.45 -58.55 3.23 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' B' ' 37' ' ' GLN . 15.4 mt-30 -67.55 -38.51 84.26 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.781 -1.2 . . . . 0.0 109.721 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' B' ' 44' ' ' ASP . 5.7 mm -61.07 -52.66 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' B' ' 42' ' ' ILE . 54.3 tp -37.81 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.151 -0.343 . . . . 0.0 110.826 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' B' ' 42' ' ' ILE . 90.7 m-20 -125.11 -24.76 3.95 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.732 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.0 tm? -59.77 -39.95 86.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.014 -1.679 . . . . 0.0 106.898 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.653 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.5 m -85.86 -63.81 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 109.065 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.823 ' O ' ' N ' ' B' ' 49' ' ' VAL . 2.5 p -40.03 -15.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.777 -0.577 . . . . 0.0 110.535 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.72 64.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.289 1.042 . . . . 0.0 109.986 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.823 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.4 p 169.89 -33.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.16 160.02 33.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.67 93.56 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.47 2.113 . . . . 0.0 111.731 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -45.67 165.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 109.4 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.38 -47.46 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.25 -0.906 . . . . 0.0 110.256 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.487 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 79.5 m-20 -126.54 142.37 51.56 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.49 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 24.9 tp -130.8 129.65 42.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -138.09 134.65 34.94 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.109 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 4.7 tpp -126.54 132.51 51.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.734 -0.603 . . . . 0.0 109.445 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 75.2 mtm -151.77 155.96 39.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.472 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.424 ' O ' ' HD3' ' B' ' 61' ' ' PRO . 0.0 OUTLIER -117.86 -177.07 3.17 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 41.1 p-10 -100.7 102.28 18.71 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 110.933 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 37.3 Cg_endo -89.36 -59.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.429 2.086 . . . . 0.0 110.738 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -81.49 -50.23 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.512 -0.743 . . . . 0.0 109.048 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 48.0 p -57.64 -44.35 85.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 109.522 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.441 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 70.03 24.63 76.38 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.539 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 46.4 mmm-85 -118.38 -68.23 0.93 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -1.104 . . . . 0.0 110.277 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD1' ' B' ' 69' ' ' TYR . 0.2 OUTLIER -58.52 118.88 6.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 110.343 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -79.88 -74.25 0.31 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 108.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -117.41 80.54 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . 0.534 ' CD1' ' CB ' ' B' ' 66' ' ' SER . 4.9 m-85 -92.38 132.13 36.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.012 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.0 141.18 31.31 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.522 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' B' ' 71' ' ' PHE . 2.8 m-85 -114.88 122.92 47.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 109.229 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.69 102.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.866 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.487 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 46.5 mt-10 -80.48 128.37 33.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.789 -1.194 . . . . 0.0 111.123 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -93.54 174.22 7.3 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.68 0.752 . . . . 0.0 110.793 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 81.4 mtt-85 -50.5 -41.32 53.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.717 -0.614 . . . . 0.0 110.56 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.77 178.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -39.81 -19.0 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.566 -0.709 . . . . 0.0 110.392 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.1 tt0 -71.74 -74.69 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.69 -1.256 . . . . 0.0 108.733 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 43.3 m -60.37 -40.5 91.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -34.64 76.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.501 -0.749 . . . . 0.0 109.282 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -61.77 -59.82 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 24.5 t -64.74 -36.83 85.57 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.72 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.09 -64.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 109.988 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' B' ' 88' ' ' ASN . 35.0 t -51.75 -39.29 23.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.018 -1.051 . . . . 0.0 109.627 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . 0.462 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmp_? -69.28 -48.52 61.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.885 -1.134 . . . . 0.0 109.697 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.88 -48.0 15.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.057 . . . . 0.0 109.669 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' B' ' 83' ' ' ALA . 59.4 mt -93.85 27.91 2.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -54.91 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.48 121.04 2.19 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -136.27 142.67 43.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.513 -1.58 . . . . 0.0 108.796 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . 0.597 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -27.25 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.609 0.719 . . . . 0.0 111.06 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.7 tt -151.44 128.23 10.92 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.696 -0.627 . . . . 0.0 109.309 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' B' ' 92' ' ' LEU . . . 46.36 -175.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 37.4 t -66.02 -17.15 64.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.008 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.456 ' CG ' ' OG ' ' B' ' 32' ' ' SER . 24.5 mmt180 -134.67 149.81 50.56 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.133 -0.98 . . . . 0.0 109.58 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.9 m-85 -103.5 142.77 33.7 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.293 0.568 . . . . 0.0 110.388 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -39.93 151.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -134.87 170.05 16.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.262 -0.899 . . . . 0.0 110.2 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 2.3 p -73.33 -176.08 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.355 -0.841 . . . . 0.0 109.245 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' B' ' 29' ' ' TYR . . . 160.3 177.14 33.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.614 ' O ' ' N ' ' B' ' 103' ' ' SER . 21.8 p90 -149.15 -3.08 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.053 -1.263 . . . . 0.0 111.065 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' SER . . . . . 0.565 ' H ' ' HH ' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -35.57 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.227 -0.921 . . . . 0.0 110.602 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' SER . . . . . 0.717 ' HG ' HH12 ' B' ' 26' ' ' ARG . 17.2 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 120.981 -1.075 . . . . 0.0 109.509 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 158' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 99.9 p . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . 0.592 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER 170.35 -26.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . 0.492 ' NZ ' ' CD1' ' C' ' 204' ' ' PHE . 17.6 tttm -80.97 139.08 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 161' ' ' MET . . . . . 0.507 ' SD ' ' CG1' ' C' ' 216' ' ' VAL . 2.3 ttp -121.32 165.57 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -138.36 77.93 1.65 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.497 -0.752 . . . . 0.0 110.192 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 49.6 mt -54.19 141.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -137.04 168.51 24.3 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.435 ' H ' ' NH2' ' C' ' 200' ' ' ARG . . . 66.72 31.35 78.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' C' ' 166' ' ' LEU . 7.6 mp -68.26 172.25 6.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 108.046 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' C' ' 168' ' ' TRP . 1.6 t-20 -67.79 -73.23 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.929 -1.107 . . . . 0.0 108.421 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . 0.472 ' N ' ' OD1' ' C' ' 167' ' ' ASN . 0.0 OUTLIER 178.72 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.32 178.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . 0.588 ' OD1' ' NZ ' ' C' ' 192' ' ' LYS . 68.5 t0 -135.73 92.34 2.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.892 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 86.6 m -125.8 143.53 51.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.459 -0.775 . . . . 0.0 109.2 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 172.7 8.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.602 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -79.06 -71.27 0.45 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.924 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' C' ' 174' ' ' ASN . 90.0 m-20 -40.24 -72.37 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . 0.543 ' C ' ' O ' ' C' ' 173' ' ' ASP . 0.1 OUTLIER -34.7 -44.57 0.22 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.98 -57.97 9.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 109.779 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' C' ' 178' ' ' TYR . 7.4 ptm180 -67.28 -54.11 23.81 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . 0.513 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -38.51 -30.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.108 -0.995 . . . . 0.0 108.394 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' C' ' 176' ' ' ARG . 20.4 t80 -86.94 -40.19 15.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 110.143 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' C' ' 176' ' ' ARG . 25.8 m-85 -90.94 16.75 8.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.139 -0.976 . . . . 0.0 111.149 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.36 25.74 24.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -102.77 10.87 38.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . 0.488 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 90.3 m-85 -109.62 -77.0 0.6 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.19 -122.09 2.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 38.9 m -124.17 139.94 53.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.556 -0.967 . . . . 0.0 109.416 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.434 HG21 HH21 ' C' ' 176' ' ' ARG . 35.8 m -112.17 139.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 186' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' C' ' 187' ' ' ASP . 11.1 t -105.2 -38.08 6.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.05 -1.031 . . . . 0.0 110.116 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . 0.416 ' N ' ' CG2' ' C' ' 186' ' ' THR . 17.5 t70 -163.43 166.17 23.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' C' ' 188' ' ' LEU . 1.8 pt? -161.59 150.8 16.15 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 0.0 108.921 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -124.0 141.66 51.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 109.091 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.1 tt -166.61 107.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.059 -1.026 . . . . 0.0 108.392 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 191' ' ' MET . . . . . 0.477 ' O ' ' C ' ' C' ' 192' ' ' LYS . 5.2 ptp -115.83 71.45 0.78 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . 0.588 ' NZ ' ' OD1' ' C' ' 169' ' ' ASP . 4.0 pttt -39.25 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.287 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' C' ' 195' ' ' ALA . 4.8 t0 -147.58 106.53 3.77 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -48.31 -5.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' C' ' 193' ' ' ASP . . . -103.47 -85.61 0.45 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 10.2 t -103.46 -41.57 5.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 109.764 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' C' ' 168' ' ' TRP . . . 127.35 13.43 2.87 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -98.27 86.92 3.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 109.711 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 199' ' ' SER . . . . . 0.624 ' O ' ' N ' ' C' ' 201' ' ' GLY . 42.7 t -161.48 149.23 15.06 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' C' ' 201' ' ' GLY . 47.2 tpt85 -42.53 90.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.14 138.15 21.53 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.538 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . 0.443 ' CD2' ' O ' ' C' ' 200' ' ' ARG . 1.1 p90 -138.84 169.47 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -130.78 130.61 6.18 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.142 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . 0.492 ' CD1' ' NZ ' ' C' ' 160' ' ' LYS . 48.7 m-85 -107.33 95.97 6.08 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.02 106.38 18.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.5 t -77.48 77.35 4.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.395 -0.816 . . . . 0.0 109.531 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . 0.592 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 34.5 m-85 -71.69 107.52 4.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 109.927 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.73 -39.8 81.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -85.25 105.09 5.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.744 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.08 -28.73 20.07 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.744 1.629 . . . . 0.0 112.997 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.545 ' O ' ' N ' ' C' ' 213' ' ' VAL . 83.9 p -68.18 -57.76 5.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.986 -1.072 . . . . 0.0 110.383 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.441 ' C ' ' O ' ' C' ' 211' ' ' SER . 91.2 p -40.81 -22.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.862 . . . . 0.0 109.955 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 211' ' ' SER . 97.1 t -70.4 -37.78 71.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 108.939 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.8 t0 -57.91 -48.86 78.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 109.813 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.13 -36.83 77.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.894 -1.129 . . . . 0.0 109.611 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . 0.507 ' CG1' ' SD ' ' C' ' 161' ' ' MET . 84.2 t -56.14 -46.85 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.767 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 25.2 m -78.13 -36.79 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.027 . . . . 0.0 110.102 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -67.14 -50.55 60.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 0.0 109.868 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -73.04 144.85 46.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.688 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -98.66 138.28 36.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.695 ' CD2' ' N ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -136.46 150.24 48.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.99 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.57 89.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 27.0 tp -58.44 -56.68 19.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.697 -0.627 . . . . 0.0 111.17 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.46 13.9 29.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.087 -1.008 . . . . 0.0 108.598 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 75.54 26.69 64.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.589 -2.205 . . . . 0.0 107.589 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . 0.409 ' HD3' HD21 ' C' ' 167' ' ' ASN . 0.1 OUTLIER -101.9 -154.25 0.48 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 t -121.41 94.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 109.329 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 30.1 pt -105.27 149.59 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' C' ' 231' ' ' LYS . 0.4 OUTLIER -124.17 100.17 36.48 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 0.0 109.813 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -74.87 131.11 14.07 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.981 1.787 . . . . 0.0 111.244 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' C' ' 229' ' ' ASP . 19.4 mttm -149.91 151.08 32.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -62.07 149.09 42.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.72 . . . . 0.0 109.265 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.72 29.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.045 . . . . 0.0 109.123 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.11 116.68 32.46 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.32 159.05 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.237 1.958 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.701 ' HE ' ' N ' ' C' ' 236' ' ' ARG . 0.2 OUTLIER -57.44 -52.14 66.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.414 -0.804 . . . . 0.0 110.343 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' C' ' 241' ' ' LYS . 90.9 m-20 -61.44 -41.68 97.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.12 -39.55 95.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.692 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -62.83 -41.36 99.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.974 -1.079 . . . . 0.0 108.613 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.85 -22.31 31.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.788 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' C' ' 237' ' ' ASP . 48.9 tttm -54.64 -16.81 2.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 0.0 110.302 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 10.2 p -102.36 162.6 12.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.893 -1.129 . . . . 0.0 109.449 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.87 154.08 17.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -129.92 126.61 38.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.056 -1.261 . . . . 0.0 109.972 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . 0.44 HG23 HD11 ' C' ' 245' ' ' ILE . 0.1 OUTLIER -117.33 138.55 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.765 0.793 . . . . 0.0 108.895 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . 0.556 ' C ' ' CD1' ' C' ' 246' ' ' PHE . 0.4 OUTLIER -80.56 161.28 24.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.458 0.647 . . . . 0.0 109.51 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . 0.546 ' N ' ' CD1' ' C' ' 246' ' ' PHE . 39.8 t -134.85 132.69 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.66 152.4 18.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 61.73 120.17 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.87 165.82 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -1.096 . . . . 0.0 108.743 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -47.07 145.71 4.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.31 -49.38 10.34 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.906 1.737 . . . . 0.0 112.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -122.14 33.87 5.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.741 . . . . 0.0 109.387 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 2.5 p -44.97 141.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -110.71 158.37 35.79 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.24 -30.66 81.81 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.35 2.033 . . . . 0.0 111.169 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -51.56 -62.64 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . 0.704 ' O ' ' N ' ' C' ' 261' ' ' GLU . 0.0 OUTLIER -62.57 -87.71 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . 0.631 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.3 t80 -9.03 -70.39 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 121.441 0.639 . . . . 0.0 110.942 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' C' ' 258' ' ' GLU . 85.0 tt0 -56.06 -44.14 78.59 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.271 0.558 . . . . 0.0 110.39 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . 0.704 ' N ' ' O ' ' C' ' 258' ' ' GLU . 46.4 tp10 -68.53 -41.93 79.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' C' ' 263' ' ' PHE . 42.1 t80 -54.69 -77.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.924 -0.485 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.611 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 61.3 m-85 -42.04 -48.77 4.69 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.706 -1.246 . . . . 0.0 110.24 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.0 OUTLIER -35.26 -37.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' C' ' 263' ' ' PHE . 1.7 pp0? -55.86 -7.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.0 113.246 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.611 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.2 p90 -146.35 -53.42 0.25 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.86 -1.775 . . . . 0.0 111.318 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . 0.597 ' N ' ' CD1' ' C' ' 266' ' ' TRP . . . -83.83 -178.52 51.82 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 268' ' ' THR . . . . . 0.56 ' O ' ' C ' ' C' ' 269' ' ' ILE . 34.1 p -102.19 9.5 40.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.924 -1.339 . . . . 0.0 111.706 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . 0.56 ' C ' ' O ' ' C' ' 268' ' ' THR . 0.9 OUTLIER -16.45 104.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.264 0.938 . . . . 0.0 112.98 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.6 mm -92.74 -33.11 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' C' ' 272' ' ' ALA . 88.0 m-20 -115.19 17.72 16.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.42 -0.8 . . . . 0.0 110.457 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . 0.551 ' C ' ' O ' ' C' ' 271' ' ' ASP . . . -25.92 130.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.998 -0.438 . . . . 0.0 110.275 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' C' ' 288' ' ' PHE . 14.0 pt20 -152.52 132.5 13.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.695 -1.253 . . . . 0.0 111.64 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . 0.481 ' CD2' ' O ' ' C' ' 274' ' ' LEU . 0.3 OUTLIER -126.58 152.46 46.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 275' ' ' MET . . . . . 0.44 ' C ' ' OG ' ' C' ' 283' ' ' SER . 17.8 mmt -88.54 168.44 12.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.651 -1.281 . . . . 0.0 109.872 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.639 ' N ' ' CD1' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -144.59 176.98 9.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.788 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -78.71 -35.78 44.39 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 110.39 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -56.31 -36.43 68.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.062 -1.024 . . . . 0.0 109.789 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -53.55 -52.43 59.73 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.668 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 1.1 t 178.83 0.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' C' ' 283' ' ' SER . . . 102.47 9.07 42.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.41 ' O ' ' CE2' ' C' ' 286' ' ' PHE . 50.7 mm-40 -77.42 23.27 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -1.03 . . . . 0.0 109.958 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 283' ' ' SER . . . . . 0.532 ' OG ' ' CA ' ' C' ' 276' ' ' LEU . 3.0 m -107.44 59.07 0.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.434 -0.792 . . . . 0.0 109.798 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.77 -27.69 19.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 108.618 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 143.29 17.37 0.25 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' C' ' 286' ' ' PHE . 46.1 p90 -108.55 176.77 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.42 178.17 39.1 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . 0.402 ' O ' ' O ' ' C' ' 273' ' ' GLN . 73.7 m-85 -147.55 156.31 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.325 -1.691 . . . . 0.0 109.676 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.51 152.11 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.042 -1.036 . . . . 0.0 108.626 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.65 120.09 28.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . 0.485 ' CE1' ' CG2' ' C' ' 269' ' ' ILE . 93.9 m-85 -109.18 136.69 48.25 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.82 -50.67 72.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.592 -1.317 . . . . 0.0 109.381 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 75.4 m -93.54 169.38 10.39 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.309 -0.869 . . . . 0.0 108.89 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -103.54 -9.81 18.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.67 -46.24 74.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.01 76.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.807 . . . . 0.0 109.049 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 67.9 t -62.53 -61.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -56.11 -29.17 60.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 109.135 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -62.94 -60.8 2.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.58 ' CG2' HD22 ' C' ' 303' ' ' ASN . 14.4 p -63.06 -27.89 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.647 -0.658 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . 0.496 ' C ' ' O ' ' C' ' 300' ' ' VAL . 65.1 m -45.27 -49.37 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -46.13 -32.83 3.14 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.872 -0.518 . . . . 0.0 109.654 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.766 ' ND2' ' O ' ' C' ' 303' ' ' ASN . 1.0 OUTLIER -101.5 81.77 2.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -72.62 -14.98 61.73 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.64 -1.913 . . . . 0.0 108.739 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -126.05 122.28 35.38 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . 0.566 ' CG1' ' ND2' ' C' ' 303' ' ' ASN . 82.7 mt -117.18 149.87 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.13 96.69 10.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.624 ' O ' ' C ' ' C' ' 309' ' ' LYS . 34.7 t80 -104.32 -176.65 3.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.776 ' O ' ' N ' ' C' ' 311' ' ' ARG . 71.2 mttt -25.26 133.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' C' ' 309' ' ' LYS . 23.8 t70 -17.79 69.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.405 0.622 . . . . 0.0 112.057 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . 0.776 ' N ' ' O ' ' C' ' 309' ' ' LYS . 54.1 ttm-85 177.98 109.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 153.12 4.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.064 . . . . 0.0 108.742 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.88 153.31 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.104 -0.997 . . . . 0.0 108.972 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -116.04 121.41 42.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 109.791 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 2.0 mm -88.84 154.9 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -160.96 159.94 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.165 -0.959 . . . . 0.0 108.421 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -71.92 150.75 43.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.81 -1.181 . . . . 0.0 109.175 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.24 -0.7 10.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.842 -1.161 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.778 . . . . 0.0 109.929 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.59 ' OD1' ' CE2' ' B' ' 101' ' ' TYR . 2.4 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.464 0.649 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.01 154.47 70.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.936 2.424 . . . . 0.0 112.255 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.24 3.39 4.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.719 2.28 . . . . 0.0 112.315 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -154.3 133.42 12.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.93 . . . . 0.0 109.276 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -43.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.0 109.333 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' B' ' 100' ' ' GLY . 2.7 t -119.81 151.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -142.44 134.41 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.66 -1.275 . . . . 0.0 107.994 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -129.36 155.57 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 110.475 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.24 147.93 44.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -123.39 -45.13 0.29 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.04 87.51 6.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.964 -1.315 . . . . 0.0 109.706 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.439 ' N ' HD13 ' B' ' 33' ' ' ILE . 3.4 mp -143.44 126.81 9.08 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 108.886 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' B' ' 36' ' ' ASP . 39.3 Cg_endo -73.43 155.85 50.44 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.451 1.434 . . . . 0.0 111.583 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.607 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 8.2 m-85 -60.24 5.85 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 109.621 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.2 m-20 -61.51 -41.93 98.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.048 -1.032 . . . . 0.0 108.584 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.536 ' CD ' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -125.4 112.04 15.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.39 -0.819 . . . . 0.0 109.57 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -107.45 -143.19 0.38 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.379 -0.826 . . . . 0.0 110.963 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 21.7 pt-20 -65.97 -29.19 69.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.815 -1.178 . . . . 0.0 110.955 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -64.0 -54.78 28.91 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.882 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.536 HE21 ' CD ' ' B' ' 37' ' ' GLN . 6.0 tt0 -69.52 -48.11 61.6 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 110.359 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' B' ' 44' ' ' ASP . 6.5 mm -56.76 -54.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' B' ' 39' ' ' GLU . 41.4 tp -36.9 -20.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.2 t0 -124.02 -22.22 4.88 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.178 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.579 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 3.4 tm? -61.6 -37.59 84.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.165 -1.584 . . . . 0.0 107.94 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' B' ' 48' ' ' ASN . 86.6 m -92.77 -63.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.95 -1.093 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.412 ' C ' ' O ' ' B' ' 46' ' ' CYS . 17.6 t -37.76 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.806 -0.559 . . . . 0.0 110.788 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' B' ' 46' ' ' CYS . 5.9 p30 -71.38 -59.05 2.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.784 -1.198 . . . . 0.0 109.844 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.568 ' N ' ' OD1' ' B' ' 48' ' ' ASN . 0.9 OUTLIER -42.37 -51.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.714 -0.616 . . . . 0.0 110.207 -178.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.426 ' N ' HG12 ' B' ' 49' ' ' VAL . . . -157.22 167.63 33.94 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.21 131.06 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.905 1.737 . . . . 0.0 111.495 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.584 ' CG1' ' N ' ' B' ' 53' ' ' ILE . 0.9 OUTLIER -99.66 -172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.328 -0.857 . . . . 0.0 108.998 -178.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.584 ' N ' ' CG1' ' B' ' 52' ' ' VAL . 24.0 mm -142.86 -44.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 86.8 m-20 -149.52 155.53 40.5 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.662 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 tp -146.61 130.23 16.94 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.444 ' CG ' ' SD ' ' B' ' 58' ' ' MET . 43.1 tptt -145.81 116.54 7.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.671 -1.268 . . . . 0.0 110.143 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.46 130.41 35.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 109.297 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' MET . . . . . 0.447 ' O ' ' O ' ' B' ' 69' ' ' TYR . 2.3 mpp? -141.3 144.18 34.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.112 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.607 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 14.0 m-85 -98.89 -179.15 4.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.513 ' OD1' ' CG2' ' B' ' 63' ' ' THR . 0.4 OUTLIER -117.1 69.86 5.24 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.497 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -68.17 -61.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.916 2.411 . . . . 0.0 113.281 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -64.08 -40.94 97.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -0.829 . . . . 0.0 110.818 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.513 ' CG2' ' OD1' ' B' ' 60' ' ' ASP . 7.8 p -70.84 -43.38 68.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.69 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.61 -2.45 85.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -1.08 . . . . 0.0 110.016 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' B' ' 60' ' ' ASP . 0.1 OUTLIER -177.24 -161.94 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.927 -1.108 . . . . 0.0 111.11 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.463 ' HA ' ' H ' ' B' ' 60' ' ' ASP . 29.8 mttm -144.62 38.15 1.23 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 109.913 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.27 63.3 0.5 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.88 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . 0.468 ' CE2' ' OD2' ' B' ' 60' ' ' ASP . 66.4 m-85 -116.8 123.57 47.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.279 -1.13 . . . . 0.0 109.498 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 135.9 36.59 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.296 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.79 125.35 50.89 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.516 0.674 . . . . 0.0 111.549 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.87 153.01 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 81.7 tt0 -133.48 136.51 45.16 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -103.0 169.76 8.37 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.035 0.921 . . . . 0.0 111.583 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 51.6 ttt85 -55.52 -42.37 74.45 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.841 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 159.64 -176.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.502 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 3.8 mm? -38.77 -21.73 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.852 -0.53 . . . . 0.0 110.313 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.3 mt-10 -70.28 -79.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.9 t -62.57 -36.62 83.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.5 t -62.82 -37.75 88.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -60.31 -58.16 9.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.409 -1.432 . . . . 0.0 108.534 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.3 t -64.58 -34.19 77.68 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.415 0.626 . . . . 0.0 111.995 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -84.23 -58.26 2.83 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.932 -1.105 . . . . 0.0 110.596 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.491 ' O ' ' CG ' ' B' ' 88' ' ' ASN . 58.7 t -53.59 -40.74 43.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 120.331 -1.481 . . . . 0.0 108.561 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -69.63 -46.9 65.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.826 -1.171 . . . . 0.0 109.782 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' B' ' 88' ' ' ASN . 73.7 m-20 -88.07 -59.48 2.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.851 -1.155 . . . . 0.0 109.006 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.69 ' N ' ' O ' ' B' ' 83' ' ' ALA . 11.8 tp -73.85 32.11 0.08 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -71.85 -73.07 0.2 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.029 -1.044 . . . . 0.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.07 120.96 2.22 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -138.43 141.1 39.54 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.45 -1.617 . . . . 0.0 107.294 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.8 mm-40 -31.16 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.781 0.8 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' B' ' 90' ' ' TYR . 20.8 tp -152.16 117.78 5.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.42 -168.9 48.0 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -11.94 59.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.028 -1.278 . . . . 0.0 108.872 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -134.44 155.24 50.68 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' B' ' 97' ' ' LEU . 6.8 m-85 -97.09 134.17 40.78 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.27 -0.894 . . . . 0.0 109.207 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -29.21 136.91 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.505 0.669 . . . . 0.0 111.084 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -112.76 126.81 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 109.054 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 14.7 p -89.27 129.96 35.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 111.168 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -130.8 -168.16 12.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.59 ' CE2' ' OD1' ' B' ' 22' ' ' ASN . 38.5 p90 -137.49 161.36 36.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.682 -0.893 . . . . 0.0 109.076 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 26.9 t -179.24 92.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.438 -0.789 . . . . 0.0 108.945 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 -179.54 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 158' ' ' SER . . . . . 0.536 ' C ' ' H ' ' C' ' 160' ' ' LYS . 28.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . 0.409 ' CB ' ' O ' ' C' ' 209' ' ' LYS . 27.4 p -72.42 28.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.741 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' C' ' 158' ' ' SER . 38.7 tttt -104.51 134.81 47.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.545 -0.722 . . . . 0.0 109.997 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 8.3 ptm -118.26 159.26 23.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -0.842 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' C' ' 163' ' ' ILE . 44.3 t80 -122.83 77.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 110.29 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' C' ' 162' ' ' PHE . 0.6 OUTLIER -50.11 140.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -139.11 166.66 25.39 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' C' ' 227' ' ' VAL . . . 53.91 24.51 27.15 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . 0.493 ' CD2' ' O ' ' C' ' 201' ' ' GLY . 1.7 pp -75.06 162.37 28.61 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.362 -1.081 . . . . 0.0 110.653 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.483 ' O ' ' CD1' ' C' ' 166' ' ' LEU . 63.5 t30 -75.29 123.98 26.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.025 -1.047 . . . . 0.0 109.528 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' C' ' 167' ' ' ASN . 3.2 m0 -37.52 -39.28 0.3 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 111.054 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.7 84.41 7.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.694 -1.253 . . . . 0.0 110.94 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 170' ' ' THR . . . . . 0.405 ' O ' ' CD1' ' C' ' 190' ' ' ILE . 57.9 m -146.18 133.82 21.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.991 . . . . 0.0 109.368 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 171' ' ' THR . . . . . 0.445 ' O ' ' C ' ' C' ' 172' ' ' GLU . 1.4 m -124.33 138.92 54.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.343 -0.848 . . . . 0.0 109.128 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' C' ' 175' ' ' LEU . 0.5 OUTLIER -39.38 -72.99 0.05 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.138 -0.976 . . . . 0.0 110.744 -178.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' C' ' 172' ' ' GLU . 53.9 t0 -38.68 -39.46 0.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.542 -0.724 . . . . 0.0 110.139 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -76.51 -44.22 36.05 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' C' ' 172' ' ' GLU . 0.9 OUTLIER -53.1 -54.05 41.27 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' C' ' 179' ' ' PHE . 5.6 ptm180 -68.81 -55.54 10.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.43 -1.308 . . . . 0.0 108.534 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' C' ' 176' ' ' ARG . 84.6 tt0 -35.94 -33.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' C' ' 176' ' ' ARG . 21.1 t80 -91.93 -31.14 15.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.724 . . . . 0.0 110.564 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' C' ' 176' ' ' ARG . 6.0 m-85 -95.49 15.92 18.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.84 -1.163 . . . . 0.0 110.832 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.67 29.57 2.63 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' C' ' 179' ' ' PHE . 0.5 OUTLIER -116.57 22.79 12.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -1.079 . . . . 0.0 109.195 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . 0.609 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 99.2 m-85 -127.91 -3.84 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.486 -0.759 . . . . 0.0 109.628 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 151.33 -126.19 2.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 2.9 t -131.58 149.7 52.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -1.077 . . . . 0.0 108.844 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 86.0 t -103.25 134.42 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.915 . . . . 0.0 109.663 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 53.0 p -122.3 -29.51 4.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.378 -0.826 . . . . 0.0 110.562 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -153.9 150.51 28.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 109.62 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 1.2 pp -171.93 154.84 3.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.588 -1.32 . . . . 0.0 110.111 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -140.35 118.52 11.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 108.337 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . 0.411 HG23 ' N ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -141.11 148.66 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.777 -1.202 . . . . 0.0 110.33 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 9.8 mtt -121.63 174.13 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 140.05 1.13 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.523 -1.361 . . . . 0.0 109.118 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' C' ' 193' ' ' ASP . 0.0 OUTLIER -74.9 143.46 78.02 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.069 -1.019 . . . . 0.0 110.045 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.74 -40.73 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.946 1.764 . . . . 0.0 110.994 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . 178.93 -39.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.566 -0.709 . . . . 0.0 109.771 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 50.1 p -123.4 5.44 9.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' C' ' 198' ' ' ARG . . . -105.03 42.64 1.85 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' C' ' 197' ' ' GLY . 49.6 mtm180 -41.91 133.73 2.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -1.109 . . . . 0.0 109.63 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 199' ' ' SER . . . . . . . . . . . . . 23.0 t -154.67 167.04 31.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.55 ' NE ' ' N ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -59.94 92.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . 0.493 ' O ' ' CD2' ' C' ' 166' ' ' LEU . . . -83.11 93.13 1.68 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -109.14 154.54 22.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -115.6 134.09 11.31 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.522 -1.799 . . . . 0.0 110.087 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -114.14 91.44 3.63 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.23 111.87 24.17 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.175 -0.953 . . . . 0.0 110.442 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 7.7 t -106.61 135.6 47.85 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -104.43 -121.41 0.21 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -141.05 -14.25 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.188 -1.57 . . . . 0.0 108.867 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.51 ' HZ2' ' CB ' ' C' ' 209' ' ' LYS . 7.6 mtmp? -130.0 170.45 10.98 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -97.66 -11.82 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.638 2.225 . . . . 0.0 112.481 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.587 ' O ' ' N ' ' C' ' 213' ' ' VAL . 15.1 m -68.58 -61.64 1.74 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.924 -1.11 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.445 ' C ' ' O ' ' C' ' 211' ' ' SER . 42.8 m -40.64 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -0.763 . . . . 0.0 109.873 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' C' ' 211' ' ' SER . 84.0 t -73.64 -35.79 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.754 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -63.83 -49.32 73.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.75 . . . . 0.0 110.409 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' C' ' 215' ' ' GLU . 0.0 OUTLIER -69.04 -42.7 76.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.797 -1.189 . . . . 0.0 108.674 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . . . . . . . . . 4.8 t -51.55 -47.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.551 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.7 -36.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -77.93 8.95 3.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.786 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 18.0 m -129.38 142.95 50.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.879 . . . . 0.0 108.762 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.95 136.27 45.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.656 ' CD2' ' N ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -131.18 153.01 49.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.726 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . 0.628 ' CD1' ' N ' ' C' ' 222' ' ' ILE . 0.0 OUTLIER -117.62 86.85 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.672 0.748 . . . . 0.0 109.102 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.27 -66.75 0.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.855 . . . . 0.0 110.242 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -96.05 8.31 44.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.665 -1.272 . . . . 0.0 109.401 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 81.95 14.88 76.4 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . 0.582 ' CA ' ' HZ3' ' C' ' 226' ' ' LYS . 0.0 OUTLIER -95.69 -154.39 0.43 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' C' ' 165' ' ' GLY . 7.6 t -115.07 95.91 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 26.3 pt -105.65 136.94 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.78 108.44 53.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.798 . . . . 0.0 109.612 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . 0.427 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 37.2 Cg_endo -81.7 137.33 10.03 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.968 1.779 . . . . 0.0 111.939 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -145.99 159.52 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 234' ' ' ILE . 26.8 ptt-85 -87.61 152.14 22.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.04 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -49.15 99.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 108.761 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 232' ' ' ARG . 4.4 mt -90.76 127.44 52.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.03 149.36 2.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.062 1.841 . . . . 0.0 112.55 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -57.33 -45.83 83.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -59.41 -41.73 90.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 108.704 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -66.3 -36.39 82.83 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.434 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . 0.497 ' O ' ' OG1' ' C' ' 242' ' ' THR . 30.5 tp60 -61.19 -44.82 96.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -73.0 -41.2 64.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.362 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -72.28 -13.93 61.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 111.805 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 242' ' ' THR . . . . . 0.517 ' O ' ' O ' ' C' ' 291' ' ' TYR . 0.9 OUTLIER -47.64 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.525 -1.359 . . . . 0.0 110.284 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . 0.408 ' H ' ' HG1' ' C' ' 242' ' ' THR . . . 107.66 108.76 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -140.72 134.33 30.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.715 -1.462 . . . . 0.0 110.6 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.16 159.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 109.875 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -106.93 131.19 54.29 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.46 132.25 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.652 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.19 148.75 18.26 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.39 72.53 0.87 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.224 -1.162 . . . . 0.0 111.223 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' C' ' 251' ' ' GLY . 19.6 mt -118.34 145.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -1.057 . . . . 0.0 109.096 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' C' ' 250' ' ' ILE . . . -42.66 126.88 4.74 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.29 -40.76 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.822 1.681 . . . . 0.0 112.207 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' C' ' 254' ' ' VAL . 90.5 m-20 -95.17 6.31 49.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.376 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' C' ' 253' ' ' ASP . 10.7 p -42.26 165.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.88 . . . . 0.0 109.982 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . 0.424 ' N ' ' CG2' ' C' ' 254' ' ' VAL . 14.4 mtt180 -137.3 156.76 75.12 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.0 109.052 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.14 -28.14 48.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.467 2.111 . . . . 0.0 111.913 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -52.13 -64.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . 0.718 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.0 tp10 -59.77 -83.2 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.727 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . 0.608 ' C ' ' O ' ' C' ' 258' ' ' GLU . 75.9 t80 -12.67 -70.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.207 0.527 . . . . 0.0 111.45 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.31 -41.77 72.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.431 -0.793 . . . . 0.0 109.691 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . 0.718 ' N ' ' O ' ' C' ' 258' ' ' GLU . 44.3 tp10 -67.46 -46.69 72.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . 0.612 ' O ' ' HG2' ' C' ' 265' ' ' GLN . 60.3 t80 -49.68 -72.32 0.05 Allowed 'General case' 0 C--O 1.193 -1.907 0 O-C-N 121.573 -0.705 . . . . 0.0 110.512 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' C' ' 265' ' ' GLN . 88.4 m-85 -53.59 -45.1 69.89 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.044 -1.035 . . . . 0.0 112.083 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.502 ' C ' ' O ' ' C' ' 263' ' ' PHE . 0.3 OUTLIER -24.07 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.636 ' N ' ' O ' ' C' ' 263' ' ' PHE . 1.0 OUTLIER -48.41 -100.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.762 -1.212 . . . . 0.0 111.042 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.503 ' H ' ' HG3' ' C' ' 265' ' ' GLN . 1.7 p90 -60.77 148.71 38.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 51.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 86.2 m -49.77 141.71 9.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.289 . . . . 0.0 108.558 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -95.41 106.71 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.986 -1.071 . . . . 0.0 110.753 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.13 -55.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.705 -1.247 . . . . 0.0 108.862 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -141.25 102.43 4.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' C' ' 273' ' ' GLN . . . -131.71 157.36 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' C' ' 272' ' ' ALA . 14.6 pt20 168.69 173.31 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.685 1.231 . . . . 0.0 111.796 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.12 148.36 22.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 96.8 mmm -97.71 -172.55 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.448 -1.407 . . . . 0.0 110.933 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 175.29 88.56 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' C' ' 280' ' ' THR . 83.0 m-20 -84.34 47.5 1.35 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' C' ' 277' ' ' ASP . 15.6 pttp -40.41 -33.22 0.24 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -58.41 -37.12 74.68 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.356 -0.937 . . . . 0.0 108.484 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 280' ' ' THR . . . . . 0.597 ' N ' ' O ' ' C' ' 277' ' ' ASP . 0.4 OUTLIER -141.73 -79.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . 0.57 ' N ' ' OG1' ' C' ' 280' ' ' THR . . . -65.27 -165.34 1.26 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.0 tt0 -167.09 158.59 12.34 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.338 -1.095 . . . . 0.0 109.828 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 283' ' ' SER . . . . . 0.41 ' N ' ' HG2' ' C' ' 282' ' ' GLN . 1.0 OUTLIER -61.17 67.59 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.203 0.525 . . . . 0.0 109.774 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' C' ' 282' ' ' GLN . 60.8 ttm-85 -50.07 -24.74 2.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.86 22.93 0.26 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -111.36 173.36 6.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 110.668 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.93 36.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' C' ' 246' ' ' PHE . 21.8 m-85 -143.1 158.45 43.6 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.417 -1.637 . . . . 0.0 109.189 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 19.8 t -141.59 143.94 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.81 -1.181 . . . . 0.0 108.253 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 18.6 m -130.97 128.71 40.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.869 -1.144 . . . . 0.0 109.56 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . 0.517 ' O ' ' O ' ' C' ' 242' ' ' THR . 42.0 m-85 -114.42 143.64 44.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER -62.48 -48.56 79.08 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 293' ' ' SER . . . . . 0.543 ' N ' ' CG ' ' C' ' 292' ' ' ASP . 12.4 m -73.93 132.93 42.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -76.33 -32.7 58.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -50.95 -38.48 50.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.702 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.44 -46.09 83.97 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.99 -56.56 14.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -54.5 -21.39 9.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.585 -0.697 . . . . 0.0 109.79 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -75.07 -60.82 2.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.96 -27.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 109.684 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' C' ' 300' ' ' VAL . 26.8 t -43.74 -57.2 3.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.124 -0.985 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -51.71 -24.09 5.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 108.914 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' C' ' 300' ' ' VAL . 89.1 m-20 -99.55 91.39 4.87 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -75.95 -84.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.558 -1.339 . . . . 0.0 109.218 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -66.59 124.93 24.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 79.8 mt -125.04 139.78 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.42 -0.8 . . . . 0.0 109.305 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -64.62 129.91 41.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.913 . . . . 0.0 109.741 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 87.8 t80 -137.31 171.41 14.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 0.0 110.713 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 31.7 ttmt -32.35 -71.18 0.06 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.115 0.483 . . . . 0.0 111.265 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.16 -71.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.49 -166.36 2.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.079 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -56.37 157.97 4.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.365 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . 0.513 ' O ' ' CG1' ' C' ' 313' ' ' ILE . 2.1 pt -131.85 121.77 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.26 106.9 7.01 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.2 -0.938 . . . . 0.0 110.02 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 2.8 mm -79.71 154.0 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.047 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -157.27 157.49 34.32 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.836 -1.165 . . . . 0.0 109.01 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -67.65 143.88 55.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.668 -1.27 . . . . 0.0 109.254 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -84.92 44.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.006 -1.059 . . . . 0.0 109.939 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.512 ' CB ' ' CD ' ' B' ' 24' ' ' PRO . 26.5 Cg_exo -57.92 -172.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.881 2.387 . . . . 0.0 111.877 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.562 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 52.4 Cg_endo -89.32 23.4 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.02 2.48 . . . . 0.0 112.163 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.29 120.59 5.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.101 -1.0 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.514 ' CA ' ' HG ' ' B' ' 80' ' ' SER . 4.3 ttt85 -179.28 -45.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.425 HG21 ' N ' ' B' ' 28' ' ' VAL . 2.0 p -139.0 158.61 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.081 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.425 ' N ' HG21 ' B' ' 27' ' ' VAL . 7.1 p -120.98 142.16 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.45 ' CZ ' ' HA3' ' B' ' 100' ' ' GLY . 2.9 m-30 -105.32 141.48 36.75 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mt -129.26 117.21 20.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.478 -0.764 . . . . 0.0 110.562 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.434 ' N ' HD12 ' B' ' 33' ' ' ILE . . . -132.95 -23.54 0.77 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.652 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -91.65 71.79 5.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.847 -1.384 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.462 ' N ' HD11 ' B' ' 33' ' ' ILE . 1.2 mp -145.74 125.18 6.81 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 109.829 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.635 ' C ' ' H ' ' B' ' 36' ' ' ASP . 29.7 Cg_endo -73.83 163.0 38.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.07 1.18 . . . . 0.0 109.935 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.451 ' OH ' ' CB ' ' B' ' 59' ' ' PHE . 4.7 m-85 -55.71 3.45 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 109.887 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.635 ' H ' ' C ' ' B' ' 34' ' ' PRO . 85.5 m-20 -66.17 -45.03 82.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.905 -1.122 . . . . 0.0 109.575 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.4 107.52 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -102.45 -153.25 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.466 -0.771 . . . . 0.0 111.53 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.43 ' N ' ' SD ' ' B' ' 57' ' ' MET . 1.1 pp20? -58.2 -23.69 56.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.69 -54.7 12.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.37 -38.76 88.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 110.845 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 24.7 mm -60.2 -51.53 71.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.8 -37.31 73.53 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.495 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 24.0 t70 -55.73 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.909 1.338 . . . . 0.0 109.377 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.436 ' CD2' ' OH ' ' B' ' 90' ' ' TYR . 14.4 tp -52.1 -48.84 64.54 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.417 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' B' ' 49' ' ' VAL . 94.9 m -60.26 -68.07 0.33 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.138 -0.976 . . . . 0.0 109.044 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.58 ' C ' ' H ' ' B' ' 49' ' ' VAL . 85.1 p -31.72 -33.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.979 0.419 . . . . 0.0 110.576 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' B' ' 46' ' ' CYS . 72.9 m-80 -67.25 5.73 0.68 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.948 -1.095 . . . . 0.0 109.234 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 46' ' ' CYS . 65.9 t -111.67 -55.06 4.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' B' ' 52' ' ' VAL . . . 174.63 154.24 10.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 52' ' ' VAL . 51.4 Cg_exo -44.76 80.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.308 2.006 . . . . 0.0 112.194 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' B' ' 50' ' ' GLY . 0.8 OUTLIER -39.37 157.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.828 . . . . 0.0 109.61 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mm -87.56 -60.76 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.193 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.588 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 73.7 m-20 -119.86 126.12 50.18 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.104 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -125.35 126.37 44.93 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -140.81 118.63 11.75 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.017 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' B' ' 39' ' ' GLU . 0.1 OUTLIER -113.41 143.81 43.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.255 0.55 . . . . 0.0 109.901 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' MET . . . . . 0.559 ' C ' ' SD ' ' B' ' 58' ' ' MET . 0.0 OUTLIER -161.54 157.18 24.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.603 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -129.88 149.24 51.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.507 ' HB3' ' N ' ' B' ' 66' ' ' SER . 4.7 p30 -42.87 98.04 0.16 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 111.383 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 42.3 Cg_endo -92.5 -17.58 0.83 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 122.807 2.338 . . . . 0.0 111.54 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -87.42 -65.93 0.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 111.267 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 -34.71 9.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.181 -0.949 . . . . 0.0 111.367 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.465 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 108.07 30.41 3.94 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.043 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.461 ' C ' ' OD2' ' B' ' 60' ' ' ASP . 81.1 mtp180 -93.88 -71.0 0.68 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.297 . . . . 0.0 110.3 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.507 ' N ' ' HB3' ' B' ' 60' ' ' ASP . 25.8 t -43.68 121.92 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -86.86 5.32 37.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.184 -0.948 . . . . 0.0 109.024 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.21 88.89 0.1 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . 0.439 ' CD1' ' OG ' ' B' ' 66' ' ' SER . 1.9 m-85 -105.7 133.33 50.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.53 -0.983 . . . . 0.0 109.782 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.84 146.03 26.9 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.947 -1.095 . . . . 0.0 112.536 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -114.51 130.11 56.72 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.705 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.651 ' N ' ' CD1' ' B' ' 72' ' ' ILE . 1.1 mp -121.93 102.33 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.35 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.588 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 29.4 mt-10 -93.05 136.71 33.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.252 -1.53 . . . . 0.0 110.244 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -98.32 176.53 5.67 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.853 0.835 . . . . 0.0 111.366 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 5.5 ttp180 -48.3 -42.01 29.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.858 -0.526 . . . . 0.0 111.42 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' B' ' 78' ' ' GLU . 3.5 m-20 156.62 -175.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.534 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 2.5 mm? -37.48 -23.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.655 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.8 mm-40 -70.24 -75.98 0.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.862 -1.149 . . . . 0.0 109.822 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 52.0 m -63.54 -40.59 97.41 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.514 ' HG ' ' CA ' ' B' ' 26' ' ' ARG . 25.7 t -58.92 -34.9 72.25 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -65.87 -61.29 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.676 -1.265 . . . . 0.0 109.031 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.602 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 22.0 t -60.21 -42.56 95.42 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.27 -0.894 . . . . 0.0 111.395 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.54 -65.66 0.9 Allowed 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.551 -0.718 . . . . 0.0 111.771 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -52.94 -37.84 27.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.296 -1.362 . . . . 0.0 109.212 -176.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -67.87 -47.47 68.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.365 -1.459 . . . . 0.0 108.382 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' B' ' 82' ' ' SER . 91.2 m-20 -67.5 -42.74 82.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.056 -1.028 . . . . 0.0 109.27 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -106.35 28.72 7.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.333 -0.855 . . . . 0.0 110.084 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.625 ' N ' ' O ' ' B' ' 84' ' ' VAL . 1.2 m-20 -61.51 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.82 -1.175 . . . . 0.0 109.188 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.68 107.77 0.86 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.642 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -134.1 148.81 51.05 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 119.677 1.739 . . . . 0.0 110.917 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -46.25 91.59 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 119.876 -1.765 . . . . 0.0 108.456 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.1 tt -153.2 104.81 2.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.85 -175.39 43.47 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -67.12 -27.36 67.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.248 . . . . 0.0 109.617 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt85 -135.95 163.95 29.09 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.453 ' O ' ' C ' ' B' ' 97' ' ' LEU . 2.3 m-85 -92.69 133.99 35.47 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.31 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.653 ' N ' ' CD1' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -38.94 152.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.263 0.554 . . . . 0.0 109.562 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -108.46 146.84 32.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 109.268 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . 0.571 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.0 OUTLIER -91.9 124.78 36.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 109.781 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' B' ' 29' ' ' TYR . . . -137.17 -175.5 13.85 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.375 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 4.3 p90 -120.82 6.15 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -1.051 . . . . 0.0 110.562 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' SER . . . . . 0.464 ' C ' ' O ' ' B' ' 101' ' ' TYR . 0.6 OUTLIER -39.92 125.05 1.87 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 0.0 109.913 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.241 179.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 1.0 OUTLIER -175.41 39.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.425 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -100.4 102.89 14.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.6 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 71.3 mtp -87.23 133.04 33.71 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.701 -1.199 . . . . 0.0 111.144 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' C' ' 202' ' ' PHE . 76.9 t80 -104.77 90.69 3.56 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . 0.421 HD12 HG21 ' C' ' 163' ' ' ILE . 5.6 mm -59.99 127.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' C' ' 165' ' ' GLY . . . -130.34 -177.2 14.75 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' C' ' 164' ' ' GLY . . . 42.84 41.1 4.33 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 13.5 mt -83.96 170.84 13.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -1.041 . . . . 0.0 109.725 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.478 ' O ' ' OD1' ' C' ' 167' ' ' ASN . 39.9 p-10 -85.45 140.21 30.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -48.95 -27.85 3.43 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.676 -1.265 . . . . 0.0 110.018 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . 0.444 ' O ' ' ND2' ' C' ' 167' ' ' ASN . 58.3 t0 -90.49 102.43 15.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.978 -1.076 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 33.0 m -147.2 144.51 28.98 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.46 173.5 6.38 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.222 -0.924 . . . . 0.0 109.142 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . 0.483 ' OE2' ' NZ ' ' C' ' 192' ' ' LYS . 11.5 mp0 -84.18 -77.04 0.28 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.799 -1.188 . . . . 0.0 109.587 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' C' ' 176' ' ' ARG . 49.5 t0 -49.08 -55.45 12.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.629 -1.295 . . . . 0.0 108.388 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' C' ' 173' ' ' ASP . 64.2 t30 -43.23 -53.18 5.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.93 -35.19 70.75 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.215 -0.928 . . . . 0.0 108.994 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' C' ' 178' ' ' TYR . 67.5 ttp85 -70.98 -63.52 1.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 108.904 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' C' ' 176' ' ' ARG . 77.3 mm-40 -43.78 -25.91 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' C' ' 176' ' ' ARG . 34.1 t80 -76.37 -47.05 24.69 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.557 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 176' ' ' ARG . 26.2 m-85 -95.7 15.85 18.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.257 -0.902 . . . . 0.0 111.655 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.17 14.44 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -106.13 9.73 32.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -1.077 . . . . 0.0 108.228 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . 0.521 ' HH ' ' CG2' ' C' ' 219' ' ' THR . 19.8 m-85 -121.61 -4.25 9.27 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 144.12 -134.69 5.86 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -126.69 145.65 50.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -1.041 . . . . 0.0 109.297 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.76 134.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 186' ' ' THR . . . . . 0.519 ' H ' ' HG1' ' C' ' 186' ' ' THR . 0.1 OUTLIER -78.52 -61.47 2.0 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.985 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . 0.589 ' OD2' ' NZ ' ' C' ' 189' ' ' LYS . 0.3 OUTLIER -121.22 84.79 2.29 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.329 1.061 . . . . 0.0 112.021 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 7.1 tt -81.28 107.03 13.73 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . 0.589 ' NZ ' ' OD2' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -121.31 96.13 4.96 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.22 -0.925 . . . . 0.0 110.893 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . 0.562 ' O ' ' SD ' ' C' ' 191' ' ' MET . 0.0 OUTLIER -107.8 141.13 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 191' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' C' ' 190' ' ' ILE . 10.7 mmt -125.33 78.99 1.77 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.059 -1.026 . . . . 0.0 110.647 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . 0.483 ' NZ ' ' OE2' ' C' ' 172' ' ' GLU . 26.1 pttm -79.52 153.77 29.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.107 -0.995 . . . . 0.0 109.305 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 11.9 t0 -52.68 114.69 6.05 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.038 -1.039 . . . . 0.0 108.699 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.01 -21.54 4.02 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.827 1.685 . . . . 0.0 112.661 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -80.18 -86.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.24 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 45.5 p -109.35 -28.63 8.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.212 -0.93 . . . . 0.0 109.677 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 122.28 17.63 3.59 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -90.79 58.47 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.072 -1.252 . . . . 0.0 109.519 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 199' ' ' SER . . . . . 0.477 ' O ' ' C ' ' C' ' 200' ' ' ARG . 39.4 t -142.99 169.83 16.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' C' ' 199' ' ' SER . 19.3 mmt180 -37.06 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.92 92.29 1.49 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.302 -1.427 . . . . 0.0 109.861 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . 0.432 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 48.5 p90 -125.9 155.65 40.92 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.512 -0.993 . . . . 0.0 108.611 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.93 123.11 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.957 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -93.25 86.44 5.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.843 -1.387 . . . . 0.0 107.981 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 33.2 mt -87.49 85.27 7.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.727 -1.233 . . . . 0.0 110.321 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 206' ' ' SER . . . . . 0.475 ' CB ' ' H ' ' C' ' 187' ' ' ASP . 0.1 OUTLIER -65.47 85.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.596 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . 0.534 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 14.5 m-85 -68.08 122.3 17.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.155 -0.966 . . . . 0.0 110.917 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.87 -50.32 36.44 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.788 -0.57 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -83.56 115.19 58.22 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 110.86 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.58 -38.22 44.53 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.186 1.924 . . . . 0.0 112.799 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 86.1 p -64.53 -49.95 69.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.444 ' O ' ' CG2' ' C' ' 216' ' ' VAL . 22.6 t -43.56 -33.21 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 109.224 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.17 -40.44 85.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.168 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' C' ' 211' ' ' SER . 57.6 t0 -59.68 -51.14 71.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.505 -0.747 . . . . 0.0 110.665 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . 0.467 ' O ' ' OG1' ' C' ' 219' ' ' THR . 5.5 pt-20 -68.17 -33.37 74.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' C' ' 212' ' ' SER . 55.8 t -58.97 -47.99 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.009 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.48 -30.04 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.1 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -89.71 21.53 3.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 109.742 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.578 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 41.3 m -129.82 149.43 51.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' C' ' 221' ' ' HIS . 13.1 tt0 -75.92 -177.85 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.125 -0.985 . . . . 0.0 109.392 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' C' ' 220' ' ' GLN . 55.3 m-70 -158.28 130.52 6.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 110.3 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . 0.46 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 24.6 mt -153.35 80.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.737 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 16.5 mt -51.43 -71.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.735 -1.228 . . . . 0.0 109.54 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -101.51 -55.77 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 108.855 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 159.9 30.9 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . 0.76 ' HZ3' ' N ' ' C' ' 279' ' ' ASP . 0.0 OUTLIER -94.1 -76.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.107 -1.231 . . . . 0.0 108.601 178.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' C' ' 226' ' ' LYS . 2.1 t 155.39 90.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 23.2 pt -94.2 152.05 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.34 96.41 44.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.543 -0.723 . . . . 0.0 110.768 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . 0.508 ' CG ' ' CD2' ' C' ' 221' ' ' HIS . 18.9 Cg_endo -81.82 121.51 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.709 2.273 . . . . 0.0 111.645 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -142.52 148.26 37.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 0.0 110.127 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.52 159.36 0.51 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.5 144.28 37.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 38.4 mt -132.6 91.15 31.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.486 -0.759 . . . . 0.0 109.418 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.42 161.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.11 1.873 . . . . 0.0 111.742 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.559 ' CG ' HH11 ' C' ' 236' ' ' ARG . 0.0 OUTLIER -51.57 -49.2 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.975 . . . . 0.0 111.312 -178.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -59.66 -43.28 94.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.845 -1.159 . . . . 0.0 109.824 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -68.36 -36.91 79.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.131 -0.98 . . . . 0.0 110.001 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -61.17 -41.46 96.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.171 -0.956 . . . . 0.0 108.838 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.3 -25.03 31.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.473 -0.767 . . . . 0.0 109.599 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -51.2 -16.11 0.45 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.692 . . . . 0.0 110.432 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 13.9 p -106.38 159.69 15.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.918 -1.113 . . . . 0.0 109.231 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -115.41 154.87 16.67 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . 0.556 ' N ' HH12 ' C' ' 317' ' ' ARG . 0.0 OUTLIER -140.05 147.28 40.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.268 . . . . 0.0 111.235 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.68 154.44 40.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.729 0.776 . . . . 0.0 109.142 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 2.0 t80 -102.19 128.19 48.81 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.75 143.64 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 110.368 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.9 154.21 16.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.0 56.26 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 120.939 -1.33 . . . . 0.0 111.209 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' C' ' 286' ' ' PHE . 1.5 pp -111.26 137.69 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.903 -1.351 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . 0.657 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 157.81 -37.8 0.54 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 50.0 Cg_exo -54.06 -127.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.512 2.142 . . . . 0.0 112.22 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -69.86 19.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 109.681 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' C' ' 252' ' ' PRO . 1.3 m -93.19 137.3 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.918 -1.114 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -103.45 163.07 18.19 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.59 -21.43 70.41 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.46 2.107 . . . . 0.0 111.372 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -62.25 -58.57 7.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.655 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.59 -41.72 86.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' C' ' 263' ' ' PHE . 29.0 t80 -52.6 -63.18 1.23 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.93 -43.43 98.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.911 -0.493 . . . . 0.0 110.28 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.97 -18.83 64.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.093 -1.005 . . . . 0.0 108.979 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . 0.606 ' O ' ' NE2' ' C' ' 265' ' ' GLN . 33.8 t80 -88.95 -77.75 0.37 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.234 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.575 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 43.2 m-85 -43.5 -36.26 1.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.928 -1.107 . . . . 0.0 109.494 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.499 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.8 t -30.72 -40.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.325 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.67 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 0.0 OUTLIER -60.76 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.429 -1.419 . . . . 0.0 110.981 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.67 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.2 OUTLIER -60.15 147.83 38.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.397 -1.439 . . . . 0.0 109.402 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' C' ' 269' ' ' ILE . . . 58.91 86.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 268' ' ' THR . . . . . 0.506 ' O ' ' C ' ' C' ' 269' ' ' ILE . 3.8 t -53.59 43.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.483 -1.01 . . . . 0.0 113.625 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . 0.684 ' N ' ' O ' ' C' ' 267' ' ' GLY . 1.7 tt -13.77 111.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.9 mm -87.2 -33.95 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.439 -1.413 . . . . 0.0 107.81 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.04 99.1 5.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -108.32 132.78 53.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.321 -0.862 . . . . 0.0 109.371 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -160.59 123.56 3.34 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 117.919 -1.512 . . . . 0.0 112.081 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . 0.491 ' CD2' ' C ' ' C' ' 274' ' ' LEU . 0.2 OUTLIER -100.63 155.08 18.08 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 275' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' C' ' 280' ' ' THR . 20.8 mmt -90.08 161.24 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.398 . . . . 0.0 109.619 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' C' ' 280' ' ' THR . 1.0 OUTLIER -126.62 -165.41 1.45 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.494 0.664 . . . . 0.0 109.689 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . 0.454 ' C ' ' OD1' ' C' ' 277' ' ' ASP . 53.5 p30 -97.98 -9.97 25.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.448 -0.782 . . . . 0.0 109.339 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' C' ' 277' ' ' ASP . 49.9 mmtt -60.6 -54.6 43.38 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . 0.76 ' N ' ' HZ3' ' C' ' 226' ' ' LYS . 0.2 OUTLIER 177.51 -6.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.598 -0.689 . . . . 0.0 110.895 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 280' ' ' THR . . . . . 0.717 ' N ' ' HZ2' ' C' ' 226' ' ' LYS . 42.8 p -64.88 -3.14 3.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.446 -1.409 . . . . 0.0 108.708 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' C' ' 279' ' ' ASP . . . 155.04 -119.48 0.93 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.601 ' C ' ' H ' ' C' ' 284' ' ' ARG . 55.9 mt-30 -147.1 129.09 15.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 109.881 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 51.5 p -66.01 15.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 109.518 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . 0.601 ' H ' ' C ' ' C' ' 282' ' ' GLN . 10.1 tpp85 -49.86 -38.15 34.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.86 70.52 0.06 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.448 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' C' ' 250' ' ' ILE . 22.3 p90 -170.58 179.31 3.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.173 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -174.21 -167.48 33.79 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.9 154.51 43.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.471 -1.605 . . . . 0.0 109.465 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' C' ' 291' ' ' TYR . 0.7 OUTLIER -141.55 152.82 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 11.0 m -133.57 126.75 31.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.968 -1.083 . . . . 0.0 110.497 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . 0.46 ' CE2' ' CG2' ' C' ' 289' ' ' VAL . 49.8 m-85 -113.15 143.71 43.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.37 -50.84 71.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.298 -1.501 . . . . 0.0 109.064 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 16.6 t -91.29 171.19 9.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' C' ' 297' ' ' VAL . . . -105.29 -20.03 13.62 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 294' ' ' ALA . 91.5 m-20 -47.05 -39.63 13.28 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.43 -33.6 72.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' C' ' 294' ' ' ALA . 60.4 t -69.86 -63.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.06 -18.29 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.046 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' C' ' 297' ' ' VAL . 1.7 ttt85 -78.37 -57.39 3.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.485 -0.759 . . . . 0.0 109.004 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' C' ' 303' ' ' ASN . 3.3 p -65.76 -25.97 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . 0.437 ' C ' ' N ' ' C' ' 303' ' ' ASN . 33.5 m -44.77 -58.83 2.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.863 -1.148 . . . . 0.0 109.005 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' C' ' 301' ' ' CYS . 26.3 mt-30 -47.19 -23.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.011 . . . . 0.0 108.394 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' C' ' 300' ' ' VAL . 97.1 m-20 -100.16 70.75 1.56 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -68.93 -9.28 51.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.53 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -137.53 122.26 18.69 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 0.0 108.832 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 54.2 mt -121.65 145.85 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.889 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -79.46 120.12 23.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 108.519 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.638 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 73.5 t80 -120.03 -179.1 3.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.638 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 33.0 ttpt -43.61 -30.13 0.57 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . 0.591 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 46.1 t0 -86.25 -154.23 0.21 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . 0.591 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 35.7 ptt180 -79.0 -48.11 15.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 109.041 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' C' ' 311' ' ' ARG . 6.5 ttmt -165.72 155.31 12.34 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . 0.446 HG22 HD13 ' C' ' 313' ' ' ILE . 37.3 pt -131.2 157.68 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -110.43 152.54 26.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.959 . . . . 0.0 109.83 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 6.7 mm -119.38 142.26 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.36 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -145.93 144.23 30.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.192 -0.942 . . . . 0.0 108.859 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . 0.556 HH12 ' N ' ' C' ' 244' ' ' LYS . 20.9 tpt180 -70.64 135.51 48.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 319' ' ' GLU . . . -60.9 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' C' ' 317' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 109.432 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' B' ' 102' ' ' SER . 2.0 m120 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.34 147.03 87.2 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.46 2.107 . . . . 0.0 111.899 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.25 3.47 5.71 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.486 2.124 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.92 130.14 8.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.955 -1.091 . . . . 0.0 109.409 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.546 ' C ' ' HG ' ' B' ' 80' ' ' SER . 4.6 ttt85 -176.51 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -0.793 . . . . 0.0 109.249 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 100' ' ' GLY . 1.6 p -140.85 165.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.1 t -124.9 144.64 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.402 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 5.7 m-85 -111.53 130.91 55.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 8.5 mp -115.98 105.33 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -103.21 -72.54 0.92 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.887 -1.149 . . . . 0.0 112.113 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.468 ' OG ' ' OG ' ' B' ' 94' ' ' SER . 8.5 t -68.85 86.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.332 . . . . 0.0 110.338 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 mp -147.38 126.09 6.23 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' B' ' 36' ' ' ASP . 37.2 Cg_endo -69.73 165.96 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.721 1.614 . . . . 0.0 112.836 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.654 ' N ' ' CD1' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -70.59 1.47 5.17 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' B' ' 34' ' ' PRO . 88.7 m-20 -64.74 -34.28 77.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.41 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -118.77 112.26 19.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.103 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.5 p -107.2 -142.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.502 0.667 . . . . 0.0 110.891 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.63 -28.36 68.48 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.927 -1.108 . . . . 0.0 110.322 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.59 -53.98 16.24 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.078 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.2 OUTLIER -68.84 -44.5 73.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.874 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' B' ' 44' ' ' ASP . 14.2 mm -59.79 -52.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.868 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 42' ' ' ILE . 0.7 OUTLIER -38.94 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.809 -0.557 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' B' ' 42' ' ' ILE . 97.4 m-20 -122.54 -23.71 5.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.658 -1.276 . . . . 0.0 110.552 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.441 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.0 tm? -59.25 -43.85 92.39 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.16 -1.588 . . . . 0.0 106.922 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.0 OUTLIER -82.14 -63.23 1.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.189 -0.944 . . . . 0.0 109.289 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.775 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.9 t -37.91 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.655 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.6 OUTLIER -51.81 67.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.441 1.115 . . . . 0.0 110.153 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.775 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.22 -34.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.278 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.66 -173.05 46.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.46 159.33 20.11 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 123.046 2.498 . . . . 0.0 112.535 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 t -129.4 145.96 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 43.3 mm -91.28 -67.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.054 . . . . 0.0 111.877 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.538 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 74.7 m-20 -117.72 146.28 43.86 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.079 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.64 129.89 23.67 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -143.29 147.92 35.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.884 -1.135 . . . . 0.0 109.741 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 4.5 ttm -125.92 136.48 53.09 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' MET . . . . . 0.589 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -155.69 154.97 32.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.874 -1.141 . . . . 0.0 111.105 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.589 ' O ' ' SD ' ' B' ' 58' ' ' MET . 3.3 m-85 -111.43 176.4 5.04 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.616 -0.677 . . . . 0.0 110.167 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' B' ' 66' ' ' SER . 40.9 m-20 -114.24 84.9 9.77 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 0.0 110.901 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -60.82 -61.96 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.018 2.478 . . . . 0.0 113.136 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -81.62 -65.7 0.98 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.553 -0.717 . . . . 0.0 111.004 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.3 p -47.96 -45.13 30.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.113 -0.992 . . . . 0.0 109.135 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.92 12.21 81.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.481 HH12 HH22 ' C' ' 200' ' ' ARG . 78.5 mtm180 -59.52 -40.2 86.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.004 -1.292 . . . . 0.0 109.428 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.505 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -174.47 170.97 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.946 -1.096 . . . . 0.0 111.118 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 69' ' ' TYR . 37.9 mmtm -108.65 -68.09 0.93 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.266 -0.897 . . . . 0.0 110.437 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -60.32 68.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.138 0 O-C-N 120.595 -1.315 . . . . 0.0 111.571 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . 0.561 ' N ' ' O ' ' B' ' 67' ' ' LYS . 1.2 m-85 -106.96 125.82 51.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.688 -1.478 . . . . 0.0 109.18 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.21 140.0 32.19 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.499 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -106.5 123.56 48.27 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 72' ' ' ILE . 3.4 mp -118.73 97.3 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.633 -0.667 . . . . 0.0 111.152 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.538 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 83.1 tt0 -84.48 131.06 34.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.437 -1.415 . . . . 0.0 110.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -92.85 178.76 5.67 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.708 0.766 . . . . 0.0 111.056 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.611 ' H ' ' HG ' ' B' ' 79' ' ' SER . 10.4 tpt180 -52.16 -41.74 62.83 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.591 -0.693 . . . . 0.0 111.315 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.8 m-20 159.06 176.86 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 3.1 mp -36.63 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.816 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' B' ' 76' ' ' ASP . 50.1 mp0 -70.3 -74.74 0.13 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.389 -1.445 . . . . 0.0 108.459 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' B' ' 75' ' ' ARG . 61.7 p -61.78 -39.76 92.81 Favored 'General case' 0 C--O 1.195 -1.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.546 ' HG ' ' C ' ' B' ' 26' ' ' ARG . 0.5 OUTLIER -64.07 -34.56 78.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.139 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -60.94 -61.72 2.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.485 -1.384 . . . . 0.0 107.746 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.591 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 23.3 t -62.77 -38.79 91.97 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.621 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.57 -64.83 1.08 Allowed 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 111.293 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.421 ' CG1' ' CB ' ' B' ' 99' ' ' CYS . 28.8 t -48.54 -41.03 11.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.655 -1.278 . . . . 0.0 108.538 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . 0.57 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 61.7 ttm-85 -64.58 -49.14 72.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.938 -1.101 . . . . 0.0 109.237 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' B' ' 82' ' ' SER . 86.5 m-20 -76.23 -46.39 28.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.23 -0.919 . . . . 0.0 109.907 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' B' ' 83' ' ' ALA . 3.7 mm? -86.8 15.91 5.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.46 -0.775 . . . . 0.0 110.44 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.576 ' N ' ' OD1' ' B' ' 88' ' ' ASN . 0.5 OUTLIER -53.89 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.685 -1.26 . . . . 0.0 108.258 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.96 116.65 1.61 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -136.93 144.89 43.69 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.369 -1.665 . . . . 0.0 107.667 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -34.79 92.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.542 -0.724 . . . . 0.0 111.304 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 90' ' ' TYR . 61.2 tp -154.79 135.44 13.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.695 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.36 -162.39 10.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' SER . . . . . 0.468 ' OG ' ' OG ' ' B' ' 32' ' ' SER . 0.9 OUTLIER -88.0 -6.61 57.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.257 . . . . 0.0 109.344 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' B' ' 92' ' ' LEU . 37.8 ttm180 -134.56 160.28 38.55 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.502 ' O ' ' C ' ' B' ' 97' ' ' LEU . 57.1 m-85 -95.81 134.41 38.79 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.431 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.541 ' CB ' ' O ' ' B' ' 88' ' ' ASN . 1.9 mp -31.76 150.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -118.23 144.46 45.75 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . 0.421 ' CB ' ' CG1' ' B' ' 84' ' ' VAL . 4.8 p -78.94 107.75 11.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.252 -0.905 . . . . 0.0 110.307 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -88.42 171.04 39.59 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -156.15 92.82 1.37 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.1 -1.235 . . . . 0.0 108.066 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' SER . . . . . 0.591 ' O ' ' ND2' ' B' ' 22' ' ' ASN . 0.9 OUTLIER -27.22 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.778 0.799 . . . . 0.0 109.992 -178.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' SER . . . . . 0.43 ' N ' ' O ' ' B' ' 101' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.52 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.354 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 93.1 p . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.341 0.591 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 6.9 m -78.19 66.67 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 108.742 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . 0.458 ' NZ ' ' CD1' ' C' ' 204' ' ' PHE . 16.3 tttt -108.29 89.41 2.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.551 -0.718 . . . . 0.0 110.418 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 161' ' ' MET . . . . . 0.505 ' SD ' ' CG2' ' C' ' 217' ' ' VAL . 14.0 mmm -64.31 140.63 58.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 110.501 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -103.76 132.76 49.71 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 26.7 mm -114.02 128.01 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -131.77 -173.68 13.41 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.347 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.96 22.23 2.87 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 3.0 mt -61.66 159.0 14.14 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.483 -1.01 . . . . 0.0 109.28 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.451 ' OD1' ' OG1' ' C' ' 170' ' ' THR . 36.4 p-10 -80.31 167.3 20.42 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.174 -0.954 . . . . 0.0 108.851 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -92.76 32.45 1.24 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.63 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.16 76.97 0.63 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.001 . . . . 0.0 110.332 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 170' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' C' ' 167' ' ' ASN . 84.7 m -150.7 147.46 27.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.961 -1.087 . . . . 0.0 110.078 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 171' ' ' THR . . . . . 0.662 ' HG1' ' ND2' ' C' ' 174' ' ' ASN . 0.2 OUTLIER -106.13 172.51 6.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -69.66 -66.9 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.747 -1.221 . . . . 0.0 109.502 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 172' ' ' GLU . 57.4 t0 -43.94 -33.37 1.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.084 -1.01 . . . . 0.0 109.232 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . 0.662 ' ND2' ' HG1' ' C' ' 171' ' ' THR . 87.2 m-20 -74.93 -49.49 20.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.125 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.57 -46.36 84.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.2 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' C' ' 177' ' ' GLU . 21.9 ttp85 -63.23 -60.64 3.13 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.806 -1.184 . . . . 0.0 107.932 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' C' ' 176' ' ' ARG . 47.4 tp10 -41.94 -30.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.546 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 23.7 t80 -70.84 -53.85 13.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.038 -1.039 . . . . 0.0 108.826 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.81 ' O ' ' N ' ' C' ' 181' ' ' LYS . 72.5 m-85 -75.27 -62.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.35 -0.844 . . . . 0.0 110.192 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -41.61 2.79 0.01 OUTLIER Glycine 0 N--CA 1.503 3.154 0 O-C-N 120.555 -1.341 . . . . 0.0 112.381 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . 0.81 ' N ' ' O ' ' C' ' 179' ' ' PHE . 38.8 tttt -73.96 -15.1 61.12 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -77.46 -58.46 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.475 0.655 . . . . 0.0 110.017 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -156.61 -104.9 0.22 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 47.6 m -127.83 147.19 50.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.511 -0.994 . . . . 0.0 109.569 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.5 144.42 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 186' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' C' ' 208' ' ' GLU . 0.2 OUTLIER -91.06 -58.3 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.176 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' C' ' 206' ' ' SER . 43.8 t0 -156.86 160.76 39.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' C' ' 188' ' ' LEU . 1.7 pt? -146.09 143.89 29.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.92 85.62 2.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.012 -1.055 . . . . 0.0 109.234 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.8 156.25 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 191' ' ' MET . . . . . 0.448 ' CB ' ' CZ ' ' C' ' 202' ' ' PHE . 6.3 tpp -142.31 55.84 1.45 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.022 -1.049 . . . . 0.0 110.486 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . 0.414 ' HZ3' ' HA2' ' C' ' 201' ' ' GLY . 0.3 OUTLIER -135.74 117.5 15.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 108.887 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -135.42 80.36 45.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.383 -0.823 . . . . 0.0 109.906 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.16 -18.12 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.439 2.092 . . . . 0.0 110.914 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' C' ' 196' ' ' THR . . . -65.5 -38.42 89.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 196' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' C' ' 195' ' ' ALA . 5.8 p -165.81 -32.07 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.586 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 193' ' ' ASP . . . -102.64 100.31 1.95 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.398 -1.382 . . . . 0.0 109.842 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -103.26 133.77 47.78 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.453 -1.028 . . . . 0.0 109.557 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 199' ' ' SER . . . . . 0.588 ' O ' ' C ' ' C' ' 200' ' ' ARG . 2.7 m -156.78 151.62 25.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 109.306 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.588 ' C ' ' O ' ' C' ' 199' ' ' SER . 94.0 mtt-85 -24.97 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . 0.414 ' HA2' ' HZ3' ' C' ' 192' ' ' LYS . . . -80.9 120.58 5.18 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.151 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . 0.448 ' CZ ' ' CB ' ' C' ' 191' ' ' MET . 50.8 p90 -165.03 164.66 20.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -140.86 125.5 2.85 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.582 -1.771 . . . . 0.0 110.41 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . 0.458 ' CD1' ' NZ ' ' C' ' 160' ' ' LYS . 3.7 m-85 -89.98 65.65 6.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.37 101.48 0.44 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.845 0.831 . . . . 0.0 112.606 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 206' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.3 OUTLIER -86.1 138.69 31.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -118.05 144.01 45.94 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.537 -1.352 . . . . 0.0 109.694 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . 0.538 ' N ' ' OG1' ' C' ' 186' ' ' THR . 84.9 tt0 -68.36 -46.44 70.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -100.35 125.16 40.39 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.816 -1.178 . . . . 0.0 111.053 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . 0.416 ' O ' ' CG2' ' C' ' 213' ' ' VAL . 51.4 Cg_exo -45.74 -40.33 19.11 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.973 2.449 . . . . 0.0 114.223 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 97.8 p -61.34 -46.6 89.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.584 -1.322 . . . . 0.0 110.68 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.468 ' O ' ' CG2' ' C' ' 216' ' ' VAL . 29.6 m -39.33 -31.03 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . 0.443 HG23 ' N ' ' C' ' 214' ' ' ASP . 6.2 m -69.78 -34.52 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.21 . . . . 0.0 110.233 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' C' ' 218' ' ' LYS . 54.9 t0 -62.36 -49.17 76.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' C' ' 217' ' ' VAL . 52.1 mt-10 -68.32 -33.95 75.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 108.986 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' C' ' 212' ' ' SER . 48.1 t -82.26 33.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . 0.505 ' CG2' ' SD ' ' C' ' 161' ' ' MET . 21.1 t -154.58 -36.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.605 -0.684 . . . . 0.0 109.579 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . 0.529 ' CB ' ' HZ1' ' C' ' 218' ' ' LYS . 2.2 ttmp? -92.67 23.87 3.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.644 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.597 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 42.2 m -134.81 157.21 47.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -83.95 134.22 34.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 108.459 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' C' ' 219' ' ' THR . 18.4 m-70 -123.51 133.6 53.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . 0.546 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -145.38 106.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 110.449 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' C' ' 223' ' ' LEU . 3.9 mm? -52.8 -65.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.635 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -126.26 24.15 6.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.23 15.07 42.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -80.93 -154.36 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -1.098 . . . . 0.0 108.51 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . 0.431 ' CG1' ' OE1' ' C' ' 273' ' ' GLN . 0.3 OUTLIER -132.32 97.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 19.7 pt -107.56 153.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.622 -0.674 . . . . 0.0 109.579 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . 0.502 ' OD1' ' OD2' ' C' ' 271' ' ' ASP . 28.3 t0 -123.62 97.36 42.04 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.628 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . 0.413 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 56.9 Cg_endo -86.77 125.58 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.847 2.365 . . . . 0.0 111.928 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.82 142.39 28.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.99 . . . . 0.0 109.64 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' C' ' 233' ' ' ALA . 58.5 ttp180 -53.04 144.24 15.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 108.959 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -36.23 116.72 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 67.7 mt -99.25 134.95 20.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 0.0 109.486 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.42 149.61 62.94 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.125 1.883 . . . . 0.0 111.705 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -34.99 68.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.482 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.28 -45.57 80.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -71.23 -37.31 72.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 0.0 109.21 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . 0.527 ' O ' ' OG1' ' C' ' 242' ' ' THR . 77.5 mt-30 -58.68 -35.27 72.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 108.727 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.53 -42.47 91.95 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.197 -0.939 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' C' ' 242' ' ' THR . 18.8 mttp -69.72 -51.79 31.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 242' ' ' THR . . . . . 0.537 ' C ' ' O ' ' C' ' 241' ' ' LYS . 0.1 OUTLIER -22.62 140.33 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.284 0.564 . . . . 0.0 111.403 -178.085 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -132.65 130.19 5.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' C' ' 318' ' ' ALA . 0.0 OUTLIER -132.27 138.61 47.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.971 -1.311 . . . . 0.0 110.406 178.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . 0.406 ' HA ' ' N ' ' C' ' 318' ' ' ALA . 2.5 pt -123.96 140.39 47.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.835 0.826 . . . . 0.0 108.906 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' C' ' 247' ' ' VAL . 10.8 t80 -70.85 158.23 36.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . 0.415 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 0.6 OUTLIER -138.27 133.88 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.852 . . . . 0.0 109.473 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.73 152.13 16.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.62 -29.16 12.78 Favored Glycine 0 N--CA 1.495 2.571 0 O-C-N 121.095 -1.238 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 1.2 pp -109.58 164.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.074 -1.251 . . . . 0.0 108.941 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . 0.65 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.71 -42.98 1.32 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 45.4 Cg_exo -56.16 -132.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.874 2.382 . . . . 0.0 112.378 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.79 -36.1 67.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -0.867 . . . . 0.0 110.575 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . 0.531 ' CG1' ' OD2' ' C' ' 310' ' ' ASP . 13.7 m -55.92 127.46 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.0 109.47 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . 0.566 ' N ' ' CD ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -90.65 160.66 38.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' C' ' 257' ' ' LYS . 17.0 Cg_endo -60.34 -26.26 82.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.97 2.447 . . . . 0.0 112.259 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' C' ' 256' ' ' PRO . 26.2 mtpp -45.32 -62.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.2 tp10 -60.9 -82.88 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.409 -0.917 . . . . 0.0 108.69 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . 0.606 ' C ' ' O ' ' C' ' 258' ' ' GLU . 1.1 t80 -10.98 -62.1 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 CA-C-O 121.438 0.637 . . . . 0.0 111.263 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 258' ' ' GLU . 87.7 tt0 -64.03 -48.53 75.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.27 -0.894 . . . . 0.0 109.523 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' C' ' 258' ' ' GLU . 0.0 OUTLIER -73.04 0.95 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' C' ' 264' ' ' SER . 0.7 OUTLIER -94.54 -74.24 0.55 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.496 ' O ' ' C ' ' C' ' 264' ' ' SER . 29.2 m-85 -42.19 -27.24 0.13 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.21 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.592 ' O ' ' N ' ' C' ' 266' ' ' TRP . 29.0 t -40.15 -41.64 1.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' C' ' 264' ' ' SER . 6.3 tt0 -39.79 -19.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.756 -0.59 . . . . 0.0 110.67 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.625 ' HE1' ' CG1' ' C' ' 300' ' ' VAL . 8.8 p90 -154.13 151.79 29.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.805 -1.185 . . . . 0.0 109.111 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 62.8 -172.4 10.44 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 3.4 t -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.33 100.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.423 -1.311 . . . . 0.0 110.263 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' C' ' 290' ' ' THR . 1.4 mp -72.01 -57.71 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.634 -0.667 . . . . 0.0 110.372 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . 0.502 ' OD2' ' OD1' ' C' ' 229' ' ' ASP . 0.5 OUTLIER -129.61 106.53 8.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -120.87 142.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.903 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . 0.431 ' OE1' ' CG1' ' C' ' 227' ' ' VAL . 10.9 pt20 -171.53 136.75 1.0 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.637 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . 0.486 ' C ' ' SD ' ' C' ' 275' ' ' MET . 3.6 pp -112.01 156.9 21.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 275' ' ' MET . . . . . 0.672 ' N ' ' SD ' ' C' ' 275' ' ' MET . 0.0 OUTLIER -99.4 168.67 9.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.717 -1.239 . . . . 0.0 109.533 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' C' ' 278' ' ' LYS . 1.6 pp -157.62 -178.37 7.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.924 . . . . 0.0 109.718 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' C' ' 283' ' ' SER . 55.7 t0 -64.96 44.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 109.047 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -48.5 -32.38 7.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 278' ' ' LYS . 6.8 m-20 -179.17 27.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 280' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' C' ' 280' ' ' THR . 0.0 OUTLIER -172.67 21.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.783 -1.198 . . . . 0.0 110.394 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' C' ' 277' ' ' ASP . . . 61.86 23.5 63.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.592 ' C ' ' H ' ' C' ' 284' ' ' ARG . 3.7 tp60 -50.65 -16.23 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -1.065 . . . . 0.0 109.076 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 283' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' C' ' 277' ' ' ASP . 0.3 OUTLIER -62.92 38.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.546 -0.721 . . . . 0.0 110.072 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' C' ' 282' ' ' GLN . 0.5 OUTLIER -46.61 -33.67 4.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.08 67.88 0.21 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -176.43 -171.23 0.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.88 -1.365 . . . . 0.0 109.604 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . 175.21 -165.54 36.61 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -142.13 154.87 45.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.296 -1.708 . . . . 0.0 108.978 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . 0.41 ' CG2' ' CE1' ' C' ' 291' ' ' TYR . 0.5 OUTLIER -131.42 145.64 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 290' ' ' THR . . . . . 0.467 ' O ' ' N ' ' C' ' 270' ' ' ILE . 32.3 m -133.05 123.67 26.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.509 -1.369 . . . . 0.0 109.997 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . 0.458 ' O ' ' CB ' ' C' ' 292' ' ' ASP . 33.4 m-85 -98.95 -80.27 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.293 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER 169.39 -56.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 O-C-N 120.631 -1.293 . . . . 0.0 108.009 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 293' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 58.6 p -93.82 172.66 8.11 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.17 -8.76 23.24 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.13 -52.4 65.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 108.618 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.52 95.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 108.485 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 45.6 t -52.66 -57.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.186 -0.946 . . . . 0.0 108.611 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.07 -32.6 71.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.196 -0.94 . . . . 0.0 109.217 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.87 -62.07 2.08 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.625 ' CG1' ' HE1' ' C' ' 266' ' ' TRP . 0.2 OUTLIER -66.29 -31.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.497 -0.752 . . . . 0.0 110.203 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . 0.618 ' SG ' ' NH2' ' C' ' 317' ' ' ARG . 31.7 t -45.58 -52.13 11.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.674 -1.266 . . . . 0.0 108.817 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -50.88 -27.78 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.44 -0.788 . . . . 0.0 110.556 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.571 ' O ' ' OD1' ' C' ' 303' ' ' ASN . 30.9 p30 -100.22 63.15 1.13 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.014 -1.054 . . . . 0.0 109.808 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' C' ' 303' ' ' ASN . 15.8 tttp -45.18 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.47 -1.394 . . . . 0.0 108.905 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . 0.409 ' CE2' ' CG ' ' C' ' 314' ' ' GLU . 70.6 m-85 -67.28 127.83 34.11 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.32 -0.862 . . . . 0.0 109.497 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.92 154.19 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 108.949 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.0 128.6 33.47 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 34.3 t80 -118.07 173.62 6.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.511 -0.743 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.436 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.0 OUTLIER -56.11 -34.19 65.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.188 -0.945 . . . . 0.0 112.037 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . 0.531 ' OD2' ' CG1' ' C' ' 254' ' ' VAL . 15.6 m-20 -90.71 -71.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.734 -1.229 . . . . 0.0 109.942 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -148.06 -170.22 3.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 109.262 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -60.32 148.25 37.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.969 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 31.3 pt -132.27 153.74 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . 0.409 ' CG ' ' CE2' ' C' ' 305' ' ' PHE . 4.0 mp0 -111.44 110.17 20.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.003 -1.061 . . . . 0.0 110.842 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . 0.456 HD13 HG21 ' C' ' 315' ' ' ILE . 59.6 mt -87.91 161.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.9 -1.125 . . . . 0.0 109.838 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -163.46 160.88 23.87 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.914 -1.116 . . . . 0.0 109.043 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . 0.618 ' NH2' ' SG ' ' C' ' 301' ' ' CYS . 62.5 mtt85 -71.76 146.25 48.22 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.699 -1.251 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' C' ' 244' ' ' LYS . . . -71.72 26.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 109.411 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' C' ' 317' ' ' ARG . 7.3 pt-20 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.598 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' B' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.08 158.68 24.63 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.727 2.284 . . . . 0.0 112.208 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.47 20.2 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.848 2.365 . . . . 0.0 112.976 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.874 -1.141 . . . . 0.0 109.952 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.521 ' HE ' ' CB ' ' B' ' 103' ' ' SER . 5.3 ttp85 179.24 -45.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' B' ' 100' ' ' GLY . 10.3 t -122.56 155.02 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.71 142.32 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.447 ' CZ ' ' HA3' ' B' ' 100' ' ' GLY . 2.6 m-85 -114.98 141.81 47.47 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.072 -1.017 . . . . 0.0 110.547 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt -118.78 127.52 53.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -113.33 -50.39 0.54 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.639 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.722 ' HG ' ' N ' ' B' ' 94' ' ' SER . 9.7 p -88.76 115.38 26.26 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.743 -1.445 . . . . 0.0 107.731 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -147.85 107.16 3.72 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.887 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' B' ' 36' ' ' ASP . 7.8 Cg_exo -63.01 159.23 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.629 1.553 . . . . 0.0 109.744 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' B' ' 35' ' ' TYR . 6.2 m-30 -74.57 5.37 4.86 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' B' ' 34' ' ' PRO . 27.0 t0 -62.03 -47.09 86.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.565 ' N ' HE21 ' B' ' 37' ' ' GLN . 0.0 OUTLIER -120.12 109.13 15.08 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.872 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.545 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 45.8 p -100.14 -148.83 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.0 109.419 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.04 -26.39 67.59 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.14 -1.6 . . . . 0.0 110.902 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -73.17 -57.42 4.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.75 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' B' ' 37' ' ' GLN . 25.1 mt-30 -68.84 -44.17 73.97 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.972 -1.08 . . . . 0.0 109.231 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' B' ' 44' ' ' ASP . 2.4 mm -54.53 -54.77 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' B' ' 42' ' ' ILE . 45.6 tp -37.21 -19.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.9 t0 -123.86 -21.81 5.05 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.595 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.468 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.2 tm? -62.97 -44.06 97.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.051 -1.656 . . . . 0.0 107.029 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' B' ' 48' ' ' ASN . 74.4 m -82.98 -65.45 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.155 -0.966 . . . . 0.0 108.739 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.839 ' O ' ' N ' ' B' ' 49' ' ' VAL . 4.6 t -37.24 -15.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.79 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.4 OUTLIER -50.23 56.45 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.483 1.135 . . . . 0.0 110.551 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.839 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.4 p 178.46 -34.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 121.426 -0.796 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.68 159.57 32.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' B' ' 52' ' ' VAL . 20.5 Cg_endo -65.24 86.47 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.525 2.15 . . . . 0.0 111.525 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' B' ' 51' ' ' PRO . 0.0 OUTLIER -40.09 153.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.633 0.73 . . . . 0.0 110.072 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' B' ' 73' ' ' GLU . 15.9 mm -77.05 -45.3 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.688 -0.632 . . . . 0.0 109.662 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' B' ' 53' ' ' ILE . 87.0 m-20 -146.89 152.68 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.362 -1.335 . . . . 0.0 111.678 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 42.5 tp -143.56 128.48 18.45 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -145.58 123.91 12.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.624 -1.297 . . . . 0.0 110.194 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 9.9 ttm -116.4 150.36 37.91 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.746 0.784 . . . . 0.0 111.138 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' MET . . . . . 0.59 ' CG ' ' N ' ' B' ' 59' ' ' PHE . 2.1 ttp -168.14 165.65 13.21 Favored 'General case' 0 C--O 1.282 2.781 0 O-C-N 121.383 -0.823 . . . . 0.0 109.498 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.681 ' CD1' ' N ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -132.56 134.59 45.14 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 127.008 2.692 . . . . 0.0 110.214 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 0.1 OUTLIER -42.05 105.39 0.4 Allowed Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 112.014 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -91.63 -66.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.796 2.331 . . . . 0.0 109.325 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -105.89 -25.45 12.13 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 80.5 p -46.41 -49.54 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' B' ' 60' ' ' ASP . . . 76.77 36.7 36.21 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.769 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -137.01 -76.92 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.718 -1.46 . . . . 0.0 110.142 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' B' ' 60' ' ' ASP . 97.7 p -109.81 140.83 43.29 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.088 1.899 . . . . 0.0 111.538 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.498 ' HA ' ' H ' ' B' ' 60' ' ' ASP . 39.0 mttt -101.72 -5.49 24.89 Favored 'General case' 0 C--O 1.166 -3.332 0 CA-C-O 115.138 -2.363 . . . . 0.0 114.891 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . 0.597 ' O ' ' CD2' ' B' ' 69' ' ' TYR . . . -126.11 100.08 0.57 Allowed Glycine 1 N--CA 1.534 5.198 0 CA-C-N 123.356 2.798 . . . . 0.0 116.534 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . 0.597 ' CD2' ' O ' ' B' ' 68' ' ' GLY . 3.1 m-85 -165.9 139.6 4.38 Favored 'General case' 0 N--CA 1.516 2.83 0 C-N-CA 115.329 -2.548 . . . . 0.0 114.127 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.68 142.99 28.43 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.134 -0.979 . . . . 0.0 110.973 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -107.83 132.86 52.98 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.183 0.992 . . . . 0.0 110.4 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.27 146.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' B' ' 53' ' ' ILE . 83.9 tt0 -136.03 135.47 39.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.167 -1.583 . . . . 0.0 108.38 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.74 168.61 8.99 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.759 0.79 . . . . 0.0 110.845 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 47.6 ttp180 -53.75 -45.41 70.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.635 -0.666 . . . . 0.0 111.532 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.75 179.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.174 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 3.6 mm? -34.29 -24.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.851 -0.531 . . . . 0.0 111.142 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 91.9 mt-10 -71.05 -75.34 0.13 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.668 -1.27 . . . . 0.0 109.259 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.97 -41.56 98.14 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 21.0 m -60.28 -37.54 80.8 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.836 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -61.1 -61.8 2.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.44 -1.413 . . . . 0.0 108.912 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.521 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 67.2 m -61.89 -43.24 99.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.723 0.773 . . . . 0.0 112.022 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.613 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.37 -64.93 1.05 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.427 -0.795 . . . . 0.0 111.031 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.442 ' O ' ' CA ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -50.63 -39.36 17.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.261 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . 0.608 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 2.1 ttm-85 -66.86 -55.53 14.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.612 -1.305 . . . . 0.0 108.791 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' B' ' 82' ' ' SER . 46.9 m-80 -67.02 -43.91 81.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 109.68 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' B' ' 83' ' ' ALA . 45.7 mt -105.6 41.67 1.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.411 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' B' ' 85' ' ' ARG . 0.0 OUTLIER -70.26 -75.16 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.98 117.88 1.73 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -139.87 147.54 40.8 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.549 -1.559 . . . . 0.0 107.819 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . 0.592 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.3 mm-40 -33.94 89.09 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.822 0.82 . . . . 0.0 111.184 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' B' ' 90' ' ' TYR . 51.3 tp -140.8 125.85 18.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . 0.414 ' HA3' ' HG ' ' B' ' 32' ' ' SER . . . 52.41 -157.05 4.01 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' SER . . . . . 0.722 ' N ' ' HG ' ' B' ' 32' ' ' SER . 2.3 p -83.36 -15.65 49.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.862 -1.376 . . . . 0.0 109.896 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.625 ' N ' ' OG ' ' B' ' 32' ' ' SER . 94.4 mtt-85 -131.23 155.87 46.35 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.8 m-85 -96.07 139.35 32.38 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.47 -0.769 . . . . 0.0 109.86 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.524 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -38.47 141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -114.2 147.53 38.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.112 -0.992 . . . . 0.0 109.867 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 17.9 p -88.02 115.61 25.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.679 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -108.52 177.23 20.59 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.469 ' O ' ' C ' ' B' ' 102' ' ' SER . 48.0 p90 -131.61 -17.57 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.555 -0.968 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' SER . . . . . 0.469 ' C ' ' O ' ' B' ' 101' ' ' TYR . 8.3 t -38.02 99.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.108 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' SER . . . . . 0.521 ' CB ' ' HE ' ' B' ' 26' ' ' ARG . 60.0 p . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 158' ' ' SER . . . . . 0.594 ' O ' ' N ' ' C' ' 160' ' ' LYS . 83.8 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.248 0.547 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . 0.528 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 46.23 11.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.547 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' C' ' 158' ' ' SER . 14.5 tttp -94.75 137.82 33.36 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 161' ' ' MET . . . . . 0.693 ' SD ' ' N ' ' C' ' 162' ' ' PHE . 0.0 OUTLIER -114.9 152.58 32.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 108.986 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . 0.693 ' N ' ' SD ' ' C' ' 161' ' ' MET . 55.2 t80 -119.4 72.94 0.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.607 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . 0.688 ' N ' ' SD ' ' C' ' 161' ' ' MET . 54.5 mt -53.24 145.48 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.38 -177.43 15.98 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 56.22 20.77 30.04 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 97.5 mt -60.97 163.7 5.63 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.364 -1.08 . . . . 0.0 108.776 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' C' ' 168' ' ' TRP . 11.5 p-10 -68.65 -75.71 0.1 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.056 -1.028 . . . . 0.0 108.918 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . 0.679 ' HE1' HH21 ' C' ' 198' ' ' ARG . 0.1 OUTLIER 178.5 -24.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.872 -1.143 . . . . 0.0 109.784 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -133.01 91.46 2.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.975 . . . . 0.0 109.764 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 46.2 m -126.05 144.74 50.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.416 -0.803 . . . . 0.0 109.386 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 171' ' ' THR . . . . . 0.411 ' HG1' ' ND2' ' C' ' 174' ' ' ASN . 0.3 OUTLIER -104.84 172.62 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.022 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -67.77 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.961 -1.087 . . . . 0.0 109.861 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -43.29 -33.45 0.99 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . 0.411 ' ND2' ' HG1' ' C' ' 171' ' ' THR . 86.0 m-20 -74.92 -50.83 15.46 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 108.827 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 20.8 tp -52.67 -42.06 64.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.693 -0.63 . . . . 0.0 109.53 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' C' ' 179' ' ' PHE . 14.2 ptp180 -74.38 -57.3 4.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.511 -1.368 . . . . 0.0 108.866 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' C' ' 176' ' ' ARG . 54.0 mm-40 -37.71 -30.76 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.557 ' N ' ' O ' ' C' ' 176' ' ' ARG . 21.6 t80 -85.25 -39.85 17.29 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.103 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' C' ' 176' ' ' ARG . 22.6 m-85 -94.25 16.98 13.56 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.146 -0.971 . . . . 0.0 111.429 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.45 24.46 25.44 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . 0.697 ' NZ ' ' HH ' ' C' ' 182' ' ' TYR . 3.6 ptmm? -104.52 16.41 26.15 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.35 -1.088 . . . . 0.0 108.814 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . 0.697 ' HH ' ' NZ ' ' C' ' 181' ' ' LYS . 92.3 m-85 -119.21 -49.16 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.596 -0.69 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -164.88 -127.41 0.89 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 40.6 m -126.39 145.64 50.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.506 -0.996 . . . . 0.0 109.692 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.11 137.75 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 186' ' ' THR . . . . . 0.507 ' O ' ' OD1' ' C' ' 187' ' ' ASP . 9.7 t -96.82 -37.0 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.81 -1.181 . . . . 0.0 110.111 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' C' ' 186' ' ' THR . 79.5 m-20 -149.0 149.17 30.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.938 . . . . 0.0 108.613 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.34 144.1 36.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.828 -1.17 . . . . 0.0 108.355 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.08 129.95 50.13 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . 0.497 ' CG2' ' O ' ' C' ' 190' ' ' ILE . 0.6 OUTLIER -147.75 121.47 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.789 -1.194 . . . . 0.0 108.778 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 191' ' ' MET . . . . . 0.555 ' O ' ' CZ ' ' C' ' 202' ' ' PHE . 4.3 ptp -176.2 158.18 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 108.765 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.56 -63.89 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.686 -1.259 . . . . 0.0 109.032 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . 0.477 ' OD1' ' OG ' ' C' ' 199' ' ' SER . 0.2 OUTLIER -123.47 88.39 51.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.13 -20.86 8.26 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.356 2.037 . . . . 0.0 112.129 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.18 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.147 -0.971 . . . . 0.0 109.78 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 65.1 p -109.23 -8.66 15.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.22 15.64 76.27 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . 0.679 HH21 ' HE1' ' C' ' 168' ' ' TRP . 0.0 OUTLIER -97.68 73.22 2.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.258 . . . . 0.0 109.456 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 199' ' ' SER . . . . . 0.526 ' O ' ' C ' ' C' ' 200' ' ' ARG . 80.6 p -167.1 172.77 9.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' C' ' 199' ' ' SER . 0.0 OUTLIER -27.27 147.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.005 0.431 . . . . 0.0 110.137 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.5 158.82 22.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . 0.555 ' CZ ' ' O ' ' C' ' 191' ' ' MET . 4.7 p90 -171.18 134.11 0.9 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.359 . . . . 0.0 108.614 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -112.12 132.95 11.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.09 114.13 27.17 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.98 110.29 20.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.298 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 29.1 t -81.44 72.05 8.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -64.47 115.51 5.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.93 -38.43 90.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.18 108.74 30.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.006 -1.059 . . . . 0.0 110.44 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -52.1 -24.74 20.76 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.697 1.598 . . . . 0.0 112.5 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.507 ' O ' ' N ' ' C' ' 213' ' ' VAL . 22.9 t -66.95 -65.32 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.949 -1.094 . . . . 0.0 109.861 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.424 ' C ' ' O ' ' C' ' 211' ' ' SER . 51.0 m -40.75 -24.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.482 -0.761 . . . . 0.0 110.295 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' C' ' 211' ' ' SER . 95.0 t -69.13 -38.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 109.011 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.9 t0 -59.0 -49.41 77.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 110.094 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.08 -36.53 79.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.84 -1.162 . . . . 0.0 109.31 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . . . . . . . . . 47.9 t -54.94 -47.91 75.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 110.024 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.13 -33.33 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -72.79 6.28 2.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 109.558 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.656 ' CG2' ' CE1' ' C' ' 221' ' ' HIS . 1.3 t -134.56 167.7 20.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.134 -0.979 . . . . 0.0 109.391 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -122.82 134.42 54.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.73 -0.606 . . . . 0.0 109.403 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.656 ' CE1' ' CG2' ' C' ' 219' ' ' THR . 0.0 OUTLIER -132.07 161.03 34.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' C' ' 222' ' ' ILE . 0.4 OUTLIER -124.93 110.1 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 109.057 179.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 18.3 tp -75.14 -71.6 0.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' C' ' 224' ' ' ASP . 60.7 t0 -80.22 1.06 29.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.028 -1.045 . . . . 0.0 108.772 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.92 13.51 69.17 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . 0.695 ' HZ3' ' CA ' ' C' ' 279' ' ' ASP . 0.0 OUTLIER -90.73 -83.28 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -1.075 . . . . 0.0 109.432 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 1.3 p 172.57 89.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.19 -0.944 . . . . 0.0 109.66 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 pt -94.63 152.02 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.396 -0.815 . . . . 0.0 110.34 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' C' ' 229' ' ' ASP . 0.0 OUTLIER -116.8 106.45 47.94 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 110.042 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . 0.405 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 42.7 Cg_endo -82.17 134.23 7.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.388 2.059 . . . . 0.0 111.819 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' C' ' 232' ' ' ARG . 11.8 ttmm -152.53 164.26 37.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.98 . . . . 0.0 109.673 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' C' ' 231' ' ' LYS . 56.7 ttm-85 -72.96 159.22 34.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 116.07 3.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.205 -0.934 . . . . 0.0 111.163 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 18.5 mt -156.91 91.67 2.45 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -40.15 137.78 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.601 1.534 . . . . 0.0 111.479 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -55.69 -29.5 59.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.08 -45.13 79.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.65 -1.281 . . . . 0.0 108.663 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.88 -38.3 58.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . 0.491 ' O ' ' OG1' ' C' ' 242' ' ' THR . 4.2 tp-100 -57.92 -38.01 75.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.615 -0.678 . . . . 0.0 110.0 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -58.88 -22.59 59.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.867 . . . . 0.0 109.664 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 242' ' ' THR . . . . . 0.531 ' O ' ' O ' ' C' ' 291' ' ' TYR . 72.5 p -56.89 -36.67 70.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.13 3.22 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -138.58 138.15 37.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.025 -1.279 . . . . 0.0 110.855 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . 0.404 ' HA ' ' N ' ' C' ' 318' ' ' ALA . 3.8 pt -120.53 146.65 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . 0.552 ' C ' ' CD1' ' C' ' 246' ' ' PHE . 0.2 OUTLIER -86.54 160.37 18.98 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 28.4 t -134.11 131.17 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.56 -0.713 . . . . 0.0 109.092 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.01 147.53 18.51 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.51 5.25 79.14 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -111.12 133.06 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -1.058 . . . . 0.0 109.3 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.53 -36.35 2.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.727 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 32.0 Cg_exo -56.0 -30.0 76.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.397 2.064 . . . . 0.0 113.194 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -151.18 7.79 0.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.601 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . 0.53 ' O ' ' CD2' ' C' ' 274' ' ' LEU . 24.4 t -126.63 118.03 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 111.14 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . 0.414 ' O ' ' C ' ' C' ' 256' ' ' PRO . 0.0 OUTLIER -102.26 169.79 7.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' C' ' 257' ' ' LYS . 0.0 OUTLIER -26.22 -50.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.312 2.675 . . . . 0.0 114.677 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . 0.498 ' O ' ' OE1' ' C' ' 261' ' ' GLU . 58.4 tttp -33.09 -84.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' C' ' 261' ' ' GLU . 27.4 tp10 -58.21 -76.79 0.04 OUTLIER 'General case' 0 C--O 1.194 -1.82 0 O-C-N 120.846 -1.159 . . . . 0.0 109.384 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . 0.632 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.0 t80 -12.16 -64.39 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 121.867 0.841 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . 0.507 ' O ' ' OG ' ' C' ' 264' ' ' SER . 50.0 mt-10 -62.22 -49.39 75.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.96 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . 0.707 ' N ' ' O ' ' C' ' 258' ' ' GLU . 5.1 mp0 -71.27 2.79 4.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . 0.482 ' O ' ' CD ' ' C' ' 265' ' ' GLN . 6.1 t80 -98.21 -73.22 0.62 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.577 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 54.3 m-85 -50.52 -31.61 15.99 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.412 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' C' ' 260' ' ' GLU . 73.6 m -35.82 -38.34 0.12 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.605 -0.684 . . . . 0.0 112.445 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.482 ' CD ' ' O ' ' C' ' 262' ' ' PHE . 0.0 OUTLIER -54.75 -93.33 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.148 -1.595 . . . . 0.0 110.189 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.577 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -66.99 152.26 46.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.976 -1.078 . . . . 0.0 110.052 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 69.45 167.2 5.41 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 268' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 59.1 m -115.24 122.89 47.37 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . 0.429 HG13 ' CE2' ' C' ' 291' ' ' TYR . 3.2 mp -104.87 107.91 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.43 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 4.8 mm -77.15 -46.79 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 110.58 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' C' ' 231' ' ' LYS . 24.8 t70 -139.7 103.64 4.72 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.658 -1.276 . . . . 0.0 110.415 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -110.38 142.19 42.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.222 -0.924 . . . . 0.0 108.525 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -150.79 139.51 20.73 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.083 -1.447 . . . . 0.0 112.463 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 26.8 tp -122.96 141.24 52.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 45.7 mmm -89.17 177.3 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.149 -1.595 . . . . 0.0 109.249 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -131.95 170.28 15.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.992 -1.067 . . . . 0.0 109.505 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 54.4 p30 -90.9 -11.48 39.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.424 -0.797 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . 0.5 ' C ' ' HZ1' ' C' ' 226' ' ' LYS . 19.8 tptm -62.46 -32.78 73.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 108.838 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . 0.695 ' CA ' ' HZ3' ' C' ' 226' ' ' LYS . 34.2 p-10 -63.87 -44.38 93.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 280' ' ' THR . . . . . 0.585 ' N ' ' OD1' ' C' ' 279' ' ' ASP . 0.2 OUTLIER 177.34 5.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.099 -1.001 . . . . 0.0 110.172 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.08 57.0 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' C' ' 284' ' ' ARG . 19.4 mm100 -57.46 -34.24 68.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -1.197 . . . . 0.0 109.307 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 78.1 p -68.8 51.7 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.156 -0.965 . . . . 0.0 108.974 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' C' ' 282' ' ' GLN . 58.4 ttm-85 -49.59 -37.24 26.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 159.37 78.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 34.6 p90 -176.2 -174.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.271 . . . . 0.0 109.666 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -178.86 -170.97 41.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -147.97 152.26 37.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.22 -1.753 . . . . 0.0 108.877 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 94.2 t -130.6 145.61 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 15.5 m -128.55 130.45 47.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.814 -1.179 . . . . 0.0 110.453 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' C' ' 242' ' ' THR . 24.3 m-85 -113.37 153.33 28.72 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -74.0 18.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.014 -1.054 . . . . 0.0 109.499 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 293' ' ' SER . . . . . 0.509 ' H ' ' C ' ' C' ' 291' ' ' TYR . 59.8 p -162.67 173.88 13.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.02 -7.99 15.27 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.27 -52.0 67.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.91 90.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.852 . . . . 0.0 108.768 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.82 -57.38 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.23 -29.73 68.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -63.51 -63.75 1.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.124 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -63.71 -25.47 38.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.063 -1.023 . . . . 0.0 109.616 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . . . . . . . . . 45.3 t -45.18 -55.38 5.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 109.634 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . 0.585 ' NE2' ' OD1' ' C' ' 303' ' ' ASN . 0.0 OUTLIER -51.5 -24.98 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 108.051 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' C' ' 302' ' ' GLN . 97.1 m-20 -98.54 78.87 2.42 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -78.54 -8.97 59.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 110.48 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.06 120.19 19.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 108.952 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.96 154.88 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.802 . . . . 0.0 109.848 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -90.08 116.07 27.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 108.704 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.464 ' O ' ' C ' ' C' ' 309' ' ' LYS . 7.4 t80 -121.0 179.48 4.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' C' ' 308' ' ' PHE . 35.7 mtmt -39.07 -62.72 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.005 -1.059 . . . . 0.0 110.881 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' C' ' 309' ' ' LYS . 93.0 m-20 -44.66 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.149 -0.97 . . . . 0.0 109.354 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -175.4 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -141.35 138.69 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 109.886 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 18.8 pt -126.27 151.43 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -112.6 151.26 30.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.519 -0.738 . . . . 0.0 109.528 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 99.3 mt -125.84 154.72 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.514 -0.742 . . . . 0.0 109.126 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER 179.35 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.158 -1.589 . . . . 0.0 113.454 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . 0.616 ' O ' ' O ' ' C' ' 316' ' ' LYS . 77.8 mtm180 1.38 126.72 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.685 0 CA-C-O 121.778 0.799 . . . . 0.0 113.11 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . 0.404 ' N ' ' HA ' ' C' ' 245' ' ' ILE . . . -61.1 7.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.824 -1.173 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . 0.596 ' H ' ' C ' ' C' ' 317' ' ' ARG . 3.8 mm-40 . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.952 . . . . 0.0 108.725 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' B' ' 23' ' ' PRO . 6.3 m120 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' B' ' 22' ' ' ASN . 5.8 Cg_exo -44.68 167.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.038 2.492 . . . . 0.0 112.188 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.86 2.78 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.989 2.46 . . . . 0.0 113.355 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 72.1 m -153.26 132.67 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.672 -1.267 . . . . 0.0 109.186 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.576 ' NE ' ' OD1' ' B' ' 76' ' ' ASP . 3.5 tpt180 -177.24 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.625 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' B' ' 100' ' ' GLY . 3.2 m -129.06 170.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 t -127.2 143.25 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.705 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -110.5 122.4 47.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.269 -0.895 . . . . 0.0 108.973 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.36 107.38 17.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.15 -16.03 9.36 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.538 ' HG ' ' H ' ' B' ' 95' ' ' ARG . 65.5 p -111.58 85.08 2.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 109.728 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.433 ' N ' ' CD1' ' B' ' 33' ' ' ILE . 0.8 OUTLIER -145.47 127.26 7.78 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.575 ' C ' ' H ' ' B' ' 36' ' ' ASP . 31.8 Cg_endo -72.89 151.65 51.09 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.255 1.303 . . . . 0.0 110.703 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -59.61 -0.11 0.16 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.105 -0.997 . . . . 0.0 109.045 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.575 ' H ' ' C ' ' B' ' 34' ' ' PRO . 87.6 m-20 -64.28 -36.43 84.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.414 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -122.46 116.03 23.26 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.582 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 9.9 t -111.92 -137.09 0.37 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.441 -0.787 . . . . 0.0 110.885 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 21.1 pt-20 -63.19 -28.93 70.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.658 -1.276 . . . . 0.0 110.743 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.62 -55.45 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.811 -1.18 . . . . 0.0 110.611 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -68.93 -43.7 74.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 111.064 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.56 ' O ' ' SG ' ' B' ' 46' ' ' CYS . 51.1 mm -63.44 -52.63 55.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 118.715 -1.194 . . . . 0.0 107.959 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' B' ' 39' ' ' GLU . 46.3 tp -39.71 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.625 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 24.7 t70 -124.97 -27.13 3.62 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.432 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.479 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 0.3 OUTLIER -58.68 -45.27 89.8 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.205 -1.559 . . . . 0.0 108.101 178.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.8 p -77.68 -60.78 2.23 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.815 -1.154 . . . . 0.0 107.982 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.834 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.3 p -37.33 -18.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.73 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' B' ' 46' ' ' CYS . 1.4 m120 -47.75 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.405 0.622 . . . . 0.0 110.69 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.834 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.2 t 168.56 -32.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.23 165.24 37.65 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.236 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.87 91.48 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.047 2.498 . . . . 0.0 112.463 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -46.89 156.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.276 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 mm -100.4 -55.74 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.742 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 13.8 m-20 -118.3 127.85 54.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.314 -0.866 . . . . 0.0 111.317 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.91 130.14 48.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -139.79 125.39 19.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.808 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.8 tpt -105.93 129.4 54.08 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.17 155.85 38.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.434 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.2 OUTLIER -113.03 179.93 3.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.592 ' OD2' ' N ' ' B' ' 66' ' ' SER . 51.2 p-10 -102.75 74.52 0.18 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.15 -0.969 . . . . 0.0 110.75 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 28.6 Cg_endo -65.77 -60.1 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.966 1.777 . . . . 0.0 112.149 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.26 -50.01 6.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.936 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.593 ' HG1' ' H ' ' B' ' 65' ' ' ARG . 30.3 p -57.47 -45.06 85.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.454 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.443 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 74.87 11.72 83.47 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.593 ' H ' ' HG1' ' B' ' 63' ' ' THR . 10.8 mtp85 -66.02 -52.18 51.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.933 -1.334 . . . . 0.0 109.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.592 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 8.0 t -156.02 145.24 20.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -0.988 . . . . 0.0 110.403 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -79.98 -5.87 56.5 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.735 -1.228 . . . . 0.0 109.465 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -127.94 88.52 0.33 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.093 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -127.98 126.25 41.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.175 -1.191 . . . . 0.0 109.452 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.01 137.7 31.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.078 . . . . 0.0 110.088 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -103.49 125.3 49.98 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.378 -0.827 . . . . 0.0 108.93 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.4 HD11 ' N ' ' B' ' 72' ' ' ILE . 3.7 mp -122.01 97.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.645 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 53.2 mt-10 -86.96 127.85 35.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.707 -1.246 . . . . 0.0 110.734 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -89.68 179.86 5.93 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.621 0.724 . . . . 0.0 110.579 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 0.1 OUTLIER -57.06 -42.45 80.59 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.593 -0.692 . . . . 0.0 110.374 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.662 ' O ' ' N ' ' B' ' 78' ' ' GLU . 4.2 m-20 158.76 177.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 0.0 109.018 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.545 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 0.6 OUTLIER -33.68 -24.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.919 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.662 ' N ' ' O ' ' B' ' 76' ' ' ASP . 10.6 mp0 -69.84 -73.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.387 -1.446 . . . . 0.0 108.891 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.9 m -62.97 -41.36 99.52 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.3 m -59.6 -39.13 83.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.19 -0.943 . . . . 0.0 108.779 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -59.55 -61.21 2.79 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.141 0.972 . . . . 0.0 108.801 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.583 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 69.5 m -63.29 -39.7 95.31 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.579 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -79.6 -61.13 2.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.983 -1.073 . . . . 0.0 110.169 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.563 ' O ' ' CA ' ' B' ' 88' ' ' ASN . 26.7 t -51.19 -42.45 25.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.023 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . 0.428 ' HA ' HD21 ' B' ' 88' ' ' ASN . 23.3 ttm180 -64.9 -56.57 12.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.411 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 82' ' ' SER . 8.7 m-80 -67.47 -43.8 80.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' B' ' 83' ' ' ALA . 51.0 mt -104.83 34.87 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.0 110.433 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.563 ' CA ' ' O ' ' B' ' 84' ' ' VAL . 0.5 OUTLIER -62.6 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.123 -0.986 . . . . 0.0 108.375 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.17 116.29 1.62 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -138.1 145.8 42.1 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.369 -1.665 . . . . 0.0 107.752 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.0 OUTLIER -30.9 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.668 -0.645 . . . . 0.0 111.286 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' B' ' 90' ' ' TYR . 11.3 tp -154.03 140.8 19.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.53 -171.63 0.1 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 47.2 p -67.94 -22.39 65.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.538 ' H ' ' HG ' ' B' ' 32' ' ' SER . 94.9 mtt180 -136.23 163.52 30.2 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.2 m-85 -93.04 141.68 28.13 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.257 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -37.4 136.99 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -108.4 147.77 31.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . 0.544 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 31.2 p -87.55 116.7 25.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' B' ' 27' ' ' VAL . . . -115.03 158.39 14.37 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.51 ' CB ' ' O ' ' B' ' 23' ' ' PRO . 1.8 p90 -136.97 113.87 10.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -1.113 . . . . 0.0 109.122 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' SER . . . . . 0.696 ' HG ' ' H ' ' B' ' 103' ' ' SER . 51.0 p -136.94 -84.41 0.34 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.253 -0.904 . . . . 0.0 109.744 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' SER . . . . . 0.696 ' H ' ' HG ' ' B' ' 102' ' ' SER . 24.6 t . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.42 0.629 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 -1.98 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.79 140.08 32.7 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.015 -1.053 . . . . 0.0 108.936 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 24.8 ptm -123.32 155.61 36.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 109.345 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . 0.415 ' O ' ' C ' ' C' ' 163' ' ' ILE . 72.1 t80 -111.29 77.95 1.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' C' ' 162' ' ' PHE . 60.8 mt -49.02 135.9 5.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' C' ' 229' ' ' ASP . . . -136.02 157.14 23.27 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.125 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.02 20.65 77.43 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . 0.657 ' CB ' ' HZ3' ' C' ' 192' ' ' LYS . 83.0 mt -60.14 171.24 1.04 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.175 -1.191 . . . . 0.0 108.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.579 ' CG ' ' H ' ' C' ' 168' ' ' TRP . 17.0 p30 -68.92 -79.95 0.05 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.017 -1.052 . . . . 0.0 109.309 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . 0.579 ' H ' ' CG ' ' C' ' 167' ' ' ASN . 0.0 OUTLIER 178.8 -24.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.78 -1.2 . . . . 0.0 110.192 179.201 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . 0.453 ' C ' ' OD1' ' C' ' 169' ' ' ASP . 19.6 t0 -135.03 93.53 3.02 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.016 -1.053 . . . . 0.0 110.623 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 170' ' ' THR . . . . . 0.539 ' H ' ' CD ' ' C' ' 192' ' ' LYS . 17.4 m -139.97 145.71 38.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.309 -0.869 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.82 167.21 10.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.951 -1.093 . . . . 0.0 109.348 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.28 -56.37 22.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -48.38 -40.82 26.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.996 -1.065 . . . . 0.0 110.818 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -74.85 -53.13 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 109.962 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 10.3 tp -53.02 -45.68 68.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' C' ' 177' ' ' GLU . 27.4 ttp180 -66.12 -60.28 2.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' C' ' 176' ' ' ARG . 61.3 mm-40 -40.97 -30.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.535 ' O ' ' NZ ' ' C' ' 181' ' ' LYS . 1.1 t80 -76.67 -48.68 18.22 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.354 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.863 ' O ' ' N ' ' C' ' 181' ' ' LYS . 24.5 m-85 -72.58 -58.46 3.35 Favored 'General case' 0 C--O 1.196 -1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -43.42 10.18 0.0 OUTLIER Glycine 0 N--CA 1.507 3.379 0 O-C-N 119.845 -1.785 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . 0.863 ' N ' ' O ' ' C' ' 179' ' ' PHE . 1.5 ttmp? -75.99 -18.35 59.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.726 -1.455 . . . . 0.0 107.689 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . 0.483 ' N ' ' CD1' ' C' ' 182' ' ' TYR . 3.2 m-85 -93.14 -58.73 2.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 109.708 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -144.54 -129.86 2.24 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 28.0 m -127.16 153.88 45.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.384 -1.068 . . . . 0.0 110.154 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.39 149.39 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -42.18 11.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.904 -1.123 . . . . 0.0 110.02 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -154.52 155.91 35.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.998 . . . . 0.0 109.319 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' C' ' 189' ' ' LYS . 0.1 OUTLIER -147.15 139.62 24.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.652 -1.28 . . . . 0.0 107.809 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . 0.551 ' N ' ' CD1' ' C' ' 188' ' ' LEU . 5.9 tptp -127.61 133.85 49.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.878 -1.139 . . . . 0.0 109.64 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.62 156.24 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 108.521 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 4.0 tpp -139.84 42.3 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.022 -1.049 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . 0.657 ' HZ3' ' CB ' ' C' ' 166' ' ' LEU . 18.3 mttp -72.76 -163.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.982 -1.074 . . . . 0.0 109.432 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' C' ' 197' ' ' GLY . 0.9 OUTLIER -127.65 52.67 8.86 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.542 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 193' ' ' ASP . 83.9 Cg_endo -78.57 -4.42 14.11 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.823 2.349 . . . . 0.0 111.87 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.41 28.3 3.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.444 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 196' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' C' ' 193' ' ' ASP . 0.5 OUTLIER -153.37 -55.33 0.11 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.315 -0.866 . . . . 0.0 109.862 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . 0.58 ' N ' ' OD2' ' C' ' 193' ' ' ASP . . . 174.42 -100.94 0.15 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -136.08 136.83 40.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 109.488 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 199' ' ' SER . . . . . 0.515 ' O ' ' O ' ' C' ' 200' ' ' ARG . 9.3 t -153.36 170.61 20.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.263 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' C' ' 199' ' ' SER . 6.4 mmp_? -42.57 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 109.117 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . 0.413 ' HA2' ' HZ2' ' C' ' 192' ' ' LYS . . . -141.69 94.28 0.19 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -137.94 167.78 21.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.36 136.13 8.19 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 119.061 -1.542 . . . . 0.0 109.66 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -105.43 102.88 12.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.43 111.29 23.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.419 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 21.3 t -82.79 70.92 9.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . 0.451 ' CE1' ' OG ' ' C' ' 212' ' ' SER . 2.7 m-85 -60.01 117.98 5.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.63 -51.13 66.55 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.045 -1.035 . . . . 0.0 109.354 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' C' ' 211' ' ' SER . 50.5 mtpt -84.95 103.79 3.78 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.084 -1.01 . . . . 0.0 110.436 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.67 -15.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.823 1.682 . . . . 0.0 112.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.557 ' O ' ' N ' ' C' ' 213' ' ' VAL . 17.6 m -68.36 -69.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.855 -1.153 . . . . 0.0 109.898 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 211' ' ' SER . 0.0 OUTLIER -36.46 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.736 -0.603 . . . . 0.0 109.672 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' C' ' 211' ' ' SER . 88.4 t -65.63 -45.1 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 109.396 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -61.72 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.584 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.24 -39.33 86.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 108.965 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . 0.696 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 15.2 t -64.85 -49.7 78.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.351 0.596 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.13 -31.17 52.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.585 -1.322 . . . . 0.0 109.488 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -81.12 -44.35 18.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.131 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.579 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 41.5 m -66.39 151.23 47.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.345 -0.847 . . . . 0.0 110.632 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -80.36 148.33 30.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.592 -0.692 . . . . 0.0 109.657 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.696 ' NE2' ' O ' ' C' ' 216' ' ' VAL . 24.5 m-70 -132.84 132.74 42.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.222 -0.924 . . . . 0.0 110.623 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.2 86.61 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -55.15 -71.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 109.627 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 91.8 m-20 -96.2 7.64 45.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 109.126 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.52 12.28 61.3 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . 0.57 ' O ' ' CG1' ' C' ' 227' ' ' VAL . 0.4 OUTLIER -85.78 -86.06 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -1.089 . . . . 0.0 109.737 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . 0.57 ' CG1' ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 171.85 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.827 . . . . 0.0 109.641 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 15.4 pt -99.39 160.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.127 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' C' ' 164' ' ' GLY . 5.4 m-20 -126.76 102.17 25.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 111.016 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . 0.46 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 28.9 Cg_endo -83.28 137.29 8.17 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -164.05 168.66 18.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.912 -1.117 . . . . 0.0 109.804 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -58.64 156.07 11.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.986 . . . . 0.0 109.462 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . 0.4 ' O ' ' CG1' ' C' ' 234' ' ' ILE . . . -70.26 124.08 23.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . 0.44 ' HB ' HE21 ' C' ' 239' ' ' GLN . 13.2 mt -158.71 108.92 1.62 Allowed Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.12 132.31 8.73 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.604 1.536 . . . . 0.0 111.82 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -55.47 -36.43 66.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.173 -0.955 . . . . 0.0 109.002 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -52.82 -40.89 63.69 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -70.17 -36.14 74.47 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . 0.524 ' O ' ' OG1' ' C' ' 242' ' ' THR . 54.9 mm-40 -57.69 -38.48 75.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 108.896 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . 0.402 ' OD1' ' NZ ' ' C' ' 244' ' ' LYS . 87.2 m-20 -68.48 -37.67 80.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -60.94 -29.73 69.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 242' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 9.5 p -65.01 -21.71 66.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.968 -1.082 . . . . 0.0 110.09 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 110.35 102.66 2.72 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . 0.402 ' NZ ' ' OD1' ' C' ' 240' ' ' ASP . 4.3 ttpt -131.24 126.79 36.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.314 . . . . 0.0 110.223 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . 0.416 ' HA ' ' H ' ' C' ' 318' ' ' ALA . 0.1 OUTLIER -113.86 141.82 28.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . 0.527 ' C ' ' CD1' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -87.33 164.9 16.0 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 58.8 t -136.69 131.53 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.95 142.32 16.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' C' ' 313' ' ' ILE . . . 90.27 66.99 1.2 Allowed Glycine 0 N--CA 1.491 2.358 0 O-C-N 121.137 -1.214 . . . . 0.0 110.689 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' C' ' 285' ' ' GLY . 38.4 mm -114.2 133.82 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -1.19 . . . . 0.0 109.131 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.66 157.48 45.08 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.93 -22.82 55.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.823 2.349 . . . . 0.0 112.6 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -124.35 52.57 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.302 -0.874 . . . . 0.0 109.923 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . 0.69 ' O ' ' O ' ' C' ' 255' ' ' ARG . 47.7 t -100.56 36.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' C' ' 254' ' ' VAL . 4.0 mtp85 -16.5 146.96 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.7 0 CA-C-O 121.384 0.611 . . . . 0.0 111.851 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' C' ' 257' ' ' LYS . 31.1 Cg_endo -57.95 -19.99 42.66 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.723 2.282 . . . . 0.0 113.048 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' C' ' 256' ' ' PRO . 54.0 tttm -46.51 -67.78 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . 0.744 ' O ' ' N ' ' C' ' 261' ' ' GLU . 23.8 mp0 -60.72 -91.46 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.71 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . 0.628 ' C ' ' O ' ' C' ' 258' ' ' GLU . 56.7 t80 -6.1 -68.08 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 CA-C-O 121.179 0.514 . . . . 0.0 111.18 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 258' ' ' GLU . 83.4 tt0 -54.97 -48.02 73.78 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.617 0.723 . . . . 0.0 109.545 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . 0.744 ' N ' ' O ' ' C' ' 258' ' ' GLU . 82.1 tt0 -71.56 -45.04 63.41 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -49.84 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.61 -0.681 . . . . 0.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.528 ' O ' ' C ' ' C' ' 264' ' ' SER . 63.5 m-85 -45.3 -44.37 11.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.906 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.617 ' O ' ' N ' ' C' ' 266' ' ' TRP . 1.3 p -37.88 -36.64 0.2 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' C' ' 263' ' ' PHE . 23.4 tt0 -42.14 -9.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.946 -0.471 . . . . 0.0 111.872 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.617 ' N ' ' O ' ' C' ' 264' ' ' SER . 16.0 p90 -159.33 44.81 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.22 -1.55 . . . . 0.0 110.527 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 154.41 123.8 0.9 Allowed Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.294 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 27.8 m -56.78 140.4 47.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -1.153 . . . . 0.0 108.823 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . 0.414 HG21 ' H ' ' C' ' 272' ' ' ALA . 1.1 mp -99.03 109.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 0.0 110.762 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . 0.459 HD12 HG21 ' C' ' 270' ' ' ILE . 4.1 mt -71.9 -50.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 109.877 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . 0.561 ' O ' ' C ' ' C' ' 272' ' ' ALA . 59.4 t0 -147.01 17.45 1.23 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.839 -1.163 . . . . 0.0 111.407 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' C' ' 271' ' ' ASP . . . -27.91 138.66 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.585 -0.697 . . . . 0.0 109.979 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -133.56 124.22 26.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.231 -0.918 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . 0.436 ' HB2' ' CD2' ' C' ' 259' ' ' PHE . 1.4 tm? -121.43 129.37 52.95 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 3.8 mmt -102.09 163.81 12.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.572 -1.33 . . . . 0.0 110.021 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' C' ' 282' ' ' GLN . 1.0 OUTLIER -144.07 -175.34 4.57 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.044 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -44.93 -86.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 109.689 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -107.77 -20.74 13.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 108.992 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -52.73 -26.94 15.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 280' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -143.37 -8.34 0.77 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.651 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.71 64.99 1.7 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' C' ' 276' ' ' LEU . 9.3 tp-100 -171.93 164.24 6.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -1.173 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 283' ' ' SER . . . . . 0.434 ' H ' ' HG3' ' C' ' 282' ' ' GLN . 25.6 p -170.14 0.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.199 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . . . . . . . . . 46.7 mmt-85 -55.9 -31.2 62.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.373 -0.829 . . . . 0.0 109.661 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' C' ' 250' ' ' ILE . . . 106.81 20.64 8.72 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.184 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' C' ' 286' ' ' PHE . 26.8 p90 -109.84 175.81 5.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.068 -1.254 . . . . 0.0 110.203 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.49 -177.42 36.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -149.75 149.84 31.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.31 -1.7 . . . . 0.0 108.778 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.06 149.14 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 48.7 m -132.84 121.57 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.641 -1.287 . . . . 0.0 109.082 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -116.22 137.4 52.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.204 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' C' ' 293' ' ' SER . 17.7 p-10 -62.35 -49.67 74.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 293' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 75.7 m -67.91 124.22 22.74 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -77.36 -27.05 52.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.086 -2.191 . . . . 0.0 105.086 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -51.46 -41.72 61.08 Favored 'General case' 0 C--O 1.206 -1.222 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.23 75.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.994 -1.066 . . . . 0.0 108.393 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 83.1 t -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.72 -29.56 53.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.66 -0.65 . . . . 0.0 109.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -71.69 -62.97 1.22 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -61.5 -24.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.628 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' C' ' 300' ' ' VAL . 1.3 m -43.98 -58.4 2.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -50.8 -26.86 6.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.081 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' C' ' 300' ' ' VAL . 34.1 t-20 -99.43 86.41 3.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 109.509 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -75.05 -84.31 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.695 -1.253 . . . . 0.0 108.561 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -58.74 127.62 33.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.198 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.1 tt -138.58 142.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.641 1.21 . . . . 0.0 110.18 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' C' ' 307' ' ' ASP . 47.3 p30 -68.65 142.13 55.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.866 0.841 . . . . 0.0 110.531 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.626 ' O ' ' N ' ' C' ' 310' ' ' ASP . 9.9 t80 -169.84 -174.07 1.74 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.515 ' C ' ' O ' ' C' ' 308' ' ' PHE . 37.0 mmtt -32.75 -30.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.556 -0.715 . . . . 0.0 110.217 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' C' ' 308' ' ' PHE . 92.6 m-20 -87.1 -84.74 0.18 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.07 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.015 -1.053 . . . . 0.0 110.556 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -168.75 49.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.988 -1.07 . . . . 0.0 109.342 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' C' ' 249' ' ' GLY . 10.7 pt -49.92 138.55 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.766 0.793 . . . . 0.0 110.791 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -85.44 115.8 23.39 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.23 0.538 . . . . 0.0 110.527 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 83.8 mt -82.78 158.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 108.944 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.58 165.95 16.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.511 -1.368 . . . . 0.0 109.659 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -78.8 140.45 38.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.625 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . 0.416 ' H ' ' HA ' ' C' ' 245' ' ' ILE . . . -70.79 -29.91 66.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.909 -1.119 . . . . 0.0 108.837 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 -179.842 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . 0.439 ' O ' ' CD2' ' B' ' 101' ' ' TYR . 6.6 Cg_exo -64.53 150.03 88.92 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.231 1.954 . . . . 0.0 112.303 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -85.09 26.35 0.65 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.559 2.173 . . . . 0.0 112.78 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.01 126.28 11.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.616 -1.303 . . . . 0.0 110.23 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -179.46 -49.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 109.24 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.04 154.91 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.832 0.825 . . . . 0.0 110.436 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -108.06 139.52 29.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.41 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 5.1 m-85 -102.24 133.05 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.111 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.96 121.28 40.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -114.61 -94.17 1.99 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.612 ' H ' ' NH1' ' B' ' 95' ' ' ARG . 2.7 p -69.04 110.7 4.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.75 -1.441 . . . . 0.0 110.36 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -160.74 127.37 2.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' B' ' 36' ' ' ASP . 51.7 Cg_endo -74.85 170.87 19.41 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.604 1.536 . . . . 0.0 112.61 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.597 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 3.8 m-30 -69.29 4.72 1.56 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.3 m-20 -60.26 -38.06 82.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.129 -0.982 . . . . 0.0 109.443 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.81 116.01 18.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 109.459 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.407 ' O ' HG12 ' B' ' 42' ' ' ILE . 82.2 p -113.02 -140.64 0.38 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.696 0.76 . . . . 0.0 111.631 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.401 ' CD ' ' C ' ' B' ' 39' ' ' GLU . 1.6 pp20? -61.46 -34.28 75.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.673 -1.267 . . . . 0.0 111.358 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -71.69 -53.95 11.87 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -44.1 79.56 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.385 -0.822 . . . . 0.0 110.189 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.584 ' O ' ' N ' ' B' ' 44' ' ' ASP . 30.6 mm -58.0 -51.62 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 42' ' ' ILE . 3.1 tm? -37.43 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' B' ' 42' ' ' ILE . 83.7 m-20 -124.7 -24.48 4.15 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.3 tm? -60.09 -41.18 91.94 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.214 -1.554 . . . . 0.0 107.472 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.621 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.4 m -87.65 -63.04 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.817 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.915 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.1 p -40.11 -19.96 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.779 -0.576 . . . . 0.0 109.896 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.621 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.3 OUTLIER -42.69 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.117 0.96 . . . . 0.0 110.131 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.915 ' N ' ' O ' ' B' ' 47' ' ' SER . 0.9 OUTLIER 161.58 -28.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 47' ' ' SER . . . -169.37 123.16 1.06 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.424 -1.37 . . . . 0.0 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -48.14 100.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.579 1.52 . . . . 0.0 111.523 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -49.63 171.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.852 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 35.5 mm -107.47 -49.12 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 110.132 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.579 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 40.5 m-20 -118.35 139.17 51.76 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.103 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.96 132.2 28.2 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -137.26 121.5 18.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.045 -1.034 . . . . 0.0 109.678 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tpt -104.5 128.61 52.48 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.726 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 2.1 ttt -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.061 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.597 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 2.3 m-85 -104.11 -175.92 2.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' B' ' 66' ' ' SER . 49.8 m-20 -115.55 87.38 17.14 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.07 -1.019 . . . . 0.0 110.657 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.06 -60.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.485 2.123 . . . . 0.0 112.353 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' B' ' 63' ' ' THR . 3.4 tt0 -86.2 -62.1 1.59 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.412 ' C ' ' O ' ' B' ' 62' ' ' GLN . 5.2 p -45.24 -43.02 10.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.835 . . . . 0.0 108.91 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.41 18.26 76.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -61.99 -42.02 98.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.979 -1.307 . . . . 0.0 109.516 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -179.86 179.15 0.58 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.978 -1.076 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -117.93 78.7 1.27 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.65 48.08 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . 0.406 ' CD1' ' HA2' ' B' ' 31' ' ' GLY . 3.9 m-30 -97.01 125.44 41.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.43 158.16 43.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 111.847 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -125.97 126.99 45.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.629 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.63 ' N ' ' CD1' ' B' ' 72' ' ' ILE . 2.2 mp -118.06 98.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.724 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.579 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.8 tt0 -82.54 126.4 32.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.379 -1.451 . . . . 0.0 110.282 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -86.72 176.36 7.79 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.573 0.701 . . . . 0.0 110.038 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 58.3 mtp180 -56.63 -42.07 78.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.2 m-20 165.64 172.59 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 0.9 OUTLIER -38.07 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.062 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.1 mm-40 -74.43 -70.83 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.95 -1.094 . . . . 0.0 108.748 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 37.0 m -59.49 -45.02 92.89 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.66 -1.275 . . . . 0.0 107.691 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -62.68 -34.88 78.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 109.184 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -56.23 -59.36 5.05 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.124 -1.61 . . . . 0.0 107.231 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.502 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 33.3 t -65.58 -38.95 91.0 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.401 ' N ' HG13 ' B' ' 49' ' ' VAL . . . -79.28 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.867 -1.146 . . . . 0.0 110.197 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -52.01 -42.91 35.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.861 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmt180 -66.82 -43.53 83.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.643 -1.911 . . . . 0.0 109.258 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.61 ' N ' HD21 ' B' ' 86' ' ' ASN . 0.8 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 111.619 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.581 ' O ' ' C ' ' B' ' 88' ' ' ASN . 7.9 mt -117.09 -4.05 11.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.927 -1.108 . . . . 0.0 111.254 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' B' ' 84' ' ' VAL . 0.0 OUTLIER -16.11 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.074 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.84 108.11 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -130.37 143.4 50.75 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.699 -1.471 . . . . 0.0 108.087 -179.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . 0.568 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.0 OUTLIER -32.66 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.648 -0.658 . . . . 0.0 110.832 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 90' ' ' TYR . 5.3 tt -148.36 132.36 17.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.23 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.81 -157.94 1.58 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -21.18 52.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -1.125 . . . . 0.0 108.646 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.612 ' NH1' ' H ' ' B' ' 32' ' ' SER . 32.0 ttm105 -136.85 146.92 46.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' B' ' 96' ' ' PHE . 1.6 m-30 -93.1 143.92 25.77 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.511 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 88' ' ' ASN . 0.2 OUTLIER -46.68 157.69 0.14 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.174 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 147.97 42.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 109.888 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 17.2 p -77.2 121.46 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -135.89 174.56 21.32 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.515 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' B' ' 23' ' ' PRO . 7.1 t80 -147.69 125.25 11.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.571 -0.958 . . . . 0.0 109.784 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -137.84 101.64 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.651 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 158' ' ' SER . . . . . 0.632 ' O ' ' N ' ' C' ' 160' ' ' LYS . 23.1 t . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . 0.448 ' HG ' ' CG2' ' C' ' 213' ' ' VAL . 3.2 t -54.83 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' C' ' 158' ' ' SER . 11.3 tptp -88.21 136.17 33.1 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.611 0.72 . . . . 0.0 110.19 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 39.2 mmm -115.62 150.65 36.35 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.604 -0.685 . . . . 0.0 109.633 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -116.48 123.84 48.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 5.2 mm -105.1 133.61 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.09 171.19 21.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.1 28.71 72.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . 0.42 ' HB3' ' HZ2' ' C' ' 192' ' ' LYS . 97.5 mt -77.2 150.69 35.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 110.536 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' C' ' 169' ' ' ASP . 0.4 OUTLIER -75.3 153.85 37.7 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -69.42 19.07 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.886 -1.134 . . . . 0.0 110.032 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' C' ' 167' ' ' ASN . 59.5 t0 -145.14 84.47 1.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.946 -1.096 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 170' ' ' THR . . . . . 0.583 ' OG1' ' NZ ' ' C' ' 192' ' ' LYS . 0.2 OUTLIER -146.61 119.96 8.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.17 158.55 15.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 0.0 109.465 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' C' ' 173' ' ' ASP . 87.9 mt-10 -61.7 -69.29 0.25 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.829 -1.169 . . . . 0.0 110.915 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' C' ' 172' ' ' GLU . 55.1 t0 -42.31 -36.61 1.3 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.684 -1.26 . . . . 0.0 109.818 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -80.02 -47.85 14.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.412 -0.805 . . . . 0.0 109.69 179.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.406 ' N ' ' ND2' ' C' ' 174' ' ' ASN . 7.6 tt -57.19 -42.26 80.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.034 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' C' ' 179' ' ' PHE . 70.8 ttp85 -67.34 -57.94 5.71 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' C' ' 176' ' ' ARG . 49.1 tp10 -39.75 -31.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.53 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 15.4 t80 -74.13 -49.39 23.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.725 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.891 ' O ' ' N ' ' C' ' 181' ' ' LYS . 28.9 m-85 -74.87 -62.94 1.37 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -39.43 4.19 0.0 OUTLIER Glycine 0 N--CA 1.508 3.457 0 O-C-N 120.345 -1.472 . . . . 0.0 112.38 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . 0.891 ' N ' ' O ' ' C' ' 179' ' ' PHE . 6.2 tttm -64.63 -28.57 69.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.779 -1.424 . . . . 0.0 107.839 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . 0.536 ' OH ' ' CG2' ' C' ' 219' ' ' THR . 32.0 m-85 -78.39 -35.55 47.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.267 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.7 -126.1 0.88 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 41.3 m -129.28 154.92 46.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.44 159.7 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 108.978 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 186' ' ' THR . . . . . 0.492 ' O ' ' OD1' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -99.01 -43.92 6.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 110.248 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' C' ' 186' ' ' THR . 68.8 m-20 -151.93 147.57 26.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.833 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.519 ' C ' ' CD2' ' C' ' 188' ' ' LEU . 0.2 OUTLIER -141.73 146.21 35.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.934 -1.104 . . . . 0.0 108.486 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.3 123.2 29.5 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.978 -1.076 . . . . 0.0 109.88 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 92.6 mt -134.75 121.63 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.478 -1.388 . . . . 0.0 108.169 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -114.66 44.49 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.865 0.841 . . . . 0.0 108.806 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . 0.583 ' NZ ' ' OG1' ' C' ' 170' ' ' THR . 4.5 ttmt -64.45 -162.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' C' ' 192' ' ' LYS . 0.5 OUTLIER -134.25 66.64 71.57 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.767 -1.208 . . . . 0.0 110.696 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.35 -0.91 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.426 2.751 . . . . 0.0 110.889 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.36 15.86 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.343 0.592 . . . . 0.0 109.424 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.1 -59.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.2 -91.82 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -142.0 144.87 33.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.502 -0.999 . . . . 0.0 109.64 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 199' ' ' SER . . . . . . . . . . . . . 42.2 t -161.86 160.58 28.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.48 ' O ' ' CD1' ' C' ' 202' ' ' PHE . 64.1 mmt-85 -47.75 114.38 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 109.122 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.42 113.05 3.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' C' ' 200' ' ' ARG . 16.0 p90 -141.31 153.27 45.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -1.163 . . . . 0.0 108.419 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -122.65 139.61 12.66 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.803 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -118.34 103.55 9.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.06 109.22 20.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.972 . . . . 0.0 111.016 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 7.2 t -94.81 132.62 39.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.21 143.43 45.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.924 -1.11 . . . . 0.0 109.559 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . 0.433 ' C ' ' OE1' ' C' ' 208' ' ' GLU . 1.7 tm-20 -68.15 -54.34 18.72 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.015 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.16 108.22 26.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.968 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -44.38 -20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.206 1.937 . . . . 0.0 113.683 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.574 ' O ' ' N ' ' C' ' 213' ' ' VAL . 11.3 t -61.83 -69.38 0.25 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.542 -1.349 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.488 ' C ' ' O ' ' C' ' 211' ' ' SER . 83.0 p -35.45 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.161 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' C' ' 211' ' ' SER . 0.4 OUTLIER -64.91 -37.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.0 109.229 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' C' ' 211' ' ' SER . 91.0 m-20 -63.68 -46.05 87.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 55.2 mp0 -68.76 -35.69 77.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . 0.586 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 54.5 t -62.01 -52.62 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.45 -38.79 79.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -73.31 -45.28 56.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.44 -0.788 . . . . 0.0 110.411 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.536 ' CG2' ' OH ' ' C' ' 182' ' ' TYR . 24.9 m -68.75 145.65 53.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.21 -0.931 . . . . 0.0 111.658 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -80.33 149.94 30.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.586 ' NE2' ' O ' ' C' ' 216' ' ' VAL . 20.5 m-70 -127.68 132.19 49.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . 0.53 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -142.56 103.21 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.326 -0.859 . . . . 0.0 109.678 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.02 -62.58 1.41 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.023 -1.048 . . . . 0.0 109.216 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -110.26 12.66 23.21 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 97.99 5.06 57.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -73.48 -171.61 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -1.084 . . . . 0.0 108.17 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.04 102.21 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 15.8 pt -102.13 151.55 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.478 -0.764 . . . . 0.0 108.955 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -119.27 107.27 41.65 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.354 -0.841 . . . . 0.0 110.888 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -89.19 135.23 2.65 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 111.431 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -148.27 146.0 28.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.852 -1.155 . . . . 0.0 110.199 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' C' ' 233' ' ' ALA . 35.5 mtm105 -56.63 147.68 21.87 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.2 133.93 6.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.926 -1.109 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.86 124.15 34.36 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 109.667 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.15 142.42 4.07 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.939 1.759 . . . . 0.0 112.077 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -58.12 -43.68 87.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 110.688 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 29.7 p-10 -62.72 -39.26 93.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . 0.556 ' N ' ' OD1' ' C' ' 237' ' ' ASP . 97.8 mt-10 -68.41 -41.84 79.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.692 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -65.44 -43.46 90.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.588 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -63.86 -41.57 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.887 . . . . 0.0 109.785 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -61.45 -47.18 86.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.746 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 59.6 p -54.59 137.65 42.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.48 150.14 17.98 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -130.08 132.27 46.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -1.046 . . . . 0.0 109.983 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . 0.52 ' C ' ' CD1' ' C' ' 245' ' ' ILE . 0.0 OUTLIER -121.15 156.59 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.572 -0.705 . . . . 0.0 109.148 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -105.48 135.01 47.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.578 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.49 131.7 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.778 0.799 . . . . 0.0 110.082 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.69 145.93 16.21 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.34 64.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -129.73 154.85 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -1.076 . . . . 0.0 109.198 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 130.53 -39.6 1.78 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.629 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 87.6 Cg_exo -48.62 -120.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.612 2.208 . . . . 0.0 112.963 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -81.42 17.79 1.29 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 41.3 t -89.68 140.56 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.963 -1.086 . . . . 0.0 109.97 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -104.95 154.81 38.4 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.91 -24.89 74.2 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.157 1.905 . . . . 0.0 112.345 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -51.17 -64.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.714 -0.616 . . . . 0.0 109.697 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . 0.68 ' O ' ' N ' ' C' ' 261' ' ' GLU . 33.8 tt0 -61.16 -78.17 0.04 OUTLIER 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.176 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . 0.655 ' C ' ' O ' ' C' ' 258' ' ' GLU . 59.7 t80 -11.93 -65.74 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 121.52 0.676 . . . . 0.0 110.082 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' C' ' 258' ' ' GLU . 2.9 tm-20 -59.9 -45.73 91.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.574 -0.704 . . . . 0.0 110.799 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' C' ' 258' ' ' GLU . 63.2 mm-40 -71.89 -17.3 62.12 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.985 -1.072 . . . . 0.0 108.892 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' C' ' 263' ' ' PHE . 4.6 t80 -78.96 -80.52 0.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' C' ' 265' ' ' GLN . 31.0 m-85 -38.25 -42.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.235 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.575 ' C ' ' O ' ' C' ' 263' ' ' PHE . 73.0 p -30.82 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.609 ' N ' ' O ' ' C' ' 263' ' ' PHE . 6.4 tt0 -45.26 -23.07 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.822 -0.549 . . . . 0.0 110.969 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.564 ' CZ2' ' CD2' ' C' ' 263' ' ' PHE . 8.2 p90 -151.58 151.1 31.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.644 -1.285 . . . . 0.0 109.246 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 82.08 176.3 51.12 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 268' ' ' THR . . . . . 0.511 ' O ' ' C ' ' C' ' 269' ' ' ILE . 43.1 p -115.35 19.61 15.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.733 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' C' ' 268' ' ' THR . 0.0 OUTLIER -15.35 104.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 41.5 mm -83.4 -34.16 10.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -132.86 97.2 3.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -108.99 131.47 55.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.442 -0.786 . . . . 0.0 109.158 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -160.94 129.91 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.422 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.12 157.89 15.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 275' ' ' MET . . . . . 0.458 ' N ' ' SD ' ' C' ' 275' ' ' MET . 0.5 OUTLIER -93.76 168.19 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.316 -1.49 . . . . 0.0 109.336 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' C' ' 277' ' ' ASP . 0.2 OUTLIER -150.35 -155.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' C' ' 279' ' ' ASP . 77.2 m-20 -54.16 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.463 -0.773 . . . . 0.0 110.447 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' C' ' 278' ' ' LYS . 0.0 OUTLIER -49.46 -8.15 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.298 -0.876 . . . . 0.0 110.146 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' C' ' 277' ' ' ASP . 85.3 m-20 -59.61 -66.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 110.073 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 131.89 43.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 56.53 -124.5 35.22 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.578 ' C ' ' H ' ' C' ' 284' ' ' ARG . 6.9 tt0 -146.95 147.2 30.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.235 -1.156 . . . . 0.0 110.136 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.23 21.73 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' C' ' 282' ' ' GLN . 0.1 OUTLIER -51.47 -33.3 30.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.664 -1.272 . . . . 0.0 108.016 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' C' ' 250' ' ' ILE . . . 117.34 69.62 0.4 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' C' ' 250' ' ' ILE . 32.6 p90 -162.18 175.01 12.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.609 . . . . 0.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -154.63 178.8 31.18 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.071 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' C' ' 246' ' ' PHE . 7.8 m-85 -142.41 157.13 45.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.722 -1.458 . . . . 0.0 108.929 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . 0.406 ' CG1' ' CE1' ' C' ' 291' ' ' TYR . 1.0 OUTLIER -149.12 148.46 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.714 -1.241 . . . . 0.0 108.904 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 12.6 m -129.46 130.94 46.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.05 -1.031 . . . . 0.0 111.101 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . 0.571 ' C ' ' H ' ' C' ' 293' ' ' SER . 46.5 m-85 -112.88 142.5 45.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' C' ' 292' ' ' ASP . 56.6 p30 -75.79 13.03 0.9 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.437 -1.415 . . . . 0.0 107.544 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 293' ' ' SER . . . . . 0.571 ' H ' ' C ' ' C' ' 291' ' ' TYR . 1.8 m -131.04 112.02 12.54 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.49 76.16 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -50.6 -38.0 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.95 83.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.31 -57.67 10.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.57 -19.13 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -77.11 -60.42 2.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.141 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.5 p -60.97 -20.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.146 -0.972 . . . . 0.0 109.039 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' C' ' 300' ' ' VAL . 0.0 OUTLIER -43.17 -58.54 2.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 108.867 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -49.82 -27.67 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' C' ' 300' ' ' VAL . 94.1 m-20 -99.94 68.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.21 -9.5 59.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.088 . . . . 0.0 109.94 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.76 125.06 32.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . 0.448 HD11 HG21 ' C' ' 306' ' ' ILE . 69.4 mt -132.67 145.5 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.0 111.099 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' C' ' 307' ' ' ASP . 3.3 p30 -81.53 94.81 6.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.488 ' CE1' ' CD2' ' C' ' 262' ' ' PHE . 36.7 t80 -104.26 -176.28 3.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' C' ' 308' ' ' PHE . 56.0 mttt -38.84 -32.77 0.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.787 -1.195 . . . . 0.0 109.691 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . 0.593 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 44.1 t0 -95.13 -154.47 0.43 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 108.853 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . 0.649 ' O ' ' N ' ' C' ' 313' ' ' ILE . 17.3 ttp180 -79.66 -167.74 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 108.916 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . 0.445 ' H ' ' HG2' ' C' ' 311' ' ' ARG . 10.3 tptt -55.01 75.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.905 0.86 . . . . 0.0 109.672 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' C' ' 311' ' ' ARG . 3.6 pt -45.46 153.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.947 . . . . 0.0 108.896 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -107.3 155.22 20.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.478 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 77.8 mt -125.31 152.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -154.63 149.88 27.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.952 -1.093 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' C' ' 319' ' ' GLU . 42.5 mtt85 -67.33 145.46 55.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.085 -1.009 . . . . 0.0 109.333 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -78.08 13.45 1.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.905 -1.122 . . . . 0.0 109.116 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' C' ' 317' ' ' ARG . 1.8 mp0 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.8 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.453 ' ND2' ' CD2' ' B' ' 101' ' ' TYR . 1.1 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.52 142.01 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.685 2.257 . . . . 0.0 111.986 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.15 12.08 1.61 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.424 2.083 . . . . 0.0 112.545 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -158.5 129.92 6.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.02 -1.05 . . . . 0.0 109.513 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.567 ' N ' ' OG ' ' B' ' 80' ' ' SER . 42.4 ttt-85 -177.48 -44.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.831 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -138.8 154.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.92 139.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.295 -0.878 . . . . 0.0 108.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' B' ' 101' ' ' TYR . 2.0 m-30 -106.68 135.99 47.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 111.196 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 54.0 mt -110.21 119.27 38.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -78.52 -137.46 1.22 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 23.2 p -69.42 122.42 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.65 -1.5 . . . . 0.0 109.673 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 mp -126.53 137.78 31.08 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.59 153.53 23.28 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.433 1.422 . . . . 0.0 112.526 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -72.39 -0.91 13.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 109.986 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.4 -35.81 78.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.026 . . . . 0.0 108.513 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.401 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -131.44 117.84 19.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.585 -0.697 . . . . 0.0 109.718 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.457 ' O ' ' CD1' ' B' ' 42' ' ' ILE . 82.1 p -111.42 -135.68 0.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.478 -0.764 . . . . 0.0 110.971 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -64.33 -32.42 74.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.029 -1.044 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.7 -54.44 27.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.184 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -68.11 -42.11 80.73 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.592 -0.693 . . . . 0.0 110.385 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' B' ' 44' ' ' ASP . 1.7 mp -61.1 -53.3 51.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tt -39.58 -21.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.554 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.596 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 91.5 m-20 -125.45 -24.24 3.95 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.732 -1.23 . . . . 0.0 110.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 2.9 tm? -57.22 -39.02 74.64 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.108 -1.62 . . . . 0.0 106.877 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' B' ' 48' ' ' ASN . 85.4 m -83.26 -63.42 1.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.799 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.1 m -37.16 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.775 -0.578 . . . . 0.0 110.119 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' B' ' 46' ' ' CYS . 1.2 m120 -48.09 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.525 0.678 . . . . 0.0 111.112 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.799 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.1 t 174.5 -31.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.19 -174.63 46.89 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.6 158.87 15.01 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.143 2.562 . . . . 0.0 113.028 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.76 145.26 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -90.56 -66.49 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 112.011 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.573 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 64.0 m-20 -117.86 139.72 50.71 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.598 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.15 127.63 38.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -138.02 129.89 28.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.673 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' MET . . . . . 0.417 ' SD ' ' C ' ' B' ' 38' ' ' THR . 0.8 OUTLIER -133.25 144.68 49.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.591 0.71 . . . . 0.0 110.379 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -172.07 170.76 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.491 -0.756 . . . . 0.0 109.134 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' PHE . . . . . 0.51 ' O ' ' SD ' ' B' ' 58' ' ' MET . 0.1 OUTLIER -116.12 -166.93 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.0 109.21 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' B' ' 64' ' ' GLY . 6.6 t0 -105.03 73.98 0.24 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.184 -0.948 . . . . 0.0 110.622 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.41 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 5.9 Cg_endo -57.09 -31.33 89.98 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.04 1.827 . . . . 0.0 112.404 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -63.09 -37.76 88.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.599 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.97 -32.8 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 110.206 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 60' ' ' ASP . . . 99.5 -1.34 57.08 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.51 -40.79 83.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.848 -1.384 . . . . 0.0 109.606 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.491 ' OG ' ' OD2' ' B' ' 60' ' ' ASP . 0.5 OUTLIER -89.6 116.24 27.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.102 -0.999 . . . . 0.0 108.709 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.89 -72.58 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.734 -0.604 . . . . 0.0 109.638 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -123.01 95.74 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' TYR . . . . . 0.711 ' OH ' ' CZ ' ' B' ' 71' ' ' PHE . 0.8 OUTLIER -108.67 130.61 55.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.473 -1.016 . . . . 0.0 109.126 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.73 24.38 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.834 -1.146 . . . . 0.0 112.193 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . 0.711 ' CZ ' ' OH ' ' B' ' 69' ' ' TYR . 12.7 m-30 -115.32 129.4 56.59 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.882 0.849 . . . . 0.0 109.782 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ILE . . . . . 0.526 ' N ' ' CD1' ' B' ' 72' ' ' ILE . 2.2 mp -120.25 102.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.121 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.573 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.5 mt-10 -83.95 131.42 34.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.573 -1.33 . . . . 0.0 110.472 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -93.66 178.24 5.75 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.474 0.654 . . . . 0.0 110.176 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 50.4 ttt180 -52.71 -44.3 66.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 110.216 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 158.58 -177.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.553 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 2.3 mp -35.52 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.683 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.4 tt0 -70.06 -75.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.548 -1.345 . . . . 0.0 109.227 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -62.31 -40.26 95.74 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' B' ' 26' ' ' ARG . 34.0 t -61.64 -39.6 91.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.055 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -57.44 -60.86 3.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' SER . . . . . 0.473 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 21.5 t -63.07 -35.05 78.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.905 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.748 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -73.51 -67.71 0.56 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 0.0 110.411 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' B' ' 80' ' ' SER . 26.2 m -53.59 -37.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.506 -1.371 . . . . 0.0 110.077 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 10.2 mmt180 -62.9 -43.35 99.02 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.559 -1.338 . . . . 0.0 107.898 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' B' ' 82' ' ' SER . 87.0 m-20 -84.0 -45.97 12.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.641 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.748 ' N ' ' O ' ' B' ' 83' ' ' ALA . 0.4 OUTLIER -125.18 84.06 2.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.36 -0.838 . . . . 0.0 110.315 -179.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.4 OUTLIER -110.47 -68.46 0.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' B' ' 88' ' ' ASN . . . -127.66 108.1 0.92 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -139.42 147.55 41.57 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.468 -1.607 . . . . 0.0 108.843 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.6 tp60 -31.32 89.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.556 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 90' ' ' TYR . 60.0 tp -148.89 135.22 19.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.09 -1.006 . . . . 0.0 109.531 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 45.86 -168.74 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 36.7 m -64.83 -25.18 67.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.492 -1.004 . . . . 0.0 110.345 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' B' ' 92' ' ' LEU . 1.1 mmm180 -131.3 160.67 34.27 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.213 -0.929 . . . . 0.0 109.2 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' B' ' 97' ' ' LEU . 6.8 m-85 -95.18 138.89 32.27 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.624 -0.673 . . . . 0.0 110.148 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -43.89 157.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.67 159.84 38.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 109.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' CYS . . . . . 0.578 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.5 OUTLIER -110.49 129.14 55.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.393 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.4 -165.8 13.59 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.531 -1.318 . . . . 0.0 110.824 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.526 ' N ' ' OH ' ' B' ' 29' ' ' TYR . 30.2 p90 -130.53 171.29 13.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.635 -0.92 . . . . 0.0 109.452 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 5.8 t 179.79 27.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 109.964 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 109.395 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 158' ' ' SER . . . . . 0.53 ' C ' ' SG ' ' C' ' 159' ' ' CYS . 23.9 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.343 0.592 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 159' ' ' CYS . . . . . 0.53 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 61.84 14.45 6.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.321 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -102.28 99.24 9.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 3.4 mmm -71.24 151.89 43.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 110.027 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -126.37 78.3 1.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mm -49.94 137.25 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' C' ' 166' ' ' LEU . . . -140.18 172.32 23.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.06 11.44 0.12 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 166' ' ' LEU . . . . . 0.584 ' H ' ' C ' ' C' ' 164' ' ' GLY . 1.2 pp -62.27 163.96 7.68 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.929 . . . . 0.0 109.353 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 167' ' ' ASN . . . . . 0.462 ' O ' ' C ' ' C' ' 168' ' ' TRP . 22.5 t-20 -68.68 123.99 22.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.935 -1.103 . . . . 0.0 109.503 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 168' ' ' TRP . . . . . 0.622 ' CZ2' ' CZ ' ' C' ' 198' ' ' ARG . 3.8 m-90 -37.74 -33.24 0.07 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.784 -0.572 . . . . 0.0 110.437 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 169' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' C' ' 167' ' ' ASN . 23.6 t70 -101.33 99.21 9.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.949 -1.095 . . . . 0.0 111.112 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 3.0 m -157.19 116.12 3.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.26 -0.9 . . . . 0.0 109.314 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 171' ' ' THR . . . . . 0.538 ' O ' ' OD1' ' C' ' 174' ' ' ASN . 0.0 OUTLIER -75.5 173.89 10.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.783 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 172' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -75.47 -71.92 0.34 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.348 -0.845 . . . . 0.0 110.252 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' C' ' 176' ' ' ARG . 91.5 m-20 -38.34 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 174' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' C' ' 175' ' ' LEU . 29.6 p-10 -36.1 -44.83 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.709 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' C' ' 174' ' ' ASN . 5.3 tt -54.79 -46.39 74.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 176' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' C' ' 178' ' ' TYR . 60.9 ttp85 -72.15 -60.34 2.28 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.009 -1.057 . . . . 0.0 108.72 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 177' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' C' ' 176' ' ' ARG . 78.1 mm-40 -40.06 -22.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.067 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 178' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' C' ' 176' ' ' ARG . 16.3 t80 -95.24 -36.57 11.38 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.729 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 179' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' C' ' 176' ' ' ARG . 12.6 m-85 -90.02 12.59 17.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.094 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 180' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' C' ' 182' ' ' TYR . . . -61.28 -55.87 26.81 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.035 -1.041 . . . . 0.0 111.174 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.82 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.765 -1.433 . . . . 0.0 112.048 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 182' ' ' TYR . . . . . 0.634 ' H ' ' C ' ' C' ' 180' ' ' GLY . 22.3 m-85 -107.48 -3.93 18.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.999 -1.063 . . . . 0.0 109.567 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.87 -165.34 27.3 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 184' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' C' ' 208' ' ' GLU . 0.1 OUTLIER -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.286 . . . . 0.0 108.522 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.29 129.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 186' ' ' THR . . . . . 0.543 ' H ' ' HG1' ' C' ' 186' ' ' THR . 0.6 OUTLIER -90.17 -51.42 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.962 . . . . 0.0 109.414 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -149.84 160.91 43.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp -157.62 143.05 17.13 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.22 -1.55 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -117.14 161.25 19.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.142 -0.974 . . . . 0.0 108.774 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 176.78 104.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 191' ' ' MET . . . . . 0.552 ' O ' ' C ' ' C' ' 192' ' ' LYS . 12.9 mtm -122.4 80.04 1.68 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 110.885 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 192' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' C' ' 191' ' ' MET . 41.5 mttp -24.07 -83.66 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 193' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -153.26 152.5 27.87 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.963 . . . . 0.0 109.233 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.55 -57.64 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.166 1.911 . . . . 0.0 112.303 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.48 ' O ' ' C ' ' C' ' 196' ' ' THR . . . -175.53 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 109.071 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 196' ' ' THR . . . . . 0.48 ' C ' ' O ' ' C' ' 195' ' ' ALA . 37.3 p -28.44 -72.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.84 -55.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 198' ' ' ARG . . . . . 0.622 ' CZ ' ' CZ2' ' C' ' 168' ' ' TRP . 18.2 ptt180 -169.33 158.75 8.32 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 199' ' ' SER . . . . . 0.552 ' O ' ' N ' ' C' ' 201' ' ' GLY . 90.3 p -156.42 170.3 22.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.0 -1.063 . . . . 0.0 109.417 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 200' ' ' ARG . . . . . 0.545 ' C ' ' O ' ' C' ' 199' ' ' SER . 0.0 OUTLIER -26.56 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.436 0.636 . . . . 0.0 110.735 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 201' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.33 109.35 2.78 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . 0.466 ' CD2' ' O ' ' C' ' 200' ' ' ARG . 13.0 p90 -129.56 166.67 19.24 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.785 -0.832 . . . . 0.0 108.783 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -137.65 130.02 4.9 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.171 -1.49 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -104.08 115.55 30.62 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.607 -1.525 . . . . 0.0 107.596 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 3.5 mt -115.32 97.02 5.95 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.838 0.828 . . . . 0.0 109.967 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 2.4 m -69.31 80.6 0.36 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.284 0.564 . . . . 0.0 109.651 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . 0.65 ' O ' ' O ' ' C' ' 208' ' ' GLU . 44.2 m-85 -79.56 123.6 27.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 110.943 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 208' ' ' GLU . . . . . 0.65 ' O ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -36.59 -103.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.621 ' H ' ' CG ' ' C' ' 208' ' ' GLU . 9.4 ptmt -51.39 160.6 0.93 Allowed Pre-proline 0 C--N 1.298 -1.665 0 O-C-N 119.744 -1.847 . . . . 0.0 108.326 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -94.85 14.07 1.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.614 2.209 . . . . 0.0 112.478 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 211' ' ' SER . . . . . 0.636 ' HG ' ' N ' ' C' ' 212' ' ' SER . 60.0 p -82.64 -51.16 7.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 212' ' ' SER . . . . . 0.636 ' N ' ' HG ' ' C' ' 211' ' ' SER . 60.6 p -39.58 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.47 -0.769 . . . . 0.0 109.317 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 213' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' C' ' 211' ' ' SER . 4.1 m -66.28 -37.96 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.962 -1.086 . . . . 0.0 108.31 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 214' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' C' ' 211' ' ' SER . 89.9 m-20 -65.19 -49.83 68.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.3 -39.74 94.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 108.68 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' C' ' 212' ' ' SER . 47.7 t -56.49 -49.18 78.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.96 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' C' ' 219' ' ' THR . 13.1 p -82.83 -31.45 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.868 -1.145 . . . . 0.0 111.264 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -74.17 12.87 0.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.933 -1.104 . . . . 0.0 109.697 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.46 ' H ' ' C ' ' C' ' 217' ' ' VAL . 15.8 m -131.28 142.58 50.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.349 -0.844 . . . . 0.0 108.885 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -107.23 67.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 108.973 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 221' ' ' HIS . . . . . 0.796 ' CD2' ' H ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -55.54 163.95 1.16 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.706 -0.621 . . . . 0.0 109.95 -179.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 222' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' C' ' 226' ' ' LYS . 0.2 OUTLIER -142.14 74.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.902 0.858 . . . . 0.0 108.789 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 223' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -49.08 -71.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.233 -0.917 . . . . 0.0 110.67 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 224' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' C' ' 224' ' ' ASP . 58.3 t0 -89.81 12.19 17.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.75 -1.219 . . . . 0.0 109.606 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 81.01 17.12 73.06 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 226' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' C' ' 222' ' ' ILE . 27.3 mmtp -95.16 -153.94 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.4 90.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.071 -1.018 . . . . 0.0 109.921 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 34.0 pt -84.97 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -114.63 96.61 44.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.362 -0.837 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 230' ' ' PRO . . . . . 0.573 ' CG ' ' HE2' ' C' ' 221' ' ' HIS . 1.7 Cg_endo -74.65 125.67 9.67 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.384 2.056 . . . . 0.0 111.704 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.64 134.3 35.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 109.767 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -62.73 148.84 45.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.322 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -46.91 139.86 5.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.992 . . . . 0.0 109.196 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 234' ' ' ILE . . . . . 0.425 HG21 HD11 ' C' ' 234' ' ' ILE . 28.6 mt -121.84 127.51 25.97 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.52 -0.737 . . . . 0.0 109.491 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.84 147.78 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.874 1.716 . . . . 0.0 112.276 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -58.66 -38.43 78.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.86 -41.42 74.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 109.134 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 238' ' ' GLU . . . . . 0.592 ' N ' ' OE1' ' C' ' 238' ' ' GLU . 9.1 mp0 -71.79 -39.91 69.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.912 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 239' ' ' GLN . . . . . 0.456 ' O ' ' OG1' ' C' ' 242' ' ' THR . 9.2 tt0 -58.98 -43.68 91.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.17 -41.89 76.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 241' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' C' ' 242' ' ' THR . 16.0 ttmm -61.08 -45.38 94.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.124 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 242' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 50.0 p -40.63 139.28 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.148 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.67 143.35 17.78 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -118.71 130.26 55.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.86 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.57 143.43 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 246' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -104.14 128.57 51.81 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.48 0.657 . . . . 0.0 109.975 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 14.1 t -100.63 133.07 45.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.951 0.881 . . . . 0.0 110.392 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.64 158.32 14.4 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.07 83.0 0.2 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.063 -1.257 . . . . 0.0 110.542 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.37 127.86 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -1.108 . . . . 0.0 108.855 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 251' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' C' ' 254' ' ' VAL . . . -52.61 111.87 1.83 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.92 -20.86 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.802 1.668 . . . . 0.0 111.66 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -96.52 16.17 19.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.479 -0.763 . . . . 0.0 109.265 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 254' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' C' ' 251' ' ' GLY . 48.8 t -97.86 135.62 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.96 163.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 108.964 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.36 -25.89 80.8 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.653 2.235 . . . . 0.0 112.09 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -50.03 -62.74 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.233 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 258' ' ' GLU . . . . . 0.626 ' O ' ' N ' ' C' ' 261' ' ' GLU . 77.3 mm-40 -60.43 -74.18 0.08 Allowed 'General case' 0 C--O 1.194 -1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 108.51 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 259' ' ' PHE . . . . . 0.575 ' C ' ' O ' ' C' ' 258' ' ' GLU . 89.1 t80 -16.82 -67.51 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.889 0.852 . . . . 0.0 111.045 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -61.24 -44.65 96.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 109.51 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 261' ' ' GLU . . . . . 0.626 ' N ' ' O ' ' C' ' 258' ' ' GLU . 35.5 tp10 -68.37 -7.68 33.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 262' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' C' ' 263' ' ' PHE . 13.9 t80 -92.76 -76.45 0.46 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 263' ' ' PHE . . . . . 0.561 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 82.4 m-85 -45.74 -33.57 3.1 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.093 -1.443 . . . . 0.0 109.466 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 264' ' ' SER . . . . . 0.476 ' HG ' ' C ' ' C' ' 261' ' ' GLU . 48.1 p -34.6 -37.5 0.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.942 -0.474 . . . . 0.0 111.786 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 265' ' ' GLN . . . . . 0.573 ' C ' ' H ' ' C' ' 267' ' ' GLY . 0.2 OUTLIER -58.52 -95.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.19 -1.569 . . . . 0.0 110.118 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 266' ' ' TRP . . . . . 0.679 ' CD1' ' O ' ' C' ' 266' ' ' TRP . 0.6 OUTLIER -69.92 19.25 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.025 -1.047 . . . . 0.0 109.38 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 267' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' C' ' 265' ' ' GLN . . . -136.17 128.16 4.45 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 268' ' ' THR . . . . . 0.528 ' O ' ' C ' ' C' ' 269' ' ' ILE . 58.1 p -85.5 6.6 26.27 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.365 -1.079 . . . . 0.0 109.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 269' ' ' ILE . . . . . 0.528 ' C ' ' O ' ' C' ' 268' ' ' THR . 5.4 pt -14.67 96.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 122.451 1.119 . . . . 0.0 113.865 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.85 -35.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -135.94 94.87 3.12 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 272' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -137.81 172.05 13.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 273' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 7.7 tt0 164.99 156.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.563 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 274' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 16.3 tp -97.0 140.63 31.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -90.4 156.33 18.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.564 -1.335 . . . . 0.0 108.686 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.67 -169.22 3.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.125 -0.984 . . . . 0.0 109.397 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 277' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 36.8 p-10 -61.84 -38.38 88.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 278' ' ' LYS . . . . . 0.583 ' N ' ' OD1' ' C' ' 277' ' ' ASP . 13.3 tttp -63.29 -42.8 99.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -66.76 -61.03 2.17 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.114 -0.991 . . . . 0.0 109.243 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 178.74 129.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.1 -118.78 5.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 282' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.3 tt0 -166.37 150.33 7.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.311 . . . . 0.0 111.009 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 283' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' C' ' 283' ' ' SER . 4.5 t -62.17 66.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 110.213 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 284' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' C' ' 282' ' ' GLN . 72.3 mtt85 -55.77 -22.28 23.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 137.73 12.81 0.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 32.4 p90 -106.5 165.09 11.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 110.534 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.71 178.99 37.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -134.61 154.44 51.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.441 -1.623 . . . . 0.0 109.725 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.01 138.04 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 290' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' C' ' 269' ' ' ILE . 10.1 m -123.0 126.0 46.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.96 -1.088 . . . . 0.0 109.943 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 291' ' ' TYR . . . . . 0.469 ' CE1' ' CA ' ' C' ' 267' ' ' GLY . 41.0 m-85 -113.55 133.09 55.45 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 292' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' C' ' 293' ' ' SER . 25.9 p-10 -53.02 -46.22 68.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.625 -1.297 . . . . 0.0 108.767 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 293' ' ' SER . . . . . 0.567 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 67.3 m -88.15 164.75 15.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.11 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 294' ' ' ALA . . . . . 0.406 ' O ' ' CG1' ' C' ' 297' ' ' VAL . . . -102.83 -22.38 13.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -50.08 -38.51 38.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.005 -1.06 . . . . 0.0 108.535 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.69 31.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 297' ' ' VAL . . . . . 0.575 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 1.4 p -54.99 -54.95 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.339 -1.476 . . . . 0.0 108.242 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 298' ' ' ASP . . . . . 0.416 ' H ' HG13 ' C' ' 297' ' ' VAL . 92.4 m-20 -57.84 -19.5 29.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.895 -1.128 . . . . 0.0 109.606 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -76.9 -58.37 3.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 108.877 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 300' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' C' ' 303' ' ' ASN . 7.2 p -68.11 -25.22 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 301' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 65.6 m -43.9 -52.07 7.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.115 -0.991 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -50.92 -22.21 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 303' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' C' ' 300' ' ' VAL . 20.1 t-20 -100.13 65.76 1.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.0 109.446 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 304' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' C' ' 303' ' ' ASN . 55.7 tttp -46.17 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.688 -1.257 . . . . 0.0 108.753 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 305' ' ' PHE . . . . . 0.644 ' CE1' ' CG ' ' C' ' 314' ' ' GLU . 90.9 m-85 -76.79 133.93 39.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.5 mt -130.39 148.34 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.369 -0.832 . . . . 0.0 109.019 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 307' ' ' ASP . . . . . 0.571 ' OD1' ' NZ ' ' C' ' 312' ' ' LYS . 78.1 m-20 -76.66 123.97 26.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 108.608 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 308' ' ' PHE . . . . . 0.579 ' O ' ' N ' ' C' ' 310' ' ' ASP . 52.6 t80 -123.44 173.16 8.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -0.873 . . . . 0.0 109.345 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 309' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -40.45 -23.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 310' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 46.0 t0 -94.23 -154.5 0.42 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 311' ' ' ARG . . . . . 0.601 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 87.8 mtt180 -79.0 -55.71 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 312' ' ' LYS . . . . . 0.571 ' NZ ' ' OD1' ' C' ' 307' ' ' ASP . 24.9 tptt -157.37 147.04 20.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.176 -0.953 . . . . 0.0 109.183 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 313' ' ' ILE . . . . . 0.431 HG22 HD12 ' C' ' 313' ' ' ILE . 41.7 pt -129.85 147.64 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.877 . . . . 0.0 109.229 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 314' ' ' GLU . . . . . 0.644 ' CG ' ' CE1' ' C' ' 305' ' ' PHE . 85.2 mt-10 -99.43 144.31 28.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 36.2 mt -118.39 147.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.909 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -155.58 148.23 24.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.001 . . . . 0.0 108.976 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 317' ' ' ARG . . . . . 0.441 ' NH1' ' CB ' ' C' ' 317' ' ' ARG . 5.7 ptm85 -68.77 152.49 45.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.948 -1.095 . . . . 0.0 109.579 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.57 93.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 109.109 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.632 -179.554 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.904 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.921 1 C5'-C4'-C3' 107.702 -5.199 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.904 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.444 2.529 1 C5'-C4'-C3' 108.209 -4.861 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 0.679 " O2'" H5'' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.435 1.787 1 C5'-C4'-C3' 108.002 -4.999 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.73 ' C4 ' ' CZ2' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.443 2.4 1 C5'-C4'-C3' 106.622 -5.919 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.81 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.782 1 C3'-C2'-C1' 105.598 4.553 OUTLIER-DELTA 0.552 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.978 " H4'" " C5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.61 1.667 2 C5'-C4'-C3' 109.396 -4.07 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.978 " C5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.421 1 C5'-C4'-C3' 107.809 -5.127 . 0.186 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.626 ' OP2' " H4'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.705 1 C5'-C4'-C3' 107.937 -5.042 . 0.524 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.893 " H4'" ' CE2' ' B' ' 69' ' ' TYR . . . . . . . . 0 O4'--C4' 1.423 -2.498 0 C5'-C4'-C3' 110.168 -3.555 . 0.661 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 0.87 " H2'" ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 C5'-C4'-C3' 109.551 -3.966 . 0.432 7a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.87 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.611 1.779 1 C5'-C4'-C3' 107.851 -5.099 . 0.929 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.757 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 1.96 1 C5'-C4'-C3' 107.258 -5.495 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.517 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.891 1 C5'-C4'-C3' 107.59 -5.273 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.424 0.63 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.28 175.2 3.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.956 2.437 . . . . 0.0 111.827 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.36 -2.88 9.37 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.825 2.35 . . . . 0.0 113.117 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' B' ' 77' ' ' LEU . 60.0 p -156.77 136.98 12.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.908 -1.12 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -179.12 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.529 0.68 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' B' ' 100' ' ' GLY . 2.4 t -128.05 163.48 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.891 . . . . 0.0 109.953 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.44 136.63 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 108.404 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.696 ' CZ ' ' C2 ' ' A' ' 9' ' ' ' A' . 10.3 m-30 -106.78 119.49 39.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.017 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.435 ' N ' ' CD2' ' B' ' 30' ' ' LEU . 1.7 mm? -106.61 105.45 15.48 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -107.03 -72.79 0.81 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.84 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.418 ' OG ' ' CB ' ' B' ' 94' ' ' SER . 7.8 t -69.2 82.71 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.929 -1.336 . . . . 0.0 110.014 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.94 121.29 6.09 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.59 ' C ' ' H ' ' B' ' 36' ' ' ASP . 30.0 Cg_endo -69.72 164.35 34.83 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.515 1.477 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -59.73 2.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.589 -0.694 . . . . 0.0 109.468 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.59 ' H ' ' C ' ' B' ' 34' ' ' PRO . 89.3 m-20 -63.99 -39.16 93.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.23 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.4 113.98 18.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.581 -0.699 . . . . 0.0 109.158 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.4 p -110.05 -139.88 0.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 111.2 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.43 ' C ' ' CD ' ' B' ' 39' ' ' GLU . 0.5 OUTLIER -63.02 -29.45 70.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.962 -1.086 . . . . 0.0 110.794 -178.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -71.18 -54.39 11.18 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.343 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -49.05 64.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' B' ' 44' ' ' ASP . 24.1 mm -55.33 -52.58 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 42' ' ' ILE . 42.0 tp -37.6 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.839 -0.538 . . . . 0.0 110.846 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.604 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 88.8 m-20 -123.5 -24.75 4.51 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.585 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.407 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.2 tm? -57.64 -39.44 76.98 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 119.905 -1.747 . . . . 0.0 106.612 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.623 ' O ' ' N ' ' B' ' 48' ' ' ASN . 0.8 OUTLIER -84.48 -63.68 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.801 . . . . 0.0 109.289 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.758 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.7 t -38.8 -21.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.797 -0.564 . . . . 0.0 109.798 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.623 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.36 68.9 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.893 0.854 . . . . 0.0 110.511 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.758 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.51 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.804 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.36 -155.7 19.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.75 159.83 38.24 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.325 2.016 . . . . 0.0 112.327 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.489 ' CG1' ' H ' ' B' ' 53' ' ' ILE . 3.0 t -120.92 -152.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.489 ' H ' ' CG1' ' B' ' 52' ' ' VAL . 31.8 mm -151.91 -64.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.827 -1.171 . . . . 0.0 109.577 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -126.65 146.56 50.14 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.645 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.37 130.69 26.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -137.08 144.59 43.2 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 108.827 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.91 135.24 39.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.5 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 0.533 ' CE ' ' C2 ' ' A' ' 10' ' ' ' U' . 3.8 mpp? -158.39 166.88 31.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.416 -0.802 . . . . 0.0 109.202 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.442 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.1 OUTLIER -122.06 -168.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.559 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 25.2 p-10 -101.1 73.88 0.11 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 112.508 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.545 ' HD2' H5'' ' A' ' 11' ' ' ' A' . 28.6 Cg_endo -67.68 -36.65 18.46 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.623 1.549 . . . . 0.0 111.222 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -101.99 -59.91 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.517 -0.74 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 75.5 p -48.7 -40.72 29.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.419 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.67 26.81 68.62 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.559 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 32.1 mtp180 -131.8 -68.01 0.66 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -1.115 . . . . 0.0 110.216 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.554 ' CB ' " H4'" ' A' ' 10' ' ' ' U' . 0.0 OUTLIER -50.01 120.39 4.36 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.832 0.825 . . . . 0.0 110.791 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.32 -74.61 0.43 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.066 -1.021 . . . . 0.0 108.699 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -115.69 94.7 0.67 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 0.893 ' CE2' " H4'" ' A' ' 9' ' ' ' A' . 2.0 m-85 -112.52 130.49 55.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.039 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.41 138.86 31.41 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.356 -0.937 . . . . 0.0 109.574 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.721 ' CZ ' ' N3 ' ' A' ' 9' ' ' ' A' . 4.2 m-30 -105.68 122.98 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.617 ' CD1' ' N ' ' B' ' 72' ' ' ILE . 1.6 mp -118.17 98.81 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.294 -0.879 . . . . 0.0 111.485 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -83.11 133.14 35.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.495 -1.378 . . . . 0.0 110.91 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.39 174.87 6.92 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.629 0.728 . . . . 0.0 110.996 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 11.7 ttt-85 -53.2 -42.36 66.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.708 -0.62 . . . . 0.0 110.967 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.5 m-20 160.7 179.19 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.534 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 9.3 mt -38.09 -22.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.856 -0.528 . . . . 0.0 109.63 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.7 mt-10 -70.23 -73.3 0.17 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.215 1.007 . . . . 0.0 109.324 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m -61.73 -40.93 96.84 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.824 -1.173 . . . . 0.0 108.297 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.3 m -62.54 -35.67 80.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.193 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -59.64 -56.66 19.09 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.598 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 70.2 m -65.25 -35.95 82.61 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.955 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -80.43 -61.86 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 110.9 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.583 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 41.5 t -56.16 -40.61 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.03 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' B' ' 81' ' ' ALA . 0.0 OUTLIER -68.14 -51.55 44.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.021 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' B' ' 82' ' ' SER . 81.4 m-20 -67.52 -44.21 78.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' B' ' 83' ' ' ALA . 1.7 pp -139.98 121.45 15.1 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.129 -0.982 . . . . 0.0 110.15 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 84' ' ' VAL . 1.4 p30 -143.89 -56.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.11 104.35 0.77 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -138.11 146.39 42.81 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.537 -1.566 . . . . 0.0 108.255 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.556 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.1 tp-100 -33.72 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.508 -0.745 . . . . 0.0 111.217 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 90' ' ' TYR . 62.5 tp -146.19 126.16 13.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.69 -147.62 48.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' SER . . . . . 0.418 ' CB ' ' OG ' ' B' ' 32' ' ' SER . 0.2 OUTLIER -92.36 -18.87 22.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.054 -1.263 . . . . 0.0 109.537 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' B' ' 92' ' ' LEU . 60.2 mtp180 -131.02 161.19 32.53 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.458 ' O ' ' C ' ' B' ' 97' ' ' LEU . 8.9 m-85 -94.57 137.41 33.73 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.2 -0.937 . . . . 0.0 110.072 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.515 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -40.44 145.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -109.74 151.98 26.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 11.0 p -77.37 108.46 10.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.471 -0.768 . . . . 0.0 109.214 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -87.0 173.17 44.6 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 54.8 p90 -152.15 -32.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -1.065 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' SER . . . . . 0.464 ' C ' ' O ' ' B' ' 101' ' ' TYR . 74.3 m -37.01 143.33 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.35 -0.844 . . . . 0.0 110.666 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 16.5 t -133.9 141.03 47.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -108.8 124.95 51.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.355 -0.84 . . . . 0.0 109.44 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.464 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 28.4 mttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.252 0.548 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . 0.537 ' O ' ' NH2' ' C' ' 232' ' ' ARG . 97.0 mt-10 -62.44 -34.82 77.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.805 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 158' ' ' SER . . . . . 0.527 ' CB ' ' HE ' ' C' ' 232' ' ' ARG . 32.9 t -138.7 140.61 38.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 109.979 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.8 OUTLIER 170.36 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . 0.624 ' HZ3' ' HZ3' ' C' ' 189' ' ' LYS . 12.1 ttmm -83.7 140.22 32.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.036 -1.04 . . . . 0.0 108.275 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 2.4 ptm -125.78 169.92 12.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.952 -1.092 . . . . 0.0 109.323 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.692 ' CZ ' ' C8 ' ' A' ' 6' ' ' ' A' . 54.0 t80 -121.5 80.8 1.72 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.567 -0.708 . . . . 0.0 109.693 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mm -50.29 131.98 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' C' ' 229' ' ' ASP . . . -133.88 156.36 22.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.668 ' N ' ' O4 ' ' A' ' 5' ' ' ' U' . . . 75.39 28.42 61.78 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.41 142.32 53.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.52 -0.988 . . . . 0.0 109.768 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' C' ' 169' ' ' ASP . 47.5 t30 -69.27 140.89 54.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.73 ' CZ2' ' C4 ' ' A' ' 4' ' ' ' A' . 7.5 m0 -63.63 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.069 -1.019 . . . . 0.0 110.307 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . 0.6 ' H ' ' C ' ' C' ' 167' ' ' ASN . 57.4 m-20 -157.66 64.95 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.938 -1.102 . . . . 0.0 109.825 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 34.0 m -134.16 153.3 51.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.133 -0.98 . . . . 0.0 110.688 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.97 167.71 11.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.495 -0.753 . . . . 0.0 109.117 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.69 -67.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.754 -1.216 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -47.23 -36.13 8.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.034 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . 0.444 ' OD1' ' C ' ' C' ' 174' ' ' ASN . 1.6 t30 -69.74 -52.21 27.44 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 12.4 tp -55.46 -41.84 73.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' C' ' 177' ' ' GLU . 25.4 ttp85 -66.12 -60.43 2.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.103 -0.998 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -44.76 -31.35 1.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.231 -0.918 . . . . 0.0 108.783 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' C' ' 178' ' ' TYR . 21.8 t80 -76.01 -49.58 17.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.739 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.781 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.4 m-85 -72.16 -49.37 36.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.309 -0.869 . . . . 0.0 111.664 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.21 23.91 0.01 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 119.568 -1.958 . . . . 0.0 112.405 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . 0.781 ' N ' ' O ' ' C' ' 179' ' ' PHE . 4.9 ttpm? -90.24 -13.85 34.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.89 -1.359 . . . . 0.0 107.614 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . 0.616 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 32.0 m-85 -91.08 -62.69 1.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.4 -125.22 2.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 27.4 m -122.89 145.61 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -1.0 . . . . 0.0 109.86 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.66 142.61 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 9.7 t -97.1 -37.47 10.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 110.337 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' C' ' 206' ' ' SER . 42.9 t0 -165.08 160.39 18.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.986 -1.071 . . . . 0.0 110.202 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.36 147.71 22.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . 0.624 ' HZ3' ' HZ3' ' C' ' 160' ' ' LYS . 23.6 mttp -114.86 90.85 3.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 110.175 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 10.3 tt -84.79 142.35 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 191' ' ' MET . . . . . 0.533 ' O ' ' C ' ' C' ' 192' ' ' LYS . 0.0 OUTLIER -98.85 -47.56 5.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.188 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' C' ' 191' ' ' MET . 0.1 OUTLIER -30.8 124.53 0.19 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.636 0.732 . . . . 0.0 110.214 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . 0.438 ' CG ' ' OG1' ' C' ' 196' ' ' THR . 15.7 t0 -134.45 87.16 33.13 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.13 -22.62 75.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.312 2.008 . . . . 0.0 111.389 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.41 -52.51 15.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.627 -0.67 . . . . 0.0 109.894 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 196' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' C' ' 193' ' ' ASP . 3.0 p -70.61 -35.9 73.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 109.78 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 153.9 -76.22 0.22 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -168.65 155.1 7.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -1.18 . . . . 0.0 110.171 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 199' ' ' SER . . . . . 0.428 ' O ' ' C ' ' C' ' 200' ' ' ARG . 23.0 t -151.68 168.73 24.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' C' ' 199' ' ' SER . 14.1 mmp_? -46.44 143.52 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.937 -1.102 . . . . 0.0 108.286 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . 0.555 ' O ' ' O2 ' ' A' ' 5' ' ' ' U' . . . -94.27 91.25 1.42 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.121 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' C' ' 202' ' ' PHE . 25.1 p90 -152.25 167.17 29.47 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.38 130.99 3.32 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 118.149 -1.977 . . . . 0.0 110.766 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.14 120.7 29.74 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 119.992 -1.887 . . . . 0.0 107.271 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.33 104.79 14.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 109.148 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.4 OUTLIER -80.44 73.08 7.35 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.543 0.687 . . . . 0.0 109.606 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -67.95 114.74 6.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.981 -1.074 . . . . 0.0 109.408 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.75 -48.03 83.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 108.947 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' C' ' 211' ' ' SER . 1.8 mtmp? -84.36 101.3 1.41 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.992 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -39.38 -23.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 121.871 1.714 . . . . 0.0 112.704 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.473 ' N ' ' O ' ' C' ' 209' ' ' LYS . 17.9 t -62.26 -57.1 12.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.013 -1.054 . . . . 0.0 110.585 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.545 ' O ' ' CG2' ' C' ' 216' ' ' VAL . 24.7 m -41.51 -34.91 0.62 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.29 -0.881 . . . . 0.0 109.53 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.97 -43.02 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' C' ' 211' ' ' SER . 61.8 t0 -60.83 -50.64 72.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 0.0 110.506 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . 0.478 ' O ' ' OG1' ' C' ' 219' ' ' THR . 19.7 pt-20 -73.63 -31.83 63.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.967 -1.083 . . . . 0.0 109.972 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' C' ' 212' ' ' SER . 22.6 t -61.48 -50.99 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.747 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 8.5 p -74.02 -29.9 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.511 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -85.01 17.48 2.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.495 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' C' ' 215' ' ' GLU . 32.0 m -136.43 147.3 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.921 -1.112 . . . . 0.0 109.46 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -102.63 136.33 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.248 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.705 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -139.82 167.65 21.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.858 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.0 107.2 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.825 . . . . 0.0 108.899 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . 0.408 ' CD1' ' CG ' ' C' ' 178' ' ' TYR . 1.0 OUTLIER -73.43 -71.96 0.29 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 109.796 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . 0.574 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 60.2 t0 -84.95 0.45 51.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.039 -1.038 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.03 13.23 72.21 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . 0.579 ' NZ ' ' O ' ' C' ' 278' ' ' LYS . 1.2 tpmt? -90.09 -78.76 0.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -1.019 . . . . 0.0 109.325 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 174.75 109.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.251 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 17.9 pt -113.96 148.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.706 -0.621 . . . . 0.0 110.132 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' C' ' 164' ' ' GLY . 0.7 OUTLIER -125.43 96.68 38.36 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . 0.4 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 46.8 Cg_endo -85.4 125.31 2.93 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.564 2.176 . . . . 0.0 112.028 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -141.18 143.05 34.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.699 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.537 ' NH2' ' O ' ' C' ' 157' ' ' GLU . 75.1 ttt-85 -57.45 153.96 11.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 108.591 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -44.31 137.57 3.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 108.856 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.92 135.99 22.51 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.406 -0.809 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.24 139.19 16.39 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.809 1.672 . . . . 0.0 112.125 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.25 -44.58 88.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.518 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 34.0 p-10 -63.31 -38.65 91.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 109.856 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . 0.589 ' N ' ' OD1' ' C' ' 237' ' ' ASP . 48.6 tp10 -66.0 -40.34 91.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.399 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . 0.656 ' NE2' ' C8 ' ' A' ' 6' ' ' ' A' . 14.3 tt0 -62.31 -43.91 97.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.1 -39.24 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.049 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -63.32 -39.53 94.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.936 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 66.9 p -50.76 141.65 12.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.851 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.09 160.5 14.74 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' C' ' 318' ' ' ALA . 22.9 tttt -136.37 133.39 36.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.243 . . . . 0.0 110.45 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.61 147.57 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.51 -0.744 . . . . 0.0 109.463 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 4.7 t80 -103.0 130.42 50.09 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 10.1 t -100.14 134.97 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.784 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 249' ' ' GLY . . . -105.89 155.85 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 248' ' ' GLY . . . 59.66 141.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 2.7 tp -162.5 164.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.427 -1.043 . . . . 0.0 109.158 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -54.82 155.03 8.86 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.81 -28.78 86.99 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.548 2.166 . . . . 0.0 112.119 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.69 73.98 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.05 134.58 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.638 0.732 . . . . 0.0 109.932 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -96.32 157.05 36.19 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -57.74 -21.75 49.49 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.593 2.196 . . . . 0.0 111.859 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -51.98 -63.66 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.605 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . 0.723 ' O ' ' N ' ' C' ' 261' ' ' GLU . 76.0 mm-40 -58.21 -88.11 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . 0.619 ' C ' ' O ' ' C' ' 258' ' ' GLU . 36.9 t80 -9.59 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.309 0.576 . . . . 0.0 111.449 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' C' ' 258' ' ' GLU . 96.9 mt-10 -56.71 -44.29 81.43 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.07 -1.019 . . . . 0.0 109.404 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . 0.723 ' N ' ' O ' ' C' ' 258' ' ' GLU . 76.3 mm-40 -69.44 -40.28 77.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . 0.417 ' O ' ' CG ' ' C' ' 265' ' ' GLN . 70.3 t80 -49.37 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.505 -0.747 . . . . 0.0 109.363 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.471 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 93.5 m-85 -55.39 -32.12 62.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.576 -1.328 . . . . 0.0 110.465 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.423 ' C ' ' O ' ' C' ' 263' ' ' PHE . 13.0 t -38.29 -38.32 0.35 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.822 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' C' ' 264' ' ' SER . 0.2 OUTLIER -52.11 -95.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.322 -1.486 . . . . 0.0 109.9 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.471 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -63.56 152.55 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.29 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 52.96 103.2 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 60.5 m -49.9 138.47 15.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.245 . . . . 0.0 107.785 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -99.63 104.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.103 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.5 -50.29 35.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.8 -1.187 . . . . 0.0 109.189 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . 0.497 ' O ' ' OG1' ' C' ' 290' ' ' THR . 57.4 t0 -142.36 98.05 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 109.611 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -128.25 166.39 18.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 109.419 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.1 OUTLIER 167.26 162.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.214 1.007 . . . . 0.0 111.367 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 5.9 tp -99.82 144.24 29.1 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 275' ' ' MET . . . . . 0.556 ' SD ' ' OD2' ' C' ' 279' ' ' ASP . 23.0 mmm -92.01 160.02 15.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.195 -1.566 . . . . 0.0 108.304 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.28 153.3 42.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' C' ' 281' ' ' GLY . 0.0 OUTLIER -49.73 -31.89 12.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 108.619 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . 0.579 ' O ' ' NZ ' ' C' ' 226' ' ' LYS . 57.4 tttp -54.99 -40.46 70.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.366 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' C' ' 275' ' ' MET . 91.3 m-20 -60.9 -37.4 82.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.35 -39.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.777 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' C' ' 277' ' ' ASP . . . 125.63 30.64 0.88 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.597 ' O ' ' N ' ' C' ' 284' ' ' ARG . 60.8 mm-40 -119.4 42.72 2.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.352 -1.087 . . . . 0.0 110.13 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 283' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' C' ' 283' ' ' SER . 6.6 t -62.51 39.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.247 -0.908 . . . . 0.0 110.032 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' C' ' 282' ' ' GLN . 68.2 mtp85 -55.87 -34.17 65.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -0.974 . . . . 0.0 109.44 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.85 79.55 0.38 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' C' ' 282' ' ' GLN . 0.0 OUTLIER -146.75 -176.02 5.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.578 -1.542 . . . . 0.0 111.984 -178.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -157.89 164.65 33.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . 0.455 ' CZ ' " O4'" ' A' ' 3' ' ' ' U' . 64.8 m-85 -138.06 151.02 47.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.951 -1.323 . . . . 0.0 108.55 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -146.29 141.97 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.433 -1.417 . . . . 0.0 108.389 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 290' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' C' ' 271' ' ' ASP . 23.9 m -130.12 129.24 43.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.044 -1.035 . . . . 0.0 109.988 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.98 156.0 27.04 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . 0.454 ' C ' ' OD1' ' C' ' 292' ' ' ASP . 54.2 p30 -79.95 15.54 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.733 -1.23 . . . . 0.0 109.714 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 22.7 t -158.76 168.57 26.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.195 -0.94 . . . . 0.0 108.985 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.05 -12.05 20.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -57.31 -48.32 79.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.469 -0.769 . . . . 0.0 109.162 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.22 88.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.047 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.08 -57.74 6.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.22 -30.23 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' C' ' 302' ' ' GLN . 59.2 ttm-85 -63.86 -64.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.44 -0.787 . . . . 0.0 109.325 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' C' ' 303' ' ' ASN . 9.0 p -65.54 -23.0 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.415 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . 0.498 ' SG ' ' NH1' ' C' ' 317' ' ' ARG . 45.0 t -48.24 -57.32 6.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.062 -1.024 . . . . 0.0 109.706 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' C' ' 299' ' ' ARG . 3.9 pt20 -49.45 -22.33 1.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.109 . . . . 0.0 108.515 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' C' ' 300' ' ' VAL . 92.4 m-20 -99.67 69.73 1.62 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.9 -82.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.672 -1.268 . . . . 0.0 108.869 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -69.63 126.6 30.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.162 -0.961 . . . . 0.0 109.493 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 59.6 mt -120.22 145.45 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.37 114.69 11.87 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' C' ' 309' ' ' LYS . 22.1 t80 -114.59 -178.08 3.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.578 ' C ' ' O ' ' C' ' 308' ' ' PHE . 73.8 mttt -19.75 -82.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 0.0 111.998 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' C' ' 311' ' ' ARG . 47.6 p30 -127.97 -16.41 4.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 110.201 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . 0.429 ' N ' ' OD1' ' C' ' 310' ' ' ASP . 40.1 mtp180 -121.2 125.81 48.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -52.77 164.96 0.31 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.43 -0.793 . . . . 0.0 109.398 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.59 122.85 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.83 103.79 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 0.0 109.68 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 5.6 mm -72.53 146.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.014 -1.054 . . . . 0.0 110.046 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -154.04 152.39 30.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . 0.625 ' CD ' ' H ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER -59.73 149.69 30.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 108.998 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . 0.555 ' O ' ' N1 ' ' A' ' 2' ' ' ' A' . . . -50.77 -25.32 4.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.899 -1.126 . . . . 0.0 108.921 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . 0.485 ' OE1' ' O4 ' ' A' ' 3' ' ' ' U' . 2.0 mt-10 179.13 -51.05 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' C' ' 319' ' ' GLU . 55.3 Cg_exo -49.05 103.32 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.272 1.981 . . . . 0.0 112.419 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -60.1 -35.08 74.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.407 -0.808 . . . . 0.0 109.479 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 10.8 t60 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.463 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.849 HO5' ' P ' ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.441 2.235 1 C5'-C4'-C3' 107.8 -5.133 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.802 " O2'" ' H6 ' ' A' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.054 1 C5'-C4'-C3' 108.197 -4.869 . 0.742 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 1.073 " O2'" " H5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 P--O5' 1.612 1.904 2 O4'-C1'-N19 113.422 5.222 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 1.073 " H5'" " O2'" ' A' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.442 2.332 1 C5'-C4'-C3' 108.866 -4.423 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.845 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.446 2.682 1 C5'-C4'-C3' 108.895 -4.403 . 0.634 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 1.021 " H4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.429 -1.998 1 C5'-C4'-C3' 108.068 -4.955 . 0.642 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 1.021 " H5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.618 2.55 1 C5'-C4'-C3' 106.183 -6.211 . 0.137 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.678 ' OP2' " H4'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.443 2.423 1 C5'-C4'-C3' 108.042 -4.972 . 0.459 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.915 H5'' ' CZ ' ' B' ' 69' ' ' TYR . . . . . . . . 0 P--O5' 1.611 1.78 2 C5'-C4'-C3' 108.347 -4.769 . 0.585 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 0.853 " O5'" ' H6 ' ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.438 1.994 2 C5'-C4'-C3' 107.94 -5.04 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.692 ' H8 ' " C2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.431 -1.796 1 C5'-C4'-C3' 105.751 -6.5 . 0.075 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.678 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.95 1 C5'-C4'-C3' 107.426 -5.383 . 0.052 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.518 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.844 1 C5'-C4'-C3' 107.61 -5.26 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.57 ' O ' ' CG ' ' B' ' 101' ' ' TYR . 16.1 Cg_exo -63.05 -176.92 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.819 2.346 . . . . 0.0 111.84 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 23' ' ' PRO . 71.0 Cg_endo -86.9 25.79 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.91 2.407 . . . . 0.0 112.811 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.58 107.22 2.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.907 -1.121 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.526 ' N ' ' HG ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -162.74 -40.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' B' ' 28' ' ' VAL . 1.2 p -139.56 158.0 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.664 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.436 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.9 t -108.59 134.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.625 ' CZ ' ' N1 ' ' A' ' 9' ' ' ' A' . 9.1 m-30 -99.51 117.08 33.12 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.603 0.716 . . . . 0.0 109.682 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' B' ' 30' ' ' LEU . 1.1 mm? -101.98 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.581 ' C ' ' H ' ' B' ' 33' ' ' ILE . . . -146.75 -53.84 0.02 OUTLIER Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.986 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 27.6 t -69.5 30.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -1.21 . . . . 0.0 109.981 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.581 ' H ' ' C ' ' B' ' 31' ' ' GLY . 4.9 mp -108.71 136.37 19.98 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' B' ' 36' ' ' ASP . 83.0 Cg_endo -87.64 -176.01 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.743 1.629 . . . . 0.0 111.444 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.606 ' OH ' ' CG ' ' B' ' 59' ' ' PHE . 3.0 m-30 -67.1 0.45 2.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.73 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.554 ' CB ' HE22 ' B' ' 37' ' ' GLN . 62.7 m-20 -67.08 -45.27 77.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.964 -1.085 . . . . 0.0 108.968 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.554 HE22 ' CB ' ' B' ' 36' ' ' ASP . 11.8 mp0 -107.25 100.32 9.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.236 -0.915 . . . . 0.0 109.09 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -98.57 -153.95 0.45 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.651 -0.656 . . . . 0.0 110.079 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 40.2 tt0 -57.22 -26.29 60.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.141 -0.974 . . . . 0.0 109.884 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.7 -56.84 6.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.507 -0.746 . . . . 0.0 110.997 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.27 -41.63 80.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.948 . . . . 0.0 111.479 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mm -63.19 -52.28 60.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' B' ' 47' ' ' SER . 32.4 tp -58.5 -36.63 74.08 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -55.34 -74.77 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.416 1.103 . . . . 0.0 109.979 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -45.63 90.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.089 -177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' B' ' 48' ' ' ASN . 96.6 m -61.59 -68.67 0.3 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.003 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 87.7 p -33.39 -31.41 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.0 OUTLIER -78.37 -43.35 27.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.976 -1.078 . . . . 0.0 109.431 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' B' ' 46' ' ' CYS . 13.2 t -43.4 -56.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.564 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.9 -158.79 11.63 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.938 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' B' ' 52' ' ' VAL . 57.9 Cg_endo -79.9 82.08 2.59 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.798 2.332 . . . . 0.0 112.788 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.556 ' O ' ' O ' ' B' ' 51' ' ' PRO . 0.3 OUTLIER -51.08 -166.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.424 HG12 ' O ' ' B' ' 52' ' ' VAL . 0.7 OUTLIER -160.09 -57.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.594 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 78.6 m-20 -117.91 132.64 56.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.402 HD12 ' N ' ' B' ' 56' ' ' LYS . 16.9 tp -133.0 126.36 31.77 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.402 ' N ' HD12 ' B' ' 55' ' ' LEU . 59.4 mttp -138.7 138.0 37.33 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.068 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.426 ' SD ' ' CB ' ' B' ' 70' ' ' ALA . 1.8 tpt -127.9 134.32 49.35 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 0.6 ' CE ' ' N7 ' ' A' ' 11' ' ' ' A' . 0.1 OUTLIER -153.66 150.13 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 109.87 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.606 ' CG ' ' OH ' ' B' ' 35' ' ' TYR . 4.0 m-85 -106.33 -177.54 3.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.345 -0.847 . . . . 0.0 109.555 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.582 ' OD2' ' N ' ' B' ' 66' ' ' SER . 13.6 m-20 -103.98 71.89 0.17 Allowed Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.908 -1.12 . . . . 0.0 111.939 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 17.0 Cg_exo -49.22 -65.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.239 1.959 . . . . 0.0 112.88 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -85.2 -54.14 4.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.429 -0.794 . . . . 0.0 110.255 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.456 ' C ' ' H ' ' B' ' 65' ' ' ARG . 62.4 p -51.99 -38.4 56.6 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.224 -0.923 . . . . 0.0 108.751 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.73 3.24 3.05 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' B' ' 63' ' ' THR . 83.0 mtt85 -65.83 -37.8 87.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.387 -1.067 . . . . 0.0 111.138 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.582 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.8 OUTLIER -155.4 150.12 26.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.379 -1.451 . . . . 0.0 112.305 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -115.98 77.97 1.14 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.65 54.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 0.915 ' CZ ' H5'' ' A' ' 9' ' ' ' A' . 2.5 m-85 -104.48 127.33 52.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 108.602 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.426 ' CB ' ' SD ' ' B' ' 57' ' ' MET . . . -144.35 145.85 32.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.441 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.825 ' CZ ' " H1'" ' A' ' 9' ' ' ' A' . 6.6 m-85 -124.77 129.63 50.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.49 108.67 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.701 -0.799 . . . . 0.0 111.701 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.594 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 31.9 tt0 -92.9 134.12 35.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.352 -1.468 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -96.66 171.63 8.41 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.858 0.837 . . . . 0.0 110.415 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' B' ' 76' ' ' ASP . 4.0 tpt180 -42.88 -40.84 3.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.785 -0.572 . . . . 0.0 112.322 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' B' ' 78' ' ' GLU . 17.8 t70 166.61 -177.73 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.35 0.595 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 2.0 mm? -39.58 -21.88 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.072 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.2 mm-40 -70.59 -74.42 0.14 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.753 -1.217 . . . . 0.0 109.096 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 29.8 m -60.87 -41.89 96.86 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.526 ' HG ' ' N ' ' B' ' 26' ' ' ARG . 0.1 OUTLIER -62.35 -29.93 70.81 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.076 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -67.23 -60.91 2.21 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.947 -1.095 . . . . 0.0 108.461 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.653 ' HG ' HH21 ' B' ' 85' ' ' ARG . 59.0 m -61.51 -45.77 92.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.452 -0.78 . . . . 0.0 110.792 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.449 ' HA ' ' OD1' ' B' ' 86' ' ' ASN . . . -68.46 -67.31 0.48 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' B' ' 88' ' ' ASN . 16.1 t -49.73 -31.77 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.8 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . 0.653 HH21 ' HG ' ' B' ' 82' ' ' SER . 76.2 mtm180 -65.0 -52.44 56.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 109.559 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.589 ' OD1' ' O ' ' B' ' 82' ' ' SER . 0.0 OUTLIER -75.08 -42.8 56.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 117.973 -1.491 . . . . 0.0 108.183 178.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' B' ' 88' ' ' ASN . 17.1 mt -79.63 -2.08 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 110.185 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.603 ' N ' ' O ' ' B' ' 84' ' ' VAL . 0.5 OUTLIER -48.51 -82.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.55 114.9 1.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.639 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -139.71 149.76 44.03 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 119.936 1.868 . . . . 0.0 110.821 -179.169 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -47.87 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.102 -1.624 . . . . 0.0 110.044 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -154.71 113.09 3.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.247 -0.908 . . . . 0.0 108.627 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.55 -171.83 36.86 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 44.9 m -79.44 -14.74 58.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.899 -1.353 . . . . 0.0 109.929 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.435 ' N ' ' OG ' ' B' ' 32' ' ' SER . 14.8 ttm180 -146.78 163.64 35.36 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.3 m-85 -93.41 127.36 39.0 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.867 -1.146 . . . . 0.0 110.502 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.636 ' CD1' ' N ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -41.37 156.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.383 0.611 . . . . 0.0 109.482 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.534 ' HE3' " H1'" ' A' ' 8' ' ' ' A' . 9.7 mtmm -111.27 149.23 31.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.568 -0.708 . . . . 0.0 110.124 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' OD1' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -75.07 113.69 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.777 -0.577 . . . . 0.0 109.64 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.427 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -111.21 161.81 12.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' B' ' 23' ' ' PRO . 5.2 p90 -148.37 108.46 4.07 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.479 -1.013 . . . . 0.0 109.21 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 29.6 t -144.72 128.56 17.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.274 -0.891 . . . . 0.0 109.272 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 11.3 t 179.61 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.1 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.04 -52.74 64.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.853 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 109.412 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . 0.402 ' HZ2' ' HB2' ' C' ' 156' ' ' LYS . 2.9 ttmp? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.28 134.86 46.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.467 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 30.3 t -158.73 155.14 27.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.901 . . . . 0.0 109.194 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . 0.41 ' SG ' ' CG2' ' C' ' 213' ' ' VAL . 8.6 t -116.04 87.32 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.057 0.932 . . . . 0.0 109.527 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -94.63 148.88 21.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -115.72 170.7 8.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.998 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.717 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 10.5 t80 -128.81 68.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 8.2 mm -57.26 129.39 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.79 -173.9 13.26 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' C' ' 227' ' ' VAL . . . 53.94 27.23 36.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . 0.562 ' O ' ' C8 ' ' A' ' 4' ' ' ' A' . 4.1 mm? -59.73 161.93 5.76 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.353 -1.087 . . . . 0.0 108.559 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.609 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 3.2 p30 -68.2 -71.84 0.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.697 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.1 OUTLIER 178.56 -32.97 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.884 -1.135 . . . . 0.0 109.636 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.29 96.96 3.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 11.9 m -129.21 141.94 51.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.872 . . . . 0.0 108.958 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 171' ' ' THR . . . . . 0.613 ' HG1' HD21 ' C' ' 174' ' ' ASN . 0.2 OUTLIER -92.56 156.59 17.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 109.594 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.81 -63.92 1.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.275 -0.891 . . . . 0.0 110.526 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.55 -33.53 22.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.929 -1.107 . . . . 0.0 109.696 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . 0.613 HD21 ' HG1' ' C' ' 171' ' ' THR . 87.9 m-20 -70.45 -50.84 34.12 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.911 0.863 . . . . 0.0 108.68 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -37.76 79.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.655 -0.653 . . . . 0.0 110.011 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -69.4 -60.74 2.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.48 -28.1 4.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.329 -0.857 . . . . 0.0 108.816 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' C' ' 178' ' ' TYR . 18.6 t80 -70.08 -53.61 16.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.922 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.763 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.6 m-85 -72.87 -41.87 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.608 -0.683 . . . . 0.0 112.501 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.77 30.01 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 119.347 -2.096 . . . . 0.0 111.431 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . 0.763 ' N ' ' O ' ' C' ' 179' ' ' PHE . 28.5 ttmt -94.01 -12.27 29.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . 0.617 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 44.0 m-85 -99.77 -50.7 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.405 0.622 . . . . 0.0 109.744 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -143.66 -130.89 2.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 39.7 m -122.76 141.25 52.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -1.064 . . . . 0.0 109.567 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.96 135.34 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.409 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.19 -41.52 9.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.921 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -160.1 158.0 29.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 109.657 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' C' ' 189' ' ' LYS . 0.6 OUTLIER -139.97 140.38 36.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . 0.453 ' N ' ' CD1' ' C' ' 188' ' ' LEU . 0.2 OUTLIER -105.74 92.51 4.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.175 . . . . 0.0 110.2 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.8 tt -117.13 145.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 191' ' ' MET . . . . . 0.42 ' SD ' " H1'" ' A' ' 7' ' ' ' U' . 13.0 ptp -154.19 61.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 109.986 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -68.22 171.86 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.998 -1.064 . . . . 0.0 109.614 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . 0.507 ' OD2' ' OG ' ' C' ' 199' ' ' SER . 0.5 OUTLIER -52.51 124.71 34.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 108.962 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.98 -4.82 15.98 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.153 1.902 . . . . 0.0 112.706 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.67 -85.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 32.5 p -98.69 -12.57 20.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 110.018 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 79.84 18.96 71.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -96.13 74.72 2.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.298 . . . . 0.0 110.176 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 199' ' ' SER . . . . . 0.571 ' O ' ' O ' ' C' ' 200' ' ' ARG . 37.0 m -167.31 171.64 10.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.576 ' NE ' ' C ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -34.98 162.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 110.128 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.06 108.29 0.36 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.535 ' HB3' " H1'" ' A' ' 5' ' ' ' U' . 7.8 p90 -130.41 158.1 40.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -1.097 . . . . 0.0 109.377 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.16 116.96 1.54 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.747 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.07 82.72 6.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.716 -1.461 . . . . 0.0 107.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.5 mt -70.59 104.14 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.935 . . . . 0.0 111.621 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.0 t -76.75 76.34 3.39 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.5 122.84 17.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.526 -0.734 . . . . 0.0 110.459 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.19 -47.12 71.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.163 -0.961 . . . . 0.0 109.397 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -93.96 118.5 67.27 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.802 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.14 -2.25 2.91 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.516 ' O ' ' N ' ' C' ' 213' ' ' VAL . 18.6 t -74.53 -70.44 0.4 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.707 -1.246 . . . . 0.0 109.877 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.432 ' C ' ' O ' ' C' ' 211' ' ' SER . 28.2 t -39.28 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.5 -0.75 . . . . 0.0 109.96 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' C' ' 211' ' ' SER . 0.5 OUTLIER -61.99 -20.18 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.765 -1.209 . . . . 0.0 110.106 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.97 -45.09 9.94 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.045 0.926 . . . . 0.0 108.863 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . 0.5 ' OE2' ' OG1' ' C' ' 219' ' ' THR . 48.7 tp10 -70.92 -27.85 64.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.79 -0.569 . . . . 0.0 109.849 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' C' ' 217' ' ' VAL . 3.3 p -61.41 -49.11 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . 0.532 ' N ' ' CG1' ' C' ' 216' ' ' VAL . 14.4 p -78.27 -40.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.94 -1.1 . . . . 0.0 109.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -59.4 -48.67 80.75 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.441 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.5 ' OG1' ' OE2' ' C' ' 215' ' ' GLU . 28.6 m -79.06 155.07 28.95 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.738 0.78 . . . . 0.0 110.898 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -112.07 138.45 48.71 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.674 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -136.44 163.19 31.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.26 119.47 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.51 -72.28 0.05 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -126.22 20.7 7.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 109.171 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.42 8.94 58.26 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . 0.716 ' NZ ' ' HZ2' ' C' ' 278' ' ' LYS . 2.1 tpmt? -87.58 -76.8 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.368 -1.077 . . . . 0.0 109.188 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' C' ' 165' ' ' GLY . 1.2 t 169.13 135.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.385 -0.822 . . . . 0.0 109.629 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 17.9 pt -139.62 159.18 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.625 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.79 98.05 12.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 109.088 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . 0.431 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 83.8 Cg_endo -87.94 123.33 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.964 2.442 . . . . 0.0 113.252 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -141.61 139.1 33.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.054 . . . . 0.0 109.6 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' C' ' 233' ' ' ALA . 70.7 ttt180 -66.54 151.46 47.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.081 . . . . 0.0 109.868 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.64 138.17 4.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' C' ' 232' ' ' ARG . 3.4 mt -134.74 119.09 13.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.924 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -45.94 156.03 0.51 Allowed 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.037 1.825 . . . . 0.0 111.551 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.628 HH22 " C2'" ' A' ' 6' ' ' ' A' . 0.3 OUTLIER -60.16 -45.62 92.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 0.0 110.485 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.13 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -70.42 -39.51 74.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.89 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . 0.411 HE22 ' CZ ' ' C' ' 236' ' ' ARG . 6.7 tt0 -58.45 -39.46 79.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.06 -36.71 84.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.975 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . 0.515 ' O ' ' C ' ' C' ' 242' ' ' THR . 19.4 tttt -56.77 -65.71 0.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 242' ' ' THR . . . . . 0.515 ' C ' ' O ' ' C' ' 241' ' ' LYS . 39.9 p -33.04 145.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.779 -0.575 . . . . 0.0 110.074 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -131.38 147.32 18.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 130.58 27.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -1.205 . . . . 0.0 109.832 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.42 152.59 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.701 0.762 . . . . 0.0 109.679 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.69 ' CD2' ' C6 ' ' A' ' 2' ' ' ' A' . 0.0 OUTLIER -108.16 136.09 48.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.675 -0.641 . . . . 0.0 109.329 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 9.7 t -109.6 144.26 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.551 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 168.1 14.45 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . 0.582 ' O ' ' NH1' ' C' ' 311' ' ' ARG . . . 88.65 17.54 56.53 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 121.107 -1.231 . . . . 0.0 110.349 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 4.6 mt -116.04 136.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -1.053 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -108.67 178.15 20.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.96 -20.41 38.68 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.623 2.215 . . . . 0.0 112.379 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -56.1 -35.7 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.906 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 2.8 p -76.78 148.01 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.161 -0.962 . . . . 0.0 109.584 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -106.18 158.31 32.85 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.51 -21.31 61.28 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.455 2.103 . . . . 0.0 111.276 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -62.71 -54.76 34.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.04 -43.24 95.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -56.29 -59.67 4.61 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 109.936 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' C' ' 264' ' ' SER . 84.5 tt0 -60.66 -49.16 78.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . 0.487 ' C ' ' HG ' ' C' ' 264' ' ' SER . 47.4 tp10 -57.98 -22.56 49.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 0.0 108.75 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . 0.476 ' O ' ' OE1' ' C' ' 265' ' ' GLN . 67.6 t80 -81.25 -79.73 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.537 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 91.4 m-85 -52.61 -33.61 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.023 -1.048 . . . . 0.0 110.162 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' C' ' 260' ' ' GLU . 2.7 p -35.59 -38.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 111.996 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.658 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 1.8 pt20 -57.09 -90.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.422 -1.424 . . . . 0.0 110.339 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.658 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.7 OUTLIER -67.47 150.93 48.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.548 -1.345 . . . . 0.0 110.203 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 59.43 95.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 47.6 m -48.05 137.11 10.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.878 -1.366 . . . . 0.0 108.232 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -94.65 96.93 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 111.059 -178.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 6.4 mm -67.93 -39.57 81.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.449 -1.407 . . . . 0.0 108.497 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . 0.427 ' O ' ' OG1' ' C' ' 290' ' ' THR . 59.9 t0 -160.59 92.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.439 -0.788 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -123.42 172.33 8.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 109.888 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.0 OUTLIER 169.29 160.11 0.05 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.167 0.984 . . . . 0.0 111.277 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' C' ' 275' ' ' MET . 0.1 OUTLIER -107.7 152.59 24.12 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 275' ' ' MET . . . . . 0.443 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 0.0 OUTLIER -87.78 -179.12 6.21 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.492 -1.38 . . . . 0.0 109.858 -178.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.619 ' N ' ' HG1' ' C' ' 280' ' ' THR . 0.9 OUTLIER -153.21 -160.47 1.13 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.999 -1.063 . . . . 0.0 110.259 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . 0.449 ' HA ' ' N ' ' C' ' 283' ' ' SER . 1.2 m-20 -61.79 -85.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.281 -0.887 . . . . 0.0 111.58 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . 0.716 ' HZ2' ' NZ ' ' C' ' 226' ' ' LYS . 11.3 tptp -103.69 -32.11 9.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 109.805 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.54 -39.03 75.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 280' ' ' THR . . . . . 0.619 ' HG1' ' N ' ' C' ' 276' ' ' LEU . 75.6 p -151.14 132.33 14.45 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.688 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.84 -127.95 28.72 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' C' ' 283' ' ' SER . 96.3 mt-30 -141.53 147.26 37.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -1.078 . . . . 0.0 110.987 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 283' ' ' SER . . . . . 0.604 ' C ' ' H ' ' C' ' 285' ' ' GLY . 0.0 OUTLIER -16.57 -52.22 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.106 -177.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' C' ' 282' ' ' GLN . 97.3 mtt180 -69.21 47.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' C' ' 283' ' ' SER . . . -40.36 102.46 0.02 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.669 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 0.0 OUTLIER -67.42 -163.73 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -130.21 149.92 19.03 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.923 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . 0.455 ' CZ ' ' H2 ' ' A' ' 2' ' ' ' A' . 2.0 m-85 -139.39 151.61 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 2.3 t -147.77 143.24 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.735 -1.228 . . . . 0.0 108.501 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 290' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' C' ' 271' ' ' ASP . 24.4 m -129.7 125.32 35.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.106 -0.996 . . . . 0.0 108.974 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -115.94 144.79 43.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.17 -50.2 73.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.658 -1.276 . . . . 0.0 109.149 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 72.9 m -98.02 178.95 4.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.27 -11.73 14.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -51.18 -44.38 61.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.0 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.85 . . . . 0.0 109.088 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . 0.566 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 59.4 t -60.16 -60.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -57.48 -28.18 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -64.29 -62.93 1.3 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.79 -28.17 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.798 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 67.5 m -45.78 -55.78 6.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 0.0 108.853 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' C' ' 301' ' ' CYS . 15.8 mm100 -47.63 -25.05 1.04 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' C' ' 300' ' ' VAL . 82.7 m-20 -98.98 72.66 1.91 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -65.74 -12.29 52.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.821 -1.174 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -132.0 122.75 26.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.831 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 46.7 mt -119.93 147.41 23.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 307' ' ' ASP . 47.3 p30 -69.79 159.43 33.6 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 109.012 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.745 ' O ' ' O ' ' C' ' 309' ' ' LYS . 13.9 t80 -167.31 -171.46 1.72 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.745 ' O ' ' O ' ' C' ' 308' ' ' PHE . 68.2 mttt -42.27 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.107 0.956 . . . . 0.0 110.937 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 310' ' ' ASP . 44.6 p30 -61.14 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.375 -1.453 . . . . 0.0 110.912 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' C' ' 309' ' ' LYS . 0.3 OUTLIER -166.75 112.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.979 -1.075 . . . . 0.0 109.641 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.49 168.94 0.5 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 48.4 pt -133.25 157.21 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 109.937 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -112.2 157.0 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.352 -0.842 . . . . 0.0 109.133 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.6 142.48 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -156.52 155.14 31.45 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . 0.671 ' CZ ' HH22 ' C' ' 321' ' ' ARG . 37.4 mtp180 -60.72 143.45 54.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.026 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.58 61.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.322 -0.862 . . . . 0.0 109.383 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . 0.404 ' O ' ' NH1' ' C' ' 321' ' ' ARG . 7.8 mm-40 -128.75 85.82 59.2 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 109.774 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -56.03 142.57 85.37 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.424 2.083 . . . . 0.0 111.965 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . 0.671 HH22 ' CZ ' ' C' ' 317' ' ' ARG . 90.8 mtm-85 -151.86 108.07 3.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.088 -1.007 . . . . 0.0 109.248 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 20.8 p80 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.42 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.892 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.83 1 C5'-C4'-C3' 107.655 -5.23 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.892 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.442 2.335 1 C5'-C4'-C3' 107.808 -5.128 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 0.712 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.436 1.84 1 C5'-C4'-C3' 108.193 -4.872 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.68 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.44 2.201 1 C5'-C4'-C3' 107.085 -5.61 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.824 " H5'" ' CD ' ' C' ' 200' ' ' ARG . . . . . . . . 0 O4'--C1' 1.441 2.286 0 C5'-C4'-C3' 109.876 -3.749 . 0.464 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 1.038 " O4'" H5'' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.051 1 O4'-C1'-N19 112.245 4.045 OUTLIER-EPSILON 0.087 1b . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 1.038 H5'' " O4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.616 2.27 2 C5'-C4'-C3' 106.639 -5.908 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.877 ' OP2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.448 2.852 1 C5'-C4'-C3' 109.181 -4.213 . 0.791 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.901 " H2'" ' C6 ' ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.464 1 C5'-C4'-C3' 109.446 -4.036 . 0.759 &a . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 0.901 ' C6 ' " H2'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 2.0 1 C5'-C4'-C3' 107.655 -5.23 . 0.766 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.889 " O2'" ' H8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.435 1.712 1 C5'-C4'-C3' 106.774 -5.818 . 0.13 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.889 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.611 1.843 1 C5'-C4'-C3' 107.128 -5.582 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.86 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 2.011 1 C5'-C4'-C3' 107.49 -5.34 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.411 ' HD2' HH21 ' B' ' 26' ' ' ARG . 30.5 Cg_endo -67.78 157.15 63.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.715 2.277 . . . . 0.0 112.067 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.86 -5.67 16.14 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.927 2.418 . . . . 0.0 112.832 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 75.5 m -148.5 130.23 15.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 109.669 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.717 HH12 ' HG ' ' B' ' 103' ' ' SER . 23.3 ttp85 179.05 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.07 151.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.592 -0.693 . . . . 0.0 109.637 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 10.8 t -103.49 131.84 51.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.706 ' CD2' ' H2 ' ' A' ' 8' ' ' ' A' . 3.2 m-85 -102.2 116.93 33.68 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.816 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 mp -102.71 129.19 49.25 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -106.12 -112.15 3.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.456 ' OG ' ' CG ' ' B' ' 95' ' ' ARG . 10.4 p -70.08 131.0 43.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -1.219 . . . . 0.0 109.331 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -163.42 132.88 3.08 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.572 ' C ' ' H ' ' B' ' 36' ' ' ASP . 14.8 Cg_endo -60.74 146.6 97.04 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.259 1.306 . . . . 0.0 112.162 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -62.98 3.66 0.22 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' B' ' 34' ' ' PRO . 93.0 m-20 -57.65 -37.77 73.92 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.362 -0.836 . . . . 0.0 108.913 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.429 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -119.27 113.23 20.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.769 . . . . 0.0 110.176 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.508 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 67.4 p -106.76 -141.18 0.37 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 0.0 109.88 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.79 -31.39 71.59 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.798 -1.189 . . . . 0.0 111.092 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -73.45 -58.55 3.23 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' B' ' 37' ' ' GLN . 15.4 mt-30 -67.55 -38.51 84.26 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.781 -1.2 . . . . 0.0 109.721 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' B' ' 44' ' ' ASP . 5.7 mm -61.07 -52.66 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' B' ' 42' ' ' ILE . 54.3 tp -37.81 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.151 -0.343 . . . . 0.0 110.826 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' B' ' 42' ' ' ILE . 90.7 m-20 -125.11 -24.76 3.95 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.732 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.0 tm? -59.77 -39.95 86.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.014 -1.679 . . . . 0.0 106.898 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.653 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.5 m -85.86 -63.81 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 109.065 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.823 ' O ' ' N ' ' B' ' 49' ' ' VAL . 2.5 p -40.03 -15.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.777 -0.577 . . . . 0.0 110.535 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.72 64.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.289 1.042 . . . . 0.0 109.986 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.823 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.4 p 169.89 -33.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.16 160.02 33.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.67 93.56 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.47 2.113 . . . . 0.0 111.731 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -45.67 165.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 109.4 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 mm -99.38 -47.46 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.25 -0.906 . . . . 0.0 110.256 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.487 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 79.5 m-20 -126.54 142.37 51.56 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.49 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 24.9 tp -130.8 129.65 42.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.561 ' NZ ' ' C4 ' ' A' ' 11' ' ' ' A' . 11.3 tptm -138.09 134.65 34.94 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.109 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 4.7 tpp -126.54 132.51 51.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.734 -0.603 . . . . 0.0 109.445 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 0.629 ' SD ' ' C8 ' ' A' ' 11' ' ' ' A' . 75.2 mtm -151.77 155.96 39.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.472 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.424 ' O ' ' HD3' ' B' ' 61' ' ' PRO . 0.0 OUTLIER -117.86 -177.07 3.17 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 41.1 p-10 -100.7 102.28 18.71 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 110.933 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.431 ' CG ' ' OP1' ' A' ' 11' ' ' ' A' . 37.3 Cg_endo -89.36 -59.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.429 2.086 . . . . 0.0 110.738 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -81.49 -50.23 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.512 -0.743 . . . . 0.0 109.048 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 48.0 p -57.64 -44.35 85.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 109.522 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.441 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 70.03 24.63 76.38 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.539 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 46.4 mmm-85 -118.38 -68.23 0.93 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -1.104 . . . . 0.0 110.277 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD1' ' B' ' 69' ' ' TYR . 0.2 OUTLIER -58.52 118.88 6.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 110.343 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -79.88 -74.25 0.31 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 108.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -117.41 80.54 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 0.846 ' CE2' " H4'" ' A' ' 9' ' ' ' A' . 4.9 m-85 -92.38 132.13 36.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.012 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.0 141.18 31.31 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.522 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.683 ' CE1' ' N3 ' ' A' ' 9' ' ' ' A' . 2.8 m-85 -114.88 122.92 47.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 109.229 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.69 102.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.866 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.487 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 46.5 mt-10 -80.48 128.37 33.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.789 -1.194 . . . . 0.0 111.123 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -93.54 174.22 7.3 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.68 0.752 . . . . 0.0 110.793 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 81.4 mtt-85 -50.5 -41.32 53.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.717 -0.614 . . . . 0.0 110.56 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.77 178.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -39.81 -19.0 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.566 -0.709 . . . . 0.0 110.392 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.1 tt0 -71.74 -74.69 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.69 -1.256 . . . . 0.0 108.733 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 43.3 m -60.37 -40.5 91.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -34.64 76.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.501 -0.749 . . . . 0.0 109.282 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -61.77 -59.82 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 24.5 t -64.74 -36.83 85.57 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.72 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.09 -64.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 109.988 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' B' ' 88' ' ' ASN . 35.0 t -51.75 -39.29 23.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.018 -1.051 . . . . 0.0 109.627 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . 0.462 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmp_? -69.28 -48.52 61.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.885 -1.134 . . . . 0.0 109.697 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.88 -48.0 15.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.057 . . . . 0.0 109.669 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' B' ' 83' ' ' ALA . 59.4 mt -93.85 27.91 2.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -54.91 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.48 121.04 2.19 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -136.27 142.67 43.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.513 -1.58 . . . . 0.0 108.796 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.597 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -27.25 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.609 0.719 . . . . 0.0 111.06 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.7 tt -151.44 128.23 10.92 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.696 -0.627 . . . . 0.0 109.309 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' B' ' 92' ' ' LEU . . . 46.36 -175.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 37.4 t -66.02 -17.15 64.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.008 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.456 ' CG ' ' OG ' ' B' ' 32' ' ' SER . 24.5 mmt180 -134.67 149.81 50.56 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.133 -0.98 . . . . 0.0 109.58 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.9 m-85 -103.5 142.77 33.7 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.293 0.568 . . . . 0.0 110.388 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -39.93 151.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -134.87 170.05 16.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.262 -0.899 . . . . 0.0 110.2 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 2.3 p -73.33 -176.08 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.355 -0.841 . . . . 0.0 109.245 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' B' ' 29' ' ' TYR . . . 160.3 177.14 33.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.614 ' O ' ' N ' ' B' ' 103' ' ' SER . 21.8 p90 -149.15 -3.08 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.053 -1.263 . . . . 0.0 111.065 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' SER . . . . . 0.565 ' H ' ' HH ' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -35.57 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.227 -0.921 . . . . 0.0 110.602 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' SER . . . . . 0.717 ' HG ' HH12 ' B' ' 26' ' ' ARG . 17.2 t -58.37 -38.64 77.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.981 -1.075 . . . . 0.0 109.509 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -130.78 131.97 45.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.452 -0.78 . . . . 0.0 109.478 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.468 ' C ' ' N6 ' ' A' ' 11' ' ' ' A' . 22.3 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.464 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 52.6 pttt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.21 0.529 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -102.83 59.3 0.78 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.626 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 158' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 99.9 p -119.99 142.0 49.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 108.903 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . 0.592 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER 170.35 -26.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . 0.492 ' NZ ' ' CD1' ' C' ' 204' ' ' PHE . 17.6 tttm -80.97 139.08 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 161' ' ' MET . . . . . 0.507 ' SD ' ' CG1' ' C' ' 216' ' ' VAL . 2.3 ttp -121.32 165.57 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.688 ' CD2' ' C6 ' ' A' ' 6' ' ' ' A' . 50.9 t80 -138.36 77.93 1.65 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.497 -0.752 . . . . 0.0 110.192 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 49.6 mt -54.19 141.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -137.04 168.51 24.3 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.435 ' H ' ' NH2' ' C' ' 200' ' ' ARG . . . 66.72 31.35 78.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . 0.552 ' O ' ' C8 ' ' A' ' 4' ' ' ' A' . 7.6 mp -68.26 172.25 6.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 108.046 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.594 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 1.6 t-20 -67.79 -73.23 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.929 -1.107 . . . . 0.0 108.421 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.68 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.0 OUTLIER 178.72 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.32 178.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . 0.588 ' OD1' ' NZ ' ' C' ' 192' ' ' LYS . 68.5 t0 -135.73 92.34 2.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.892 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 86.6 m -125.8 143.53 51.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.459 -0.775 . . . . 0.0 109.2 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 172.7 8.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.602 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . 0.602 ' H ' ' CD ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -79.06 -71.27 0.45 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.924 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' C' ' 174' ' ' ASN . 90.0 m-20 -40.24 -72.37 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . 0.543 ' C ' ' O ' ' C' ' 173' ' ' ASP . 0.1 OUTLIER -34.7 -44.57 0.22 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.98 -57.97 9.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 109.779 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' C' ' 178' ' ' TYR . 7.4 ptm180 -67.28 -54.11 23.81 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . 0.513 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -38.51 -30.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.108 -0.995 . . . . 0.0 108.394 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' C' ' 176' ' ' ARG . 20.4 t80 -86.94 -40.19 15.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 110.143 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' C' ' 176' ' ' ARG . 25.8 m-85 -90.94 16.75 8.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.139 -0.976 . . . . 0.0 111.149 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.36 25.74 24.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -102.77 10.87 38.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . 0.488 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 90.3 m-85 -109.62 -77.0 0.6 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.19 -122.09 2.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 38.9 m -124.17 139.94 53.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.556 -0.967 . . . . 0.0 109.416 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.434 HG21 HH21 ' C' ' 176' ' ' ARG . 35.8 m -112.17 139.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 186' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' C' ' 187' ' ' ASP . 11.1 t -105.2 -38.08 6.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.05 -1.031 . . . . 0.0 110.116 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . 0.416 ' N ' ' CG2' ' C' ' 186' ' ' THR . 17.5 t70 -163.43 166.17 23.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' C' ' 188' ' ' LEU . 1.8 pt? -161.59 150.8 16.15 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 0.0 108.921 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -124.0 141.66 51.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 109.091 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.1 tt -166.61 107.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.059 -1.026 . . . . 0.0 108.392 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 191' ' ' MET . . . . . 0.666 ' SD ' ' C2 ' ' A' ' 7' ' ' ' U' . 5.2 ptp -115.83 71.45 0.78 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . 0.588 ' NZ ' ' OD1' ' C' ' 169' ' ' ASP . 4.0 pttt -39.25 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.287 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' C' ' 195' ' ' ALA . 4.8 t0 -147.58 106.53 3.77 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -48.31 -5.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' C' ' 193' ' ' ASP . . . -103.47 -85.61 0.45 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 10.2 t -103.46 -41.57 5.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 109.764 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' C' ' 168' ' ' TRP . . . 127.35 13.43 2.87 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -98.27 86.92 3.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 109.711 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 199' ' ' SER . . . . . 0.624 ' O ' ' N ' ' C' ' 201' ' ' GLY . 42.7 t -161.48 149.23 15.06 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.824 ' CD ' " H5'" ' A' ' 5' ' ' ' U' . 47.2 tpt85 -42.53 90.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.14 138.15 21.53 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.538 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.581 ' CZ ' " H1'" ' A' ' 7' ' ' ' U' . 1.1 p90 -138.84 169.47 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -130.78 130.61 6.18 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.142 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . 0.492 ' CD1' ' NZ ' ' C' ' 160' ' ' LYS . 48.7 m-85 -107.33 95.97 6.08 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.02 106.38 18.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.5 t -77.48 77.35 4.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.395 -0.816 . . . . 0.0 109.531 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . 0.592 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 34.5 m-85 -71.69 107.52 4.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 109.927 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.73 -39.8 81.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -85.25 105.09 5.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.744 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.08 -28.73 20.07 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.744 1.629 . . . . 0.0 112.997 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.545 ' O ' ' N ' ' C' ' 213' ' ' VAL . 83.9 p -68.18 -57.76 5.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.986 -1.072 . . . . 0.0 110.383 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.441 ' C ' ' O ' ' C' ' 211' ' ' SER . 91.2 p -40.81 -22.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.862 . . . . 0.0 109.955 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 211' ' ' SER . 97.1 t -70.4 -37.78 71.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 108.939 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.8 t0 -57.91 -48.86 78.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 109.813 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.13 -36.83 77.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.894 -1.129 . . . . 0.0 109.611 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . 0.507 ' CG1' ' SD ' ' C' ' 161' ' ' MET . 84.2 t -56.14 -46.85 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.767 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 25.2 m -78.13 -36.79 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.027 . . . . 0.0 110.102 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -67.14 -50.55 60.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 0.0 109.868 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -73.04 144.85 46.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.688 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -98.66 138.28 36.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.695 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -136.46 150.24 48.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.99 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.57 89.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 27.0 tp -58.44 -56.68 19.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.697 -0.627 . . . . 0.0 111.17 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.46 13.9 29.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.087 -1.008 . . . . 0.0 108.598 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 75.54 26.69 64.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.589 -2.205 . . . . 0.0 107.589 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . 0.409 ' HD3' HD21 ' C' ' 167' ' ' ASN . 0.1 OUTLIER -101.9 -154.25 0.48 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 t -121.41 94.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 109.329 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 30.1 pt -105.27 149.59 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' C' ' 231' ' ' LYS . 0.4 OUTLIER -124.17 100.17 36.48 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 0.0 109.813 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -74.87 131.11 14.07 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.981 1.787 . . . . 0.0 111.244 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' C' ' 229' ' ' ASP . 19.4 mttm -149.91 151.08 32.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -62.07 149.09 42.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.72 . . . . 0.0 109.265 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.72 29.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.045 . . . . 0.0 109.123 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.11 116.68 32.46 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.32 159.05 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.237 1.958 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.701 ' HE ' ' N ' ' C' ' 236' ' ' ARG . 0.2 OUTLIER -57.44 -52.14 66.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.414 -0.804 . . . . 0.0 110.343 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' C' ' 241' ' ' LYS . 90.9 m-20 -61.44 -41.68 97.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.12 -39.55 95.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.692 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . 0.68 ' NE2' ' N7 ' ' A' ' 6' ' ' ' A' . 8.4 tp-100 -62.83 -41.36 99.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.974 -1.079 . . . . 0.0 108.613 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.85 -22.31 31.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.788 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' C' ' 237' ' ' ASP . 48.9 tttm -54.64 -16.81 2.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 0.0 110.302 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 10.2 p -102.36 162.6 12.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.893 -1.129 . . . . 0.0 109.449 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.87 154.08 17.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -129.92 126.61 38.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.056 -1.261 . . . . 0.0 109.972 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . 0.44 HG23 HD11 ' C' ' 245' ' ' ILE . 0.1 OUTLIER -117.33 138.55 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.765 0.793 . . . . 0.0 108.895 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.556 ' C ' ' CD1' ' C' ' 246' ' ' PHE . 0.4 OUTLIER -80.56 161.28 24.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.458 0.647 . . . . 0.0 109.51 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . 0.546 ' N ' ' CD1' ' C' ' 246' ' ' PHE . 39.8 t -134.85 132.69 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.66 152.4 18.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 61.73 120.17 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.87 165.82 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -1.096 . . . . 0.0 108.743 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -47.07 145.71 4.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.31 -49.38 10.34 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.906 1.737 . . . . 0.0 112.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -122.14 33.87 5.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.741 . . . . 0.0 109.387 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 2.5 p -44.97 141.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -110.71 158.37 35.79 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.24 -30.66 81.81 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.35 2.033 . . . . 0.0 111.169 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -51.56 -62.64 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . 0.704 ' O ' ' N ' ' C' ' 261' ' ' GLU . 0.0 OUTLIER -62.57 -87.71 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . 0.631 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.3 t80 -9.03 -70.39 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 121.441 0.639 . . . . 0.0 110.942 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' C' ' 258' ' ' GLU . 85.0 tt0 -56.06 -44.14 78.59 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.271 0.558 . . . . 0.0 110.39 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . 0.704 ' N ' ' O ' ' C' ' 258' ' ' GLU . 46.4 tp10 -68.53 -41.93 79.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' C' ' 263' ' ' PHE . 42.1 t80 -54.69 -77.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.924 -0.485 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.611 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 61.3 m-85 -42.04 -48.77 4.69 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.706 -1.246 . . . . 0.0 110.24 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.0 OUTLIER -35.26 -37.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' C' ' 263' ' ' PHE . 1.7 pp0? -55.86 -7.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.0 113.246 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.611 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.2 p90 -146.35 -53.42 0.25 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.86 -1.775 . . . . 0.0 111.318 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . 0.597 ' N ' ' CD1' ' C' ' 266' ' ' TRP . . . -83.83 -178.52 51.82 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 268' ' ' THR . . . . . 0.56 ' O ' ' C ' ' C' ' 269' ' ' ILE . 34.1 p -102.19 9.5 40.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.924 -1.339 . . . . 0.0 111.706 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . 0.56 ' C ' ' O ' ' C' ' 268' ' ' THR . 0.9 OUTLIER -16.45 104.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.264 0.938 . . . . 0.0 112.98 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.6 mm -92.74 -33.11 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' C' ' 272' ' ' ALA . 88.0 m-20 -115.19 17.72 16.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.42 -0.8 . . . . 0.0 110.457 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . 0.551 ' C ' ' O ' ' C' ' 271' ' ' ASP . . . -25.92 130.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.998 -0.438 . . . . 0.0 110.275 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' C' ' 288' ' ' PHE . 14.0 pt20 -152.52 132.5 13.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.695 -1.253 . . . . 0.0 111.64 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . 0.481 ' CD2' ' O ' ' C' ' 274' ' ' LEU . 0.3 OUTLIER -126.58 152.46 46.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 275' ' ' MET . . . . . 0.471 ' CE ' ' OP1' ' A' ' 4' ' ' ' A' . 17.8 mmt -88.54 168.44 12.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.651 -1.281 . . . . 0.0 109.872 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.639 ' N ' ' CD1' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -144.59 176.98 9.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.788 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -78.71 -35.78 44.39 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 110.39 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -56.31 -36.43 68.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.062 -1.024 . . . . 0.0 109.789 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . 0.478 ' OD1' ' N6 ' ' A' ' 4' ' ' ' A' . 53.3 t0 -53.55 -52.43 59.73 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.668 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 1.1 t 178.83 0.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' C' ' 283' ' ' SER . . . 102.47 9.07 42.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.459 ' OE1' ' OP1' ' A' ' 3' ' ' ' U' . 50.7 mm-40 -77.42 23.27 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -1.03 . . . . 0.0 109.958 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 283' ' ' SER . . . . . 0.532 ' OG ' ' CA ' ' C' ' 276' ' ' LEU . 3.0 m -107.44 59.07 0.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.434 -0.792 . . . . 0.0 109.798 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.77 -27.69 19.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 108.618 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 143.29 17.37 0.25 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.712 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 46.1 p90 -108.55 176.77 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.42 178.17 39.1 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . 0.414 ' CE1' " O4'" ' A' ' 3' ' ' ' U' . 73.7 m-85 -147.55 156.31 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.325 -1.691 . . . . 0.0 109.676 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.51 152.11 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.042 -1.036 . . . . 0.0 108.626 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.65 120.09 28.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . 0.485 ' CE1' ' CG2' ' C' ' 269' ' ' ILE . 93.9 m-85 -109.18 136.69 48.25 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.82 -50.67 72.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.592 -1.317 . . . . 0.0 109.381 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 75.4 m -93.54 169.38 10.39 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.309 -0.869 . . . . 0.0 108.89 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -103.54 -9.81 18.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.67 -46.24 74.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.01 76.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.807 . . . . 0.0 109.049 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 67.9 t -62.53 -61.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -56.11 -29.17 60.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 109.135 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -62.94 -60.8 2.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.58 ' CG2' HD22 ' C' ' 303' ' ' ASN . 14.4 p -63.06 -27.89 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.647 -0.658 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . 0.496 ' C ' ' O ' ' C' ' 300' ' ' VAL . 65.1 m -45.27 -49.37 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -46.13 -32.83 3.14 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.872 -0.518 . . . . 0.0 109.654 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.766 ' ND2' ' O ' ' C' ' 303' ' ' ASN . 1.0 OUTLIER -101.5 81.77 2.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -72.62 -14.98 61.73 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.64 -1.913 . . . . 0.0 108.739 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -126.05 122.28 35.38 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . 0.566 ' CG1' ' ND2' ' C' ' 303' ' ' ASN . 82.7 mt -117.18 149.87 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.13 96.69 10.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.624 ' O ' ' C ' ' C' ' 309' ' ' LYS . 34.7 t80 -104.32 -176.65 3.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.776 ' O ' ' N ' ' C' ' 311' ' ' ARG . 71.2 mttt -25.26 133.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' C' ' 309' ' ' LYS . 23.8 t70 -17.79 69.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.405 0.622 . . . . 0.0 112.057 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . 0.776 ' N ' ' O ' ' C' ' 309' ' ' LYS . 54.1 ttm-85 177.98 109.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 153.12 4.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.064 . . . . 0.0 108.742 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.88 153.31 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.104 -0.997 . . . . 0.0 108.972 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -116.04 121.41 42.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 109.791 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 2.0 mm -88.84 154.9 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -160.96 159.94 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.165 -0.959 . . . . 0.0 108.421 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -71.92 150.75 43.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.81 -1.181 . . . . 0.0 109.175 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.24 -0.7 10.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.842 -1.161 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.86 85.23 9.25 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.778 . . . . 0.0 109.929 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . 0.462 ' CG ' ' H61' ' A' ' 2' ' ' ' A' . 31.7 Cg_exo -54.94 137.75 76.54 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.463 2.109 . . . . 0.0 111.988 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . 0.444 ' O ' ' CB ' ' C' ' 322' ' ' HIS . 58.3 ttt85 -58.39 -38.37 77.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.66 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . 0.474 ' NE2' ' C5 ' ' A' ' 12' ' ' ' A' . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.478 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.865 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.957 1 C5'-C4'-C3' 107.627 -5.249 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.865 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.084 2 C5'-C4'-C3' 107.353 -5.432 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 0.683 " H3'" ' OD2' ' C' ' 277' ' ' ASP . . . . . . . . 0 O4'--C1' 1.433 1.601 1 C5'-C4'-C3' 106.607 -5.929 . 0.581 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.717 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.439 2.107 1 C5'-C4'-C3' 107.039 -5.641 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.68 ' O4 ' ' N ' ' C' ' 165' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.776 2 C3'-C2'-C1' 105.446 4.384 . 0.541 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 1.002 " C4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.611 1.85 1 C5'-C4'-C3' 107.489 -5.341 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 1.002 " H5'" " C4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.618 2.543 1 C5'-C4'-C3' 107.4 -5.4 . 0.241 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.719 ' OP2' " H4'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.447 2.748 1 C5'-C4'-C3' 107.282 -5.479 . 0.41 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.735 ' C4 ' ' CE2' ' B' ' 29' ' ' TYR . . . . . . . . 0 O4'--C4' 1.417 -2.983 0 C5'-C4'-C3' 109.759 -3.828 . 0.789 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 0.811 H5'' ' CG ' ' B' ' 60' ' ' ASP . . . . . . . . 0 O4'--C1' 1.442 2.295 1 C5'-C4'-C3' 108.609 -4.594 . 0.527 &a . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.929 " O2'" ' H8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 P--O5' 1.612 1.934 2 C5'-C4'-C3' 107.987 -5.009 . 0.503 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.929 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.614 2.06 1 C5'-C4'-C3' 107.37 -5.42 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.508 " O5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 1.965 1 C5'-C4'-C3' 107.442 -5.372 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.59 ' OD1' ' CE2' ' B' ' 101' ' ' TYR . 2.4 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.464 0.649 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.01 154.47 70.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.936 2.424 . . . . 0.0 112.255 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.24 3.39 4.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.719 2.28 . . . . 0.0 112.315 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -154.3 133.42 12.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.93 . . . . 0.0 109.276 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -43.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.0 109.333 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' B' ' 100' ' ' GLY . 2.7 t -119.81 151.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -142.44 134.41 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.66 -1.275 . . . . 0.0 107.994 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.735 ' CE2' ' C4 ' ' A' ' 9' ' ' ' A' . 0.1 OUTLIER -129.36 155.57 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 110.475 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.24 147.93 44.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -123.39 -45.13 0.29 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.04 87.51 6.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.964 -1.315 . . . . 0.0 109.706 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.439 ' N ' HD13 ' B' ' 33' ' ' ILE . 3.4 mp -143.44 126.81 9.08 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 108.886 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' B' ' 36' ' ' ASP . 39.3 Cg_endo -73.43 155.85 50.44 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.451 1.434 . . . . 0.0 111.583 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.607 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 8.2 m-85 -60.24 5.85 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 109.621 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.2 m-20 -61.51 -41.93 98.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.048 -1.032 . . . . 0.0 108.584 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.536 ' CD ' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -125.4 112.04 15.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.39 -0.819 . . . . 0.0 109.57 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -107.45 -143.19 0.38 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.379 -0.826 . . . . 0.0 110.963 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 21.7 pt-20 -65.97 -29.19 69.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.815 -1.178 . . . . 0.0 110.955 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -64.0 -54.78 28.91 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.882 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.536 HE21 ' CD ' ' B' ' 37' ' ' GLN . 6.0 tt0 -69.52 -48.11 61.6 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 110.359 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' B' ' 44' ' ' ASP . 6.5 mm -56.76 -54.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' B' ' 39' ' ' GLU . 41.4 tp -36.9 -20.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.2 t0 -124.02 -22.22 4.88 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.178 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.579 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 3.4 tm? -61.6 -37.59 84.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.165 -1.584 . . . . 0.0 107.94 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' B' ' 48' ' ' ASN . 86.6 m -92.77 -63.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.95 -1.093 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.412 ' C ' ' O ' ' B' ' 46' ' ' CYS . 17.6 t -37.76 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.806 -0.559 . . . . 0.0 110.788 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' B' ' 46' ' ' CYS . 5.9 p30 -71.38 -59.05 2.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.784 -1.198 . . . . 0.0 109.844 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.568 ' N ' ' OD1' ' B' ' 48' ' ' ASN . 0.9 OUTLIER -42.37 -51.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.714 -0.616 . . . . 0.0 110.207 -178.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.426 ' N ' HG12 ' B' ' 49' ' ' VAL . . . -157.22 167.63 33.94 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.21 131.06 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.905 1.737 . . . . 0.0 111.495 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.584 ' CG1' ' N ' ' B' ' 53' ' ' ILE . 0.9 OUTLIER -99.66 -172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.328 -0.857 . . . . 0.0 108.998 -178.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.584 ' N ' ' CG1' ' B' ' 52' ' ' VAL . 24.0 mm -142.86 -44.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 86.8 m-20 -149.52 155.53 40.5 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.662 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 tp -146.61 130.23 16.94 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.444 ' CG ' ' SD ' ' B' ' 58' ' ' MET . 43.1 tptt -145.81 116.54 7.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.671 -1.268 . . . . 0.0 110.143 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.46 130.41 35.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 109.297 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 0.806 ' CE ' " H1'" ' A' ' 10' ' ' ' U' . 2.3 mpp? -141.3 144.18 34.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.112 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.607 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 14.0 m-85 -98.89 -179.15 4.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.811 ' CG ' H5'' ' A' ' 10' ' ' ' U' . 0.4 OUTLIER -117.1 69.86 5.24 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.497 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -68.17 -61.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.916 2.411 . . . . 0.0 113.281 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -64.08 -40.94 97.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -0.829 . . . . 0.0 110.818 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.513 ' CG2' ' OD1' ' B' ' 60' ' ' ASP . 7.8 p -70.84 -43.38 68.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.69 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.61 -2.45 85.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -1.08 . . . . 0.0 110.016 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' B' ' 60' ' ' ASP . 0.1 OUTLIER -177.24 -161.94 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.927 -1.108 . . . . 0.0 111.11 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.463 ' HA ' ' H ' ' B' ' 60' ' ' ASP . 29.8 mttm -144.62 38.15 1.23 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 109.913 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.27 63.3 0.5 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.88 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 0.685 ' CE1' " H4'" ' A' ' 9' ' ' ' A' . 66.4 m-85 -116.8 123.57 47.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.279 -1.13 . . . . 0.0 109.498 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 135.9 36.59 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.296 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.73 ' CE2' ' C2 ' ' A' ' 9' ' ' ' A' . 3.5 m-85 -106.79 125.35 50.89 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.516 0.674 . . . . 0.0 111.549 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.87 153.01 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 81.7 tt0 -133.48 136.51 45.16 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -103.0 169.76 8.37 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.035 0.921 . . . . 0.0 111.583 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 51.6 ttt85 -55.52 -42.37 74.45 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.841 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 159.64 -176.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.502 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 3.8 mm? -38.77 -21.73 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.852 -0.53 . . . . 0.0 110.313 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.3 mt-10 -70.28 -79.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.9 t -62.57 -36.62 83.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.5 t -62.82 -37.75 88.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -60.31 -58.16 9.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.409 -1.432 . . . . 0.0 108.534 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.3 t -64.58 -34.19 77.68 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.415 0.626 . . . . 0.0 111.995 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -84.23 -58.26 2.83 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.932 -1.105 . . . . 0.0 110.596 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.491 ' O ' ' CG ' ' B' ' 88' ' ' ASN . 58.7 t -53.59 -40.74 43.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 120.331 -1.481 . . . . 0.0 108.561 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -69.63 -46.9 65.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.826 -1.171 . . . . 0.0 109.782 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' B' ' 88' ' ' ASN . 73.7 m-20 -88.07 -59.48 2.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.851 -1.155 . . . . 0.0 109.006 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.69 ' N ' ' O ' ' B' ' 83' ' ' ALA . 11.8 tp -73.85 32.11 0.08 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -71.85 -73.07 0.2 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.029 -1.044 . . . . 0.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.07 120.96 2.22 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -138.43 141.1 39.54 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.45 -1.617 . . . . 0.0 107.294 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.8 mm-40 -31.16 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.781 0.8 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' B' ' 90' ' ' TYR . 20.8 tp -152.16 117.78 5.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.42 -168.9 48.0 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -11.94 59.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.028 -1.278 . . . . 0.0 108.872 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.476 ' NH2' " H4'" ' A' ' 8' ' ' ' A' . 0.1 OUTLIER -134.44 155.24 50.68 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' B' ' 97' ' ' LEU . 6.8 m-85 -97.09 134.17 40.78 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.27 -0.894 . . . . 0.0 109.207 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -29.21 136.91 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.505 0.669 . . . . 0.0 111.084 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -112.76 126.81 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 109.054 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 14.7 p -89.27 129.96 35.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 111.168 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -130.8 -168.16 12.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.59 ' CE2' ' OD1' ' B' ' 22' ' ' ASN . 38.5 p90 -137.49 161.36 36.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.682 -0.893 . . . . 0.0 109.076 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 26.9 t -179.24 92.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.438 -0.789 . . . . 0.0 108.945 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 60.7 p -151.91 168.44 25.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' B' ' 104' ' ' ASN . 33.3 p-10 -125.71 -178.06 4.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.473 -0.767 . . . . 0.0 109.653 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.616 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 6.9 tptt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.92 140.23 32.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 109.58 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 158' ' ' SER . . . . . 0.536 ' C ' ' H ' ' C' ' 160' ' ' LYS . 28.2 t -111.93 142.49 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.766 . . . . 0.0 109.336 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . 0.409 ' CB ' ' O ' ' C' ' 209' ' ' LYS . 27.4 p -72.42 28.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.741 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' C' ' 158' ' ' SER . 38.7 tttt -104.51 134.81 47.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.545 -0.722 . . . . 0.0 109.997 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 8.3 ptm -118.26 159.26 23.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -0.842 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.437 ' CG ' ' C2 ' ' A' ' 6' ' ' ' A' . 44.3 t80 -122.83 77.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 110.29 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' C' ' 162' ' ' PHE . 0.6 OUTLIER -50.11 140.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . 0.474 ' HA2' ' C5 ' ' A' ' 5' ' ' ' U' . . . -139.11 166.66 25.39 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.68 ' N ' ' O4 ' ' A' ' 5' ' ' ' U' . . . 53.91 24.51 27.15 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . 0.501 ' O ' ' C8 ' ' A' ' 4' ' ' ' A' . 1.7 pp -75.06 162.37 28.61 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.362 -1.081 . . . . 0.0 110.653 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.483 ' O ' ' CD1' ' C' ' 166' ' ' LEU . 63.5 t30 -75.29 123.98 26.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.025 -1.047 . . . . 0.0 109.528 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.717 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 3.2 m0 -37.52 -39.28 0.3 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 111.054 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.7 84.41 7.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.694 -1.253 . . . . 0.0 110.94 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 170' ' ' THR . . . . . 0.405 ' O ' ' CD1' ' C' ' 190' ' ' ILE . 57.9 m -146.18 133.82 21.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.991 . . . . 0.0 109.368 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 171' ' ' THR . . . . . 0.445 ' O ' ' C ' ' C' ' 172' ' ' GLU . 1.4 m -124.33 138.92 54.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.343 -0.848 . . . . 0.0 109.128 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' C' ' 175' ' ' LEU . 0.5 OUTLIER -39.38 -72.99 0.05 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.138 -0.976 . . . . 0.0 110.744 -178.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' C' ' 172' ' ' GLU . 53.9 t0 -38.68 -39.46 0.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.542 -0.724 . . . . 0.0 110.139 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -76.51 -44.22 36.05 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' C' ' 172' ' ' GLU . 0.9 OUTLIER -53.1 -54.05 41.27 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' C' ' 179' ' ' PHE . 5.6 ptm180 -68.81 -55.54 10.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.43 -1.308 . . . . 0.0 108.534 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' C' ' 176' ' ' ARG . 84.6 tt0 -35.94 -33.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' C' ' 176' ' ' ARG . 21.1 t80 -91.93 -31.14 15.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.724 . . . . 0.0 110.564 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' C' ' 176' ' ' ARG . 6.0 m-85 -95.49 15.92 18.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.84 -1.163 . . . . 0.0 110.832 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.67 29.57 2.63 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' C' ' 179' ' ' PHE . 0.5 OUTLIER -116.57 22.79 12.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -1.079 . . . . 0.0 109.195 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . 0.609 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 99.2 m-85 -127.91 -3.84 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.486 -0.759 . . . . 0.0 109.628 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 151.33 -126.19 2.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 2.9 t -131.58 149.7 52.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -1.077 . . . . 0.0 108.844 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 86.0 t -103.25 134.42 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.915 . . . . 0.0 109.663 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 53.0 p -122.3 -29.51 4.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.378 -0.826 . . . . 0.0 110.562 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -153.9 150.51 28.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 109.62 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 1.2 pp -171.93 154.84 3.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.588 -1.32 . . . . 0.0 110.111 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -140.35 118.52 11.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 108.337 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . 0.411 HG23 ' N ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -141.11 148.66 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.777 -1.202 . . . . 0.0 110.33 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 9.8 mtt -121.63 174.13 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 140.05 1.13 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.523 -1.361 . . . . 0.0 109.118 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' C' ' 193' ' ' ASP . 0.0 OUTLIER -74.9 143.46 78.02 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.069 -1.019 . . . . 0.0 110.045 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.74 -40.73 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.946 1.764 . . . . 0.0 110.994 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . 178.93 -39.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.566 -0.709 . . . . 0.0 109.771 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 50.1 p -123.4 5.44 9.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' C' ' 198' ' ' ARG . . . -105.03 42.64 1.85 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' C' ' 197' ' ' GLY . 49.6 mtm180 -41.91 133.73 2.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -1.109 . . . . 0.0 109.63 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 199' ' ' SER . . . . . . . . . . . . . 23.0 t -154.67 167.04 31.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.55 ' N ' ' NE ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -59.94 92.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . 0.679 ' O ' ' N3 ' ' A' ' 5' ' ' ' U' . . . -83.11 93.13 1.68 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -109.14 154.54 22.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -115.6 134.09 11.31 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.522 -1.799 . . . . 0.0 110.087 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -114.14 91.44 3.63 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.23 111.87 24.17 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.175 -0.953 . . . . 0.0 110.442 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 7.7 t -106.61 135.6 47.85 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -104.43 -121.41 0.21 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -141.05 -14.25 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.188 -1.57 . . . . 0.0 108.867 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.51 ' HZ2' ' CB ' ' C' ' 209' ' ' LYS . 7.6 mtmp? -130.0 170.45 10.98 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -97.66 -11.82 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.638 2.225 . . . . 0.0 112.481 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.587 ' O ' ' N ' ' C' ' 213' ' ' VAL . 15.1 m -68.58 -61.64 1.74 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.924 -1.11 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.445 ' C ' ' O ' ' C' ' 211' ' ' SER . 42.8 m -40.64 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -0.763 . . . . 0.0 109.873 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' C' ' 211' ' ' SER . 84.0 t -73.64 -35.79 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.754 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -63.83 -49.32 73.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.75 . . . . 0.0 110.409 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' C' ' 215' ' ' GLU . 0.0 OUTLIER -69.04 -42.7 76.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.797 -1.189 . . . . 0.0 108.674 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . . . . . . . . . 4.8 t -51.55 -47.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.551 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.7 -36.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -77.93 8.95 3.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.786 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 18.0 m -129.38 142.95 50.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.879 . . . . 0.0 108.762 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.95 136.27 45.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.656 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -131.18 153.01 49.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.726 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.628 ' CD1' ' N ' ' C' ' 222' ' ' ILE . 0.0 OUTLIER -117.62 86.85 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.672 0.748 . . . . 0.0 109.102 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.27 -66.75 0.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.855 . . . . 0.0 110.242 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -96.05 8.31 44.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.665 -1.272 . . . . 0.0 109.401 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 81.95 14.88 76.4 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . 0.582 ' HZ3' ' CA ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER -95.69 -154.39 0.43 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' C' ' 165' ' ' GLY . 7.6 t -115.07 95.91 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 26.3 pt -105.65 136.94 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.78 108.44 53.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.798 . . . . 0.0 109.612 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . 0.427 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 37.2 Cg_endo -81.7 137.33 10.03 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.968 1.779 . . . . 0.0 111.939 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -145.99 159.52 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 234' ' ' ILE . 26.8 ptt-85 -87.61 152.14 22.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.04 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -49.15 99.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 108.761 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 232' ' ' ARG . 4.4 mt -90.76 127.44 52.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.03 149.36 2.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.062 1.841 . . . . 0.0 112.55 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -57.33 -45.83 83.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -59.41 -41.73 90.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 108.704 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -66.3 -36.39 82.83 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.434 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . 0.544 ' CD ' ' N7 ' ' A' ' 6' ' ' ' A' . 30.5 tp60 -61.19 -44.82 96.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -73.0 -41.2 64.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.362 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -72.28 -13.93 61.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 111.805 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 242' ' ' THR . . . . . 0.517 ' O ' ' O ' ' C' ' 291' ' ' TYR . 0.9 OUTLIER -47.64 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.525 -1.359 . . . . 0.0 110.284 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . 0.408 ' H ' ' HG1' ' C' ' 242' ' ' THR . . . 107.66 108.76 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -140.72 134.33 30.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.715 -1.462 . . . . 0.0 110.6 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.16 159.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 109.875 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.717 ' CE2' ' C4 ' ' A' ' 2' ' ' ' A' . 0.0 OUTLIER -106.93 131.19 54.29 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.46 132.25 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.652 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.19 148.75 18.26 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . 0.786 ' H ' ' H3 ' ' A' ' 1' ' ' ' U' . . . 70.39 72.53 0.87 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.224 -1.162 . . . . 0.0 111.223 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' C' ' 251' ' ' GLY . 19.6 mt -118.34 145.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -1.057 . . . . 0.0 109.096 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' C' ' 250' ' ' ILE . . . -42.66 126.88 4.74 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.29 -40.76 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.822 1.681 . . . . 0.0 112.207 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' C' ' 254' ' ' VAL . 90.5 m-20 -95.17 6.31 49.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.376 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' C' ' 253' ' ' ASP . 10.7 p -42.26 165.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.88 . . . . 0.0 109.982 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.424 ' N ' ' CG2' ' C' ' 254' ' ' VAL . 14.4 mtt180 -137.3 156.76 75.12 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.0 109.052 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.14 -28.14 48.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.467 2.111 . . . . 0.0 111.913 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -52.13 -64.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . 0.718 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.0 tp10 -59.77 -83.2 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.727 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . 0.608 ' C ' ' O ' ' C' ' 258' ' ' GLU . 75.9 t80 -12.67 -70.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.207 0.527 . . . . 0.0 111.45 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.31 -41.77 72.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.431 -0.793 . . . . 0.0 109.691 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . 0.718 ' N ' ' O ' ' C' ' 258' ' ' GLU . 44.3 tp10 -67.46 -46.69 72.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . 0.612 ' O ' ' HG2' ' C' ' 265' ' ' GLN . 60.3 t80 -49.68 -72.32 0.05 Allowed 'General case' 0 C--O 1.193 -1.907 0 O-C-N 121.573 -0.705 . . . . 0.0 110.512 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' C' ' 265' ' ' GLN . 88.4 m-85 -53.59 -45.1 69.89 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.044 -1.035 . . . . 0.0 112.083 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.502 ' C ' ' O ' ' C' ' 263' ' ' PHE . 0.3 OUTLIER -24.07 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.636 ' N ' ' O ' ' C' ' 263' ' ' PHE . 1.0 OUTLIER -48.41 -100.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.762 -1.212 . . . . 0.0 111.042 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.503 ' H ' ' HG3' ' C' ' 265' ' ' GLN . 1.7 p90 -60.77 148.71 38.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 51.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 86.2 m -49.77 141.71 9.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.289 . . . . 0.0 108.558 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -95.41 106.71 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.986 -1.071 . . . . 0.0 110.753 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.13 -55.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.705 -1.247 . . . . 0.0 108.862 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -141.25 102.43 4.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' C' ' 273' ' ' GLN . . . -131.71 157.36 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' C' ' 272' ' ' ALA . 14.6 pt20 168.69 173.31 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.685 1.231 . . . . 0.0 111.796 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.12 148.36 22.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 275' ' ' MET . . . . . 0.498 ' HE3' " H4'" ' A' ' 3' ' ' ' U' . 96.8 mmm -97.71 -172.55 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.448 -1.407 . . . . 0.0 110.933 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 175.29 88.56 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . 0.683 ' OD2' " H3'" ' A' ' 3' ' ' ' U' . 83.0 m-20 -84.34 47.5 1.35 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' C' ' 277' ' ' ASP . 15.6 pttp -40.41 -33.22 0.24 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -58.41 -37.12 74.68 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.356 -0.937 . . . . 0.0 108.484 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 280' ' ' THR . . . . . 0.597 ' N ' ' O ' ' C' ' 277' ' ' ASP . 0.4 OUTLIER -141.73 -79.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . 0.57 ' N ' ' OG1' ' C' ' 280' ' ' THR . . . -65.27 -165.34 1.26 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.0 tt0 -167.09 158.59 12.34 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.338 -1.095 . . . . 0.0 109.828 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 283' ' ' SER . . . . . 0.41 ' N ' ' HG2' ' C' ' 282' ' ' GLN . 1.0 OUTLIER -61.17 67.59 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.203 0.525 . . . . 0.0 109.774 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' C' ' 282' ' ' GLN . 60.8 ttm-85 -50.07 -24.74 2.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.86 22.93 0.26 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.557 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 23.0 p90 -111.36 173.36 6.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 110.668 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.93 36.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' C' ' 246' ' ' PHE . 21.8 m-85 -143.1 158.45 43.6 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.417 -1.637 . . . . 0.0 109.189 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 19.8 t -141.59 143.94 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.81 -1.181 . . . . 0.0 108.253 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 18.6 m -130.97 128.71 40.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.869 -1.144 . . . . 0.0 109.56 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . 0.517 ' O ' ' O ' ' C' ' 242' ' ' THR . 42.0 m-85 -114.42 143.64 44.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER -62.48 -48.56 79.08 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 293' ' ' SER . . . . . 0.543 ' N ' ' CG ' ' C' ' 292' ' ' ASP . 12.4 m -73.93 132.93 42.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -76.33 -32.7 58.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -50.95 -38.48 50.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.702 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.44 -46.09 83.97 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.99 -56.56 14.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -54.5 -21.39 9.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.585 -0.697 . . . . 0.0 109.79 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -75.07 -60.82 2.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.96 -27.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 109.684 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' C' ' 300' ' ' VAL . 26.8 t -43.74 -57.2 3.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.124 -0.985 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -51.71 -24.09 5.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 108.914 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' C' ' 300' ' ' VAL . 89.1 m-20 -99.55 91.39 4.87 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -75.95 -84.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.558 -1.339 . . . . 0.0 109.218 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -66.59 124.93 24.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 79.8 mt -125.04 139.78 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.42 -0.8 . . . . 0.0 109.305 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -64.62 129.91 41.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.913 . . . . 0.0 109.741 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 87.8 t80 -137.31 171.41 14.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 0.0 110.713 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 31.7 ttmt -32.35 -71.18 0.06 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.115 0.483 . . . . 0.0 111.265 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.16 -71.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.49 -166.36 2.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.079 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -56.37 157.97 4.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.365 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . 0.513 ' CG1' ' O ' ' C' ' 313' ' ' ILE . 2.1 pt -131.85 121.77 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.26 106.9 7.01 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.2 -0.938 . . . . 0.0 110.02 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 2.8 mm -79.71 154.0 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.047 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -157.27 157.49 34.32 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.836 -1.165 . . . . 0.0 109.01 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -67.65 143.88 55.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.668 -1.27 . . . . 0.0 109.254 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -84.92 44.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.006 -1.059 . . . . 0.0 109.939 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' C' ' 320' ' ' PRO . 0.3 OUTLIER -127.31 55.25 14.75 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 319' ' ' GLU . 54.1 Cg_endo -70.95 -63.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.873 2.382 . . . . 0.0 112.393 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -104.99 0.75 28.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.467 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.558 -179.474 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.845 HO5' ' P ' ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.079 1 C5'-C4'-C3' 107.807 -5.129 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.89 " H4'" ' CE1' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.444 2.519 1 C5'-C4'-C3' 108.327 -4.782 . 0.616 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 0.648 ' H6 ' HO2' ' A' ' 2' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 2.033 1 C5'-C4'-C3' 108.666 -4.556 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.712 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.445 2.571 1 C5'-C4'-C3' 107.442 -5.372 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.713 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.66 2 C3'-C2'-C1' 105.701 4.668 . 0.754 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 1.017 " H4'" " C5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.432 -1.773 1 C5'-C4'-C3' 108.535 -4.643 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 1.017 " C5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.616 2.301 1 C5'-C4'-C3' 107.232 -5.512 . 0.214 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.569 " O2'" " O5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.444 2.535 1 C5'-C4'-C3' 106.118 -6.255 . 0.621 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.764 ' N3 ' ' CE1' ' B' ' 71' ' ' PHE . . . . . . . . 0 C2'--C1' 1.498 -3.009 3 O4'-C1'-N19 116.428 8.228 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 1.12 " H5'" ' CE1' ' B' ' 71' ' ' PHE . . . . . . . . 0 P--O5' 1.627 3.386 0 O5'-C5'-C4' 115.605 3.86 . 0.021 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.831 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.614 2.066 2 C5'-C4'-C3' 108.244 -4.837 . 0.719 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.825 " O2'" ' H6 ' ' A' ' 13' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.431 -1.837 1 C5'-C4'-C3' 106.054 -6.297 . 0.523 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.825 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.439 2.053 1 C5'-C4'-C3' 107.585 -5.277 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.512 ' CB ' ' CD ' ' B' ' 24' ' ' PRO . 26.5 Cg_exo -57.92 -172.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.881 2.387 . . . . 0.0 111.877 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.562 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 52.4 Cg_endo -89.32 23.4 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.02 2.48 . . . . 0.0 112.163 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.29 120.59 5.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.101 -1.0 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.514 ' CA ' ' HG ' ' B' ' 80' ' ' SER . 4.3 ttt85 -179.28 -45.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.425 HG21 ' N ' ' B' ' 28' ' ' VAL . 2.0 p -139.0 158.61 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.081 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.425 ' N ' HG21 ' B' ' 27' ' ' VAL . 7.1 p -120.98 142.16 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.74 ' CZ ' ' C2 ' ' A' ' 9' ' ' ' A' . 2.9 m-30 -105.32 141.48 36.75 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.512 ' O ' ' P ' ' A' ' 10' ' ' ' U' . 7.0 mt -129.26 117.21 20.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.478 -0.764 . . . . 0.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.434 ' N ' HD12 ' B' ' 33' ' ' ILE . . . -132.95 -23.54 0.77 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.652 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -91.65 71.79 5.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.847 -1.384 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.462 ' N ' HD11 ' B' ' 33' ' ' ILE . 1.2 mp -145.74 125.18 6.81 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 109.829 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.635 ' C ' ' H ' ' B' ' 36' ' ' ASP . 29.7 Cg_endo -73.83 163.0 38.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.07 1.18 . . . . 0.0 109.935 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.451 ' OH ' ' CB ' ' B' ' 59' ' ' PHE . 4.7 m-85 -55.71 3.45 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 109.887 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.635 ' H ' ' C ' ' B' ' 34' ' ' PRO . 85.5 m-20 -66.17 -45.03 82.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.905 -1.122 . . . . 0.0 109.575 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.4 107.52 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -102.45 -153.25 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.466 -0.771 . . . . 0.0 111.53 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.43 ' N ' ' SD ' ' B' ' 57' ' ' MET . 1.1 pp20? -58.2 -23.69 56.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.69 -54.7 12.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.37 -38.76 88.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 110.845 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 24.7 mm -60.2 -51.53 71.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.8 -37.31 73.53 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.495 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 24.0 t70 -55.73 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.909 1.338 . . . . 0.0 109.377 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.436 ' CD2' ' OH ' ' B' ' 90' ' ' TYR . 14.4 tp -52.1 -48.84 64.54 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.417 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' B' ' 49' ' ' VAL . 94.9 m -60.26 -68.07 0.33 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.138 -0.976 . . . . 0.0 109.044 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.58 ' C ' ' H ' ' B' ' 49' ' ' VAL . 85.1 p -31.72 -33.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.979 0.419 . . . . 0.0 110.576 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' B' ' 46' ' ' CYS . 72.9 m-80 -67.25 5.73 0.68 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.948 -1.095 . . . . 0.0 109.234 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 46' ' ' CYS . 65.9 t -111.67 -55.06 4.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' B' ' 52' ' ' VAL . . . 174.63 154.24 10.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 52' ' ' VAL . 51.4 Cg_exo -44.76 80.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.308 2.006 . . . . 0.0 112.194 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' B' ' 50' ' ' GLY . 0.8 OUTLIER -39.37 157.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.828 . . . . 0.0 109.61 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mm -87.56 -60.76 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.193 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.588 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 73.7 m-20 -119.86 126.12 50.18 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.104 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -125.35 126.37 44.93 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -140.81 118.63 11.75 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.017 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.543 ' O ' ' N6 ' ' A' ' 12' ' ' ' A' . 0.1 OUTLIER -113.41 143.81 43.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.255 0.55 . . . . 0.0 109.901 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 0.616 ' CE ' ' C8 ' ' A' ' 11' ' ' ' A' . 0.0 OUTLIER -161.54 157.18 24.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.603 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -129.88 149.24 51.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.507 ' HB3' ' N ' ' B' ' 66' ' ' SER . 4.7 p30 -42.87 98.04 0.16 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 111.383 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 42.3 Cg_endo -92.5 -17.58 0.83 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 122.807 2.338 . . . . 0.0 111.54 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -87.42 -65.93 0.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 111.267 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 -34.71 9.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.181 -0.949 . . . . 0.0 111.367 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.465 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 108.07 30.41 3.94 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.043 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.461 ' C ' ' OD2' ' B' ' 60' ' ' ASP . 81.1 mtp180 -93.88 -71.0 0.68 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.297 . . . . 0.0 110.3 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.507 ' N ' ' HB3' ' B' ' 60' ' ' ASP . 25.8 t -43.68 121.92 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -86.86 5.32 37.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.184 -0.948 . . . . 0.0 109.024 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.21 88.89 0.1 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 0.772 ' CG ' ' OP2' ' A' ' 10' ' ' ' U' . 1.9 m-85 -105.7 133.33 50.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.53 -0.983 . . . . 0.0 109.782 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.597 ' N ' ' OP1' ' A' ' 10' ' ' ' U' . . . -149.84 146.03 26.9 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.947 -1.095 . . . . 0.0 112.536 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 1.12 ' CE1' " H5'" ' A' ' 10' ' ' ' U' . 10.4 m-85 -114.51 130.11 56.72 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.705 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.651 ' CD1' ' N ' ' B' ' 72' ' ' ILE . 1.1 mp -121.93 102.33 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.35 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.588 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 29.4 mt-10 -93.05 136.71 33.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.252 -1.53 . . . . 0.0 110.244 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -98.32 176.53 5.67 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.853 0.835 . . . . 0.0 111.366 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 5.5 ttp180 -48.3 -42.01 29.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.858 -0.526 . . . . 0.0 111.42 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' B' ' 78' ' ' GLU . 3.5 m-20 156.62 -175.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.534 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 2.5 mm? -37.48 -23.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.655 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.8 mm-40 -70.24 -75.98 0.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.862 -1.149 . . . . 0.0 109.822 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 52.0 m -63.54 -40.59 97.41 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.514 ' HG ' ' CA ' ' B' ' 26' ' ' ARG . 25.7 t -58.92 -34.9 72.25 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -65.87 -61.29 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.676 -1.265 . . . . 0.0 109.031 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.602 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 22.0 t -60.21 -42.56 95.42 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.27 -0.894 . . . . 0.0 111.395 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.54 -65.66 0.9 Allowed 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.551 -0.718 . . . . 0.0 111.771 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -52.94 -37.84 27.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.296 -1.362 . . . . 0.0 109.212 -176.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -67.87 -47.47 68.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.365 -1.459 . . . . 0.0 108.382 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' B' ' 82' ' ' SER . 91.2 m-20 -67.5 -42.74 82.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.056 -1.028 . . . . 0.0 109.27 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -106.35 28.72 7.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.333 -0.855 . . . . 0.0 110.084 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.625 ' N ' ' O ' ' B' ' 84' ' ' VAL . 1.2 m-20 -61.51 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.82 -1.175 . . . . 0.0 109.188 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.68 107.77 0.86 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.642 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -134.1 148.81 51.05 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 119.677 1.739 . . . . 0.0 110.917 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -46.25 91.59 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 119.876 -1.765 . . . . 0.0 108.456 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.1 tt -153.2 104.81 2.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.85 -175.39 43.47 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -67.12 -27.36 67.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.248 . . . . 0.0 109.617 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt85 -135.95 163.95 29.09 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.453 ' O ' ' C ' ' B' ' 97' ' ' LEU . 2.3 m-85 -92.69 133.99 35.47 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.31 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.653 ' CD1' ' N ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -38.94 152.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.263 0.554 . . . . 0.0 109.562 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -108.46 146.84 32.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 109.268 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . 0.571 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.0 OUTLIER -91.9 124.78 36.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 109.781 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' B' ' 29' ' ' TYR . . . -137.17 -175.5 13.85 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.375 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 4.3 p90 -120.82 6.15 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -1.051 . . . . 0.0 110.562 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' SER . . . . . 0.464 ' C ' ' O ' ' B' ' 101' ' ' TYR . 0.6 OUTLIER -39.92 125.05 1.87 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 0.0 109.913 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t -174.7 79.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.241 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -106.67 122.34 46.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 109.429 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.412 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . 0.66 ' HZ2' ' HG ' ' C' ' 158' ' ' SER . 15.4 pttp . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -99.8 125.89 45.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.368 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 158' ' ' SER . . . . . 0.66 ' HG ' ' HZ2' ' C' ' 156' ' ' LYS . 50.5 m -134.95 150.01 50.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.563 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 1.0 OUTLIER -175.41 39.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.425 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -100.4 102.89 14.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.6 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 71.3 mtp -87.23 133.04 33.71 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.701 -1.199 . . . . 0.0 111.144 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.677 ' CZ ' ' C8 ' ' A' ' 6' ' ' ' A' . 76.9 t80 -104.77 90.69 3.56 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . 0.421 HD12 HG21 ' C' ' 163' ' ' ILE . 5.6 mm -59.99 127.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . 0.436 ' C ' ' O4 ' ' A' ' 5' ' ' ' U' . . . -130.34 -177.2 14.75 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.687 ' N ' ' O4 ' ' A' ' 5' ' ' ' U' . . . 42.84 41.1 4.33 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 13.5 mt -83.96 170.84 13.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -1.041 . . . . 0.0 109.725 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.478 ' O ' ' OD1' ' C' ' 167' ' ' ASN . 39.9 p-10 -85.45 140.21 30.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.712 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 2.1 m0 -48.95 -27.85 3.43 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.676 -1.265 . . . . 0.0 110.018 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . 0.444 ' O ' ' ND2' ' C' ' 167' ' ' ASN . 58.3 t0 -90.49 102.43 15.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.978 -1.076 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 33.0 m -147.2 144.51 28.98 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.46 173.5 6.38 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.222 -0.924 . . . . 0.0 109.142 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . 0.483 ' OE2' ' NZ ' ' C' ' 192' ' ' LYS . 11.5 mp0 -84.18 -77.04 0.28 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.799 -1.188 . . . . 0.0 109.587 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' C' ' 176' ' ' ARG . 49.5 t0 -49.08 -55.45 12.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.629 -1.295 . . . . 0.0 108.388 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' C' ' 173' ' ' ASP . 64.2 t30 -43.23 -53.18 5.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.93 -35.19 70.75 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.215 -0.928 . . . . 0.0 108.994 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' C' ' 178' ' ' TYR . 67.5 ttp85 -70.98 -63.52 1.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 108.904 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' C' ' 176' ' ' ARG . 77.3 mm-40 -43.78 -25.91 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' C' ' 176' ' ' ARG . 34.1 t80 -76.37 -47.05 24.69 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.557 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 176' ' ' ARG . 26.2 m-85 -95.7 15.85 18.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.257 -0.902 . . . . 0.0 111.655 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.17 14.44 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -106.13 9.73 32.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -1.077 . . . . 0.0 108.228 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . 0.521 ' HH ' ' CG2' ' C' ' 219' ' ' THR . 19.8 m-85 -121.61 -4.25 9.27 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 144.12 -134.69 5.86 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -126.69 145.65 50.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -1.041 . . . . 0.0 109.297 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.76 134.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 186' ' ' THR . . . . . 0.519 ' H ' ' HG1' ' C' ' 186' ' ' THR . 0.1 OUTLIER -78.52 -61.47 2.0 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.985 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . 0.589 ' OD2' ' NZ ' ' C' ' 189' ' ' LYS . 0.3 OUTLIER -121.22 84.79 2.29 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.329 1.061 . . . . 0.0 112.021 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 7.1 tt -81.28 107.03 13.73 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . 0.589 ' NZ ' ' OD2' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -121.31 96.13 4.96 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.22 -0.925 . . . . 0.0 110.893 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . 0.562 ' O ' ' SD ' ' C' ' 191' ' ' MET . 0.0 OUTLIER -107.8 141.13 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 191' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' C' ' 190' ' ' ILE . 10.7 mmt -125.33 78.99 1.77 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.059 -1.026 . . . . 0.0 110.647 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . 0.483 ' NZ ' ' OE2' ' C' ' 172' ' ' GLU . 26.1 pttm -79.52 153.77 29.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.107 -0.995 . . . . 0.0 109.305 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 11.9 t0 -52.68 114.69 6.05 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.038 -1.039 . . . . 0.0 108.699 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.01 -21.54 4.02 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.827 1.685 . . . . 0.0 112.661 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -80.18 -86.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.24 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 45.5 p -109.35 -28.63 8.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.212 -0.93 . . . . 0.0 109.677 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 122.28 17.63 3.59 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -90.79 58.47 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.072 -1.252 . . . . 0.0 109.519 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 199' ' ' SER . . . . . 0.477 ' O ' ' C ' ' C' ' 200' ' ' ARG . 39.4 t -142.99 169.83 16.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' C' ' 199' ' ' SER . 19.3 mmt180 -37.06 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . 0.69 ' O ' ' N3 ' ' A' ' 5' ' ' ' U' . . . -94.92 92.29 1.49 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.302 -1.427 . . . . 0.0 109.861 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.432 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 48.5 p90 -125.9 155.65 40.92 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.512 -0.993 . . . . 0.0 108.611 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.93 123.11 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.957 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -93.25 86.44 5.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.843 -1.387 . . . . 0.0 107.981 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 33.2 mt -87.49 85.27 7.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.727 -1.233 . . . . 0.0 110.321 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 206' ' ' SER . . . . . 0.475 ' CB ' ' H ' ' C' ' 187' ' ' ASP . 0.1 OUTLIER -65.47 85.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.596 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . 0.534 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 14.5 m-85 -68.08 122.3 17.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.155 -0.966 . . . . 0.0 110.917 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.87 -50.32 36.44 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.788 -0.57 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -83.56 115.19 58.22 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 110.86 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.58 -38.22 44.53 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.186 1.924 . . . . 0.0 112.799 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 86.1 p -64.53 -49.95 69.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.444 ' O ' ' CG2' ' C' ' 216' ' ' VAL . 22.6 t -43.56 -33.21 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 109.224 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.17 -40.44 85.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.168 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' C' ' 211' ' ' SER . 57.6 t0 -59.68 -51.14 71.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.505 -0.747 . . . . 0.0 110.665 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . 0.467 ' O ' ' OG1' ' C' ' 219' ' ' THR . 5.5 pt-20 -68.17 -33.37 74.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' C' ' 212' ' ' SER . 55.8 t -58.97 -47.99 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.009 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.48 -30.04 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.1 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -89.71 21.53 3.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 109.742 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.578 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 41.3 m -129.82 149.43 51.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' C' ' 221' ' ' HIS . 13.1 tt0 -75.92 -177.85 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.125 -0.985 . . . . 0.0 109.392 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' C' ' 220' ' ' GLN . 55.3 m-70 -158.28 130.52 6.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 110.3 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.46 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 24.6 mt -153.35 80.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.737 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 16.5 mt -51.43 -71.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.735 -1.228 . . . . 0.0 109.54 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -101.51 -55.77 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 108.855 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 159.9 30.9 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . 0.76 ' HZ3' ' N ' ' C' ' 279' ' ' ASP . 0.0 OUTLIER -94.1 -76.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.107 -1.231 . . . . 0.0 108.601 178.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' C' ' 226' ' ' LYS . 2.1 t 155.39 90.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 23.2 pt -94.2 152.05 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.34 96.41 44.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.543 -0.723 . . . . 0.0 110.768 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . 0.508 ' CG ' ' CD2' ' C' ' 221' ' ' HIS . 18.9 Cg_endo -81.82 121.51 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.709 2.273 . . . . 0.0 111.645 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -142.52 148.26 37.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 0.0 110.127 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.52 159.36 0.51 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.5 144.28 37.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 38.4 mt -132.6 91.15 31.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.486 -0.759 . . . . 0.0 109.418 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.42 161.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.11 1.873 . . . . 0.0 111.742 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.665 ' NH2' ' P ' ' A' ' 6' ' ' ' A' . 0.0 OUTLIER -51.57 -49.2 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.975 . . . . 0.0 111.312 -178.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -59.66 -43.28 94.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.845 -1.159 . . . . 0.0 109.824 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -68.36 -36.91 79.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.131 -0.98 . . . . 0.0 110.001 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -61.17 -41.46 96.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.171 -0.956 . . . . 0.0 108.838 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . 0.413 ' HB2' HH21 ' C' ' 321' ' ' ARG . 22.9 t70 -83.3 -25.03 31.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.473 -0.767 . . . . 0.0 109.599 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -51.2 -16.11 0.45 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.692 . . . . 0.0 110.432 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 13.9 p -106.38 159.69 15.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.918 -1.113 . . . . 0.0 109.231 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -115.41 154.87 16.67 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . 0.556 ' N ' HH12 ' C' ' 317' ' ' ARG . 0.0 OUTLIER -140.05 147.28 40.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.268 . . . . 0.0 111.235 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.68 154.44 40.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.729 0.776 . . . . 0.0 109.142 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.635 ' CD2' ' N3 ' ' A' ' 2' ' ' ' A' . 2.0 t80 -102.19 128.19 48.81 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.75 143.64 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 110.368 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.9 154.21 16.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.0 56.26 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 120.939 -1.33 . . . . 0.0 111.209 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' C' ' 286' ' ' PHE . 1.5 pp -111.26 137.69 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.903 -1.351 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . 0.657 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 157.81 -37.8 0.54 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 50.0 Cg_exo -54.06 -127.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.512 2.142 . . . . 0.0 112.22 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -69.86 19.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 109.681 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' C' ' 252' ' ' PRO . 1.3 m -93.19 137.3 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.918 -1.114 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -103.45 163.07 18.19 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.59 -21.43 70.41 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.46 2.107 . . . . 0.0 111.372 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -62.25 -58.57 7.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.655 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.59 -41.72 86.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' C' ' 263' ' ' PHE . 29.0 t80 -52.6 -63.18 1.23 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.93 -43.43 98.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.911 -0.493 . . . . 0.0 110.28 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.97 -18.83 64.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.093 -1.005 . . . . 0.0 108.979 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . 0.606 ' O ' ' NE2' ' C' ' 265' ' ' GLN . 33.8 t80 -88.95 -77.75 0.37 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.234 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.575 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 43.2 m-85 -43.5 -36.26 1.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.928 -1.107 . . . . 0.0 109.494 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.499 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.8 t -30.72 -40.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.325 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.67 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 0.0 OUTLIER -60.76 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.429 -1.419 . . . . 0.0 110.981 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.67 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.2 OUTLIER -60.15 147.83 38.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.397 -1.439 . . . . 0.0 109.402 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' C' ' 269' ' ' ILE . . . 58.91 86.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 268' ' ' THR . . . . . 0.506 ' O ' ' C ' ' C' ' 269' ' ' ILE . 3.8 t -53.59 43.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.483 -1.01 . . . . 0.0 113.625 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . 0.684 ' N ' ' O ' ' C' ' 267' ' ' GLY . 1.7 tt -13.77 111.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.9 mm -87.2 -33.95 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.439 -1.413 . . . . 0.0 107.81 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.04 99.1 5.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -108.32 132.78 53.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.321 -0.862 . . . . 0.0 109.371 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -160.59 123.56 3.34 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 117.919 -1.512 . . . . 0.0 112.081 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . 0.491 ' C ' ' CD2' ' C' ' 274' ' ' LEU . 0.2 OUTLIER -100.63 155.08 18.08 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 275' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' C' ' 280' ' ' THR . 20.8 mmt -90.08 161.24 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.398 . . . . 0.0 109.619 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' C' ' 280' ' ' THR . 1.0 OUTLIER -126.62 -165.41 1.45 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.494 0.664 . . . . 0.0 109.689 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . 0.454 ' C ' ' OD1' ' C' ' 277' ' ' ASP . 53.5 p30 -97.98 -9.97 25.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.448 -0.782 . . . . 0.0 109.339 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' C' ' 277' ' ' ASP . 49.9 mmtt -60.6 -54.6 43.38 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . 0.76 ' N ' ' HZ3' ' C' ' 226' ' ' LYS . 0.2 OUTLIER 177.51 -6.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.598 -0.689 . . . . 0.0 110.895 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 280' ' ' THR . . . . . 0.717 ' N ' ' HZ2' ' C' ' 226' ' ' LYS . 42.8 p -64.88 -3.14 3.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.446 -1.409 . . . . 0.0 108.708 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' C' ' 279' ' ' ASP . . . 155.04 -119.48 0.93 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.601 ' C ' ' H ' ' C' ' 284' ' ' ARG . 55.9 mt-30 -147.1 129.09 15.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 109.881 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 51.5 p -66.01 15.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 109.518 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . 0.755 ' NH1' " H4'" ' A' ' 1' ' ' ' U' . 10.1 tpp85 -49.86 -38.15 34.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.86 70.52 0.06 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.448 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.89 ' CE1' " H4'" ' A' ' 2' ' ' ' A' . 22.3 p90 -170.58 179.31 3.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.173 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -174.21 -167.48 33.79 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . 0.427 ' CZ ' ' H2 ' ' A' ' 2' ' ' ' A' . 1.4 m-85 -143.9 154.51 43.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.471 -1.605 . . . . 0.0 109.465 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' C' ' 291' ' ' TYR . 0.7 OUTLIER -141.55 152.82 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 11.0 m -133.57 126.75 31.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.968 -1.083 . . . . 0.0 110.497 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . 0.46 ' CE2' ' CG2' ' C' ' 289' ' ' VAL . 49.8 m-85 -113.15 143.71 43.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.37 -50.84 71.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.298 -1.501 . . . . 0.0 109.064 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 16.6 t -91.29 171.19 9.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' C' ' 297' ' ' VAL . . . -105.29 -20.03 13.62 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 294' ' ' ALA . 91.5 m-20 -47.05 -39.63 13.28 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.43 -33.6 72.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' C' ' 294' ' ' ALA . 60.4 t -69.86 -63.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.06 -18.29 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.046 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' C' ' 297' ' ' VAL . 1.7 ttt85 -78.37 -57.39 3.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.485 -0.759 . . . . 0.0 109.004 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' C' ' 303' ' ' ASN . 3.3 p -65.76 -25.97 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . 0.437 ' C ' ' N ' ' C' ' 303' ' ' ASN . 33.5 m -44.77 -58.83 2.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.863 -1.148 . . . . 0.0 109.005 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' C' ' 301' ' ' CYS . 26.3 mt-30 -47.19 -23.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.011 . . . . 0.0 108.394 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' C' ' 300' ' ' VAL . 97.1 m-20 -100.16 70.75 1.56 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -68.93 -9.28 51.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.53 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -137.53 122.26 18.69 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 0.0 108.832 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 54.2 mt -121.65 145.85 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.889 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -79.46 120.12 23.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 108.519 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.638 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 73.5 t80 -120.03 -179.1 3.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.638 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 33.0 ttpt -43.61 -30.13 0.57 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . 0.591 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 46.1 t0 -86.25 -154.23 0.21 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . 0.591 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 35.7 ptt180 -79.0 -48.11 15.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 109.041 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' C' ' 311' ' ' ARG . 6.5 ttmt -165.72 155.31 12.34 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . 0.446 HG22 HD13 ' C' ' 313' ' ' ILE . 37.3 pt -131.2 157.68 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -110.43 152.54 26.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.959 . . . . 0.0 109.83 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 6.7 mm -119.38 142.26 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.36 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -145.93 144.23 30.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.192 -0.942 . . . . 0.0 108.859 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . 0.556 HH12 ' N ' ' C' ' 244' ' ' LYS . 20.9 tpt180 -70.64 135.51 48.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 319' ' ' GLU . . . -60.9 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' C' ' 317' ' ' ARG . 0.6 OUTLIER -44.64 -51.11 22.34 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 109.432 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' C' ' 319' ' ' GLU . 17.3 Cg_exo -64.35 135.8 48.07 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.887 1.725 . . . . 0.0 111.588 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . 0.43 ' O ' ' NZ ' ' C' ' 244' ' ' LYS . 80.2 ttt-85 -58.45 -38.33 77.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.966 . . . . 0.0 109.681 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 45.2 m80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.578 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.872 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.93 1 C5'-C4'-C3' 107.488 -5.342 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.872 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.437 1.889 2 C5'-C4'-C3' 107.291 -5.473 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 0.662 " O2'" " H4'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 P--O5' 1.61 1.67 1 C5'-C4'-C3' 105.886 -6.409 . 0.69 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.836 ' C6 ' ' CD1' ' C' ' 168' ' ' TRP . . . . . . . . 0 C2'--O2' 1.432 1.468 2 O4'-C1'-N19 113.325 5.125 . 0.069 2u . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.754 ' C2 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 O4'--C1' 1.446 2.676 1 C5'-C4'-C3' 108.748 -4.502 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.744 ' C5 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 P--O5' 1.616 2.327 1 C5'-C4'-C3' 107.07 -5.62 OUTLIER-EPSILON 0.644 1b . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.771 ' H5 ' ' CE2' ' C' ' 204' ' ' PHE . . . . . . . . 0 O4'--C1' 1.442 2.328 1 C5'-C4'-C3' 107.509 -5.327 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.722 " H4'" ' NH1' ' B' ' 95' ' ' ARG . . . . . . . . 0 O4'--C1' 1.439 2.112 2 C3'-C2'-C1' 105.638 4.598 . 0.01 6p . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 1.007 H5'' ' OH ' ' B' ' 69' ' ' TYR . . . . . . . . 0 P--O5' 1.613 2.044 2 O4'-C1'-N19 112.858 4.658 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 0.937 " H2'" ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.443 2.381 1 C5'-C4'-C3' 108.903 -4.398 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.937 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.442 2.309 1 C5'-C4'-C3' 106.131 -6.246 . 0.73 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.87 " H4'" ' NE ' ' C' ' 321' ' ' ARG . . . . . . . . 0 O4'--C4' 1.43 -1.918 1 C5'-C4'-C3' 106.961 -5.693 . 0.697 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.834 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 2.01 1 C5'-C4'-C3' 107.69 -5.206 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' B' ' 102' ' ' SER . 2.0 m120 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.34 147.03 87.2 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.46 2.107 . . . . 0.0 111.899 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.25 3.47 5.71 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.486 2.124 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.92 130.14 8.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.955 -1.091 . . . . 0.0 109.409 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.546 ' C ' ' HG ' ' B' ' 80' ' ' SER . 4.6 ttt85 -176.51 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -0.793 . . . . 0.0 109.249 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 100' ' ' GLY . 1.6 p -140.85 165.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.1 t -124.9 144.64 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.723 ' CE1' ' C2 ' ' A' ' 9' ' ' ' A' . 5.7 m-85 -111.53 130.91 55.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 8.5 mp -115.98 105.33 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -103.21 -72.54 0.92 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.887 -1.149 . . . . 0.0 112.113 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.468 ' OG ' ' OG ' ' B' ' 94' ' ' SER . 8.5 t -68.85 86.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.332 . . . . 0.0 110.338 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 mp -147.38 126.09 6.23 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' B' ' 36' ' ' ASP . 37.2 Cg_endo -69.73 165.96 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.721 1.614 . . . . 0.0 112.836 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -70.59 1.47 5.17 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' B' ' 34' ' ' PRO . 88.7 m-20 -64.74 -34.28 77.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.41 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -118.77 112.26 19.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.103 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.5 p -107.2 -142.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.502 0.667 . . . . 0.0 110.891 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.63 -28.36 68.48 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.927 -1.108 . . . . 0.0 110.322 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.59 -53.98 16.24 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.078 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.2 OUTLIER -68.84 -44.5 73.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.874 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' B' ' 44' ' ' ASP . 14.2 mm -59.79 -52.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.868 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 42' ' ' ILE . 0.7 OUTLIER -38.94 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.809 -0.557 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' B' ' 42' ' ' ILE . 97.4 m-20 -122.54 -23.71 5.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.658 -1.276 . . . . 0.0 110.552 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.441 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.0 tm? -59.25 -43.85 92.39 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.16 -1.588 . . . . 0.0 106.922 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.0 OUTLIER -82.14 -63.23 1.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.189 -0.944 . . . . 0.0 109.289 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.775 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.9 t -37.91 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.655 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.6 OUTLIER -51.81 67.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.441 1.115 . . . . 0.0 110.153 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.775 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.22 -34.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.278 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.66 -173.05 46.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.46 159.33 20.11 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 123.046 2.498 . . . . 0.0 112.535 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 20.8 t -129.4 145.96 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 43.3 mm -91.28 -67.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.054 . . . . 0.0 111.877 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.538 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 74.7 m-20 -117.72 146.28 43.86 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.079 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.64 129.89 23.67 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -143.29 147.92 35.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.884 -1.135 . . . . 0.0 109.741 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 4.5 ttm -125.92 136.48 53.09 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 0.589 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -155.69 154.97 32.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.874 -1.141 . . . . 0.0 111.105 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.589 ' O ' ' SD ' ' B' ' 58' ' ' MET . 3.3 m-85 -111.43 176.4 5.04 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.616 -0.677 . . . . 0.0 110.167 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' B' ' 66' ' ' SER . 40.9 m-20 -114.24 84.9 9.77 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 0.0 110.901 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -60.82 -61.96 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.018 2.478 . . . . 0.0 113.136 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -81.62 -65.7 0.98 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.553 -0.717 . . . . 0.0 111.004 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.3 p -47.96 -45.13 30.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.113 -0.992 . . . . 0.0 109.135 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.92 12.21 81.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.649 ' NH2' ' C5 ' ' A' ' 10' ' ' ' U' . 78.5 mtm180 -59.52 -40.2 86.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.004 -1.292 . . . . 0.0 109.428 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.505 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -174.47 170.97 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.946 -1.096 . . . . 0.0 111.118 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 69' ' ' TYR . 37.9 mmtm -108.65 -68.09 0.93 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.266 -0.897 . . . . 0.0 110.437 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -60.32 68.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.138 0 O-C-N 120.595 -1.315 . . . . 0.0 111.571 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 1.007 ' OH ' H5'' ' A' ' 9' ' ' ' A' . 1.2 m-85 -106.96 125.82 51.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.688 -1.478 . . . . 0.0 109.18 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.21 140.0 32.19 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.499 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.788 ' CZ ' ' N3 ' ' A' ' 9' ' ' ' A' . 4.8 m-30 -106.5 123.56 48.27 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 72' ' ' ILE . 3.4 mp -118.73 97.3 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.633 -0.667 . . . . 0.0 111.152 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.538 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 83.1 tt0 -84.48 131.06 34.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.437 -1.415 . . . . 0.0 110.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -92.85 178.76 5.67 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.708 0.766 . . . . 0.0 111.056 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.611 ' H ' ' HG ' ' B' ' 79' ' ' SER . 10.4 tpt180 -52.16 -41.74 62.83 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.591 -0.693 . . . . 0.0 111.315 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.8 m-20 159.06 176.86 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 3.1 mp -36.63 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.816 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' B' ' 76' ' ' ASP . 50.1 mp0 -70.3 -74.74 0.13 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.389 -1.445 . . . . 0.0 108.459 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' B' ' 75' ' ' ARG . 61.7 p -61.78 -39.76 92.81 Favored 'General case' 0 C--O 1.195 -1.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.546 ' HG ' ' C ' ' B' ' 26' ' ' ARG . 0.5 OUTLIER -64.07 -34.56 78.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.139 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -60.94 -61.72 2.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.485 -1.384 . . . . 0.0 107.746 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.591 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 23.3 t -62.77 -38.79 91.97 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.621 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.57 -64.83 1.08 Allowed 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 111.293 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.421 ' CG1' ' CB ' ' B' ' 99' ' ' CYS . 28.8 t -48.54 -41.03 11.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.655 -1.278 . . . . 0.0 108.538 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . 0.57 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 61.7 ttm-85 -64.58 -49.14 72.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.938 -1.101 . . . . 0.0 109.237 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' B' ' 82' ' ' SER . 86.5 m-20 -76.23 -46.39 28.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.23 -0.919 . . . . 0.0 109.907 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' B' ' 83' ' ' ALA . 3.7 mm? -86.8 15.91 5.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.46 -0.775 . . . . 0.0 110.44 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.576 ' N ' ' OD1' ' B' ' 88' ' ' ASN . 0.5 OUTLIER -53.89 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.685 -1.26 . . . . 0.0 108.258 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.96 116.65 1.61 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -136.93 144.89 43.69 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.369 -1.665 . . . . 0.0 107.667 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -34.79 92.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.542 -0.724 . . . . 0.0 111.304 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 90' ' ' TYR . 61.2 tp -154.79 135.44 13.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.695 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.36 -162.39 10.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' SER . . . . . 0.468 ' OG ' ' OG ' ' B' ' 32' ' ' SER . 0.9 OUTLIER -88.0 -6.61 57.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.257 . . . . 0.0 109.344 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.722 ' NH1' " H4'" ' A' ' 8' ' ' ' A' . 37.8 ttm180 -134.56 160.28 38.55 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.502 ' O ' ' C ' ' B' ' 97' ' ' LEU . 57.1 m-85 -95.81 134.41 38.79 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.431 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.541 ' CB ' ' O ' ' B' ' 88' ' ' ASN . 1.9 mp -31.76 150.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -118.23 144.46 45.75 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . 0.558 ' O ' ' N1 ' ' A' ' 8' ' ' ' A' . 4.8 p -78.94 107.75 11.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.252 -0.905 . . . . 0.0 110.307 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -88.42 171.04 39.59 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.593 ' OH ' ' C6 ' ' A' ' 8' ' ' ' A' . 0.1 OUTLIER -156.15 92.82 1.37 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.1 -1.235 . . . . 0.0 108.066 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' SER . . . . . 0.591 ' O ' ' ND2' ' B' ' 22' ' ' ASN . 0.9 OUTLIER -27.22 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.778 0.799 . . . . 0.0 109.992 -178.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' SER . . . . . 0.43 ' N ' ' O ' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -133.24 -6.55 3.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.354 -177.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.14 -37.23 71.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.032 . . . . 0.0 109.631 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.439 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' C' ' 157' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' C' ' 156' ' ' LYS . 84.8 tt0 -57.96 -33.58 69.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 93.1 p -133.85 154.44 51.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.91 . . . . 0.0 109.727 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 6.9 m -78.19 66.67 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 108.742 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . 0.458 ' NZ ' ' CD1' ' C' ' 204' ' ' PHE . 16.3 tttt -108.29 89.41 2.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.551 -0.718 . . . . 0.0 110.418 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 161' ' ' MET . . . . . 0.505 ' SD ' ' CG2' ' C' ' 217' ' ' VAL . 14.0 mmm -64.31 140.63 58.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 110.501 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.754 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 5.6 t80 -103.76 132.76 49.71 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . 0.51 ' O ' ' O2 ' ' A' ' 5' ' ' ' U' . 26.7 mm -114.02 128.01 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . 0.425 ' CA ' ' C2 ' ' A' ' 5' ' ' ' U' . . . -131.77 -173.68 13.41 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.347 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.96 22.23 2.87 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . 0.676 ' O ' ' H8 ' ' A' ' 4' ' ' ' A' . 3.0 mt -61.66 159.0 14.14 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.483 -1.01 . . . . 0.0 109.28 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.544 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 36.4 p-10 -80.31 167.3 20.42 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.174 -0.954 . . . . 0.0 108.851 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.836 ' CD1' ' C6 ' ' A' ' 4' ' ' ' A' . 0.5 OUTLIER -92.76 32.45 1.24 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.63 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.16 76.97 0.63 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.001 . . . . 0.0 110.332 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 170' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' C' ' 167' ' ' ASN . 84.7 m -150.7 147.46 27.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.961 -1.087 . . . . 0.0 110.078 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 171' ' ' THR . . . . . 0.662 ' HG1' ' ND2' ' C' ' 174' ' ' ASN . 0.2 OUTLIER -106.13 172.51 6.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -69.66 -66.9 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.747 -1.221 . . . . 0.0 109.502 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 172' ' ' GLU . 57.4 t0 -43.94 -33.37 1.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.084 -1.01 . . . . 0.0 109.232 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . 0.662 ' ND2' ' HG1' ' C' ' 171' ' ' THR . 87.2 m-20 -74.93 -49.49 20.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.125 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.57 -46.36 84.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.2 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' C' ' 177' ' ' GLU . 21.9 ttp85 -63.23 -60.64 3.13 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.806 -1.184 . . . . 0.0 107.932 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' C' ' 176' ' ' ARG . 47.4 tp10 -41.94 -30.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.546 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 23.7 t80 -70.84 -53.85 13.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.038 -1.039 . . . . 0.0 108.826 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.81 ' O ' ' N ' ' C' ' 181' ' ' LYS . 72.5 m-85 -75.27 -62.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.35 -0.844 . . . . 0.0 110.192 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -41.61 2.79 0.01 OUTLIER Glycine 0 N--CA 1.503 3.154 0 O-C-N 120.555 -1.341 . . . . 0.0 112.381 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . 0.81 ' N ' ' O ' ' C' ' 179' ' ' PHE . 38.8 tttt -73.96 -15.1 61.12 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -77.46 -58.46 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.475 0.655 . . . . 0.0 110.017 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -156.61 -104.9 0.22 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 47.6 m -127.83 147.19 50.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.511 -0.994 . . . . 0.0 109.569 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.5 144.42 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 186' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' C' ' 208' ' ' GLU . 0.2 OUTLIER -91.06 -58.3 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.176 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' C' ' 206' ' ' SER . 43.8 t0 -156.86 160.76 39.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' C' ' 188' ' ' LEU . 1.7 pt? -146.09 143.89 29.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.92 85.62 2.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.012 -1.055 . . . . 0.0 109.234 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.8 156.25 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 191' ' ' MET . . . . . 0.448 ' CB ' ' CZ ' ' C' ' 202' ' ' PHE . 6.3 tpp -142.31 55.84 1.45 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.022 -1.049 . . . . 0.0 110.486 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . 0.414 ' HZ3' ' HA2' ' C' ' 201' ' ' GLY . 0.3 OUTLIER -135.74 117.5 15.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 108.887 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -135.42 80.36 45.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.383 -0.823 . . . . 0.0 109.906 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.16 -18.12 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.439 2.092 . . . . 0.0 110.914 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' C' ' 196' ' ' THR . . . -65.5 -38.42 89.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 196' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' C' ' 195' ' ' ALA . 5.8 p -165.81 -32.07 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.586 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 193' ' ' ASP . . . -102.64 100.31 1.95 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.398 -1.382 . . . . 0.0 109.842 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -103.26 133.77 47.78 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.453 -1.028 . . . . 0.0 109.557 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 199' ' ' SER . . . . . 0.629 ' O ' ' N1 ' ' A' ' 4' ' ' ' A' . 2.7 m -156.78 151.62 25.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 109.306 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.588 ' C ' ' O ' ' C' ' 199' ' ' SER . 94.0 mtt-85 -24.97 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . 0.427 ' HA3' ' C5 ' ' A' ' 4' ' ' ' A' . . . -80.9 120.58 5.18 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.151 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.763 ' CG ' ' N3 ' ' A' ' 7' ' ' ' U' . 50.8 p90 -165.03 164.66 20.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -140.86 125.5 2.85 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.582 -1.771 . . . . 0.0 110.41 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . 0.771 ' CE2' ' H5 ' ' A' ' 7' ' ' ' U' . 3.7 m-85 -89.98 65.65 6.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.37 101.48 0.44 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.845 0.831 . . . . 0.0 112.606 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 206' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.3 OUTLIER -86.1 138.69 31.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -118.05 144.01 45.94 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.537 -1.352 . . . . 0.0 109.694 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . 0.538 ' N ' ' OG1' ' C' ' 186' ' ' THR . 84.9 tt0 -68.36 -46.44 70.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -100.35 125.16 40.39 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.816 -1.178 . . . . 0.0 111.053 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . 0.416 ' O ' ' CG2' ' C' ' 213' ' ' VAL . 51.4 Cg_exo -45.74 -40.33 19.11 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.973 2.449 . . . . 0.0 114.223 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 97.8 p -61.34 -46.6 89.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.584 -1.322 . . . . 0.0 110.68 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.468 ' O ' ' CG2' ' C' ' 216' ' ' VAL . 29.6 m -39.33 -31.03 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . 0.443 HG23 ' N ' ' C' ' 214' ' ' ASP . 6.2 m -69.78 -34.52 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.21 . . . . 0.0 110.233 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' C' ' 218' ' ' LYS . 54.9 t0 -62.36 -49.17 76.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' C' ' 217' ' ' VAL . 52.1 mt-10 -68.32 -33.95 75.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 108.986 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' C' ' 212' ' ' SER . 48.1 t -82.26 33.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . 0.505 ' CG2' ' SD ' ' C' ' 161' ' ' MET . 21.1 t -154.58 -36.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.605 -0.684 . . . . 0.0 109.579 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . 0.529 ' HZ1' ' CB ' ' C' ' 218' ' ' LYS . 2.2 ttmp? -92.67 23.87 3.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.644 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.597 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 42.2 m -134.81 157.21 47.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -83.95 134.22 34.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 108.459 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' C' ' 219' ' ' THR . 18.4 m-70 -123.51 133.6 53.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.546 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -145.38 106.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 110.449 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' C' ' 223' ' ' LEU . 3.9 mm? -52.8 -65.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.635 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -126.26 24.15 6.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.23 15.07 42.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -80.93 -154.36 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -1.098 . . . . 0.0 108.51 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . 0.431 ' CG1' ' OE1' ' C' ' 273' ' ' GLN . 0.3 OUTLIER -132.32 97.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 19.7 pt -107.56 153.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.622 -0.674 . . . . 0.0 109.579 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . 0.502 ' OD1' ' OD2' ' C' ' 271' ' ' ASP . 28.3 t0 -123.62 97.36 42.04 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.628 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . 0.413 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 56.9 Cg_endo -86.77 125.58 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.847 2.365 . . . . 0.0 111.928 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.82 142.39 28.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.99 . . . . 0.0 109.64 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' C' ' 233' ' ' ALA . 58.5 ttp180 -53.04 144.24 15.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 108.959 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -36.23 116.72 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . 0.669 ' H ' ' N6 ' ' A' ' 6' ' ' ' A' . 67.7 mt -99.25 134.95 20.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 0.0 109.486 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.42 149.61 62.94 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.125 1.883 . . . . 0.0 111.705 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -34.99 68.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.482 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.28 -45.57 80.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -71.23 -37.31 72.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 0.0 109.21 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . 0.527 ' O ' ' OG1' ' C' ' 242' ' ' THR . 77.5 mt-30 -58.68 -35.27 72.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 108.727 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.53 -42.47 91.95 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.197 -0.939 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' C' ' 242' ' ' THR . 18.8 mttp -69.72 -51.79 31.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 242' ' ' THR . . . . . 0.537 ' C ' ' O ' ' C' ' 241' ' ' LYS . 0.1 OUTLIER -22.62 140.33 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.284 0.564 . . . . 0.0 111.403 -178.085 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -132.65 130.19 5.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' C' ' 318' ' ' ALA . 0.0 OUTLIER -132.27 138.61 47.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.971 -1.311 . . . . 0.0 110.406 178.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . 0.406 ' HA ' ' N ' ' C' ' 318' ' ' ALA . 2.5 pt -123.96 140.39 47.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.835 0.826 . . . . 0.0 108.906 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' C' ' 247' ' ' VAL . 10.8 t80 -70.85 158.23 36.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . 0.415 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 0.6 OUTLIER -138.27 133.88 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.852 . . . . 0.0 109.473 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.73 152.13 16.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.62 -29.16 12.78 Favored Glycine 0 N--CA 1.495 2.571 0 O-C-N 121.095 -1.238 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 1.2 pp -109.58 164.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.074 -1.251 . . . . 0.0 108.941 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . 0.65 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.71 -42.98 1.32 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 45.4 Cg_exo -56.16 -132.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.874 2.382 . . . . 0.0 112.378 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.79 -36.1 67.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -0.867 . . . . 0.0 110.575 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . 0.531 ' CG1' ' OD2' ' C' ' 310' ' ' ASP . 13.7 m -55.92 127.46 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.0 109.47 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.566 ' N ' ' CD ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -90.65 160.66 38.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' C' ' 257' ' ' LYS . 17.0 Cg_endo -60.34 -26.26 82.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.97 2.447 . . . . 0.0 112.259 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' C' ' 256' ' ' PRO . 26.2 mtpp -45.32 -62.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.2 tp10 -60.9 -82.88 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.409 -0.917 . . . . 0.0 108.69 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . 0.606 ' C ' ' O ' ' C' ' 258' ' ' GLU . 1.1 t80 -10.98 -62.1 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 CA-C-O 121.438 0.637 . . . . 0.0 111.263 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 258' ' ' GLU . 87.7 tt0 -64.03 -48.53 75.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.27 -0.894 . . . . 0.0 109.523 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' C' ' 258' ' ' GLU . 0.0 OUTLIER -73.04 0.95 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' C' ' 264' ' ' SER . 0.7 OUTLIER -94.54 -74.24 0.55 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.496 ' O ' ' C ' ' C' ' 264' ' ' SER . 29.2 m-85 -42.19 -27.24 0.13 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.21 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.592 ' O ' ' N ' ' C' ' 266' ' ' TRP . 29.0 t -40.15 -41.64 1.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' C' ' 264' ' ' SER . 6.3 tt0 -39.79 -19.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.756 -0.59 . . . . 0.0 110.67 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.625 ' HE1' ' CG1' ' C' ' 300' ' ' VAL . 8.8 p90 -154.13 151.79 29.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.805 -1.185 . . . . 0.0 109.111 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 62.8 -172.4 10.44 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 3.4 t -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.33 100.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.423 -1.311 . . . . 0.0 110.263 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' C' ' 290' ' ' THR . 1.4 mp -72.01 -57.71 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.634 -0.667 . . . . 0.0 110.372 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . 0.502 ' OD2' ' OD1' ' C' ' 229' ' ' ASP . 0.5 OUTLIER -129.61 106.53 8.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -120.87 142.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.903 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . 0.431 ' OE1' ' CG1' ' C' ' 227' ' ' VAL . 10.9 pt20 -171.53 136.75 1.0 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.637 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . 0.486 ' C ' ' SD ' ' C' ' 275' ' ' MET . 3.6 pp -112.01 156.9 21.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 275' ' ' MET . . . . . 0.672 ' N ' ' SD ' ' C' ' 275' ' ' MET . 0.0 OUTLIER -99.4 168.67 9.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.717 -1.239 . . . . 0.0 109.533 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' C' ' 278' ' ' LYS . 1.6 pp -157.62 -178.37 7.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.924 . . . . 0.0 109.718 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' C' ' 283' ' ' SER . 55.7 t0 -64.96 44.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 109.047 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -48.5 -32.38 7.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 278' ' ' LYS . 6.8 m-20 -179.17 27.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 280' ' ' THR . . . . . 0.485 ' O ' ' OG1' ' C' ' 280' ' ' THR . 0.0 OUTLIER -172.67 21.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.783 -1.198 . . . . 0.0 110.394 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' C' ' 277' ' ' ASP . . . 61.86 23.5 63.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.592 ' C ' ' H ' ' C' ' 284' ' ' ARG . 3.7 tp60 -50.65 -16.23 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -1.065 . . . . 0.0 109.076 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 283' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' C' ' 277' ' ' ASP . 0.3 OUTLIER -62.92 38.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.546 -0.721 . . . . 0.0 110.072 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' C' ' 282' ' ' GLN . 0.5 OUTLIER -46.61 -33.67 4.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.08 67.88 0.21 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.555 ' CE2' " H5'" ' A' ' 3' ' ' ' U' . 38.8 p90 -176.43 -171.23 0.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.88 -1.365 . . . . 0.0 109.604 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . 175.21 -165.54 36.61 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -142.13 154.87 45.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.296 -1.708 . . . . 0.0 108.978 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . 0.41 ' CG2' ' CE1' ' C' ' 291' ' ' TYR . 0.5 OUTLIER -131.42 145.64 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 290' ' ' THR . . . . . 0.467 ' O ' ' N ' ' C' ' 270' ' ' ILE . 32.3 m -133.05 123.67 26.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.509 -1.369 . . . . 0.0 109.997 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . 0.458 ' O ' ' CB ' ' C' ' 292' ' ' ASP . 33.4 m-85 -98.95 -80.27 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.293 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER 169.39 -56.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 O-C-N 120.631 -1.293 . . . . 0.0 108.009 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 293' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 58.6 p -93.82 172.66 8.11 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.17 -8.76 23.24 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.13 -52.4 65.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 108.618 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.52 95.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 108.485 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 45.6 t -52.66 -57.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.186 -0.946 . . . . 0.0 108.611 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.07 -32.6 71.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.196 -0.94 . . . . 0.0 109.217 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.87 -62.07 2.08 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.625 ' CG1' ' HE1' ' C' ' 266' ' ' TRP . 0.2 OUTLIER -66.29 -31.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.497 -0.752 . . . . 0.0 110.203 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . 0.618 ' SG ' ' NH2' ' C' ' 317' ' ' ARG . 31.7 t -45.58 -52.13 11.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.674 -1.266 . . . . 0.0 108.817 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -50.88 -27.78 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.44 -0.788 . . . . 0.0 110.556 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.571 ' O ' ' OD1' ' C' ' 303' ' ' ASN . 30.9 p30 -100.22 63.15 1.13 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.014 -1.054 . . . . 0.0 109.808 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' C' ' 303' ' ' ASN . 15.8 tttp -45.18 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.47 -1.394 . . . . 0.0 108.905 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . 0.409 ' CE2' ' CG ' ' C' ' 314' ' ' GLU . 70.6 m-85 -67.28 127.83 34.11 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.32 -0.862 . . . . 0.0 109.497 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.92 154.19 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 108.949 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.0 128.6 33.47 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 34.3 t80 -118.07 173.62 6.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.511 -0.743 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.436 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.0 OUTLIER -56.11 -34.19 65.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.188 -0.945 . . . . 0.0 112.037 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . 0.531 ' OD2' ' CG1' ' C' ' 254' ' ' VAL . 15.6 m-20 -90.71 -71.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.734 -1.229 . . . . 0.0 109.942 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -148.06 -170.22 3.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 109.262 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -60.32 148.25 37.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.969 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 31.3 pt -132.27 153.74 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . 0.409 ' CG ' ' CE2' ' C' ' 305' ' ' PHE . 4.0 mp0 -111.44 110.17 20.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.003 -1.061 . . . . 0.0 110.842 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . 0.456 HD13 HG21 ' C' ' 315' ' ' ILE . 59.6 mt -87.91 161.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.9 -1.125 . . . . 0.0 109.838 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -163.46 160.88 23.87 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.914 -1.116 . . . . 0.0 109.043 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . 0.618 ' NH2' ' SG ' ' C' ' 301' ' ' CYS . 62.5 mtt85 -71.76 146.25 48.22 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.699 -1.251 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' C' ' 244' ' ' LYS . . . -71.72 26.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 109.411 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' C' ' 317' ' ' ARG . 7.3 pt-20 -83.44 148.07 54.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.598 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.67 -27.0 45.52 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.413 2.075 . . . . 0.0 112.301 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . 0.87 ' NE ' " H4'" ' A' ' 12' ' ' ' A' . 75.0 ttt-85 -161.44 -70.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.467 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.843 HO5' ' P ' ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.44 2.208 1 C5'-C4'-C3' 107.625 -5.25 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.583 ' N6 ' ' O ' ' C' ' 319' ' ' GLU . . . . . . . . 0 O4'--C1' 1.438 2.001 1 C5'-C4'-C3' 108.042 -4.972 . 0.413 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 0.566 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.439 2.052 1 C5'-C4'-C3' 107.668 -5.221 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.716 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.44 2.151 1 C5'-C4'-C3' 107.278 -5.481 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.829 " H1'" ' O ' ' C' ' 201' ' ' GLY . . . . . . . . 0 O4'--C4' 1.424 -2.401 1 C3'-C2'-C1' 105.273 4.192 OUTLIER-DELTA 0.267 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.949 " H4'" " C5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.611 1.793 1 C5'-C4'-C3' 109.089 -4.274 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.949 " C5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.615 2.226 1 C5'-C4'-C3' 107.027 -5.649 . 0.225 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.481 " O2'" " O5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.433 1.605 1 C5'-C4'-C3' 106.564 -5.957 . 0.392 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.719 ' N3 ' ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 C2'--C1' 1.498 -2.984 2 O4'-C1'-N19 115.958 7.758 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 0.899 " H5'" ' CE2' ' B' ' 71' ' ' PHE . . . . . . . . 0 O4'--C4' 1.431 -1.844 2 C5'-C4'-C3' 107.549 -5.301 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 1.357 " H3'" ' N ' ' B' ' 69' ' ' TYR . . . . . . . . 1 O3'--C3' 1.494 5.087 1 C5'-C4'-C3' 108.97 -4.353 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 1.136 " H5'" ' O ' ' B' ' 67' ' ' LYS . . . . . . . . 2 P--O3' 1.706 8.226 2 O4'-C1'-N19 114.099 5.899 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.751 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.406 1 C5'-C4'-C3' 108.277 -4.816 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' B' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.08 158.68 24.63 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.727 2.284 . . . . 0.0 112.208 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.47 20.2 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.848 2.365 . . . . 0.0 112.976 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.874 -1.141 . . . . 0.0 109.952 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.521 ' HE ' ' CB ' ' B' ' 103' ' ' SER . 5.3 ttp85 179.24 -45.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' B' ' 100' ' ' GLY . 10.3 t -122.56 155.02 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.71 142.32 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.678 ' CE1' ' C2 ' ' A' ' 9' ' ' ' A' . 2.6 m-85 -114.98 141.81 47.47 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.072 -1.017 . . . . 0.0 110.547 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt -118.78 127.52 53.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.491 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -113.33 -50.39 0.54 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.639 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.722 ' HG ' ' N ' ' B' ' 94' ' ' SER . 9.7 p -88.76 115.38 26.26 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.743 -1.445 . . . . 0.0 107.731 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.463 ' O ' ' OP2' ' A' ' 13' ' ' ' U' . 4.2 mp -147.85 107.16 3.72 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.887 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' B' ' 36' ' ' ASP . 7.8 Cg_exo -63.01 159.23 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.629 1.553 . . . . 0.0 109.744 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.88 ' OH ' H5'' ' A' ' 12' ' ' ' A' . 6.2 m-30 -74.57 5.37 4.86 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' B' ' 34' ' ' PRO . 27.0 t0 -62.03 -47.09 86.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.565 ' N ' HE21 ' B' ' 37' ' ' GLN . 0.0 OUTLIER -120.12 109.13 15.08 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.872 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.545 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 45.8 p -100.14 -148.83 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.0 109.419 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.04 -26.39 67.59 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.14 -1.6 . . . . 0.0 110.902 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -73.17 -57.42 4.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.75 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' B' ' 37' ' ' GLN . 25.1 mt-30 -68.84 -44.17 73.97 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.972 -1.08 . . . . 0.0 109.231 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' B' ' 44' ' ' ASP . 2.4 mm -54.53 -54.77 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' B' ' 42' ' ' ILE . 45.6 tp -37.21 -19.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.9 t0 -123.86 -21.81 5.05 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.595 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.468 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.2 tm? -62.97 -44.06 97.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.051 -1.656 . . . . 0.0 107.029 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' B' ' 48' ' ' ASN . 74.4 m -82.98 -65.45 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.155 -0.966 . . . . 0.0 108.739 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.839 ' O ' ' N ' ' B' ' 49' ' ' VAL . 4.6 t -37.24 -15.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.79 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.4 OUTLIER -50.23 56.45 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.483 1.135 . . . . 0.0 110.551 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.839 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.4 p 178.46 -34.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 121.426 -0.796 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.68 159.57 32.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' B' ' 52' ' ' VAL . 20.5 Cg_endo -65.24 86.47 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.525 2.15 . . . . 0.0 111.525 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' B' ' 51' ' ' PRO . 0.0 OUTLIER -40.09 153.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.633 0.73 . . . . 0.0 110.072 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' B' ' 73' ' ' GLU . 15.9 mm -77.05 -45.3 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.688 -0.632 . . . . 0.0 109.662 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' B' ' 53' ' ' ILE . 87.0 m-20 -146.89 152.68 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.362 -1.335 . . . . 0.0 111.678 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 42.5 tp -143.56 128.48 18.45 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -145.58 123.91 12.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.624 -1.297 . . . . 0.0 110.194 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 9.9 ttm -116.4 150.36 37.91 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.746 0.784 . . . . 0.0 111.138 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 1.071 ' C ' " H4'" ' A' ' 11' ' ' ' A' . 2.1 ttp -168.14 165.65 13.21 Favored 'General case' 0 C--O 1.282 2.781 0 O-C-N 121.383 -0.823 . . . . 0.0 109.498 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.774 ' HA ' " O3'" ' A' ' 11' ' ' ' A' . 0.0 OUTLIER -132.56 134.59 45.14 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 127.008 2.692 . . . . 0.0 110.214 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 0.1 OUTLIER -42.05 105.39 0.4 Allowed Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 112.014 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -91.63 -66.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.796 2.331 . . . . 0.0 109.325 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -105.89 -25.45 12.13 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.608 ' OG1' ' C2 ' ' A' ' 11' ' ' ' A' . 80.5 p -46.41 -49.54 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' B' ' 60' ' ' ASP . . . 76.77 36.7 36.21 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.769 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.407 ' HB2' ' N1 ' ' A' ' 11' ' ' ' A' . 20.7 mtp180 -137.01 -76.92 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.718 -1.46 . . . . 0.0 110.142 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.782 ' O ' " H1'" ' A' ' 11' ' ' ' A' . 97.7 p -109.81 140.83 43.29 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.088 1.899 . . . . 0.0 111.538 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 1.136 ' O ' " H5'" ' A' ' 12' ' ' ' A' . 39.0 mttt -101.72 -5.49 24.89 Favored 'General case' 0 C--O 1.166 -3.332 0 CA-C-O 115.138 -2.363 . . . . 0.0 114.891 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . 1.045 ' HA2' " O5'" ' A' ' 12' ' ' ' A' . . . -126.11 100.08 0.57 Allowed Glycine 1 N--CA 1.534 5.198 0 CA-C-N 123.356 2.798 . . . . 0.0 116.534 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 1.357 ' N ' " H3'" ' A' ' 11' ' ' ' A' . 3.1 m-85 -165.9 139.6 4.38 Favored 'General case' 0 N--CA 1.516 2.83 0 C-N-CA 115.329 -2.548 . . . . 0.0 114.127 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.68 142.99 28.43 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.134 -0.979 . . . . 0.0 110.973 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.899 ' CE2' " H5'" ' A' ' 10' ' ' ' U' . 6.2 m-30 -107.83 132.86 52.98 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.183 0.992 . . . . 0.0 110.4 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.27 146.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' B' ' 53' ' ' ILE . 83.9 tt0 -136.03 135.47 39.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.167 -1.583 . . . . 0.0 108.38 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.74 168.61 8.99 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.759 0.79 . . . . 0.0 110.845 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 47.6 ttp180 -53.75 -45.41 70.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.635 -0.666 . . . . 0.0 111.532 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.75 179.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.174 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 3.6 mm? -34.29 -24.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.851 -0.531 . . . . 0.0 111.142 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 91.9 mt-10 -71.05 -75.34 0.13 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.668 -1.27 . . . . 0.0 109.259 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.97 -41.56 98.14 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 21.0 m -60.28 -37.54 80.8 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.836 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -61.1 -61.8 2.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.44 -1.413 . . . . 0.0 108.912 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.521 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 67.2 m -61.89 -43.24 99.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.723 0.773 . . . . 0.0 112.022 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.613 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.37 -64.93 1.05 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.427 -0.795 . . . . 0.0 111.031 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -50.63 -39.36 17.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.261 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . 0.608 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 2.1 ttm-85 -66.86 -55.53 14.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.612 -1.305 . . . . 0.0 108.791 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' B' ' 82' ' ' SER . 46.9 m-80 -67.02 -43.91 81.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 109.68 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' B' ' 83' ' ' ALA . 45.7 mt -105.6 41.67 1.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.411 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' B' ' 85' ' ' ARG . 0.0 OUTLIER -70.26 -75.16 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.98 117.88 1.73 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -139.87 147.54 40.8 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.549 -1.559 . . . . 0.0 107.819 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.592 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.3 mm-40 -33.94 89.09 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.822 0.82 . . . . 0.0 111.184 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' B' ' 90' ' ' TYR . 51.3 tp -140.8 125.85 18.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . 0.414 ' HA3' ' HG ' ' B' ' 32' ' ' SER . . . 52.41 -157.05 4.01 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' SER . . . . . 0.722 ' N ' ' HG ' ' B' ' 32' ' ' SER . 2.3 p -83.36 -15.65 49.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.862 -1.376 . . . . 0.0 109.896 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.625 ' N ' ' OG ' ' B' ' 32' ' ' SER . 94.4 mtt-85 -131.23 155.87 46.35 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.8 m-85 -96.07 139.35 32.38 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.47 -0.769 . . . . 0.0 109.86 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.524 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -38.47 141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -114.2 147.53 38.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.112 -0.992 . . . . 0.0 109.867 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 17.9 p -88.02 115.61 25.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.679 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -108.52 177.23 20.59 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.469 ' O ' ' C ' ' B' ' 102' ' ' SER . 48.0 p90 -131.61 -17.57 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.555 -0.968 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' SER . . . . . 0.533 ' CB ' ' N1 ' ' A' ' 9' ' ' ' A' . 8.3 t -38.02 99.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.108 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' SER . . . . . 0.521 ' CB ' ' HE ' ' B' ' 26' ' ' ARG . 60.0 p -93.91 159.17 15.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' B' ' 105' ' ' SER . 39.2 t-20 -156.4 -137.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 0.0 109.284 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' B' ' 104' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' C' ' 157' ' ' GLU . 0.0 OUTLIER -104.32 141.22 36.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.192 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 158' ' ' SER . . . . . 0.594 ' O ' ' N ' ' C' ' 160' ' ' LYS . 83.8 p -147.51 159.94 43.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.965 . . . . 0.0 109.553 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . 0.528 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 46.23 11.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.547 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' C' ' 158' ' ' SER . 14.5 tttp -94.75 137.82 33.36 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 161' ' ' MET . . . . . 0.693 ' SD ' ' N ' ' C' ' 162' ' ' PHE . 0.0 OUTLIER -114.9 152.58 32.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 108.986 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.711 ' CG ' ' C6 ' ' A' ' 6' ' ' ' A' . 55.2 t80 -119.4 72.94 0.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.607 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . 0.688 ' N ' ' SD ' ' C' ' 161' ' ' MET . 54.5 mt -53.24 145.48 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.38 -177.43 15.98 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.712 ' H ' ' H3 ' ' A' ' 5' ' ' ' U' . . . 56.22 20.77 30.04 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . 0.567 ' O ' ' C8 ' ' A' ' 4' ' ' ' A' . 97.5 mt -60.97 163.7 5.63 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.364 -1.08 . . . . 0.0 108.776 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' C' ' 168' ' ' TRP . 11.5 p-10 -68.65 -75.71 0.1 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.056 -1.028 . . . . 0.0 108.918 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.716 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.1 OUTLIER 178.5 -24.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.872 -1.143 . . . . 0.0 109.784 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -133.01 91.46 2.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.975 . . . . 0.0 109.764 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 46.2 m -126.05 144.74 50.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.416 -0.803 . . . . 0.0 109.386 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 171' ' ' THR . . . . . 0.411 ' HG1' ' ND2' ' C' ' 174' ' ' ASN . 0.3 OUTLIER -104.84 172.62 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.022 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -67.77 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.961 -1.087 . . . . 0.0 109.861 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -43.29 -33.45 0.99 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . 0.411 ' ND2' ' HG1' ' C' ' 171' ' ' THR . 86.0 m-20 -74.92 -50.83 15.46 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 108.827 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 20.8 tp -52.67 -42.06 64.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.693 -0.63 . . . . 0.0 109.53 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' C' ' 179' ' ' PHE . 14.2 ptp180 -74.38 -57.3 4.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.511 -1.368 . . . . 0.0 108.866 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' C' ' 176' ' ' ARG . 54.0 mm-40 -37.71 -30.76 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.557 ' N ' ' O ' ' C' ' 176' ' ' ARG . 21.6 t80 -85.25 -39.85 17.29 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.103 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' C' ' 176' ' ' ARG . 22.6 m-85 -94.25 16.98 13.56 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.146 -0.971 . . . . 0.0 111.429 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.45 24.46 25.44 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . 0.697 ' NZ ' ' HH ' ' C' ' 182' ' ' TYR . 3.6 ptmm? -104.52 16.41 26.15 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.35 -1.088 . . . . 0.0 108.814 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . 0.697 ' HH ' ' NZ ' ' C' ' 181' ' ' LYS . 92.3 m-85 -119.21 -49.16 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.596 -0.69 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -164.88 -127.41 0.89 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 40.6 m -126.39 145.64 50.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.506 -0.996 . . . . 0.0 109.692 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.11 137.75 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 186' ' ' THR . . . . . 0.507 ' O ' ' OD1' ' C' ' 187' ' ' ASP . 9.7 t -96.82 -37.0 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.81 -1.181 . . . . 0.0 110.111 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' C' ' 186' ' ' THR . 79.5 m-20 -149.0 149.17 30.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.938 . . . . 0.0 108.613 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 7.7 tt -140.34 144.1 36.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.828 -1.17 . . . . 0.0 108.355 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.08 129.95 50.13 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . 0.497 ' O ' ' CG2' ' C' ' 190' ' ' ILE . 0.6 OUTLIER -147.75 121.47 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.789 -1.194 . . . . 0.0 108.778 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 191' ' ' MET . . . . . 0.559 ' SD ' ' O2 ' ' A' ' 7' ' ' ' U' . 4.3 ptp -176.2 158.18 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 108.765 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . 0.411 ' O ' ' OP1' ' A' ' 8' ' ' ' A' . 0.0 OUTLIER -164.56 -63.89 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.686 -1.259 . . . . 0.0 109.032 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . 0.477 ' OD1' ' OG ' ' C' ' 199' ' ' SER . 0.2 OUTLIER -123.47 88.39 51.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.13 -20.86 8.26 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.356 2.037 . . . . 0.0 112.129 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.18 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.147 -0.971 . . . . 0.0 109.78 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 65.1 p -109.23 -8.66 15.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 81.22 15.64 76.27 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . 0.679 HH21 ' HE1' ' C' ' 168' ' ' TRP . 0.0 OUTLIER -97.68 73.22 2.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.258 . . . . 0.0 109.456 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 199' ' ' SER . . . . . 0.526 ' O ' ' C ' ' C' ' 200' ' ' ARG . 80.6 p -167.1 172.77 9.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' C' ' 199' ' ' SER . 0.0 OUTLIER -27.27 147.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.005 0.431 . . . . 0.0 110.137 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . 0.829 ' O ' " H1'" ' A' ' 5' ' ' ' U' . . . -131.5 158.82 22.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.638 ' CZ ' " H4'" ' A' ' 7' ' ' ' U' . 4.7 p90 -171.18 134.11 0.9 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.359 . . . . 0.0 108.614 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -112.12 132.95 11.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.09 114.13 27.17 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.98 110.29 20.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.298 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 29.1 t -81.44 72.05 8.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -64.47 115.51 5.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.93 -38.43 90.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.18 108.74 30.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.006 -1.059 . . . . 0.0 110.44 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -52.1 -24.74 20.76 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.697 1.598 . . . . 0.0 112.5 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.507 ' O ' ' N ' ' C' ' 213' ' ' VAL . 22.9 t -66.95 -65.32 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.949 -1.094 . . . . 0.0 109.861 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.424 ' C ' ' O ' ' C' ' 211' ' ' SER . 51.0 m -40.75 -24.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.482 -0.761 . . . . 0.0 110.295 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' C' ' 211' ' ' SER . 95.0 t -69.13 -38.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 109.011 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.9 t0 -59.0 -49.41 77.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 110.094 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.08 -36.53 79.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.84 -1.162 . . . . 0.0 109.31 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . . . . . . . . . 47.9 t -54.94 -47.91 75.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 110.024 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.13 -33.33 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -72.79 6.28 2.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 109.558 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.656 ' CG2' ' CE1' ' C' ' 221' ' ' HIS . 1.3 t -134.56 167.7 20.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.134 -0.979 . . . . 0.0 109.391 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -122.82 134.42 54.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.73 -0.606 . . . . 0.0 109.403 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.656 ' CE1' ' CG2' ' C' ' 219' ' ' THR . 0.0 OUTLIER -132.07 161.03 34.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' C' ' 222' ' ' ILE . 0.4 OUTLIER -124.93 110.1 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 109.057 179.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 18.3 tp -75.14 -71.6 0.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' C' ' 224' ' ' ASP . 60.7 t0 -80.22 1.06 29.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.028 -1.045 . . . . 0.0 108.772 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.92 13.51 69.17 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . 0.695 ' HZ3' ' CA ' ' C' ' 279' ' ' ASP . 0.0 OUTLIER -90.73 -83.28 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -1.075 . . . . 0.0 109.432 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 1.3 p 172.57 89.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.19 -0.944 . . . . 0.0 109.66 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 pt -94.63 152.02 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.396 -0.815 . . . . 0.0 110.34 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' C' ' 229' ' ' ASP . 0.0 OUTLIER -116.8 106.45 47.94 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 110.042 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . 0.405 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 42.7 Cg_endo -82.17 134.23 7.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.388 2.059 . . . . 0.0 111.819 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' C' ' 232' ' ' ARG . 11.8 ttmm -152.53 164.26 37.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.98 . . . . 0.0 109.673 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' C' ' 231' ' ' LYS . 56.7 ttm-85 -72.96 159.22 34.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 116.07 3.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.205 -0.934 . . . . 0.0 111.163 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . 0.628 ' O ' ' C6 ' ' A' ' 6' ' ' ' A' . 18.5 mt -156.91 91.67 2.45 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -40.15 137.78 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.601 1.534 . . . . 0.0 111.479 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.415 ' HG2' ' N7 ' ' A' ' 6' ' ' ' A' . 8.5 mmm-85 -55.69 -29.5 59.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.08 -45.13 79.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.65 -1.281 . . . . 0.0 108.663 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.88 -38.3 58.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . 0.491 ' O ' ' OG1' ' C' ' 242' ' ' THR . 4.2 tp-100 -57.92 -38.01 75.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.615 -0.678 . . . . 0.0 110.0 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -58.88 -22.59 59.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.867 . . . . 0.0 109.664 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 242' ' ' THR . . . . . 0.531 ' O ' ' O ' ' C' ' 291' ' ' TYR . 72.5 p -56.89 -36.67 70.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.13 3.22 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -138.58 138.15 37.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.025 -1.279 . . . . 0.0 110.855 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . 0.404 ' HA ' ' N ' ' C' ' 318' ' ' ALA . 3.8 pt -120.53 146.65 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.552 ' C ' ' CD1' ' C' ' 246' ' ' PHE . 0.2 OUTLIER -86.54 160.37 18.98 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 28.4 t -134.11 131.17 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.56 -0.713 . . . . 0.0 109.092 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.01 147.53 18.51 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.51 5.25 79.14 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -111.12 133.06 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -1.058 . . . . 0.0 109.3 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.53 -36.35 2.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.727 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 32.0 Cg_exo -56.0 -30.0 76.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.397 2.064 . . . . 0.0 113.194 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -151.18 7.79 0.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.601 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . 0.53 ' O ' ' CD2' ' C' ' 274' ' ' LEU . 24.4 t -126.63 118.03 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 111.14 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.414 ' O ' ' C ' ' C' ' 256' ' ' PRO . 0.0 OUTLIER -102.26 169.79 7.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' C' ' 257' ' ' LYS . 0.0 OUTLIER -26.22 -50.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.312 2.675 . . . . 0.0 114.677 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . 0.498 ' O ' ' OE1' ' C' ' 261' ' ' GLU . 58.4 tttp -33.09 -84.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' C' ' 261' ' ' GLU . 27.4 tp10 -58.21 -76.79 0.04 OUTLIER 'General case' 0 C--O 1.194 -1.82 0 O-C-N 120.846 -1.159 . . . . 0.0 109.384 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . 0.632 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.0 t80 -12.16 -64.39 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 121.867 0.841 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . 0.507 ' O ' ' OG ' ' C' ' 264' ' ' SER . 50.0 mt-10 -62.22 -49.39 75.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.96 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . 0.707 ' N ' ' O ' ' C' ' 258' ' ' GLU . 5.1 mp0 -71.27 2.79 4.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . 0.482 ' O ' ' CD ' ' C' ' 265' ' ' GLN . 6.1 t80 -98.21 -73.22 0.62 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.577 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 54.3 m-85 -50.52 -31.61 15.99 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.412 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' C' ' 260' ' ' GLU . 73.6 m -35.82 -38.34 0.12 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.605 -0.684 . . . . 0.0 112.445 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.482 ' CD ' ' O ' ' C' ' 262' ' ' PHE . 0.0 OUTLIER -54.75 -93.33 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.148 -1.595 . . . . 0.0 110.189 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.577 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -66.99 152.26 46.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.976 -1.078 . . . . 0.0 110.052 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 69.45 167.2 5.41 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 268' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 59.1 m -115.24 122.89 47.37 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . 0.429 HG13 ' CE2' ' C' ' 291' ' ' TYR . 3.2 mp -104.87 107.91 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.43 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 4.8 mm -77.15 -46.79 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 110.58 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' C' ' 231' ' ' LYS . 24.8 t70 -139.7 103.64 4.72 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.658 -1.276 . . . . 0.0 110.415 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -110.38 142.19 42.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.222 -0.924 . . . . 0.0 108.525 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -150.79 139.51 20.73 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.083 -1.447 . . . . 0.0 112.463 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 26.8 tp -122.96 141.24 52.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 45.7 mmm -89.17 177.3 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.149 -1.595 . . . . 0.0 109.249 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -131.95 170.28 15.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.992 -1.067 . . . . 0.0 109.505 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 54.4 p30 -90.9 -11.48 39.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.424 -0.797 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . 0.5 ' C ' ' HZ1' ' C' ' 226' ' ' LYS . 19.8 tptm -62.46 -32.78 73.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 108.838 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . 0.695 ' CA ' ' HZ3' ' C' ' 226' ' ' LYS . 34.2 p-10 -63.87 -44.38 93.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 280' ' ' THR . . . . . 0.585 ' N ' ' OD1' ' C' ' 279' ' ' ASP . 0.2 OUTLIER 177.34 5.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.099 -1.001 . . . . 0.0 110.172 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.08 57.0 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.532 ' NE2' ' OP2' ' A' ' 4' ' ' ' A' . 19.4 mm100 -57.46 -34.24 68.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -1.197 . . . . 0.0 109.307 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 78.1 p -68.8 51.7 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.156 -0.965 . . . . 0.0 108.974 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' C' ' 282' ' ' GLN . 58.4 ttm-85 -49.59 -37.24 26.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 159.37 78.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.566 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 34.6 p90 -176.2 -174.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.271 . . . . 0.0 109.666 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -178.86 -170.97 41.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -147.97 152.26 37.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.22 -1.753 . . . . 0.0 108.877 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 94.2 t -130.6 145.61 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 15.5 m -128.55 130.45 47.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.814 -1.179 . . . . 0.0 110.453 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' C' ' 242' ' ' THR . 24.3 m-85 -113.37 153.33 28.72 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -74.0 18.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.014 -1.054 . . . . 0.0 109.499 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 293' ' ' SER . . . . . 0.509 ' H ' ' C ' ' C' ' 291' ' ' TYR . 59.8 p -162.67 173.88 13.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.02 -7.99 15.27 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.27 -52.0 67.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.91 90.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.852 . . . . 0.0 108.768 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.82 -57.38 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.23 -29.73 68.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -63.51 -63.75 1.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.124 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -63.71 -25.47 38.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.063 -1.023 . . . . 0.0 109.616 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . . . . . . . . . 45.3 t -45.18 -55.38 5.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 109.634 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . 0.585 ' NE2' ' OD1' ' C' ' 303' ' ' ASN . 0.0 OUTLIER -51.5 -24.98 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 108.051 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' C' ' 302' ' ' GLN . 97.1 m-20 -98.54 78.87 2.42 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -78.54 -8.97 59.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 110.48 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.06 120.19 19.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 108.952 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.96 154.88 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.802 . . . . 0.0 109.848 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -90.08 116.07 27.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 108.704 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.464 ' O ' ' C ' ' C' ' 309' ' ' LYS . 7.4 t80 -121.0 179.48 4.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' C' ' 308' ' ' PHE . 35.7 mtmt -39.07 -62.72 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.005 -1.059 . . . . 0.0 110.881 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' C' ' 309' ' ' LYS . 93.0 m-20 -44.66 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.149 -0.97 . . . . 0.0 109.354 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -175.4 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -141.35 138.69 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 109.886 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 18.8 pt -126.27 151.43 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . 0.536 ' OE1' ' N3 ' ' A' ' 1' ' ' ' U' . 56.6 mt-10 -112.6 151.26 30.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.519 -0.738 . . . . 0.0 109.528 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 99.3 mt -125.84 154.72 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.514 -0.742 . . . . 0.0 109.126 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER 179.35 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.158 -1.589 . . . . 0.0 113.454 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . 0.616 ' O ' ' O ' ' C' ' 316' ' ' LYS . 77.8 mtm180 1.38 126.72 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.685 0 CA-C-O 121.778 0.799 . . . . 0.0 113.11 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . 0.404 ' N ' ' HA ' ' C' ' 245' ' ' ILE . . . -61.1 7.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.824 -1.173 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . 0.596 ' H ' ' C ' ' C' ' 317' ' ' ARG . 3.8 mm-40 -57.44 154.01 25.54 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.952 . . . . 0.0 108.725 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -52.89 -85.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.252 1.968 . . . . 0.0 111.92 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -117.96 5.11 12.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 0.0 109.426 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 82.5 t60 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.523 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.925 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.932 1 C5'-C4'-C3' 107.802 -5.132 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.925 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.441 2.253 1 C5'-C4'-C3' 107.626 -5.249 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 0.456 " H5'" ' CE2' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.438 1.958 1 C5'-C4'-C3' 107.175 -5.55 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.714 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.438 2.012 1 C5'-C4'-C3' 106.757 -5.828 . 0.01 2u . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.722 ' H3 ' ' H ' ' C' ' 165' ' ' GLY . . . . . . . . 0 O4'--C4' 1.425 -2.306 1 C3'-C2'-C1' 105.512 4.458 OUTLIER-DELTA 0.348 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 1.037 " O4'" H5'' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O3'--C3' 1.454 2.187 2 O4'-C1'-N19 112.379 4.179 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 1.037 H5'' " O4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O3' 1.632 2.063 2 C5'-C4'-C3' 107.22 -5.52 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.757 ' OP2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.895 1 C5'-C4'-C3' 109.304 -4.131 . 0.817 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.914 " H4'" ' CE1' ' B' ' 69' ' ' TYR . . . . . . . . 0 P--O5' 1.611 1.829 2 C5'-C4'-C3' 108.335 -4.777 . 0.76 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 0.863 " O2'" ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.439 2.045 2 C3'-C2'-C1' 106.222 5.247 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.863 ' H8 ' " O2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.438 1.996 1 C5'-C4'-C3' 106.165 -6.223 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.615 ' N6 ' ' SD ' ' B' ' 58' ' ' MET . . . . . . . . 0 O4'--C1' 1.433 1.603 1 C5'-C4'-C3' 106.607 -5.929 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.554 ' C6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.861 1 C5'-C4'-C3' 107.573 -5.285 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' B' ' 23' ' ' PRO . 6.3 m120 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' B' ' 22' ' ' ASN . 5.8 Cg_exo -44.68 167.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.038 2.492 . . . . 0.0 112.188 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.86 2.78 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.989 2.46 . . . . 0.0 113.355 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 72.1 m -153.26 132.67 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.672 -1.267 . . . . 0.0 109.186 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.576 ' NE ' ' OD1' ' B' ' 76' ' ' ASP . 3.5 tpt180 -177.24 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.625 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' B' ' 100' ' ' GLY . 3.2 m -129.06 170.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 t -127.2 143.25 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.705 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.708 ' CZ ' ' C2 ' ' A' ' 9' ' ' ' A' . 15.8 m-30 -110.5 122.4 47.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.269 -0.895 . . . . 0.0 108.973 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.36 107.38 17.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -112.15 -16.03 9.36 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.538 ' HG ' ' H ' ' B' ' 95' ' ' ARG . 65.5 p -111.58 85.08 2.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 109.728 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' B' ' 33' ' ' ILE . 0.8 OUTLIER -145.47 127.26 7.78 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.575 ' C ' ' H ' ' B' ' 36' ' ' ASP . 31.8 Cg_endo -72.89 151.65 51.09 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.255 1.303 . . . . 0.0 110.703 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -59.61 -0.11 0.16 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.105 -0.997 . . . . 0.0 109.045 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.575 ' H ' ' C ' ' B' ' 34' ' ' PRO . 87.6 m-20 -64.28 -36.43 84.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.414 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -122.46 116.03 23.26 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.582 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 9.9 t -111.92 -137.09 0.37 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.441 -0.787 . . . . 0.0 110.885 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 21.1 pt-20 -63.19 -28.93 70.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.658 -1.276 . . . . 0.0 110.743 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.62 -55.45 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.811 -1.18 . . . . 0.0 110.611 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -68.93 -43.7 74.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 111.064 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.56 ' O ' ' SG ' ' B' ' 46' ' ' CYS . 51.1 mm -63.44 -52.63 55.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 118.715 -1.194 . . . . 0.0 107.959 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' B' ' 39' ' ' GLU . 46.3 tp -39.71 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.625 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 24.7 t70 -124.97 -27.13 3.62 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.432 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.479 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 0.3 OUTLIER -58.68 -45.27 89.8 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.205 -1.559 . . . . 0.0 108.101 178.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.8 p -77.68 -60.78 2.23 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.815 -1.154 . . . . 0.0 107.982 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.834 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.3 p -37.33 -18.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.73 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' B' ' 46' ' ' CYS . 1.4 m120 -47.75 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.405 0.622 . . . . 0.0 110.69 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.834 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.2 t 168.56 -32.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.23 165.24 37.65 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.236 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.87 91.48 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.047 2.498 . . . . 0.0 112.463 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -46.89 156.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.276 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 mm -100.4 -55.74 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.742 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 13.8 m-20 -118.3 127.85 54.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.314 -0.866 . . . . 0.0 111.317 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.91 130.14 48.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -139.79 125.39 19.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.808 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.8 tpt -105.93 129.4 54.08 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 0.62 ' HE3' " H2'" ' A' ' 11' ' ' ' A' . 0.0 OUTLIER -152.17 155.85 38.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.434 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.2 OUTLIER -113.03 179.93 3.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.592 ' OD2' ' N ' ' B' ' 66' ' ' SER . 51.2 p-10 -102.75 74.52 0.18 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.15 -0.969 . . . . 0.0 110.75 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 28.6 Cg_endo -65.77 -60.1 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.966 1.777 . . . . 0.0 112.149 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.26 -50.01 6.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.936 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.593 ' HG1' ' H ' ' B' ' 65' ' ' ARG . 30.3 p -57.47 -45.06 85.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.454 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.443 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 74.87 11.72 83.47 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.593 ' H ' ' HG1' ' B' ' 63' ' ' THR . 10.8 mtp85 -66.02 -52.18 51.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.933 -1.334 . . . . 0.0 109.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.592 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 8.0 t -156.02 145.24 20.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -0.988 . . . . 0.0 110.403 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -79.98 -5.87 56.5 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.735 -1.228 . . . . 0.0 109.465 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -127.94 88.52 0.33 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.093 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 0.914 ' CE1' " H4'" ' A' ' 9' ' ' ' A' . 1.5 m-85 -127.98 126.25 41.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.175 -1.191 . . . . 0.0 109.452 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.01 137.7 31.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.078 . . . . 0.0 110.088 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.802 ' CZ ' ' N3 ' ' A' ' 9' ' ' ' A' . 4.9 m-30 -103.49 125.3 49.98 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.378 -0.827 . . . . 0.0 108.93 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.4 HD11 ' N ' ' B' ' 72' ' ' ILE . 3.7 mp -122.01 97.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.645 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 53.2 mt-10 -86.96 127.85 35.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.707 -1.246 . . . . 0.0 110.734 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -89.68 179.86 5.93 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.621 0.724 . . . . 0.0 110.579 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 0.1 OUTLIER -57.06 -42.45 80.59 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.593 -0.692 . . . . 0.0 110.374 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.662 ' O ' ' N ' ' B' ' 78' ' ' GLU . 4.2 m-20 158.76 177.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 0.0 109.018 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.545 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 0.6 OUTLIER -33.68 -24.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.919 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.662 ' N ' ' O ' ' B' ' 76' ' ' ASP . 10.6 mp0 -69.84 -73.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.387 -1.446 . . . . 0.0 108.891 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.9 m -62.97 -41.36 99.52 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.3 m -59.6 -39.13 83.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.19 -0.943 . . . . 0.0 108.779 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -59.55 -61.21 2.79 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.141 0.972 . . . . 0.0 108.801 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.583 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 69.5 m -63.29 -39.7 95.31 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.579 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -79.6 -61.13 2.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.983 -1.073 . . . . 0.0 110.169 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.563 ' O ' ' CA ' ' B' ' 88' ' ' ASN . 26.7 t -51.19 -42.45 25.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.023 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . 0.428 ' HA ' HD21 ' B' ' 88' ' ' ASN . 23.3 ttm180 -64.9 -56.57 12.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.411 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 82' ' ' SER . 8.7 m-80 -67.47 -43.8 80.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' B' ' 83' ' ' ALA . 51.0 mt -104.83 34.87 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.0 110.433 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.563 ' CA ' ' O ' ' B' ' 84' ' ' VAL . 0.5 OUTLIER -62.6 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.123 -0.986 . . . . 0.0 108.375 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.17 116.29 1.62 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -138.1 145.8 42.1 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.369 -1.665 . . . . 0.0 107.752 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.0 OUTLIER -30.9 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.668 -0.645 . . . . 0.0 111.286 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' B' ' 90' ' ' TYR . 11.3 tp -154.03 140.8 19.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.53 -171.63 0.1 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 47.2 p -67.94 -22.39 65.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.538 ' H ' ' HG ' ' B' ' 32' ' ' SER . 94.9 mtt180 -136.23 163.52 30.2 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.2 m-85 -93.04 141.68 28.13 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.257 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -37.4 136.99 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -108.4 147.77 31.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . 0.544 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 31.2 p -87.55 116.7 25.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' B' ' 27' ' ' VAL . . . -115.03 158.39 14.37 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.51 ' CB ' ' O ' ' B' ' 23' ' ' PRO . 1.8 p90 -136.97 113.87 10.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -1.113 . . . . 0.0 109.122 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' SER . . . . . 0.696 ' HG ' ' H ' ' B' ' 103' ' ' SER . 51.0 p -136.94 -84.41 0.34 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.253 -0.904 . . . . 0.0 109.744 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' SER . . . . . 0.696 ' H ' ' HG ' ' B' ' 102' ' ' SER . 24.6 t -144.78 146.59 32.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -113.07 17.14 19.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.468 -0.77 . . . . 0.0 109.281 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.625 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 65.2 tttt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -110.18 144.91 38.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 48.7 m -123.96 140.63 52.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 109.909 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 -1.98 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.79 140.08 32.7 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.015 -1.053 . . . . 0.0 108.936 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 24.8 ptm -123.32 155.61 36.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 109.345 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.717 ' CD2' ' C6 ' ' A' ' 6' ' ' ' A' . 72.1 t80 -111.29 77.95 1.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' C' ' 162' ' ' PHE . 60.8 mt -49.02 135.9 5.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' C' ' 229' ' ' ASP . . . -136.02 157.14 23.27 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.125 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.722 ' H ' ' H3 ' ' A' ' 5' ' ' ' U' . . . 76.02 20.65 77.43 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . 0.657 ' CB ' ' HZ3' ' C' ' 192' ' ' LYS . 83.0 mt -60.14 171.24 1.04 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.175 -1.191 . . . . 0.0 108.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.59 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 17.0 p30 -68.92 -79.95 0.05 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.017 -1.052 . . . . 0.0 109.309 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.714 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.0 OUTLIER 178.8 -24.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.78 -1.2 . . . . 0.0 110.192 179.201 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . 0.453 ' OD1' ' C ' ' C' ' 169' ' ' ASP . 19.6 t0 -135.03 93.53 3.02 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.016 -1.053 . . . . 0.0 110.623 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 170' ' ' THR . . . . . 0.539 ' H ' ' CD ' ' C' ' 192' ' ' LYS . 17.4 m -139.97 145.71 38.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.309 -0.869 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.82 167.21 10.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.951 -1.093 . . . . 0.0 109.348 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.28 -56.37 22.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -48.38 -40.82 26.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.996 -1.065 . . . . 0.0 110.818 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -74.85 -53.13 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 109.962 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 10.3 tp -53.02 -45.68 68.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' C' ' 177' ' ' GLU . 27.4 ttp180 -66.12 -60.28 2.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' C' ' 176' ' ' ARG . 61.3 mm-40 -40.97 -30.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.535 ' O ' ' NZ ' ' C' ' 181' ' ' LYS . 1.1 t80 -76.67 -48.68 18.22 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.354 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.863 ' O ' ' N ' ' C' ' 181' ' ' LYS . 24.5 m-85 -72.58 -58.46 3.35 Favored 'General case' 0 C--O 1.196 -1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -43.42 10.18 0.0 OUTLIER Glycine 0 N--CA 1.507 3.379 0 O-C-N 119.845 -1.785 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . 0.863 ' N ' ' O ' ' C' ' 179' ' ' PHE . 1.5 ttmp? -75.99 -18.35 59.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.726 -1.455 . . . . 0.0 107.689 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . 0.483 ' N ' ' CD1' ' C' ' 182' ' ' TYR . 3.2 m-85 -93.14 -58.73 2.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 109.708 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -144.54 -129.86 2.24 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 28.0 m -127.16 153.88 45.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.384 -1.068 . . . . 0.0 110.154 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.39 149.39 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.02 -42.18 11.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.904 -1.123 . . . . 0.0 110.02 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -154.52 155.91 35.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.998 . . . . 0.0 109.319 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' C' ' 189' ' ' LYS . 0.1 OUTLIER -147.15 139.62 24.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.652 -1.28 . . . . 0.0 107.809 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . 0.551 ' N ' ' CD1' ' C' ' 188' ' ' LEU . 5.9 tptp -127.61 133.85 49.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.878 -1.139 . . . . 0.0 109.64 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.62 156.24 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 108.521 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 4.0 tpp -139.84 42.3 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.022 -1.049 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . 0.657 ' HZ3' ' CB ' ' C' ' 166' ' ' LEU . 18.3 mttp -72.76 -163.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.982 -1.074 . . . . 0.0 109.432 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' C' ' 197' ' ' GLY . 0.9 OUTLIER -127.65 52.67 8.86 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.542 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 193' ' ' ASP . 83.9 Cg_endo -78.57 -4.42 14.11 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.823 2.349 . . . . 0.0 111.87 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.41 28.3 3.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.444 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 196' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' C' ' 193' ' ' ASP . 0.5 OUTLIER -153.37 -55.33 0.11 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.315 -0.866 . . . . 0.0 109.862 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . 0.58 ' N ' ' OD2' ' C' ' 193' ' ' ASP . . . 174.42 -100.94 0.15 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -136.08 136.83 40.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 109.488 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 199' ' ' SER . . . . . 0.515 ' O ' ' O ' ' C' ' 200' ' ' ARG . 9.3 t -153.36 170.61 20.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.263 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' C' ' 199' ' ' SER . 6.4 mmp_? -42.57 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 109.117 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . 0.413 ' HA2' ' HZ2' ' C' ' 192' ' ' LYS . . . -141.69 94.28 0.19 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.889 ' CZ ' " H4'" ' A' ' 7' ' ' ' U' . 21.0 p90 -137.94 167.78 21.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.36 136.13 8.19 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 119.061 -1.542 . . . . 0.0 109.66 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -105.43 102.88 12.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.43 111.29 23.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.419 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 21.3 t -82.79 70.92 9.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . 0.451 ' CE1' ' OG ' ' C' ' 212' ' ' SER . 2.7 m-85 -60.01 117.98 5.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.63 -51.13 66.55 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.045 -1.035 . . . . 0.0 109.354 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' C' ' 211' ' ' SER . 50.5 mtpt -84.95 103.79 3.78 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.084 -1.01 . . . . 0.0 110.436 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.67 -15.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.823 1.682 . . . . 0.0 112.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.557 ' O ' ' N ' ' C' ' 213' ' ' VAL . 17.6 m -68.36 -69.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.855 -1.153 . . . . 0.0 109.898 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 211' ' ' SER . 0.0 OUTLIER -36.46 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.736 -0.603 . . . . 0.0 109.672 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' C' ' 211' ' ' SER . 88.4 t -65.63 -45.1 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 109.396 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -61.72 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.584 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.24 -39.33 86.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 108.965 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . 0.696 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 15.2 t -64.85 -49.7 78.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.351 0.596 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.13 -31.17 52.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.585 -1.322 . . . . 0.0 109.488 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -81.12 -44.35 18.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.131 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.579 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 41.5 m -66.39 151.23 47.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.345 -0.847 . . . . 0.0 110.632 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -80.36 148.33 30.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.592 -0.692 . . . . 0.0 109.657 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.696 ' NE2' ' O ' ' C' ' 216' ' ' VAL . 24.5 m-70 -132.84 132.74 42.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.222 -0.924 . . . . 0.0 110.623 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.2 86.61 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -55.15 -71.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 109.627 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 91.8 m-20 -96.2 7.64 45.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 109.126 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.52 12.28 61.3 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . 0.57 ' O ' ' CG1' ' C' ' 227' ' ' VAL . 0.4 OUTLIER -85.78 -86.06 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -1.089 . . . . 0.0 109.737 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . 0.57 ' CG1' ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 171.85 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.827 . . . . 0.0 109.641 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 15.4 pt -99.39 160.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.127 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' C' ' 164' ' ' GLY . 5.4 m-20 -126.76 102.17 25.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 111.016 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . 0.46 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 28.9 Cg_endo -83.28 137.29 8.17 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -164.05 168.66 18.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.912 -1.117 . . . . 0.0 109.804 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -58.64 156.07 11.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.986 . . . . 0.0 109.462 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . 0.4 ' O ' ' CG1' ' C' ' 234' ' ' ILE . . . -70.26 124.08 23.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . 0.629 ' O ' ' C6 ' ' A' ' 6' ' ' ' A' . 13.2 mt -158.71 108.92 1.62 Allowed Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.12 132.31 8.73 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.604 1.536 . . . . 0.0 111.82 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.445 ' NH2' ' H5 ' ' A' ' 5' ' ' ' U' . 5.3 tpp180 -55.47 -36.43 66.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.173 -0.955 . . . . 0.0 109.002 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . 0.406 ' OD1' ' CZ ' ' C' ' 321' ' ' ARG . 54.7 t0 -52.82 -40.89 63.69 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -70.17 -36.14 74.47 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . 0.524 ' O ' ' OG1' ' C' ' 242' ' ' THR . 54.9 mm-40 -57.69 -38.48 75.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 108.896 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . 0.402 ' OD1' ' NZ ' ' C' ' 244' ' ' LYS . 87.2 m-20 -68.48 -37.67 80.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -60.94 -29.73 69.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 242' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 9.5 p -65.01 -21.71 66.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.968 -1.082 . . . . 0.0 110.09 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 110.35 102.66 2.72 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . 0.402 ' NZ ' ' OD1' ' C' ' 240' ' ' ASP . 4.3 ttpt -131.24 126.79 36.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.314 . . . . 0.0 110.223 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . 0.416 ' HA ' ' H ' ' C' ' 318' ' ' ALA . 0.1 OUTLIER -113.86 141.82 28.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.527 ' C ' ' CD1' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -87.33 164.9 16.0 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 58.8 t -136.69 131.53 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.95 142.32 16.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' C' ' 313' ' ' ILE . . . 90.27 66.99 1.2 Allowed Glycine 0 N--CA 1.491 2.358 0 O-C-N 121.137 -1.214 . . . . 0.0 110.689 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' C' ' 285' ' ' GLY . 38.4 mm -114.2 133.82 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -1.19 . . . . 0.0 109.131 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.66 157.48 45.08 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.93 -22.82 55.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.823 2.349 . . . . 0.0 112.6 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -124.35 52.57 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.302 -0.874 . . . . 0.0 109.923 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . 0.69 ' O ' ' O ' ' C' ' 255' ' ' ARG . 47.7 t -100.56 36.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' C' ' 254' ' ' VAL . 4.0 mtp85 -16.5 146.96 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.7 0 CA-C-O 121.384 0.611 . . . . 0.0 111.851 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' C' ' 257' ' ' LYS . 31.1 Cg_endo -57.95 -19.99 42.66 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.723 2.282 . . . . 0.0 113.048 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' C' ' 256' ' ' PRO . 54.0 tttm -46.51 -67.78 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . 0.744 ' O ' ' N ' ' C' ' 261' ' ' GLU . 23.8 mp0 -60.72 -91.46 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.71 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . 0.628 ' C ' ' O ' ' C' ' 258' ' ' GLU . 56.7 t80 -6.1 -68.08 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 CA-C-O 121.179 0.514 . . . . 0.0 111.18 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 258' ' ' GLU . 83.4 tt0 -54.97 -48.02 73.78 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.617 0.723 . . . . 0.0 109.545 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . 0.744 ' N ' ' O ' ' C' ' 258' ' ' GLU . 82.1 tt0 -71.56 -45.04 63.41 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -49.84 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.61 -0.681 . . . . 0.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.528 ' O ' ' C ' ' C' ' 264' ' ' SER . 63.5 m-85 -45.3 -44.37 11.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.906 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.617 ' O ' ' N ' ' C' ' 266' ' ' TRP . 1.3 p -37.88 -36.64 0.2 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' C' ' 263' ' ' PHE . 23.4 tt0 -42.14 -9.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.946 -0.471 . . . . 0.0 111.872 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.617 ' N ' ' O ' ' C' ' 264' ' ' SER . 16.0 p90 -159.33 44.81 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.22 -1.55 . . . . 0.0 110.527 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 154.41 123.8 0.9 Allowed Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.294 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 27.8 m -56.78 140.4 47.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -1.153 . . . . 0.0 108.823 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . 0.414 HG21 ' H ' ' C' ' 272' ' ' ALA . 1.1 mp -99.03 109.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 0.0 110.762 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . 0.459 HD12 HG21 ' C' ' 270' ' ' ILE . 4.1 mt -71.9 -50.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 109.877 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . 0.561 ' O ' ' C ' ' C' ' 272' ' ' ALA . 59.4 t0 -147.01 17.45 1.23 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.839 -1.163 . . . . 0.0 111.407 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' C' ' 271' ' ' ASP . . . -27.91 138.66 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.585 -0.697 . . . . 0.0 109.979 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -133.56 124.22 26.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.231 -0.918 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . 0.436 ' HB2' ' CD2' ' C' ' 259' ' ' PHE . 1.4 tm? -121.43 129.37 52.95 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 3.8 mmt -102.09 163.81 12.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.572 -1.33 . . . . 0.0 110.021 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' C' ' 282' ' ' GLN . 1.0 OUTLIER -144.07 -175.34 4.57 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.044 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -44.93 -86.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 109.689 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -107.77 -20.74 13.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 108.992 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -52.73 -26.94 15.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 280' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -143.37 -8.34 0.77 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.651 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.71 64.99 1.7 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' C' ' 276' ' ' LEU . 9.3 tp-100 -171.93 164.24 6.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -1.173 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 283' ' ' SER . . . . . 0.434 ' H ' ' HG3' ' C' ' 282' ' ' GLN . 25.6 p -170.14 0.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.199 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . . . . . . . . . 46.7 mmt-85 -55.9 -31.2 62.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.373 -0.829 . . . . 0.0 109.661 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' C' ' 250' ' ' ILE . . . 106.81 20.64 8.72 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.184 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.456 ' CE2' " H5'" ' A' ' 3' ' ' ' U' . 26.8 p90 -109.84 175.81 5.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.068 -1.254 . . . . 0.0 110.203 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.49 -177.42 36.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -149.75 149.84 31.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.31 -1.7 . . . . 0.0 108.778 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.06 149.14 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 48.7 m -132.84 121.57 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.641 -1.287 . . . . 0.0 109.082 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -116.22 137.4 52.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.204 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' C' ' 293' ' ' SER . 17.7 p-10 -62.35 -49.67 74.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 293' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 75.7 m -67.91 124.22 22.74 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -77.36 -27.05 52.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.086 -2.191 . . . . 0.0 105.086 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -51.46 -41.72 61.08 Favored 'General case' 0 C--O 1.206 -1.222 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.23 75.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.994 -1.066 . . . . 0.0 108.393 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 83.1 t -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.72 -29.56 53.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.66 -0.65 . . . . 0.0 109.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -71.69 -62.97 1.22 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -61.5 -24.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.628 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' C' ' 300' ' ' VAL . 1.3 m -43.98 -58.4 2.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -50.8 -26.86 6.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.081 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' C' ' 300' ' ' VAL . 34.1 t-20 -99.43 86.41 3.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 109.509 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -75.05 -84.31 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.695 -1.253 . . . . 0.0 108.561 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -58.74 127.62 33.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.198 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.1 tt -138.58 142.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.641 1.21 . . . . 0.0 110.18 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' C' ' 307' ' ' ASP . 47.3 p30 -68.65 142.13 55.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.866 0.841 . . . . 0.0 110.531 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.626 ' O ' ' N ' ' C' ' 310' ' ' ASP . 9.9 t80 -169.84 -174.07 1.74 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.515 ' C ' ' O ' ' C' ' 308' ' ' PHE . 37.0 mmtt -32.75 -30.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.556 -0.715 . . . . 0.0 110.217 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' C' ' 308' ' ' PHE . 92.6 m-20 -87.1 -84.74 0.18 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.07 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.015 -1.053 . . . . 0.0 110.556 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -168.75 49.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.988 -1.07 . . . . 0.0 109.342 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' C' ' 249' ' ' GLY . 10.7 pt -49.92 138.55 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.766 0.793 . . . . 0.0 110.791 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -85.44 115.8 23.39 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.23 0.538 . . . . 0.0 110.527 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 83.8 mt -82.78 158.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 108.944 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.58 165.95 16.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.511 -1.368 . . . . 0.0 109.659 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -78.8 140.45 38.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.625 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . 0.416 ' H ' ' HA ' ' C' ' 245' ' ' ILE . . . -70.79 -29.91 66.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.909 -1.119 . . . . 0.0 108.837 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 178.08 154.0 0.49 Allowed Pre-proline 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.29 136.8 27.27 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.078 1.852 . . . . 0.0 112.326 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . 0.406 ' CZ ' ' OD1' ' C' ' 237' ' ' ASP . 4.5 mtt-85 179.41 -29.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.199 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 17.7 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.569 179.809 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.86 HO5' ' P ' ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.436 1.828 1 C5'-C4'-C3' 107.587 -5.275 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.772 " O2'" ' H6 ' ' A' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.115 1 C5'-C4'-C3' 108.023 -4.984 . 0.137 2z . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 0.781 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 P--O5' 1.613 1.966 1 C5'-C4'-C3' 108.214 -4.857 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.751 ' H8 ' ' O ' ' C' ' 166' ' ' LEU . . . . . . . . 0 O4'--C1' 1.439 2.044 1 C5'-C4'-C3' 106.623 -5.918 . 0.22 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.875 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.446 2.67 0 C5'-C4'-C3' 109.622 -3.918 . 0.599 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.983 " C4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.616 2.252 1 C5'-C4'-C3' 108.64 -4.574 . 0.442 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.983 " H5'" " C4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.621 2.835 1 C5'-C4'-C3' 108.273 -4.818 . 0.195 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.643 ' N3 ' ' CD2' ' B' ' 29' ' ' TYR . . . . . . . . 0 O4'--C4' 1.428 -2.09 2 C5'-C4'-C3' 106.132 -6.245 OUTLIER-DELTA 0.303 2[ . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.935 " H1'" ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 P--O5' 1.612 1.899 2 C5'-C4'-C3' 108.737 -4.509 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 0.671 " O5'" ' H6 ' ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.614 2.088 1 C5'-C4'-C3' 108.234 -4.844 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.853 " O2'" ' H8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.925 1 C5'-C4'-C3' 106.937 -5.709 . 0.424 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.853 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.611 1.807 1 C5'-C4'-C3' 106.929 -5.714 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.516 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.927 1 C5'-C4'-C3' 107.571 -5.286 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.439 ' O ' ' CD2' ' B' ' 101' ' ' TYR . 6.6 Cg_exo -64.53 150.03 88.92 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.231 1.954 . . . . 0.0 112.303 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -85.09 26.35 0.65 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.559 2.173 . . . . 0.0 112.78 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.01 126.28 11.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.616 -1.303 . . . . 0.0 110.23 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -179.46 -49.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 109.24 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.04 154.91 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.832 0.825 . . . . 0.0 110.436 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -108.06 139.52 29.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.693 ' CE2' ' C2 ' ' A' ' 9' ' ' ' A' . 5.1 m-85 -102.24 133.05 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.111 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.96 121.28 40.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -114.61 -94.17 1.99 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.612 ' H ' ' NH1' ' B' ' 95' ' ' ARG . 2.7 p -69.04 110.7 4.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.75 -1.441 . . . . 0.0 110.36 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -160.74 127.37 2.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' B' ' 36' ' ' ASP . 51.7 Cg_endo -74.85 170.87 19.41 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.604 1.536 . . . . 0.0 112.61 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.597 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 3.8 m-30 -69.29 4.72 1.56 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.3 m-20 -60.26 -38.06 82.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.129 -0.982 . . . . 0.0 109.443 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.81 116.01 18.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 109.459 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.407 ' O ' HG12 ' B' ' 42' ' ' ILE . 82.2 p -113.02 -140.64 0.38 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.696 0.76 . . . . 0.0 111.631 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.401 ' CD ' ' C ' ' B' ' 39' ' ' GLU . 1.6 pp20? -61.46 -34.28 75.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.673 -1.267 . . . . 0.0 111.358 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -71.69 -53.95 11.87 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -44.1 79.56 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.385 -0.822 . . . . 0.0 110.189 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.584 ' O ' ' N ' ' B' ' 44' ' ' ASP . 30.6 mm -58.0 -51.62 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 42' ' ' ILE . 3.1 tm? -37.43 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' B' ' 42' ' ' ILE . 83.7 m-20 -124.7 -24.48 4.15 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 3.3 tm? -60.09 -41.18 91.94 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.214 -1.554 . . . . 0.0 107.472 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.621 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.4 m -87.65 -63.04 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.817 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.915 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.1 p -40.11 -19.96 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.779 -0.576 . . . . 0.0 109.896 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.621 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.3 OUTLIER -42.69 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.117 0.96 . . . . 0.0 110.131 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.915 ' N ' ' O ' ' B' ' 47' ' ' SER . 0.9 OUTLIER 161.58 -28.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 47' ' ' SER . . . -169.37 123.16 1.06 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.424 -1.37 . . . . 0.0 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -48.14 100.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.579 1.52 . . . . 0.0 111.523 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -49.63 171.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.852 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 35.5 mm -107.47 -49.12 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 110.132 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.579 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 40.5 m-20 -118.35 139.17 51.76 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.103 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.96 132.2 28.2 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -137.26 121.5 18.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.045 -1.034 . . . . 0.0 109.678 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tpt -104.5 128.61 52.48 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.726 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 0.63 ' CE ' ' N7 ' ' A' ' 11' ' ' ' A' . 2.1 ttt -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.061 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.597 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 2.3 m-85 -104.11 -175.92 2.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' B' ' 66' ' ' SER . 49.8 m-20 -115.55 87.38 17.14 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.07 -1.019 . . . . 0.0 110.657 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.06 -60.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.485 2.123 . . . . 0.0 112.353 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' B' ' 63' ' ' THR . 3.4 tt0 -86.2 -62.1 1.59 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.412 ' C ' ' O ' ' B' ' 62' ' ' GLN . 5.2 p -45.24 -43.02 10.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.835 . . . . 0.0 108.91 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.41 18.26 76.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.547 ' CZ ' ' O4 ' ' A' ' 10' ' ' ' U' . 25.5 mmt85 -61.99 -42.02 98.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.979 -1.307 . . . . 0.0 109.516 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -179.86 179.15 0.58 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.978 -1.076 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -117.93 78.7 1.27 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.65 48.08 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 0.915 ' CE2' H5'' ' A' ' 9' ' ' ' A' . 3.9 m-30 -97.01 125.44 41.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.43 158.16 43.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 111.847 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.935 ' CZ ' " H1'" ' A' ' 9' ' ' ' A' . 5.7 m-85 -125.97 126.99 45.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.629 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.63 ' CD1' ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -118.06 98.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.724 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.579 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.8 tt0 -82.54 126.4 32.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.379 -1.451 . . . . 0.0 110.282 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -86.72 176.36 7.79 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.573 0.701 . . . . 0.0 110.038 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 58.3 mtp180 -56.63 -42.07 78.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.2 m-20 165.64 172.59 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 0.9 OUTLIER -38.07 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.062 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.1 mm-40 -74.43 -70.83 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.95 -1.094 . . . . 0.0 108.748 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 37.0 m -59.49 -45.02 92.89 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.66 -1.275 . . . . 0.0 107.691 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -62.68 -34.88 78.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 109.184 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -56.23 -59.36 5.05 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.124 -1.61 . . . . 0.0 107.231 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.502 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 33.3 t -65.58 -38.95 91.0 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.401 ' N ' HG13 ' B' ' 49' ' ' VAL . . . -79.28 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.867 -1.146 . . . . 0.0 110.197 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -52.01 -42.91 35.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.861 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmt180 -66.82 -43.53 83.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.643 -1.911 . . . . 0.0 109.258 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.61 HD21 ' N ' ' B' ' 86' ' ' ASN . 0.8 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 111.619 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.581 ' O ' ' C ' ' B' ' 88' ' ' ASN . 7.9 mt -117.09 -4.05 11.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.927 -1.108 . . . . 0.0 111.254 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' B' ' 84' ' ' VAL . 0.0 OUTLIER -16.11 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.074 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.84 108.11 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -130.37 143.4 50.75 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.699 -1.471 . . . . 0.0 108.087 -179.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.568 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.0 OUTLIER -32.66 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.648 -0.658 . . . . 0.0 110.832 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 90' ' ' TYR . 5.3 tt -148.36 132.36 17.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.23 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.81 -157.94 1.58 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -21.18 52.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -1.125 . . . . 0.0 108.646 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.612 ' NH1' ' H ' ' B' ' 32' ' ' SER . 32.0 ttm105 -136.85 146.92 46.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' B' ' 96' ' ' PHE . 1.6 m-30 -93.1 143.92 25.77 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.511 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 88' ' ' ASN . 0.2 OUTLIER -46.68 157.69 0.14 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.174 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 147.97 42.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 109.888 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 17.2 p -77.2 121.46 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -135.89 174.56 21.32 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.515 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' B' ' 23' ' ' PRO . 7.1 t80 -147.69 125.25 11.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.571 -0.958 . . . . 0.0 109.784 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -137.84 101.64 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.651 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.04 127.73 0.16 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -113.35 137.44 51.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.481 -0.762 . . . . 0.0 109.289 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.503 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 5.9 tptm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -114.85 163.42 15.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.398 -0.813 . . . . 0.0 109.62 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 158' ' ' SER . . . . . 0.632 ' O ' ' N ' ' C' ' 160' ' ' LYS . 23.1 t -112.11 155.63 23.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.451 -0.781 . . . . 0.0 109.528 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . 0.448 ' HG ' ' CG2' ' C' ' 213' ' ' VAL . 3.2 t -54.83 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' C' ' 158' ' ' SER . 11.3 tptp -88.21 136.17 33.1 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.611 0.72 . . . . 0.0 110.19 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 39.2 mmm -115.62 150.65 36.35 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.604 -0.685 . . . . 0.0 109.633 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.72 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 4.9 t80 -116.48 123.84 48.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . 0.564 ' O ' ' O2 ' ' A' ' 5' ' ' ' U' . 5.2 mm -105.1 133.61 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.09 171.19 21.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.1 28.71 72.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . 0.751 ' O ' ' H8 ' ' A' ' 4' ' ' ' A' . 97.5 mt -77.2 150.69 35.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 110.536 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' C' ' 169' ' ' ASP . 0.4 OUTLIER -75.3 153.85 37.7 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.669 ' CH2' ' C2 ' ' A' ' 4' ' ' ' A' . 2.5 m0 -69.42 19.07 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.886 -1.134 . . . . 0.0 110.032 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' C' ' 167' ' ' ASN . 59.5 t0 -145.14 84.47 1.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.946 -1.096 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 170' ' ' THR . . . . . 0.583 ' OG1' ' NZ ' ' C' ' 192' ' ' LYS . 0.2 OUTLIER -146.61 119.96 8.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.17 158.55 15.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 0.0 109.465 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' C' ' 173' ' ' ASP . 87.9 mt-10 -61.7 -69.29 0.25 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.829 -1.169 . . . . 0.0 110.915 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' C' ' 172' ' ' GLU . 55.1 t0 -42.31 -36.61 1.3 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.684 -1.26 . . . . 0.0 109.818 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -80.02 -47.85 14.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.412 -0.805 . . . . 0.0 109.69 179.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.406 ' N ' ' ND2' ' C' ' 174' ' ' ASN . 7.6 tt -57.19 -42.26 80.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.034 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' C' ' 179' ' ' PHE . 70.8 ttp85 -67.34 -57.94 5.71 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' C' ' 176' ' ' ARG . 49.1 tp10 -39.75 -31.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.53 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 15.4 t80 -74.13 -49.39 23.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.725 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.891 ' O ' ' N ' ' C' ' 181' ' ' LYS . 28.9 m-85 -74.87 -62.94 1.37 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -39.43 4.19 0.0 OUTLIER Glycine 0 N--CA 1.508 3.457 0 O-C-N 120.345 -1.472 . . . . 0.0 112.38 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . 0.891 ' N ' ' O ' ' C' ' 179' ' ' PHE . 6.2 tttm -64.63 -28.57 69.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.779 -1.424 . . . . 0.0 107.839 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . 0.536 ' OH ' ' CG2' ' C' ' 219' ' ' THR . 32.0 m-85 -78.39 -35.55 47.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.267 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.7 -126.1 0.88 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 41.3 m -129.28 154.92 46.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 1.1 m -120.44 159.7 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 108.978 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 186' ' ' THR . . . . . 0.492 ' O ' ' OD1' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -99.01 -43.92 6.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 110.248 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' C' ' 186' ' ' THR . 68.8 m-20 -151.93 147.57 26.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.833 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.519 ' CD2' ' C ' ' C' ' 188' ' ' LEU . 0.2 OUTLIER -141.73 146.21 35.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.934 -1.104 . . . . 0.0 108.486 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.3 123.2 29.5 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.978 -1.076 . . . . 0.0 109.88 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 92.6 mt -134.75 121.63 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.478 -1.388 . . . . 0.0 108.169 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -114.66 44.49 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.865 0.841 . . . . 0.0 108.806 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . 0.583 ' NZ ' ' OG1' ' C' ' 170' ' ' THR . 4.5 ttmt -64.45 -162.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' C' ' 192' ' ' LYS . 0.5 OUTLIER -134.25 66.64 71.57 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.767 -1.208 . . . . 0.0 110.696 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.35 -0.91 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.426 2.751 . . . . 0.0 110.889 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.36 15.86 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.343 0.592 . . . . 0.0 109.424 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.1 -59.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.2 -91.82 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -142.0 144.87 33.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.502 -0.999 . . . . 0.0 109.64 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 199' ' ' SER . . . . . 0.463 ' OG ' ' OP1' ' A' ' 8' ' ' ' A' . 42.2 t -161.86 160.58 28.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.48 ' O ' ' CD1' ' C' ' 202' ' ' PHE . 64.1 mmt-85 -47.75 114.38 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 109.122 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . 0.419 ' O ' " O4'" ' A' ' 5' ' ' ' U' . . . -83.42 113.05 3.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.602 ' CE1' " H4'" ' A' ' 7' ' ' ' U' . 16.0 p90 -141.31 153.27 45.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -1.163 . . . . 0.0 108.419 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -122.65 139.61 12.66 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.803 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -118.34 103.55 9.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.06 109.22 20.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.972 . . . . 0.0 111.016 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 7.2 t -94.81 132.62 39.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -116.21 143.43 45.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.924 -1.11 . . . . 0.0 109.559 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . 0.433 ' OE1' ' C ' ' C' ' 208' ' ' GLU . 1.7 tm-20 -68.15 -54.34 18.72 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.015 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.16 108.22 26.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.968 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -44.38 -20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.206 1.937 . . . . 0.0 113.683 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.574 ' O ' ' N ' ' C' ' 213' ' ' VAL . 11.3 t -61.83 -69.38 0.25 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.542 -1.349 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.488 ' C ' ' O ' ' C' ' 211' ' ' SER . 83.0 p -35.45 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.161 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' C' ' 211' ' ' SER . 0.4 OUTLIER -64.91 -37.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.0 109.229 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' C' ' 211' ' ' SER . 91.0 m-20 -63.68 -46.05 87.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 55.2 mp0 -68.76 -35.69 77.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . 0.586 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 54.5 t -62.01 -52.62 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.45 -38.79 79.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -73.31 -45.28 56.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.44 -0.788 . . . . 0.0 110.411 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.536 ' CG2' ' OH ' ' C' ' 182' ' ' TYR . 24.9 m -68.75 145.65 53.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.21 -0.931 . . . . 0.0 111.658 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -80.33 149.94 30.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.586 ' NE2' ' O ' ' C' ' 216' ' ' VAL . 20.5 m-70 -127.68 132.19 49.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.53 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -142.56 103.21 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.326 -0.859 . . . . 0.0 109.678 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.02 -62.58 1.41 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.023 -1.048 . . . . 0.0 109.216 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -110.26 12.66 23.21 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 97.99 5.06 57.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -73.48 -171.61 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -1.084 . . . . 0.0 108.17 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.04 102.21 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 15.8 pt -102.13 151.55 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.478 -0.764 . . . . 0.0 108.955 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -119.27 107.27 41.65 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.354 -0.841 . . . . 0.0 110.888 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -89.19 135.23 2.65 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 111.431 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . 0.584 ' NZ ' ' O4 ' ' A' ' 5' ' ' ' U' . 9.9 mtmp? -148.27 146.0 28.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.852 -1.155 . . . . 0.0 110.199 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' C' ' 233' ' ' ALA . 35.5 mtm105 -56.63 147.68 21.87 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.2 133.93 6.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.926 -1.109 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.86 124.15 34.36 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 109.667 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.15 142.42 4.07 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.939 1.759 . . . . 0.0 112.077 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.56 ' NH1' " O2'" ' A' ' 6' ' ' ' A' . 14.7 tpt180 -58.12 -43.68 87.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 110.688 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 29.7 p-10 -62.72 -39.26 93.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . 0.556 ' N ' ' OD1' ' C' ' 237' ' ' ASP . 97.8 mt-10 -68.41 -41.84 79.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.692 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . 0.615 ' NE2' ' N7 ' ' A' ' 6' ' ' ' A' . 4.5 tp-100 -65.44 -43.46 90.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.588 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -63.86 -41.57 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.887 . . . . 0.0 109.785 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -61.45 -47.18 86.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.746 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 59.6 p -54.59 137.65 42.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.48 150.14 17.98 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -130.08 132.27 46.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -1.046 . . . . 0.0 109.983 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . 0.52 ' CD1' ' C ' ' C' ' 245' ' ' ILE . 0.0 OUTLIER -121.15 156.59 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.572 -0.705 . . . . 0.0 109.148 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.684 ' CE2' ' C4 ' ' A' ' 2' ' ' ' A' . 0.0 OUTLIER -105.48 135.01 47.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.578 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.49 131.7 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.778 0.799 . . . . 0.0 110.082 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.69 145.93 16.21 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.34 64.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -129.73 154.85 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -1.076 . . . . 0.0 109.198 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 130.53 -39.6 1.78 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.629 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 87.6 Cg_exo -48.62 -120.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.612 2.208 . . . . 0.0 112.963 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -81.42 17.79 1.29 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . . . . . . . . . 41.3 t -89.68 140.56 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.963 -1.086 . . . . 0.0 109.97 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -104.95 154.81 38.4 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.91 -24.89 74.2 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.157 1.905 . . . . 0.0 112.345 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -51.17 -64.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.714 -0.616 . . . . 0.0 109.697 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . 0.68 ' O ' ' N ' ' C' ' 261' ' ' GLU . 33.8 tt0 -61.16 -78.17 0.04 OUTLIER 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.176 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . 0.655 ' C ' ' O ' ' C' ' 258' ' ' GLU . 59.7 t80 -11.93 -65.74 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 121.52 0.676 . . . . 0.0 110.082 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' C' ' 258' ' ' GLU . 2.9 tm-20 -59.9 -45.73 91.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.574 -0.704 . . . . 0.0 110.799 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' C' ' 258' ' ' GLU . 63.2 mm-40 -71.89 -17.3 62.12 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.985 -1.072 . . . . 0.0 108.892 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' C' ' 263' ' ' PHE . 4.6 t80 -78.96 -80.52 0.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' C' ' 265' ' ' GLN . 31.0 m-85 -38.25 -42.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.235 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.575 ' C ' ' O ' ' C' ' 263' ' ' PHE . 73.0 p -30.82 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.609 ' N ' ' O ' ' C' ' 263' ' ' PHE . 6.4 tt0 -45.26 -23.07 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.822 -0.549 . . . . 0.0 110.969 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.564 ' CZ2' ' CD2' ' C' ' 263' ' ' PHE . 8.2 p90 -151.58 151.1 31.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.644 -1.285 . . . . 0.0 109.246 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 82.08 176.3 51.12 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 268' ' ' THR . . . . . 0.511 ' O ' ' C ' ' C' ' 269' ' ' ILE . 43.1 p -115.35 19.61 15.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.733 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' C' ' 268' ' ' THR . 0.0 OUTLIER -15.35 104.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 41.5 mm -83.4 -34.16 10.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -132.86 97.2 3.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -108.99 131.47 55.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.442 -0.786 . . . . 0.0 109.158 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -160.94 129.91 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.422 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.12 157.89 15.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 275' ' ' MET . . . . . 0.458 ' N ' ' SD ' ' C' ' 275' ' ' MET . 0.5 OUTLIER -93.76 168.19 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.316 -1.49 . . . . 0.0 109.336 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' C' ' 277' ' ' ASP . 0.2 OUTLIER -150.35 -155.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' C' ' 279' ' ' ASP . 77.2 m-20 -54.16 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.463 -0.773 . . . . 0.0 110.447 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' C' ' 278' ' ' LYS . 0.0 OUTLIER -49.46 -8.15 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.298 -0.876 . . . . 0.0 110.146 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' C' ' 277' ' ' ASP . 85.3 m-20 -59.61 -66.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 110.073 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 131.89 43.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 56.53 -124.5 35.22 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.578 ' C ' ' H ' ' C' ' 284' ' ' ARG . 6.9 tt0 -146.95 147.2 30.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.235 -1.156 . . . . 0.0 110.136 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.23 21.73 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' C' ' 282' ' ' GLN . 0.1 OUTLIER -51.47 -33.3 30.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.664 -1.272 . . . . 0.0 108.016 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' C' ' 250' ' ' ILE . . . 117.34 69.62 0.4 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.781 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 32.6 p90 -162.18 175.01 12.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.609 . . . . 0.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -154.63 178.8 31.18 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.071 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' C' ' 246' ' ' PHE . 7.8 m-85 -142.41 157.13 45.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.722 -1.458 . . . . 0.0 108.929 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . 0.406 ' CG1' ' CE1' ' C' ' 291' ' ' TYR . 1.0 OUTLIER -149.12 148.46 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.714 -1.241 . . . . 0.0 108.904 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 12.6 m -129.46 130.94 46.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.05 -1.031 . . . . 0.0 111.101 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . 0.571 ' C ' ' H ' ' C' ' 293' ' ' SER . 46.5 m-85 -112.88 142.5 45.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' C' ' 292' ' ' ASP . 56.6 p30 -75.79 13.03 0.9 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.437 -1.415 . . . . 0.0 107.544 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 293' ' ' SER . . . . . 0.571 ' H ' ' C ' ' C' ' 291' ' ' TYR . 1.8 m -131.04 112.02 12.54 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.49 76.16 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -50.6 -38.0 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.95 83.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.31 -57.67 10.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.57 -19.13 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -77.11 -60.42 2.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.141 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.5 p -60.97 -20.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.146 -0.972 . . . . 0.0 109.039 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' C' ' 300' ' ' VAL . 0.0 OUTLIER -43.17 -58.54 2.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 108.867 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -49.82 -27.67 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' C' ' 300' ' ' VAL . 94.1 m-20 -99.94 68.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.21 -9.5 59.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.088 . . . . 0.0 109.94 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.76 125.06 32.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . 0.448 HD11 HG21 ' C' ' 306' ' ' ILE . 69.4 mt -132.67 145.5 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.0 111.099 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' C' ' 307' ' ' ASP . 3.3 p30 -81.53 94.81 6.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.488 ' CE1' ' CD2' ' C' ' 262' ' ' PHE . 36.7 t80 -104.26 -176.28 3.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' C' ' 308' ' ' PHE . 56.0 mttt -38.84 -32.77 0.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.787 -1.195 . . . . 0.0 109.691 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . 0.593 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 44.1 t0 -95.13 -154.47 0.43 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 108.853 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . 0.649 ' O ' ' N ' ' C' ' 313' ' ' ILE . 17.3 ttp180 -79.66 -167.74 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 108.916 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . 0.445 ' H ' ' HG2' ' C' ' 311' ' ' ARG . 10.3 tptt -55.01 75.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.905 0.86 . . . . 0.0 109.672 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' C' ' 311' ' ' ARG . 3.6 pt -45.46 153.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.947 . . . . 0.0 108.896 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -107.3 155.22 20.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.478 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 77.8 mt -125.31 152.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -154.63 149.88 27.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.952 -1.093 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' C' ' 319' ' ' GLU . 42.5 mtt85 -67.33 145.46 55.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.085 -1.009 . . . . 0.0 109.333 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -78.08 13.45 1.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.905 -1.122 . . . . 0.0 109.116 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' C' ' 317' ' ' ARG . 1.8 mp0 -78.51 151.57 77.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.8 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' C' ' 322' ' ' HIS . 50.4 Cg_endo -72.54 158.32 51.17 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.621 2.214 . . . . 0.0 112.061 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' C' ' 322' ' ' HIS . 60.0 ttt85 -62.99 68.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . 0.561 ' N ' ' O ' ' C' ' 320' ' ' PRO . 70.2 m80 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.938 -1.03 . . . . 0.0 109.588 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ' U' . . . . . 0.853 HO5' ' P ' ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.064 1 C5'-C4'-C3' 107.476 -5.349 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.945 " H4'" ' CD1' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.441 2.228 1 C5'-C4'-C3' 107.261 -5.493 . 0.544 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ' U' . . . . . 0.749 " H5'" ' CE2' ' C' ' 286' ' ' PHE . . . . . . . . 0 P--O5' 1.612 1.876 1 C5'-C4'-C3' 107.88 -5.08 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.63 ' C4 ' ' CH2' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.436 1.836 1 C5'-C4'-C3' 107.761 -5.159 . 0.112 4p . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ' U' . . . . . 0.834 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.249 0 C3'-C2'-C1' 104.883 3.758 . 0.696 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.939 " H4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.62 2.671 1 C5'-C4'-C3' 108.485 -4.676 . 0.508 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.939 " H5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.429 1 C5'-C4'-C3' 107.163 -5.558 . 0.238 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ' A' . . . . . 0.913 " H4'" ' NH2' ' B' ' 95' ' ' ARG . . . . . . . . 0 O4'--C1' 1.44 2.172 2 C5'-C4'-C3' 105.167 -6.889 . 0.449 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.743 ' N3 ' ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 C2'--C1' 1.51 -1.786 2 O4'-C1'-N19 114.196 5.996 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ' U' . . . . . 0.944 H5'' ' CZ ' ' B' ' 69' ' ' TYR . . . . . . . . 0 O4'--C1' 1.438 1.981 2 C5'-C4'-C3' 107.214 -5.524 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.873 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.612 1.905 1 C5'-C4'-C3' 107.524 -5.317 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.784 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 1.969 1 C5'-C4'-C3' 107.319 -5.454 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.512 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.883 1 C5'-C4'-C3' 107.462 -5.359 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.453 ' ND2' ' CD2' ' B' ' 101' ' ' TYR . 1.1 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.52 142.01 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.685 2.257 . . . . 0.0 111.986 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.15 12.08 1.61 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.424 2.083 . . . . 0.0 112.545 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -158.5 129.92 6.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.02 -1.05 . . . . 0.0 109.513 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.567 ' N ' ' OG ' ' B' ' 80' ' ' SER . 42.4 ttt-85 -177.48 -44.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.831 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -138.8 154.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.92 139.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.295 -0.878 . . . . 0.0 108.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.719 ' CZ ' ' N1 ' ' A' ' 9' ' ' ' A' . 2.0 m-30 -106.68 135.99 47.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 111.196 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 54.0 mt -110.21 119.27 38.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -78.52 -137.46 1.22 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 23.2 p -69.42 122.42 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.65 -1.5 . . . . 0.0 109.673 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 mp -126.53 137.78 31.08 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.59 153.53 23.28 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.433 1.422 . . . . 0.0 112.526 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -72.39 -0.91 13.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 109.986 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.4 -35.81 78.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.026 . . . . 0.0 108.513 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.401 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -131.44 117.84 19.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.585 -0.697 . . . . 0.0 109.718 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.457 ' O ' ' CD1' ' B' ' 42' ' ' ILE . 82.1 p -111.42 -135.68 0.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.478 -0.764 . . . . 0.0 110.971 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -64.33 -32.42 74.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.029 -1.044 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.7 -54.44 27.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.184 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -68.11 -42.11 80.73 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.592 -0.693 . . . . 0.0 110.385 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' B' ' 44' ' ' ASP . 1.7 mp -61.1 -53.3 51.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tt -39.58 -21.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.554 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.596 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 91.5 m-20 -125.45 -24.24 3.95 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.732 -1.23 . . . . 0.0 110.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' B' ' 45' ' ' LEU . 2.9 tm? -57.22 -39.02 74.64 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.108 -1.62 . . . . 0.0 106.877 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' B' ' 48' ' ' ASN . 85.4 m -83.26 -63.42 1.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.799 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.1 m -37.16 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.775 -0.578 . . . . 0.0 110.119 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' B' ' 46' ' ' CYS . 1.2 m120 -48.09 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.525 0.678 . . . . 0.0 111.112 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.799 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.1 t 174.5 -31.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.19 -174.63 46.89 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.6 158.87 15.01 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.143 2.562 . . . . 0.0 113.028 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.76 145.26 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -90.56 -66.49 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 112.011 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.573 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 64.0 m-20 -117.86 139.72 50.71 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.598 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.15 127.63 38.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -138.02 129.89 28.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.673 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' MET . . . . . 0.62 ' N ' ' H61' ' A' ' 12' ' ' ' A' . 0.8 OUTLIER -133.25 144.68 49.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.591 0.71 . . . . 0.0 110.379 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -172.07 170.76 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.491 -0.756 . . . . 0.0 109.134 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' PHE . . . . . 0.51 ' O ' ' SD ' ' B' ' 58' ' ' MET . 0.1 OUTLIER -116.12 -166.93 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.0 109.21 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' B' ' 64' ' ' GLY . 6.6 t0 -105.03 73.98 0.24 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.184 -0.948 . . . . 0.0 110.622 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.41 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 5.9 Cg_endo -57.09 -31.33 89.98 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.04 1.827 . . . . 0.0 112.404 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -63.09 -37.76 88.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.599 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.97 -32.8 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 110.206 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 60' ' ' ASP . . . 99.5 -1.34 57.08 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.51 -40.79 83.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.848 -1.384 . . . . 0.0 109.606 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.491 ' OG ' ' OD2' ' B' ' 60' ' ' ASP . 0.5 OUTLIER -89.6 116.24 27.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.102 -0.999 . . . . 0.0 108.709 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.89 -72.58 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.734 -0.604 . . . . 0.0 109.638 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -123.01 95.74 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' TYR . . . . . 0.944 ' CZ ' H5'' ' A' ' 10' ' ' ' U' . 0.8 OUTLIER -108.67 130.61 55.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.473 -1.016 . . . . 0.0 109.126 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.73 24.38 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.834 -1.146 . . . . 0.0 112.193 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.743 ' CZ ' ' N3 ' ' A' ' 9' ' ' ' A' . 12.7 m-30 -115.32 129.4 56.59 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.882 0.849 . . . . 0.0 109.782 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . 0.526 ' CD1' ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -120.25 102.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.121 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.573 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.5 mt-10 -83.95 131.42 34.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.573 -1.33 . . . . 0.0 110.472 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -93.66 178.24 5.75 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.474 0.654 . . . . 0.0 110.176 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 50.4 ttt180 -52.71 -44.3 66.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 110.216 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 158.58 -177.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.553 ' O ' ' CB ' ' B' ' 81' ' ' ALA . 2.3 mp -35.52 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.683 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.4 tt0 -70.06 -75.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.548 -1.345 . . . . 0.0 109.227 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -62.31 -40.26 95.74 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.567 ' OG ' ' N ' ' B' ' 26' ' ' ARG . 34.0 t -61.64 -39.6 91.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.055 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' B' ' 77' ' ' LEU . . . -57.44 -60.86 3.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.473 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 21.5 t -63.07 -35.05 78.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.905 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.748 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -73.51 -67.71 0.56 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 0.0 110.411 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' B' ' 80' ' ' SER . 26.2 m -53.59 -37.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.506 -1.371 . . . . 0.0 110.077 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 10.2 mmt180 -62.9 -43.35 99.02 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.559 -1.338 . . . . 0.0 107.898 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' B' ' 82' ' ' SER . 87.0 m-20 -84.0 -45.97 12.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.641 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.748 ' N ' ' O ' ' B' ' 83' ' ' ALA . 0.4 OUTLIER -125.18 84.06 2.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.36 -0.838 . . . . 0.0 110.315 -179.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.4 OUTLIER -110.47 -68.46 0.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' B' ' 88' ' ' ASN . . . -127.66 108.1 0.92 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -139.42 147.55 41.57 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.468 -1.607 . . . . 0.0 108.843 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.6 tp60 -31.32 89.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.556 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 90' ' ' TYR . 60.0 tp -148.89 135.22 19.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.09 -1.006 . . . . 0.0 109.531 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 45.86 -168.74 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 36.7 m -64.83 -25.18 67.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.492 -1.004 . . . . 0.0 110.345 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.913 ' NH2' " H4'" ' A' ' 8' ' ' ' A' . 1.1 mmm180 -131.3 160.67 34.27 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.213 -0.929 . . . . 0.0 109.2 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' B' ' 97' ' ' LEU . 6.8 m-85 -95.18 138.89 32.27 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.624 -0.673 . . . . 0.0 110.148 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -43.89 157.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.67 159.84 38.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 109.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' CYS . . . . . 0.578 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.5 OUTLIER -110.49 129.14 55.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.393 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.4 -165.8 13.59 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.531 -1.318 . . . . 0.0 110.824 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.526 ' N ' ' OH ' ' B' ' 29' ' ' TYR . 30.2 p90 -130.53 171.29 13.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.635 -0.92 . . . . 0.0 109.452 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 5.8 t 179.79 27.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 109.964 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 28.1 t -137.48 141.2 41.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 109.395 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.541 ' ND2' ' C ' ' B' ' 104' ' ' ASN . 0.2 OUTLIER -118.86 -17.8 9.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.496 -0.752 . . . . 0.0 109.596 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.439 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 157' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' C' ' 157' ' ' GLU . 58.4 mp0 -106.84 154.7 20.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.794 . . . . 0.0 109.445 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 158' ' ' SER . . . . . 0.53 ' C ' ' SG ' ' C' ' 159' ' ' CYS . 23.9 t -142.06 162.01 36.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 109.716 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 159' ' ' CYS . . . . . 0.53 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 61.84 14.45 6.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.321 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -102.28 99.24 9.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 3.4 mmm -71.24 151.89 43.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 110.027 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 162' ' ' PHE . . . . . 0.708 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 25.6 t80 -126.37 78.3 1.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 163' ' ' ILE . . . . . 0.454 ' O ' ' O2 ' ' A' ' 5' ' ' ' U' . 4.1 mm -49.94 137.25 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' C' ' 166' ' ' LEU . . . -140.18 172.32 23.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.06 11.44 0.12 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 166' ' ' LEU . . . . . 0.584 ' H ' ' C ' ' C' ' 164' ' ' GLY . 1.2 pp -62.27 163.96 7.68 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.929 . . . . 0.0 109.353 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 167' ' ' ASN . . . . . 0.462 ' O ' ' C ' ' C' ' 168' ' ' TRP . 22.5 t-20 -68.68 123.99 22.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.935 -1.103 . . . . 0.0 109.503 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 168' ' ' TRP . . . . . 0.63 ' CH2' ' C4 ' ' A' ' 4' ' ' ' A' . 3.8 m-90 -37.74 -33.24 0.07 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.784 -0.572 . . . . 0.0 110.437 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 169' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' C' ' 167' ' ' ASN . 23.6 t70 -101.33 99.21 9.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.949 -1.095 . . . . 0.0 111.112 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 3.0 m -157.19 116.12 3.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.26 -0.9 . . . . 0.0 109.314 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 171' ' ' THR . . . . . 0.538 ' O ' ' OD1' ' C' ' 174' ' ' ASN . 0.0 OUTLIER -75.5 173.89 10.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.783 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 172' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -75.47 -71.92 0.34 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.348 -0.845 . . . . 0.0 110.252 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' C' ' 176' ' ' ARG . 91.5 m-20 -38.34 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 174' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' C' ' 175' ' ' LEU . 29.6 p-10 -36.1 -44.83 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.709 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' C' ' 174' ' ' ASN . 5.3 tt -54.79 -46.39 74.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 176' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' C' ' 178' ' ' TYR . 60.9 ttp85 -72.15 -60.34 2.28 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.009 -1.057 . . . . 0.0 108.72 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 177' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' C' ' 176' ' ' ARG . 78.1 mm-40 -40.06 -22.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.067 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 178' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' C' ' 176' ' ' ARG . 16.3 t80 -95.24 -36.57 11.38 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.729 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 179' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' C' ' 176' ' ' ARG . 12.6 m-85 -90.02 12.59 17.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.094 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 180' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' C' ' 182' ' ' TYR . . . -61.28 -55.87 26.81 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.035 -1.041 . . . . 0.0 111.174 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.82 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.765 -1.433 . . . . 0.0 112.048 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 182' ' ' TYR . . . . . 0.634 ' H ' ' C ' ' C' ' 180' ' ' GLY . 22.3 m-85 -107.48 -3.93 18.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.999 -1.063 . . . . 0.0 109.567 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.87 -165.34 27.3 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 184' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' C' ' 208' ' ' GLU . 0.1 OUTLIER -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.286 . . . . 0.0 108.522 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.29 129.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 186' ' ' THR . . . . . 0.543 ' H ' ' HG1' ' C' ' 186' ' ' THR . 0.6 OUTLIER -90.17 -51.42 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.962 . . . . 0.0 109.414 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -149.84 160.91 43.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp -157.62 143.05 17.13 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.22 -1.55 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -117.14 161.25 19.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.142 -0.974 . . . . 0.0 108.774 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 176.78 104.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 191' ' ' MET . . . . . 0.552 ' O ' ' C ' ' C' ' 192' ' ' LYS . 12.9 mtm -122.4 80.04 1.68 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 110.885 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 192' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' C' ' 191' ' ' MET . 41.5 mttp -24.07 -83.66 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 193' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -153.26 152.5 27.87 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.963 . . . . 0.0 109.233 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.55 -57.64 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.166 1.911 . . . . 0.0 112.303 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.48 ' O ' ' C ' ' C' ' 196' ' ' THR . . . -175.53 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 109.071 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 196' ' ' THR . . . . . 0.48 ' C ' ' O ' ' C' ' 195' ' ' ALA . 37.3 p -28.44 -72.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.84 -55.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 198' ' ' ARG . . . . . 0.622 ' CZ ' ' CZ2' ' C' ' 168' ' ' TRP . 18.2 ptt180 -169.33 158.75 8.32 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 199' ' ' SER . . . . . 0.552 ' O ' ' N ' ' C' ' 201' ' ' GLY . 90.3 p -156.42 170.3 22.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.0 -1.063 . . . . 0.0 109.417 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 200' ' ' ARG . . . . . 0.659 ' CB ' " H4'" ' A' ' 5' ' ' ' U' . 0.0 OUTLIER -26.56 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.436 0.636 . . . . 0.0 110.735 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 201' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.33 109.35 2.78 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.576 ' HB3' " H1'" ' A' ' 5' ' ' ' U' . 13.0 p90 -129.56 166.67 19.24 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.785 -0.832 . . . . 0.0 108.783 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -137.65 130.02 4.9 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.171 -1.49 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -104.08 115.55 30.62 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.607 -1.525 . . . . 0.0 107.596 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 3.5 mt -115.32 97.02 5.95 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.838 0.828 . . . . 0.0 109.967 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 2.4 m -69.31 80.6 0.36 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.284 0.564 . . . . 0.0 109.651 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . 0.65 ' O ' ' O ' ' C' ' 208' ' ' GLU . 44.2 m-85 -79.56 123.6 27.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 110.943 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 208' ' ' GLU . . . . . 0.65 ' O ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -36.59 -103.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.621 ' H ' ' CG ' ' C' ' 208' ' ' GLU . 9.4 ptmt -51.39 160.6 0.93 Allowed Pre-proline 0 C--N 1.298 -1.665 0 O-C-N 119.744 -1.847 . . . . 0.0 108.326 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -94.85 14.07 1.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.614 2.209 . . . . 0.0 112.478 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' SER . . . . . 0.636 ' HG ' ' N ' ' C' ' 212' ' ' SER . 60.0 p -82.64 -51.16 7.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.636 ' N ' ' HG ' ' C' ' 211' ' ' SER . 60.6 p -39.58 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.47 -0.769 . . . . 0.0 109.317 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' C' ' 211' ' ' SER . 4.1 m -66.28 -37.96 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.962 -1.086 . . . . 0.0 108.31 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' C' ' 211' ' ' SER . 89.9 m-20 -65.19 -49.83 68.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.3 -39.74 94.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 108.68 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' C' ' 212' ' ' SER . 47.7 t -56.49 -49.18 78.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.96 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' C' ' 219' ' ' THR . 13.1 p -82.83 -31.45 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.868 -1.145 . . . . 0.0 111.264 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -74.17 12.87 0.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.933 -1.104 . . . . 0.0 109.697 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.46 ' H ' ' C ' ' C' ' 217' ' ' VAL . 15.8 m -131.28 142.58 50.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.349 -0.844 . . . . 0.0 108.885 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -107.23 67.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 108.973 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' HIS . . . . . 0.796 ' H ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -55.54 163.95 1.16 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.706 -0.621 . . . . 0.0 109.95 -179.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' C' ' 226' ' ' LYS . 0.2 OUTLIER -142.14 74.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.902 0.858 . . . . 0.0 108.789 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -49.08 -71.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.233 -0.917 . . . . 0.0 110.67 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' C' ' 224' ' ' ASP . 58.3 t0 -89.81 12.19 17.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.75 -1.219 . . . . 0.0 109.606 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 81.01 17.12 73.06 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' C' ' 222' ' ' ILE . 27.3 mmtp -95.16 -153.94 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.4 90.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.071 -1.018 . . . . 0.0 109.921 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 34.0 pt -84.97 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -114.63 96.61 44.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.362 -0.837 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 230' ' ' PRO . . . . . 0.573 ' CG ' ' HE2' ' C' ' 221' ' ' HIS . 1.7 Cg_endo -74.65 125.67 9.67 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.384 2.056 . . . . 0.0 111.704 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.64 134.3 35.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 109.767 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -62.73 148.84 45.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.322 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -46.91 139.86 5.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.992 . . . . 0.0 109.196 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . 0.425 HD11 HG21 ' C' ' 234' ' ' ILE . 28.6 mt -121.84 127.51 25.97 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.52 -0.737 . . . . 0.0 109.491 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.84 147.78 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.874 1.716 . . . . 0.0 112.276 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -58.66 -38.43 78.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.86 -41.42 74.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 109.134 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 238' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' C' ' 238' ' ' GLU . 9.1 mp0 -71.79 -39.91 69.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.912 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 239' ' ' GLN . . . . . 0.687 HE22 HO2' ' A' ' 6' ' ' ' A' . 9.2 tt0 -58.98 -43.68 91.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.17 -41.89 76.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 241' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' C' ' 242' ' ' THR . 16.0 ttmm -61.08 -45.38 94.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.124 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 242' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 50.0 p -40.63 139.28 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.148 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.67 143.35 17.78 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -118.71 130.26 55.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.86 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 245' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.57 143.43 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 246' ' ' PHE . . . . . 0.519 ' CD2' ' N3 ' ' A' ' 2' ' ' ' A' . 6.9 t80 -104.14 128.57 51.81 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.48 0.657 . . . . 0.0 109.975 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 14.1 t -100.63 133.07 45.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.951 0.881 . . . . 0.0 110.392 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.64 158.32 14.4 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.07 83.0 0.2 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.063 -1.257 . . . . 0.0 110.542 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 250' ' ' ILE . . . . . . . . . . . . . 3.7 mm -127.37 127.86 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -1.108 . . . . 0.0 108.855 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 251' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' C' ' 254' ' ' VAL . . . -52.61 111.87 1.83 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.92 -20.86 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.802 1.668 . . . . 0.0 111.66 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -96.52 16.17 19.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.479 -0.763 . . . . 0.0 109.265 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 254' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' C' ' 251' ' ' GLY . 48.8 t -97.86 135.62 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.96 163.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 108.964 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.36 -25.89 80.8 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.653 2.235 . . . . 0.0 112.09 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -50.03 -62.74 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.233 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 258' ' ' GLU . . . . . 0.626 ' O ' ' N ' ' C' ' 261' ' ' GLU . 77.3 mm-40 -60.43 -74.18 0.08 Allowed 'General case' 0 C--O 1.194 -1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 108.51 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 259' ' ' PHE . . . . . 0.575 ' C ' ' O ' ' C' ' 258' ' ' GLU . 89.1 t80 -16.82 -67.51 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.889 0.852 . . . . 0.0 111.045 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -61.24 -44.65 96.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 109.51 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 261' ' ' GLU . . . . . 0.626 ' N ' ' O ' ' C' ' 258' ' ' GLU . 35.5 tp10 -68.37 -7.68 33.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 262' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' C' ' 263' ' ' PHE . 13.9 t80 -92.76 -76.45 0.46 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 263' ' ' PHE . . . . . 0.561 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 82.4 m-85 -45.74 -33.57 3.1 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.093 -1.443 . . . . 0.0 109.466 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 264' ' ' SER . . . . . 0.476 ' HG ' ' C ' ' C' ' 261' ' ' GLU . 48.1 p -34.6 -37.5 0.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.942 -0.474 . . . . 0.0 111.786 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 265' ' ' GLN . . . . . 0.573 ' C ' ' H ' ' C' ' 267' ' ' GLY . 0.2 OUTLIER -58.52 -95.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.19 -1.569 . . . . 0.0 110.118 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 266' ' ' TRP . . . . . 0.679 ' CD1' ' O ' ' C' ' 266' ' ' TRP . 0.6 OUTLIER -69.92 19.25 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.025 -1.047 . . . . 0.0 109.38 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 267' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' C' ' 265' ' ' GLN . . . -136.17 128.16 4.45 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 268' ' ' THR . . . . . 0.528 ' O ' ' C ' ' C' ' 269' ' ' ILE . 58.1 p -85.5 6.6 26.27 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.365 -1.079 . . . . 0.0 109.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 269' ' ' ILE . . . . . 0.528 ' C ' ' O ' ' C' ' 268' ' ' THR . 5.4 pt -14.67 96.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 122.451 1.119 . . . . 0.0 113.865 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.85 -35.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -135.94 94.87 3.12 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 272' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -137.81 172.05 13.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 273' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 7.7 tt0 164.99 156.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.563 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 274' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 16.3 tp -97.0 140.63 31.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -90.4 156.33 18.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.564 -1.335 . . . . 0.0 108.686 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.67 -169.22 3.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.125 -0.984 . . . . 0.0 109.397 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 277' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 36.8 p-10 -61.84 -38.38 88.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 278' ' ' LYS . . . . . 0.583 ' N ' ' OD1' ' C' ' 277' ' ' ASP . 13.3 tttp -63.29 -42.8 99.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 279' ' ' ASP . . . . . 0.412 ' O ' ' N1 ' ' A' ' 4' ' ' ' A' . 87.3 m-20 -66.76 -61.03 2.17 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.114 -0.991 . . . . 0.0 109.243 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 178.74 129.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.1 -118.78 5.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 282' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.3 tt0 -166.37 150.33 7.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.311 . . . . 0.0 111.009 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 283' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' C' ' 283' ' ' SER . 4.5 t -62.17 66.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 110.213 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 284' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' C' ' 282' ' ' GLN . 72.3 mtt85 -55.77 -22.28 23.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 137.73 12.81 0.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.945 ' CD1' " H4'" ' A' ' 2' ' ' ' A' . 32.4 p90 -106.5 165.09 11.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 110.534 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.71 178.99 37.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -134.61 154.44 51.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.441 -1.623 . . . . 0.0 109.725 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.01 138.04 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 290' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' C' ' 269' ' ' ILE . 10.1 m -123.0 126.0 46.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.96 -1.088 . . . . 0.0 109.943 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 291' ' ' TYR . . . . . 0.469 ' CE1' ' CA ' ' C' ' 267' ' ' GLY . 41.0 m-85 -113.55 133.09 55.45 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 292' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' C' ' 293' ' ' SER . 25.9 p-10 -53.02 -46.22 68.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.625 -1.297 . . . . 0.0 108.767 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 293' ' ' SER . . . . . 0.567 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 67.3 m -88.15 164.75 15.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.11 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 294' ' ' ALA . . . . . 0.406 ' O ' ' CG1' ' C' ' 297' ' ' VAL . . . -102.83 -22.38 13.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -50.08 -38.51 38.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.005 -1.06 . . . . 0.0 108.535 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.69 31.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 297' ' ' VAL . . . . . 0.575 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 1.4 p -54.99 -54.95 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.339 -1.476 . . . . 0.0 108.242 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 298' ' ' ASP . . . . . 0.416 ' H ' HG13 ' C' ' 297' ' ' VAL . 92.4 m-20 -57.84 -19.5 29.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.895 -1.128 . . . . 0.0 109.606 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -76.9 -58.37 3.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 108.877 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 300' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' C' ' 303' ' ' ASN . 7.2 p -68.11 -25.22 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 301' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 65.6 m -43.9 -52.07 7.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.115 -0.991 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -50.92 -22.21 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 303' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' C' ' 300' ' ' VAL . 20.1 t-20 -100.13 65.76 1.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.0 109.446 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 304' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' C' ' 303' ' ' ASN . 55.7 tttp -46.17 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.688 -1.257 . . . . 0.0 108.753 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 305' ' ' PHE . . . . . 0.644 ' CE1' ' CG ' ' C' ' 314' ' ' GLU . 90.9 m-85 -76.79 133.93 39.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.5 mt -130.39 148.34 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.369 -0.832 . . . . 0.0 109.019 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 307' ' ' ASP . . . . . 0.571 ' OD1' ' NZ ' ' C' ' 312' ' ' LYS . 78.1 m-20 -76.66 123.97 26.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 108.608 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 308' ' ' PHE . . . . . 0.579 ' O ' ' N ' ' C' ' 310' ' ' ASP . 52.6 t80 -123.44 173.16 8.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -0.873 . . . . 0.0 109.345 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 309' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -40.45 -23.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 310' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 46.0 t0 -94.23 -154.5 0.42 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 311' ' ' ARG . . . . . 0.601 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 87.8 mtt180 -79.0 -55.71 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 312' ' ' LYS . . . . . 0.571 ' NZ ' ' OD1' ' C' ' 307' ' ' ASP . 24.9 tptt -157.37 147.04 20.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.176 -0.953 . . . . 0.0 109.183 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 313' ' ' ILE . . . . . 0.431 HG22 HD12 ' C' ' 313' ' ' ILE . 41.7 pt -129.85 147.64 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.877 . . . . 0.0 109.229 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 314' ' ' GLU . . . . . 0.644 ' CG ' ' CE1' ' C' ' 305' ' ' PHE . 85.2 mt-10 -99.43 144.31 28.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 315' ' ' ILE . . . . . . . . . . . . . 36.2 mt -118.39 147.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.909 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -155.58 148.23 24.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.001 . . . . 0.0 108.976 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 317' ' ' ARG . . . . . 0.441 ' CB ' ' NH1' ' C' ' 317' ' ' ARG . 5.7 ptm85 -68.77 152.49 45.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.948 -1.095 . . . . 0.0 109.579 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.57 93.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 109.109 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 319' ' ' GLU . . . . . 0.472 ' O ' ' C ' ' C' ' 320' ' ' PRO . 3.2 mm-40 -128.28 74.57 79.54 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.632 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 320' ' ' PRO . . . . . 0.472 ' C ' ' O ' ' C' ' 319' ' ' GLU . 98.9 Cg_exo -26.09 -67.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.984 2.456 . . . . 0.0 112.955 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 321' ' ' ARG . . . . . 0.477 ' O ' ' OXT' ' C' ' 322' ' ' HIS . 36.6 mmm-85 -122.85 89.85 3.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.328 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 322' ' ' HIS . . . . . 0.477 ' OXT' ' O ' ' C' ' 321' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.74 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.424 0.63 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.28 175.2 3.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.956 2.437 . . . . 0.0 111.827 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.36 -2.88 9.37 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.825 2.35 . . . . 0.0 113.117 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' B' ' 77' ' ' LEU . 60.0 p -156.77 136.98 12.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.908 -1.12 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -179.12 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.529 0.68 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' B' ' 73' ' ' GLU . 2.4 t -128.05 163.48 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.891 . . . . 0.0 109.953 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.44 136.63 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 108.404 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.459 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 10.3 m-30 -106.78 119.49 39.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.017 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' B' ' 33' ' ' ILE . 1.7 mm? -106.61 105.45 15.48 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -107.03 -72.79 0.81 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.84 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.497 ' HB3' ' H ' ' B' ' 95' ' ' ARG . 7.8 t -69.2 82.71 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.929 -1.336 . . . . 0.0 110.014 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' B' ' 30' ' ' LEU . 3.7 mp -144.94 121.29 6.09 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' B' ' 36' ' ' ASP . 30.0 Cg_endo -69.72 164.35 34.83 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.515 1.477 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -59.73 2.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.589 -0.694 . . . . 0.0 109.468 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' B' ' 34' ' ' PRO . 89.3 m-20 -63.99 -39.16 93.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.23 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.548 ' OE1' HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -124.4 113.98 18.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.581 -0.699 . . . . 0.0 109.158 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.4 p -110.05 -139.88 0.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 111.2 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.43 ' C ' ' CD ' ' B' ' 39' ' ' GLU . 0.5 OUTLIER -63.02 -29.45 70.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.962 -1.086 . . . . 0.0 110.794 -178.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -71.18 -54.39 11.18 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.343 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -49.05 64.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' B' ' 44' ' ' ASP . 24.1 mm -55.33 -52.58 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 42' ' ' ILE . 42.0 tp -37.6 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.839 -0.538 . . . . 0.0 110.846 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' B' ' 42' ' ' ILE . 88.8 m-20 -123.5 -24.75 4.51 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.585 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.749 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.2 tm? -57.64 -39.44 76.98 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 119.905 -1.747 . . . . 0.0 106.612 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.623 ' O ' ' N ' ' B' ' 48' ' ' ASN . 0.8 OUTLIER -84.48 -63.68 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.801 . . . . 0.0 109.289 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.758 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.7 t -38.8 -21.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.797 -0.564 . . . . 0.0 109.798 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.623 ' N ' ' O ' ' B' ' 46' ' ' CYS . 3.3 m-20 -50.36 68.9 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.893 0.854 . . . . 0.0 110.511 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.758 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.51 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.804 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.36 -155.7 19.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.75 159.83 38.24 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.325 2.016 . . . . 0.0 112.327 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.821 HG12 ' H ' ' B' ' 53' ' ' ILE . 3.0 t -120.92 -152.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.821 ' H ' HG12 ' B' ' 52' ' ' VAL . 31.8 mm -151.91 -64.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.827 -1.171 . . . . 0.0 109.577 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.555 ' OD1' HG22 ' B' ' 53' ' ' ILE . 71.6 m-20 -126.65 146.56 50.14 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.645 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.575 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.5 OUTLIER -139.37 130.69 26.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.116 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.575 ' N ' HD23 ' B' ' 55' ' ' LEU . 61.3 mttp -137.08 144.59 43.2 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 108.827 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.91 135.24 39.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.5 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -158.39 166.88 31.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.416 -0.802 . . . . 0.0 109.202 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.442 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.1 OUTLIER -122.06 -168.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.559 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 25.2 p-10 -101.1 73.88 0.11 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 112.508 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.442 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 28.6 Cg_endo -67.68 -36.65 18.46 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.623 1.549 . . . . 0.0 111.222 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -101.99 -59.91 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.517 -0.74 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 75.5 p -48.7 -40.72 29.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.419 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' B' ' 60' ' ' ASP . . . 73.67 26.81 68.62 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.559 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 32.1 mtp180 -131.8 -68.01 0.66 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -1.115 . . . . 0.0 110.216 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' B' ' 60' ' ' ASP . 0.0 OUTLIER -50.01 120.39 4.36 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.832 0.825 . . . . 0.0 110.791 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.32 -74.61 0.43 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.066 -1.021 . . . . 0.0 108.699 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -115.69 94.7 0.67 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.52 130.49 55.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.039 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' B' ' 56' ' ' LYS . . . -142.41 138.86 31.41 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.356 -0.937 . . . . 0.0 109.574 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.496 ' C ' HD12 ' B' ' 72' ' ' ILE . 4.2 m-30 -105.68 122.98 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.905 HD12 ' N ' ' B' ' 72' ' ' ILE . 1.6 mp -118.17 98.81 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.294 -0.879 . . . . 0.0 111.485 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.709 ' HA ' HG13 ' B' ' 27' ' ' VAL . 83.8 tt0 -83.11 133.14 35.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.495 -1.378 . . . . 0.0 110.91 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.39 174.87 6.92 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.629 0.728 . . . . 0.0 110.996 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 11.7 ttt-85 -53.2 -42.36 66.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.708 -0.62 . . . . 0.0 110.967 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.5 m-20 160.7 179.19 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.777 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 9.3 mt -38.09 -22.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.856 -0.528 . . . . 0.0 109.63 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.7 mt-10 -70.23 -73.3 0.17 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.215 1.007 . . . . 0.0 109.324 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m -61.73 -40.93 96.84 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.824 -1.173 . . . . 0.0 108.297 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.3 m -62.54 -35.67 80.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.193 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.777 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -59.64 -56.66 19.09 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.598 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 70.2 m -65.25 -35.95 82.61 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.955 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.607 ' HB2' HG11 ' B' ' 49' ' ' VAL . . . -80.43 -61.86 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 110.9 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.583 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 41.5 t -56.16 -40.61 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.03 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' B' ' 81' ' ' ALA . 0.0 OUTLIER -68.14 -51.55 44.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.021 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' B' ' 82' ' ' SER . 81.4 m-20 -67.52 -44.21 78.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.633 ' O ' HD12 ' B' ' 87' ' ' LEU . 1.7 pp -139.98 121.45 15.1 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.129 -0.982 . . . . 0.0 110.15 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 84' ' ' VAL . 1.4 p30 -143.89 -56.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.11 104.35 0.77 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -138.11 146.39 42.81 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.537 -1.566 . . . . 0.0 108.255 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLN . . . . . 0.556 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 16.9 tp60 -33.72 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.508 -0.745 . . . . 0.0 111.217 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.548 HD11 ' OE1' ' B' ' 37' ' ' GLN . 62.5 tp -146.19 126.16 13.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.69 -147.62 48.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' SER . . . . . 0.418 ' CB ' ' OG ' ' B' ' 32' ' ' SER . 0.2 OUTLIER -92.36 -18.87 22.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.054 -1.263 . . . . 0.0 109.537 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' B' ' 92' ' ' LEU . 60.2 mtp180 -131.02 161.19 32.53 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.458 ' O ' ' C ' ' B' ' 97' ' ' LEU . 8.9 m-85 -94.57 137.41 33.73 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.2 -0.937 . . . . 0.0 110.072 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.574 ' H ' HD23 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -40.44 145.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -109.74 151.98 26.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 11.0 p -77.37 108.46 10.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.471 -0.768 . . . . 0.0 109.214 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -87.0 173.17 44.6 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 54.8 p90 -152.15 -32.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -1.065 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' SER . . . . . 0.62 ' O ' HG21 ' B' ' 27' ' ' VAL . 74.3 m -37.01 143.33 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.35 -0.844 . . . . 0.0 110.666 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 158' ' ' SER . . . . . 0.561 ' CB ' ' HE ' ' C' ' 232' ' ' ARG . 32.9 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.327 0.584 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 159' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.8 OUTLIER 170.36 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 160' ' ' LYS . . . . . 0.585 ' NZ ' ' NZ ' ' C' ' 189' ' ' LYS . 12.1 ttmm -83.7 140.22 32.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.036 -1.04 . . . . 0.0 108.275 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 2.4 ptm -125.78 169.92 12.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.952 -1.092 . . . . 0.0 109.323 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -121.5 80.8 1.72 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.567 -0.708 . . . . 0.0 109.693 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 163' ' ' ILE . . . . . 0.404 ' H ' HG12 ' C' ' 163' ' ' ILE . 1.7 mm -50.29 131.98 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.88 156.36 22.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.39 28.42 61.78 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.41 142.32 53.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.52 -0.988 . . . . 0.0 109.768 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' C' ' 169' ' ' ASP . 11.8 t-20 -69.27 140.89 54.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 168' ' ' TRP . . . . . 0.493 ' O ' ' OD1' ' C' ' 169' ' ' ASP . 7.5 m0 -63.63 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.069 -1.019 . . . . 0.0 110.307 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 169' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' C' ' 167' ' ' ASN . 57.4 m-20 -157.66 64.95 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.938 -1.102 . . . . 0.0 109.825 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 34.0 m -134.16 153.3 51.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.133 -0.98 . . . . 0.0 110.688 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.97 167.71 11.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.495 -0.753 . . . . 0.0 109.117 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.69 -67.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.754 -1.216 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -47.23 -36.13 8.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.034 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 174' ' ' ASN . . . . . 0.444 ' OD1' ' C ' ' C' ' 174' ' ' ASN . 1.6 t30 -69.74 -52.21 27.44 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.445 ' HB2' HD12 ' C' ' 190' ' ' ILE . 12.4 tp -55.46 -41.84 73.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 176' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' C' ' 177' ' ' GLU . 25.4 ttp85 -66.12 -60.43 2.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.103 -0.998 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 177' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -44.76 -31.35 1.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.231 -0.918 . . . . 0.0 108.783 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.715 ' CD2' HD12 ' C' ' 223' ' ' LEU . 21.8 t80 -76.01 -49.58 17.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.739 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.781 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.4 m-85 -72.16 -49.37 36.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.309 -0.869 . . . . 0.0 111.664 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.21 23.91 0.01 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 119.568 -1.958 . . . . 0.0 112.405 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 181' ' ' LYS . . . . . 0.781 ' N ' ' O ' ' C' ' 179' ' ' PHE . 4.9 ttpm? -90.24 -13.85 34.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.89 -1.359 . . . . 0.0 107.614 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 182' ' ' TYR . . . . . 0.609 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 32.0 m-85 -91.08 -62.69 1.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.4 -125.22 2.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 27.4 m -122.89 145.61 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -1.0 . . . . 0.0 109.86 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.409 HG21 HD11 ' C' ' 205' ' ' LEU . 14.2 p -127.66 142.61 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.424 HG23 ' N ' ' C' ' 187' ' ' ASP . 9.7 t -97.1 -37.47 10.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 110.337 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 187' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' C' ' 206' ' ' SER . 42.9 t0 -165.08 160.39 18.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.986 -1.071 . . . . 0.0 110.202 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.36 147.71 22.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 189' ' ' LYS . . . . . 0.585 ' NZ ' ' NZ ' ' C' ' 160' ' ' LYS . 23.6 mttp -114.86 90.85 3.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 110.175 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 190' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' C' ' 175' ' ' LEU . 10.3 tt -84.79 142.35 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 191' ' ' MET . . . . . 0.533 ' O ' ' C ' ' C' ' 192' ' ' LYS . 0.0 OUTLIER -98.85 -47.56 5.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.188 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 192' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' C' ' 191' ' ' MET . 0.1 OUTLIER -30.8 124.53 0.19 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.636 0.732 . . . . 0.0 110.214 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.438 ' CG ' ' OG1' ' C' ' 196' ' ' THR . 15.7 t0 -134.45 87.16 33.13 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.13 -22.62 75.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.312 2.008 . . . . 0.0 111.389 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.41 -52.51 15.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.627 -0.67 . . . . 0.0 109.894 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 196' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' C' ' 193' ' ' ASP . 3.0 p -70.61 -35.9 73.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 109.78 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 153.9 -76.22 0.22 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -168.65 155.1 7.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -1.18 . . . . 0.0 110.171 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 199' ' ' SER . . . . . 0.428 ' O ' ' C ' ' C' ' 200' ' ' ARG . 23.0 t -151.68 168.73 24.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' C' ' 199' ' ' SER . 14.1 mmp_? -46.44 143.52 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.937 -1.102 . . . . 0.0 108.286 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.27 91.25 1.42 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.121 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' C' ' 202' ' ' PHE . 25.1 p90 -152.25 167.17 29.47 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.38 130.99 3.32 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 118.149 -1.977 . . . . 0.0 110.766 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.14 120.7 29.74 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 119.992 -1.887 . . . . 0.0 107.271 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.409 HD11 HG21 ' C' ' 185' ' ' VAL . 0.1 OUTLIER -108.33 104.79 14.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 109.148 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 206' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.4 OUTLIER -80.44 73.08 7.35 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.543 0.687 . . . . 0.0 109.606 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' C' ' 216' ' ' VAL . 10.3 m-85 -67.95 114.74 6.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.981 -1.074 . . . . 0.0 109.408 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.75 -48.03 83.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 108.947 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' C' ' 211' ' ' SER . 1.8 mtmp? -84.36 101.3 1.41 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.992 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -39.38 -23.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 121.871 1.714 . . . . 0.0 112.704 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.473 ' N ' ' O ' ' C' ' 209' ' ' LYS . 17.9 t -62.26 -57.1 12.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.013 -1.054 . . . . 0.0 110.585 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.751 ' O ' HG23 ' C' ' 216' ' ' VAL . 24.7 m -41.51 -34.91 0.62 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.29 -0.881 . . . . 0.0 109.53 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 213' ' ' VAL . . . . . 0.611 ' O ' HG12 ' C' ' 217' ' ' VAL . 86.6 t -65.97 -43.02 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 214' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' C' ' 211' ' ' SER . 61.8 t0 -60.83 -50.64 72.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 0.0 110.506 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 215' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' C' ' 219' ' ' THR . 19.7 pt-20 -73.63 -31.83 63.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.967 -1.083 . . . . 0.0 109.972 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.751 HG23 ' O ' ' C' ' 212' ' ' SER . 22.6 t -61.48 -50.99 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.747 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.611 HG12 ' O ' ' C' ' 213' ' ' VAL . 8.5 p -74.02 -29.9 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.511 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -85.01 17.48 2.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.495 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 219' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' C' ' 215' ' ' GLU . 32.0 m -136.43 147.3 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.921 -1.112 . . . . 0.0 109.46 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -102.63 136.33 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.248 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.705 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -139.82 167.65 21.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.858 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.0 107.2 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.825 . . . . 0.0 108.899 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.715 HD12 ' CD2' ' C' ' 178' ' ' TYR . 1.0 OUTLIER -73.43 -71.96 0.29 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 109.796 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 224' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 60.2 t0 -84.95 0.45 51.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.039 -1.038 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.03 13.23 72.21 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 226' ' ' LYS . . . . . 0.866 ' O ' HG13 ' C' ' 227' ' ' VAL . 1.2 tpmt? -90.09 -78.76 0.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -1.019 . . . . 0.0 109.325 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 227' ' ' VAL . . . . . 0.866 HG13 ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 174.75 109.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.251 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 228' ' ' ILE . . . . . 0.416 HD13 HG21 ' C' ' 228' ' ' ILE . 17.9 pt -113.96 148.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.706 -0.621 . . . . 0.0 110.132 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.43 96.68 38.36 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 230' ' ' PRO . . . . . 0.441 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 46.8 Cg_endo -85.4 125.31 2.93 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.564 2.176 . . . . 0.0 112.028 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -141.18 143.05 34.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.699 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.561 ' HE ' ' CB ' ' C' ' 158' ' ' SER . 75.1 ttt-85 -57.45 153.96 11.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 108.591 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 233' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -44.31 137.57 3.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 108.856 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.92 135.99 22.51 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.406 -0.809 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.24 139.19 16.39 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.809 1.672 . . . . 0.0 112.125 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.25 -44.58 88.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.518 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 237' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 34.0 p-10 -63.31 -38.65 91.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 109.856 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 238' ' ' GLU . . . . . 0.676 ' O ' HG23 ' C' ' 242' ' ' THR . 48.6 tp10 -66.0 -40.34 91.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.399 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 239' ' ' GLN . . . . . 0.467 ' O ' ' OG1' ' C' ' 242' ' ' THR . 14.3 tt0 -62.31 -43.91 97.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.1 -39.24 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.049 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -63.32 -39.53 94.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.936 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 242' ' ' THR . . . . . 0.7 HG22 ' HA ' ' C' ' 292' ' ' ASP . 66.9 p -50.76 141.65 12.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.851 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.09 160.5 14.74 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 244' ' ' LYS . . . . . 0.623 ' O ' ' HB2' ' C' ' 318' ' ' ALA . 22.9 tttt -136.37 133.39 36.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.243 . . . . 0.0 110.45 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.505 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -119.61 147.57 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.51 -0.744 . . . . 0.0 109.463 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 246' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 4.7 t80 -103.0 130.42 50.09 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 10.1 t -100.14 134.97 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.784 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 248' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 249' ' ' GLY . . . -105.89 155.85 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 249' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 248' ' ' GLY . . . 59.66 141.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.458 ' CG1' HG11 ' C' ' 254' ' ' VAL . 2.7 tp -162.5 164.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.427 -1.043 . . . . 0.0 109.158 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 251' ' ' GLY . . . . . 0.428 ' O ' HG23 ' C' ' 250' ' ' ILE . . . -54.82 155.03 8.86 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.81 -28.78 86.99 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.548 2.166 . . . . 0.0 112.119 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.69 73.98 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' C' ' 308' ' ' PHE . 8.5 p -111.05 134.58 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.638 0.732 . . . . 0.0 109.932 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -96.32 157.05 36.19 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -57.74 -21.75 49.49 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.593 2.196 . . . . 0.0 111.859 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -51.98 -63.66 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.605 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 258' ' ' GLU . . . . . 0.731 ' O ' ' N ' ' C' ' 261' ' ' GLU . 76.0 mm-40 -58.21 -88.11 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 259' ' ' PHE . . . . . 0.619 ' C ' ' O ' ' C' ' 258' ' ' GLU . 36.9 t80 -9.59 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.309 0.576 . . . . 0.0 111.449 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 260' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' C' ' 258' ' ' GLU . 96.9 mt-10 -56.71 -44.29 81.43 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.07 -1.019 . . . . 0.0 109.404 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 261' ' ' GLU . . . . . 0.731 ' N ' ' O ' ' C' ' 258' ' ' GLU . 76.3 mm-40 -69.44 -40.28 77.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 262' ' ' PHE . . . . . 0.417 ' O ' ' CG ' ' C' ' 265' ' ' GLN . 70.3 t80 -49.37 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.505 -0.747 . . . . 0.0 109.363 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.471 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 93.5 m-85 -55.39 -32.12 62.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.576 -1.328 . . . . 0.0 110.465 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.423 ' C ' ' O ' ' C' ' 263' ' ' PHE . 13.0 t -38.29 -38.32 0.35 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.822 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' C' ' 264' ' ' SER . 0.2 OUTLIER -52.11 -95.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.322 -1.486 . . . . 0.0 109.9 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.471 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -63.56 152.55 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.29 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 267' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 52.96 103.2 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 60.5 m -49.9 138.47 15.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.245 . . . . 0.0 107.785 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.619 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -99.63 104.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.103 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.5 -50.29 35.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.8 -1.187 . . . . 0.0 109.189 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 271' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' C' ' 290' ' ' THR . 57.4 t0 -142.36 98.05 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 109.611 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 272' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -128.25 166.39 18.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 109.419 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 273' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.1 OUTLIER 167.26 162.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.214 1.007 . . . . 0.0 111.367 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 5.9 tp -99.82 144.24 29.1 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 275' ' ' MET . . . . . 0.752 ' O ' HD22 ' C' ' 276' ' ' LEU . 23.0 mmm -92.01 160.02 15.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.195 -1.566 . . . . 0.0 108.304 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.752 HD22 ' O ' ' C' ' 275' ' ' MET . 0.3 OUTLIER -143.28 153.3 42.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 277' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' C' ' 281' ' ' GLY . 0.0 OUTLIER -49.73 -31.89 12.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 108.619 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 278' ' ' LYS . . . . . 0.51 ' O ' ' NZ ' ' C' ' 226' ' ' LYS . 57.4 tttp -54.99 -40.46 70.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.366 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 279' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' C' ' 275' ' ' MET . 91.3 m-20 -60.9 -37.4 82.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.35 -39.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.777 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 281' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' C' ' 277' ' ' ASP . . . 125.63 30.64 0.88 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' C' ' 284' ' ' ARG . 16.0 mm100 -119.4 42.72 2.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.352 -1.087 . . . . 0.0 110.13 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 283' ' ' SER . . . . . 0.467 ' O ' ' OG ' ' C' ' 283' ' ' SER . 6.6 t -62.51 39.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.247 -0.908 . . . . 0.0 110.032 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 284' ' ' ARG . . . . . 0.606 ' N ' ' O ' ' C' ' 282' ' ' GLN . 68.2 mtp85 -55.87 -34.17 65.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -0.974 . . . . 0.0 109.44 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.85 79.55 0.38 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' C' ' 282' ' ' GLN . 0.0 OUTLIER -146.75 -176.02 5.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.578 -1.542 . . . . 0.0 111.984 -178.249 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -157.89 164.65 33.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -138.06 151.02 47.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.951 -1.323 . . . . 0.0 108.55 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -146.29 141.97 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.433 -1.417 . . . . 0.0 108.389 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 290' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 23.9 m -130.12 129.24 43.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.044 -1.035 . . . . 0.0 109.988 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.98 156.0 27.04 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 292' ' ' ASP . . . . . 0.7 ' HA ' HG22 ' C' ' 242' ' ' THR . 54.2 p30 -79.95 15.54 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.733 -1.23 . . . . 0.0 109.714 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 22.7 t -158.76 168.57 26.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.195 -0.94 . . . . 0.0 108.985 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.05 -12.05 20.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -57.31 -48.32 79.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.469 -0.769 . . . . 0.0 109.162 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.22 88.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.047 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.08 -57.74 6.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.22 -30.23 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 299' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' C' ' 302' ' ' GLN . 59.2 ttm-85 -63.86 -64.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.44 -0.787 . . . . 0.0 109.325 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.439 ' HB ' ' HE1' ' C' ' 266' ' ' TRP . 9.0 p -65.54 -23.0 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.415 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 301' ' ' CYS . . . . . 0.498 ' SG ' ' NH1' ' C' ' 317' ' ' ARG . 45.0 t -48.24 -57.32 6.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.062 -1.024 . . . . 0.0 109.706 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 302' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' C' ' 299' ' ' ARG . 3.9 pt20 -49.45 -22.33 1.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.109 . . . . 0.0 108.515 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' C' ' 300' ' ' VAL . 92.4 m-20 -99.67 69.73 1.62 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.9 -82.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.672 -1.268 . . . . 0.0 108.869 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -69.63 126.6 30.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.162 -0.961 . . . . 0.0 109.493 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 59.6 mt -120.22 145.45 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.37 114.69 11.87 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' C' ' 309' ' ' LYS . 22.1 t80 -114.59 -178.08 3.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.578 ' C ' ' O ' ' C' ' 308' ' ' PHE . 73.8 mttt -19.75 -82.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 0.0 111.998 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 310' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' C' ' 311' ' ' ARG . 47.6 p30 -127.97 -16.41 4.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 110.201 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 311' ' ' ARG . . . . . 0.429 ' N ' ' OD1' ' C' ' 310' ' ' ASP . 40.1 mtp180 -121.2 125.81 48.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -52.77 164.96 0.31 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.43 -0.793 . . . . 0.0 109.398 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.59 122.85 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.83 103.79 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 0.0 109.68 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.505 ' CG2' HD12 ' C' ' 245' ' ' ILE . 5.6 mm -72.53 146.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.014 -1.054 . . . . 0.0 110.046 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -154.04 152.39 30.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 317' ' ' ARG . . . . . 0.705 ' CD ' ' H ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER -59.73 149.69 30.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 108.998 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 318' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' C' ' 244' ' ' LYS . . . -50.77 -25.32 4.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.899 -1.126 . . . . 0.0 108.921 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 179.232 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.57 ' O ' ' CG ' ' B' ' 101' ' ' TYR . 16.1 Cg_exo -63.05 -176.92 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.819 2.346 . . . . 0.0 111.84 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 23' ' ' PRO . 71.0 Cg_endo -86.9 25.79 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.91 2.407 . . . . 0.0 112.811 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.58 107.22 2.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.907 -1.121 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.475 ' CA ' ' OG ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -162.74 -40.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' B' ' 28' ' ' VAL . 1.2 p -139.56 158.0 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.664 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.436 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.9 t -108.59 134.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 9.1 m-30 -99.51 117.08 33.12 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.603 0.716 . . . . 0.0 109.682 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.73 HD11 HD23 ' B' ' 97' ' ' LEU . 1.1 mm? -101.98 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' B' ' 33' ' ' ILE . . . -146.75 -53.84 0.02 OUTLIER Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.986 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 27.6 t -69.5 30.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -1.21 . . . . 0.0 109.981 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.642 HD12 ' N ' ' B' ' 33' ' ' ILE . 4.9 mp -108.71 136.37 19.98 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -87.64 -176.01 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.743 1.629 . . . . 0.0 111.444 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.606 ' OH ' ' CG ' ' B' ' 59' ' ' PHE . 3.0 m-30 -67.1 0.45 2.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.73 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -67.08 -45.27 77.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.964 -1.085 . . . . 0.0 108.968 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -107.25 100.32 9.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.236 -0.915 . . . . 0.0 109.09 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -98.57 -153.95 0.45 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.651 -0.656 . . . . 0.0 110.079 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 40.2 tt0 -57.22 -26.29 60.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.141 -0.974 . . . . 0.0 109.884 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.7 -56.84 6.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.507 -0.746 . . . . 0.0 110.997 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -41.63 80.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.948 . . . . 0.0 111.479 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.4 ' N ' HD13 ' B' ' 42' ' ' ILE . 6.0 mm -63.19 -52.28 60.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' B' ' 47' ' ' SER . 32.4 tp -58.5 -36.63 74.08 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -55.34 -74.77 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.416 1.103 . . . . 0.0 109.979 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -45.63 90.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.089 -177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' B' ' 48' ' ' ASN . 96.6 m -61.59 -68.67 0.3 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.003 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 87.7 p -33.39 -31.41 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.0 OUTLIER -78.37 -43.35 27.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.976 -1.078 . . . . 0.0 109.431 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.638 HG21 HD11 ' B' ' 87' ' ' LEU . 13.2 t -43.4 -56.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.564 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.9 -158.79 11.63 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.938 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' B' ' 52' ' ' VAL . 57.9 Cg_endo -79.9 82.08 2.59 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.798 2.332 . . . . 0.0 112.788 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.556 ' O ' ' O ' ' B' ' 51' ' ' PRO . 0.3 OUTLIER -51.08 -166.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.49 ' H ' HG12 ' B' ' 52' ' ' VAL . 0.7 OUTLIER -160.09 -57.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.448 ' OD1' ' OE1' ' B' ' 73' ' ' GLU . 20.0 m120 -117.91 132.64 56.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.428 HD12 ' N ' ' B' ' 56' ' ' LYS . 16.9 tp -133.0 126.36 31.77 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.428 ' N ' HD12 ' B' ' 55' ' ' LEU . 59.4 mttp -138.7 138.0 37.33 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.068 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' B' ' 70' ' ' ALA . 1.8 tpt -127.9 134.32 49.35 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' MET . . . . . 0.599 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.1 OUTLIER -153.66 150.13 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 109.87 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.606 ' CG ' ' OH ' ' B' ' 35' ' ' TYR . 4.0 m-85 -106.33 -177.54 3.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.345 -0.847 . . . . 0.0 109.555 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.643 ' CG ' ' H ' ' B' ' 66' ' ' SER . 13.6 m-20 -103.98 71.89 0.17 Allowed Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.908 -1.12 . . . . 0.0 111.939 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 17.0 Cg_exo -49.22 -65.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.239 1.959 . . . . 0.0 112.88 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -85.2 -54.14 4.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.429 -0.794 . . . . 0.0 110.255 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.42 ' C ' ' H ' ' B' ' 65' ' ' ARG . 62.4 p -51.99 -38.4 56.6 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.224 -0.923 . . . . 0.0 108.751 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' B' ' 60' ' ' ASP . . . 60.73 3.24 3.05 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' B' ' 63' ' ' THR . 83.0 mtt85 -65.83 -37.8 87.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.387 -1.067 . . . . 0.0 111.138 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.643 ' H ' ' CG ' ' B' ' 60' ' ' ASP . 0.8 OUTLIER -155.4 150.12 26.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.379 -1.451 . . . . 0.0 112.305 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -115.98 77.97 1.14 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.65 54.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' B' ' 66' ' ' SER . 2.5 m-85 -104.48 127.33 52.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 108.602 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.693 ' HB2' ' SD ' ' B' ' 57' ' ' MET . . . -144.35 145.85 32.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.441 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -124.77 129.63 50.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 109.775 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.49 108.67 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.701 -0.799 . . . . 0.0 111.701 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.448 ' OE1' ' OD1' ' B' ' 54' ' ' ASN . 31.9 tt0 -92.9 134.12 35.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.352 -1.468 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -96.66 171.63 8.41 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.858 0.837 . . . . 0.0 110.415 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' B' ' 76' ' ' ASP . 4.0 tpt180 -42.88 -40.84 3.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.785 -0.572 . . . . 0.0 112.322 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' B' ' 78' ' ' GLU . 17.8 t70 166.61 -177.73 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.35 0.595 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.791 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.0 mm? -39.58 -21.88 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.072 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.2 mm-40 -70.59 -74.42 0.14 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.753 -1.217 . . . . 0.0 109.096 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 29.8 m -60.87 -41.89 96.86 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.55 ' O ' HG23 ' B' ' 84' ' ' VAL . 0.1 OUTLIER -62.35 -29.93 70.81 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.076 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.791 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -67.23 -60.91 2.21 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.947 -1.095 . . . . 0.0 108.461 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.589 ' O ' ' OD1' ' B' ' 86' ' ' ASN . 59.0 m -61.51 -45.77 92.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.452 -0.78 . . . . 0.0 110.792 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.566 ' CB ' HG11 ' B' ' 49' ' ' VAL . . . -68.46 -67.31 0.48 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.62 HG12 ' ND2' ' B' ' 88' ' ' ASN . 16.1 t -49.73 -31.77 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.8 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.582 ' HE ' ' C ' ' B' ' 81' ' ' ALA . 76.2 mtm180 -65.0 -52.44 56.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 109.559 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.589 ' OD1' ' O ' ' B' ' 82' ' ' SER . 0.0 OUTLIER -75.08 -42.8 56.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 117.973 -1.491 . . . . 0.0 108.183 178.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.638 HD11 HG21 ' B' ' 49' ' ' VAL . 17.1 mt -79.63 -2.08 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 110.185 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.62 ' ND2' HG12 ' B' ' 84' ' ' VAL . 0.5 OUTLIER -48.51 -82.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.55 114.9 1.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.989 ' CE1' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -139.71 149.76 44.03 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 119.936 1.868 . . . . 0.0 110.821 -179.169 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -47.87 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.102 -1.624 . . . . 0.0 110.044 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -154.71 113.09 3.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.247 -0.908 . . . . 0.0 108.627 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.55 -171.83 36.86 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 44.9 m -79.44 -14.74 58.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.899 -1.353 . . . . 0.0 109.929 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.435 ' N ' ' OG ' ' B' ' 32' ' ' SER . 14.8 ttm180 -146.78 163.64 35.36 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.3 m-85 -93.41 127.36 39.0 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.867 -1.146 . . . . 0.0 110.502 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.989 HD11 ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -41.37 156.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.383 0.611 . . . . 0.0 109.482 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -111.27 149.23 31.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.568 -0.708 . . . . 0.0 110.124 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' OD1' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -75.07 113.69 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.777 -0.577 . . . . 0.0 109.64 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -111.21 161.81 12.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' B' ' 23' ' ' PRO . 5.2 p90 -148.37 108.46 4.07 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.479 -1.013 . . . . 0.0 109.21 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 29.6 t -144.72 128.56 17.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.274 -0.891 . . . . 0.0 109.272 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.1 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 159' ' ' CYS . . . . . 0.41 ' SG ' ' CG2' ' C' ' 213' ' ' VAL . 8.6 t -116.04 87.32 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.057 0.932 . . . . 0.0 109.527 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -94.63 148.88 21.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 161' ' ' MET . . . . . 0.56 ' SD ' HG21 ' C' ' 216' ' ' VAL . 0.1 OUTLIER -115.72 170.7 8.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.998 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -128.81 68.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 163' ' ' ILE . . . . . 0.907 HG22 HD21 ' C' ' 166' ' ' LEU . 8.2 mm -57.26 129.39 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.79 -173.9 13.26 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' C' ' 227' ' ' VAL . . . 53.94 27.23 36.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 166' ' ' LEU . . . . . 0.907 HD21 HG22 ' C' ' 163' ' ' ILE . 4.1 mm? -59.73 161.93 5.76 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.353 -1.087 . . . . 0.0 108.559 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' C' ' 168' ' ' TRP . 3.2 p30 -68.2 -71.84 0.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 168' ' ' TRP . . . . . 0.559 ' N ' ' OD1' ' C' ' 167' ' ' ASN . 0.1 OUTLIER 178.56 -32.97 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.884 -1.135 . . . . 0.0 109.636 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.29 96.96 3.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 11.9 m -129.21 141.94 51.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.872 . . . . 0.0 108.958 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.56 156.59 17.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 109.594 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.81 -63.92 1.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.275 -0.891 . . . . 0.0 110.526 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.55 -33.53 22.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.929 -1.107 . . . . 0.0 109.696 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.45 -50.84 34.12 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.911 0.863 . . . . 0.0 108.68 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' C' ' 190' ' ' ILE . 0.6 OUTLIER -59.77 -37.76 79.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.655 -0.653 . . . . 0.0 110.011 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 176' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -69.4 -60.74 2.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 177' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.48 -28.1 4.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.329 -0.857 . . . . 0.0 108.816 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' C' ' 178' ' ' TYR . 18.6 t80 -70.08 -53.61 16.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.922 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.763 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.6 m-85 -72.87 -41.87 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.608 -0.683 . . . . 0.0 112.501 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.77 30.01 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 119.347 -2.096 . . . . 0.0 111.431 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 181' ' ' LYS . . . . . 0.763 ' N ' ' O ' ' C' ' 179' ' ' PHE . 28.5 ttmt -94.01 -12.27 29.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 182' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 44.0 m-85 -99.77 -50.7 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.405 0.622 . . . . 0.0 109.744 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -143.66 -130.89 2.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 39.7 m -122.76 141.25 52.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -1.064 . . . . 0.0 109.567 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.498 HG22 ' CE1' ' C' ' 207' ' ' PHE . 59.7 t -117.96 135.34 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.409 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.422 HG22 ' H ' ' C' ' 186' ' ' THR . 0.6 OUTLIER -95.19 -41.52 9.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.921 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -160.1 158.0 29.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 109.657 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.885 HD12 ' N ' ' C' ' 189' ' ' LYS . 0.6 OUTLIER -139.97 140.38 36.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 189' ' ' LYS . . . . . 0.885 ' N ' HD12 ' C' ' 188' ' ' LEU . 0.2 OUTLIER -105.74 92.51 4.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.175 . . . . 0.0 110.2 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 190' ' ' ILE . . . . . 0.629 ' CD1' HD12 ' C' ' 175' ' ' LEU . 1.8 tt -117.13 145.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 13.0 ptp -154.19 61.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 109.986 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -68.22 171.86 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.998 -1.064 . . . . 0.0 109.614 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -52.51 124.71 34.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 108.962 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.98 -4.82 15.98 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.153 1.902 . . . . 0.0 112.706 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.67 -85.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 32.5 p -98.69 -12.57 20.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 110.018 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 197' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 79.84 18.96 71.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -96.13 74.72 2.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.298 . . . . 0.0 110.176 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 199' ' ' SER . . . . . 0.571 ' O ' ' O ' ' C' ' 200' ' ' ARG . 37.0 m -167.31 171.64 10.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.576 ' NE ' ' C ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -34.98 162.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 110.128 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.06 108.29 0.36 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.53 ' CE2' ' NH2' ' C' ' 200' ' ' ARG . 7.8 p90 -130.41 158.1 40.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -1.097 . . . . 0.0 109.377 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.16 116.96 1.54 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.747 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.07 82.72 6.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.716 -1.461 . . . . 0.0 107.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.5 mt -70.59 104.14 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.935 . . . . 0.0 111.621 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.0 t -76.75 76.34 3.39 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.498 ' CE1' HG22 ' C' ' 185' ' ' VAL . 2.6 m-85 -64.5 122.84 17.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.526 -0.734 . . . . 0.0 110.459 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.19 -47.12 71.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.163 -0.961 . . . . 0.0 109.397 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -93.96 118.5 67.27 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.802 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 210' ' ' PRO . . . . . 0.674 ' O ' HG12 ' C' ' 213' ' ' VAL . 2.4 Cg_endo -62.14 -2.25 2.91 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.516 ' O ' ' N ' ' C' ' 213' ' ' VAL . 18.6 t -74.53 -70.44 0.4 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.707 -1.246 . . . . 0.0 109.877 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.432 ' C ' ' O ' ' C' ' 211' ' ' SER . 28.2 t -39.28 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.5 -0.75 . . . . 0.0 109.96 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 213' ' ' VAL . . . . . 0.674 HG12 ' O ' ' C' ' 210' ' ' PRO . 0.5 OUTLIER -61.99 -20.18 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.765 -1.209 . . . . 0.0 110.106 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 214' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.97 -45.09 9.94 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.045 0.926 . . . . 0.0 108.863 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 215' ' ' GLU . . . . . 0.5 ' OE2' ' OG1' ' C' ' 219' ' ' THR . 48.7 tp10 -70.92 -27.85 64.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.79 -0.569 . . . . 0.0 109.849 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.56 HG21 ' SD ' ' C' ' 161' ' ' MET . 3.3 p -61.41 -49.11 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.541 ' N ' HG13 ' C' ' 216' ' ' VAL . 14.4 p -78.27 -40.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.94 -1.1 . . . . 0.0 109.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 218' ' ' LYS . . . . . 0.481 ' N ' HG13 ' C' ' 217' ' ' VAL . 42.0 tptt -59.4 -48.67 80.75 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.441 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 219' ' ' THR . . . . . 0.5 ' OG1' ' OE2' ' C' ' 215' ' ' GLU . 28.6 m -79.06 155.07 28.95 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.738 0.78 . . . . 0.0 110.898 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -112.07 138.45 48.71 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.809 ' O ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -136.44 163.19 31.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 222' ' ' ILE . . . . . 0.809 HD13 ' O ' ' C' ' 221' ' ' HIS . 1.0 OUTLIER -132.26 119.47 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.416 ' HA ' ' CE2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -50.51 -72.28 0.05 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -126.22 20.7 7.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 109.171 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.42 8.94 58.26 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 226' ' ' LYS . . . . . 0.689 ' NZ ' ' NZ ' ' C' ' 278' ' ' LYS . 2.1 tpmt? -87.58 -76.8 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.368 -1.077 . . . . 0.0 109.188 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 227' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' C' ' 165' ' ' GLY . 1.2 t 169.13 135.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.385 -0.822 . . . . 0.0 109.629 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 17.9 pt -139.62 159.18 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.625 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.79 98.05 12.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 109.088 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 230' ' ' PRO . . . . . 0.458 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 83.8 Cg_endo -87.94 123.33 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.964 2.442 . . . . 0.0 113.252 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -141.61 139.1 33.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.054 . . . . 0.0 109.6 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' C' ' 233' ' ' ALA . 70.7 ttt180 -66.54 151.46 47.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.081 . . . . 0.0 109.868 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 233' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.64 138.17 4.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 234' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' C' ' 232' ' ' ARG . 3.4 mt -134.74 119.09 13.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.924 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -45.94 156.03 0.51 Allowed 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.037 1.825 . . . . 0.0 111.551 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -45.62 92.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 0.0 110.485 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.13 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -70.42 -39.51 74.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.89 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 239' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.45 -39.46 79.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.06 -36.71 84.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.975 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 241' ' ' LYS . . . . . 0.515 ' O ' ' C ' ' C' ' 242' ' ' THR . 19.4 tttt -56.77 -65.71 0.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 242' ' ' THR . . . . . 0.515 ' C ' ' O ' ' C' ' 241' ' ' LYS . 39.9 p -33.04 145.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.779 -0.575 . . . . 0.0 110.074 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -131.38 147.32 18.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 130.58 27.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -1.205 . . . . 0.0 109.832 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.584 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -123.42 152.59 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.701 0.762 . . . . 0.0 109.679 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 246' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -108.16 136.09 48.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.675 -0.641 . . . . 0.0 109.329 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 247' ' ' VAL . . . . . 0.595 HG11 HD12 ' C' ' 313' ' ' ILE . 9.7 t -109.6 144.26 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.551 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 168.1 14.45 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 249' ' ' GLY . . . . . 0.582 ' O ' ' NH1' ' C' ' 311' ' ' ARG . . . 88.65 17.54 56.53 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 121.107 -1.231 . . . . 0.0 110.349 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.73 ' CG2' HG11 ' C' ' 254' ' ' VAL . 4.6 mt -116.04 136.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -1.053 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 251' ' ' GLY . . . . . 0.715 ' O ' HG12 ' C' ' 254' ' ' VAL . . . -108.67 178.15 20.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.96 -20.41 38.68 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.623 2.215 . . . . 0.0 112.379 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -56.1 -35.7 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.906 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.73 HG11 ' CG2' ' C' ' 250' ' ' ILE . 2.8 p -76.78 148.01 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.161 -0.962 . . . . 0.0 109.584 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -106.18 158.31 32.85 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.51 -21.31 61.28 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.455 2.103 . . . . 0.0 111.276 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -62.71 -54.76 34.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.04 -43.24 95.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 259' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -56.29 -59.67 4.61 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 109.936 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 260' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' C' ' 264' ' ' SER . 84.5 tt0 -60.66 -49.16 78.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 261' ' ' GLU . . . . . 0.453 ' C ' ' HG ' ' C' ' 264' ' ' SER . 47.4 tp10 -57.98 -22.56 49.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 0.0 108.75 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 262' ' ' PHE . . . . . 0.476 ' O ' ' OE1' ' C' ' 265' ' ' GLN . 67.6 t80 -81.25 -79.73 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.537 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 91.4 m-85 -52.61 -33.61 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.023 -1.048 . . . . 0.0 110.162 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.58 ' HA ' HD13 ' C' ' 269' ' ' ILE . 2.7 p -35.59 -38.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 111.996 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.62 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 1.8 pt20 -57.09 -90.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.422 -1.424 . . . . 0.0 110.339 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.62 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.7 OUTLIER -67.47 150.93 48.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.548 -1.345 . . . . 0.0 110.203 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 267' ' ' GLY . . . . . 0.405 ' O ' HD12 ' C' ' 269' ' ' ILE . . . 59.43 95.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 47.6 m -48.05 137.11 10.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.878 -1.366 . . . . 0.0 108.232 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.711 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -94.65 96.93 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 111.059 -178.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 270' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' C' ' 292' ' ' ASP . 6.4 mm -67.93 -39.57 81.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.449 -1.407 . . . . 0.0 108.497 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.59 92.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.439 -0.788 . . . . 0.0 109.506 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 272' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -123.42 172.33 8.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 109.888 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 273' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.0 OUTLIER 169.29 160.11 0.05 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.167 0.984 . . . . 0.0 111.277 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' C' ' 275' ' ' MET . 0.1 OUTLIER -107.7 152.59 24.12 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 275' ' ' MET . . . . . 0.443 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 0.0 OUTLIER -87.78 -179.12 6.21 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.492 -1.38 . . . . 0.0 109.858 -178.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.583 ' N ' ' OG1' ' C' ' 280' ' ' THR . 0.9 OUTLIER -153.21 -160.47 1.13 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.999 -1.063 . . . . 0.0 110.259 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 277' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' C' ' 283' ' ' SER . 1.2 m-20 -61.79 -85.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.281 -0.887 . . . . 0.0 111.58 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 278' ' ' LYS . . . . . 0.689 ' NZ ' ' NZ ' ' C' ' 226' ' ' LYS . 11.3 tptp -103.69 -32.11 9.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 109.805 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.54 -39.03 75.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 280' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 75.6 p -151.14 132.33 14.45 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.688 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.84 -127.95 28.72 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' C' ' 283' ' ' SER . 96.3 mt-30 -141.53 147.26 37.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -1.078 . . . . 0.0 110.987 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 283' ' ' SER . . . . . 0.595 ' O ' ' N ' ' C' ' 285' ' ' GLY . 0.0 OUTLIER -16.57 -52.22 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.106 -177.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 284' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' C' ' 282' ' ' GLN . 97.3 mtt180 -69.21 47.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 285' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' C' ' 283' ' ' SER . . . -40.36 102.46 0.02 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' C' ' 286' ' ' PHE . 0.0 OUTLIER -67.42 -163.73 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -130.21 149.92 19.03 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.923 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -139.39 151.61 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 2.3 t -147.77 143.24 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.735 -1.228 . . . . 0.0 108.501 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 24.4 m -129.7 125.32 35.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.106 -0.996 . . . . 0.0 108.974 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -115.94 144.79 43.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 292' ' ' ASP . . . . . 0.469 ' HB2' HD11 ' C' ' 270' ' ' ILE . 11.4 t70 -57.17 -50.2 73.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.658 -1.276 . . . . 0.0 109.149 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 72.9 m -98.02 178.95 4.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.27 -11.73 14.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -51.18 -44.38 61.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.0 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.85 . . . . 0.0 109.088 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 297' ' ' VAL . . . . . 0.553 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 59.4 t -60.16 -60.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -57.48 -28.18 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -64.29 -62.93 1.3 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.79 -28.17 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.798 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 301' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 67.5 m -45.78 -55.78 6.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 0.0 108.853 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 302' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' C' ' 301' ' ' CYS . 15.8 mm100 -47.63 -25.05 1.04 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' C' ' 300' ' ' VAL . 82.7 m-20 -98.98 72.66 1.91 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -65.74 -12.29 52.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.821 -1.174 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -132.0 122.75 26.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.831 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 306' ' ' ILE . . . . . 0.573 HD12 HD11 ' C' ' 315' ' ' ILE . 46.7 mt -119.93 147.41 23.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 307' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 307' ' ' ASP . 47.3 p30 -69.79 159.43 33.6 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 109.012 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.745 ' O ' ' O ' ' C' ' 309' ' ' LYS . 13.9 t80 -167.31 -171.46 1.72 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.745 ' O ' ' O ' ' C' ' 308' ' ' PHE . 68.2 mttt -42.27 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.107 0.956 . . . . 0.0 110.937 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 310' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 310' ' ' ASP . 44.6 p30 -61.14 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.375 -1.453 . . . . 0.0 110.912 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 311' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' C' ' 309' ' ' LYS . 0.3 OUTLIER -166.75 112.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.979 -1.075 . . . . 0.0 109.641 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.49 168.94 0.5 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 313' ' ' ILE . . . . . 0.595 HD12 HG11 ' C' ' 247' ' ' VAL . 48.4 pt -133.25 157.21 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 109.937 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 314' ' ' GLU . . . . . 0.46 ' O ' HG13 ' C' ' 247' ' ' VAL . 64.4 mt-10 -112.2 157.0 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.352 -0.842 . . . . 0.0 109.133 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' C' ' 245' ' ' ILE . 5.7 mm -120.6 142.48 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -156.52 155.14 31.45 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -60.72 143.45 54.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.026 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.58 61.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.322 -0.862 . . . . 0.0 109.383 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 109.774 -179.473 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.449 ' HD2' HH21 ' B' ' 26' ' ' ARG . 30.5 Cg_endo -67.78 157.15 63.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.715 2.277 . . . . 0.0 112.067 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.86 -5.67 16.14 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.927 2.418 . . . . 0.0 112.832 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 75.5 m -148.5 130.23 15.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 109.669 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.449 HH21 ' HD2' ' B' ' 23' ' ' PRO . 23.3 ttp85 179.05 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.51 HG22 ' HG2' ' B' ' 73' ' ' GLU . 76.5 t -116.07 151.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.592 -0.693 . . . . 0.0 109.637 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.4 ' N ' HG12 ' B' ' 27' ' ' VAL . 10.8 t -103.49 131.84 51.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' B' ' 100' ' ' GLY . 3.2 m-85 -102.2 116.93 33.68 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.816 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.49 HD13 ' CD1' ' B' ' 72' ' ' ILE . 4.7 mp -102.71 129.19 49.25 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -106.12 -112.15 3.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.456 ' OG ' ' CG ' ' B' ' 95' ' ' ARG . 10.4 p -70.08 131.0 43.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -1.219 . . . . 0.0 109.331 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.447 HD12 ' O ' ' B' ' 32' ' ' SER . 0.5 OUTLIER -163.42 132.88 3.08 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' B' ' 36' ' ' ASP . 14.8 Cg_endo -60.74 146.6 97.04 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.259 1.306 . . . . 0.0 112.162 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -62.98 3.66 0.22 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' B' ' 34' ' ' PRO . 93.0 m-20 -57.65 -37.77 73.92 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.362 -0.836 . . . . 0.0 108.913 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -119.27 113.23 20.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.769 . . . . 0.0 110.176 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.508 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 67.4 p -106.76 -141.18 0.37 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 0.0 109.88 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.79 -31.39 71.59 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.798 -1.189 . . . . 0.0 111.092 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -73.45 -58.55 3.23 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -67.55 -38.51 84.26 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.781 -1.2 . . . . 0.0 109.721 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' B' ' 44' ' ' ASP . 5.7 mm -61.07 -52.66 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' B' ' 42' ' ' ILE . 54.3 tp -37.81 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.151 -0.343 . . . . 0.0 110.826 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' B' ' 42' ' ' ILE . 90.7 m-20 -125.11 -24.76 3.95 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.732 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.783 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.0 tm? -59.77 -39.95 86.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.014 -1.679 . . . . 0.0 106.898 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.653 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.5 m -85.86 -63.81 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 109.065 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.823 ' O ' ' N ' ' B' ' 49' ' ' VAL . 2.5 p -40.03 -15.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.777 -0.577 . . . . 0.0 110.535 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.72 64.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.289 1.042 . . . . 0.0 109.986 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.823 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.4 p 169.89 -33.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.16 160.02 33.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.67 93.56 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.47 2.113 . . . . 0.0 111.731 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -45.67 165.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 109.4 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.424 HD11 ' HG2' ' B' ' 75' ' ' ARG . 40.5 mm -99.38 -47.46 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.25 -0.906 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.487 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 79.5 m-20 -126.54 142.37 51.56 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.49 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 24.9 tp -130.8 129.65 42.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -138.09 134.65 34.94 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.109 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.687 ' SD ' ' HB2' ' B' ' 70' ' ' ALA . 4.7 tpp -126.54 132.51 51.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.734 -0.603 . . . . 0.0 109.445 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 75.2 mtm -151.77 155.96 39.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.472 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.451 ' O ' ' HD3' ' B' ' 61' ' ' PRO . 0.0 OUTLIER -117.86 -177.07 3.17 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 41.1 p-10 -100.7 102.28 18.71 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 110.933 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 37.3 Cg_endo -89.36 -59.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.429 2.086 . . . . 0.0 110.738 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -81.49 -50.23 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.512 -0.743 . . . . 0.0 109.048 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 48.0 p -57.64 -44.35 85.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 109.522 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.441 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 70.03 24.63 76.38 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.539 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 46.4 mmm-85 -118.38 -68.23 0.93 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -1.104 . . . . 0.0 110.277 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD1' ' B' ' 69' ' ' TYR . 0.2 OUTLIER -58.52 118.88 6.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 110.343 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -79.88 -74.25 0.31 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 108.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -117.41 80.54 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' TYR . . . . . 0.534 ' CD1' ' CB ' ' B' ' 66' ' ' SER . 4.9 m-85 -92.38 132.13 36.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.012 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.687 ' HB2' ' SD ' ' B' ' 57' ' ' MET . . . -143.0 141.18 31.31 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' B' ' 71' ' ' PHE . 2.8 m-85 -114.88 122.92 47.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 109.229 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.49 ' CD1' HD13 ' B' ' 30' ' ' LEU . 3.3 mp -116.69 102.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.866 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.51 ' HG2' HG22 ' B' ' 27' ' ' VAL . 46.5 mt-10 -80.48 128.37 33.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.789 -1.194 . . . . 0.0 111.123 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -93.54 174.22 7.3 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.68 0.752 . . . . 0.0 110.793 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 81.4 mtt-85 -50.5 -41.32 53.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.717 -0.614 . . . . 0.0 110.56 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.77 178.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.821 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -39.81 -19.0 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.566 -0.709 . . . . 0.0 110.392 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.1 tt0 -71.74 -74.69 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.69 -1.256 . . . . 0.0 108.733 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 43.3 m -60.37 -40.5 91.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -34.64 76.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.501 -0.749 . . . . 0.0 109.282 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -61.77 -59.82 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 24.5 t -64.74 -36.83 85.57 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.72 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.09 -64.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 109.988 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' B' ' 88' ' ' ASN . 35.0 t -51.75 -39.29 23.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.018 -1.051 . . . . 0.0 109.627 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.462 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmp_? -69.28 -48.52 61.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.885 -1.134 . . . . 0.0 109.697 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.88 -48.0 15.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.057 . . . . 0.0 109.669 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' B' ' 83' ' ' ALA . 59.4 mt -93.85 27.91 2.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -54.91 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.454 ' HA2' HD12 ' B' ' 97' ' ' LEU . . . -137.48 121.04 2.19 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -136.27 142.67 43.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.513 -1.58 . . . . 0.0 108.796 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLN . . . . . 0.597 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.8 mm100 -27.25 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.609 0.719 . . . . 0.0 111.06 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.7 tt -151.44 128.23 10.92 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.696 -0.627 . . . . 0.0 109.309 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' B' ' 92' ' ' LEU . . . 46.36 -175.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 37.4 t -66.02 -17.15 64.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.008 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.456 ' CG ' ' OG ' ' B' ' 32' ' ' SER . 24.5 mmt180 -134.67 149.81 50.56 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.133 -0.98 . . . . 0.0 109.58 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.9 m-85 -103.5 142.77 33.7 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.293 0.568 . . . . 0.0 110.388 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -39.93 151.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -134.87 170.05 16.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.262 -0.899 . . . . 0.0 110.2 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 2.3 p -73.33 -176.08 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.355 -0.841 . . . . 0.0 109.245 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' B' ' 29' ' ' TYR . . . 160.3 177.14 33.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.614 ' O ' ' N ' ' B' ' 103' ' ' SER . 21.8 p90 -149.15 -3.08 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.053 -1.263 . . . . 0.0 111.065 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' B' ' 102' ' ' SER . 0.1 OUTLIER -35.57 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.227 -0.921 . . . . 0.0 110.602 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.614 ' N ' ' O ' ' B' ' 101' ' ' TYR . 17.2 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 120.981 -1.075 . . . . 0.0 109.509 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 158' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 99.9 p . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 159' ' ' CYS . . . . . 0.592 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER 170.35 -26.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -80.97 139.08 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 161' ' ' MET . . . . . 0.71 ' SD ' HG11 ' C' ' 216' ' ' VAL . 2.3 ttp -121.32 165.57 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -138.36 77.93 1.65 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.497 -0.752 . . . . 0.0 110.192 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 163' ' ' ILE . . . . . 0.708 HG22 HD11 ' C' ' 166' ' ' LEU . 49.6 mt -54.19 141.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -137.04 168.51 24.3 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.464 ' H ' ' NH2' ' C' ' 200' ' ' ARG . . . 66.72 31.35 78.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 166' ' ' LEU . . . . . 0.708 HD11 HG22 ' C' ' 163' ' ' ILE . 7.6 mp -68.26 172.25 6.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 108.046 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' C' ' 168' ' ' TRP . 1.6 t-20 -67.79 -73.23 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.929 -1.107 . . . . 0.0 108.421 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 168' ' ' TRP . . . . . 0.472 ' N ' ' OD1' ' C' ' 167' ' ' ASN . 0.0 OUTLIER 178.72 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.32 178.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 169' ' ' ASP . . . . . 0.458 ' OD1' ' CD ' ' C' ' 192' ' ' LYS . 68.5 t0 -135.73 92.34 2.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.892 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 86.6 m -125.8 143.53 51.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.459 -0.775 . . . . 0.0 109.2 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 172.7 8.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.602 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 172' ' ' GLU . . . . . 0.787 ' OE1' HG23 ' C' ' 190' ' ' ILE . 0.0 OUTLIER -79.06 -71.27 0.45 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.924 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' C' ' 174' ' ' ASN . 90.0 m-20 -40.24 -72.37 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 174' ' ' ASN . . . . . 0.543 ' C ' ' O ' ' C' ' 173' ' ' ASP . 0.1 OUTLIER -34.7 -44.57 0.22 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.614 HD12 HD13 ' C' ' 190' ' ' ILE . 0.5 OUTLIER -55.98 -57.97 9.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 109.779 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 176' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' C' ' 178' ' ' TYR . 7.4 ptm180 -67.28 -54.11 23.81 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 177' ' ' GLU . . . . . 0.513 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -38.51 -30.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.108 -0.995 . . . . 0.0 108.394 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.534 ' CD2' HD12 ' C' ' 223' ' ' LEU . 20.4 t80 -86.94 -40.19 15.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 110.143 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' C' ' 176' ' ' ARG . 25.8 m-85 -90.94 16.75 8.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.139 -0.976 . . . . 0.0 111.149 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.36 25.74 24.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -102.77 10.87 38.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 182' ' ' TYR . . . . . 0.488 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 90.3 m-85 -109.62 -77.0 0.6 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.19 -122.09 2.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 38.9 m -124.17 139.94 53.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.556 -0.967 . . . . 0.0 109.416 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.523 HG23 HH21 ' C' ' 176' ' ' ARG . 35.8 m -112.17 139.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.467 HG23 ' N ' ' C' ' 187' ' ' ASP . 11.1 t -105.2 -38.08 6.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.05 -1.031 . . . . 0.0 110.116 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 187' ' ' ASP . . . . . 0.467 ' N ' HG23 ' C' ' 186' ' ' THR . 17.5 t70 -163.43 166.17 23.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.628 HD23 ' N ' ' C' ' 188' ' ' LEU . 1.8 pt? -161.59 150.8 16.15 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 0.0 108.921 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -124.0 141.66 51.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 109.091 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 190' ' ' ILE . . . . . 0.787 HG23 ' OE1' ' C' ' 172' ' ' GLU . 1.1 tt -166.61 107.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.059 -1.026 . . . . 0.0 108.392 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 191' ' ' MET . . . . . 0.477 ' O ' ' C ' ' C' ' 192' ' ' LYS . 5.2 ptp -115.83 71.45 0.78 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 192' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' C' ' 191' ' ' MET . 4.0 pttt -39.25 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.287 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' C' ' 195' ' ' ALA . 4.8 t0 -147.58 106.53 3.77 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -48.31 -5.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' C' ' 193' ' ' ASP . . . -103.47 -85.61 0.45 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 196' ' ' THR . . . . . 0.535 HG23 ' N ' ' C' ' 197' ' ' GLY . 10.2 t -103.46 -41.57 5.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 109.764 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 197' ' ' GLY . . . . . 0.535 ' N ' HG23 ' C' ' 196' ' ' THR . . . 127.35 13.43 2.87 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 198' ' ' ARG . . . . . 0.425 ' H ' HG23 ' C' ' 196' ' ' THR . 1.6 mmm180 -98.27 86.92 3.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 109.711 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 199' ' ' SER . . . . . 0.624 ' O ' ' N ' ' C' ' 201' ' ' GLY . 42.7 t -161.48 149.23 15.06 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' C' ' 201' ' ' GLY . 47.2 tpt85 -42.53 90.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 201' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.14 138.15 21.53 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.538 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.443 ' CD2' ' O ' ' C' ' 200' ' ' ARG . 1.1 p90 -138.84 169.47 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -130.78 130.61 6.18 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.142 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -107.33 95.97 6.08 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.4 ' HG ' ' CZ ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -93.02 106.38 18.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -178.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.5 t -77.48 77.35 4.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.395 -0.816 . . . . 0.0 109.531 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.592 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 34.5 m-85 -71.69 107.52 4.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 109.927 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.73 -39.8 81.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -85.25 105.09 5.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.744 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.08 -28.73 20.07 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.744 1.629 . . . . 0.0 112.997 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.545 ' O ' ' N ' ' C' ' 213' ' ' VAL . 83.9 p -68.18 -57.76 5.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.986 -1.072 . . . . 0.0 110.383 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.891 ' O ' HG23 ' C' ' 216' ' ' VAL . 91.2 p -40.81 -22.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.862 . . . . 0.0 109.955 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 213' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 211' ' ' SER . 97.1 t -70.4 -37.78 71.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 108.939 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 214' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.8 t0 -57.91 -48.86 78.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 109.813 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.13 -36.83 77.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.894 -1.129 . . . . 0.0 109.611 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.891 HG23 ' O ' ' C' ' 212' ' ' SER . 84.2 t -56.14 -46.85 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.767 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.424 HG23 ' N ' ' C' ' 218' ' ' LYS . 25.2 m -78.13 -36.79 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.027 . . . . 0.0 110.102 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 218' ' ' LYS . . . . . 0.424 ' N ' HG23 ' C' ' 217' ' ' VAL . 3.0 tmtm? -67.14 -50.55 60.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 0.0 109.868 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -73.04 144.85 46.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.688 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -98.66 138.28 36.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.695 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -136.46 150.24 48.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.99 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.57 89.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.534 HD12 ' CD2' ' C' ' 178' ' ' TYR . 27.0 tp -58.44 -56.68 19.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.697 -0.627 . . . . 0.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.46 13.9 29.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.087 -1.008 . . . . 0.0 108.598 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 75.54 26.69 64.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.589 -2.205 . . . . 0.0 107.589 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 226' ' ' LYS . . . . . 0.465 ' HD3' HD22 ' C' ' 167' ' ' ASN . 0.1 OUTLIER -101.9 -154.25 0.48 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 227' ' ' VAL . . . . . 0.532 HG12 ' O ' ' C' ' 227' ' ' VAL . 12.6 t -121.41 94.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 109.329 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 228' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' C' ' 166' ' ' LEU . 30.1 pt -105.27 149.59 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.396 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 229' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' C' ' 231' ' ' LYS . 0.4 OUTLIER -124.17 100.17 36.48 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 0.0 109.813 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 230' ' ' PRO . . . . . 0.401 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 16.6 Cg_endo -74.87 131.11 14.07 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.981 1.787 . . . . 0.0 111.244 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 231' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' C' ' 229' ' ' ASP . 19.4 mttm -149.91 151.08 32.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -62.07 149.09 42.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.72 . . . . 0.0 109.265 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.72 29.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.045 . . . . 0.0 109.123 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.11 116.68 32.46 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.32 159.05 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.237 1.958 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.729 ' HE ' ' N ' ' C' ' 236' ' ' ARG . 0.2 OUTLIER -57.44 -52.14 66.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.414 -0.804 . . . . 0.0 110.343 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 237' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' C' ' 241' ' ' LYS . 90.9 m-20 -61.44 -41.68 97.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.12 -39.55 95.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.692 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 239' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -62.83 -41.36 99.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.974 -1.079 . . . . 0.0 108.613 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.85 -22.31 31.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.788 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 241' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' C' ' 237' ' ' ASP . 48.9 tttm -54.64 -16.81 2.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 0.0 110.302 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 10.2 p -102.36 162.6 12.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.893 -1.129 . . . . 0.0 109.449 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.87 154.08 17.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -129.92 126.61 38.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.056 -1.261 . . . . 0.0 109.972 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.502 HD11 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -117.33 138.55 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.765 0.793 . . . . 0.0 108.895 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.4 OUTLIER -80.56 161.28 24.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.458 0.647 . . . . 0.0 109.51 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 247' ' ' VAL . . . . . 0.546 ' N ' ' CD1' ' C' ' 246' ' ' PHE . 39.8 t -134.85 132.69 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.66 152.4 18.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 61.73 120.17 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.592 HD11 ' O ' ' C' ' 286' ' ' PHE . 0.0 OUTLIER -151.87 165.82 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -1.096 . . . . 0.0 108.743 179.106 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -47.07 145.71 4.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.31 -49.38 10.34 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.906 1.737 . . . . 0.0 112.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -122.14 33.87 5.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.741 . . . . 0.0 109.387 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.5 HG11 ' HB ' ' C' ' 250' ' ' ILE . 2.5 p -44.97 141.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -110.71 158.37 35.79 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.24 -30.66 81.81 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.35 2.033 . . . . 0.0 111.169 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -51.56 -62.64 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 258' ' ' GLU . . . . . 0.704 ' O ' ' N ' ' C' ' 261' ' ' GLU . 0.0 OUTLIER -62.57 -87.71 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 259' ' ' PHE . . . . . 0.631 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.3 t80 -9.03 -70.39 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 121.441 0.639 . . . . 0.0 110.942 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 260' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' C' ' 272' ' ' ALA . 85.0 tt0 -56.06 -44.14 78.59 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.271 0.558 . . . . 0.0 110.39 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 261' ' ' GLU . . . . . 0.704 ' N ' ' O ' ' C' ' 258' ' ' GLU . 46.4 tp10 -68.53 -41.93 79.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 262' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' C' ' 263' ' ' PHE . 42.1 t80 -54.69 -77.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.924 -0.485 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.611 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 61.3 m-85 -42.04 -48.77 4.69 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.706 -1.246 . . . . 0.0 110.24 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.0 OUTLIER -35.26 -37.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' C' ' 263' ' ' PHE . 1.7 pp0? -55.86 -7.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.0 113.246 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.611 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.2 p90 -146.35 -53.42 0.25 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.86 -1.775 . . . . 0.0 111.318 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 267' ' ' GLY . . . . . 0.597 ' N ' ' CD1' ' C' ' 266' ' ' TRP . . . -83.83 -178.52 51.82 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 268' ' ' THR . . . . . 0.56 ' O ' ' C ' ' C' ' 269' ' ' ILE . 34.1 p -102.19 9.5 40.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.924 -1.339 . . . . 0.0 111.706 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.996 HG23 ' CE1' ' C' ' 291' ' ' TYR . 0.9 OUTLIER -16.45 104.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.264 0.938 . . . . 0.0 112.98 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.6 mm -92.74 -33.11 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 271' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' C' ' 272' ' ' ALA . 88.0 m-20 -115.19 17.72 16.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.42 -0.8 . . . . 0.0 110.457 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 272' ' ' ALA . . . . . 0.731 ' HB2' ' HB ' ' C' ' 269' ' ' ILE . . . -25.92 130.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.998 -0.438 . . . . 0.0 110.275 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 273' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' C' ' 288' ' ' PHE . 14.0 pt20 -152.52 132.5 13.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.695 -1.253 . . . . 0.0 111.64 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.941 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.3 OUTLIER -126.58 152.46 46.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 275' ' ' MET . . . . . 0.44 ' C ' ' OG ' ' C' ' 283' ' ' SER . 17.8 mmt -88.54 168.44 12.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.651 -1.281 . . . . 0.0 109.872 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.957 ' H ' HD12 ' C' ' 276' ' ' LEU . 0.0 OUTLIER -144.59 176.98 9.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.788 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -78.71 -35.78 44.39 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 110.39 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -56.31 -36.43 68.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.062 -1.024 . . . . 0.0 109.789 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -53.55 -52.43 59.73 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.668 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 280' ' ' THR . . . . . 0.41 ' H ' ' H ' ' C' ' 281' ' ' GLY . 1.1 t 178.83 0.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 281' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' C' ' 283' ' ' SER . . . 102.47 9.07 42.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.41 ' O ' ' CE2' ' C' ' 286' ' ' PHE . 50.7 mm-40 -77.42 23.27 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -1.03 . . . . 0.0 109.958 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 283' ' ' SER . . . . . 0.532 ' OG ' ' CA ' ' C' ' 276' ' ' LEU . 3.0 m -107.44 59.07 0.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.434 -0.792 . . . . 0.0 109.798 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 284' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.77 -27.69 19.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 108.618 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 143.29 17.37 0.25 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.592 ' O ' HD11 ' C' ' 250' ' ' ILE . 46.1 p90 -108.55 176.77 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.42 178.17 39.1 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 288' ' ' PHE . . . . . 0.402 ' O ' ' O ' ' C' ' 273' ' ' GLN . 73.7 m-85 -147.55 156.31 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.325 -1.691 . . . . 0.0 109.676 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 289' ' ' VAL . . . . . 0.412 ' HB ' HG22 ' C' ' 269' ' ' ILE . 1.7 m -140.51 152.11 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.042 -1.036 . . . . 0.0 108.626 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.65 120.09 28.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 291' ' ' TYR . . . . . 0.996 ' CE1' HG23 ' C' ' 269' ' ' ILE . 93.9 m-85 -109.18 136.69 48.25 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.82 -50.67 72.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.592 -1.317 . . . . 0.0 109.381 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 75.4 m -93.54 169.38 10.39 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.309 -0.869 . . . . 0.0 108.89 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -103.54 -9.81 18.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.67 -46.24 74.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.01 76.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.807 . . . . 0.0 109.049 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 297' ' ' VAL . . . . . 0.419 ' O ' HG12 ' C' ' 300' ' ' VAL . 67.9 t -62.53 -61.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -56.11 -29.17 60.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 109.135 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -62.94 -60.8 2.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.977 HG23 HD22 ' C' ' 303' ' ' ASN . 14.4 p -63.06 -27.89 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.647 -0.658 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 301' ' ' CYS . . . . . 0.496 ' C ' ' O ' ' C' ' 300' ' ' VAL . 65.1 m -45.27 -49.37 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -46.13 -32.83 3.14 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.872 -0.518 . . . . 0.0 109.654 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.977 HD22 HG23 ' C' ' 300' ' ' VAL . 13.2 p30 -101.5 81.77 2.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -72.62 -14.98 61.73 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.64 -1.913 . . . . 0.0 108.739 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -126.05 122.28 35.38 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 306' ' ' ILE . . . . . 0.418 ' CG1' ' OD1' ' C' ' 303' ' ' ASN . 82.7 mt -117.18 149.87 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.13 96.69 10.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.624 ' O ' ' C ' ' C' ' 309' ' ' LYS . 34.7 t80 -104.32 -176.65 3.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.776 ' O ' ' N ' ' C' ' 311' ' ' ARG . 71.2 mttt -25.26 133.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 310' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' C' ' 309' ' ' LYS . 23.8 t70 -17.79 69.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.405 0.622 . . . . 0.0 112.057 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 311' ' ' ARG . . . . . 0.776 ' N ' ' O ' ' C' ' 309' ' ' LYS . 54.1 ttm-85 177.98 109.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 153.12 4.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.064 . . . . 0.0 108.742 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.88 153.31 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.104 -0.997 . . . . 0.0 108.972 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -116.04 121.41 42.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 109.791 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.502 ' CG2' HD11 ' C' ' 245' ' ' ILE . 2.0 mm -88.84 154.9 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -160.96 159.94 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.165 -0.959 . . . . 0.0 108.421 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -71.92 150.75 43.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.81 -1.181 . . . . 0.0 109.175 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.24 -0.7 10.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.842 -1.161 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.778 . . . . 0.0 109.929 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.713 ' ND2' ' CE2' ' B' ' 101' ' ' TYR . 6.1 t30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.464 0.649 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.01 154.47 70.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.936 2.424 . . . . 0.0 112.255 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.24 3.39 4.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.719 2.28 . . . . 0.0 112.315 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -154.3 133.42 12.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.93 . . . . 0.0 109.276 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -43.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.0 109.333 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' B' ' 100' ' ' GLY . 2.7 t -119.81 151.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' B' ' 98' ' ' LYS . 9.0 p -142.44 134.41 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.66 -1.275 . . . . 0.0 107.994 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -129.36 155.57 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 110.475 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.62 ' HB3' HD11 ' B' ' 33' ' ' ILE . 3.4 mp -121.24 147.93 44.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.537 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -123.39 -45.13 0.29 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.413 ' C ' HD12 ' B' ' 33' ' ' ILE . 0.7 OUTLIER -92.04 87.51 6.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.964 -1.315 . . . . 0.0 109.706 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.635 HD12 ' N ' ' B' ' 33' ' ' ILE . 3.4 mp -143.44 126.81 9.08 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 108.886 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' B' ' 36' ' ' ASP . 39.3 Cg_endo -73.43 155.85 50.44 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.451 1.434 . . . . 0.0 111.583 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.449 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 8.2 m-85 -60.24 5.85 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 109.621 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.2 m-20 -61.51 -41.93 98.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.048 -1.032 . . . . 0.0 108.584 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -125.4 112.04 15.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.39 -0.819 . . . . 0.0 109.57 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.408 ' O ' HG12 ' B' ' 42' ' ' ILE . 69.3 p -107.45 -143.19 0.38 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.379 -0.826 . . . . 0.0 110.963 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 21.7 pt-20 -65.97 -29.19 69.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.815 -1.178 . . . . 0.0 110.955 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -64.0 -54.78 28.91 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.882 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -69.52 -48.11 61.6 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 110.359 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' B' ' 44' ' ' ASP . 6.5 mm -56.76 -54.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' B' ' 55' ' ' LEU . 41.4 tp -36.9 -20.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.2 t0 -124.02 -22.22 4.88 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.178 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.728 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.4 tm? -61.6 -37.59 84.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.165 -1.584 . . . . 0.0 107.94 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' B' ' 48' ' ' ASN . 86.6 m -92.77 -63.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.95 -1.093 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.412 ' C ' ' O ' ' B' ' 46' ' ' CYS . 17.6 t -37.76 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.806 -0.559 . . . . 0.0 110.788 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' B' ' 49' ' ' VAL . 5.9 p30 -71.38 -59.05 2.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.784 -1.198 . . . . 0.0 109.844 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' B' ' 48' ' ' ASN . 0.9 OUTLIER -42.37 -51.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.714 -0.616 . . . . 0.0 110.207 -178.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.507 ' N ' HG12 ' B' ' 49' ' ' VAL . . . -157.22 167.63 33.94 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.21 131.06 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.905 1.737 . . . . 0.0 111.495 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.624 HG13 ' H ' ' B' ' 53' ' ' ILE . 0.9 OUTLIER -99.66 -172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.328 -0.857 . . . . 0.0 108.998 -178.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.624 ' H ' HG13 ' B' ' 52' ' ' VAL . 24.0 mm -142.86 -44.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 86.8 m-20 -149.52 155.53 40.5 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.662 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' B' ' 43' ' ' LEU . 56.8 tp -146.61 130.23 16.94 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.444 ' CG ' ' SD ' ' B' ' 58' ' ' MET . 43.1 tptt -145.81 116.54 7.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.671 -1.268 . . . . 0.0 110.143 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.46 130.41 35.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 109.297 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' MET . . . . . 0.447 ' O ' ' O ' ' B' ' 69' ' ' TYR . 2.3 mpp? -141.3 144.18 34.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.112 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.449 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 14.0 m-85 -98.89 -179.15 4.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.513 ' OD1' ' CG2' ' B' ' 63' ' ' THR . 0.4 OUTLIER -117.1 69.86 5.24 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.497 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -68.17 -61.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.916 2.411 . . . . 0.0 113.281 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -64.08 -40.94 97.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -0.829 . . . . 0.0 110.818 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.513 ' CG2' ' OD1' ' B' ' 60' ' ' ASP . 7.8 p -70.84 -43.38 68.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.69 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.61 -2.45 85.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -1.08 . . . . 0.0 110.016 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' B' ' 60' ' ' ASP . 0.1 OUTLIER -177.24 -161.94 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.927 -1.108 . . . . 0.0 111.11 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' B' ' 60' ' ' ASP . 29.8 mttm -144.62 38.15 1.23 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 109.913 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.27 63.3 0.5 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.88 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' TYR . . . . . 0.468 ' CE2' ' OD2' ' B' ' 60' ' ' ASP . 66.4 m-85 -116.8 123.57 47.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.279 -1.13 . . . . 0.0 109.498 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 135.9 36.59 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.296 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.79 125.35 50.89 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.516 0.674 . . . . 0.0 111.549 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.87 153.01 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 81.7 tt0 -133.48 136.51 45.16 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.424 ' HD1' ' HG ' ' B' ' 79' ' ' SER . 12.0 m-85 -103.0 169.76 8.37 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.035 0.921 . . . . 0.0 111.583 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 51.6 ttt85 -55.52 -42.37 74.45 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.841 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 159.64 -176.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.502 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.789 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.8 mm? -38.77 -21.73 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.852 -0.53 . . . . 0.0 110.313 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.3 mt-10 -70.28 -79.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' SER . . . . . 0.424 ' HG ' ' HD1' ' B' ' 74' ' ' PHE . 13.9 t -62.57 -36.62 83.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.5 t -62.82 -37.75 88.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -60.31 -58.16 9.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.409 -1.432 . . . . 0.0 108.534 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.3 t -64.58 -34.19 77.68 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.415 0.626 . . . . 0.0 111.995 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -84.23 -58.26 2.83 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.932 -1.105 . . . . 0.0 110.596 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.709 HG13 ' CB ' ' B' ' 99' ' ' CYS . 58.7 t -53.59 -40.74 43.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 120.331 -1.481 . . . . 0.0 108.561 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -69.63 -46.9 65.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.826 -1.171 . . . . 0.0 109.782 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' B' ' 88' ' ' ASN . 73.7 m-20 -88.07 -59.48 2.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.851 -1.155 . . . . 0.0 109.006 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.69 ' N ' ' O ' ' B' ' 83' ' ' ALA . 11.8 tp -73.85 32.11 0.08 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -71.85 -73.07 0.2 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.029 -1.044 . . . . 0.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' B' ' 97' ' ' LEU . . . -137.07 120.96 2.22 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -138.43 141.1 39.54 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.45 -1.617 . . . . 0.0 107.294 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 5.1 mm100 -31.16 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.781 0.8 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' B' ' 90' ' ' TYR . 20.8 tp -152.16 117.78 5.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.42 -168.9 48.0 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -11.94 59.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.028 -1.278 . . . . 0.0 108.872 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -134.44 155.24 50.68 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' B' ' 97' ' ' LEU . 6.8 m-85 -97.09 134.17 40.78 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.27 -0.894 . . . . 0.0 109.207 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -29.21 136.91 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.505 0.669 . . . . 0.0 111.084 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.739 ' O ' HG23 ' B' ' 28' ' ' VAL . 1.5 mmtt -112.76 126.81 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 109.054 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' CYS . . . . . 0.709 ' CB ' HG13 ' B' ' 84' ' ' VAL . 14.7 p -89.27 129.96 35.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 111.168 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -130.8 -168.16 12.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.713 ' CE2' ' ND2' ' B' ' 22' ' ' ASN . 38.5 p90 -137.49 161.36 36.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.682 -0.893 . . . . 0.0 109.076 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' SER . . . . . 0.472 ' HB3' HG21 ' B' ' 27' ' ' VAL . 26.9 t -179.24 92.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.438 -0.789 . . . . 0.0 108.945 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 -179.54 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 158' ' ' SER . . . . . 0.502 ' C ' ' H ' ' C' ' 160' ' ' LYS . 28.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 159' ' ' CYS . . . . . 0.409 ' CB ' ' O ' ' C' ' 209' ' ' LYS . 27.4 p -72.42 28.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.741 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 160' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' C' ' 158' ' ' SER . 38.7 tttt -104.51 134.81 47.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.545 -0.722 . . . . 0.0 109.997 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 8.3 ptm -118.26 159.26 23.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -0.842 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 162' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' C' ' 202' ' ' PHE . 44.3 t80 -122.83 77.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 110.29 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 163' ' ' ILE . . . . . 0.478 ' CD1' HD21 ' C' ' 175' ' ' LEU . 0.6 OUTLIER -50.11 140.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -139.11 166.66 25.39 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' C' ' 227' ' ' VAL . . . 53.91 24.51 27.15 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 166' ' ' LEU . . . . . 0.749 ' HA ' HG22 ' C' ' 228' ' ' ILE . 1.7 pp -75.06 162.37 28.61 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.362 -1.081 . . . . 0.0 110.653 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.635 ' N ' HD12 ' C' ' 166' ' ' LEU . 63.5 t30 -75.29 123.98 26.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.025 -1.047 . . . . 0.0 109.528 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 168' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' C' ' 167' ' ' ASN . 3.2 m0 -37.52 -39.28 0.3 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 111.054 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.7 84.41 7.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.694 -1.253 . . . . 0.0 110.94 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 170' ' ' THR . . . . . 0.405 ' O ' ' CD1' ' C' ' 190' ' ' ILE . 57.9 m -146.18 133.82 21.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.991 . . . . 0.0 109.368 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 171' ' ' THR . . . . . 0.445 ' O ' ' C ' ' C' ' 172' ' ' GLU . 1.4 m -124.33 138.92 54.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.343 -0.848 . . . . 0.0 109.128 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 172' ' ' GLU . . . . . 0.566 ' HB3' HD13 ' C' ' 188' ' ' LEU . 0.5 OUTLIER -39.38 -72.99 0.05 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.138 -0.976 . . . . 0.0 110.744 -178.171 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' C' ' 172' ' ' GLU . 53.9 t0 -38.68 -39.46 0.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.542 -0.724 . . . . 0.0 110.139 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -76.51 -44.22 36.05 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' C' ' 172' ' ' GLU . 0.9 OUTLIER -53.1 -54.05 41.27 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 176' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' C' ' 179' ' ' PHE . 5.6 ptm180 -68.81 -55.54 10.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.43 -1.308 . . . . 0.0 108.534 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 177' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' C' ' 176' ' ' ARG . 84.6 tt0 -35.94 -33.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.559 ' CG ' HD12 ' C' ' 223' ' ' LEU . 21.1 t80 -91.93 -31.14 15.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.724 . . . . 0.0 110.564 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' C' ' 176' ' ' ARG . 6.0 m-85 -95.49 15.92 18.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.84 -1.163 . . . . 0.0 110.832 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.67 29.57 2.63 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.57 22.79 12.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -1.079 . . . . 0.0 109.195 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 182' ' ' TYR . . . . . 0.603 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 99.2 m-85 -127.91 -3.84 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.486 -0.759 . . . . 0.0 109.628 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 151.33 -126.19 2.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 2.9 t -131.58 149.7 52.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -1.077 . . . . 0.0 108.844 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.557 HG11 HD23 ' C' ' 188' ' ' LEU . 86.0 t -103.25 134.42 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.915 . . . . 0.0 109.663 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 53.0 p -122.3 -29.51 4.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.378 -0.826 . . . . 0.0 110.562 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -153.9 150.51 28.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 109.62 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.831 ' O ' HD12 ' C' ' 188' ' ' LEU . 1.2 pp -171.93 154.84 3.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.588 -1.32 . . . . 0.0 110.111 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -140.35 118.52 11.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 108.337 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 190' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' C' ' 170' ' ' THR . 0.0 OUTLIER -141.11 148.66 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.777 -1.202 . . . . 0.0 110.33 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 9.8 mtt -121.63 174.13 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 140.05 1.13 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.523 -1.361 . . . . 0.0 109.118 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' C' ' 193' ' ' ASP . 0.0 OUTLIER -74.9 143.46 78.02 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.069 -1.019 . . . . 0.0 110.045 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 194' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' C' ' 195' ' ' ALA . 60.3 Cg_endo -75.74 -40.73 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.946 1.764 . . . . 0.0 110.994 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' C' ' 194' ' ' PRO . . . 178.93 -39.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.566 -0.709 . . . . 0.0 109.771 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 50.1 p -123.4 5.44 9.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 197' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' C' ' 198' ' ' ARG . . . -105.03 42.64 1.85 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 198' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' C' ' 197' ' ' GLY . 49.6 mtm180 -41.91 133.73 2.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -1.109 . . . . 0.0 109.63 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 199' ' ' SER . . . . . . . . . . . . . 23.0 t -154.67 167.04 31.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.55 ' N ' ' NE ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -59.94 92.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 201' ' ' GLY . . . . . 0.493 ' O ' ' CD2' ' C' ' 166' ' ' LEU . . . -83.11 93.13 1.68 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 8.7 p90 -109.14 154.54 22.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -115.6 134.09 11.31 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.522 -1.799 . . . . 0.0 110.087 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -114.14 91.44 3.63 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.485 HD12 HD22 ' C' ' 175' ' ' LEU . 0.8 OUTLIER -100.23 111.87 24.17 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.175 -0.953 . . . . 0.0 110.442 -177.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 7.7 t -106.61 135.6 47.85 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -104.43 -121.41 0.21 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -141.05 -14.25 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.188 -1.57 . . . . 0.0 108.867 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 7.6 mtmp? -130.0 170.45 10.98 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -97.66 -11.82 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.638 2.225 . . . . 0.0 112.481 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.587 ' O ' ' N ' ' C' ' 213' ' ' VAL . 15.1 m -68.58 -61.64 1.74 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.924 -1.11 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.489 ' O ' HG23 ' C' ' 216' ' ' VAL . 42.8 m -40.64 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -0.763 . . . . 0.0 109.873 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 213' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' C' ' 211' ' ' SER . 84.0 t -73.64 -35.79 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.754 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 214' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -63.83 -49.32 73.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.75 . . . . 0.0 110.409 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 215' ' ' GLU . . . . . 0.65 ' CD ' ' H ' ' C' ' 215' ' ' GLU . 0.0 OUTLIER -69.04 -42.7 76.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.797 -1.189 . . . . 0.0 108.674 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.489 HG23 ' O ' ' C' ' 212' ' ' SER . 4.8 t -51.55 -47.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.7 -36.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -77.93 8.95 3.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.786 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 18.0 m -129.38 142.95 50.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.879 . . . . 0.0 108.762 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.95 136.27 45.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.904 ' C ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -131.18 153.01 49.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.726 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 222' ' ' ILE . . . . . 0.904 HD13 ' C ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -117.62 86.85 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.672 0.748 . . . . 0.0 109.102 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' C' ' 178' ' ' TYR . 1.1 tp -57.27 -66.75 0.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.855 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -96.05 8.31 44.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.665 -1.272 . . . . 0.0 109.401 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 81.95 14.88 76.4 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 226' ' ' LYS . . . . . 0.677 ' HB2' ' HZ2' ' C' ' 226' ' ' LYS . 0.0 OUTLIER -95.69 -154.39 0.43 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 227' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' C' ' 165' ' ' GLY . 7.6 t -115.07 95.91 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 228' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' C' ' 166' ' ' LEU . 26.3 pt -105.65 136.94 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.78 108.44 53.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.798 . . . . 0.0 109.612 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 230' ' ' PRO . . . . . 0.466 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 37.2 Cg_endo -81.7 137.33 10.03 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.968 1.779 . . . . 0.0 111.939 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -145.99 159.52 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 234' ' ' ILE . 26.8 ptt-85 -87.61 152.14 22.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.04 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -49.15 99.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 108.761 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 234' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 232' ' ' ARG . 4.4 mt -90.76 127.44 52.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.03 149.36 2.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.062 1.841 . . . . 0.0 112.55 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -57.33 -45.83 83.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -59.41 -41.73 90.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 108.704 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 238' ' ' GLU . . . . . 0.518 ' O ' HG23 ' C' ' 242' ' ' THR . 75.9 mm-40 -66.3 -36.39 82.83 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.434 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 239' ' ' GLN . . . . . 0.497 ' O ' ' OG1' ' C' ' 242' ' ' THR . 30.5 tp60 -61.19 -44.82 96.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -73.0 -41.2 64.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.362 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -72.28 -13.93 61.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 111.805 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 242' ' ' THR . . . . . 0.518 HG23 ' O ' ' C' ' 238' ' ' GLU . 0.9 OUTLIER -47.64 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.525 -1.359 . . . . 0.0 110.284 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 107.66 108.76 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -140.72 134.33 30.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.715 -1.462 . . . . 0.0 110.6 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.696 HD12 ' CG2' ' C' ' 315' ' ' ILE . 1.2 pt -126.16 159.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 109.875 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 246' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -106.93 131.19 54.29 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.46 132.25 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.652 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.19 148.75 18.26 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.39 72.53 0.87 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.224 -1.162 . . . . 0.0 111.223 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' C' ' 251' ' ' GLY . 19.6 mt -118.34 145.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -1.057 . . . . 0.0 109.096 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 251' ' ' GLY . . . . . 0.584 ' O ' HG12 ' C' ' 254' ' ' VAL . . . -42.66 126.88 4.74 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.29 -40.76 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.822 1.681 . . . . 0.0 112.207 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 253' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' C' ' 254' ' ' VAL . 90.5 m-20 -95.17 6.31 49.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.376 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.596 HG22 ' N ' ' C' ' 255' ' ' ARG . 10.7 p -42.26 165.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.88 . . . . 0.0 109.982 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 255' ' ' ARG . . . . . 0.596 ' N ' HG22 ' C' ' 254' ' ' VAL . 14.4 mtt180 -137.3 156.76 75.12 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.0 109.052 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.14 -28.14 48.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.467 2.111 . . . . 0.0 111.913 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -52.13 -64.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 258' ' ' GLU . . . . . 0.718 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.0 tp10 -59.77 -83.2 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.727 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 259' ' ' PHE . . . . . 0.608 ' C ' ' O ' ' C' ' 258' ' ' GLU . 75.9 t80 -12.67 -70.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.207 0.527 . . . . 0.0 111.45 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.31 -41.77 72.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.431 -0.793 . . . . 0.0 109.691 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 261' ' ' GLU . . . . . 0.718 ' N ' ' O ' ' C' ' 258' ' ' GLU . 44.3 tp10 -67.46 -46.69 72.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 262' ' ' PHE . . . . . 0.636 ' O ' ' HG2' ' C' ' 265' ' ' GLN . 60.3 t80 -49.68 -72.32 0.05 Allowed 'General case' 0 C--O 1.193 -1.907 0 O-C-N 121.573 -0.705 . . . . 0.0 110.512 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' C' ' 265' ' ' GLN . 88.4 m-85 -53.59 -45.1 69.89 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.044 -1.035 . . . . 0.0 112.083 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.502 ' C ' ' O ' ' C' ' 263' ' ' PHE . 0.3 OUTLIER -24.07 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' C' ' 262' ' ' PHE . 1.0 OUTLIER -48.41 -100.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.762 -1.212 . . . . 0.0 111.042 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.504 ' H ' ' HG3' ' C' ' 265' ' ' GLN . 1.7 p90 -60.77 148.71 38.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 267' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 51.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 86.2 m -49.77 141.71 9.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.289 . . . . 0.0 108.558 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.61 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -95.41 106.71 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.986 -1.071 . . . . 0.0 110.753 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 270' ' ' ILE . . . . . 0.475 HG22 ' N ' ' C' ' 271' ' ' ASP . 0.6 OUTLIER -70.13 -55.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.705 -1.247 . . . . 0.0 108.862 179.169 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 271' ' ' ASP . . . . . 0.475 ' N ' HG22 ' C' ' 270' ' ' ILE . 59.4 t0 -141.25 102.43 4.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 272' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' C' ' 273' ' ' GLN . . . -131.71 157.36 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 273' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' C' ' 272' ' ' ALA . 14.6 pt20 168.69 173.31 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.685 1.231 . . . . 0.0 111.796 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.505 HD22 HG13 ' C' ' 254' ' ' VAL . 10.4 tp -95.12 148.36 22.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 96.8 mmm -97.71 -172.55 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.448 -1.407 . . . . 0.0 110.933 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 175.29 88.56 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 277' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' C' ' 280' ' ' THR . 83.0 m-20 -84.34 47.5 1.35 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 278' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' C' ' 277' ' ' ASP . 15.6 pttp -40.41 -33.22 0.24 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -58.41 -37.12 74.68 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.356 -0.937 . . . . 0.0 108.484 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 280' ' ' THR . . . . . 0.597 ' N ' ' O ' ' C' ' 277' ' ' ASP . 0.4 OUTLIER -141.73 -79.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 281' ' ' GLY . . . . . 0.57 ' N ' ' OG1' ' C' ' 280' ' ' THR . . . -65.27 -165.34 1.26 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.0 tt0 -167.09 158.59 12.34 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.338 -1.095 . . . . 0.0 109.828 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 283' ' ' SER . . . . . 0.427 ' N ' ' HG2' ' C' ' 282' ' ' GLN . 1.0 OUTLIER -61.17 67.59 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.203 0.525 . . . . 0.0 109.774 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 284' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' C' ' 282' ' ' GLN . 60.8 ttm-85 -50.07 -24.74 2.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.86 22.93 0.26 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.408 ' C ' HD12 ' C' ' 250' ' ' ILE . 23.0 p90 -111.36 173.36 6.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 110.668 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.93 36.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 288' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' C' ' 246' ' ' PHE . 21.8 m-85 -143.1 158.45 43.6 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.417 -1.637 . . . . 0.0 109.189 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 19.8 t -141.59 143.94 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.81 -1.181 . . . . 0.0 108.253 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 290' ' ' THR . . . . . 0.453 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 18.6 m -130.97 128.71 40.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.869 -1.144 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 291' ' ' TYR . . . . . 0.517 ' O ' ' O ' ' C' ' 242' ' ' THR . 42.0 m-85 -114.42 143.64 44.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 292' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER -62.48 -48.56 79.08 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 293' ' ' SER . . . . . 0.543 ' N ' ' CG ' ' C' ' 292' ' ' ASP . 12.4 m -73.93 132.93 42.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -76.33 -32.7 58.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -50.95 -38.48 50.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.702 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.44 -46.09 83.97 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 297' ' ' VAL . . . . . 0.45 HG13 ' CG2' ' C' ' 245' ' ' ILE . 40.5 t -56.99 -56.56 14.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -54.5 -21.39 9.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.585 -0.697 . . . . 0.0 109.79 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -75.07 -60.82 2.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.96 -27.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 109.684 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 301' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' C' ' 300' ' ' VAL . 26.8 t -43.74 -57.2 3.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.124 -0.985 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -51.71 -24.09 5.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 108.914 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' C' ' 300' ' ' VAL . 89.1 m-20 -99.55 91.39 4.87 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -75.95 -84.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.558 -1.339 . . . . 0.0 109.218 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 305' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' C' ' 313' ' ' ILE . 80.2 m-85 -66.59 124.93 24.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 79.8 mt -125.04 139.78 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.42 -0.8 . . . . 0.0 109.305 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -64.62 129.91 41.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.913 . . . . 0.0 109.741 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 87.8 t80 -137.31 171.41 14.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 0.0 110.713 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 31.7 ttmt -32.35 -71.18 0.06 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.115 0.483 . . . . 0.0 111.265 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 310' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.16 -71.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.49 -166.36 2.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.079 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -56.37 157.97 4.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.365 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 313' ' ' ILE . . . . . 0.513 ' O ' ' CG1' ' C' ' 313' ' ' ILE . 2.1 pt -131.85 121.77 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.26 106.9 7.01 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.2 -0.938 . . . . 0.0 110.02 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.696 ' CG2' HD12 ' C' ' 245' ' ' ILE . 2.8 mm -79.71 154.0 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.047 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -157.27 157.49 34.32 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.836 -1.165 . . . . 0.0 109.01 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -67.65 143.88 55.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.668 -1.27 . . . . 0.0 109.254 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -84.92 44.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.006 -1.059 . . . . 0.0 109.939 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.512 ' CB ' ' CD ' ' B' ' 24' ' ' PRO . 26.5 Cg_exo -57.92 -172.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.881 2.387 . . . . 0.0 111.877 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.543 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 52.4 Cg_endo -89.32 23.4 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.02 2.48 . . . . 0.0 112.163 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.29 120.59 5.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.101 -1.0 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.49 ' N ' ' OG ' ' B' ' 80' ' ' SER . 4.3 ttt85 -179.28 -45.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.59 HG11 ' O ' ' B' ' 102' ' ' SER . 2.0 p -139.0 158.61 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.081 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.587 HG13 HD13 ' B' ' 72' ' ' ILE . 7.1 p -120.98 142.16 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.459 ' CZ ' ' HA3' ' B' ' 100' ' ' GLY . 2.9 m-30 -105.32 141.48 36.75 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.467 ' CD1' HD12 ' B' ' 42' ' ' ILE . 7.0 mt -129.26 117.21 20.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.478 -0.764 . . . . 0.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.52 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -132.95 -23.54 0.77 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.652 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -91.65 71.79 5.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.847 -1.384 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.577 HD12 ' N ' ' B' ' 33' ' ' ILE . 1.2 mp -145.74 125.18 6.81 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 109.829 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.585 ' C ' ' H ' ' B' ' 36' ' ' ASP . 29.7 Cg_endo -73.83 163.0 38.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.07 1.18 . . . . 0.0 109.935 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.451 ' OH ' ' CB ' ' B' ' 59' ' ' PHE . 4.7 m-85 -55.71 3.45 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 109.887 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' B' ' 34' ' ' PRO . 85.5 m-20 -66.17 -45.03 82.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.905 -1.122 . . . . 0.0 109.575 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.4 107.52 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -102.45 -153.25 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.466 -0.771 . . . . 0.0 111.53 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.43 ' N ' ' SD ' ' B' ' 57' ' ' MET . 1.1 pp20? -58.2 -23.69 56.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.69 -54.7 12.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.37 -38.76 88.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 110.845 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' B' ' 30' ' ' LEU . 24.7 mm -60.2 -51.53 71.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.8 -37.31 73.53 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.73 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.909 1.338 . . . . 0.0 109.377 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.637 HD21 ' CE2' ' B' ' 90' ' ' TYR . 14.4 tp -52.1 -48.84 64.54 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.417 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' B' ' 49' ' ' VAL . 94.9 m -60.26 -68.07 0.33 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.138 -0.976 . . . . 0.0 109.044 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.502 ' C ' ' H ' ' B' ' 49' ' ' VAL . 85.1 p -31.72 -33.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.979 0.419 . . . . 0.0 110.576 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' B' ' 46' ' ' CYS . 34.8 m120 -67.25 5.73 0.68 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.948 -1.095 . . . . 0.0 109.234 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 1.048 HG11 ' HB2' ' B' ' 83' ' ' ALA . 65.9 t -111.67 -55.06 4.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' B' ' 52' ' ' VAL . . . 174.63 154.24 10.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 52' ' ' VAL . 51.4 Cg_exo -44.76 80.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.308 2.006 . . . . 0.0 112.194 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' B' ' 50' ' ' GLY . 0.8 OUTLIER -39.37 157.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.828 . . . . 0.0 109.61 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' B' ' 75' ' ' ARG . 16.7 mm -87.56 -60.76 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.193 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.438 ' OD1' ' OE1' ' B' ' 73' ' ' GLU . 28.6 m120 -119.86 126.12 50.18 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.104 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -125.35 126.37 44.93 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -140.81 118.63 11.75 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.017 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' B' ' 39' ' ' GLU . 0.1 OUTLIER -113.41 143.81 43.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.255 0.55 . . . . 0.0 109.901 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 58' ' ' MET . . . . . 0.559 ' C ' ' SD ' ' B' ' 58' ' ' MET . 0.0 OUTLIER -161.54 157.18 24.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.603 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -129.88 149.24 51.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.517 ' HB3' ' N ' ' B' ' 66' ' ' SER . 4.7 p30 -42.87 98.04 0.16 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 111.383 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 42.3 Cg_endo -92.5 -17.58 0.83 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 122.807 2.338 . . . . 0.0 111.54 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -87.42 -65.93 0.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 111.267 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 -34.71 9.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.181 -0.949 . . . . 0.0 111.367 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.465 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 108.07 30.41 3.94 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.043 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.461 ' C ' ' OD2' ' B' ' 60' ' ' ASP . 81.1 mtp180 -93.88 -71.0 0.68 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.297 . . . . 0.0 110.3 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' B' ' 60' ' ' ASP . 25.8 t -43.68 121.92 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -86.86 5.32 37.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.184 -0.948 . . . . 0.0 109.024 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.21 88.89 0.1 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' TYR . . . . . 0.463 ' CD1' ' HA2' ' B' ' 31' ' ' GLY . 1.9 m-85 -105.7 133.33 50.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.53 -0.983 . . . . 0.0 109.782 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.84 146.03 26.9 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.947 -1.095 . . . . 0.0 112.536 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.434 ' C ' HD12 ' B' ' 72' ' ' ILE . 10.4 m-85 -114.51 130.11 56.72 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.705 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.929 HD12 ' N ' ' B' ' 72' ' ' ILE . 1.1 mp -121.93 102.33 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.35 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.438 ' OE1' ' OD1' ' B' ' 54' ' ' ASN . 29.4 mt-10 -93.05 136.71 33.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.252 -1.53 . . . . 0.0 110.244 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -98.32 176.53 5.67 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.853 0.835 . . . . 0.0 111.366 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 5.5 ttp180 -48.3 -42.01 29.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.858 -0.526 . . . . 0.0 111.42 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' B' ' 78' ' ' GLU . 3.5 m-20 156.62 -175.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.729 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.5 mm? -37.48 -23.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.655 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.8 mm-40 -70.24 -75.98 0.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.862 -1.149 . . . . 0.0 109.822 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 52.0 m -63.54 -40.59 97.41 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' B' ' 26' ' ' ARG . 25.7 t -58.92 -34.9 72.25 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -65.87 -61.29 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.676 -1.265 . . . . 0.0 109.031 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.602 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 22.0 t -60.21 -42.56 95.42 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.27 -0.894 . . . . 0.0 111.395 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 1.048 ' HB2' HG11 ' B' ' 49' ' ' VAL . . . -76.54 -65.66 0.9 Allowed 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.551 -0.718 . . . . 0.0 111.771 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -52.94 -37.84 27.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.296 -1.362 . . . . 0.0 109.212 -176.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.416 ' HA ' HD22 ' B' ' 88' ' ' ASN . 71.7 mtp85 -67.87 -47.47 68.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.365 -1.459 . . . . 0.0 108.382 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' B' ' 82' ' ' SER . 91.2 m-20 -67.5 -42.74 82.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.056 -1.028 . . . . 0.0 109.27 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.484 HD11 HG21 ' B' ' 49' ' ' VAL . 7.3 mt -106.35 28.72 7.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.333 -0.855 . . . . 0.0 110.084 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.69 ' O ' HD13 ' B' ' 97' ' ' LEU . 1.2 m-20 -61.51 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.82 -1.175 . . . . 0.0 109.188 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.68 107.77 0.86 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 1.051 ' CE1' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -134.1 148.81 51.05 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 119.677 1.739 . . . . 0.0 110.917 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' B' ' 90' ' ' TYR . 0.5 OUTLIER -46.25 91.59 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 119.876 -1.765 . . . . 0.0 108.456 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.1 tt -153.2 104.81 2.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.85 -175.39 43.47 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -67.12 -27.36 67.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.248 . . . . 0.0 109.617 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt85 -135.95 163.95 29.09 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.453 ' O ' ' C ' ' B' ' 97' ' ' LEU . 2.3 m-85 -92.69 133.99 35.47 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.31 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 1.051 HD11 ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -38.94 152.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.263 0.554 . . . . 0.0 109.562 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -108.46 146.84 32.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 109.268 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' CYS . . . . . 0.571 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.0 OUTLIER -91.9 124.78 36.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 109.781 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' B' ' 29' ' ' TYR . . . -137.17 -175.5 13.85 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.375 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 4.3 p90 -120.82 6.15 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -1.051 . . . . 0.0 110.562 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' SER . . . . . 0.59 ' O ' HG11 ' B' ' 27' ' ' VAL . 0.6 OUTLIER -39.92 125.05 1.87 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 0.0 109.913 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.241 179.818 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 159' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 1.0 OUTLIER -175.41 39.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.425 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 160' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 15.0 tttt -100.4 102.89 14.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 161' ' ' MET . . . . . 0.554 ' SD ' HG11 ' C' ' 216' ' ' VAL . 71.3 mtp -87.23 133.04 33.71 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.701 -1.199 . . . . 0.0 111.144 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 162' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' C' ' 202' ' ' PHE . 76.9 t80 -104.77 90.69 3.56 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 163' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' C' ' 166' ' ' LEU . 5.6 mm -59.99 127.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 164' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' C' ' 165' ' ' GLY . . . -130.34 -177.2 14.75 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' C' ' 164' ' ' GLY . . . 42.84 41.1 4.33 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 166' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' C' ' 163' ' ' ILE . 13.5 mt -83.96 170.84 13.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -1.041 . . . . 0.0 109.725 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.478 ' O ' ' OD1' ' C' ' 167' ' ' ASN . 39.9 p-10 -85.45 140.21 30.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 168' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -48.95 -27.85 3.43 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.676 -1.265 . . . . 0.0 110.018 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 169' ' ' ASP . . . . . 0.444 ' O ' ' ND2' ' C' ' 167' ' ' ASN . 58.3 t0 -90.49 102.43 15.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.978 -1.076 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 33.0 m -147.2 144.51 28.98 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.46 173.5 6.38 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.222 -0.924 . . . . 0.0 109.142 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 172' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' C' ' 192' ' ' LYS . 11.5 mp0 -84.18 -77.04 0.28 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.799 -1.188 . . . . 0.0 109.587 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' C' ' 176' ' ' ARG . 49.5 t0 -49.08 -55.45 12.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.629 -1.295 . . . . 0.0 108.388 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 174' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' C' ' 173' ' ' ASP . 64.2 t30 -43.23 -53.18 5.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.93 -35.19 70.75 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.215 -0.928 . . . . 0.0 108.994 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 176' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' C' ' 178' ' ' TYR . 67.5 ttp85 -70.98 -63.52 1.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 108.904 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 177' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' C' ' 176' ' ' ARG . 77.3 mm-40 -43.78 -25.91 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.563 ' CE2' HD23 ' C' ' 223' ' ' LEU . 34.1 t80 -76.37 -47.05 24.69 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.557 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 176' ' ' ARG . 26.2 m-85 -95.7 15.85 18.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.257 -0.902 . . . . 0.0 111.655 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.17 14.44 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -106.13 9.73 32.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -1.077 . . . . 0.0 108.228 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 182' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 19.8 m-85 -121.61 -4.25 9.27 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 144.12 -134.69 5.86 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -126.69 145.65 50.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -1.041 . . . . 0.0 109.297 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' C' ' 188' ' ' LEU . 0.6 OUTLIER -99.76 134.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.189 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.413 ' N ' ' O ' ' C' ' 206' ' ' SER . 0.1 OUTLIER -78.52 -61.47 2.0 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.985 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 187' ' ' ASP . . . . . 0.589 ' OD2' ' NZ ' ' C' ' 189' ' ' LYS . 0.3 OUTLIER -121.22 84.79 2.29 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.329 1.061 . . . . 0.0 112.021 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.71 ' O ' HD23 ' C' ' 188' ' ' LEU . 7.1 tt -81.28 107.03 13.73 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 189' ' ' LYS . . . . . 0.589 ' NZ ' ' OD2' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -121.31 96.13 4.96 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.22 -0.925 . . . . 0.0 110.893 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 190' ' ' ILE . . . . . 0.562 ' O ' ' SD ' ' C' ' 191' ' ' MET . 0.0 OUTLIER -107.8 141.13 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 191' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' C' ' 190' ' ' ILE . 10.7 mmt -125.33 78.99 1.77 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.059 -1.026 . . . . 0.0 110.647 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 192' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' C' ' 172' ' ' GLU . 26.1 pttm -79.52 153.77 29.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.107 -0.995 . . . . 0.0 109.305 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 11.9 t0 -52.68 114.69 6.05 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.038 -1.039 . . . . 0.0 108.699 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.01 -21.54 4.02 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.827 1.685 . . . . 0.0 112.661 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -80.18 -86.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.24 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 45.5 p -109.35 -28.63 8.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.212 -0.93 . . . . 0.0 109.677 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 197' ' ' GLY . . . . . 0.527 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 122.28 17.63 3.59 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -90.79 58.47 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.072 -1.252 . . . . 0.0 109.519 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 199' ' ' SER . . . . . 0.477 ' O ' ' C ' ' C' ' 200' ' ' ARG . 39.4 t -142.99 169.83 16.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' C' ' 199' ' ' SER . 19.3 mmt180 -37.06 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.92 92.29 1.49 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.302 -1.427 . . . . 0.0 109.861 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.458 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 48.5 p90 -125.9 155.65 40.92 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.512 -0.993 . . . . 0.0 108.611 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.93 123.11 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.957 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -93.25 86.44 5.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.843 -1.387 . . . . 0.0 107.981 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.433 HD12 HD11 ' C' ' 163' ' ' ILE . 33.2 mt -87.49 85.27 7.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.727 -1.233 . . . . 0.0 110.321 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 206' ' ' SER . . . . . 0.553 ' CB ' ' H ' ' C' ' 187' ' ' ASP . 0.1 OUTLIER -65.47 85.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.596 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.527 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 14.5 m-85 -68.08 122.3 17.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.155 -0.966 . . . . 0.0 110.917 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.87 -50.32 36.44 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.788 -0.57 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -83.56 115.19 58.22 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 110.86 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.58 -38.22 44.53 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.186 1.924 . . . . 0.0 112.799 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 86.1 p -64.53 -49.95 69.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.854 ' O ' HG23 ' C' ' 216' ' ' VAL . 22.6 t -43.56 -33.21 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 109.224 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 213' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.17 -40.44 85.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.168 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 214' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' C' ' 211' ' ' SER . 57.6 t0 -59.68 -51.14 71.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.505 -0.747 . . . . 0.0 110.665 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 215' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' C' ' 219' ' ' THR . 5.5 pt-20 -68.17 -33.37 74.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.854 HG23 ' O ' ' C' ' 212' ' ' SER . 55.8 t -58.97 -47.99 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.009 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.441 HG12 ' O ' ' C' ' 214' ' ' ASP . 8.8 p -71.48 -30.04 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.1 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -89.71 21.53 3.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 109.742 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 219' ' ' THR . . . . . 0.578 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 41.3 m -129.82 149.43 51.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 220' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' C' ' 221' ' ' HIS . 13.1 tt0 -75.92 -177.85 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.125 -0.985 . . . . 0.0 109.392 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.781 ' HB3' HD11 ' C' ' 228' ' ' ILE . 55.3 m-70 -158.28 130.52 6.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 110.3 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 222' ' ' ILE . . . . . 0.517 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 24.6 mt -153.35 80.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.737 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.563 HD23 ' CE2' ' C' ' 178' ' ' TYR . 16.5 mt -51.43 -71.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.735 -1.228 . . . . 0.0 109.54 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -101.51 -55.77 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 108.855 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 159.9 30.9 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 226' ' ' LYS . . . . . 0.911 ' NZ ' HG23 ' C' ' 280' ' ' THR . 0.0 OUTLIER -94.1 -76.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.107 -1.231 . . . . 0.0 108.601 178.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 227' ' ' VAL . . . . . 0.865 HG23 ' O ' ' C' ' 226' ' ' LYS . 2.1 t 155.39 90.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 228' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' C' ' 221' ' ' HIS . 23.2 pt -94.2 152.05 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.34 96.41 44.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.543 -0.723 . . . . 0.0 110.768 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 230' ' ' PRO . . . . . 0.508 ' CG ' ' CD2' ' C' ' 221' ' ' HIS . 18.9 Cg_endo -81.82 121.51 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.709 2.273 . . . . 0.0 111.645 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -142.52 148.26 37.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 0.0 110.127 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.52 159.36 0.51 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 233' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' C' ' 160' ' ' LYS . . . -57.5 144.28 37.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 234' ' ' ILE . . . . . 0.402 HG22 ' N ' ' C' ' 239' ' ' GLN . 38.4 mt -132.6 91.15 31.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.486 -0.759 . . . . 0.0 109.418 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.42 161.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.11 1.873 . . . . 0.0 111.742 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' C' ' 236' ' ' ARG . 0.0 OUTLIER -51.57 -49.2 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.975 . . . . 0.0 111.312 -178.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -59.66 -43.28 94.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.845 -1.159 . . . . 0.0 109.824 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -68.36 -36.91 79.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.131 -0.98 . . . . 0.0 110.001 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 239' ' ' GLN . . . . . 0.402 ' N ' HG22 ' C' ' 234' ' ' ILE . 35.0 tt0 -61.17 -41.46 96.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.171 -0.956 . . . . 0.0 108.838 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.3 -25.03 31.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.473 -0.767 . . . . 0.0 109.599 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -51.2 -16.11 0.45 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.692 . . . . 0.0 110.432 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 13.9 p -106.38 159.69 15.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.918 -1.113 . . . . 0.0 109.231 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -115.41 154.87 16.67 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 244' ' ' LYS . . . . . 0.569 ' N ' HH12 ' C' ' 317' ' ' ARG . 0.0 OUTLIER -140.05 147.28 40.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.268 . . . . 0.0 111.235 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.642 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -129.68 154.44 40.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.729 0.776 . . . . 0.0 109.142 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 246' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 2.0 t80 -102.19 128.19 48.81 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.75 143.64 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 110.368 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.9 154.21 16.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.0 56.26 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 120.939 -1.33 . . . . 0.0 111.209 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' C' ' 286' ' ' PHE . 1.5 pp -111.26 137.69 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.903 -1.351 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 251' ' ' GLY . . . . . 0.657 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 157.81 -37.8 0.54 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 252' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 50.0 Cg_exo -54.06 -127.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.512 2.142 . . . . 0.0 112.22 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -69.86 19.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 109.681 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' C' ' 252' ' ' PRO . 1.3 m -93.19 137.3 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.918 -1.114 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 255' ' ' ARG . . . . . 0.633 ' CD ' ' N ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -103.45 163.07 18.19 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 256' ' ' PRO . . . . . 0.477 ' HB3' HD22 ' C' ' 274' ' ' LEU . 29.6 Cg_endo -63.59 -21.43 70.41 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.46 2.107 . . . . 0.0 111.372 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -62.25 -58.57 7.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.655 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.59 -41.72 86.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 259' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' C' ' 263' ' ' PHE . 29.0 t80 -52.6 -63.18 1.23 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.93 -43.43 98.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.911 -0.493 . . . . 0.0 110.28 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 261' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.97 -18.83 64.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.093 -1.005 . . . . 0.0 108.979 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 262' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' C' ' 265' ' ' GLN . 33.8 t80 -88.95 -77.75 0.37 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.234 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.575 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 43.2 m-85 -43.5 -36.26 1.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.928 -1.107 . . . . 0.0 109.494 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.499 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.8 t -30.72 -40.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.325 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.635 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 1.1 pt20 -60.76 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.429 -1.419 . . . . 0.0 110.981 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.635 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.2 OUTLIER -60.15 147.83 38.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.397 -1.439 . . . . 0.0 109.402 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 267' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' C' ' 269' ' ' ILE . . . 58.91 86.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 268' ' ' THR . . . . . 0.506 ' O ' ' C ' ' C' ' 269' ' ' ILE . 3.8 t -53.59 43.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.483 -1.01 . . . . 0.0 113.625 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.773 HD11 ' HB ' ' C' ' 289' ' ' VAL . 1.7 tt -13.77 111.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.9 mm -87.2 -33.95 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.439 -1.413 . . . . 0.0 107.81 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.04 99.1 5.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 272' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' C' ' 269' ' ' ILE . . . -108.32 132.78 53.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.321 -0.862 . . . . 0.0 109.371 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -160.59 123.56 3.34 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 117.919 -1.512 . . . . 0.0 112.081 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.961 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.2 OUTLIER -100.63 155.08 18.08 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 275' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' C' ' 280' ' ' THR . 20.8 mmt -90.08 161.24 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.398 . . . . 0.0 109.619 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' C' ' 280' ' ' THR . 1.0 OUTLIER -126.62 -165.41 1.45 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.494 0.664 . . . . 0.0 109.689 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 277' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' C' ' 277' ' ' ASP . 53.5 p30 -97.98 -9.97 25.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.448 -0.782 . . . . 0.0 109.339 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 278' ' ' LYS . . . . . 0.504 ' HG2' HD23 ' C' ' 276' ' ' LEU . 49.9 mmtt -60.6 -54.6 43.38 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 279' ' ' ASP . . . . . 0.806 ' N ' ' HZ1' ' C' ' 226' ' ' LYS . 0.2 OUTLIER 177.51 -6.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.598 -0.689 . . . . 0.0 110.895 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 280' ' ' THR . . . . . 0.911 HG23 ' NZ ' ' C' ' 226' ' ' LYS . 42.8 p -64.88 -3.14 3.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.446 -1.409 . . . . 0.0 108.708 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 281' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' C' ' 279' ' ' ASP . . . 155.04 -119.48 0.93 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.583 ' C ' ' H ' ' C' ' 284' ' ' ARG . 55.9 mt-30 -147.1 129.09 15.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 109.881 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 51.5 p -66.01 15.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 109.518 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 284' ' ' ARG . . . . . 0.583 ' H ' ' C ' ' C' ' 282' ' ' GLN . 10.1 tpp85 -49.86 -38.15 34.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.86 70.52 0.06 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.448 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' C' ' 250' ' ' ILE . 22.3 p90 -170.58 179.31 3.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.173 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -174.21 -167.48 33.79 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.9 154.51 43.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.471 -1.605 . . . . 0.0 109.465 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 289' ' ' VAL . . . . . 0.773 ' HB ' HD11 ' C' ' 269' ' ' ILE . 0.7 OUTLIER -141.55 152.82 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 11.0 m -133.57 126.75 31.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.968 -1.083 . . . . 0.0 110.497 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 291' ' ' TYR . . . . . 0.46 ' CE2' ' CG2' ' C' ' 289' ' ' VAL . 49.8 m-85 -113.15 143.71 43.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.37 -50.84 71.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.298 -1.501 . . . . 0.0 109.064 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 16.6 t -91.29 171.19 9.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 294' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' C' ' 297' ' ' VAL . . . -105.29 -20.03 13.62 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 295' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 294' ' ' ALA . 91.5 m-20 -47.05 -39.63 13.28 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.43 -33.6 72.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 297' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' C' ' 294' ' ' ALA . 60.4 t -69.86 -63.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.06 -18.29 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.046 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 299' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' C' ' 297' ' ' VAL . 1.7 ttt85 -78.37 -57.39 3.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.485 -0.759 . . . . 0.0 109.004 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' C' ' 303' ' ' ASN . 3.3 p -65.76 -25.97 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 301' ' ' CYS . . . . . 0.437 ' C ' ' N ' ' C' ' 303' ' ' ASN . 33.5 m -44.77 -58.83 2.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.863 -1.148 . . . . 0.0 109.005 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 302' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' C' ' 301' ' ' CYS . 82.8 mt-30 -47.19 -23.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.011 . . . . 0.0 108.394 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' C' ' 300' ' ' VAL . 97.1 m-20 -100.16 70.75 1.56 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -68.93 -9.28 51.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.53 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 305' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' C' ' 314' ' ' GLU . 45.3 m-85 -137.53 122.26 18.69 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 0.0 108.832 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 306' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' C' ' 300' ' ' VAL . 54.2 mt -121.65 145.85 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.889 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -79.46 120.12 23.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 108.519 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 73.5 t80 -120.03 -179.1 3.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.641 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 33.0 ttpt -43.61 -30.13 0.57 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 310' ' ' ASP . . . . . 0.562 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 46.1 t0 -86.25 -154.23 0.21 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 311' ' ' ARG . . . . . 0.562 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 35.7 ptt180 -79.0 -48.11 15.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 109.041 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 312' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' C' ' 311' ' ' ARG . 6.5 ttmt -165.72 155.31 12.34 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 313' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' C' ' 250' ' ' ILE . 37.3 pt -131.2 157.68 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 314' ' ' GLU . . . . . 0.411 ' HG3' ' CE2' ' C' ' 305' ' ' PHE . 8.4 mp0 -110.43 152.54 26.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.959 . . . . 0.0 109.83 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.642 ' CG2' HD12 ' C' ' 245' ' ' ILE . 6.7 mm -119.38 142.26 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -145.93 144.23 30.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.192 -0.942 . . . . 0.0 108.859 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 317' ' ' ARG . . . . . 0.569 HH12 ' N ' ' C' ' 244' ' ' LYS . 20.9 tpt180 -70.64 135.51 48.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 318' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 319' ' ' GLU . . . -60.9 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 319' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' C' ' 317' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 109.432 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' B' ' 102' ' ' SER . 4.1 m-80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.34 147.03 87.2 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.46 2.107 . . . . 0.0 111.899 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.25 3.47 5.71 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.486 2.124 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.92 130.14 8.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.955 -1.091 . . . . 0.0 109.409 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.54 ' NH1' ' OD1' ' B' ' 76' ' ' ASP . 4.6 ttt85 -176.51 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -0.793 . . . . 0.0 109.249 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.69 HG12 ' H ' ' B' ' 102' ' ' SER . 1.6 p -140.85 165.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.1 t -124.9 144.64 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.498 ' C ' HD12 ' B' ' 30' ' ' LEU . 5.7 m-85 -111.53 130.91 55.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' B' ' 72' ' ' ILE . 8.5 mp -115.98 105.33 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -103.21 -72.54 0.92 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.887 -1.149 . . . . 0.0 112.113 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.467 ' HG ' ' CB ' ' B' ' 94' ' ' SER . 8.5 t -68.85 86.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.332 . . . . 0.0 110.338 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' B' ' 30' ' ' LEU . 3.1 mp -147.38 126.09 6.23 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.73 165.96 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.721 1.614 . . . . 0.0 112.836 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -70.59 1.47 5.17 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.74 -34.28 77.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.77 112.26 19.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.103 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.5 p -107.2 -142.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.502 0.667 . . . . 0.0 110.891 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.63 -28.36 68.48 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.927 -1.108 . . . . 0.0 110.322 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.59 -53.98 16.24 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.078 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -68.84 -44.5 73.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.874 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' B' ' 44' ' ' ASP . 14.2 mm -59.79 -52.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.868 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 42' ' ' ILE . 0.7 OUTLIER -38.94 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.809 -0.557 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' B' ' 42' ' ' ILE . 97.4 m-20 -122.54 -23.71 5.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.658 -1.276 . . . . 0.0 110.552 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.739 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.0 tm? -59.25 -43.85 92.39 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.16 -1.588 . . . . 0.0 106.922 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.0 OUTLIER -82.14 -63.23 1.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.189 -0.944 . . . . 0.0 109.289 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.775 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.9 t -37.91 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.655 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.6 OUTLIER -51.81 67.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.441 1.115 . . . . 0.0 110.153 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.775 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.22 -34.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.278 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.66 -173.05 46.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.46 159.33 20.11 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 123.046 2.498 . . . . 0.0 112.535 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' B' ' 74' ' ' PHE . 20.8 t -129.4 145.96 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.558 HD11 ' HD2' ' B' ' 75' ' ' ARG . 43.3 mm -91.28 -67.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.054 . . . . 0.0 111.877 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.538 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 74.7 m-20 -117.72 146.28 43.86 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.079 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.576 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.6 OUTLIER -140.64 129.89 23.67 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.06 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.576 ' N ' HD23 ' B' ' 55' ' ' LEU . 8.8 mtmp? -143.29 147.92 35.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.884 -1.135 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 4.5 ttm -125.92 136.48 53.09 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' MET . . . . . 0.589 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -155.69 154.97 32.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.874 -1.141 . . . . 0.0 111.105 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.589 ' O ' ' SD ' ' B' ' 58' ' ' MET . 3.3 m-85 -111.43 176.4 5.04 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.616 -0.677 . . . . 0.0 110.167 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' B' ' 66' ' ' SER . 40.9 m-20 -114.24 84.9 9.77 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 0.0 110.901 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -60.82 -61.96 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.018 2.478 . . . . 0.0 113.136 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -81.62 -65.7 0.98 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.553 -0.717 . . . . 0.0 111.004 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.431 HG23 ' H ' ' B' ' 63' ' ' THR . 1.3 p -47.96 -45.13 30.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.113 -0.992 . . . . 0.0 109.135 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.92 12.21 81.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.498 HH12 HH22 ' C' ' 200' ' ' ARG . 78.5 mtm180 -59.52 -40.2 86.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.004 -1.292 . . . . 0.0 109.428 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.505 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -174.47 170.97 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.946 -1.096 . . . . 0.0 111.118 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 69' ' ' TYR . 37.9 mmtm -108.65 -68.09 0.93 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.266 -0.897 . . . . 0.0 110.437 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -60.32 68.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.138 0 O-C-N 120.595 -1.315 . . . . 0.0 111.571 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' TYR . . . . . 0.561 ' N ' ' O ' ' B' ' 67' ' ' LYS . 1.2 m-85 -106.96 125.82 51.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.688 -1.478 . . . . 0.0 109.18 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.21 140.0 32.19 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.499 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -106.5 123.56 48.27 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.736 ' CD1' HD13 ' B' ' 30' ' ' LEU . 3.4 mp -118.73 97.3 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.633 -0.667 . . . . 0.0 111.152 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.538 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 83.1 tt0 -84.48 131.06 34.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.437 -1.415 . . . . 0.0 110.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' B' ' 52' ' ' VAL . 6.6 m-85 -92.85 178.76 5.67 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.708 0.766 . . . . 0.0 111.056 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.558 ' HD2' HD11 ' B' ' 53' ' ' ILE . 10.4 tpt180 -52.16 -41.74 62.83 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.591 -0.693 . . . . 0.0 111.315 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.8 m-20 159.06 176.86 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.797 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.1 mp -36.63 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.816 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' B' ' 76' ' ' ASP . 50.1 mp0 -70.3 -74.74 0.13 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.389 -1.445 . . . . 0.0 108.459 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -61.78 -39.76 92.81 Favored 'General case' 0 C--O 1.195 -1.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' B' ' 26' ' ' ARG . 0.5 OUTLIER -64.07 -34.56 78.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.139 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -60.94 -61.72 2.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.485 -1.384 . . . . 0.0 107.746 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' B' ' 86' ' ' ASN . 23.3 t -62.77 -38.79 91.97 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.621 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.57 -64.83 1.08 Allowed 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 111.293 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' B' ' 99' ' ' CYS . 28.8 t -48.54 -41.03 11.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.655 -1.278 . . . . 0.0 108.538 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.57 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 61.7 ttm-85 -64.58 -49.14 72.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.938 -1.101 . . . . 0.0 109.237 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' B' ' 82' ' ' SER . 23.9 m120 -76.23 -46.39 28.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.23 -0.919 . . . . 0.0 109.907 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' B' ' 83' ' ' ALA . 3.7 mm? -86.8 15.91 5.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.46 -0.775 . . . . 0.0 110.44 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' B' ' 88' ' ' ASN . 0.5 OUTLIER -53.89 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.685 -1.26 . . . . 0.0 108.258 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.96 116.65 1.61 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -136.93 144.89 43.69 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.369 -1.665 . . . . 0.0 107.667 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -34.79 92.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.542 -0.724 . . . . 0.0 111.304 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 90' ' ' TYR . 61.2 tp -154.79 135.44 13.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.695 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.36 -162.39 10.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' SER . . . . . 0.467 ' CB ' ' HG ' ' B' ' 32' ' ' SER . 0.9 OUTLIER -88.0 -6.61 57.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.257 . . . . 0.0 109.344 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' B' ' 92' ' ' LEU . 37.8 ttm180 -134.56 160.28 38.55 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.502 ' O ' ' C ' ' B' ' 97' ' ' LEU . 57.1 m-85 -95.81 134.41 38.79 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.431 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.571 HD23 HD11 ' B' ' 30' ' ' LEU . 1.9 mp -31.76 150.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -118.23 144.46 45.75 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' CYS . . . . . 0.478 ' HA ' HG13 ' B' ' 84' ' ' VAL . 4.8 p -78.94 107.75 11.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.252 -0.905 . . . . 0.0 110.307 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -88.42 171.04 39.59 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -156.15 92.82 1.37 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.1 -1.235 . . . . 0.0 108.066 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 102' ' ' SER . . . . . 0.69 ' H ' HG12 ' B' ' 27' ' ' VAL . 0.9 OUTLIER -27.22 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.778 0.799 . . . . 0.0 109.992 -178.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.43 ' N ' ' O ' ' B' ' 101' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.52 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.354 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 93.1 p . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.341 0.591 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 6.9 m -78.19 66.67 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 108.742 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 16.3 tttt -108.29 89.41 2.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.551 -0.718 . . . . 0.0 110.418 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 161' ' ' MET . . . . . 0.505 ' SD ' ' CG2' ' C' ' 217' ' ' VAL . 14.0 mmm -64.31 140.63 58.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 110.501 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -103.76 132.76 49.71 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 26.7 mm -114.02 128.01 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -131.77 -173.68 13.41 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.347 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.96 22.23 2.87 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 166' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' C' ' 202' ' ' PHE . 3.0 mt -61.66 159.0 14.14 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.483 -1.01 . . . . 0.0 109.28 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.449 ' OD1' ' C ' ' C' ' 167' ' ' ASN . 36.4 p-10 -80.31 167.3 20.42 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.174 -0.954 . . . . 0.0 108.851 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 168' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -92.76 32.45 1.24 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.63 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.16 76.97 0.63 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.001 . . . . 0.0 110.332 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 170' ' ' THR . . . . . 0.408 ' HG1' ' CG ' ' C' ' 167' ' ' ASN . 84.7 m -150.7 147.46 27.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.961 -1.087 . . . . 0.0 110.078 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.13 172.51 6.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 172' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -69.66 -66.9 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.747 -1.221 . . . . 0.0 109.502 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 172' ' ' GLU . 57.4 t0 -43.94 -33.37 1.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.084 -1.01 . . . . 0.0 109.232 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -74.93 -49.49 20.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.125 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.57 -46.36 84.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.2 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 176' ' ' ARG . . . . . 0.559 ' CD ' HG11 ' C' ' 185' ' ' VAL . 21.9 ttp85 -63.23 -60.64 3.13 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.806 -1.184 . . . . 0.0 107.932 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 177' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' C' ' 176' ' ' ARG . 47.4 tp10 -41.94 -30.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.57 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 23.7 t80 -70.84 -53.85 13.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.038 -1.039 . . . . 0.0 108.826 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.81 ' O ' ' N ' ' C' ' 181' ' ' LYS . 72.5 m-85 -75.27 -62.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.35 -0.844 . . . . 0.0 110.192 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -41.61 2.79 0.01 OUTLIER Glycine 0 N--CA 1.503 3.154 0 O-C-N 120.555 -1.341 . . . . 0.0 112.381 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 181' ' ' LYS . . . . . 0.81 ' N ' ' O ' ' C' ' 179' ' ' PHE . 38.8 tttt -73.96 -15.1 61.12 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 182' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -77.46 -58.46 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.475 0.655 . . . . 0.0 110.017 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -156.61 -104.9 0.22 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 47.6 m -127.83 147.19 50.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.511 -0.994 . . . . 0.0 109.569 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.559 HG11 ' CD ' ' C' ' 176' ' ' ARG . 14.7 p -126.5 144.42 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' C' ' 208' ' ' GLU . 0.2 OUTLIER -91.06 -58.3 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.176 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 187' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' C' ' 206' ' ' SER . 43.8 t0 -156.86 160.76 39.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.814 HD23 ' H ' ' C' ' 188' ' ' LEU . 1.7 pt? -146.09 143.89 29.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.92 85.62 2.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.012 -1.055 . . . . 0.0 109.234 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.8 156.25 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 191' ' ' MET . . . . . 0.448 ' CB ' ' CZ ' ' C' ' 202' ' ' PHE . 6.3 tpp -142.31 55.84 1.45 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.022 -1.049 . . . . 0.0 110.486 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.74 117.5 15.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 108.887 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -135.42 80.36 45.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.383 -0.823 . . . . 0.0 109.906 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.16 -18.12 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.439 2.092 . . . . 0.0 110.914 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.72 ' O ' HG23 ' C' ' 196' ' ' THR . . . -65.5 -38.42 89.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 196' ' ' THR . . . . . 0.72 HG23 ' O ' ' C' ' 195' ' ' ALA . 5.8 p -165.81 -32.07 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.586 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 197' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 193' ' ' ASP . . . -102.64 100.31 1.95 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.398 -1.382 . . . . 0.0 109.842 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -103.26 133.77 47.78 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.453 -1.028 . . . . 0.0 109.557 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 199' ' ' SER . . . . . 0.588 ' O ' ' C ' ' C' ' 200' ' ' ARG . 2.7 m -156.78 151.62 25.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 109.306 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.588 ' C ' ' O ' ' C' ' 199' ' ' SER . 94.0 mtt-85 -24.97 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.9 120.58 5.18 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.151 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.623 ' HA ' HD12 ' C' ' 166' ' ' LEU . 50.8 p90 -165.03 164.66 20.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -140.86 125.5 2.85 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.582 -1.771 . . . . 0.0 110.41 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 204' ' ' PHE . . . . . 0.422 ' CD1' ' NZ ' ' C' ' 160' ' ' LYS . 3.7 m-85 -89.98 65.65 6.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' C' ' 207' ' ' PHE . 0.7 OUTLIER -64.37 101.48 0.44 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.845 0.831 . . . . 0.0 112.606 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 206' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.3 OUTLIER -86.1 138.69 31.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.808 ' CE1' HD22 ' C' ' 205' ' ' LEU . 24.5 m-85 -118.05 144.01 45.94 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.537 -1.352 . . . . 0.0 109.694 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 208' ' ' GLU . . . . . 0.538 ' N ' ' OG1' ' C' ' 186' ' ' THR . 84.9 tt0 -68.36 -46.44 70.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -100.35 125.16 40.39 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.816 -1.178 . . . . 0.0 111.053 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 210' ' ' PRO . . . . . 0.904 ' O ' HG22 ' C' ' 213' ' ' VAL . 51.4 Cg_exo -45.74 -40.33 19.11 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.973 2.449 . . . . 0.0 114.223 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 97.8 p -61.34 -46.6 89.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.584 -1.322 . . . . 0.0 110.68 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.774 ' O ' HG23 ' C' ' 216' ' ' VAL . 29.6 m -39.33 -31.03 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 213' ' ' VAL . . . . . 0.904 HG22 ' O ' ' C' ' 210' ' ' PRO . 6.2 m -69.78 -34.52 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.21 . . . . 0.0 110.233 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 214' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' C' ' 218' ' ' LYS . 54.9 t0 -62.36 -49.17 76.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.32 -33.95 75.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 108.986 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.774 HG23 ' O ' ' C' ' 212' ' ' SER . 48.1 t -82.26 33.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.505 ' CG2' ' SD ' ' C' ' 161' ' ' MET . 21.1 t -154.58 -36.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.605 -0.684 . . . . 0.0 109.579 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 218' ' ' LYS . . . . . 0.492 ' NZ ' ' OD1' ' C' ' 214' ' ' ASP . 2.2 ttmp? -92.67 23.87 3.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.644 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 219' ' ' THR . . . . . 0.796 ' O ' ' CE1' ' C' ' 221' ' ' HIS . 42.2 m -134.81 157.21 47.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -83.95 134.22 34.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 108.459 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.796 ' CE1' ' O ' ' C' ' 219' ' ' THR . 12.2 m80 -123.51 133.6 53.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 222' ' ' ILE . . . . . 0.57 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -145.38 106.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 110.449 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' C' ' 178' ' ' TYR . 3.9 mm? -52.8 -65.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.635 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -126.26 24.15 6.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.23 15.07 42.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -80.93 -154.36 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -1.098 . . . . 0.0 108.51 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 227' ' ' VAL . . . . . 0.566 HG12 ' OE1' ' C' ' 273' ' ' GLN . 0.3 OUTLIER -132.32 97.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 228' ' ' ILE . . . . . 0.538 HD13 HD23 ' C' ' 223' ' ' LEU . 19.7 pt -107.56 153.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.622 -0.674 . . . . 0.0 109.579 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 229' ' ' ASP . . . . . 0.502 ' OD1' ' OD2' ' C' ' 271' ' ' ASP . 28.3 t0 -123.62 97.36 42.04 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.628 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 230' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -86.77 125.58 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.847 2.365 . . . . 0.0 111.928 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 231' ' ' LYS . . . . . 0.637 ' HG2' HD11 ' C' ' 234' ' ' ILE . 0.3 OUTLIER -145.82 142.39 28.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.99 . . . . 0.0 109.64 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' C' ' 233' ' ' ALA . 58.5 ttp180 -53.04 144.24 15.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 108.959 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 233' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -36.23 116.72 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 234' ' ' ILE . . . . . 0.637 HD11 ' HG2' ' C' ' 231' ' ' LYS . 67.7 mt -99.25 134.95 20.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 0.0 109.486 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.42 149.61 62.94 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.125 1.883 . . . . 0.0 111.705 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -34.99 68.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.482 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.28 -45.57 80.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -71.23 -37.31 72.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 0.0 109.21 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 239' ' ' GLN . . . . . 0.527 ' O ' ' OG1' ' C' ' 242' ' ' THR . 77.5 mt-30 -58.68 -35.27 72.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 108.727 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.53 -42.47 91.95 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.197 -0.939 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 241' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' C' ' 242' ' ' THR . 18.8 mttp -69.72 -51.79 31.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 242' ' ' THR . . . . . 0.537 ' C ' ' O ' ' C' ' 241' ' ' LYS . 0.1 OUTLIER -22.62 140.33 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.284 0.564 . . . . 0.0 111.403 -178.085 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -132.65 130.19 5.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 244' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' C' ' 318' ' ' ALA . 0.0 OUTLIER -132.27 138.61 47.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.971 -1.311 . . . . 0.0 110.406 178.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.419 ' CG2' HG13 ' C' ' 297' ' ' VAL . 2.5 pt -123.96 140.39 47.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.835 0.826 . . . . 0.0 108.906 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 246' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' C' ' 247' ' ' VAL . 10.8 t80 -70.85 158.23 36.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 247' ' ' VAL . . . . . 0.415 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 0.6 OUTLIER -138.27 133.88 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.852 . . . . 0.0 109.473 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.73 152.13 16.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.62 -29.16 12.78 Favored Glycine 0 N--CA 1.495 2.571 0 O-C-N 121.095 -1.238 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.402 HG22 ' CD2' ' C' ' 308' ' ' PHE . 1.2 pp -109.58 164.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.074 -1.251 . . . . 0.0 108.941 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 251' ' ' GLY . . . . . 0.65 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.71 -42.98 1.32 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 252' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 45.4 Cg_exo -56.16 -132.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.874 2.382 . . . . 0.0 112.378 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.79 -36.1 67.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -0.867 . . . . 0.0 110.575 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.531 ' CG1' ' OD2' ' C' ' 310' ' ' ASP . 13.7 m -55.92 127.46 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.0 109.47 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 255' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -90.65 160.66 38.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 256' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' C' ' 257' ' ' LYS . 17.0 Cg_endo -60.34 -26.26 82.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.97 2.447 . . . . 0.0 112.259 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 257' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' C' ' 256' ' ' PRO . 26.2 mtpp -45.32 -62.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 258' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.2 tp10 -60.9 -82.88 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.409 -0.917 . . . . 0.0 108.69 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 259' ' ' PHE . . . . . 0.606 ' C ' ' O ' ' C' ' 258' ' ' GLU . 1.1 t80 -10.98 -62.1 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 CA-C-O 121.438 0.637 . . . . 0.0 111.263 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 260' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 258' ' ' GLU . 87.7 tt0 -64.03 -48.53 75.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.27 -0.894 . . . . 0.0 109.523 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 261' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' C' ' 258' ' ' GLU . 0.0 OUTLIER -73.04 0.95 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 262' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' C' ' 264' ' ' SER . 0.7 OUTLIER -94.54 -74.24 0.55 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.496 ' O ' ' C ' ' C' ' 264' ' ' SER . 29.2 m-85 -42.19 -27.24 0.13 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.21 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.592 ' O ' ' N ' ' C' ' 266' ' ' TRP . 29.0 t -40.15 -41.64 1.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' C' ' 264' ' ' SER . 50.0 tt0 -39.79 -19.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.756 -0.59 . . . . 0.0 110.67 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.664 ' HE1' ' CG1' ' C' ' 300' ' ' VAL . 8.8 p90 -154.13 151.79 29.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.805 -1.185 . . . . 0.0 109.111 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 62.8 -172.4 10.44 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 268' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 3.4 t -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' C' ' 272' ' ' ALA . 5.0 mm -96.33 100.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.423 -1.311 . . . . 0.0 110.263 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 270' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 291' ' ' TYR . 1.4 mp -72.01 -57.71 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.634 -0.667 . . . . 0.0 110.372 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 271' ' ' ASP . . . . . 0.502 ' OD2' ' OD1' ' C' ' 229' ' ' ASP . 0.5 OUTLIER -129.61 106.53 8.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 272' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' C' ' 269' ' ' ILE . . . -120.87 142.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.903 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 273' ' ' GLN . . . . . 0.566 ' OE1' HG12 ' C' ' 227' ' ' VAL . 10.9 pt20 -171.53 136.75 1.0 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.637 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.536 HD13 ' HA2' ' C' ' 251' ' ' GLY . 3.6 pp -112.01 156.9 21.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 275' ' ' MET . . . . . 0.672 ' SD ' ' N ' ' C' ' 275' ' ' MET . 0.0 OUTLIER -99.4 168.67 9.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.717 -1.239 . . . . 0.0 109.533 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.621 ' O ' ' N ' ' C' ' 278' ' ' LYS . 1.6 pp -157.62 -178.37 7.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.924 . . . . 0.0 109.718 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 277' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' C' ' 283' ' ' SER . 55.7 t0 -64.96 44.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 109.047 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 278' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -48.5 -32.38 7.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 279' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 278' ' ' LYS . 6.8 m-20 -179.17 27.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 280' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' C' ' 280' ' ' THR . 0.0 OUTLIER -172.67 21.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.783 -1.198 . . . . 0.0 110.394 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 281' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' C' ' 277' ' ' ASP . . . 61.86 23.5 63.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' C' ' 284' ' ' ARG . 3.7 tp60 -50.65 -16.23 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -1.065 . . . . 0.0 109.076 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 283' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' C' ' 277' ' ' ASP . 0.3 OUTLIER -62.92 38.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.546 -0.721 . . . . 0.0 110.072 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 284' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' C' ' 282' ' ' GLN . 0.5 OUTLIER -46.61 -33.67 4.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.08 67.88 0.21 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.408 ' HB2' ' CZ ' ' C' ' 246' ' ' PHE . 38.8 p90 -176.43 -171.23 0.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.88 -1.365 . . . . 0.0 109.604 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . 175.21 -165.54 36.61 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -142.13 154.87 45.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.296 -1.708 . . . . 0.0 108.978 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 289' ' ' VAL . . . . . 0.41 ' CG2' ' CE1' ' C' ' 291' ' ' TYR . 0.5 OUTLIER -131.42 145.64 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 290' ' ' THR . . . . . 0.467 ' O ' ' N ' ' C' ' 270' ' ' ILE . 32.3 m -133.05 123.67 26.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.509 -1.369 . . . . 0.0 109.997 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 291' ' ' TYR . . . . . 0.591 ' O ' HD13 ' C' ' 270' ' ' ILE . 33.4 m-85 -98.95 -80.27 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.293 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 292' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER 169.39 -56.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 O-C-N 120.631 -1.293 . . . . 0.0 108.009 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 293' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 58.6 p -93.82 172.66 8.11 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.17 -8.76 23.24 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.13 -52.4 65.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 108.618 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.52 95.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 108.485 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 297' ' ' VAL . . . . . 0.419 HG13 ' CG2' ' C' ' 245' ' ' ILE . 45.6 t -52.66 -57.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.186 -0.946 . . . . 0.0 108.611 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.07 -32.6 71.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.196 -0.94 . . . . 0.0 109.217 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.87 -62.07 2.08 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.664 ' CG1' ' HE1' ' C' ' 266' ' ' TRP . 0.2 OUTLIER -66.29 -31.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.497 -0.752 . . . . 0.0 110.203 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 301' ' ' CYS . . . . . 0.618 ' SG ' ' NH2' ' C' ' 317' ' ' ARG . 31.7 t -45.58 -52.13 11.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.674 -1.266 . . . . 0.0 108.817 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -50.88 -27.78 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.44 -0.788 . . . . 0.0 110.556 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' C' ' 303' ' ' ASN . 30.9 p30 -100.22 63.15 1.13 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.014 -1.054 . . . . 0.0 109.808 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 304' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' C' ' 303' ' ' ASN . 15.8 tttp -45.18 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.47 -1.394 . . . . 0.0 108.905 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 305' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' C' ' 314' ' ' GLU . 70.6 m-85 -67.28 127.83 34.11 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.32 -0.862 . . . . 0.0 109.497 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 306' ' ' ILE . . . . . 0.649 HG21 HD11 ' C' ' 315' ' ' ILE . 0.9 OUTLIER -135.92 154.19 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 108.949 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.0 128.6 33.47 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 34.3 t80 -118.07 173.62 6.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.511 -0.743 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.436 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.0 OUTLIER -56.11 -34.19 65.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.188 -0.945 . . . . 0.0 112.037 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 310' ' ' ASP . . . . . 0.531 ' OD2' ' CG1' ' C' ' 254' ' ' VAL . 15.6 m-20 -90.71 -71.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.734 -1.229 . . . . 0.0 109.942 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -148.06 -170.22 3.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 109.262 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -60.32 148.25 37.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.969 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 313' ' ' ILE . . . . . 0.413 HG13 HG22 ' C' ' 306' ' ' ILE . 31.3 pt -132.27 153.74 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 314' ' ' GLU . . . . . 0.418 ' HG3' ' CE2' ' C' ' 305' ' ' PHE . 4.0 mp0 -111.44 110.17 20.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.003 -1.061 . . . . 0.0 110.842 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.649 HD11 HG21 ' C' ' 306' ' ' ILE . 59.6 mt -87.91 161.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.9 -1.125 . . . . 0.0 109.838 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 316' ' ' LYS . . . . . 0.422 ' N ' HG22 ' C' ' 315' ' ' ILE . 47.2 tttp -163.46 160.88 23.87 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.914 -1.116 . . . . 0.0 109.043 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 317' ' ' ARG . . . . . 0.618 ' NH2' ' SG ' ' C' ' 301' ' ' CYS . 62.5 mtt85 -71.76 146.25 48.22 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.699 -1.251 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 318' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' C' ' 244' ' ' LYS . . . -71.72 26.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 109.411 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 319' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' C' ' 317' ' ' ARG . 7.3 pt-20 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.598 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.734 ' N ' ' ND2' ' B' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.08 158.68 24.63 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.727 2.284 . . . . 0.0 112.208 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.47 20.2 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.848 2.365 . . . . 0.0 112.976 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.874 -1.141 . . . . 0.0 109.952 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.538 ' HE ' ' CB ' ' B' ' 103' ' ' SER . 5.3 ttp85 179.24 -45.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.636 HG22 ' HG3' ' B' ' 73' ' ' GLU . 10.3 t -122.56 155.02 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.637 HG22 HD13 ' B' ' 72' ' ' ILE . 0.2 OUTLIER -126.71 142.32 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.236 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.471 ' CZ ' ' HA3' ' B' ' 100' ' ' GLY . 2.6 m-85 -114.98 141.81 47.47 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.072 -1.017 . . . . 0.0 110.547 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.605 ' HB3' HD11 ' B' ' 33' ' ' ILE . 1.7 mt -118.78 127.52 53.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.545 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -113.33 -50.39 0.54 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.639 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 9.7 p -88.76 115.38 26.26 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.743 -1.445 . . . . 0.0 107.731 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.609 HD12 ' C ' ' B' ' 32' ' ' SER . 4.2 mp -147.85 107.16 3.72 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.887 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' B' ' 36' ' ' ASP . 7.8 Cg_exo -63.01 159.23 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.629 1.553 . . . . 0.0 109.744 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' B' ' 35' ' ' TYR . 6.2 m-30 -74.57 5.37 4.86 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 34' ' ' PRO . 27.0 t0 -62.03 -47.09 86.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.907 HE21 HD11 ' B' ' 92' ' ' LEU . 2.4 pm0 -120.12 109.13 15.08 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.872 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.545 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 45.8 p -100.14 -148.83 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.0 109.419 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.04 -26.39 67.59 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.14 -1.6 . . . . 0.0 110.902 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -73.17 -57.42 4.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.75 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' B' ' 36' ' ' ASP . 80.1 mt-30 -68.84 -44.17 73.97 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.972 -1.08 . . . . 0.0 109.231 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' B' ' 44' ' ' ASP . 2.4 mm -54.53 -54.77 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' B' ' 55' ' ' LEU . 45.6 tp -37.21 -19.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.9 t0 -123.86 -21.81 5.05 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.595 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.723 ' C ' HD13 ' B' ' 45' ' ' LEU . 3.2 tm? -62.97 -44.06 97.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.051 -1.656 . . . . 0.0 107.029 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' B' ' 48' ' ' ASN . 74.4 m -82.98 -65.45 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.155 -0.966 . . . . 0.0 108.739 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.839 ' O ' ' N ' ' B' ' 49' ' ' VAL . 4.6 t -37.24 -15.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.79 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.4 OUTLIER -50.23 56.45 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.483 1.135 . . . . 0.0 110.551 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.839 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.4 p 178.46 -34.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 121.426 -0.796 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.68 159.57 32.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' B' ' 52' ' ' VAL . 20.5 Cg_endo -65.24 86.47 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.525 2.15 . . . . 0.0 111.525 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.568 HG11 ' CG2' ' B' ' 72' ' ' ILE . 0.0 OUTLIER -40.09 153.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.633 0.73 . . . . 0.0 110.072 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' B' ' 73' ' ' GLU . 15.9 mm -77.05 -45.3 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.688 -0.632 . . . . 0.0 109.662 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' B' ' 53' ' ' ILE . 87.0 m-20 -146.89 152.68 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.362 -1.335 . . . . 0.0 111.678 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' B' ' 43' ' ' LEU . 42.5 tp -143.56 128.48 18.45 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -145.58 123.91 12.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.624 -1.297 . . . . 0.0 110.194 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 9.9 ttm -116.4 150.36 37.91 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.746 0.784 . . . . 0.0 111.138 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' MET . . . . . 0.59 ' CG ' ' N ' ' B' ' 59' ' ' PHE . 2.1 ttp -168.14 165.65 13.21 Favored 'General case' 0 C--O 1.282 2.781 0 O-C-N 121.383 -0.823 . . . . 0.0 109.498 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.681 ' CD1' ' N ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -132.56 134.59 45.14 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 127.008 2.692 . . . . 0.0 110.214 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.597 ' H ' ' HA ' ' B' ' 67' ' ' LYS . 0.1 OUTLIER -42.05 105.39 0.4 Allowed Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 112.014 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -91.63 -66.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.796 2.331 . . . . 0.0 109.325 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -105.89 -25.45 12.13 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 80.5 p -46.41 -49.54 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' B' ' 60' ' ' ASP . . . 76.77 36.7 36.21 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.769 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -137.01 -76.92 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.718 -1.46 . . . . 0.0 110.142 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' B' ' 60' ' ' ASP . 97.7 p -109.81 140.83 43.29 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.088 1.899 . . . . 0.0 111.538 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.597 ' HA ' ' H ' ' B' ' 60' ' ' ASP . 39.0 mttt -101.72 -5.49 24.89 Favored 'General case' 0 C--O 1.166 -3.332 0 CA-C-O 115.138 -2.363 . . . . 0.0 114.891 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLY . . . . . 0.597 ' O ' ' CD2' ' B' ' 69' ' ' TYR . . . -126.11 100.08 0.57 Allowed Glycine 1 N--CA 1.534 5.198 0 CA-C-N 123.356 2.798 . . . . 0.0 116.534 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 69' ' ' TYR . . . . . 0.597 ' CD2' ' O ' ' B' ' 68' ' ' GLY . 3.1 m-85 -165.9 139.6 4.38 Favored 'General case' 0 N--CA 1.516 2.83 0 C-N-CA 115.329 -2.548 . . . . 0.0 114.127 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.68 142.99 28.43 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.134 -0.979 . . . . 0.0 110.973 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -107.83 132.86 52.98 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.183 0.992 . . . . 0.0 110.4 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.637 HD13 HG22 ' B' ' 28' ' ' VAL . 3.8 mp -115.27 146.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.636 ' HG3' HG22 ' B' ' 27' ' ' VAL . 83.9 tt0 -136.03 135.47 39.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.167 -1.583 . . . . 0.0 108.38 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.406 ' CZ ' HG13 ' B' ' 52' ' ' VAL . 13.3 m-85 -105.74 168.61 8.99 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.759 0.79 . . . . 0.0 110.845 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 47.6 ttp180 -53.75 -45.41 70.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.635 -0.666 . . . . 0.0 111.532 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.75 179.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.174 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.6 mm? -34.29 -24.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.851 -0.531 . . . . 0.0 111.142 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 91.9 mt-10 -71.05 -75.34 0.13 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.668 -1.27 . . . . 0.0 109.259 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.97 -41.56 98.14 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 84' ' ' VAL . 21.0 m -60.28 -37.54 80.8 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.836 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -61.1 -61.8 2.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.44 -1.413 . . . . 0.0 108.912 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.521 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 67.2 m -61.89 -43.24 99.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.723 0.773 . . . . 0.0 112.022 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.37 -64.93 1.05 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.427 -0.795 . . . . 0.0 111.031 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.442 ' O ' ' CA ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -50.63 -39.36 17.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.261 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.608 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 2.1 ttm-85 -66.86 -55.53 14.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.612 -1.305 . . . . 0.0 108.791 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' B' ' 82' ' ' SER . 46.9 m-80 -67.02 -43.91 81.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 109.68 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 83' ' ' ALA . 45.7 mt -105.6 41.67 1.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.411 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' B' ' 85' ' ' ARG . 0.0 OUTLIER -70.26 -75.16 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.98 117.88 1.73 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -139.87 147.54 40.8 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.549 -1.559 . . . . 0.0 107.819 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLN . . . . . 0.592 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 4.2 mm100 -33.94 89.09 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.822 0.82 . . . . 0.0 111.184 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.907 HD11 HE21 ' B' ' 37' ' ' GLN . 51.3 tp -140.8 125.85 18.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.41 -157.05 4.01 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' SER . . . . . 0.606 ' N ' ' OG ' ' B' ' 32' ' ' SER . 2.3 p -83.36 -15.65 49.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.862 -1.376 . . . . 0.0 109.896 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.677 ' N ' ' OG ' ' B' ' 32' ' ' SER . 94.4 mtt-85 -131.23 155.87 46.35 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.8 m-85 -96.07 139.35 32.38 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.47 -0.769 . . . . 0.0 109.86 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.524 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -38.47 141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -114.2 147.53 38.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.112 -0.992 . . . . 0.0 109.867 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 17.9 p -88.02 115.61 25.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.679 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -108.52 177.23 20.59 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.469 ' O ' ' C ' ' B' ' 102' ' ' SER . 48.0 p90 -131.61 -17.57 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.555 -0.968 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' SER . . . . . 0.547 ' O ' HG21 ' B' ' 27' ' ' VAL . 8.3 t -38.02 99.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.108 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' SER . . . . . 0.538 ' CB ' ' HE ' ' B' ' 26' ' ' ARG . 60.0 p . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 158' ' ' SER . . . . . 0.594 ' O ' ' N ' ' C' ' 160' ' ' LYS . 83.8 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.248 0.547 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 159' ' ' CYS . . . . . 0.528 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 46.23 11.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.547 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 160' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' C' ' 158' ' ' SER . 14.5 tttp -94.75 137.82 33.36 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 161' ' ' MET . . . . . 0.693 ' SD ' ' N ' ' C' ' 162' ' ' PHE . 0.0 OUTLIER -114.9 152.58 32.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 108.986 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 162' ' ' PHE . . . . . 0.693 ' N ' ' SD ' ' C' ' 161' ' ' MET . 55.2 t80 -119.4 72.94 0.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.607 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 163' ' ' ILE . . . . . 0.749 HD12 HD21 ' C' ' 175' ' ' LEU . 54.5 mt -53.24 145.48 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.38 -177.43 15.98 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 56.22 20.77 30.04 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 166' ' ' LEU . . . . . 0.52 HD21 ' CG2' ' C' ' 163' ' ' ILE . 97.5 mt -60.97 163.7 5.63 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.364 -1.08 . . . . 0.0 108.776 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' C' ' 168' ' ' TRP . 11.5 p-10 -68.65 -75.71 0.1 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.056 -1.028 . . . . 0.0 108.918 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 168' ' ' TRP . . . . . 0.725 ' HE1' HH21 ' C' ' 198' ' ' ARG . 0.1 OUTLIER 178.5 -24.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.872 -1.143 . . . . 0.0 109.784 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -133.01 91.46 2.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.975 . . . . 0.0 109.764 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 170' ' ' THR . . . . . 0.478 HG21 HD13 ' C' ' 175' ' ' LEU . 46.2 m -126.05 144.74 50.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.416 -0.803 . . . . 0.0 109.386 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.84 172.62 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.022 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 172' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' C' ' 176' ' ' ARG . 0.5 OUTLIER -75.14 -67.77 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.961 -1.087 . . . . 0.0 109.861 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -43.29 -33.45 0.99 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -74.92 -50.83 15.46 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 108.827 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.749 HD21 HD12 ' C' ' 163' ' ' ILE . 20.8 tp -52.67 -42.06 64.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.693 -0.63 . . . . 0.0 109.53 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 176' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' C' ' 179' ' ' PHE . 14.2 ptp180 -74.38 -57.3 4.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.511 -1.368 . . . . 0.0 108.866 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 177' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' C' ' 176' ' ' ARG . 54.0 mm-40 -37.71 -30.76 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.717 ' CD2' HD12 ' C' ' 223' ' ' LEU . 21.6 t80 -85.25 -39.85 17.29 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.103 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' C' ' 176' ' ' ARG . 22.6 m-85 -94.25 16.98 13.56 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.146 -0.971 . . . . 0.0 111.429 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.45 24.46 25.44 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 181' ' ' LYS . . . . . 0.696 ' NZ ' ' CZ ' ' C' ' 182' ' ' TYR . 3.6 ptmm? -104.52 16.41 26.15 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.35 -1.088 . . . . 0.0 108.814 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 182' ' ' TYR . . . . . 0.696 ' CZ ' ' NZ ' ' C' ' 181' ' ' LYS . 92.3 m-85 -119.21 -49.16 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.596 -0.69 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -164.88 -127.41 0.89 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 40.6 m -126.39 145.64 50.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.506 -0.996 . . . . 0.0 109.692 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.11 137.75 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.516 HG22 ' O ' ' C' ' 206' ' ' SER . 9.7 t -96.82 -37.0 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.81 -1.181 . . . . 0.0 110.111 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 187' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' C' ' 186' ' ' THR . 79.5 m-20 -149.0 149.17 30.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.938 . . . . 0.0 108.613 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.73 HD23 ' N ' ' C' ' 189' ' ' LYS . 7.7 tt -140.34 144.1 36.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.828 -1.17 . . . . 0.0 108.355 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 189' ' ' LYS . . . . . 0.73 ' N ' HD23 ' C' ' 188' ' ' LEU . 0.1 OUTLIER -126.08 129.95 50.13 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 190' ' ' ILE . . . . . 0.624 ' CD1' HD22 ' C' ' 175' ' ' LEU . 0.6 OUTLIER -147.75 121.47 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.789 -1.194 . . . . 0.0 108.778 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 191' ' ' MET . . . . . 0.555 ' O ' ' CZ ' ' C' ' 202' ' ' PHE . 4.3 ptp -176.2 158.18 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 108.765 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.56 -63.89 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.686 -1.259 . . . . 0.0 109.032 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.473 ' OD1' ' OG ' ' C' ' 199' ' ' SER . 0.2 OUTLIER -123.47 88.39 51.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.13 -20.86 8.26 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.356 2.037 . . . . 0.0 112.129 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.18 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.147 -0.971 . . . . 0.0 109.78 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 65.1 p -109.23 -8.66 15.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 197' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 81.22 15.64 76.27 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 198' ' ' ARG . . . . . 0.725 HH21 ' HE1' ' C' ' 168' ' ' TRP . 0.0 OUTLIER -97.68 73.22 2.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.258 . . . . 0.0 109.456 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 199' ' ' SER . . . . . 0.526 ' O ' ' C ' ' C' ' 200' ' ' ARG . 80.6 p -167.1 172.77 9.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' C' ' 199' ' ' SER . 0.0 OUTLIER -27.27 147.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.005 0.431 . . . . 0.0 110.137 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.5 158.82 22.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.555 ' CZ ' ' O ' ' C' ' 191' ' ' MET . 4.7 p90 -171.18 134.11 0.9 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.359 . . . . 0.0 108.614 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -112.12 132.95 11.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.09 114.13 27.17 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' C' ' 207' ' ' PHE . 0.5 OUTLIER -112.98 110.29 20.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.298 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 206' ' ' SER . . . . . 0.516 ' O ' HG22 ' C' ' 186' ' ' THR . 29.1 t -81.44 72.05 8.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.742 ' CZ ' HD13 ' C' ' 205' ' ' LEU . 27.3 m-85 -64.47 115.51 5.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.93 -38.43 90.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.18 108.74 30.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.006 -1.059 . . . . 0.0 110.44 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -52.1 -24.74 20.76 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.697 1.598 . . . . 0.0 112.5 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.507 ' O ' ' N ' ' C' ' 213' ' ' VAL . 22.9 t -66.95 -65.32 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.949 -1.094 . . . . 0.0 109.861 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.79 ' O ' HG23 ' C' ' 216' ' ' VAL . 51.0 m -40.75 -24.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.482 -0.761 . . . . 0.0 110.295 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 213' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' C' ' 211' ' ' SER . 95.0 t -69.13 -38.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 109.011 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 214' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.9 t0 -59.0 -49.41 77.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 110.094 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.08 -36.53 79.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.84 -1.162 . . . . 0.0 109.31 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.79 HG23 ' O ' ' C' ' 212' ' ' SER . 47.9 t -54.94 -47.91 75.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 110.024 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.13 -33.33 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -72.79 6.28 2.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 109.558 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 219' ' ' THR . . . . . 0.656 ' CG2' ' CE1' ' C' ' 221' ' ' HIS . 1.3 t -134.56 167.7 20.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.134 -0.979 . . . . 0.0 109.391 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -122.82 134.42 54.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.73 -0.606 . . . . 0.0 109.403 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.862 ' C ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -132.07 161.03 34.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 222' ' ' ILE . . . . . 0.862 HD13 ' C ' ' C' ' 221' ' ' HIS . 0.4 OUTLIER -124.93 110.1 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 109.057 179.204 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.717 HD12 ' CD2' ' C' ' 178' ' ' TYR . 18.3 tp -75.14 -71.6 0.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 224' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 60.7 t0 -80.22 1.06 29.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.028 -1.045 . . . . 0.0 108.772 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.92 13.51 69.17 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 226' ' ' LYS . . . . . 0.702 ' HZ1' ' N ' ' C' ' 279' ' ' ASP . 0.0 OUTLIER -90.73 -83.28 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -1.075 . . . . 0.0 109.432 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 227' ' ' VAL . . . . . 0.587 HG22 ' O ' ' C' ' 227' ' ' VAL . 1.3 p 172.57 89.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.19 -0.944 . . . . 0.0 109.66 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 pt -94.63 152.02 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.396 -0.815 . . . . 0.0 110.34 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 229' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' C' ' 229' ' ' ASP . 0.0 OUTLIER -116.8 106.45 47.94 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 110.042 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 230' ' ' PRO . . . . . 0.44 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 42.7 Cg_endo -82.17 134.23 7.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.388 2.059 . . . . 0.0 111.819 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 231' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' C' ' 232' ' ' ARG . 11.8 ttmm -152.53 164.26 37.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.98 . . . . 0.0 109.673 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' C' ' 231' ' ' LYS . 56.7 ttm-85 -72.96 159.22 34.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 116.07 3.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.205 -0.934 . . . . 0.0 111.163 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 234' ' ' ILE . . . . . 0.417 HD13 HG21 ' C' ' 234' ' ' ILE . 18.5 mt -156.91 91.67 2.45 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -40.15 137.78 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.601 1.534 . . . . 0.0 111.479 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -55.69 -29.5 59.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.08 -45.13 79.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.65 -1.281 . . . . 0.0 108.663 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.88 -38.3 58.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 239' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' C' ' 242' ' ' THR . 4.2 tp-100 -57.92 -38.01 75.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.615 -0.678 . . . . 0.0 110.0 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -58.88 -22.59 59.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.867 . . . . 0.0 109.664 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 242' ' ' THR . . . . . 0.531 ' O ' ' O ' ' C' ' 291' ' ' TYR . 72.5 p -56.89 -36.67 70.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.13 3.22 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -138.58 138.15 37.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.025 -1.279 . . . . 0.0 110.855 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.746 HD12 ' CG2' ' C' ' 315' ' ' ILE . 3.8 pt -120.53 146.65 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 246' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.2 OUTLIER -86.54 160.37 18.98 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 247' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 28.4 t -134.11 131.17 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.56 -0.713 . . . . 0.0 109.092 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.01 147.53 18.51 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.51 5.25 79.14 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.553 HD11 ' HE2' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -111.12 133.06 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -1.058 . . . . 0.0 109.3 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 251' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.53 -36.35 2.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.727 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 252' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 32.0 Cg_exo -56.0 -30.0 76.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.397 2.064 . . . . 0.0 113.194 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -151.18 7.79 0.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.601 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.638 HG11 ' CE2' ' C' ' 308' ' ' PHE . 24.4 t -126.63 118.03 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 111.14 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 255' ' ' ARG . . . . . 0.492 ' HA ' HD23 ' C' ' 274' ' ' LEU . 0.0 OUTLIER -102.26 169.79 7.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 256' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' C' ' 257' ' ' LYS . 0.0 OUTLIER -26.22 -50.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.312 2.675 . . . . 0.0 114.677 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 257' ' ' LYS . . . . . 0.498 ' O ' ' OE1' ' C' ' 261' ' ' GLU . 58.4 tttp -33.09 -84.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 258' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' C' ' 261' ' ' GLU . 27.4 tp10 -58.21 -76.79 0.04 OUTLIER 'General case' 0 C--O 1.194 -1.82 0 O-C-N 120.846 -1.159 . . . . 0.0 109.384 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 259' ' ' PHE . . . . . 0.632 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.0 t80 -12.16 -64.39 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 121.867 0.841 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 260' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' C' ' 258' ' ' GLU . 50.0 mt-10 -62.22 -49.39 75.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.96 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 261' ' ' GLU . . . . . 0.707 ' N ' ' O ' ' C' ' 258' ' ' GLU . 5.1 mp0 -71.27 2.79 4.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 262' ' ' PHE . . . . . 0.482 ' O ' ' CD ' ' C' ' 265' ' ' GLN . 6.1 t80 -98.21 -73.22 0.62 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.577 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 54.3 m-85 -50.52 -31.61 15.99 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.412 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.422 ' C ' ' O ' ' C' ' 263' ' ' PHE . 73.6 m -35.82 -38.34 0.12 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.605 -0.684 . . . . 0.0 112.445 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.482 ' CD ' ' O ' ' C' ' 262' ' ' PHE . 0.0 OUTLIER -54.75 -93.33 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.148 -1.595 . . . . 0.0 110.189 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.577 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -66.99 152.26 46.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.976 -1.078 . . . . 0.0 110.052 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 69.45 167.2 5.41 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 268' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 59.1 m -115.24 122.89 47.37 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' C' ' 272' ' ' ALA . 3.2 mp -104.87 107.91 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.43 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 270' ' ' ILE . . . . . 0.425 HD11 ' OD2' ' C' ' 292' ' ' ASP . 4.8 mm -77.15 -46.79 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 110.58 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -139.7 103.64 4.72 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.658 -1.276 . . . . 0.0 110.415 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 272' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' C' ' 269' ' ' ILE . . . -110.38 142.19 42.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.222 -0.924 . . . . 0.0 108.525 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -150.79 139.51 20.73 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.083 -1.447 . . . . 0.0 112.463 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 26.8 tp -122.96 141.24 52.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 275' ' ' MET . . . . . 0.863 ' C ' HD13 ' C' ' 276' ' ' LEU . 45.7 mmm -89.17 177.3 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.149 -1.595 . . . . 0.0 109.249 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 1.055 HD22 ' H ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -131.95 170.28 15.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.992 -1.067 . . . . 0.0 109.505 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 277' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 54.4 p30 -90.9 -11.48 39.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.424 -0.797 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 278' ' ' LYS . . . . . 0.625 ' C ' ' HZ1' ' C' ' 226' ' ' LYS . 19.8 tptm -62.46 -32.78 73.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 108.838 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 279' ' ' ASP . . . . . 0.702 ' N ' ' HZ1' ' C' ' 226' ' ' LYS . 34.2 p-10 -63.87 -44.38 93.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 280' ' ' THR . . . . . 0.655 HG22 ' C ' ' C' ' 279' ' ' ASP . 0.2 OUTLIER 177.34 5.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.099 -1.001 . . . . 0.0 110.172 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.08 57.0 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.557 ' HG2' HG23 ' C' ' 280' ' ' THR . 85.9 mm-40 -57.46 -34.24 68.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -1.197 . . . . 0.0 109.307 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 78.1 p -68.8 51.7 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.156 -0.965 . . . . 0.0 108.974 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 284' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' C' ' 282' ' ' GLN . 58.4 ttm-85 -49.59 -37.24 26.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 159.37 78.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 34.6 p90 -176.2 -174.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.271 . . . . 0.0 109.666 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -178.86 -170.97 41.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -147.97 152.26 37.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.22 -1.753 . . . . 0.0 108.877 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 94.2 t -130.6 145.61 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 15.5 m -128.55 130.45 47.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.814 -1.179 . . . . 0.0 110.453 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 291' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' C' ' 242' ' ' THR . 24.3 m-85 -113.37 153.33 28.72 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 292' ' ' ASP . . . . . 0.425 ' OD2' HD11 ' C' ' 270' ' ' ILE . 1.8 t0 -74.0 18.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.014 -1.054 . . . . 0.0 109.499 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 293' ' ' SER . . . . . 0.463 ' H ' ' C ' ' C' ' 291' ' ' TYR . 59.8 p -162.67 173.88 13.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.02 -7.99 15.27 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.27 -52.0 67.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.91 90.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.852 . . . . 0.0 108.768 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 297' ' ' VAL . . . . . 0.489 HG13 HG22 ' C' ' 245' ' ' ILE . 55.8 t -54.82 -57.38 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.23 -29.73 68.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -63.51 -63.75 1.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.124 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -63.71 -25.47 38.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.063 -1.023 . . . . 0.0 109.616 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 301' ' ' CYS . . . . . . . . . . . . . 45.3 t -45.18 -55.38 5.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 109.634 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 302' ' ' GLN . . . . . 0.585 ' NE2' ' OD1' ' C' ' 303' ' ' ASN . 0.0 OUTLIER -51.5 -24.98 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 108.051 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' C' ' 302' ' ' GLN . 97.1 m-20 -98.54 78.87 2.42 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -78.54 -8.97 59.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 110.48 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.06 120.19 19.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 108.952 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 306' ' ' ILE . . . . . 0.51 HD12 HD11 ' C' ' 315' ' ' ILE . 60.8 mt -123.96 154.88 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.802 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -90.08 116.07 27.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 108.704 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.638 ' CE2' HG11 ' C' ' 254' ' ' VAL . 7.4 t80 -121.0 179.48 4.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' C' ' 254' ' ' VAL . 35.7 mtmt -39.07 -62.72 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.005 -1.059 . . . . 0.0 110.881 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 310' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' C' ' 309' ' ' LYS . 93.0 m-20 -44.66 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.149 -0.97 . . . . 0.0 109.354 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -175.4 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -141.35 138.69 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 109.886 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 313' ' ' ILE . . . . . 0.463 HD11 ' HB ' ' C' ' 306' ' ' ILE . 18.8 pt -126.27 151.43 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -112.6 151.26 30.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.519 -0.738 . . . . 0.0 109.528 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.746 ' CG2' HD12 ' C' ' 245' ' ' ILE . 99.3 mt -125.84 154.72 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.514 -0.742 . . . . 0.0 109.126 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 316' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER 179.35 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.158 -1.589 . . . . 0.0 113.454 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 317' ' ' ARG . . . . . 0.616 ' O ' ' O ' ' C' ' 316' ' ' LYS . 77.8 mtm180 1.38 126.72 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.685 0 CA-C-O 121.778 0.799 . . . . 0.0 113.11 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 318' ' ' ALA . . . . . 0.414 ' N ' ' HA ' ' C' ' 245' ' ' ILE . . . -61.1 7.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.824 -1.173 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 319' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' C' ' 317' ' ' ARG . 3.8 mm-40 . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.952 . . . . 0.0 108.725 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' B' ' 23' ' ' PRO . 65.4 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' B' ' 22' ' ' ASN . 5.8 Cg_exo -44.68 167.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.038 2.492 . . . . 0.0 112.188 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.86 2.78 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.989 2.46 . . . . 0.0 113.355 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 72.1 m -153.26 132.67 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.672 -1.267 . . . . 0.0 109.186 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.576 ' NE ' ' OD1' ' B' ' 76' ' ' ASP . 3.5 tpt180 -177.24 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.625 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' B' ' 100' ' ' GLY . 3.2 m -129.06 170.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.468 HG13 ' O ' ' B' ' 98' ' ' LYS . 3.8 t -127.2 143.25 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.705 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -110.5 122.4 47.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.269 -0.895 . . . . 0.0 108.973 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.568 ' C ' HD11 ' B' ' 33' ' ' ILE . 2.9 mm? -110.36 107.38 17.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.411 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -112.15 -16.03 9.36 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.485 ' CB ' ' H ' ' B' ' 95' ' ' ARG . 65.5 p -111.58 85.08 2.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 109.728 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.652 HD12 ' N ' ' B' ' 33' ' ' ILE . 0.8 OUTLIER -145.47 127.26 7.78 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' B' ' 36' ' ' ASP . 31.8 Cg_endo -72.89 151.65 51.09 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.255 1.303 . . . . 0.0 110.703 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -59.61 -0.11 0.16 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.105 -0.997 . . . . 0.0 109.045 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 34' ' ' PRO . 87.6 m-20 -64.28 -36.43 84.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.46 116.03 23.26 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.582 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.537 HG23 ' N ' ' B' ' 39' ' ' GLU . 9.9 t -111.92 -137.09 0.37 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.441 -0.787 . . . . 0.0 110.885 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.537 ' N ' HG23 ' B' ' 38' ' ' THR . 21.1 pt-20 -63.19 -28.93 70.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.658 -1.276 . . . . 0.0 110.743 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.62 -55.45 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.811 -1.18 . . . . 0.0 110.611 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -68.93 -43.7 74.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 111.064 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.558 ' O ' ' SG ' ' B' ' 46' ' ' CYS . 51.1 mm -63.44 -52.63 55.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 118.715 -1.194 . . . . 0.0 107.959 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' B' ' 39' ' ' GLU . 46.3 tp -39.71 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' B' ' 42' ' ' ILE . 24.7 t70 -124.97 -27.13 3.62 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.432 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.861 ' O ' HD12 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -58.68 -45.27 89.8 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.205 -1.559 . . . . 0.0 108.101 178.207 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.8 p -77.68 -60.78 2.23 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.815 -1.154 . . . . 0.0 107.982 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.834 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.3 p -37.33 -18.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.73 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' B' ' 46' ' ' CYS . 16.0 m-20 -47.75 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.405 0.622 . . . . 0.0 110.69 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.834 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.2 t 168.56 -32.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.23 165.24 37.65 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.236 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.87 91.48 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.047 2.498 . . . . 0.0 112.463 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.535 HG11 ' CG2' ' B' ' 72' ' ' ILE . 1.8 t -46.89 156.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 mm -100.4 -55.74 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.742 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 13.8 m-20 -118.3 127.85 54.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.314 -0.866 . . . . 0.0 111.317 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.91 130.14 48.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -139.79 125.39 19.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.808 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.8 tpt -105.93 129.4 54.08 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.17 155.85 38.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.434 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.2 OUTLIER -113.03 179.93 3.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' B' ' 66' ' ' SER . 51.2 p-10 -102.75 74.52 0.18 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.15 -0.969 . . . . 0.0 110.75 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 28.6 Cg_endo -65.77 -60.1 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.966 1.777 . . . . 0.0 112.149 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.26 -50.01 6.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.936 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p -57.47 -45.06 85.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.454 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.443 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 74.87 11.72 83.47 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.42 HH22 ' CZ ' ' C' ' 200' ' ' ARG . 10.8 mtp85 -66.02 -52.18 51.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.933 -1.334 . . . . 0.0 109.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.643 ' H ' ' HB3' ' B' ' 60' ' ' ASP . 8.0 t -156.02 145.24 20.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -0.988 . . . . 0.0 110.403 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -79.98 -5.87 56.5 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.735 -1.228 . . . . 0.0 109.465 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -127.94 88.52 0.33 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.093 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' TYR . . . . . 0.411 ' CD1' ' HA2' ' B' ' 31' ' ' GLY . 1.5 m-85 -127.98 126.25 41.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.175 -1.191 . . . . 0.0 109.452 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.01 137.7 31.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.078 . . . . 0.0 110.088 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -103.49 125.3 49.98 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.378 -0.827 . . . . 0.0 108.93 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.538 HD12 ' N ' ' B' ' 72' ' ' ILE . 3.7 mp -122.01 97.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.645 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 53.2 mt-10 -86.96 127.85 35.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.707 -1.246 . . . . 0.0 110.734 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -89.68 179.86 5.93 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.621 0.724 . . . . 0.0 110.579 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 0.1 OUTLIER -57.06 -42.45 80.59 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.593 -0.692 . . . . 0.0 110.374 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.662 ' O ' ' N ' ' B' ' 78' ' ' GLU . 4.2 m-20 158.76 177.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 0.0 109.018 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.758 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.6 OUTLIER -33.68 -24.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.919 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.662 ' N ' ' O ' ' B' ' 76' ' ' ASP . 10.6 mp0 -69.84 -73.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.387 -1.446 . . . . 0.0 108.891 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.9 m -62.97 -41.36 99.52 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.41 ' O ' HG23 ' B' ' 84' ' ' VAL . 1.3 m -59.6 -39.13 83.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.19 -0.943 . . . . 0.0 108.779 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -59.55 -61.21 2.79 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.141 0.972 . . . . 0.0 108.801 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.583 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 69.5 m -63.29 -39.7 95.31 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.579 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -79.6 -61.13 2.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.983 -1.073 . . . . 0.0 110.169 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.563 ' O ' ' CA ' ' B' ' 88' ' ' ASN . 26.7 t -51.19 -42.45 25.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.023 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -64.9 -56.57 12.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.411 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 82' ' ' SER . 8.7 m-80 -67.47 -43.8 80.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' B' ' 83' ' ' ALA . 51.0 mt -104.83 34.87 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.0 110.433 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.563 ' CA ' ' O ' ' B' ' 84' ' ' VAL . 0.2 OUTLIER -62.6 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.123 -0.986 . . . . 0.0 108.375 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.17 116.29 1.62 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -138.1 145.8 42.1 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.369 -1.665 . . . . 0.0 107.752 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 16.6 tp60 -30.9 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.668 -0.645 . . . . 0.0 111.286 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.564 HD22 HD21 ' B' ' 45' ' ' LEU . 11.3 tp -154.03 140.8 19.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.53 -171.63 0.1 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 47.2 p -67.94 -22.39 65.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' B' ' 92' ' ' LEU . 94.9 mtt180 -136.23 163.52 30.2 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.2 m-85 -93.04 141.68 28.13 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.257 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -37.4 136.99 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.468 ' O ' HG13 ' B' ' 28' ' ' VAL . 67.9 mmtt -108.4 147.77 31.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' CYS . . . . . 0.544 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 31.2 p -87.55 116.7 25.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' B' ' 27' ' ' VAL . . . -115.03 158.39 14.37 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.51 ' CB ' ' O ' ' B' ' 23' ' ' PRO . 1.8 p90 -136.97 113.87 10.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -1.113 . . . . 0.0 109.122 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 51.0 p -136.94 -84.41 0.34 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.253 -0.904 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.648 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.42 0.629 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 -1.98 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.79 140.08 32.7 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.015 -1.053 . . . . 0.0 108.936 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 24.8 ptm -123.32 155.61 36.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 109.345 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 162' ' ' PHE . . . . . 0.415 ' O ' ' C ' ' C' ' 163' ' ' ILE . 72.1 t80 -111.29 77.95 1.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 163' ' ' ILE . . . . . 0.709 HD11 HD13 ' C' ' 205' ' ' LEU . 60.8 mt -49.02 135.9 5.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 164' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' C' ' 229' ' ' ASP . . . -136.02 157.14 23.27 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.125 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.02 20.65 77.43 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 166' ' ' LEU . . . . . 0.647 ' CB ' ' HZ1' ' C' ' 192' ' ' LYS . 83.0 mt -60.14 171.24 1.04 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.175 -1.191 . . . . 0.0 108.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.55 ' CG ' ' H ' ' C' ' 168' ' ' TRP . 17.0 p30 -68.92 -79.95 0.05 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.017 -1.052 . . . . 0.0 109.309 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 168' ' ' TRP . . . . . 0.55 ' H ' ' CG ' ' C' ' 167' ' ' ASN . 0.0 OUTLIER 178.8 -24.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.78 -1.2 . . . . 0.0 110.192 179.201 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 169' ' ' ASP . . . . . 0.453 ' OD1' ' C ' ' C' ' 169' ' ' ASP . 19.6 t0 -135.03 93.53 3.02 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.016 -1.053 . . . . 0.0 110.623 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 170' ' ' THR . . . . . 0.586 ' H ' ' CD ' ' C' ' 192' ' ' LYS . 17.4 m -139.97 145.71 38.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.309 -0.869 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.82 167.21 10.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.951 -1.093 . . . . 0.0 109.348 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.28 -56.37 22.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -48.38 -40.82 26.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.996 -1.065 . . . . 0.0 110.818 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -74.85 -53.13 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 109.962 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.571 HD22 HD11 ' C' ' 190' ' ' ILE . 10.3 tp -53.02 -45.68 68.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 176' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' C' ' 177' ' ' GLU . 27.4 ttp180 -66.12 -60.28 2.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 177' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' C' ' 176' ' ' ARG . 61.3 mm-40 -40.97 -30.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.535 ' O ' ' NZ ' ' C' ' 181' ' ' LYS . 1.1 t80 -76.67 -48.68 18.22 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.354 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.863 ' O ' ' N ' ' C' ' 181' ' ' LYS . 24.5 m-85 -72.58 -58.46 3.35 Favored 'General case' 0 C--O 1.196 -1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -43.42 10.18 0.0 OUTLIER Glycine 0 N--CA 1.507 3.379 0 O-C-N 119.845 -1.785 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 181' ' ' LYS . . . . . 0.863 ' N ' ' O ' ' C' ' 179' ' ' PHE . 1.5 ttmp? -75.99 -18.35 59.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.726 -1.455 . . . . 0.0 107.689 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 182' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 3.2 m-85 -93.14 -58.73 2.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 109.708 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -144.54 -129.86 2.24 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 28.0 m -127.16 153.88 45.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.384 -1.068 . . . . 0.0 110.154 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.39 149.39 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.44 HG22 ' O ' ' C' ' 206' ' ' SER . 0.0 OUTLIER -90.02 -42.18 11.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.904 -1.123 . . . . 0.0 110.02 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -154.52 155.91 35.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.998 . . . . 0.0 109.319 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 1.059 HD12 ' N ' ' C' ' 189' ' ' LYS . 0.1 OUTLIER -147.15 139.62 24.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.652 -1.28 . . . . 0.0 107.809 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 189' ' ' LYS . . . . . 1.059 ' N ' HD12 ' C' ' 188' ' ' LEU . 5.9 tptp -127.61 133.85 49.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.878 -1.139 . . . . 0.0 109.64 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 190' ' ' ILE . . . . . 0.571 HD11 HD22 ' C' ' 175' ' ' LEU . 0.2 OUTLIER -127.62 156.24 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 108.521 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 4.0 tpp -139.84 42.3 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.022 -1.049 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 192' ' ' LYS . . . . . 0.647 ' HZ1' ' CB ' ' C' ' 166' ' ' LEU . 18.3 mttp -72.76 -163.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.982 -1.074 . . . . 0.0 109.432 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' C' ' 197' ' ' GLY . 0.9 OUTLIER -127.65 52.67 8.86 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.542 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 194' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 193' ' ' ASP . 83.9 Cg_endo -78.57 -4.42 14.11 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.823 2.349 . . . . 0.0 111.87 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.41 28.3 3.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.444 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 196' ' ' THR . . . . . 0.471 ' OG1' ' OD1' ' C' ' 193' ' ' ASP . 0.5 OUTLIER -153.37 -55.33 0.11 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.315 -0.866 . . . . 0.0 109.862 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 197' ' ' GLY . . . . . 0.58 ' N ' ' OD2' ' C' ' 193' ' ' ASP . . . 174.42 -100.94 0.15 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -136.08 136.83 40.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 109.488 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 199' ' ' SER . . . . . 0.515 ' O ' ' O ' ' C' ' 200' ' ' ARG . 9.3 t -153.36 170.61 20.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.263 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' C' ' 199' ' ' SER . 6.4 mmp_? -42.57 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 109.117 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 201' ' ' GLY . . . . . 0.435 ' HA2' ' HZ2' ' C' ' 192' ' ' LYS . . . -141.69 94.28 0.19 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.487 ' CA ' HD12 ' C' ' 166' ' ' LEU . 21.0 p90 -137.94 167.78 21.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.36 136.13 8.19 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 119.061 -1.542 . . . . 0.0 109.66 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -105.43 102.88 12.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.709 HD13 HD11 ' C' ' 163' ' ' ILE . 0.5 OUTLIER -101.43 111.29 23.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.419 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 206' ' ' SER . . . . . 0.44 ' O ' HG22 ' C' ' 186' ' ' THR . 21.3 t -82.79 70.92 9.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.623 ' CE2' HD23 ' C' ' 205' ' ' LEU . 2.7 m-85 -60.01 117.98 5.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.63 -51.13 66.55 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.045 -1.035 . . . . 0.0 109.354 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' C' ' 211' ' ' SER . 50.5 mtpt -84.95 103.79 3.78 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.084 -1.01 . . . . 0.0 110.436 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.67 -15.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.823 1.682 . . . . 0.0 112.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.557 ' O ' ' N ' ' C' ' 213' ' ' VAL . 17.6 m -68.36 -69.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.855 -1.153 . . . . 0.0 109.898 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 211' ' ' SER . 0.0 OUTLIER -36.46 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.736 -0.603 . . . . 0.0 109.672 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 213' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' C' ' 211' ' ' SER . 88.4 t -65.63 -45.1 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 109.396 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 214' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -61.72 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.584 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.24 -39.33 86.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 108.965 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.696 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 15.2 t -64.85 -49.7 78.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.351 0.596 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.13 -31.17 52.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.585 -1.322 . . . . 0.0 109.488 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -81.12 -44.35 18.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.131 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 219' ' ' THR . . . . . 0.579 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 41.5 m -66.39 151.23 47.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.345 -0.847 . . . . 0.0 110.632 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -80.36 148.33 30.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.592 -0.692 . . . . 0.0 109.657 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.704 ' HB3' HD11 ' C' ' 228' ' ' ILE . 24.5 m-70 -132.84 132.74 42.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.222 -0.924 . . . . 0.0 110.623 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.2 86.61 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -55.15 -71.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 109.627 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 224' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 91.8 m-20 -96.2 7.64 45.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 109.126 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.52 12.28 61.3 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 226' ' ' LYS . . . . . 0.91 ' O ' HG13 ' C' ' 227' ' ' VAL . 0.4 OUTLIER -85.78 -86.06 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -1.089 . . . . 0.0 109.737 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 227' ' ' VAL . . . . . 0.91 HG13 ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 171.85 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.827 . . . . 0.0 109.641 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 228' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' C' ' 221' ' ' HIS . 15.4 pt -99.39 160.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.127 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 229' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' C' ' 164' ' ' GLY . 5.4 m-20 -126.76 102.17 25.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 111.016 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 230' ' ' PRO . . . . . 0.5 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 28.9 Cg_endo -83.28 137.29 8.17 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -164.05 168.66 18.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.912 -1.117 . . . . 0.0 109.804 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -58.64 156.07 11.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.986 . . . . 0.0 109.462 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 233' ' ' ALA . . . . . 0.4 ' O ' ' CG1' ' C' ' 234' ' ' ILE . . . -70.26 124.08 23.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 234' ' ' ILE . . . . . 0.479 ' HB ' HE21 ' C' ' 239' ' ' GLN . 13.2 mt -158.71 108.92 1.62 Allowed Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.12 132.31 8.73 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.604 1.536 . . . . 0.0 111.82 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -55.47 -36.43 66.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.173 -0.955 . . . . 0.0 109.002 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -52.82 -40.89 63.69 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -70.17 -36.14 74.47 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 239' ' ' GLN . . . . . 0.512 ' O ' ' OG1' ' C' ' 242' ' ' THR . 54.9 mm-40 -57.69 -38.48 75.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 108.896 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 240' ' ' ASP . . . . . 0.402 ' OD1' ' NZ ' ' C' ' 244' ' ' LYS . 87.2 m-20 -68.48 -37.67 80.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -60.94 -29.73 69.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 242' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 9.5 p -65.01 -21.71 66.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.968 -1.082 . . . . 0.0 110.09 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 110.35 102.66 2.72 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 244' ' ' LYS . . . . . 0.402 ' NZ ' ' OD1' ' C' ' 240' ' ' ASP . 4.3 ttpt -131.24 126.79 36.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.314 . . . . 0.0 110.223 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.489 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -113.86 141.82 28.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 246' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -87.33 164.9 16.0 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 247' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 58.8 t -136.69 131.53 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.95 142.32 16.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 249' ' ' GLY . . . . . 0.637 ' O ' HG22 ' C' ' 313' ' ' ILE . . . 90.27 66.99 1.2 Allowed Glycine 0 N--CA 1.491 2.358 0 O-C-N 121.137 -1.214 . . . . 0.0 110.689 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' C' ' 285' ' ' GLY . 38.4 mm -114.2 133.82 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -1.19 . . . . 0.0 109.131 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.66 157.48 45.08 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.93 -22.82 55.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.823 2.349 . . . . 0.0 112.6 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -124.35 52.57 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.302 -0.874 . . . . 0.0 109.923 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.764 HG13 ' HG3' ' C' ' 309' ' ' LYS . 47.7 t -100.56 36.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 255' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' C' ' 254' ' ' VAL . 4.0 mtp85 -16.5 146.96 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.7 0 CA-C-O 121.384 0.611 . . . . 0.0 111.851 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 256' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' C' ' 257' ' ' LYS . 31.1 Cg_endo -57.95 -19.99 42.66 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.723 2.282 . . . . 0.0 113.048 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 257' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' C' ' 256' ' ' PRO . 54.0 tttm -46.51 -67.78 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 258' ' ' GLU . . . . . 0.744 ' O ' ' N ' ' C' ' 261' ' ' GLU . 23.8 mp0 -60.72 -91.46 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.71 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 259' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' C' ' 274' ' ' LEU . 56.7 t80 -6.1 -68.08 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 CA-C-O 121.179 0.514 . . . . 0.0 111.18 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 260' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 258' ' ' GLU . 83.4 tt0 -54.97 -48.02 73.78 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.617 0.723 . . . . 0.0 109.545 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 261' ' ' GLU . . . . . 0.744 ' N ' ' O ' ' C' ' 258' ' ' GLU . 82.1 tt0 -71.56 -45.04 63.41 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 262' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -49.84 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.61 -0.681 . . . . 0.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.528 ' O ' ' C ' ' C' ' 264' ' ' SER . 63.5 m-85 -45.3 -44.37 11.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.906 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.617 ' O ' ' N ' ' C' ' 266' ' ' TRP . 1.3 p -37.88 -36.64 0.2 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' C' ' 263' ' ' PHE . 23.4 tt0 -42.14 -9.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.946 -0.471 . . . . 0.0 111.872 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.617 ' N ' ' O ' ' C' ' 264' ' ' SER . 16.0 p90 -159.33 44.81 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.22 -1.55 . . . . 0.0 110.527 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 267' ' ' GLY . . . . . 0.448 ' O ' HD12 ' C' ' 269' ' ' ILE . . . 154.41 123.8 0.9 Allowed Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.294 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 27.8 m -56.78 140.4 47.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -1.153 . . . . 0.0 108.823 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.569 HG22 ' O ' ' C' ' 269' ' ' ILE . 1.1 mp -99.03 109.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 0.0 110.762 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.9 -50.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 109.877 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 271' ' ' ASP . . . . . 0.561 ' O ' ' C ' ' C' ' 272' ' ' ALA . 59.4 t0 -147.01 17.45 1.23 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.839 -1.163 . . . . 0.0 111.407 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 272' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' C' ' 271' ' ' ASP . . . -27.91 138.66 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.585 -0.697 . . . . 0.0 109.979 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -133.56 124.22 26.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.231 -0.918 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' C' ' 259' ' ' PHE . 1.4 tm? -121.43 129.37 52.95 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 275' ' ' MET . . . . . 0.765 ' N ' HD13 ' C' ' 274' ' ' LEU . 3.8 mmt -102.09 163.81 12.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.572 -1.33 . . . . 0.0 110.021 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.762 HD12 ' O ' ' C' ' 275' ' ' MET . 1.0 OUTLIER -144.07 -175.34 4.57 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.044 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -44.93 -86.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 109.689 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -107.77 -20.74 13.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 108.992 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 279' ' ' ASP . . . . . 0.753 ' O ' HG11 ' C' ' 227' ' ' VAL . 21.5 t70 -52.73 -26.94 15.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 280' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -143.37 -8.34 0.77 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.651 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.71 64.99 1.7 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' C' ' 276' ' ' LEU . 9.3 tp-100 -171.93 164.24 6.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -1.173 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 283' ' ' SER . . . . . 0.423 ' H ' ' H ' ' C' ' 284' ' ' ARG . 25.6 p -170.14 0.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.199 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 284' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' C' ' 283' ' ' SER . 46.7 mmt-85 -55.9 -31.2 62.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.373 -0.829 . . . . 0.0 109.661 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 285' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' C' ' 250' ' ' ILE . . . 106.81 20.64 8.72 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.184 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' C' ' 286' ' ' PHE . 26.8 p90 -109.84 175.81 5.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.068 -1.254 . . . . 0.0 110.203 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.49 -177.42 36.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -149.75 149.84 31.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.31 -1.7 . . . . 0.0 108.778 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 289' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' C' ' 291' ' ' TYR . 17.0 t -130.06 149.14 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 290' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 48.7 m -132.84 121.57 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.641 -1.287 . . . . 0.0 109.082 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 291' ' ' TYR . . . . . 0.507 ' CZ ' HG11 ' C' ' 289' ' ' VAL . 46.5 m-85 -116.22 137.4 52.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.204 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 292' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' C' ' 293' ' ' SER . 17.7 p-10 -62.35 -49.67 74.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 293' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 75.7 m -67.91 124.22 22.74 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -77.36 -27.05 52.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.086 -2.191 . . . . 0.0 105.086 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -51.46 -41.72 61.08 Favored 'General case' 0 C--O 1.206 -1.222 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.23 75.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.994 -1.066 . . . . 0.0 108.393 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 83.1 t -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.72 -29.56 53.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.66 -0.65 . . . . 0.0 109.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -71.69 -62.97 1.22 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -61.5 -24.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.628 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 301' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' C' ' 300' ' ' VAL . 1.3 m -43.98 -58.4 2.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -50.8 -26.86 6.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.081 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' C' ' 300' ' ' VAL . 34.1 t-20 -99.43 86.41 3.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 109.509 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 304' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' C' ' 314' ' ' GLU . 13.5 tttp -75.05 -84.31 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.695 -1.253 . . . . 0.0 108.561 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -58.74 127.62 33.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.198 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.1 tt -138.58 142.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.641 1.21 . . . . 0.0 110.18 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 307' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' C' ' 307' ' ' ASP . 47.3 p30 -68.65 142.13 55.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.866 0.841 . . . . 0.0 110.531 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.626 ' O ' ' N ' ' C' ' 310' ' ' ASP . 9.9 t80 -169.84 -174.07 1.74 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.764 ' HG3' HG13 ' C' ' 254' ' ' VAL . 37.0 mmtt -32.75 -30.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.556 -0.715 . . . . 0.0 110.217 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 310' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' C' ' 308' ' ' PHE . 92.6 m-20 -87.1 -84.74 0.18 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.07 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.015 -1.053 . . . . 0.0 110.556 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -168.75 49.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.988 -1.07 . . . . 0.0 109.342 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 313' ' ' ILE . . . . . 0.637 HG22 ' O ' ' C' ' 249' ' ' GLY . 10.7 pt -49.92 138.55 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.766 0.793 . . . . 0.0 110.791 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 314' ' ' GLU . . . . . 0.55 ' HB3' ' HZ2' ' C' ' 304' ' ' LYS . 54.8 mt-10 -85.44 115.8 23.39 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.23 0.538 . . . . 0.0 110.527 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' C' ' 245' ' ' ILE . 83.8 mt -82.78 158.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 108.944 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 316' ' ' LYS . . . . . 0.413 ' N ' HG22 ' C' ' 315' ' ' ILE . 0.1 OUTLIER -166.58 165.95 16.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.511 -1.368 . . . . 0.0 109.659 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -78.8 140.45 38.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.625 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 318' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' C' ' 245' ' ' ILE . . . -70.79 -29.91 66.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.909 -1.119 . . . . 0.0 108.837 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 -179.842 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PRO . . . . . 0.439 ' O ' ' CD2' ' B' ' 101' ' ' TYR . 6.6 Cg_exo -64.53 150.03 88.92 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.231 1.954 . . . . 0.0 112.303 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -85.09 26.35 0.65 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.559 2.173 . . . . 0.0 112.78 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.01 126.28 11.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.616 -1.303 . . . . 0.0 110.23 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -179.46 -49.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 109.24 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' B' ' 101' ' ' TYR . 3.0 p -125.04 154.91 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.832 0.825 . . . . 0.0 110.436 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.413 ' N ' HG22 ' B' ' 27' ' ' VAL . 3.0 t -108.06 139.52 29.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.412 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 5.1 m-85 -102.24 133.05 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.111 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' B' ' 72' ' ' ILE . 4.5 mp -116.96 121.28 40.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -114.61 -94.17 1.99 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.649 ' H ' ' NH1' ' B' ' 95' ' ' ARG . 2.7 p -69.04 110.7 4.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.75 -1.441 . . . . 0.0 110.36 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -160.74 127.37 2.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' B' ' 36' ' ' ASP . 51.7 Cg_endo -74.85 170.87 19.41 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.604 1.536 . . . . 0.0 112.61 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.589 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 3.8 m-30 -69.29 4.72 1.56 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.3 m-20 -60.26 -38.06 82.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.129 -0.982 . . . . 0.0 109.443 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.81 116.01 18.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 109.459 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.427 ' O ' HG12 ' B' ' 42' ' ' ILE . 82.2 p -113.02 -140.64 0.38 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.696 0.76 . . . . 0.0 111.631 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.401 ' CD ' ' C ' ' B' ' 39' ' ' GLU . 1.6 pp20? -61.46 -34.28 75.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.673 -1.267 . . . . 0.0 111.358 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -71.69 -53.95 11.87 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -44.1 79.56 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.385 -0.822 . . . . 0.0 110.189 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.584 ' O ' ' N ' ' B' ' 44' ' ' ASP . 30.6 mm -58.0 -51.62 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.808 HD13 ' O ' ' B' ' 43' ' ' LEU . 3.1 tm? -37.43 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' B' ' 42' ' ' ILE . 83.7 m-20 -124.7 -24.48 4.15 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.713 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.3 tm? -60.09 -41.18 91.94 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.214 -1.554 . . . . 0.0 107.472 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.621 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.4 m -87.65 -63.04 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.817 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.915 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.1 p -40.11 -19.96 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.779 -0.576 . . . . 0.0 109.896 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.671 ' O ' HG23 ' B' ' 49' ' ' VAL . 1.2 m-20 -42.69 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.117 0.96 . . . . 0.0 110.131 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.915 ' N ' ' O ' ' B' ' 47' ' ' SER . 0.9 OUTLIER 161.58 -28.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 47' ' ' SER . . . -169.37 123.16 1.06 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.424 -1.37 . . . . 0.0 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -48.14 100.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.579 1.52 . . . . 0.0 111.523 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.436 ' H ' HG13 ' B' ' 52' ' ' VAL . 0.8 OUTLIER -49.63 171.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.852 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.406 HD11 ' HG2' ' B' ' 75' ' ' ARG . 35.5 mm -107.47 -49.12 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 110.132 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.579 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 40.5 m-20 -118.35 139.17 51.76 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.103 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.558 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.6 OUTLIER -139.96 132.2 28.2 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.558 ' N ' HD23 ' B' ' 55' ' ' LEU . 21.4 tptp -137.26 121.5 18.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.045 -1.034 . . . . 0.0 109.678 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tpt -104.5 128.61 52.48 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.726 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 2.1 ttt -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.061 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.589 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 2.3 m-85 -104.11 -175.92 2.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' B' ' 66' ' ' SER . 49.8 m-20 -115.55 87.38 17.14 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.07 -1.019 . . . . 0.0 110.657 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.06 -60.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.485 2.123 . . . . 0.0 112.353 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' B' ' 63' ' ' THR . 14.8 tt0 -86.2 -62.1 1.59 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.446 HG23 ' H ' ' B' ' 63' ' ' THR . 5.2 p -45.24 -43.02 10.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.835 . . . . 0.0 108.91 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.41 18.26 76.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -61.99 -42.02 98.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.979 -1.307 . . . . 0.0 109.516 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -179.86 179.15 0.58 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.978 -1.076 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -117.93 78.7 1.27 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.65 48.08 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' TYR . . . . . 0.413 ' CD1' ' HA2' ' B' ' 31' ' ' GLY . 3.9 m-30 -97.01 125.44 41.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.43 158.16 43.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 111.847 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.537 ' C ' HD12 ' B' ' 72' ' ' ILE . 5.7 m-85 -125.97 126.99 45.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.629 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.896 HD12 ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -118.06 98.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.724 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.579 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.8 tt0 -82.54 126.4 32.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.379 -1.451 . . . . 0.0 110.282 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -86.72 176.36 7.79 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.573 0.701 . . . . 0.0 110.038 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 58.3 mtp180 -56.63 -42.07 78.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.2 m-20 165.64 172.59 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.843 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.9 OUTLIER -38.07 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.062 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.1 mm-40 -74.43 -70.83 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.95 -1.094 . . . . 0.0 108.748 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 37.0 m -59.49 -45.02 92.89 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.66 -1.275 . . . . 0.0 107.691 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' B' ' 84' ' ' VAL . 8.6 t -62.68 -34.88 78.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 109.184 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.843 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -56.23 -59.36 5.05 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.124 -1.61 . . . . 0.0 107.231 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' SER . . . . . 0.457 ' O ' ' CG ' ' B' ' 86' ' ' ASN . 33.3 t -65.58 -38.95 91.0 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.501 ' N ' HG11 ' B' ' 49' ' ' VAL . . . -79.28 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.867 -1.146 . . . . 0.0 110.197 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -52.01 -42.91 35.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.861 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmt180 -66.82 -43.53 83.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.643 -1.911 . . . . 0.0 109.258 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' B' ' 82' ' ' SER . 3.7 m-20 -68.59 -39.47 80.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 111.619 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.768 ' O ' HD11 ' B' ' 97' ' ' LEU . 7.9 mt -117.09 -4.05 11.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.927 -1.108 . . . . 0.0 111.254 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' B' ' 84' ' ' VAL . 0.0 OUTLIER -16.11 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.074 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.84 108.11 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -130.37 143.4 50.75 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.699 -1.471 . . . . 0.0 108.087 -179.258 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLN . . . . . 0.568 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 16.7 tp60 -32.66 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.648 -0.658 . . . . 0.0 110.832 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 90' ' ' TYR . 5.3 tt -148.36 132.36 17.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.23 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.81 -157.94 1.58 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -21.18 52.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -1.125 . . . . 0.0 108.646 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.649 ' NH1' ' H ' ' B' ' 32' ' ' SER . 32.0 ttm105 -136.85 146.92 46.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 1.6 m-30 -93.1 143.92 25.77 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.511 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.768 HD11 ' O ' ' B' ' 87' ' ' LEU . 0.2 OUTLIER -46.68 157.69 0.14 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.174 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 147.97 42.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 109.888 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 17.2 p -77.2 121.46 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.412 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -135.89 174.56 21.32 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.515 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.505 ' HA ' HG12 ' B' ' 27' ' ' VAL . 7.1 t80 -147.69 125.25 11.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.571 -0.958 . . . . 0.0 109.784 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -137.84 101.64 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.651 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 158' ' ' SER . . . . . 0.632 ' O ' ' N ' ' C' ' 160' ' ' LYS . 23.1 t . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 159' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' C' ' 213' ' ' VAL . 3.2 t -54.83 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 160' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' C' ' 158' ' ' SER . 11.3 tptp -88.21 136.17 33.1 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.611 0.72 . . . . 0.0 110.19 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 161' ' ' MET . . . . . 0.641 ' HE1' HG22 ' C' ' 217' ' ' VAL . 39.2 mmm -115.62 150.65 36.35 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.604 -0.685 . . . . 0.0 109.633 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -116.48 123.84 48.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 163' ' ' ILE . . . . . 0.611 ' CG2' HD21 ' C' ' 166' ' ' LEU . 5.2 mm -105.1 133.61 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.09 171.19 21.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.555 ' O ' HG22 ' C' ' 228' ' ' ILE . . . 69.1 28.71 72.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 166' ' ' LEU . . . . . 0.611 HD21 ' CG2' ' C' ' 163' ' ' ILE . 97.5 mt -77.2 150.69 35.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 110.536 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' C' ' 169' ' ' ASP . 0.4 OUTLIER -75.3 153.85 37.7 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.084 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 168' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -69.42 19.07 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.886 -1.134 . . . . 0.0 110.032 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 169' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' C' ' 167' ' ' ASN . 59.5 t0 -145.14 84.47 1.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.946 -1.096 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 170' ' ' THR . . . . . 0.583 ' OG1' ' NZ ' ' C' ' 192' ' ' LYS . 0.2 OUTLIER -146.61 119.96 8.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.17 158.55 15.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 0.0 109.465 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 172' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' C' ' 173' ' ' ASP . 87.9 mt-10 -61.7 -69.29 0.25 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.829 -1.169 . . . . 0.0 110.915 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' C' ' 172' ' ' GLU . 55.1 t0 -42.31 -36.61 1.3 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.684 -1.26 . . . . 0.0 109.818 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -47.85 14.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.412 -0.805 . . . . 0.0 109.69 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' C' ' 190' ' ' ILE . 7.6 tt -57.19 -42.26 80.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.034 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 176' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' C' ' 179' ' ' PHE . 70.8 ttp85 -67.34 -57.94 5.71 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 177' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' C' ' 176' ' ' ARG . 49.1 tp10 -39.75 -31.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.53 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 15.4 t80 -74.13 -49.39 23.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.725 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.891 ' O ' ' N ' ' C' ' 181' ' ' LYS . 28.9 m-85 -74.87 -62.94 1.37 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -39.43 4.19 0.0 OUTLIER Glycine 0 N--CA 1.508 3.457 0 O-C-N 120.345 -1.472 . . . . 0.0 112.38 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 181' ' ' LYS . . . . . 0.891 ' N ' ' O ' ' C' ' 179' ' ' PHE . 6.2 tttm -64.63 -28.57 69.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.779 -1.424 . . . . 0.0 107.839 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 182' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' C' ' 219' ' ' THR . 32.0 m-85 -78.39 -35.55 47.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.267 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.7 -126.1 0.88 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 41.3 m -129.28 154.92 46.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.61 HG12 ' CE1' ' C' ' 207' ' ' PHE . 1.1 m -120.44 159.7 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 108.978 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 186' ' ' THR . . . . . 0.492 ' O ' ' OD1' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -99.01 -43.92 6.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 110.248 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 187' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' C' ' 186' ' ' THR . 68.8 m-20 -151.93 147.57 26.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.833 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.737 HD23 ' C ' ' C' ' 188' ' ' LEU . 0.2 OUTLIER -141.73 146.21 35.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.934 -1.104 . . . . 0.0 108.486 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.3 123.2 29.5 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.978 -1.076 . . . . 0.0 109.88 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 190' ' ' ILE . . . . . 0.596 ' CD1' HD13 ' C' ' 175' ' ' LEU . 92.6 mt -134.75 121.63 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.478 -1.388 . . . . 0.0 108.169 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -114.66 44.49 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.865 0.841 . . . . 0.0 108.806 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 192' ' ' LYS . . . . . 0.583 ' NZ ' ' OG1' ' C' ' 170' ' ' THR . 4.5 ttmt -64.45 -162.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.428 ' H ' ' HG2' ' C' ' 192' ' ' LYS . 0.5 OUTLIER -134.25 66.64 71.57 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.767 -1.208 . . . . 0.0 110.696 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.35 -0.91 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.426 2.751 . . . . 0.0 110.889 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.36 15.86 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.343 0.592 . . . . 0.0 109.424 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.1 -59.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.2 -91.82 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -142.0 144.87 33.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.502 -0.999 . . . . 0.0 109.64 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 199' ' ' SER . . . . . . . . . . . . . 42.2 t -161.86 160.58 28.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.48 ' O ' ' CD1' ' C' ' 202' ' ' PHE . 64.1 mmt-85 -47.75 114.38 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 109.122 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.42 113.05 3.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' C' ' 200' ' ' ARG . 16.0 p90 -141.31 153.27 45.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -1.163 . . . . 0.0 108.419 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -122.65 139.61 12.66 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.803 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -118.34 103.55 9.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.06 109.22 20.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.972 . . . . 0.0 111.016 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 206' ' ' SER . . . . . 0.527 ' HB2' ' HZ3' ' C' ' 160' ' ' LYS . 7.2 t -94.81 132.62 39.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' C' ' 185' ' ' VAL . 63.1 m-85 -116.21 143.43 45.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.924 -1.11 . . . . 0.0 109.559 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 208' ' ' GLU . . . . . 0.433 ' OE1' ' C ' ' C' ' 208' ' ' GLU . 1.7 tm-20 -68.15 -54.34 18.72 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.015 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' C' ' 210' ' ' PRO . 0.7 OUTLIER -91.16 108.22 26.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.968 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 210' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' C' ' 209' ' ' LYS . 2.2 Cg_endo -44.38 -20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.206 1.937 . . . . 0.0 113.683 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.574 ' O ' ' N ' ' C' ' 213' ' ' VAL . 11.3 t -61.83 -69.38 0.25 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.542 -1.349 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.679 ' O ' HG23 ' C' ' 216' ' ' VAL . 83.0 p -35.45 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.161 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 213' ' ' VAL . . . . . 0.595 HG21 ' SG ' ' C' ' 159' ' ' CYS . 0.4 OUTLIER -64.91 -37.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.0 109.229 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 214' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' C' ' 211' ' ' SER . 91.0 m-20 -63.68 -46.05 87.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 55.2 mp0 -68.76 -35.69 77.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.679 HG23 ' O ' ' C' ' 212' ' ' SER . 54.5 t -62.01 -52.62 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.641 HG22 ' HE1' ' C' ' 161' ' ' MET . 45.5 t -68.45 -38.79 79.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -73.31 -45.28 56.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.44 -0.788 . . . . 0.0 110.411 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 219' ' ' THR . . . . . 0.587 HG21 ' OH ' ' C' ' 182' ' ' TYR . 24.9 m -68.75 145.65 53.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.21 -0.931 . . . . 0.0 111.658 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -80.33 149.94 30.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.62 ' HB2' HD11 ' C' ' 228' ' ' ILE . 20.5 m-70 -127.68 132.19 49.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 222' ' ' ILE . . . . . 0.53 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -142.56 103.21 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.326 -0.859 . . . . 0.0 109.678 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.516 ' N ' HD12 ' C' ' 223' ' ' LEU . 10.7 mp -73.02 -62.58 1.41 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.023 -1.048 . . . . 0.0 109.216 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -110.26 12.66 23.21 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 97.99 5.06 57.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -73.48 -171.61 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -1.084 . . . . 0.0 108.17 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.04 102.21 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 228' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' C' ' 221' ' ' HIS . 15.8 pt -102.13 151.55 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.478 -0.764 . . . . 0.0 108.955 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -119.27 107.27 41.65 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.354 -0.841 . . . . 0.0 110.888 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 230' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 95.9 Cg_endo -89.19 135.23 2.65 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 111.431 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -148.27 146.0 28.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.852 -1.155 . . . . 0.0 110.199 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' C' ' 233' ' ' ALA . 35.5 mtm105 -56.63 147.68 21.87 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 233' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.2 133.93 6.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.926 -1.109 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.86 124.15 34.36 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 109.667 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.15 142.42 4.07 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.939 1.759 . . . . 0.0 112.077 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -58.12 -43.68 87.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 110.688 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 237' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 29.7 p-10 -62.72 -39.26 93.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 238' ' ' GLU . . . . . 0.73 ' O ' HG23 ' C' ' 242' ' ' THR . 97.8 mt-10 -68.41 -41.84 79.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.692 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 239' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -65.44 -43.46 90.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.588 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -63.86 -41.57 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.887 . . . . 0.0 109.785 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -61.45 -47.18 86.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.746 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 242' ' ' THR . . . . . 0.73 HG23 ' O ' ' C' ' 238' ' ' GLU . 59.6 p -54.59 137.65 42.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.48 150.14 17.98 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -130.08 132.27 46.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -1.046 . . . . 0.0 109.983 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.949 HD13 ' O ' ' C' ' 245' ' ' ILE . 0.0 OUTLIER -121.15 156.59 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.572 -0.705 . . . . 0.0 109.148 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 246' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -105.48 135.01 47.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.578 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.49 131.7 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.778 0.799 . . . . 0.0 110.082 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.69 145.93 16.21 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.34 64.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -129.73 154.85 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -1.076 . . . . 0.0 109.198 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 251' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 130.53 -39.6 1.78 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.629 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 252' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 87.6 Cg_exo -48.62 -120.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.612 2.208 . . . . 0.0 112.963 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -81.42 17.79 1.29 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' C' ' 308' ' ' PHE . 41.3 t -89.68 140.56 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.963 -1.086 . . . . 0.0 109.97 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -104.95 154.81 38.4 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.91 -24.89 74.2 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.157 1.905 . . . . 0.0 112.345 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -51.17 -64.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.714 -0.616 . . . . 0.0 109.697 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 258' ' ' GLU . . . . . 0.68 ' O ' ' N ' ' C' ' 261' ' ' GLU . 33.8 tt0 -61.16 -78.17 0.04 OUTLIER 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.176 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 259' ' ' PHE . . . . . 0.655 ' C ' ' O ' ' C' ' 258' ' ' GLU . 59.7 t80 -11.93 -65.74 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 121.52 0.676 . . . . 0.0 110.082 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 260' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' C' ' 258' ' ' GLU . 2.9 tm-20 -59.9 -45.73 91.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.574 -0.704 . . . . 0.0 110.799 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 261' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' C' ' 258' ' ' GLU . 63.2 mm-40 -71.89 -17.3 62.12 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.985 -1.072 . . . . 0.0 108.892 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 262' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' C' ' 263' ' ' PHE . 4.6 t80 -78.96 -80.52 0.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' C' ' 265' ' ' GLN . 31.0 m-85 -38.25 -42.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.235 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.615 ' N ' HD11 ' C' ' 269' ' ' ILE . 73.0 p -30.82 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.609 ' N ' ' O ' ' C' ' 263' ' ' PHE . 49.7 tt0 -45.26 -23.07 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.822 -0.549 . . . . 0.0 110.969 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.564 ' CZ2' ' CD2' ' C' ' 263' ' ' PHE . 8.2 p90 -151.58 151.1 31.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.644 -1.285 . . . . 0.0 109.246 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 82.08 176.3 51.12 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 268' ' ' THR . . . . . 0.511 ' O ' ' C ' ' C' ' 269' ' ' ILE . 43.1 p -115.35 19.61 15.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.733 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.615 HD11 ' N ' ' C' ' 264' ' ' SER . 0.0 OUTLIER -15.35 104.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 41.5 mm -83.4 -34.16 10.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -132.86 97.2 3.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -108.99 131.47 55.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.442 -0.786 . . . . 0.0 109.158 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -160.94 129.91 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.422 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.717 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.4 OUTLIER -97.12 157.89 15.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 275' ' ' MET . . . . . 0.708 ' O ' HD22 ' C' ' 276' ' ' LEU . 0.5 OUTLIER -93.76 168.19 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.316 -1.49 . . . . 0.0 109.336 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.708 HD22 ' O ' ' C' ' 275' ' ' MET . 0.2 OUTLIER -150.35 -155.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 277' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' C' ' 279' ' ' ASP . 77.2 m-20 -54.16 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.463 -0.773 . . . . 0.0 110.447 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 278' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' C' ' 278' ' ' LYS . 0.0 OUTLIER -49.46 -8.15 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.298 -0.876 . . . . 0.0 110.146 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 279' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 277' ' ' ASP . 85.3 m-20 -59.61 -66.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 110.073 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 131.89 43.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 56.53 -124.5 35.22 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.557 ' C ' ' H ' ' C' ' 284' ' ' ARG . 57.0 tt0 -146.95 147.2 30.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.235 -1.156 . . . . 0.0 110.136 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.23 21.73 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 284' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' C' ' 282' ' ' GLN . 0.1 OUTLIER -51.47 -33.3 30.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.664 -1.272 . . . . 0.0 108.016 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 285' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' C' ' 250' ' ' ILE . . . 117.34 69.62 0.4 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' C' ' 250' ' ' ILE . 32.6 p90 -162.18 175.01 12.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.609 . . . . 0.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -154.63 178.8 31.18 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.071 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 288' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' C' ' 246' ' ' PHE . 7.8 m-85 -142.41 157.13 45.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.722 -1.458 . . . . 0.0 108.929 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 289' ' ' VAL . . . . . 0.489 HG12 HD12 ' C' ' 245' ' ' ILE . 1.0 OUTLIER -149.12 148.46 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.714 -1.241 . . . . 0.0 108.904 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 12.6 m -129.46 130.94 46.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.05 -1.031 . . . . 0.0 111.101 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 291' ' ' TYR . . . . . 0.55 ' CE2' HG23 ' C' ' 269' ' ' ILE . 46.5 m-85 -112.88 142.5 45.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 292' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' C' ' 292' ' ' ASP . 56.6 p30 -75.79 13.03 0.9 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.437 -1.415 . . . . 0.0 107.544 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 293' ' ' SER . . . . . 0.516 ' H ' ' C ' ' C' ' 291' ' ' TYR . 1.8 m -131.04 112.02 12.54 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.49 76.16 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -50.6 -38.0 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.95 83.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 297' ' ' VAL . . . . . 0.448 HG22 ' CG2' ' C' ' 245' ' ' ILE . 59.5 t -59.31 -57.67 10.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.57 -19.13 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -77.11 -60.42 2.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.141 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.5 p -60.97 -20.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.146 -0.972 . . . . 0.0 109.039 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 301' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' C' ' 300' ' ' VAL . 0.0 OUTLIER -43.17 -58.54 2.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 108.867 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -49.82 -27.67 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' C' ' 300' ' ' VAL . 94.1 m-20 -99.94 68.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.21 -9.5 59.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.088 . . . . 0.0 109.94 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.76 125.06 32.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 306' ' ' ILE . . . . . 0.539 HD12 HD11 ' C' ' 315' ' ' ILE . 69.4 mt -132.67 145.5 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.0 111.099 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 307' ' ' ASP . . . . . 0.48 ' O ' ' OD1' ' C' ' 307' ' ' ASP . 3.3 p30 -81.53 94.81 6.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.577 ' HE2' HG11 ' C' ' 254' ' ' VAL . 36.7 t80 -104.26 -176.28 3.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' C' ' 308' ' ' PHE . 56.0 mttt -38.84 -32.77 0.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.787 -1.195 . . . . 0.0 109.691 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 310' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 44.1 t0 -95.13 -154.47 0.43 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 108.853 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 311' ' ' ARG . . . . . 0.65 ' O ' ' N ' ' C' ' 313' ' ' ILE . 17.3 ttp180 -79.66 -167.74 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 108.916 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 312' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' C' ' 311' ' ' ARG . 10.3 tptt -55.01 75.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.905 0.86 . . . . 0.0 109.672 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 313' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' C' ' 311' ' ' ARG . 3.6 pt -45.46 153.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.947 . . . . 0.0 108.896 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -107.3 155.22 20.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.478 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.539 HD11 HD12 ' C' ' 306' ' ' ILE . 77.8 mt -125.31 152.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -154.63 149.88 27.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.952 -1.093 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -67.33 145.46 55.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.085 -1.009 . . . . 0.0 109.333 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -78.08 13.45 1.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.905 -1.122 . . . . 0.0 109.116 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.8 -179.534 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.52 142.01 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.685 2.257 . . . . 0.0 111.986 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.15 12.08 1.61 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.424 2.083 . . . . 0.0 112.545 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -158.5 129.92 6.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.02 -1.05 . . . . 0.0 109.513 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.567 ' N ' ' OG ' ' B' ' 80' ' ' SER . 42.4 ttt-85 -177.48 -44.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.831 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -138.8 154.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.92 139.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.295 -0.878 . . . . 0.0 108.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' B' ' 101' ' ' TYR . 2.0 m-30 -106.68 135.99 47.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 111.196 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.66 HD12 HD11 ' B' ' 72' ' ' ILE . 54.0 mt -110.21 119.27 38.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -78.52 -137.46 1.22 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' SER . . . . . 0.417 ' C ' HD12 ' B' ' 33' ' ' ILE . 23.2 p -69.42 122.42 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.65 -1.5 . . . . 0.0 109.673 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' B' ' 30' ' ' LEU . 1.2 mp -126.53 137.78 31.08 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.59 153.53 23.28 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.433 1.422 . . . . 0.0 112.526 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -72.39 -0.91 13.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 109.986 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.4 -35.81 78.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.026 . . . . 0.0 108.513 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.44 117.84 19.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.585 -0.697 . . . . 0.0 109.718 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.772 ' O ' HD13 ' B' ' 42' ' ' ILE . 82.1 p -111.42 -135.68 0.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.478 -0.764 . . . . 0.0 110.971 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -64.33 -32.42 74.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.029 -1.044 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.7 -54.44 27.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.184 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -68.11 -42.11 80.73 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.592 -0.693 . . . . 0.0 110.385 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.772 HD13 ' O ' ' B' ' 38' ' ' THR . 1.7 mp -61.1 -53.3 51.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.539 HD23 ' OD1' ' B' ' 44' ' ' ASP . 4.9 tt -39.58 -21.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.554 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.539 ' OD1' HD23 ' B' ' 43' ' ' LEU . 91.5 m-20 -125.45 -24.24 3.95 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.732 -1.23 . . . . 0.0 110.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.709 ' C ' HD13 ' B' ' 45' ' ' LEU . 2.9 tm? -57.22 -39.02 74.64 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.108 -1.62 . . . . 0.0 106.877 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' B' ' 48' ' ' ASN . 85.4 m -83.26 -63.42 1.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.799 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.1 m -37.16 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.775 -0.578 . . . . 0.0 110.119 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' B' ' 46' ' ' CYS . 12.4 m-20 -48.09 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.525 0.678 . . . . 0.0 111.112 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.799 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.1 t 174.5 -31.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.19 -174.63 46.89 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.6 158.87 15.01 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.143 2.562 . . . . 0.0 113.028 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.602 HG21 ' OG ' ' B' ' 47' ' ' SER . 23.2 t -128.76 145.26 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.712 HG22 ' OD1' ' B' ' 54' ' ' ASN . 45.6 mm -90.56 -66.49 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 112.011 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.712 ' OD1' HG22 ' B' ' 53' ' ' ILE . 64.0 m-20 -117.86 139.72 50.71 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.598 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.15 127.63 38.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -138.02 129.89 28.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.673 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' MET . . . . . 0.417 ' SD ' ' C ' ' B' ' 38' ' ' THR . 0.8 OUTLIER -133.25 144.68 49.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.591 0.71 . . . . 0.0 110.379 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 58' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -172.07 170.76 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.491 -0.756 . . . . 0.0 109.134 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 59' ' ' PHE . . . . . 0.51 ' O ' ' SD ' ' B' ' 58' ' ' MET . 0.1 OUTLIER -116.12 -166.93 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.0 109.21 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' B' ' 64' ' ' GLY . 6.6 t0 -105.03 73.98 0.24 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.184 -0.948 . . . . 0.0 110.622 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.41 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 5.9 Cg_endo -57.09 -31.33 89.98 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.04 1.827 . . . . 0.0 112.404 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -63.09 -37.76 88.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.599 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.431 HG23 ' H ' ' B' ' 65' ' ' ARG . 0.2 OUTLIER -140.97 -32.8 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 110.206 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 60' ' ' ASP . . . 99.5 -1.34 57.08 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.431 ' H ' HG23 ' B' ' 63' ' ' THR . 99.1 mtt180 -58.51 -40.79 83.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.848 -1.384 . . . . 0.0 109.606 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.529 ' H ' ' HB2' ' B' ' 60' ' ' ASP . 0.5 OUTLIER -89.6 116.24 27.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.102 -0.999 . . . . 0.0 108.709 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.89 -72.58 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.734 -0.604 . . . . 0.0 109.638 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -123.01 95.74 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' TYR . . . . . 0.711 ' OH ' ' CZ ' ' B' ' 71' ' ' PHE . 0.8 OUTLIER -108.67 130.61 55.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.473 -1.016 . . . . 0.0 109.126 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.73 24.38 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.834 -1.146 . . . . 0.0 112.193 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.711 ' CZ ' ' OH ' ' B' ' 69' ' ' TYR . 12.7 m-30 -115.32 129.4 56.59 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.882 0.849 . . . . 0.0 109.782 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ILE . . . . . 0.747 HD12 ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -120.25 102.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.121 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.573 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.5 mt-10 -83.95 131.42 34.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.573 -1.33 . . . . 0.0 110.472 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' B' ' 52' ' ' VAL . 7.2 m-85 -93.66 178.24 5.75 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.474 0.654 . . . . 0.0 110.176 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 50.4 ttt180 -52.71 -44.3 66.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 110.216 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 158.58 -177.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.754 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.3 mp -35.52 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.683 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.4 tt0 -70.06 -75.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.548 -1.345 . . . . 0.0 109.227 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -62.31 -40.26 95.74 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.978 ' O ' HG22 ' B' ' 84' ' ' VAL . 34.0 t -61.64 -39.6 91.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.055 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -57.44 -60.86 3.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 21.5 t -63.07 -35.05 78.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.905 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.748 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -73.51 -67.71 0.56 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 0.0 110.411 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.978 HG22 ' O ' ' B' ' 80' ' ' SER . 26.2 m -53.59 -37.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.506 -1.371 . . . . 0.0 110.077 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 10.2 mmt180 -62.9 -43.35 99.02 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.559 -1.338 . . . . 0.0 107.898 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -84.0 -45.97 12.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.641 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.748 ' N ' ' O ' ' B' ' 83' ' ' ALA . 0.4 OUTLIER -125.18 84.06 2.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.36 -0.838 . . . . 0.0 110.315 -179.371 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.4 OUTLIER -110.47 -68.46 0.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 89' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' B' ' 88' ' ' ASN . . . -127.66 108.1 0.92 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -139.42 147.55 41.57 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.468 -1.607 . . . . 0.0 108.843 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.3 tp-100 -31.32 89.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.556 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 90' ' ' TYR . 60.0 tp -148.89 135.22 19.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.09 -1.006 . . . . 0.0 109.531 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 45.86 -168.74 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 36.7 m -64.83 -25.18 67.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.492 -1.004 . . . . 0.0 110.345 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' B' ' 92' ' ' LEU . 1.1 mmm180 -131.3 160.67 34.27 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.213 -0.929 . . . . 0.0 109.2 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' PHE . . . . . 0.45 ' HB3' ' N ' ' B' ' 90' ' ' TYR . 6.8 m-85 -95.18 138.89 32.27 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.624 -0.673 . . . . 0.0 110.148 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LEU . . . . . 0.629 HD23 ' H ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -43.89 157.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.67 159.84 38.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 109.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' CYS . . . . . 0.578 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.5 OUTLIER -110.49 129.14 55.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.393 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.4 -165.8 13.59 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.531 -1.318 . . . . 0.0 110.824 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.526 ' N ' ' OH ' ' B' ' 29' ' ' TYR . 30.2 p90 -130.53 171.29 13.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.635 -0.92 . . . . 0.0 109.452 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' B' ' 102' ' ' SER . 5.8 t 179.79 27.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 109.964 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 109.395 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 158' ' ' SER . . . . . 0.53 ' C ' ' SG ' ' C' ' 159' ' ' CYS . 23.9 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.343 0.592 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 159' ' ' CYS . . . . . 0.53 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 61.84 14.45 6.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.321 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 160' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 13.4 tttp -102.28 99.24 9.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 161' ' ' MET . . . . . 0.618 ' HE2' HD13 ' C' ' 163' ' ' ILE . 3.4 mmm -71.24 151.89 43.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 110.027 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 162' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' C' ' 202' ' ' PHE . 25.6 t80 -126.37 78.3 1.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 163' ' ' ILE . . . . . 0.936 HD11 HD12 ' C' ' 205' ' ' LEU . 4.1 mm -49.94 137.25 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 164' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 166' ' ' LEU . . . -140.18 172.32 23.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.06 11.44 0.12 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 166' ' ' LEU . . . . . 0.636 ' HA ' HG22 ' C' ' 228' ' ' ILE . 1.2 pp -62.27 163.96 7.68 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.929 . . . . 0.0 109.353 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 167' ' ' ASN . . . . . 0.633 ' O ' HD12 ' C' ' 166' ' ' LEU . 29.9 t30 -68.68 123.99 22.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.935 -1.103 . . . . 0.0 109.503 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 168' ' ' TRP . . . . . 0.622 ' CZ2' ' CZ ' ' C' ' 198' ' ' ARG . 3.8 m-90 -37.74 -33.24 0.07 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.784 -0.572 . . . . 0.0 110.437 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 169' ' ' ASP . . . . . 0.457 ' H ' ' ND2' ' C' ' 167' ' ' ASN . 23.6 t70 -101.33 99.21 9.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.949 -1.095 . . . . 0.0 111.112 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 3.0 m -157.19 116.12 3.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.26 -0.9 . . . . 0.0 109.314 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 171' ' ' THR . . . . . 0.538 ' O ' ' OD1' ' C' ' 174' ' ' ASN . 0.0 OUTLIER -75.5 173.89 10.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.783 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 172' ' ' GLU . . . . . 0.673 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -75.47 -71.92 0.34 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.348 -0.845 . . . . 0.0 110.252 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' C' ' 176' ' ' ARG . 91.5 m-20 -38.34 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 174' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' C' ' 175' ' ' LEU . 29.6 p-10 -36.1 -44.83 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.709 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.623 ' CD2' HD11 ' C' ' 205' ' ' LEU . 5.3 tt -54.79 -46.39 74.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 176' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' C' ' 178' ' ' TYR . 60.9 ttp85 -72.15 -60.34 2.28 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.009 -1.057 . . . . 0.0 108.72 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 177' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' C' ' 176' ' ' ARG . 78.1 mm-40 -40.06 -22.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.067 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 178' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' C' ' 176' ' ' ARG . 16.3 t80 -95.24 -36.57 11.38 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.729 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 179' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' C' ' 176' ' ' ARG . 12.6 m-85 -90.02 12.59 17.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.094 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 180' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' C' ' 182' ' ' TYR . . . -61.28 -55.87 26.81 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.035 -1.041 . . . . 0.0 111.174 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.82 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.765 -1.433 . . . . 0.0 112.048 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 182' ' ' TYR . . . . . 0.596 ' H ' ' C ' ' C' ' 180' ' ' GLY . 22.3 m-85 -107.48 -3.93 18.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.999 -1.063 . . . . 0.0 109.567 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.87 -165.34 27.3 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 184' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' C' ' 208' ' ' GLU . 0.1 OUTLIER -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.286 . . . . 0.0 108.522 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.543 HG22 ' CE1' ' C' ' 207' ' ' PHE . 22.7 t -104.29 129.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -51.42 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.962 . . . . 0.0 109.414 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 187' ' ' ASP . . . . . 0.454 ' H ' ' HB2' ' C' ' 206' ' ' SER . 21.1 t70 -149.84 160.91 43.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp -157.62 143.05 17.13 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.22 -1.55 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 189' ' ' LYS . . . . . 0.456 ' H ' ' HB2' ' C' ' 204' ' ' PHE . 43.8 mttm -117.14 161.25 19.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.142 -0.974 . . . . 0.0 108.774 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 176.78 104.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 191' ' ' MET . . . . . 0.552 ' O ' ' C ' ' C' ' 192' ' ' LYS . 12.9 mtm -122.4 80.04 1.68 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 110.885 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 192' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' C' ' 191' ' ' MET . 41.5 mttp -24.07 -83.66 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 193' ' ' ASP . . . . . 0.406 ' HB3' ' N ' ' C' ' 199' ' ' SER . 3.8 p-10 -153.26 152.5 27.87 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.963 . . . . 0.0 109.233 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.55 -57.64 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.166 1.911 . . . . 0.0 112.303 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.48 ' O ' ' C ' ' C' ' 196' ' ' THR . . . -175.53 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 109.071 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 196' ' ' THR . . . . . 0.48 ' C ' ' O ' ' C' ' 195' ' ' ALA . 37.3 p -28.44 -72.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.84 -55.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 198' ' ' ARG . . . . . 0.622 ' CZ ' ' CZ2' ' C' ' 168' ' ' TRP . 18.2 ptt180 -169.33 158.75 8.32 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 199' ' ' SER . . . . . 0.552 ' O ' ' N ' ' C' ' 201' ' ' GLY . 90.3 p -156.42 170.3 22.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.0 -1.063 . . . . 0.0 109.417 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 200' ' ' ARG . . . . . 0.545 ' C ' ' O ' ' C' ' 199' ' ' SER . 0.0 OUTLIER -26.56 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.436 0.636 . . . . 0.0 110.735 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 201' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.33 109.35 2.78 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.466 ' CD2' ' O ' ' C' ' 200' ' ' ARG . 13.0 p90 -129.56 166.67 19.24 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.785 -0.832 . . . . 0.0 108.783 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -137.65 130.02 4.9 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.171 -1.49 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 204' ' ' PHE . . . . . 0.456 ' HB2' ' H ' ' C' ' 189' ' ' LYS . 61.6 m-85 -104.08 115.55 30.62 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.607 -1.525 . . . . 0.0 107.596 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.936 HD12 HD11 ' C' ' 163' ' ' ILE . 3.5 mt -115.32 97.02 5.95 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.838 0.828 . . . . 0.0 109.967 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 206' ' ' SER . . . . . 0.454 ' HB2' ' H ' ' C' ' 187' ' ' ASP . 2.4 m -69.31 80.6 0.36 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.284 0.564 . . . . 0.0 109.651 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 207' ' ' PHE . . . . . 0.65 ' O ' ' O ' ' C' ' 208' ' ' GLU . 44.2 m-85 -79.56 123.6 27.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 110.943 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 208' ' ' GLU . . . . . 0.65 ' O ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -36.59 -103.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.617 ' H ' ' CG ' ' C' ' 208' ' ' GLU . 9.4 ptmt -51.39 160.6 0.93 Allowed Pre-proline 0 C--N 1.298 -1.665 0 O-C-N 119.744 -1.847 . . . . 0.0 108.326 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 210' ' ' PRO . . . . . 0.698 ' O ' HG22 ' C' ' 213' ' ' VAL . 8.6 Cg_endo -94.85 14.07 1.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.614 2.209 . . . . 0.0 112.478 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 211' ' ' SER . . . . . 0.586 ' O ' ' N ' ' C' ' 214' ' ' ASP . 60.0 p -82.64 -51.16 7.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 212' ' ' SER . . . . . 0.852 ' O ' HG23 ' C' ' 216' ' ' VAL . 60.6 p -39.58 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.47 -0.769 . . . . 0.0 109.317 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 213' ' ' VAL . . . . . 0.698 HG22 ' O ' ' C' ' 210' ' ' PRO . 4.1 m -66.28 -37.96 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.962 -1.086 . . . . 0.0 108.31 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 214' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' C' ' 211' ' ' SER . 89.9 m-20 -65.19 -49.83 68.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.3 -39.74 94.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 108.68 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 216' ' ' VAL . . . . . 0.852 HG23 ' O ' ' C' ' 212' ' ' SER . 47.7 t -56.49 -49.18 78.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.96 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.489 HG23 ' O ' ' C' ' 230' ' ' PRO . 13.1 p -82.83 -31.45 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.868 -1.145 . . . . 0.0 111.264 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -74.17 12.87 0.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.933 -1.104 . . . . 0.0 109.697 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 219' ' ' THR . . . . . 0.411 ' H ' ' C ' ' C' ' 217' ' ' VAL . 15.8 m -131.28 142.58 50.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.349 -0.844 . . . . 0.0 108.885 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -107.23 67.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 108.973 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 221' ' ' HIS . . . . . 0.831 ' CD2' ' H ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -55.54 163.95 1.16 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.706 -0.621 . . . . 0.0 109.95 -179.168 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 222' ' ' ILE . . . . . 0.426 HG22 ' C ' ' C' ' 225' ' ' GLY . 0.2 OUTLIER -142.14 74.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.902 0.858 . . . . 0.0 108.789 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 223' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -49.08 -71.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.233 -0.917 . . . . 0.0 110.67 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 224' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 58.3 t0 -89.81 12.19 17.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.75 -1.219 . . . . 0.0 109.606 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 225' ' ' GLY . . . . . 0.426 ' C ' HG22 ' C' ' 222' ' ' ILE . . . 81.01 17.12 73.06 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 226' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' C' ' 222' ' ' ILE . 27.3 mmtp -95.16 -153.94 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 227' ' ' VAL . . . . . 0.513 HG22 ' O ' ' C' ' 227' ' ' VAL . 2.0 p -122.4 90.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.071 -1.018 . . . . 0.0 109.921 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 228' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' C' ' 166' ' ' LEU . 34.0 pt -84.97 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -114.63 96.61 44.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.362 -0.837 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 230' ' ' PRO . . . . . 0.534 ' HB2' HG12 ' C' ' 216' ' ' VAL . 1.7 Cg_endo -74.65 125.67 9.67 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.384 2.056 . . . . 0.0 111.704 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.64 134.3 35.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 109.767 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.432 ' HD3' HG21 ' C' ' 213' ' ' VAL . 69.0 ttp85 -62.73 148.84 45.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.322 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 233' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' C' ' 160' ' ' LYS . . . -46.91 139.86 5.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.992 . . . . 0.0 109.196 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 28.6 mt -121.84 127.51 25.97 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.52 -0.737 . . . . 0.0 109.491 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.84 147.78 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.874 1.716 . . . . 0.0 112.276 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -58.66 -38.43 78.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.86 -41.42 74.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 109.134 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 238' ' ' GLU . . . . . 0.688 ' O ' HG23 ' C' ' 242' ' ' THR . 9.1 mp0 -71.79 -39.91 69.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.912 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 239' ' ' GLN . . . . . 0.456 ' O ' ' OG1' ' C' ' 242' ' ' THR . 9.2 tt0 -58.98 -43.68 91.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.17 -41.89 76.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 241' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' C' ' 242' ' ' THR . 16.0 ttmm -61.08 -45.38 94.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.124 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 242' ' ' THR . . . . . 0.688 HG23 ' O ' ' C' ' 238' ' ' GLU . 50.0 p -40.63 139.28 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.148 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.67 143.35 17.78 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 244' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' C' ' 290' ' ' THR . 16.7 tptp -118.71 130.26 55.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.86 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 245' ' ' ILE . . . . . 0.641 HD11 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -120.57 143.43 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 246' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -104.14 128.57 51.81 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.48 0.657 . . . . 0.0 109.975 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 247' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' C' ' 263' ' ' PHE . 14.1 t -100.63 133.07 45.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.951 0.881 . . . . 0.0 110.392 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.64 158.32 14.4 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.07 83.0 0.2 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.063 -1.257 . . . . 0.0 110.542 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 250' ' ' ILE . . . . . 0.546 HG21 HD22 ' C' ' 274' ' ' LEU . 3.7 mm -127.37 127.86 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -1.108 . . . . 0.0 108.855 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 251' ' ' GLY . . . . . 0.454 ' O ' HG23 ' C' ' 254' ' ' VAL . . . -52.61 111.87 1.83 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.92 -20.86 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.802 1.668 . . . . 0.0 111.66 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -96.52 16.17 19.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.479 -0.763 . . . . 0.0 109.265 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 254' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 251' ' ' GLY . 48.8 t -97.86 135.62 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.96 163.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 108.964 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.36 -25.89 80.8 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.653 2.235 . . . . 0.0 112.09 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -50.03 -62.74 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.233 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 258' ' ' GLU . . . . . 0.626 ' O ' ' N ' ' C' ' 261' ' ' GLU . 77.3 mm-40 -60.43 -74.18 0.08 Allowed 'General case' 0 C--O 1.194 -1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 108.51 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 259' ' ' PHE . . . . . 0.722 ' CZ ' HG13 ' C' ' 289' ' ' VAL . 89.1 t80 -16.82 -67.51 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.889 0.852 . . . . 0.0 111.045 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 260' ' ' GLU . . . . . 0.449 ' O ' HD11 ' C' ' 269' ' ' ILE . 93.6 mt-10 -61.24 -44.65 96.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 109.51 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 261' ' ' GLU . . . . . 0.626 ' N ' ' O ' ' C' ' 258' ' ' GLU . 35.5 tp10 -68.37 -7.68 33.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 262' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' C' ' 263' ' ' PHE . 13.9 t80 -92.76 -76.45 0.46 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 263' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' C' ' 247' ' ' VAL . 82.4 m-85 -45.74 -33.57 3.1 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.093 -1.443 . . . . 0.0 109.466 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 264' ' ' SER . . . . . 0.429 ' C ' ' O ' ' C' ' 263' ' ' PHE . 48.1 p -34.6 -37.5 0.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.942 -0.474 . . . . 0.0 111.786 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 265' ' ' GLN . . . . . 0.546 ' C ' ' H ' ' C' ' 267' ' ' GLY . 0.2 OUTLIER -58.52 -95.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.19 -1.569 . . . . 0.0 110.118 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 266' ' ' TRP . . . . . 0.679 ' CD1' ' O ' ' C' ' 266' ' ' TRP . 0.6 OUTLIER -69.92 19.25 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.025 -1.047 . . . . 0.0 109.38 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 267' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' C' ' 265' ' ' GLN . . . -136.17 128.16 4.45 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 268' ' ' THR . . . . . 0.528 ' O ' ' C ' ' C' ' 269' ' ' ILE . 58.1 p -85.5 6.6 26.27 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.365 -1.079 . . . . 0.0 109.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 269' ' ' ILE . . . . . 0.761 HG23 ' CE1' ' C' ' 291' ' ' TYR . 5.4 pt -14.67 96.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 122.451 1.119 . . . . 0.0 113.865 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.85 -35.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -135.94 94.87 3.12 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 272' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -137.81 172.05 13.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 273' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 7.7 tt0 164.99 156.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.563 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 274' ' ' LEU . . . . . 0.546 HD22 HG21 ' C' ' 250' ' ' ILE . 16.3 tp -97.0 140.63 31.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 275' ' ' MET . . . . . 0.503 ' H ' HD12 ' C' ' 274' ' ' LEU . 1.7 mpp? -90.4 156.33 18.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.564 -1.335 . . . . 0.0 108.686 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.67 -169.22 3.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.125 -0.984 . . . . 0.0 109.397 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 277' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 36.8 p-10 -61.84 -38.38 88.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 278' ' ' LYS . . . . . 0.583 ' N ' ' OD1' ' C' ' 277' ' ' ASP . 13.3 tttp -63.29 -42.8 99.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -66.76 -61.03 2.17 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.114 -0.991 . . . . 0.0 109.243 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 178.74 129.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.1 -118.78 5.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 282' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.3 tt0 -166.37 150.33 7.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.311 . . . . 0.0 111.009 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 4.5 t -62.17 66.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 110.213 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 284' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' C' ' 282' ' ' GLN . 72.3 mtt85 -55.77 -22.28 23.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 137.73 12.81 0.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 32.4 p90 -106.5 165.09 11.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 110.534 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.71 178.99 37.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -134.61 154.44 51.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.441 -1.623 . . . . 0.0 109.725 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 289' ' ' VAL . . . . . 0.722 HG13 ' CZ ' ' C' ' 259' ' ' PHE . 0.0 OUTLIER -148.01 138.04 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.365 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 290' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' C' ' 269' ' ' ILE . 10.1 m -123.0 126.0 46.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.96 -1.088 . . . . 0.0 109.943 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 291' ' ' TYR . . . . . 0.761 ' CE1' HG23 ' C' ' 269' ' ' ILE . 41.0 m-85 -113.55 133.09 55.45 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 292' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' C' ' 293' ' ' SER . 25.9 p-10 -53.02 -46.22 68.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.625 -1.297 . . . . 0.0 108.767 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 293' ' ' SER . . . . . 0.567 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 67.3 m -88.15 164.75 15.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.11 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 294' ' ' ALA . . . . . 0.406 ' O ' ' CG1' ' C' ' 297' ' ' VAL . . . -102.83 -22.38 13.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -50.08 -38.51 38.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.005 -1.06 . . . . 0.0 108.535 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.69 31.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 297' ' ' VAL . . . . . 0.575 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 1.4 p -54.99 -54.95 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.339 -1.476 . . . . 0.0 108.242 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 298' ' ' ASP . . . . . 0.456 ' H ' HG13 ' C' ' 297' ' ' VAL . 92.4 m-20 -57.84 -19.5 29.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.895 -1.128 . . . . 0.0 109.606 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -76.9 -58.37 3.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 108.877 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 300' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' C' ' 303' ' ' ASN . 7.2 p -68.11 -25.22 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 301' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 65.6 m -43.9 -52.07 7.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.115 -0.991 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -50.92 -22.21 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 303' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' C' ' 300' ' ' VAL . 20.1 t-20 -100.13 65.76 1.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.0 109.446 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 304' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' C' ' 303' ' ' ASN . 55.7 tttp -46.17 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.688 -1.257 . . . . 0.0 108.753 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 305' ' ' PHE . . . . . 0.644 ' CE1' ' CG ' ' C' ' 314' ' ' GLU . 90.9 m-85 -76.79 133.93 39.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.5 mt -130.39 148.34 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.369 -0.832 . . . . 0.0 109.019 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 307' ' ' ASP . . . . . 0.543 ' OD1' ' NZ ' ' C' ' 312' ' ' LYS . 78.1 m-20 -76.66 123.97 26.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 108.608 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 308' ' ' PHE . . . . . 0.579 ' O ' ' N ' ' C' ' 310' ' ' ASP . 52.6 t80 -123.44 173.16 8.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -0.873 . . . . 0.0 109.345 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 309' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -40.45 -23.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 310' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 308' ' ' PHE . 46.0 t0 -94.23 -154.5 0.42 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 311' ' ' ARG . . . . . 0.563 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 87.8 mtt180 -79.0 -55.71 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 312' ' ' LYS . . . . . 0.543 ' NZ ' ' OD1' ' C' ' 307' ' ' ASP . 24.9 tptt -157.37 147.04 20.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.176 -0.953 . . . . 0.0 109.183 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 313' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' C' ' 308' ' ' PHE . 41.7 pt -129.85 147.64 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.877 . . . . 0.0 109.229 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 314' ' ' GLU . . . . . 0.644 ' CG ' ' CE1' ' C' ' 305' ' ' PHE . 85.2 mt-10 -99.43 144.31 28.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 315' ' ' ILE . . . . . 0.641 ' CG2' HD11 ' C' ' 245' ' ' ILE . 36.2 mt -118.39 147.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.909 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -155.58 148.23 24.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.001 . . . . 0.0 108.976 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 317' ' ' ARG . . . . . 0.441 ' NH1' ' CB ' ' C' ' 317' ' ' ARG . 5.7 ptm85 -68.77 152.49 45.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.948 -1.095 . . . . 0.0 109.579 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.57 93.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 109.109 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.632 -179.554 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.896 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.921 1 C5'-C4'-C3' 107.702 -5.199 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.896 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.444 2.529 1 C5'-C4'-C3' 108.209 -4.861 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 0.697 " O2'" H5'' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.435 1.787 1 C5'-C4'-C3' 108.002 -4.999 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.73 ' C4 ' ' CZ2' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.443 2.4 1 C5'-C4'-C3' 106.622 -5.919 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.668 ' O4 ' ' N ' ' C' ' 165' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.782 1 C3'-C2'-C1' 105.598 4.553 OUTLIER-DELTA 0.552 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 1.003 " H4'" " C5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.61 1.667 2 C5'-C4'-C3' 109.396 -4.07 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 1.003 " C5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.421 1 C5'-C4'-C3' 107.809 -5.127 . 0.186 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.606 ' OP2' " H4'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.705 1 C5'-C4'-C3' 107.937 -5.042 . 0.524 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.888 " H4'" ' CE2' ' B' ' 69' ' ' TYR . . . . . . . . 0 O4'--C4' 1.423 -2.498 0 C5'-C4'-C3' 110.168 -3.555 . 0.661 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 0.876 " H2'" ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 C5'-C4'-C3' 109.551 -3.966 . 0.432 7a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.876 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.611 1.779 1 C5'-C4'-C3' 107.851 -5.099 . 0.929 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.855 ' H8 ' HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 1.96 1 C5'-C4'-C3' 107.258 -5.495 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.517 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.891 1 C5'-C4'-C3' 107.59 -5.273 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.424 0.63 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.28 175.2 3.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.956 2.437 . . . . 0.0 111.827 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.36 -2.88 9.37 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.825 2.35 . . . . 0.0 113.117 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' B' ' 77' ' ' LEU . 60.0 p -156.77 136.98 12.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.908 -1.12 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -179.12 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.529 0.68 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' B' ' 73' ' ' GLU . 2.4 t -128.05 163.48 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.891 . . . . 0.0 109.953 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.44 136.63 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 108.404 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.696 ' CZ ' ' C2 ' ' A' ' 9' ' ' ' A' . 10.3 m-30 -106.78 119.49 39.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.017 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' B' ' 33' ' ' ILE . 1.7 mm? -106.61 105.45 15.48 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -107.03 -72.79 0.81 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.84 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.497 ' HB3' ' H ' ' B' ' 95' ' ' ARG . 7.8 t -69.2 82.71 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.929 -1.336 . . . . 0.0 110.014 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' B' ' 30' ' ' LEU . 3.7 mp -144.94 121.29 6.09 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' B' ' 36' ' ' ASP . 30.0 Cg_endo -69.72 164.35 34.83 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.515 1.477 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -59.73 2.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.589 -0.694 . . . . 0.0 109.468 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' B' ' 34' ' ' PRO . 89.3 m-20 -63.99 -39.16 93.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.23 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.548 ' OE1' HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -124.4 113.98 18.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.581 -0.699 . . . . 0.0 109.158 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.4 p -110.05 -139.88 0.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 111.2 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.43 ' CD ' ' C ' ' B' ' 39' ' ' GLU . 0.5 OUTLIER -63.02 -29.45 70.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.962 -1.086 . . . . 0.0 110.794 -178.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -71.18 -54.39 11.18 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.343 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -49.05 64.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' B' ' 44' ' ' ASP . 24.1 mm -55.33 -52.58 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 42' ' ' ILE . 42.0 tp -37.6 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.839 -0.538 . . . . 0.0 110.846 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' B' ' 42' ' ' ILE . 88.8 m-20 -123.5 -24.75 4.51 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.585 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.749 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.2 tm? -57.64 -39.44 76.98 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 119.905 -1.747 . . . . 0.0 106.612 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.623 ' O ' ' N ' ' B' ' 48' ' ' ASN . 0.8 OUTLIER -84.48 -63.68 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.801 . . . . 0.0 109.289 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.758 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.7 t -38.8 -21.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.797 -0.564 . . . . 0.0 109.798 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.623 ' N ' ' O ' ' B' ' 46' ' ' CYS . 3.3 m-20 -50.36 68.9 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.893 0.854 . . . . 0.0 110.511 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.758 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.51 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.804 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.36 -155.7 19.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.75 159.83 38.24 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.325 2.016 . . . . 0.0 112.327 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.821 HG12 ' H ' ' B' ' 53' ' ' ILE . 3.0 t -120.92 -152.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.821 ' H ' HG12 ' B' ' 52' ' ' VAL . 31.8 mm -151.91 -64.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.827 -1.171 . . . . 0.0 109.577 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.555 ' OD1' HG22 ' B' ' 53' ' ' ILE . 71.6 m-20 -126.65 146.56 50.14 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.645 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.575 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.5 OUTLIER -139.37 130.69 26.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.575 ' N ' HD23 ' B' ' 55' ' ' LEU . 61.3 mttp -137.08 144.59 43.2 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 108.827 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.91 135.24 39.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.5 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' MET . . . . . 0.533 ' CE ' ' C2 ' ' A' ' 10' ' ' ' U' . 3.8 mpp? -158.39 166.88 31.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.416 -0.802 . . . . 0.0 109.202 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.442 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.1 OUTLIER -122.06 -168.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.559 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 25.2 p-10 -101.1 73.88 0.11 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 112.508 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.559 ' HD2' H5'' ' A' ' 11' ' ' ' A' . 28.6 Cg_endo -67.68 -36.65 18.46 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.623 1.549 . . . . 0.0 111.222 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -101.99 -59.91 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.517 -0.74 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 75.5 p -48.7 -40.72 29.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.419 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' B' ' 60' ' ' ASP . . . 73.67 26.81 68.62 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.559 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 32.1 mtp180 -131.8 -68.01 0.66 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -1.115 . . . . 0.0 110.216 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.598 ' CB ' " H4'" ' A' ' 10' ' ' ' U' . 0.0 OUTLIER -50.01 120.39 4.36 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.832 0.825 . . . . 0.0 110.791 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.32 -74.61 0.43 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.066 -1.021 . . . . 0.0 108.699 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -115.69 94.7 0.67 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 0.888 ' CE2' " H4'" ' A' ' 9' ' ' ' A' . 2.0 m-85 -112.52 130.49 55.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.039 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' B' ' 56' ' ' LYS . . . -142.41 138.86 31.41 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.356 -0.937 . . . . 0.0 109.574 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.721 ' CZ ' ' N3 ' ' A' ' 9' ' ' ' A' . 4.2 m-30 -105.68 122.98 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.905 HD12 ' N ' ' B' ' 72' ' ' ILE . 1.6 mp -118.17 98.81 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.294 -0.879 . . . . 0.0 111.485 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.709 ' HA ' HG13 ' B' ' 27' ' ' VAL . 83.8 tt0 -83.11 133.14 35.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.495 -1.378 . . . . 0.0 110.91 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.39 174.87 6.92 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.629 0.728 . . . . 0.0 110.996 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 11.7 ttt-85 -53.2 -42.36 66.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.708 -0.62 . . . . 0.0 110.967 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.5 m-20 160.7 179.19 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.777 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 9.3 mt -38.09 -22.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.856 -0.528 . . . . 0.0 109.63 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.7 mt-10 -70.23 -73.3 0.17 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.215 1.007 . . . . 0.0 109.324 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m -61.73 -40.93 96.84 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.824 -1.173 . . . . 0.0 108.297 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.3 m -62.54 -35.67 80.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.193 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.777 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -59.64 -56.66 19.09 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.598 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 70.2 m -65.25 -35.95 82.61 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.955 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.607 ' HB2' HG11 ' B' ' 49' ' ' VAL . . . -80.43 -61.86 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 110.9 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.583 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 41.5 t -56.16 -40.61 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.03 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' B' ' 81' ' ' ALA . 0.0 OUTLIER -68.14 -51.55 44.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.021 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' B' ' 82' ' ' SER . 81.4 m-20 -67.52 -44.21 78.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.633 ' O ' HD12 ' B' ' 87' ' ' LEU . 1.7 pp -139.98 121.45 15.1 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.129 -0.982 . . . . 0.0 110.15 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 84' ' ' VAL . 1.4 p30 -143.89 -56.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.11 104.35 0.77 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -138.11 146.39 42.81 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.537 -1.566 . . . . 0.0 108.255 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.556 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 16.9 tp60 -33.72 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.508 -0.745 . . . . 0.0 111.217 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.548 HD11 ' OE1' ' B' ' 37' ' ' GLN . 62.5 tp -146.19 126.16 13.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.69 -147.62 48.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' SER . . . . . 0.418 ' CB ' ' OG ' ' B' ' 32' ' ' SER . 0.2 OUTLIER -92.36 -18.87 22.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.054 -1.263 . . . . 0.0 109.537 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' B' ' 92' ' ' LEU . 60.2 mtp180 -131.02 161.19 32.53 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.458 ' O ' ' C ' ' B' ' 97' ' ' LEU . 8.9 m-85 -94.57 137.41 33.73 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.2 -0.937 . . . . 0.0 110.072 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.574 HD23 ' H ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -40.44 145.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -109.74 151.98 26.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 11.0 p -77.37 108.46 10.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.471 -0.768 . . . . 0.0 109.214 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -87.0 173.17 44.6 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 54.8 p90 -152.15 -32.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -1.065 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.778 ' HG ' ' H61' ' A' ' 9' ' ' ' A' . 74.3 m -37.01 143.33 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.35 -0.844 . . . . 0.0 110.666 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 16.5 t -133.9 141.03 47.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -108.8 124.95 51.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.355 -0.84 . . . . 0.0 109.44 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.464 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 28.4 mttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.252 0.548 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 157' ' ' GLU . . . . . 0.537 ' O ' ' NH2' ' C' ' 232' ' ' ARG . 97.0 mt-10 -62.44 -34.82 77.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.805 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 158' ' ' SER . . . . . 0.561 ' CB ' ' HE ' ' C' ' 232' ' ' ARG . 32.9 t -138.7 140.61 38.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 109.979 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 159' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.8 OUTLIER 170.36 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 160' ' ' LYS . . . . . 0.585 ' NZ ' ' NZ ' ' C' ' 189' ' ' LYS . 12.1 ttmm -83.7 140.22 32.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.036 -1.04 . . . . 0.0 108.275 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 2.4 ptm -125.78 169.92 12.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.952 -1.092 . . . . 0.0 109.323 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.692 ' CZ ' ' C8 ' ' A' ' 6' ' ' ' A' . 54.0 t80 -121.5 80.8 1.72 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.567 -0.708 . . . . 0.0 109.693 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.404 ' H ' HG12 ' C' ' 163' ' ' ILE . 1.7 mm -50.29 131.98 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.88 156.36 22.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.668 ' N ' ' O4 ' ' A' ' 5' ' ' ' U' . . . 75.39 28.42 61.78 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.41 142.32 53.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.52 -0.988 . . . . 0.0 109.768 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' C' ' 169' ' ' ASP . 11.8 t-20 -69.27 140.89 54.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.73 ' CZ2' ' C4 ' ' A' ' 4' ' ' ' A' . 7.5 m0 -63.63 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.069 -1.019 . . . . 0.0 110.307 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 169' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' C' ' 167' ' ' ASN . 57.4 m-20 -157.66 64.95 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.938 -1.102 . . . . 0.0 109.825 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 34.0 m -134.16 153.3 51.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.133 -0.98 . . . . 0.0 110.688 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.97 167.71 11.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.495 -0.753 . . . . 0.0 109.117 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.69 -67.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.754 -1.216 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -47.23 -36.13 8.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.034 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 174' ' ' ASN . . . . . 0.444 ' OD1' ' C ' ' C' ' 174' ' ' ASN . 1.6 t30 -69.74 -52.21 27.44 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.445 ' HB2' HD12 ' C' ' 190' ' ' ILE . 12.4 tp -55.46 -41.84 73.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 176' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' C' ' 177' ' ' GLU . 25.4 ttp85 -66.12 -60.43 2.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.103 -0.998 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 177' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -44.76 -31.35 1.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.231 -0.918 . . . . 0.0 108.783 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.715 ' CD2' HD12 ' C' ' 223' ' ' LEU . 21.8 t80 -76.01 -49.58 17.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.739 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.781 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.4 m-85 -72.16 -49.37 36.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.309 -0.869 . . . . 0.0 111.664 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.21 23.91 0.01 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 119.568 -1.958 . . . . 0.0 112.405 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 181' ' ' LYS . . . . . 0.781 ' N ' ' O ' ' C' ' 179' ' ' PHE . 4.9 ttpm? -90.24 -13.85 34.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.89 -1.359 . . . . 0.0 107.614 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 182' ' ' TYR . . . . . 0.609 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 32.0 m-85 -91.08 -62.69 1.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.4 -125.22 2.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 27.4 m -122.89 145.61 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -1.0 . . . . 0.0 109.86 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.409 HG21 HD11 ' C' ' 205' ' ' LEU . 14.2 p -127.66 142.61 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.424 HG23 ' N ' ' C' ' 187' ' ' ASP . 9.7 t -97.1 -37.47 10.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 110.337 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 187' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' C' ' 206' ' ' SER . 42.9 t0 -165.08 160.39 18.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.986 -1.071 . . . . 0.0 110.202 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.36 147.71 22.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 189' ' ' LYS . . . . . 0.585 ' NZ ' ' NZ ' ' C' ' 160' ' ' LYS . 23.6 mttp -114.86 90.85 3.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 110.175 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 190' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' C' ' 175' ' ' LEU . 10.3 tt -84.79 142.35 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 191' ' ' MET . . . . . 0.556 ' HE1' ' C2 ' ' A' ' 7' ' ' ' U' . 0.0 OUTLIER -98.85 -47.56 5.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.188 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 192' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' C' ' 191' ' ' MET . 0.1 OUTLIER -30.8 124.53 0.19 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.636 0.732 . . . . 0.0 110.214 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.438 ' CG ' ' OG1' ' C' ' 196' ' ' THR . 15.7 t0 -134.45 87.16 33.13 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.13 -22.62 75.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.312 2.008 . . . . 0.0 111.389 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.41 -52.51 15.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.627 -0.67 . . . . 0.0 109.894 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 196' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' C' ' 193' ' ' ASP . 3.0 p -70.61 -35.9 73.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 109.78 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 153.9 -76.22 0.22 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -168.65 155.1 7.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -1.18 . . . . 0.0 110.171 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 199' ' ' SER . . . . . 0.428 ' O ' ' C ' ' C' ' 200' ' ' ARG . 23.0 t -151.68 168.73 24.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' C' ' 199' ' ' SER . 14.1 mmp_? -46.44 143.52 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.937 -1.102 . . . . 0.0 108.286 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 201' ' ' GLY . . . . . 0.555 ' O ' ' O2 ' ' A' ' 5' ' ' ' U' . . . -94.27 91.25 1.42 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.121 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' C' ' 202' ' ' PHE . 25.1 p90 -152.25 167.17 29.47 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.38 130.99 3.32 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 118.149 -1.977 . . . . 0.0 110.766 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.14 120.7 29.74 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 119.992 -1.887 . . . . 0.0 107.271 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.409 HD11 HG21 ' C' ' 185' ' ' VAL . 0.1 OUTLIER -108.33 104.79 14.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 109.148 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 206' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.4 OUTLIER -80.44 73.08 7.35 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.543 0.687 . . . . 0.0 109.606 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' C' ' 216' ' ' VAL . 10.3 m-85 -67.95 114.74 6.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.981 -1.074 . . . . 0.0 109.408 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.75 -48.03 83.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 108.947 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' C' ' 211' ' ' SER . 1.8 mtmp? -84.36 101.3 1.41 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.992 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -39.38 -23.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 121.871 1.714 . . . . 0.0 112.704 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.473 ' N ' ' O ' ' C' ' 209' ' ' LYS . 17.9 t -62.26 -57.1 12.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.013 -1.054 . . . . 0.0 110.585 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.751 ' O ' HG23 ' C' ' 216' ' ' VAL . 24.7 m -41.51 -34.91 0.62 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.29 -0.881 . . . . 0.0 109.53 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 213' ' ' VAL . . . . . 0.611 ' O ' HG12 ' C' ' 217' ' ' VAL . 86.6 t -65.97 -43.02 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 214' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' C' ' 211' ' ' SER . 61.8 t0 -60.83 -50.64 72.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 0.0 110.506 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 215' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' C' ' 219' ' ' THR . 19.7 pt-20 -73.63 -31.83 63.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.967 -1.083 . . . . 0.0 109.972 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.751 HG23 ' O ' ' C' ' 212' ' ' SER . 22.6 t -61.48 -50.99 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.747 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.611 HG12 ' O ' ' C' ' 213' ' ' VAL . 8.5 p -74.02 -29.9 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.511 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -85.01 17.48 2.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.495 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 219' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' C' ' 215' ' ' GLU . 32.0 m -136.43 147.3 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.921 -1.112 . . . . 0.0 109.46 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -102.63 136.33 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.248 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.705 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -139.82 167.65 21.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.858 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.0 107.2 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.825 . . . . 0.0 108.899 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.715 HD12 ' CD2' ' C' ' 178' ' ' TYR . 1.0 OUTLIER -73.43 -71.96 0.29 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 109.796 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 224' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 60.2 t0 -84.95 0.45 51.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.039 -1.038 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.03 13.23 72.21 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' LYS . . . . . 0.866 ' O ' HG13 ' C' ' 227' ' ' VAL . 1.2 tpmt? -90.09 -78.76 0.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -1.019 . . . . 0.0 109.325 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 227' ' ' VAL . . . . . 0.866 HG13 ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 174.75 109.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.251 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ILE . . . . . 0.416 HD13 HG21 ' C' ' 228' ' ' ILE . 17.9 pt -113.96 148.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.706 -0.621 . . . . 0.0 110.132 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.43 96.68 38.36 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 230' ' ' PRO . . . . . 0.441 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 46.8 Cg_endo -85.4 125.31 2.93 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.564 2.176 . . . . 0.0 112.028 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -141.18 143.05 34.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.699 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.561 ' HE ' ' CB ' ' C' ' 158' ' ' SER . 75.1 ttt-85 -57.45 153.96 11.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 108.591 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 233' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -44.31 137.57 3.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 108.856 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 234' ' ' ILE . . . . . 0.439 HD12 ' H62' ' A' ' 6' ' ' ' A' . 55.5 mt -114.92 135.99 22.51 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.406 -0.809 . . . . 0.0 109.811 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.24 139.19 16.39 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.809 1.672 . . . . 0.0 112.125 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.25 -44.58 88.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.518 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 237' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 34.0 p-10 -63.31 -38.65 91.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 109.856 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 238' ' ' GLU . . . . . 0.676 ' O ' HG23 ' C' ' 242' ' ' THR . 48.6 tp10 -66.0 -40.34 91.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.399 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.511 ' OE1' ' C8 ' ' A' ' 6' ' ' ' A' . 30.0 tt0 -62.31 -43.91 97.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.1 -39.24 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.049 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -63.32 -39.53 94.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.936 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 242' ' ' THR . . . . . 0.7 HG22 ' HA ' ' C' ' 292' ' ' ASP . 66.9 p -50.76 141.65 12.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.851 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.09 160.5 14.74 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 244' ' ' LYS . . . . . 0.623 ' O ' ' HB2' ' C' ' 318' ' ' ALA . 22.9 tttt -136.37 133.39 36.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.243 . . . . 0.0 110.45 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.505 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -119.61 147.57 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.51 -0.744 . . . . 0.0 109.463 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 4.7 t80 -103.0 130.42 50.09 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 10.1 t -100.14 134.97 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.784 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 248' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 249' ' ' GLY . . . -105.89 155.85 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 249' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 248' ' ' GLY . . . 59.66 141.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.458 ' CG1' HG11 ' C' ' 254' ' ' VAL . 2.7 tp -162.5 164.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.427 -1.043 . . . . 0.0 109.158 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 251' ' ' GLY . . . . . 0.428 ' O ' HG23 ' C' ' 250' ' ' ILE . . . -54.82 155.03 8.86 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.81 -28.78 86.99 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.548 2.166 . . . . 0.0 112.119 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.69 73.98 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' C' ' 308' ' ' PHE . 8.5 p -111.05 134.58 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.638 0.732 . . . . 0.0 109.932 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -96.32 157.05 36.19 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -57.74 -21.75 49.49 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.593 2.196 . . . . 0.0 111.859 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -51.98 -63.66 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.605 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 258' ' ' GLU . . . . . 0.731 ' O ' ' N ' ' C' ' 261' ' ' GLU . 76.0 mm-40 -58.21 -88.11 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 259' ' ' PHE . . . . . 0.619 ' C ' ' O ' ' C' ' 258' ' ' GLU . 36.9 t80 -9.59 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.309 0.576 . . . . 0.0 111.449 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 260' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' C' ' 258' ' ' GLU . 96.9 mt-10 -56.71 -44.29 81.43 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.07 -1.019 . . . . 0.0 109.404 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 261' ' ' GLU . . . . . 0.731 ' N ' ' O ' ' C' ' 258' ' ' GLU . 76.3 mm-40 -69.44 -40.28 77.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 262' ' ' PHE . . . . . 0.417 ' O ' ' CG ' ' C' ' 265' ' ' GLN . 70.3 t80 -49.37 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.505 -0.747 . . . . 0.0 109.363 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.471 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 93.5 m-85 -55.39 -32.12 62.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.576 -1.328 . . . . 0.0 110.465 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.423 ' C ' ' O ' ' C' ' 263' ' ' PHE . 13.0 t -38.29 -38.32 0.35 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.822 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' C' ' 264' ' ' SER . 0.2 OUTLIER -52.11 -95.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.322 -1.486 . . . . 0.0 109.9 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.471 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -63.56 152.55 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.29 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 267' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 52.96 103.2 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 60.5 m -49.9 138.47 15.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.245 . . . . 0.0 107.785 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.619 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -99.63 104.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.103 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.5 -50.29 35.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.8 -1.187 . . . . 0.0 109.189 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 271' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' C' ' 290' ' ' THR . 57.4 t0 -142.36 98.05 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 109.611 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 272' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -128.25 166.39 18.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 109.419 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 273' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.1 OUTLIER 167.26 162.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.214 1.007 . . . . 0.0 111.367 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 5.9 tp -99.82 144.24 29.1 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 275' ' ' MET . . . . . 0.752 ' O ' HD22 ' C' ' 276' ' ' LEU . 23.0 mmm -92.01 160.02 15.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.195 -1.566 . . . . 0.0 108.304 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.752 HD22 ' O ' ' C' ' 275' ' ' MET . 0.3 OUTLIER -143.28 153.3 42.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 277' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' C' ' 281' ' ' GLY . 0.0 OUTLIER -49.73 -31.89 12.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 108.619 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 278' ' ' LYS . . . . . 0.51 ' O ' ' NZ ' ' C' ' 226' ' ' LYS . 57.4 tttp -54.99 -40.46 70.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.366 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 279' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' C' ' 275' ' ' MET . 91.3 m-20 -60.9 -37.4 82.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.35 -39.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.777 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 281' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' C' ' 277' ' ' ASP . . . 125.63 30.64 0.88 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' C' ' 284' ' ' ARG . 16.0 mm100 -119.4 42.72 2.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.352 -1.087 . . . . 0.0 110.13 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 283' ' ' SER . . . . . 0.467 ' O ' ' OG ' ' C' ' 283' ' ' SER . 6.6 t -62.51 39.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.247 -0.908 . . . . 0.0 110.032 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 284' ' ' ARG . . . . . 0.606 ' N ' ' O ' ' C' ' 282' ' ' GLN . 68.2 mtp85 -55.87 -34.17 65.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -0.974 . . . . 0.0 109.44 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.85 79.55 0.38 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' C' ' 282' ' ' GLN . 0.0 OUTLIER -146.75 -176.02 5.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.578 -1.542 . . . . 0.0 111.984 -178.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -157.89 164.65 33.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 288' ' ' PHE . . . . . 0.455 ' CZ ' " O4'" ' A' ' 3' ' ' ' U' . 64.8 m-85 -138.06 151.02 47.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.951 -1.323 . . . . 0.0 108.55 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -146.29 141.97 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.433 -1.417 . . . . 0.0 108.389 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 290' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 23.9 m -130.12 129.24 43.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.044 -1.035 . . . . 0.0 109.988 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.98 156.0 27.04 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 292' ' ' ASP . . . . . 0.7 ' HA ' HG22 ' C' ' 242' ' ' THR . 54.2 p30 -79.95 15.54 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.733 -1.23 . . . . 0.0 109.714 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 22.7 t -158.76 168.57 26.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.195 -0.94 . . . . 0.0 108.985 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.05 -12.05 20.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -57.31 -48.32 79.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.469 -0.769 . . . . 0.0 109.162 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.22 88.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.047 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.08 -57.74 6.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.22 -30.23 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 299' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' C' ' 302' ' ' GLN . 59.2 ttm-85 -63.86 -64.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.44 -0.787 . . . . 0.0 109.325 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.439 ' HB ' ' HE1' ' C' ' 266' ' ' TRP . 9.0 p -65.54 -23.0 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.415 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 301' ' ' CYS . . . . . 0.498 ' SG ' ' NH1' ' C' ' 317' ' ' ARG . 45.0 t -48.24 -57.32 6.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.062 -1.024 . . . . 0.0 109.706 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 302' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' C' ' 299' ' ' ARG . 3.9 pt20 -49.45 -22.33 1.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.109 . . . . 0.0 108.515 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' C' ' 300' ' ' VAL . 92.4 m-20 -99.67 69.73 1.62 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.9 -82.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.672 -1.268 . . . . 0.0 108.869 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -69.63 126.6 30.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.162 -0.961 . . . . 0.0 109.493 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 59.6 mt -120.22 145.45 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.37 114.69 11.87 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' C' ' 309' ' ' LYS . 22.1 t80 -114.59 -178.08 3.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.578 ' C ' ' O ' ' C' ' 308' ' ' PHE . 73.8 mttt -19.75 -82.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 0.0 111.998 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 310' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' C' ' 311' ' ' ARG . 47.6 p30 -127.97 -16.41 4.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 110.201 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 311' ' ' ARG . . . . . 0.429 ' N ' ' OD1' ' C' ' 310' ' ' ASP . 40.1 mtp180 -121.2 125.81 48.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -52.77 164.96 0.31 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.43 -0.793 . . . . 0.0 109.398 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.59 122.85 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.83 103.79 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 0.0 109.68 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.505 ' CG2' HD12 ' C' ' 245' ' ' ILE . 5.6 mm -72.53 146.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.014 -1.054 . . . . 0.0 110.046 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -154.04 152.39 30.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 317' ' ' ARG . . . . . 0.705 ' CD ' ' H ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER -59.73 149.69 30.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 108.998 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 318' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' C' ' 244' ' ' LYS . . . -50.77 -25.32 4.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.899 -1.126 . . . . 0.0 108.921 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 319' ' ' GLU . . . . . 0.485 ' OE1' ' O4 ' ' A' ' 3' ' ' ' U' . 2.0 mt-10 179.13 -51.05 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 320' ' ' PRO . . . . . 0.466 ' HD2' ' H ' ' C' ' 319' ' ' GLU . 55.3 Cg_exo -49.05 103.32 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.272 1.981 . . . . 0.0 112.419 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 321' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -60.1 -35.08 74.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.407 -0.808 . . . . 0.0 109.479 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 10.8 t60 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.463 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.493 ' H6 ' " H2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.441 2.235 1 C5'-C4'-C3' 107.8 -5.133 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.796 " O2'" ' H6 ' ' A' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.054 1 C5'-C4'-C3' 108.197 -4.869 . 0.742 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 1.059 " O2'" " H5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 P--O5' 1.612 1.904 2 O4'-C1'-N19 113.422 5.222 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 1.059 " H5'" " O2'" ' A' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.442 2.332 1 C5'-C4'-C3' 108.866 -4.423 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.717 ' C2 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 O4'--C1' 1.446 2.682 1 C5'-C4'-C3' 108.895 -4.403 . 0.634 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 1.055 " H4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.429 -1.998 1 C5'-C4'-C3' 108.068 -4.955 . 0.642 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 1.055 " H5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.618 2.55 1 C5'-C4'-C3' 106.183 -6.211 . 0.137 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.637 ' OP2' " H4'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.443 2.423 1 C5'-C4'-C3' 108.042 -4.972 . 0.459 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.923 H5'' ' CZ ' ' B' ' 69' ' ' TYR . . . . . . . . 0 P--O5' 1.611 1.78 2 C5'-C4'-C3' 108.347 -4.769 . 0.585 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 0.899 HO2' ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 1.994 2 C5'-C4'-C3' 107.94 -5.04 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.899 ' H8 ' HO2' ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.431 -1.796 1 C5'-C4'-C3' 105.751 -6.5 . 0.075 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.678 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.95 1 C5'-C4'-C3' 107.426 -5.383 . 0.052 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.518 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.844 1 C5'-C4'-C3' 107.61 -5.26 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.57 ' O ' ' CG ' ' B' ' 101' ' ' TYR . 16.1 Cg_exo -63.05 -176.92 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.819 2.346 . . . . 0.0 111.84 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 23' ' ' PRO . 71.0 Cg_endo -86.9 25.79 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.91 2.407 . . . . 0.0 112.811 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.58 107.22 2.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.907 -1.121 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.475 ' CA ' ' OG ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -162.74 -40.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' B' ' 28' ' ' VAL . 1.2 p -139.56 158.0 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.664 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.436 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.9 t -108.59 134.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.625 ' CZ ' ' N1 ' ' A' ' 9' ' ' ' A' . 9.1 m-30 -99.51 117.08 33.12 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.603 0.716 . . . . 0.0 109.682 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.73 HD11 HD23 ' B' ' 97' ' ' LEU . 1.1 mm? -101.98 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' B' ' 33' ' ' ILE . . . -146.75 -53.84 0.02 OUTLIER Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.986 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 27.6 t -69.5 30.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -1.21 . . . . 0.0 109.981 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.642 HD12 ' N ' ' B' ' 33' ' ' ILE . 4.9 mp -108.71 136.37 19.98 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -87.64 -176.01 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.743 1.629 . . . . 0.0 111.444 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.606 ' OH ' ' CG ' ' B' ' 59' ' ' PHE . 3.0 m-30 -67.1 0.45 2.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.73 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -67.08 -45.27 77.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.964 -1.085 . . . . 0.0 108.968 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -107.25 100.32 9.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.236 -0.915 . . . . 0.0 109.09 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -98.57 -153.95 0.45 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.651 -0.656 . . . . 0.0 110.079 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 40.2 tt0 -57.22 -26.29 60.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.141 -0.974 . . . . 0.0 109.884 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.7 -56.84 6.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.507 -0.746 . . . . 0.0 110.997 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -41.63 80.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.948 . . . . 0.0 111.479 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.4 ' N ' HD13 ' B' ' 42' ' ' ILE . 6.0 mm -63.19 -52.28 60.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' B' ' 47' ' ' SER . 32.4 tp -58.5 -36.63 74.08 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -55.34 -74.77 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.416 1.103 . . . . 0.0 109.979 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -45.63 90.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.089 -177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' B' ' 48' ' ' ASN . 96.6 m -61.59 -68.67 0.3 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.003 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 87.7 p -33.39 -31.41 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.0 OUTLIER -78.37 -43.35 27.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.976 -1.078 . . . . 0.0 109.431 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.638 HG21 HD11 ' B' ' 87' ' ' LEU . 13.2 t -43.4 -56.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.564 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.9 -158.79 11.63 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.938 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' B' ' 52' ' ' VAL . 57.9 Cg_endo -79.9 82.08 2.59 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.798 2.332 . . . . 0.0 112.788 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.556 ' O ' ' O ' ' B' ' 51' ' ' PRO . 0.3 OUTLIER -51.08 -166.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.49 ' H ' HG12 ' B' ' 52' ' ' VAL . 0.7 OUTLIER -160.09 -57.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.448 ' OD1' ' OE1' ' B' ' 73' ' ' GLU . 20.0 m120 -117.91 132.64 56.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.428 HD12 ' N ' ' B' ' 56' ' ' LYS . 16.9 tp -133.0 126.36 31.77 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.428 ' N ' HD12 ' B' ' 55' ' ' LEU . 59.4 mttp -138.7 138.0 37.33 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.068 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' B' ' 70' ' ' ALA . 1.8 tpt -127.9 134.32 49.35 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' MET . . . . . 0.6 ' CE ' ' N7 ' ' A' ' 11' ' ' ' A' . 0.1 OUTLIER -153.66 150.13 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 109.87 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.606 ' CG ' ' OH ' ' B' ' 35' ' ' TYR . 4.0 m-85 -106.33 -177.54 3.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.345 -0.847 . . . . 0.0 109.555 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.643 ' CG ' ' H ' ' B' ' 66' ' ' SER . 13.6 m-20 -103.98 71.89 0.17 Allowed Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.908 -1.12 . . . . 0.0 111.939 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 17.0 Cg_exo -49.22 -65.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.239 1.959 . . . . 0.0 112.88 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -85.2 -54.14 4.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.429 -0.794 . . . . 0.0 110.255 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.42 ' C ' ' H ' ' B' ' 65' ' ' ARG . 62.4 p -51.99 -38.4 56.6 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.224 -0.923 . . . . 0.0 108.751 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' B' ' 60' ' ' ASP . . . 60.73 3.24 3.05 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' B' ' 63' ' ' THR . 83.0 mtt85 -65.83 -37.8 87.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.387 -1.067 . . . . 0.0 111.138 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.643 ' H ' ' CG ' ' B' ' 60' ' ' ASP . 0.8 OUTLIER -155.4 150.12 26.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.379 -1.451 . . . . 0.0 112.305 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -115.98 77.97 1.14 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.65 54.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 0.923 ' CZ ' H5'' ' A' ' 9' ' ' ' A' . 2.5 m-85 -104.48 127.33 52.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 108.602 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.693 ' HB2' ' SD ' ' B' ' 57' ' ' MET . . . -144.35 145.85 32.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.441 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.814 ' CZ ' " H1'" ' A' ' 9' ' ' ' A' . 6.6 m-85 -124.77 129.63 50.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.49 108.67 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.701 -0.799 . . . . 0.0 111.701 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.448 ' OE1' ' OD1' ' B' ' 54' ' ' ASN . 31.9 tt0 -92.9 134.12 35.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.352 -1.468 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -96.66 171.63 8.41 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.858 0.837 . . . . 0.0 110.415 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' B' ' 76' ' ' ASP . 4.0 tpt180 -42.88 -40.84 3.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.785 -0.572 . . . . 0.0 112.322 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' B' ' 78' ' ' GLU . 17.8 t70 166.61 -177.73 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.35 0.595 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.791 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.0 mm? -39.58 -21.88 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.072 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.2 mm-40 -70.59 -74.42 0.14 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.753 -1.217 . . . . 0.0 109.096 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 29.8 m -60.87 -41.89 96.86 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.55 ' O ' HG23 ' B' ' 84' ' ' VAL . 0.1 OUTLIER -62.35 -29.93 70.81 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.076 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.791 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -67.23 -60.91 2.21 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.947 -1.095 . . . . 0.0 108.461 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.589 ' O ' ' OD1' ' B' ' 86' ' ' ASN . 59.0 m -61.51 -45.77 92.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.452 -0.78 . . . . 0.0 110.792 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.566 ' CB ' HG11 ' B' ' 49' ' ' VAL . . . -68.46 -67.31 0.48 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.62 HG12 ' ND2' ' B' ' 88' ' ' ASN . 16.1 t -49.73 -31.77 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.8 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.582 ' HE ' ' C ' ' B' ' 81' ' ' ALA . 76.2 mtm180 -65.0 -52.44 56.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 109.559 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.589 ' OD1' ' O ' ' B' ' 82' ' ' SER . 0.0 OUTLIER -75.08 -42.8 56.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 117.973 -1.491 . . . . 0.0 108.183 178.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.638 HD11 HG21 ' B' ' 49' ' ' VAL . 17.1 mt -79.63 -2.08 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 110.185 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.62 ' ND2' HG12 ' B' ' 84' ' ' VAL . 0.5 OUTLIER -48.51 -82.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.55 114.9 1.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.989 ' CE1' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -139.71 149.76 44.03 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 119.936 1.868 . . . . 0.0 110.821 -179.169 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -47.87 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.102 -1.624 . . . . 0.0 110.044 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -154.71 113.09 3.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.247 -0.908 . . . . 0.0 108.627 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.55 -171.83 36.86 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 44.9 m -79.44 -14.74 58.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.899 -1.353 . . . . 0.0 109.929 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.435 ' N ' ' OG ' ' B' ' 32' ' ' SER . 14.8 ttm180 -146.78 163.64 35.36 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.3 m-85 -93.41 127.36 39.0 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.867 -1.146 . . . . 0.0 110.502 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.989 HD11 ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -41.37 156.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.383 0.611 . . . . 0.0 109.482 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.51 ' HE3' " H1'" ' A' ' 8' ' ' ' A' . 9.7 mtmm -111.27 149.23 31.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.568 -0.708 . . . . 0.0 110.124 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' OD1' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -75.07 113.69 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.777 -0.577 . . . . 0.0 109.64 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -111.21 161.81 12.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' B' ' 23' ' ' PRO . 5.2 p90 -148.37 108.46 4.07 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.479 -1.013 . . . . 0.0 109.21 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 29.6 t -144.72 128.56 17.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.274 -0.891 . . . . 0.0 109.272 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 11.3 t 179.61 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.1 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.04 -52.74 64.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.853 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 109.412 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.28 134.86 46.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.467 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 30.3 t -158.73 155.14 27.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.901 . . . . 0.0 109.194 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 159' ' ' CYS . . . . . 0.41 ' SG ' ' CG2' ' C' ' 213' ' ' VAL . 8.6 t -116.04 87.32 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.057 0.932 . . . . 0.0 109.527 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -94.63 148.88 21.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 161' ' ' MET . . . . . 0.56 ' SD ' HG21 ' C' ' 216' ' ' VAL . 0.1 OUTLIER -115.72 170.7 8.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.998 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.717 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 10.5 t80 -128.81 68.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.907 HG22 HD21 ' C' ' 166' ' ' LEU . 8.2 mm -57.26 129.39 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 164' ' ' GLY . . . . . 0.408 ' HA3' ' C2 ' ' A' ' 5' ' ' ' U' . . . -134.79 -173.9 13.26 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' C' ' 227' ' ' VAL . . . 53.94 27.23 36.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 166' ' ' LEU . . . . . 0.907 HD21 HG22 ' C' ' 163' ' ' ILE . 4.1 mm? -59.73 161.93 5.76 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.353 -1.087 . . . . 0.0 108.559 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.609 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 3.2 p30 -68.2 -71.84 0.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.697 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.1 OUTLIER 178.56 -32.97 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.884 -1.135 . . . . 0.0 109.636 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.29 96.96 3.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 11.9 m -129.21 141.94 51.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.872 . . . . 0.0 108.958 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.56 156.59 17.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 109.594 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.81 -63.92 1.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.275 -0.891 . . . . 0.0 110.526 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.55 -33.53 22.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.929 -1.107 . . . . 0.0 109.696 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.45 -50.84 34.12 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.911 0.863 . . . . 0.0 108.68 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' C' ' 190' ' ' ILE . 0.6 OUTLIER -59.77 -37.76 79.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.655 -0.653 . . . . 0.0 110.011 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 176' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -69.4 -60.74 2.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 177' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.48 -28.1 4.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.329 -0.857 . . . . 0.0 108.816 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' C' ' 178' ' ' TYR . 18.6 t80 -70.08 -53.61 16.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.922 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.763 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.6 m-85 -72.87 -41.87 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.608 -0.683 . . . . 0.0 112.501 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.77 30.01 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 119.347 -2.096 . . . . 0.0 111.431 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 181' ' ' LYS . . . . . 0.763 ' N ' ' O ' ' C' ' 179' ' ' PHE . 28.5 ttmt -94.01 -12.27 29.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 182' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 44.0 m-85 -99.77 -50.7 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.405 0.622 . . . . 0.0 109.744 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -143.66 -130.89 2.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 39.7 m -122.76 141.25 52.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -1.064 . . . . 0.0 109.567 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.498 HG22 ' CE1' ' C' ' 207' ' ' PHE . 59.7 t -117.96 135.34 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.409 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.422 HG22 ' H ' ' C' ' 186' ' ' THR . 0.6 OUTLIER -95.19 -41.52 9.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.921 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -160.1 158.0 29.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 109.657 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.885 HD12 ' N ' ' C' ' 189' ' ' LYS . 0.6 OUTLIER -139.97 140.38 36.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 189' ' ' LYS . . . . . 0.885 ' N ' HD12 ' C' ' 188' ' ' LEU . 0.2 OUTLIER -105.74 92.51 4.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.175 . . . . 0.0 110.2 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 190' ' ' ILE . . . . . 0.629 ' CD1' HD12 ' C' ' 175' ' ' LEU . 1.8 tt -117.13 145.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 191' ' ' MET . . . . . 0.442 ' SD ' " H1'" ' A' ' 7' ' ' ' U' . 13.0 ptp -154.19 61.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 109.986 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -68.22 171.86 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.998 -1.064 . . . . 0.0 109.614 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -52.51 124.71 34.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 108.962 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.98 -4.82 15.98 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.153 1.902 . . . . 0.0 112.706 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.67 -85.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 32.5 p -98.69 -12.57 20.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 110.018 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 197' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 79.84 18.96 71.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -96.13 74.72 2.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.298 . . . . 0.0 110.176 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 199' ' ' SER . . . . . 0.571 ' O ' ' O ' ' C' ' 200' ' ' ARG . 37.0 m -167.31 171.64 10.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.576 ' NE ' ' C ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -34.98 162.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 110.128 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.06 108.29 0.36 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.53 ' CE2' ' NH2' ' C' ' 200' ' ' ARG . 7.8 p90 -130.41 158.1 40.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -1.097 . . . . 0.0 109.377 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.16 116.96 1.54 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.747 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.07 82.72 6.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.716 -1.461 . . . . 0.0 107.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.5 mt -70.59 104.14 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.935 . . . . 0.0 111.621 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.0 t -76.75 76.34 3.39 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.498 ' CE1' HG22 ' C' ' 185' ' ' VAL . 2.6 m-85 -64.5 122.84 17.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.526 -0.734 . . . . 0.0 110.459 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.19 -47.12 71.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.163 -0.961 . . . . 0.0 109.397 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -93.96 118.5 67.27 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.802 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 210' ' ' PRO . . . . . 0.674 ' O ' HG12 ' C' ' 213' ' ' VAL . 2.4 Cg_endo -62.14 -2.25 2.91 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.516 ' O ' ' N ' ' C' ' 213' ' ' VAL . 18.6 t -74.53 -70.44 0.4 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.707 -1.246 . . . . 0.0 109.877 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.432 ' C ' ' O ' ' C' ' 211' ' ' SER . 28.2 t -39.28 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.5 -0.75 . . . . 0.0 109.96 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 213' ' ' VAL . . . . . 0.674 HG12 ' O ' ' C' ' 210' ' ' PRO . 0.5 OUTLIER -61.99 -20.18 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.765 -1.209 . . . . 0.0 110.106 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 214' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.97 -45.09 9.94 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.045 0.926 . . . . 0.0 108.863 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 215' ' ' GLU . . . . . 0.5 ' OE2' ' OG1' ' C' ' 219' ' ' THR . 48.7 tp10 -70.92 -27.85 64.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.79 -0.569 . . . . 0.0 109.849 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.56 HG21 ' SD ' ' C' ' 161' ' ' MET . 3.3 p -61.41 -49.11 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.541 ' N ' HG13 ' C' ' 216' ' ' VAL . 14.4 p -78.27 -40.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.94 -1.1 . . . . 0.0 109.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.481 ' N ' HG13 ' C' ' 217' ' ' VAL . 42.0 tptt -59.4 -48.67 80.75 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.441 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 219' ' ' THR . . . . . 0.5 ' OG1' ' OE2' ' C' ' 215' ' ' GLU . 28.6 m -79.06 155.07 28.95 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.738 0.78 . . . . 0.0 110.898 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -112.07 138.45 48.71 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.809 ' O ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -136.44 163.19 31.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.809 HD13 ' O ' ' C' ' 221' ' ' HIS . 1.0 OUTLIER -132.26 119.47 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.416 ' HA ' ' CE2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -50.51 -72.28 0.05 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -126.22 20.7 7.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 109.171 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.42 8.94 58.26 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 226' ' ' LYS . . . . . 0.689 ' NZ ' ' NZ ' ' C' ' 278' ' ' LYS . 2.1 tpmt? -87.58 -76.8 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.368 -1.077 . . . . 0.0 109.188 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 227' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' C' ' 165' ' ' GLY . 1.2 t 169.13 135.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.385 -0.822 . . . . 0.0 109.629 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 17.9 pt -139.62 159.18 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.625 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.79 98.05 12.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 109.088 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 230' ' ' PRO . . . . . 0.458 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 83.8 Cg_endo -87.94 123.33 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.964 2.442 . . . . 0.0 113.252 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -141.61 139.1 33.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.054 . . . . 0.0 109.6 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' C' ' 233' ' ' ALA . 70.7 ttt180 -66.54 151.46 47.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.081 . . . . 0.0 109.868 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 233' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.64 138.17 4.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 234' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' C' ' 232' ' ' ARG . 3.4 mt -134.74 119.09 13.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.924 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -45.94 156.03 0.51 Allowed 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.037 1.825 . . . . 0.0 111.551 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.644 HH22 " C2'" ' A' ' 6' ' ' ' A' . 0.3 OUTLIER -60.16 -45.62 92.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 0.0 110.485 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.13 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -70.42 -39.51 74.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.89 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.437 ' NE2' ' N7 ' ' A' ' 6' ' ' ' A' . 54.2 tt0 -58.45 -39.46 79.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.06 -36.71 84.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.975 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 241' ' ' LYS . . . . . 0.515 ' O ' ' C ' ' C' ' 242' ' ' THR . 19.4 tttt -56.77 -65.71 0.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 242' ' ' THR . . . . . 0.515 ' C ' ' O ' ' C' ' 241' ' ' LYS . 39.9 p -33.04 145.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.779 -0.575 . . . . 0.0 110.074 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -131.38 147.32 18.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 130.58 27.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -1.205 . . . . 0.0 109.832 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.584 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -123.42 152.59 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.701 0.762 . . . . 0.0 109.679 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.69 ' CD2' ' C6 ' ' A' ' 2' ' ' ' A' . 0.0 OUTLIER -108.16 136.09 48.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.675 -0.641 . . . . 0.0 109.329 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 247' ' ' VAL . . . . . 0.595 HG11 HD12 ' C' ' 313' ' ' ILE . 9.7 t -109.6 144.26 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.551 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 168.1 14.45 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 249' ' ' GLY . . . . . 0.582 ' O ' ' NH1' ' C' ' 311' ' ' ARG . . . 88.65 17.54 56.53 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 121.107 -1.231 . . . . 0.0 110.349 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.73 ' CG2' HG11 ' C' ' 254' ' ' VAL . 4.6 mt -116.04 136.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -1.053 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 251' ' ' GLY . . . . . 0.715 ' O ' HG12 ' C' ' 254' ' ' VAL . . . -108.67 178.15 20.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.96 -20.41 38.68 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.623 2.215 . . . . 0.0 112.379 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -56.1 -35.7 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.906 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.73 HG11 ' CG2' ' C' ' 250' ' ' ILE . 2.8 p -76.78 148.01 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.161 -0.962 . . . . 0.0 109.584 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -106.18 158.31 32.85 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.51 -21.31 61.28 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.455 2.103 . . . . 0.0 111.276 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -62.71 -54.76 34.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.04 -43.24 95.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 259' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -56.29 -59.67 4.61 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 109.936 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 260' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' C' ' 264' ' ' SER . 84.5 tt0 -60.66 -49.16 78.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 261' ' ' GLU . . . . . 0.453 ' C ' ' HG ' ' C' ' 264' ' ' SER . 47.4 tp10 -57.98 -22.56 49.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 0.0 108.75 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 262' ' ' PHE . . . . . 0.476 ' O ' ' OE1' ' C' ' 265' ' ' GLN . 67.6 t80 -81.25 -79.73 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.537 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 91.4 m-85 -52.61 -33.61 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.023 -1.048 . . . . 0.0 110.162 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.58 ' HA ' HD13 ' C' ' 269' ' ' ILE . 2.7 p -35.59 -38.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 111.996 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.62 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 1.8 pt20 -57.09 -90.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.422 -1.424 . . . . 0.0 110.339 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.62 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.7 OUTLIER -67.47 150.93 48.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.548 -1.345 . . . . 0.0 110.203 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 267' ' ' GLY . . . . . 0.405 ' O ' HD12 ' C' ' 269' ' ' ILE . . . 59.43 95.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 47.6 m -48.05 137.11 10.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.878 -1.366 . . . . 0.0 108.232 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.711 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -94.65 96.93 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 111.059 -178.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 270' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' C' ' 292' ' ' ASP . 6.4 mm -67.93 -39.57 81.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.449 -1.407 . . . . 0.0 108.497 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.59 92.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.439 -0.788 . . . . 0.0 109.506 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 272' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -123.42 172.33 8.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 109.888 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 273' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.0 OUTLIER 169.29 160.11 0.05 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.167 0.984 . . . . 0.0 111.277 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' C' ' 275' ' ' MET . 0.1 OUTLIER -107.7 152.59 24.12 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 275' ' ' MET . . . . . 0.443 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 0.0 OUTLIER -87.78 -179.12 6.21 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.492 -1.38 . . . . 0.0 109.858 -178.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.583 ' N ' ' OG1' ' C' ' 280' ' ' THR . 0.9 OUTLIER -153.21 -160.47 1.13 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.999 -1.063 . . . . 0.0 110.259 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 277' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' C' ' 283' ' ' SER . 1.2 m-20 -61.79 -85.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.281 -0.887 . . . . 0.0 111.58 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 278' ' ' LYS . . . . . 0.689 ' NZ ' ' NZ ' ' C' ' 226' ' ' LYS . 11.3 tptp -103.69 -32.11 9.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 109.805 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.54 -39.03 75.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 280' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 75.6 p -151.14 132.33 14.45 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.688 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.84 -127.95 28.72 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' C' ' 283' ' ' SER . 96.3 mt-30 -141.53 147.26 37.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -1.078 . . . . 0.0 110.987 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 283' ' ' SER . . . . . 0.595 ' O ' ' N ' ' C' ' 285' ' ' GLY . 0.0 OUTLIER -16.57 -52.22 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.106 -177.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 284' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' C' ' 282' ' ' GLN . 97.3 mtt180 -69.21 47.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 285' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' C' ' 283' ' ' SER . . . -40.36 102.46 0.02 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.67 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 0.0 OUTLIER -67.42 -163.73 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -130.21 149.92 19.03 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.923 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 288' ' ' PHE . . . . . 0.446 ' CZ ' ' H2 ' ' A' ' 2' ' ' ' A' . 2.0 m-85 -139.39 151.61 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 2.3 t -147.77 143.24 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.735 -1.228 . . . . 0.0 108.501 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 24.4 m -129.7 125.32 35.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.106 -0.996 . . . . 0.0 108.974 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -115.94 144.79 43.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 292' ' ' ASP . . . . . 0.469 ' HB2' HD11 ' C' ' 270' ' ' ILE . 11.4 t70 -57.17 -50.2 73.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.658 -1.276 . . . . 0.0 109.149 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 72.9 m -98.02 178.95 4.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.27 -11.73 14.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -51.18 -44.38 61.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.0 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.85 . . . . 0.0 109.088 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 297' ' ' VAL . . . . . 0.553 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 59.4 t -60.16 -60.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -57.48 -28.18 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -64.29 -62.93 1.3 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.79 -28.17 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.798 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 301' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 67.5 m -45.78 -55.78 6.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 0.0 108.853 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 302' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' C' ' 301' ' ' CYS . 15.8 mm100 -47.63 -25.05 1.04 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' C' ' 300' ' ' VAL . 82.7 m-20 -98.98 72.66 1.91 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -65.74 -12.29 52.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.821 -1.174 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -132.0 122.75 26.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.831 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 306' ' ' ILE . . . . . 0.573 HD12 HD11 ' C' ' 315' ' ' ILE . 46.7 mt -119.93 147.41 23.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 307' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 307' ' ' ASP . 47.3 p30 -69.79 159.43 33.6 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 109.012 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.745 ' O ' ' O ' ' C' ' 309' ' ' LYS . 13.9 t80 -167.31 -171.46 1.72 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.745 ' O ' ' O ' ' C' ' 308' ' ' PHE . 68.2 mttt -42.27 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.107 0.956 . . . . 0.0 110.937 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 310' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 310' ' ' ASP . 44.6 p30 -61.14 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.375 -1.453 . . . . 0.0 110.912 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 311' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' C' ' 309' ' ' LYS . 0.3 OUTLIER -166.75 112.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.979 -1.075 . . . . 0.0 109.641 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.49 168.94 0.5 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.595 HD12 HG11 ' C' ' 247' ' ' VAL . 48.4 pt -133.25 157.21 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 109.937 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 314' ' ' GLU . . . . . 0.46 ' O ' HG13 ' C' ' 247' ' ' VAL . 64.4 mt-10 -112.2 157.0 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.352 -0.842 . . . . 0.0 109.133 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' C' ' 245' ' ' ILE . 5.7 mm -120.6 142.48 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -156.52 155.14 31.45 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 317' ' ' ARG . . . . . 0.69 ' CZ ' HH22 ' C' ' 321' ' ' ARG . 37.4 mtp180 -60.72 143.45 54.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.026 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.58 61.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.322 -0.862 . . . . 0.0 109.383 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 319' ' ' GLU . . . . . 0.404 ' O ' ' NH1' ' C' ' 321' ' ' ARG . 7.8 mm-40 -128.75 85.82 59.2 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 109.774 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -56.03 142.57 85.37 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.424 2.083 . . . . 0.0 111.965 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 321' ' ' ARG . . . . . 0.69 HH22 ' CZ ' ' C' ' 317' ' ' ARG . 90.8 mtm-85 -151.86 108.07 3.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.088 -1.007 . . . . 0.0 109.248 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 20.8 p80 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.42 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.886 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.83 1 C5'-C4'-C3' 107.655 -5.23 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.886 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.442 2.335 1 C5'-C4'-C3' 107.808 -5.128 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 0.726 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.436 1.84 1 C5'-C4'-C3' 108.193 -4.872 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.68 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.44 2.201 1 C5'-C4'-C3' 107.085 -5.61 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.818 " H5'" ' CD ' ' C' ' 200' ' ' ARG . . . . . . . . 0 O4'--C1' 1.441 2.286 0 C5'-C4'-C3' 109.876 -3.749 . 0.464 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 1.047 " O4'" H5'' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.051 1 O4'-C1'-N19 112.245 4.045 OUTLIER-EPSILON 0.087 1b . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 1.047 H5'' " O4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.616 2.27 2 C5'-C4'-C3' 106.639 -5.908 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.873 ' OP2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.448 2.852 1 C5'-C4'-C3' 109.181 -4.213 . 0.791 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.958 " H2'" ' C6 ' ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.464 1 C5'-C4'-C3' 109.446 -4.036 . 0.759 &a . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 0.958 ' C6 ' " H2'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 2.0 1 C5'-C4'-C3' 107.655 -5.23 . 0.766 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.878 " O2'" ' H8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.435 1.712 1 C5'-C4'-C3' 106.774 -5.818 . 0.13 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.878 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.611 1.843 1 C5'-C4'-C3' 107.128 -5.582 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.849 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 2.011 1 C5'-C4'-C3' 107.49 -5.34 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.449 ' HD2' HH21 ' B' ' 26' ' ' ARG . 30.5 Cg_endo -67.78 157.15 63.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.715 2.277 . . . . 0.0 112.067 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.86 -5.67 16.14 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.927 2.418 . . . . 0.0 112.832 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 75.5 m -148.5 130.23 15.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 109.669 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.449 HH21 ' HD2' ' B' ' 23' ' ' PRO . 23.3 ttp85 179.05 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.51 HG22 ' HG2' ' B' ' 73' ' ' GLU . 76.5 t -116.07 151.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.592 -0.693 . . . . 0.0 109.637 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.4 ' N ' HG12 ' B' ' 27' ' ' VAL . 10.8 t -103.49 131.84 51.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.699 ' CD2' ' H2 ' ' A' ' 8' ' ' ' A' . 3.2 m-85 -102.2 116.93 33.68 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.816 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.49 HD13 ' CD1' ' B' ' 72' ' ' ILE . 4.7 mp -102.71 129.19 49.25 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -106.12 -112.15 3.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.456 ' OG ' ' CG ' ' B' ' 95' ' ' ARG . 10.4 p -70.08 131.0 43.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -1.219 . . . . 0.0 109.331 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.447 HD12 ' O ' ' B' ' 32' ' ' SER . 0.5 OUTLIER -163.42 132.88 3.08 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' B' ' 36' ' ' ASP . 14.8 Cg_endo -60.74 146.6 97.04 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.259 1.306 . . . . 0.0 112.162 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -62.98 3.66 0.22 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' B' ' 34' ' ' PRO . 93.0 m-20 -57.65 -37.77 73.92 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.362 -0.836 . . . . 0.0 108.913 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -119.27 113.23 20.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.769 . . . . 0.0 110.176 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.508 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 67.4 p -106.76 -141.18 0.37 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 0.0 109.88 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.79 -31.39 71.59 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.798 -1.189 . . . . 0.0 111.092 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -73.45 -58.55 3.23 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -67.55 -38.51 84.26 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.781 -1.2 . . . . 0.0 109.721 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' B' ' 44' ' ' ASP . 5.7 mm -61.07 -52.66 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' B' ' 42' ' ' ILE . 54.3 tp -37.81 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.151 -0.343 . . . . 0.0 110.826 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' B' ' 42' ' ' ILE . 90.7 m-20 -125.11 -24.76 3.95 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.732 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.783 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.0 tm? -59.77 -39.95 86.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.014 -1.679 . . . . 0.0 106.898 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.653 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.5 m -85.86 -63.81 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 109.065 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.823 ' O ' ' N ' ' B' ' 49' ' ' VAL . 2.5 p -40.03 -15.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.777 -0.577 . . . . 0.0 110.535 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.72 64.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.289 1.042 . . . . 0.0 109.986 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.823 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.4 p 169.89 -33.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.16 160.02 33.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.67 93.56 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.47 2.113 . . . . 0.0 111.731 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -45.67 165.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 109.4 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.424 HD11 ' HG2' ' B' ' 75' ' ' ARG . 40.5 mm -99.38 -47.46 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.25 -0.906 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.487 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 79.5 m-20 -126.54 142.37 51.56 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.49 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 24.9 tp -130.8 129.65 42.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.485 ' NZ ' ' C4 ' ' A' ' 11' ' ' ' A' . 11.3 tptm -138.09 134.65 34.94 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.109 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.687 ' SD ' ' HB2' ' B' ' 70' ' ' ALA . 4.7 tpp -126.54 132.51 51.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.734 -0.603 . . . . 0.0 109.445 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' MET . . . . . 0.629 ' SD ' ' C8 ' ' A' ' 11' ' ' ' A' . 75.2 mtm -151.77 155.96 39.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.472 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.451 ' O ' ' HD3' ' B' ' 61' ' ' PRO . 0.0 OUTLIER -117.86 -177.07 3.17 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 41.1 p-10 -100.7 102.28 18.71 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 110.933 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 37.3 Cg_endo -89.36 -59.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.429 2.086 . . . . 0.0 110.738 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -81.49 -50.23 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.512 -0.743 . . . . 0.0 109.048 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 48.0 p -57.64 -44.35 85.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 109.522 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.441 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 70.03 24.63 76.38 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.539 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 46.4 mmm-85 -118.38 -68.23 0.93 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -1.104 . . . . 0.0 110.277 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD1' ' B' ' 69' ' ' TYR . 0.2 OUTLIER -58.52 118.88 6.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 110.343 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -79.88 -74.25 0.31 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 108.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -117.41 80.54 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 0.842 ' CE2' " H4'" ' A' ' 9' ' ' ' A' . 4.9 m-85 -92.38 132.13 36.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.012 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.687 ' HB2' ' SD ' ' B' ' 57' ' ' MET . . . -143.0 141.18 31.31 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.683 ' CE1' ' N3 ' ' A' ' 9' ' ' ' A' . 2.8 m-85 -114.88 122.92 47.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 109.229 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.49 ' CD1' HD13 ' B' ' 30' ' ' LEU . 3.3 mp -116.69 102.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.866 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.51 ' HG2' HG22 ' B' ' 27' ' ' VAL . 46.5 mt-10 -80.48 128.37 33.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.789 -1.194 . . . . 0.0 111.123 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -93.54 174.22 7.3 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.68 0.752 . . . . 0.0 110.793 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 81.4 mtt-85 -50.5 -41.32 53.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.717 -0.614 . . . . 0.0 110.56 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.77 178.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.821 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -39.81 -19.0 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.566 -0.709 . . . . 0.0 110.392 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.1 tt0 -71.74 -74.69 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.69 -1.256 . . . . 0.0 108.733 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 43.3 m -60.37 -40.5 91.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -34.64 76.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.501 -0.749 . . . . 0.0 109.282 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -61.77 -59.82 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 24.5 t -64.74 -36.83 85.57 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.72 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.09 -64.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 109.988 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' B' ' 88' ' ' ASN . 35.0 t -51.75 -39.29 23.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.018 -1.051 . . . . 0.0 109.627 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.462 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmp_? -69.28 -48.52 61.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.885 -1.134 . . . . 0.0 109.697 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.88 -48.0 15.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.057 . . . . 0.0 109.669 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' B' ' 83' ' ' ALA . 59.4 mt -93.85 27.91 2.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -54.91 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.454 ' HA2' HD12 ' B' ' 97' ' ' LEU . . . -137.48 121.04 2.19 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -136.27 142.67 43.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.513 -1.58 . . . . 0.0 108.796 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.597 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.8 mm100 -27.25 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.609 0.719 . . . . 0.0 111.06 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.7 tt -151.44 128.23 10.92 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.696 -0.627 . . . . 0.0 109.309 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' B' ' 92' ' ' LEU . . . 46.36 -175.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 37.4 t -66.02 -17.15 64.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.008 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.456 ' CG ' ' OG ' ' B' ' 32' ' ' SER . 24.5 mmt180 -134.67 149.81 50.56 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.133 -0.98 . . . . 0.0 109.58 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.9 m-85 -103.5 142.77 33.7 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.293 0.568 . . . . 0.0 110.388 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -39.93 151.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -134.87 170.05 16.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.262 -0.899 . . . . 0.0 110.2 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 2.3 p -73.33 -176.08 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.355 -0.841 . . . . 0.0 109.245 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' B' ' 29' ' ' TYR . . . 160.3 177.14 33.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.614 ' O ' ' N ' ' B' ' 103' ' ' SER . 21.8 p90 -149.15 -3.08 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.053 -1.263 . . . . 0.0 111.065 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' B' ' 102' ' ' SER . 0.1 OUTLIER -35.57 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.227 -0.921 . . . . 0.0 110.602 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.614 ' N ' ' O ' ' B' ' 101' ' ' TYR . 17.2 t -58.37 -38.64 77.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.981 -1.075 . . . . 0.0 109.509 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -130.78 131.97 45.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.452 -0.78 . . . . 0.0 109.478 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.468 ' C ' ' N6 ' ' A' ' 11' ' ' ' A' . 22.3 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.464 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 52.6 pttt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.21 0.529 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -102.83 59.3 0.78 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.626 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 158' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 99.9 p -119.99 142.0 49.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 108.903 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 159' ' ' CYS . . . . . 0.592 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER 170.35 -26.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -80.97 139.08 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 161' ' ' MET . . . . . 0.71 ' SD ' HG11 ' C' ' 216' ' ' VAL . 2.3 ttp -121.32 165.57 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.688 ' CD2' ' C6 ' ' A' ' 6' ' ' ' A' . 50.9 t80 -138.36 77.93 1.65 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.497 -0.752 . . . . 0.0 110.192 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.708 HG22 HD11 ' C' ' 166' ' ' LEU . 49.6 mt -54.19 141.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -137.04 168.51 24.3 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.464 ' H ' ' NH2' ' C' ' 200' ' ' ARG . . . 66.72 31.35 78.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 166' ' ' LEU . . . . . 0.708 HD11 HG22 ' C' ' 163' ' ' ILE . 7.6 mp -68.26 172.25 6.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 108.046 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.594 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 1.6 t-20 -67.79 -73.23 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.929 -1.107 . . . . 0.0 108.421 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.68 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.0 OUTLIER 178.72 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.32 178.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 169' ' ' ASP . . . . . 0.458 ' OD1' ' CD ' ' C' ' 192' ' ' LYS . 68.5 t0 -135.73 92.34 2.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.892 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 86.6 m -125.8 143.53 51.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.459 -0.775 . . . . 0.0 109.2 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 172.7 8.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.602 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 172' ' ' GLU . . . . . 0.787 ' OE1' HG23 ' C' ' 190' ' ' ILE . 0.0 OUTLIER -79.06 -71.27 0.45 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.924 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' C' ' 174' ' ' ASN . 90.0 m-20 -40.24 -72.37 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 174' ' ' ASN . . . . . 0.543 ' C ' ' O ' ' C' ' 173' ' ' ASP . 0.1 OUTLIER -34.7 -44.57 0.22 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.614 HD12 HD13 ' C' ' 190' ' ' ILE . 0.5 OUTLIER -55.98 -57.97 9.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 109.779 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 176' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' C' ' 178' ' ' TYR . 7.4 ptm180 -67.28 -54.11 23.81 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 177' ' ' GLU . . . . . 0.513 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -38.51 -30.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.108 -0.995 . . . . 0.0 108.394 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.534 ' CD2' HD12 ' C' ' 223' ' ' LEU . 20.4 t80 -86.94 -40.19 15.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 110.143 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' C' ' 176' ' ' ARG . 25.8 m-85 -90.94 16.75 8.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.139 -0.976 . . . . 0.0 111.149 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.36 25.74 24.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -102.77 10.87 38.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 182' ' ' TYR . . . . . 0.488 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 90.3 m-85 -109.62 -77.0 0.6 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.19 -122.09 2.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 38.9 m -124.17 139.94 53.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.556 -0.967 . . . . 0.0 109.416 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.523 HG23 HH21 ' C' ' 176' ' ' ARG . 35.8 m -112.17 139.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.467 HG23 ' N ' ' C' ' 187' ' ' ASP . 11.1 t -105.2 -38.08 6.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.05 -1.031 . . . . 0.0 110.116 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 187' ' ' ASP . . . . . 0.467 ' N ' HG23 ' C' ' 186' ' ' THR . 17.5 t70 -163.43 166.17 23.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.628 ' N ' HD23 ' C' ' 188' ' ' LEU . 1.8 pt? -161.59 150.8 16.15 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 0.0 108.921 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -124.0 141.66 51.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 109.091 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 190' ' ' ILE . . . . . 0.787 HG23 ' OE1' ' C' ' 172' ' ' GLU . 1.1 tt -166.61 107.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.059 -1.026 . . . . 0.0 108.392 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 191' ' ' MET . . . . . 0.666 ' SD ' ' C2 ' ' A' ' 7' ' ' ' U' . 5.2 ptp -115.83 71.45 0.78 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 192' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' C' ' 191' ' ' MET . 4.0 pttt -39.25 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.287 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' C' ' 195' ' ' ALA . 4.8 t0 -147.58 106.53 3.77 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -48.31 -5.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' C' ' 193' ' ' ASP . . . -103.47 -85.61 0.45 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 196' ' ' THR . . . . . 0.535 HG23 ' N ' ' C' ' 197' ' ' GLY . 10.2 t -103.46 -41.57 5.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 109.764 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 197' ' ' GLY . . . . . 0.535 ' N ' HG23 ' C' ' 196' ' ' THR . . . 127.35 13.43 2.87 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 198' ' ' ARG . . . . . 0.425 ' H ' HG23 ' C' ' 196' ' ' THR . 1.6 mmm180 -98.27 86.92 3.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 109.711 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 199' ' ' SER . . . . . 0.624 ' O ' ' N ' ' C' ' 201' ' ' GLY . 42.7 t -161.48 149.23 15.06 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.818 ' CD ' " H5'" ' A' ' 5' ' ' ' U' . 47.2 tpt85 -42.53 90.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 201' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.14 138.15 21.53 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.538 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.53 ' CZ ' " H1'" ' A' ' 7' ' ' ' U' . 1.1 p90 -138.84 169.47 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -130.78 130.61 6.18 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.142 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 204' ' ' PHE . . . . . 0.407 ' HZ ' " H5'" ' A' ' 7' ' ' ' U' . 48.7 m-85 -107.33 95.97 6.08 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.4 ' HG ' ' CZ ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -93.02 106.38 18.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -178.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.5 t -77.48 77.35 4.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.395 -0.816 . . . . 0.0 109.531 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.592 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 34.5 m-85 -71.69 107.52 4.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 109.927 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.73 -39.8 81.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -85.25 105.09 5.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.744 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.08 -28.73 20.07 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.744 1.629 . . . . 0.0 112.997 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.545 ' O ' ' N ' ' C' ' 213' ' ' VAL . 83.9 p -68.18 -57.76 5.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.986 -1.072 . . . . 0.0 110.383 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.891 ' O ' HG23 ' C' ' 216' ' ' VAL . 91.2 p -40.81 -22.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.862 . . . . 0.0 109.955 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 213' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 211' ' ' SER . 97.1 t -70.4 -37.78 71.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 108.939 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 214' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.8 t0 -57.91 -48.86 78.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 109.813 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.13 -36.83 77.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.894 -1.129 . . . . 0.0 109.611 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.891 HG23 ' O ' ' C' ' 212' ' ' SER . 84.2 t -56.14 -46.85 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.767 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.424 HG23 ' N ' ' C' ' 218' ' ' LYS . 25.2 m -78.13 -36.79 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.027 . . . . 0.0 110.102 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.424 ' N ' HG23 ' C' ' 217' ' ' VAL . 3.0 tmtm? -67.14 -50.55 60.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 0.0 109.868 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -73.04 144.85 46.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.688 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -98.66 138.28 36.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.695 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -136.46 150.24 48.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.99 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.57 89.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.534 HD12 ' CD2' ' C' ' 178' ' ' TYR . 27.0 tp -58.44 -56.68 19.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.697 -0.627 . . . . 0.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.46 13.9 29.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.087 -1.008 . . . . 0.0 108.598 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 75.54 26.69 64.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.589 -2.205 . . . . 0.0 107.589 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 226' ' ' LYS . . . . . 0.465 ' HD3' HD22 ' C' ' 167' ' ' ASN . 0.1 OUTLIER -101.9 -154.25 0.48 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 227' ' ' VAL . . . . . 0.532 ' O ' HG12 ' C' ' 227' ' ' VAL . 12.6 t -121.41 94.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 109.329 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 228' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' C' ' 166' ' ' LEU . 30.1 pt -105.27 149.59 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.396 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 229' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' C' ' 231' ' ' LYS . 0.4 OUTLIER -124.17 100.17 36.48 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 0.0 109.813 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 230' ' ' PRO . . . . . 0.401 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 16.6 Cg_endo -74.87 131.11 14.07 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.981 1.787 . . . . 0.0 111.244 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 231' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' C' ' 229' ' ' ASP . 19.4 mttm -149.91 151.08 32.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -62.07 149.09 42.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.72 . . . . 0.0 109.265 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.72 29.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.045 . . . . 0.0 109.123 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.11 116.68 32.46 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.32 159.05 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.237 1.958 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.729 ' N ' ' HE ' ' C' ' 236' ' ' ARG . 0.2 OUTLIER -57.44 -52.14 66.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.414 -0.804 . . . . 0.0 110.343 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 237' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' C' ' 241' ' ' LYS . 90.9 m-20 -61.44 -41.68 97.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.12 -39.55 95.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.692 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.538 ' OE1' ' N7 ' ' A' ' 6' ' ' ' A' . 55.8 tp60 -62.83 -41.36 99.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.974 -1.079 . . . . 0.0 108.613 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.85 -22.31 31.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.788 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 241' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' C' ' 237' ' ' ASP . 48.9 tttm -54.64 -16.81 2.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 0.0 110.302 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 10.2 p -102.36 162.6 12.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.893 -1.129 . . . . 0.0 109.449 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.87 154.08 17.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -129.92 126.61 38.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.056 -1.261 . . . . 0.0 109.972 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.502 HD11 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -117.33 138.55 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.765 0.793 . . . . 0.0 108.895 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.4 OUTLIER -80.56 161.28 24.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.458 0.647 . . . . 0.0 109.51 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 247' ' ' VAL . . . . . 0.546 ' N ' ' CD1' ' C' ' 246' ' ' PHE . 39.8 t -134.85 132.69 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.66 152.4 18.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 61.73 120.17 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.592 HD11 ' O ' ' C' ' 286' ' ' PHE . 0.0 OUTLIER -151.87 165.82 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -1.096 . . . . 0.0 108.743 179.106 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -47.07 145.71 4.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.31 -49.38 10.34 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.906 1.737 . . . . 0.0 112.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -122.14 33.87 5.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.741 . . . . 0.0 109.387 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.5 HG11 ' HB ' ' C' ' 250' ' ' ILE . 2.5 p -44.97 141.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -110.71 158.37 35.79 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.24 -30.66 81.81 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.35 2.033 . . . . 0.0 111.169 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -51.56 -62.64 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 258' ' ' GLU . . . . . 0.704 ' O ' ' N ' ' C' ' 261' ' ' GLU . 0.0 OUTLIER -62.57 -87.71 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 259' ' ' PHE . . . . . 0.631 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.3 t80 -9.03 -70.39 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 121.441 0.639 . . . . 0.0 110.942 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 260' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' C' ' 272' ' ' ALA . 85.0 tt0 -56.06 -44.14 78.59 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.271 0.558 . . . . 0.0 110.39 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 261' ' ' GLU . . . . . 0.704 ' N ' ' O ' ' C' ' 258' ' ' GLU . 46.4 tp10 -68.53 -41.93 79.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 262' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' C' ' 263' ' ' PHE . 42.1 t80 -54.69 -77.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.924 -0.485 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.611 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 61.3 m-85 -42.04 -48.77 4.69 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.706 -1.246 . . . . 0.0 110.24 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.0 OUTLIER -35.26 -37.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' C' ' 263' ' ' PHE . 1.7 pp0? -55.86 -7.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.0 113.246 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.611 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.2 p90 -146.35 -53.42 0.25 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.86 -1.775 . . . . 0.0 111.318 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 267' ' ' GLY . . . . . 0.597 ' N ' ' CD1' ' C' ' 266' ' ' TRP . . . -83.83 -178.52 51.82 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 268' ' ' THR . . . . . 0.56 ' O ' ' C ' ' C' ' 269' ' ' ILE . 34.1 p -102.19 9.5 40.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.924 -1.339 . . . . 0.0 111.706 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.996 HG23 ' CE1' ' C' ' 291' ' ' TYR . 0.9 OUTLIER -16.45 104.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.264 0.938 . . . . 0.0 112.98 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.6 mm -92.74 -33.11 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 271' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' C' ' 272' ' ' ALA . 88.0 m-20 -115.19 17.72 16.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.42 -0.8 . . . . 0.0 110.457 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 272' ' ' ALA . . . . . 0.731 ' HB2' ' HB ' ' C' ' 269' ' ' ILE . . . -25.92 130.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.998 -0.438 . . . . 0.0 110.275 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 273' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' C' ' 288' ' ' PHE . 14.0 pt20 -152.52 132.5 13.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.695 -1.253 . . . . 0.0 111.64 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.941 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.3 OUTLIER -126.58 152.46 46.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 275' ' ' MET . . . . . 0.471 ' CE ' ' OP1' ' A' ' 4' ' ' ' A' . 17.8 mmt -88.54 168.44 12.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.651 -1.281 . . . . 0.0 109.872 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.957 ' H ' HD12 ' C' ' 276' ' ' LEU . 0.0 OUTLIER -144.59 176.98 9.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.788 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -78.71 -35.78 44.39 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 110.39 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -56.31 -36.43 68.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.062 -1.024 . . . . 0.0 109.789 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 279' ' ' ASP . . . . . 0.478 ' OD1' ' N6 ' ' A' ' 4' ' ' ' A' . 53.3 t0 -53.55 -52.43 59.73 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.668 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 280' ' ' THR . . . . . 0.41 ' H ' ' H ' ' C' ' 281' ' ' GLY . 1.1 t 178.83 0.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 281' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' C' ' 283' ' ' SER . . . 102.47 9.07 42.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.609 ' NE2' ' OP1' ' A' ' 3' ' ' ' U' . 11.6 mm100 -77.42 23.27 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -1.03 . . . . 0.0 109.958 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 283' ' ' SER . . . . . 0.532 ' OG ' ' CA ' ' C' ' 276' ' ' LEU . 3.0 m -107.44 59.07 0.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.434 -0.792 . . . . 0.0 109.798 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 284' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.77 -27.69 19.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 108.618 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 143.29 17.37 0.25 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.726 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 46.1 p90 -108.55 176.77 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.42 178.17 39.1 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 288' ' ' PHE . . . . . 0.414 ' CE1' " O4'" ' A' ' 3' ' ' ' U' . 73.7 m-85 -147.55 156.31 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.325 -1.691 . . . . 0.0 109.676 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 289' ' ' VAL . . . . . 0.412 ' HB ' HG22 ' C' ' 269' ' ' ILE . 1.7 m -140.51 152.11 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.042 -1.036 . . . . 0.0 108.626 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.65 120.09 28.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 291' ' ' TYR . . . . . 0.996 ' CE1' HG23 ' C' ' 269' ' ' ILE . 93.9 m-85 -109.18 136.69 48.25 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.82 -50.67 72.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.592 -1.317 . . . . 0.0 109.381 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 75.4 m -93.54 169.38 10.39 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.309 -0.869 . . . . 0.0 108.89 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -103.54 -9.81 18.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.67 -46.24 74.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.01 76.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.807 . . . . 0.0 109.049 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 297' ' ' VAL . . . . . 0.419 ' O ' HG12 ' C' ' 300' ' ' VAL . 67.9 t -62.53 -61.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -56.11 -29.17 60.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 109.135 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -62.94 -60.8 2.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.977 HG23 HD22 ' C' ' 303' ' ' ASN . 14.4 p -63.06 -27.89 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.647 -0.658 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 301' ' ' CYS . . . . . 0.496 ' C ' ' O ' ' C' ' 300' ' ' VAL . 65.1 m -45.27 -49.37 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -46.13 -32.83 3.14 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.872 -0.518 . . . . 0.0 109.654 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.977 HD22 HG23 ' C' ' 300' ' ' VAL . 13.2 p30 -101.5 81.77 2.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -72.62 -14.98 61.73 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.64 -1.913 . . . . 0.0 108.739 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -126.05 122.28 35.38 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 306' ' ' ILE . . . . . 0.418 ' CG1' ' OD1' ' C' ' 303' ' ' ASN . 82.7 mt -117.18 149.87 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.13 96.69 10.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.624 ' O ' ' C ' ' C' ' 309' ' ' LYS . 34.7 t80 -104.32 -176.65 3.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.776 ' O ' ' N ' ' C' ' 311' ' ' ARG . 71.2 mttt -25.26 133.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 310' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' C' ' 309' ' ' LYS . 23.8 t70 -17.79 69.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.405 0.622 . . . . 0.0 112.057 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 311' ' ' ARG . . . . . 0.776 ' N ' ' O ' ' C' ' 309' ' ' LYS . 54.1 ttm-85 177.98 109.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 153.12 4.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.064 . . . . 0.0 108.742 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.88 153.31 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.104 -0.997 . . . . 0.0 108.972 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -116.04 121.41 42.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 109.791 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.502 ' CG2' HD11 ' C' ' 245' ' ' ILE . 2.0 mm -88.84 154.9 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -160.96 159.94 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.165 -0.959 . . . . 0.0 108.421 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -71.92 150.75 43.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.81 -1.181 . . . . 0.0 109.175 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.24 -0.7 10.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.842 -1.161 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.86 85.23 9.25 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.778 . . . . 0.0 109.929 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 320' ' ' PRO . . . . . 0.467 ' CG ' ' H61' ' A' ' 2' ' ' ' A' . 31.7 Cg_exo -54.94 137.75 76.54 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.463 2.109 . . . . 0.0 111.988 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 321' ' ' ARG . . . . . 0.444 ' O ' ' CB ' ' C' ' 322' ' ' HIS . 58.3 ttt85 -58.39 -38.37 77.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.66 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 322' ' ' HIS . . . . . 0.474 ' NE2' ' C5 ' ' A' ' 12' ' ' ' A' . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.478 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.855 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.957 1 C5'-C4'-C3' 107.627 -5.249 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.855 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.084 2 C5'-C4'-C3' 107.353 -5.432 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 0.682 " H3'" ' OD2' ' C' ' 277' ' ' ASP . . . . . . . . 0 O4'--C1' 1.433 1.601 1 C5'-C4'-C3' 106.607 -5.929 . 0.581 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.717 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.439 2.107 1 C5'-C4'-C3' 107.039 -5.641 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.68 ' O4 ' ' N ' ' C' ' 165' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.776 2 C3'-C2'-C1' 105.446 4.384 . 0.541 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 1.023 " C4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.611 1.85 1 C5'-C4'-C3' 107.489 -5.341 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 1.023 " H5'" " C4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.618 2.543 1 C5'-C4'-C3' 107.4 -5.4 . 0.241 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.692 ' OP2' " H4'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.447 2.748 1 C5'-C4'-C3' 107.282 -5.479 . 0.41 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.735 ' C4 ' ' CE2' ' B' ' 29' ' ' TYR . . . . . . . . 0 O4'--C4' 1.417 -2.983 0 C5'-C4'-C3' 109.759 -3.828 . 0.789 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 0.824 " H1'" ' CE ' ' B' ' 58' ' ' MET . . . . . . . . 0 O4'--C1' 1.442 2.295 1 C5'-C4'-C3' 108.609 -4.594 . 0.527 &a . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.922 " O2'" ' H8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 P--O5' 1.612 1.934 2 C5'-C4'-C3' 107.987 -5.009 . 0.503 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.922 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.614 2.06 1 C5'-C4'-C3' 107.37 -5.42 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.508 " O5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 1.965 1 C5'-C4'-C3' 107.442 -5.372 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.713 ' ND2' ' CE2' ' B' ' 101' ' ' TYR . 6.1 t30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.464 0.649 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.01 154.47 70.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.936 2.424 . . . . 0.0 112.255 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.24 3.39 4.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.719 2.28 . . . . 0.0 112.315 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -154.3 133.42 12.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.93 . . . . 0.0 109.276 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -43.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.0 109.333 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' B' ' 100' ' ' GLY . 2.7 t -119.81 151.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' B' ' 98' ' ' LYS . 9.0 p -142.44 134.41 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.66 -1.275 . . . . 0.0 107.994 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.735 ' CE2' ' C4 ' ' A' ' 9' ' ' ' A' . 0.1 OUTLIER -129.36 155.57 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 110.475 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.62 ' HB3' HD11 ' B' ' 33' ' ' ILE . 3.4 mp -121.24 147.93 44.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.537 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -123.39 -45.13 0.29 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.413 ' C ' HD12 ' B' ' 33' ' ' ILE . 0.7 OUTLIER -92.04 87.51 6.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.964 -1.315 . . . . 0.0 109.706 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.635 HD12 ' N ' ' B' ' 33' ' ' ILE . 3.4 mp -143.44 126.81 9.08 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 108.886 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' B' ' 36' ' ' ASP . 39.3 Cg_endo -73.43 155.85 50.44 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.451 1.434 . . . . 0.0 111.583 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.449 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 8.2 m-85 -60.24 5.85 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 109.621 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.2 m-20 -61.51 -41.93 98.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.048 -1.032 . . . . 0.0 108.584 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -125.4 112.04 15.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.39 -0.819 . . . . 0.0 109.57 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.408 ' O ' HG12 ' B' ' 42' ' ' ILE . 69.3 p -107.45 -143.19 0.38 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.379 -0.826 . . . . 0.0 110.963 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 21.7 pt-20 -65.97 -29.19 69.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.815 -1.178 . . . . 0.0 110.955 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -64.0 -54.78 28.91 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.882 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -69.52 -48.11 61.6 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 110.359 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' B' ' 44' ' ' ASP . 6.5 mm -56.76 -54.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' B' ' 55' ' ' LEU . 41.4 tp -36.9 -20.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.2 t0 -124.02 -22.22 4.88 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.178 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.728 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.4 tm? -61.6 -37.59 84.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.165 -1.584 . . . . 0.0 107.94 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' B' ' 48' ' ' ASN . 86.6 m -92.77 -63.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.95 -1.093 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.412 ' C ' ' O ' ' B' ' 46' ' ' CYS . 17.6 t -37.76 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.806 -0.559 . . . . 0.0 110.788 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' B' ' 49' ' ' VAL . 5.9 p30 -71.38 -59.05 2.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.784 -1.198 . . . . 0.0 109.844 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' B' ' 48' ' ' ASN . 0.9 OUTLIER -42.37 -51.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.714 -0.616 . . . . 0.0 110.207 -178.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.507 ' N ' HG12 ' B' ' 49' ' ' VAL . . . -157.22 167.63 33.94 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.21 131.06 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.905 1.737 . . . . 0.0 111.495 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.624 HG13 ' H ' ' B' ' 53' ' ' ILE . 0.9 OUTLIER -99.66 -172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.328 -0.857 . . . . 0.0 108.998 -178.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.624 ' H ' HG13 ' B' ' 52' ' ' VAL . 24.0 mm -142.86 -44.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 86.8 m-20 -149.52 155.53 40.5 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.662 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' B' ' 43' ' ' LEU . 56.8 tp -146.61 130.23 16.94 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.444 ' CG ' ' SD ' ' B' ' 58' ' ' MET . 43.1 tptt -145.81 116.54 7.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.671 -1.268 . . . . 0.0 110.143 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.46 130.41 35.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 109.297 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' MET . . . . . 0.824 ' CE ' " H1'" ' A' ' 10' ' ' ' U' . 2.3 mpp? -141.3 144.18 34.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.112 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.449 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 14.0 m-85 -98.89 -179.15 4.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.822 ' CG ' H5'' ' A' ' 10' ' ' ' U' . 0.4 OUTLIER -117.1 69.86 5.24 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.497 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -68.17 -61.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.916 2.411 . . . . 0.0 113.281 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -64.08 -40.94 97.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -0.829 . . . . 0.0 110.818 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.513 ' CG2' ' OD1' ' B' ' 60' ' ' ASP . 7.8 p -70.84 -43.38 68.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.69 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.61 -2.45 85.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -1.08 . . . . 0.0 110.016 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' B' ' 60' ' ' ASP . 0.1 OUTLIER -177.24 -161.94 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.927 -1.108 . . . . 0.0 111.11 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' B' ' 60' ' ' ASP . 29.8 mttm -144.62 38.15 1.23 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 109.913 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.27 63.3 0.5 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.88 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 0.705 ' CE1' " H4'" ' A' ' 9' ' ' ' A' . 66.4 m-85 -116.8 123.57 47.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.279 -1.13 . . . . 0.0 109.498 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 135.9 36.59 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.296 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.73 ' CE2' ' C2 ' ' A' ' 9' ' ' ' A' . 3.5 m-85 -106.79 125.35 50.89 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.516 0.674 . . . . 0.0 111.549 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.87 153.01 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 81.7 tt0 -133.48 136.51 45.16 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.424 ' HD1' ' HG ' ' B' ' 79' ' ' SER . 12.0 m-85 -103.0 169.76 8.37 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.035 0.921 . . . . 0.0 111.583 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 51.6 ttt85 -55.52 -42.37 74.45 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.841 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 159.64 -176.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.502 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.789 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.8 mm? -38.77 -21.73 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.852 -0.53 . . . . 0.0 110.313 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.3 mt-10 -70.28 -79.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' SER . . . . . 0.424 ' HG ' ' HD1' ' B' ' 74' ' ' PHE . 13.9 t -62.57 -36.62 83.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.5 t -62.82 -37.75 88.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -60.31 -58.16 9.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.409 -1.432 . . . . 0.0 108.534 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.3 t -64.58 -34.19 77.68 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.415 0.626 . . . . 0.0 111.995 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -84.23 -58.26 2.83 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.932 -1.105 . . . . 0.0 110.596 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.709 HG13 ' CB ' ' B' ' 99' ' ' CYS . 58.7 t -53.59 -40.74 43.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 120.331 -1.481 . . . . 0.0 108.561 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -69.63 -46.9 65.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.826 -1.171 . . . . 0.0 109.782 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' B' ' 88' ' ' ASN . 73.7 m-20 -88.07 -59.48 2.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.851 -1.155 . . . . 0.0 109.006 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.69 ' N ' ' O ' ' B' ' 83' ' ' ALA . 11.8 tp -73.85 32.11 0.08 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -71.85 -73.07 0.2 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.029 -1.044 . . . . 0.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' B' ' 97' ' ' LEU . . . -137.07 120.96 2.22 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -138.43 141.1 39.54 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.45 -1.617 . . . . 0.0 107.294 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 5.1 mm100 -31.16 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.781 0.8 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.59 ' N ' ' O ' ' B' ' 90' ' ' TYR . 20.8 tp -152.16 117.78 5.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.42 -168.9 48.0 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -11.94 59.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.028 -1.278 . . . . 0.0 108.872 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.536 ' NH2' " H4'" ' A' ' 8' ' ' ' A' . 0.1 OUTLIER -134.44 155.24 50.68 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' B' ' 97' ' ' LEU . 6.8 m-85 -97.09 134.17 40.78 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.27 -0.894 . . . . 0.0 109.207 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -29.21 136.91 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.505 0.669 . . . . 0.0 111.084 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.739 ' O ' HG23 ' B' ' 28' ' ' VAL . 1.5 mmtt -112.76 126.81 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 109.054 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' CYS . . . . . 0.709 ' CB ' HG13 ' B' ' 84' ' ' VAL . 14.7 p -89.27 129.96 35.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 111.168 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -130.8 -168.16 12.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.713 ' CE2' ' ND2' ' B' ' 22' ' ' ASN . 38.5 p90 -137.49 161.36 36.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.682 -0.893 . . . . 0.0 109.076 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.472 ' HB3' HG21 ' B' ' 27' ' ' VAL . 26.9 t -179.24 92.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.438 -0.789 . . . . 0.0 108.945 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 60.7 p -151.91 168.44 25.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' B' ' 104' ' ' ASN . 33.3 p-10 -125.71 -178.06 4.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.473 -0.767 . . . . 0.0 109.653 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.616 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 6.9 tptt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.92 140.23 32.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 109.58 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 158' ' ' SER . . . . . 0.502 ' C ' ' H ' ' C' ' 160' ' ' LYS . 28.2 t -111.93 142.49 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.766 . . . . 0.0 109.336 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 159' ' ' CYS . . . . . 0.409 ' CB ' ' O ' ' C' ' 209' ' ' LYS . 27.4 p -72.42 28.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.741 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 160' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' C' ' 158' ' ' SER . 38.7 tttt -104.51 134.81 47.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.545 -0.722 . . . . 0.0 109.997 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 8.3 ptm -118.26 159.26 23.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -0.842 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.437 ' CG ' ' C2 ' ' A' ' 6' ' ' ' A' . 44.3 t80 -122.83 77.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 110.29 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.478 ' CD1' HD21 ' C' ' 175' ' ' LEU . 0.6 OUTLIER -50.11 140.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 164' ' ' GLY . . . . . 0.497 ' HA2' ' C5 ' ' A' ' 5' ' ' ' U' . . . -139.11 166.66 25.39 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.68 ' N ' ' O4 ' ' A' ' 5' ' ' ' U' . . . 53.91 24.51 27.15 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 166' ' ' LEU . . . . . 0.749 ' HA ' HG22 ' C' ' 228' ' ' ILE . 1.7 pp -75.06 162.37 28.61 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.362 -1.081 . . . . 0.0 110.653 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.635 ' N ' HD12 ' C' ' 166' ' ' LEU . 63.5 t30 -75.29 123.98 26.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.025 -1.047 . . . . 0.0 109.528 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.717 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 3.2 m0 -37.52 -39.28 0.3 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 111.054 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.7 84.41 7.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.694 -1.253 . . . . 0.0 110.94 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 170' ' ' THR . . . . . 0.405 ' O ' ' CD1' ' C' ' 190' ' ' ILE . 57.9 m -146.18 133.82 21.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.991 . . . . 0.0 109.368 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 171' ' ' THR . . . . . 0.445 ' O ' ' C ' ' C' ' 172' ' ' GLU . 1.4 m -124.33 138.92 54.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.343 -0.848 . . . . 0.0 109.128 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 172' ' ' GLU . . . . . 0.566 ' HB3' HD13 ' C' ' 188' ' ' LEU . 0.5 OUTLIER -39.38 -72.99 0.05 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.138 -0.976 . . . . 0.0 110.744 -178.171 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' C' ' 172' ' ' GLU . 53.9 t0 -38.68 -39.46 0.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.542 -0.724 . . . . 0.0 110.139 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -76.51 -44.22 36.05 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' C' ' 172' ' ' GLU . 0.9 OUTLIER -53.1 -54.05 41.27 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 176' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' C' ' 179' ' ' PHE . 5.6 ptm180 -68.81 -55.54 10.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.43 -1.308 . . . . 0.0 108.534 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 177' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' C' ' 176' ' ' ARG . 84.6 tt0 -35.94 -33.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.559 ' CG ' HD12 ' C' ' 223' ' ' LEU . 21.1 t80 -91.93 -31.14 15.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.724 . . . . 0.0 110.564 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' C' ' 176' ' ' ARG . 6.0 m-85 -95.49 15.92 18.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.84 -1.163 . . . . 0.0 110.832 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.67 29.57 2.63 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.57 22.79 12.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -1.079 . . . . 0.0 109.195 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 182' ' ' TYR . . . . . 0.603 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 99.2 m-85 -127.91 -3.84 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.486 -0.759 . . . . 0.0 109.628 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 151.33 -126.19 2.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 2.9 t -131.58 149.7 52.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -1.077 . . . . 0.0 108.844 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.557 HG11 HD23 ' C' ' 188' ' ' LEU . 86.0 t -103.25 134.42 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.915 . . . . 0.0 109.663 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 53.0 p -122.3 -29.51 4.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.378 -0.826 . . . . 0.0 110.562 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -153.9 150.51 28.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 109.62 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.831 ' O ' HD12 ' C' ' 188' ' ' LEU . 1.2 pp -171.93 154.84 3.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.588 -1.32 . . . . 0.0 110.111 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -140.35 118.52 11.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 108.337 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 190' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' C' ' 170' ' ' THR . 0.0 OUTLIER -141.11 148.66 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.777 -1.202 . . . . 0.0 110.33 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 9.8 mtt -121.63 174.13 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 140.05 1.13 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.523 -1.361 . . . . 0.0 109.118 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' C' ' 193' ' ' ASP . 0.0 OUTLIER -74.9 143.46 78.02 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.069 -1.019 . . . . 0.0 110.045 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 194' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' C' ' 195' ' ' ALA . 60.3 Cg_endo -75.74 -40.73 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.946 1.764 . . . . 0.0 110.994 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' C' ' 194' ' ' PRO . . . 178.93 -39.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.566 -0.709 . . . . 0.0 109.771 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 50.1 p -123.4 5.44 9.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 197' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' C' ' 198' ' ' ARG . . . -105.03 42.64 1.85 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 198' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' C' ' 197' ' ' GLY . 49.6 mtm180 -41.91 133.73 2.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -1.109 . . . . 0.0 109.63 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 199' ' ' SER . . . . . . . . . . . . . 23.0 t -154.67 167.04 31.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.55 ' NE ' ' N ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -59.94 92.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 201' ' ' GLY . . . . . 0.679 ' O ' ' N3 ' ' A' ' 5' ' ' ' U' . . . -83.11 93.13 1.68 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 8.7 p90 -109.14 154.54 22.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -115.6 134.09 11.31 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.522 -1.799 . . . . 0.0 110.087 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -114.14 91.44 3.63 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.485 HD12 HD22 ' C' ' 175' ' ' LEU . 0.8 OUTLIER -100.23 111.87 24.17 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.175 -0.953 . . . . 0.0 110.442 -177.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 7.7 t -106.61 135.6 47.85 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -104.43 -121.41 0.21 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -141.05 -14.25 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.188 -1.57 . . . . 0.0 108.867 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 7.6 mtmp? -130.0 170.45 10.98 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -97.66 -11.82 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.638 2.225 . . . . 0.0 112.481 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.587 ' O ' ' N ' ' C' ' 213' ' ' VAL . 15.1 m -68.58 -61.64 1.74 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.924 -1.11 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.489 ' O ' HG23 ' C' ' 216' ' ' VAL . 42.8 m -40.64 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -0.763 . . . . 0.0 109.873 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 213' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' C' ' 211' ' ' SER . 84.0 t -73.64 -35.79 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.754 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 214' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -63.83 -49.32 73.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.75 . . . . 0.0 110.409 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 215' ' ' GLU . . . . . 0.65 ' CD ' ' H ' ' C' ' 215' ' ' GLU . 0.0 OUTLIER -69.04 -42.7 76.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.797 -1.189 . . . . 0.0 108.674 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.489 HG23 ' O ' ' C' ' 212' ' ' SER . 4.8 t -51.55 -47.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.7 -36.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -77.93 8.95 3.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.786 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 18.0 m -129.38 142.95 50.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.879 . . . . 0.0 108.762 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.95 136.27 45.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.904 ' C ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -131.18 153.01 49.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.726 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.904 HD13 ' C ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -117.62 86.85 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.672 0.748 . . . . 0.0 109.102 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' C' ' 178' ' ' TYR . 1.1 tp -57.27 -66.75 0.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.855 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -96.05 8.31 44.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.665 -1.272 . . . . 0.0 109.401 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 81.95 14.88 76.4 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 226' ' ' LYS . . . . . 0.677 ' HB2' ' HZ2' ' C' ' 226' ' ' LYS . 0.0 OUTLIER -95.69 -154.39 0.43 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 227' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' C' ' 165' ' ' GLY . 7.6 t -115.07 95.91 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 228' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' C' ' 166' ' ' LEU . 26.3 pt -105.65 136.94 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.78 108.44 53.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.798 . . . . 0.0 109.612 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 230' ' ' PRO . . . . . 0.466 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 37.2 Cg_endo -81.7 137.33 10.03 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.968 1.779 . . . . 0.0 111.939 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -145.99 159.52 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 234' ' ' ILE . 26.8 ptt-85 -87.61 152.14 22.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.04 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -49.15 99.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 108.761 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 234' ' ' ILE . . . . . 0.451 HD12 ' H61' ' A' ' 6' ' ' ' A' . 4.4 mt -90.76 127.44 52.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.03 149.36 2.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.062 1.841 . . . . 0.0 112.55 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -57.33 -45.83 83.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -59.41 -41.73 90.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 108.704 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 238' ' ' GLU . . . . . 0.518 ' O ' HG23 ' C' ' 242' ' ' THR . 75.9 mm-40 -66.3 -36.39 82.83 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.434 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.544 ' CD ' ' N7 ' ' A' ' 6' ' ' ' A' . 30.5 tp60 -61.19 -44.82 96.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -73.0 -41.2 64.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.362 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -72.28 -13.93 61.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 111.805 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 242' ' ' THR . . . . . 0.518 HG23 ' O ' ' C' ' 238' ' ' GLU . 0.9 OUTLIER -47.64 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.525 -1.359 . . . . 0.0 110.284 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 107.66 108.76 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -140.72 134.33 30.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.715 -1.462 . . . . 0.0 110.6 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.696 HD12 ' CG2' ' C' ' 315' ' ' ILE . 1.2 pt -126.16 159.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 109.875 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.717 ' CE2' ' C4 ' ' A' ' 2' ' ' ' A' . 0.0 OUTLIER -106.93 131.19 54.29 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.46 132.25 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.652 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.19 148.75 18.26 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 249' ' ' GLY . . . . . 0.852 ' H ' ' H3 ' ' A' ' 1' ' ' ' U' . . . 70.39 72.53 0.87 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.224 -1.162 . . . . 0.0 111.223 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' C' ' 251' ' ' GLY . 19.6 mt -118.34 145.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -1.057 . . . . 0.0 109.096 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 251' ' ' GLY . . . . . 0.584 ' O ' HG12 ' C' ' 254' ' ' VAL . . . -42.66 126.88 4.74 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.29 -40.76 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.822 1.681 . . . . 0.0 112.207 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 253' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' C' ' 254' ' ' VAL . 90.5 m-20 -95.17 6.31 49.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.376 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.596 HG22 ' N ' ' C' ' 255' ' ' ARG . 10.7 p -42.26 165.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.88 . . . . 0.0 109.982 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.596 ' N ' HG22 ' C' ' 254' ' ' VAL . 14.4 mtt180 -137.3 156.76 75.12 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.0 109.052 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.14 -28.14 48.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.467 2.111 . . . . 0.0 111.913 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -52.13 -64.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 258' ' ' GLU . . . . . 0.718 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.0 tp10 -59.77 -83.2 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.727 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 259' ' ' PHE . . . . . 0.608 ' C ' ' O ' ' C' ' 258' ' ' GLU . 75.9 t80 -12.67 -70.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.207 0.527 . . . . 0.0 111.45 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.31 -41.77 72.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.431 -0.793 . . . . 0.0 109.691 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 261' ' ' GLU . . . . . 0.718 ' N ' ' O ' ' C' ' 258' ' ' GLU . 44.3 tp10 -67.46 -46.69 72.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 262' ' ' PHE . . . . . 0.636 ' O ' ' HG2' ' C' ' 265' ' ' GLN . 60.3 t80 -49.68 -72.32 0.05 Allowed 'General case' 0 C--O 1.193 -1.907 0 O-C-N 121.573 -0.705 . . . . 0.0 110.512 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' C' ' 265' ' ' GLN . 88.4 m-85 -53.59 -45.1 69.89 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.044 -1.035 . . . . 0.0 112.083 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.502 ' C ' ' O ' ' C' ' 263' ' ' PHE . 0.3 OUTLIER -24.07 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' C' ' 262' ' ' PHE . 1.0 OUTLIER -48.41 -100.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.762 -1.212 . . . . 0.0 111.042 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.504 ' H ' ' HG3' ' C' ' 265' ' ' GLN . 1.7 p90 -60.77 148.71 38.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 267' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 51.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 86.2 m -49.77 141.71 9.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.289 . . . . 0.0 108.558 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.61 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -95.41 106.71 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.986 -1.071 . . . . 0.0 110.753 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 270' ' ' ILE . . . . . 0.475 HG22 ' N ' ' C' ' 271' ' ' ASP . 0.6 OUTLIER -70.13 -55.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.705 -1.247 . . . . 0.0 108.862 179.169 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 271' ' ' ASP . . . . . 0.475 ' N ' HG22 ' C' ' 270' ' ' ILE . 59.4 t0 -141.25 102.43 4.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 272' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' C' ' 273' ' ' GLN . . . -131.71 157.36 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 273' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' C' ' 272' ' ' ALA . 14.6 pt20 168.69 173.31 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.685 1.231 . . . . 0.0 111.796 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.505 HD22 HG13 ' C' ' 254' ' ' VAL . 10.4 tp -95.12 148.36 22.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 96.8 mmm -97.71 -172.55 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.448 -1.407 . . . . 0.0 110.933 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 175.29 88.56 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 277' ' ' ASP . . . . . 0.682 ' OD2' " H3'" ' A' ' 3' ' ' ' U' . 83.0 m-20 -84.34 47.5 1.35 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 278' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' C' ' 277' ' ' ASP . 15.6 pttp -40.41 -33.22 0.24 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -58.41 -37.12 74.68 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.356 -0.937 . . . . 0.0 108.484 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 280' ' ' THR . . . . . 0.597 ' N ' ' O ' ' C' ' 277' ' ' ASP . 0.4 OUTLIER -141.73 -79.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 281' ' ' GLY . . . . . 0.57 ' N ' ' OG1' ' C' ' 280' ' ' THR . . . -65.27 -165.34 1.26 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.0 tt0 -167.09 158.59 12.34 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.338 -1.095 . . . . 0.0 109.828 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 283' ' ' SER . . . . . 0.427 ' N ' ' HG2' ' C' ' 282' ' ' GLN . 1.0 OUTLIER -61.17 67.59 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.203 0.525 . . . . 0.0 109.774 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 284' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' C' ' 282' ' ' GLN . 60.8 ttm-85 -50.07 -24.74 2.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.86 22.93 0.26 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.571 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 23.0 p90 -111.36 173.36 6.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 110.668 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.93 36.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 288' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' C' ' 246' ' ' PHE . 21.8 m-85 -143.1 158.45 43.6 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.417 -1.637 . . . . 0.0 109.189 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 19.8 t -141.59 143.94 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.81 -1.181 . . . . 0.0 108.253 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 290' ' ' THR . . . . . 0.453 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 18.6 m -130.97 128.71 40.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.869 -1.144 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 291' ' ' TYR . . . . . 0.517 ' O ' ' O ' ' C' ' 242' ' ' THR . 42.0 m-85 -114.42 143.64 44.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 292' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER -62.48 -48.56 79.08 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 293' ' ' SER . . . . . 0.543 ' N ' ' CG ' ' C' ' 292' ' ' ASP . 12.4 m -73.93 132.93 42.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -76.33 -32.7 58.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -50.95 -38.48 50.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.702 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.44 -46.09 83.97 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 297' ' ' VAL . . . . . 0.45 HG13 ' CG2' ' C' ' 245' ' ' ILE . 40.5 t -56.99 -56.56 14.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -54.5 -21.39 9.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.585 -0.697 . . . . 0.0 109.79 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -75.07 -60.82 2.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.96 -27.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 109.684 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 301' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' C' ' 300' ' ' VAL . 26.8 t -43.74 -57.2 3.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.124 -0.985 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -51.71 -24.09 5.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 108.914 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' C' ' 300' ' ' VAL . 89.1 m-20 -99.55 91.39 4.87 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -75.95 -84.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.558 -1.339 . . . . 0.0 109.218 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 305' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' C' ' 313' ' ' ILE . 80.2 m-85 -66.59 124.93 24.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 79.8 mt -125.04 139.78 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.42 -0.8 . . . . 0.0 109.305 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -64.62 129.91 41.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.913 . . . . 0.0 109.741 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 87.8 t80 -137.31 171.41 14.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 0.0 110.713 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 31.7 ttmt -32.35 -71.18 0.06 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.115 0.483 . . . . 0.0 111.265 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 310' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.16 -71.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.49 -166.36 2.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.079 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -56.37 157.97 4.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.365 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.513 ' O ' ' CG1' ' C' ' 313' ' ' ILE . 2.1 pt -131.85 121.77 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.26 106.9 7.01 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.2 -0.938 . . . . 0.0 110.02 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.696 ' CG2' HD12 ' C' ' 245' ' ' ILE . 2.8 mm -79.71 154.0 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.047 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -157.27 157.49 34.32 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.836 -1.165 . . . . 0.0 109.01 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -67.65 143.88 55.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.668 -1.27 . . . . 0.0 109.254 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -84.92 44.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.006 -1.059 . . . . 0.0 109.939 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 319' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' C' ' 320' ' ' PRO . 0.3 OUTLIER -127.31 55.25 14.75 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 320' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 319' ' ' GLU . 54.1 Cg_endo -70.95 -63.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.873 2.382 . . . . 0.0 112.393 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 321' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -104.99 0.75 28.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.467 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.558 -179.474 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.761 " H4'" ' NH1' ' C' ' 284' ' ' ARG . . . . . . . . 0 O4'--C1' 1.439 2.079 1 C5'-C4'-C3' 107.807 -5.129 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.884 " H4'" ' CE1' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.444 2.519 1 C5'-C4'-C3' 108.327 -4.782 . 0.616 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 0.607 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 P--O5' 1.613 2.033 1 C5'-C4'-C3' 108.666 -4.556 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.712 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.445 2.571 1 C5'-C4'-C3' 107.442 -5.372 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.69 ' N3 ' ' O ' ' C' ' 201' ' ' GLY . . . . . . . . 0 O4'--C4' 1.421 -2.66 2 C3'-C2'-C1' 105.701 4.668 . 0.754 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 1.034 " H4'" " C5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.432 -1.773 1 C5'-C4'-C3' 108.535 -4.643 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 1.034 " C5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.616 2.301 1 C5'-C4'-C3' 107.232 -5.512 . 0.214 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.569 " O2'" " O5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.444 2.535 1 C5'-C4'-C3' 106.118 -6.255 . 0.621 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.764 ' N3 ' ' CE1' ' B' ' 71' ' ' PHE . . . . . . . . 0 C2'--C1' 1.498 -3.009 3 O4'-C1'-N19 116.428 8.228 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 1.142 " H5'" ' CE1' ' B' ' 71' ' ' PHE . . . . . . . . 0 P--O5' 1.627 3.386 0 O5'-C5'-C4' 115.605 3.86 . 0.021 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.893 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.614 2.066 2 C5'-C4'-C3' 108.244 -4.837 . 0.719 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.816 " O2'" ' H6 ' ' A' ' 13' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.431 -1.837 1 C5'-C4'-C3' 106.054 -6.297 . 0.523 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.816 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.439 2.053 1 C5'-C4'-C3' 107.585 -5.277 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.512 ' CB ' ' CD ' ' B' ' 24' ' ' PRO . 26.5 Cg_exo -57.92 -172.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.881 2.387 . . . . 0.0 111.877 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.543 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 52.4 Cg_endo -89.32 23.4 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.02 2.48 . . . . 0.0 112.163 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.29 120.59 5.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.101 -1.0 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.49 ' N ' ' OG ' ' B' ' 80' ' ' SER . 4.3 ttt85 -179.28 -45.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.59 HG11 ' O ' ' B' ' 102' ' ' SER . 2.0 p -139.0 158.61 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.081 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.587 HG13 HD13 ' B' ' 72' ' ' ILE . 7.1 p -120.98 142.16 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.74 ' CZ ' ' C2 ' ' A' ' 9' ' ' ' A' . 2.9 m-30 -105.32 141.48 36.75 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.512 ' O ' ' P ' ' A' ' 10' ' ' ' U' . 7.0 mt -129.26 117.21 20.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.478 -0.764 . . . . 0.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.52 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -132.95 -23.54 0.77 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.652 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -91.65 71.79 5.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.847 -1.384 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.577 HD12 ' N ' ' B' ' 33' ' ' ILE . 1.2 mp -145.74 125.18 6.81 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 109.829 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.585 ' C ' ' H ' ' B' ' 36' ' ' ASP . 29.7 Cg_endo -73.83 163.0 38.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.07 1.18 . . . . 0.0 109.935 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.451 ' OH ' ' CB ' ' B' ' 59' ' ' PHE . 4.7 m-85 -55.71 3.45 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 109.887 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' B' ' 34' ' ' PRO . 85.5 m-20 -66.17 -45.03 82.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.905 -1.122 . . . . 0.0 109.575 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.4 107.52 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -102.45 -153.25 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.466 -0.771 . . . . 0.0 111.53 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.43 ' N ' ' SD ' ' B' ' 57' ' ' MET . 1.1 pp20? -58.2 -23.69 56.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.69 -54.7 12.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.37 -38.76 88.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 110.845 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' B' ' 30' ' ' LEU . 24.7 mm -60.2 -51.53 71.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.8 -37.31 73.53 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -55.73 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.909 1.338 . . . . 0.0 109.377 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.637 HD21 ' CE2' ' B' ' 90' ' ' TYR . 14.4 tp -52.1 -48.84 64.54 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.417 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' B' ' 49' ' ' VAL . 94.9 m -60.26 -68.07 0.33 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.138 -0.976 . . . . 0.0 109.044 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.502 ' C ' ' H ' ' B' ' 49' ' ' VAL . 85.1 p -31.72 -33.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.979 0.419 . . . . 0.0 110.576 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' B' ' 46' ' ' CYS . 34.8 m120 -67.25 5.73 0.68 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.948 -1.095 . . . . 0.0 109.234 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 1.048 HG11 ' HB2' ' B' ' 83' ' ' ALA . 65.9 t -111.67 -55.06 4.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' B' ' 52' ' ' VAL . . . 174.63 154.24 10.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 52' ' ' VAL . 51.4 Cg_exo -44.76 80.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.308 2.006 . . . . 0.0 112.194 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' B' ' 50' ' ' GLY . 0.8 OUTLIER -39.37 157.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.828 . . . . 0.0 109.61 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' B' ' 75' ' ' ARG . 16.7 mm -87.56 -60.76 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.193 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.438 ' OD1' ' OE1' ' B' ' 73' ' ' GLU . 28.6 m120 -119.86 126.12 50.18 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.104 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -125.35 126.37 44.93 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -140.81 118.63 11.75 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.017 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.543 ' O ' ' N6 ' ' A' ' 12' ' ' ' A' . 0.1 OUTLIER -113.41 143.81 43.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.255 0.55 . . . . 0.0 109.901 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 58' ' ' MET . . . . . 0.616 ' CE ' ' C8 ' ' A' ' 11' ' ' ' A' . 0.0 OUTLIER -161.54 157.18 24.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.603 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -129.88 149.24 51.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.517 ' HB3' ' N ' ' B' ' 66' ' ' SER . 4.7 p30 -42.87 98.04 0.16 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 111.383 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 42.3 Cg_endo -92.5 -17.58 0.83 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 122.807 2.338 . . . . 0.0 111.54 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -87.42 -65.93 0.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 111.267 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 -34.71 9.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.181 -0.949 . . . . 0.0 111.367 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.465 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 108.07 30.41 3.94 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.043 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.461 ' C ' ' OD2' ' B' ' 60' ' ' ASP . 81.1 mtp180 -93.88 -71.0 0.68 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.297 . . . . 0.0 110.3 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' B' ' 60' ' ' ASP . 25.8 t -43.68 121.92 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -86.86 5.32 37.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.184 -0.948 . . . . 0.0 109.024 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.21 88.89 0.1 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 0.772 ' CG ' ' OP2' ' A' ' 10' ' ' ' U' . 1.9 m-85 -105.7 133.33 50.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.53 -0.983 . . . . 0.0 109.782 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.597 ' N ' ' OP1' ' A' ' 10' ' ' ' U' . . . -149.84 146.03 26.9 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.947 -1.095 . . . . 0.0 112.536 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 1.142 ' CE1' " H5'" ' A' ' 10' ' ' ' U' . 10.4 m-85 -114.51 130.11 56.72 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.705 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.929 HD12 ' N ' ' B' ' 72' ' ' ILE . 1.1 mp -121.93 102.33 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.35 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.438 ' OE1' ' OD1' ' B' ' 54' ' ' ASN . 29.4 mt-10 -93.05 136.71 33.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.252 -1.53 . . . . 0.0 110.244 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -98.32 176.53 5.67 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.853 0.835 . . . . 0.0 111.366 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 5.5 ttp180 -48.3 -42.01 29.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.858 -0.526 . . . . 0.0 111.42 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' B' ' 78' ' ' GLU . 3.5 m-20 156.62 -175.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.729 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.5 mm? -37.48 -23.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.655 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.8 mm-40 -70.24 -75.98 0.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.862 -1.149 . . . . 0.0 109.822 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 52.0 m -63.54 -40.59 97.41 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' B' ' 26' ' ' ARG . 25.7 t -58.92 -34.9 72.25 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -65.87 -61.29 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.676 -1.265 . . . . 0.0 109.031 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.602 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 22.0 t -60.21 -42.56 95.42 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.27 -0.894 . . . . 0.0 111.395 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 1.048 ' HB2' HG11 ' B' ' 49' ' ' VAL . . . -76.54 -65.66 0.9 Allowed 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.551 -0.718 . . . . 0.0 111.771 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -52.94 -37.84 27.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.296 -1.362 . . . . 0.0 109.212 -176.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.416 ' HA ' HD22 ' B' ' 88' ' ' ASN . 71.7 mtp85 -67.87 -47.47 68.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.365 -1.459 . . . . 0.0 108.382 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' B' ' 82' ' ' SER . 91.2 m-20 -67.5 -42.74 82.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.056 -1.028 . . . . 0.0 109.27 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.484 HD11 HG21 ' B' ' 49' ' ' VAL . 7.3 mt -106.35 28.72 7.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.333 -0.855 . . . . 0.0 110.084 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.69 ' O ' HD13 ' B' ' 97' ' ' LEU . 1.2 m-20 -61.51 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.82 -1.175 . . . . 0.0 109.188 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.68 107.77 0.86 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 1.051 ' CE1' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -134.1 148.81 51.05 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 119.677 1.739 . . . . 0.0 110.917 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' B' ' 90' ' ' TYR . 0.5 OUTLIER -46.25 91.59 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 119.876 -1.765 . . . . 0.0 108.456 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.1 tt -153.2 104.81 2.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.85 -175.39 43.47 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -67.12 -27.36 67.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.248 . . . . 0.0 109.617 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt85 -135.95 163.95 29.09 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.453 ' O ' ' C ' ' B' ' 97' ' ' LEU . 2.3 m-85 -92.69 133.99 35.47 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.31 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 1.051 HD11 ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -38.94 152.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.263 0.554 . . . . 0.0 109.562 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -108.46 146.84 32.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 109.268 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' CYS . . . . . 0.571 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.0 OUTLIER -91.9 124.78 36.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 109.781 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' B' ' 29' ' ' TYR . . . -137.17 -175.5 13.85 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.375 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 4.3 p90 -120.82 6.15 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -1.051 . . . . 0.0 110.562 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.59 ' O ' HG11 ' B' ' 27' ' ' VAL . 0.6 OUTLIER -39.92 125.05 1.87 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 0.0 109.913 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t -174.7 79.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.241 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -106.67 122.34 46.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 109.429 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.412 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 15.4 pttp . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -99.8 125.89 45.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.368 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m -134.95 150.01 50.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.563 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 159' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 1.0 OUTLIER -175.41 39.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.425 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 160' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 15.0 tttt -100.4 102.89 14.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 161' ' ' MET . . . . . 0.554 ' SD ' HG11 ' C' ' 216' ' ' VAL . 71.3 mtp -87.23 133.04 33.71 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.701 -1.199 . . . . 0.0 111.144 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.677 ' CZ ' ' C8 ' ' A' ' 6' ' ' ' A' . 76.9 t80 -104.77 90.69 3.56 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' C' ' 166' ' ' LEU . 5.6 mm -59.99 127.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 164' ' ' GLY . . . . . 0.438 ' HA2' ' C4 ' ' A' ' 5' ' ' ' U' . . . -130.34 -177.2 14.75 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.687 ' N ' ' O4 ' ' A' ' 5' ' ' ' U' . . . 42.84 41.1 4.33 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 166' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' C' ' 163' ' ' ILE . 13.5 mt -83.96 170.84 13.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -1.041 . . . . 0.0 109.725 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.478 ' O ' ' OD1' ' C' ' 167' ' ' ASN . 39.9 p-10 -85.45 140.21 30.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.712 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 2.1 m0 -48.95 -27.85 3.43 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.676 -1.265 . . . . 0.0 110.018 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 169' ' ' ASP . . . . . 0.444 ' O ' ' ND2' ' C' ' 167' ' ' ASN . 58.3 t0 -90.49 102.43 15.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.978 -1.076 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 33.0 m -147.2 144.51 28.98 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.46 173.5 6.38 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.222 -0.924 . . . . 0.0 109.142 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 172' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' C' ' 192' ' ' LYS . 11.5 mp0 -84.18 -77.04 0.28 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.799 -1.188 . . . . 0.0 109.587 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' C' ' 176' ' ' ARG . 49.5 t0 -49.08 -55.45 12.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.629 -1.295 . . . . 0.0 108.388 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 174' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' C' ' 173' ' ' ASP . 64.2 t30 -43.23 -53.18 5.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.93 -35.19 70.75 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.215 -0.928 . . . . 0.0 108.994 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 176' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' C' ' 178' ' ' TYR . 67.5 ttp85 -70.98 -63.52 1.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 108.904 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 177' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' C' ' 176' ' ' ARG . 77.3 mm-40 -43.78 -25.91 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.563 ' CE2' HD23 ' C' ' 223' ' ' LEU . 34.1 t80 -76.37 -47.05 24.69 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.557 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 176' ' ' ARG . 26.2 m-85 -95.7 15.85 18.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.257 -0.902 . . . . 0.0 111.655 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.17 14.44 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -106.13 9.73 32.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -1.077 . . . . 0.0 108.228 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 182' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 19.8 m-85 -121.61 -4.25 9.27 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 144.12 -134.69 5.86 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -126.69 145.65 50.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -1.041 . . . . 0.0 109.297 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' C' ' 188' ' ' LEU . 0.6 OUTLIER -99.76 134.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.189 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.413 ' N ' ' O ' ' C' ' 206' ' ' SER . 0.1 OUTLIER -78.52 -61.47 2.0 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.985 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 187' ' ' ASP . . . . . 0.589 ' OD2' ' NZ ' ' C' ' 189' ' ' LYS . 0.3 OUTLIER -121.22 84.79 2.29 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.329 1.061 . . . . 0.0 112.021 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.71 ' O ' HD23 ' C' ' 188' ' ' LEU . 7.1 tt -81.28 107.03 13.73 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 189' ' ' LYS . . . . . 0.589 ' NZ ' ' OD2' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -121.31 96.13 4.96 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.22 -0.925 . . . . 0.0 110.893 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 190' ' ' ILE . . . . . 0.562 ' O ' ' SD ' ' C' ' 191' ' ' MET . 0.0 OUTLIER -107.8 141.13 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 191' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' C' ' 190' ' ' ILE . 10.7 mmt -125.33 78.99 1.77 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.059 -1.026 . . . . 0.0 110.647 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 192' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' C' ' 172' ' ' GLU . 26.1 pttm -79.52 153.77 29.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.107 -0.995 . . . . 0.0 109.305 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 11.9 t0 -52.68 114.69 6.05 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.038 -1.039 . . . . 0.0 108.699 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.01 -21.54 4.02 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.827 1.685 . . . . 0.0 112.661 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -80.18 -86.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.24 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 45.5 p -109.35 -28.63 8.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.212 -0.93 . . . . 0.0 109.677 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 197' ' ' GLY . . . . . 0.527 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 122.28 17.63 3.59 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -90.79 58.47 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.072 -1.252 . . . . 0.0 109.519 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 199' ' ' SER . . . . . 0.477 ' O ' ' C ' ' C' ' 200' ' ' ARG . 39.4 t -142.99 169.83 16.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' C' ' 199' ' ' SER . 19.3 mmt180 -37.06 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 201' ' ' GLY . . . . . 0.69 ' O ' ' N3 ' ' A' ' 5' ' ' ' U' . . . -94.92 92.29 1.49 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.302 -1.427 . . . . 0.0 109.861 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.458 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 48.5 p90 -125.9 155.65 40.92 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.512 -0.993 . . . . 0.0 108.611 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.93 123.11 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.957 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -93.25 86.44 5.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.843 -1.387 . . . . 0.0 107.981 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.433 HD12 HD11 ' C' ' 163' ' ' ILE . 33.2 mt -87.49 85.27 7.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.727 -1.233 . . . . 0.0 110.321 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 206' ' ' SER . . . . . 0.553 ' CB ' ' H ' ' C' ' 187' ' ' ASP . 0.1 OUTLIER -65.47 85.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.596 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.527 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 14.5 m-85 -68.08 122.3 17.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.155 -0.966 . . . . 0.0 110.917 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.87 -50.32 36.44 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.788 -0.57 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -83.56 115.19 58.22 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 110.86 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.58 -38.22 44.53 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.186 1.924 . . . . 0.0 112.799 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 86.1 p -64.53 -49.95 69.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.854 ' O ' HG23 ' C' ' 216' ' ' VAL . 22.6 t -43.56 -33.21 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 109.224 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 213' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.17 -40.44 85.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.168 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 214' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' C' ' 211' ' ' SER . 57.6 t0 -59.68 -51.14 71.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.505 -0.747 . . . . 0.0 110.665 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 215' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' C' ' 219' ' ' THR . 5.5 pt-20 -68.17 -33.37 74.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.854 HG23 ' O ' ' C' ' 212' ' ' SER . 55.8 t -58.97 -47.99 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.009 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.441 HG12 ' O ' ' C' ' 214' ' ' ASP . 8.8 p -71.48 -30.04 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.1 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -89.71 21.53 3.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 109.742 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 219' ' ' THR . . . . . 0.578 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 41.3 m -129.82 149.43 51.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 220' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' C' ' 221' ' ' HIS . 13.1 tt0 -75.92 -177.85 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.125 -0.985 . . . . 0.0 109.392 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.781 ' HB3' HD11 ' C' ' 228' ' ' ILE . 55.3 m-70 -158.28 130.52 6.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 110.3 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.517 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 24.6 mt -153.35 80.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.737 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.563 HD23 ' CE2' ' C' ' 178' ' ' TYR . 16.5 mt -51.43 -71.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.735 -1.228 . . . . 0.0 109.54 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -101.51 -55.77 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 108.855 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 159.9 30.9 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 226' ' ' LYS . . . . . 0.911 ' NZ ' HG23 ' C' ' 280' ' ' THR . 0.0 OUTLIER -94.1 -76.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.107 -1.231 . . . . 0.0 108.601 178.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 227' ' ' VAL . . . . . 0.865 HG23 ' O ' ' C' ' 226' ' ' LYS . 2.1 t 155.39 90.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 228' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' C' ' 221' ' ' HIS . 23.2 pt -94.2 152.05 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.34 96.41 44.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.543 -0.723 . . . . 0.0 110.768 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 230' ' ' PRO . . . . . 0.508 ' CG ' ' CD2' ' C' ' 221' ' ' HIS . 18.9 Cg_endo -81.82 121.51 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.709 2.273 . . . . 0.0 111.645 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -142.52 148.26 37.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 0.0 110.127 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.52 159.36 0.51 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 233' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' C' ' 160' ' ' LYS . . . -57.5 144.28 37.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 234' ' ' ILE . . . . . 0.402 HG22 ' N ' ' C' ' 239' ' ' GLN . 38.4 mt -132.6 91.15 31.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.486 -0.759 . . . . 0.0 109.418 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.42 161.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.11 1.873 . . . . 0.0 111.742 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.665 ' NH2' ' P ' ' A' ' 6' ' ' ' A' . 0.0 OUTLIER -51.57 -49.2 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.975 . . . . 0.0 111.312 -178.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -59.66 -43.28 94.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.845 -1.159 . . . . 0.0 109.824 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -68.36 -36.91 79.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.131 -0.98 . . . . 0.0 110.001 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.402 ' N ' HG22 ' C' ' 234' ' ' ILE . 35.0 tt0 -61.17 -41.46 96.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.171 -0.956 . . . . 0.0 108.838 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 240' ' ' ASP . . . . . 0.438 ' HB2' HH21 ' C' ' 321' ' ' ARG . 22.9 t70 -83.3 -25.03 31.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.473 -0.767 . . . . 0.0 109.599 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -51.2 -16.11 0.45 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.692 . . . . 0.0 110.432 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 13.9 p -106.38 159.69 15.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.918 -1.113 . . . . 0.0 109.231 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -115.41 154.87 16.67 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 244' ' ' LYS . . . . . 0.569 ' N ' HH12 ' C' ' 317' ' ' ARG . 0.0 OUTLIER -140.05 147.28 40.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.268 . . . . 0.0 111.235 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.642 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -129.68 154.44 40.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.729 0.776 . . . . 0.0 109.142 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.635 ' CD2' ' N3 ' ' A' ' 2' ' ' ' A' . 2.0 t80 -102.19 128.19 48.81 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.75 143.64 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 110.368 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.9 154.21 16.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.0 56.26 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 120.939 -1.33 . . . . 0.0 111.209 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' C' ' 286' ' ' PHE . 1.5 pp -111.26 137.69 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.903 -1.351 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 251' ' ' GLY . . . . . 0.657 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 157.81 -37.8 0.54 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 252' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 50.0 Cg_exo -54.06 -127.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.512 2.142 . . . . 0.0 112.22 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -69.86 19.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 109.681 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' C' ' 252' ' ' PRO . 1.3 m -93.19 137.3 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.918 -1.114 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.633 ' CD ' ' N ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -103.45 163.07 18.19 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 256' ' ' PRO . . . . . 0.477 ' HB3' HD22 ' C' ' 274' ' ' LEU . 29.6 Cg_endo -63.59 -21.43 70.41 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.46 2.107 . . . . 0.0 111.372 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -62.25 -58.57 7.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.655 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.59 -41.72 86.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 259' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' C' ' 263' ' ' PHE . 29.0 t80 -52.6 -63.18 1.23 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.93 -43.43 98.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.911 -0.493 . . . . 0.0 110.28 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 261' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.97 -18.83 64.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.093 -1.005 . . . . 0.0 108.979 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 262' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' C' ' 265' ' ' GLN . 33.8 t80 -88.95 -77.75 0.37 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.234 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.575 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 43.2 m-85 -43.5 -36.26 1.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.928 -1.107 . . . . 0.0 109.494 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.499 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.8 t -30.72 -40.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.325 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.635 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 1.1 pt20 -60.76 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.429 -1.419 . . . . 0.0 110.981 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.635 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.2 OUTLIER -60.15 147.83 38.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.397 -1.439 . . . . 0.0 109.402 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 267' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' C' ' 269' ' ' ILE . . . 58.91 86.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 268' ' ' THR . . . . . 0.506 ' O ' ' C ' ' C' ' 269' ' ' ILE . 3.8 t -53.59 43.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.483 -1.01 . . . . 0.0 113.625 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.773 HD11 ' HB ' ' C' ' 289' ' ' VAL . 1.7 tt -13.77 111.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.9 mm -87.2 -33.95 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.439 -1.413 . . . . 0.0 107.81 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.04 99.1 5.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 272' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' C' ' 269' ' ' ILE . . . -108.32 132.78 53.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.321 -0.862 . . . . 0.0 109.371 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -160.59 123.56 3.34 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 117.919 -1.512 . . . . 0.0 112.081 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.961 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.2 OUTLIER -100.63 155.08 18.08 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 275' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' C' ' 280' ' ' THR . 20.8 mmt -90.08 161.24 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.398 . . . . 0.0 109.619 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' C' ' 280' ' ' THR . 1.0 OUTLIER -126.62 -165.41 1.45 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.494 0.664 . . . . 0.0 109.689 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 277' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' C' ' 277' ' ' ASP . 53.5 p30 -97.98 -9.97 25.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.448 -0.782 . . . . 0.0 109.339 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 278' ' ' LYS . . . . . 0.504 ' HG2' HD23 ' C' ' 276' ' ' LEU . 49.9 mmtt -60.6 -54.6 43.38 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 279' ' ' ASP . . . . . 0.806 ' N ' ' HZ1' ' C' ' 226' ' ' LYS . 0.2 OUTLIER 177.51 -6.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.598 -0.689 . . . . 0.0 110.895 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 280' ' ' THR . . . . . 0.911 HG23 ' NZ ' ' C' ' 226' ' ' LYS . 42.8 p -64.88 -3.14 3.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.446 -1.409 . . . . 0.0 108.708 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 281' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' C' ' 279' ' ' ASP . . . 155.04 -119.48 0.93 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.583 ' C ' ' H ' ' C' ' 284' ' ' ARG . 55.9 mt-30 -147.1 129.09 15.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 109.881 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 51.5 p -66.01 15.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 109.518 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 284' ' ' ARG . . . . . 0.761 ' NH1' " H4'" ' A' ' 1' ' ' ' U' . 10.1 tpp85 -49.86 -38.15 34.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.86 70.52 0.06 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.448 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.884 ' CE1' " H4'" ' A' ' 2' ' ' ' A' . 22.3 p90 -170.58 179.31 3.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.173 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -174.21 -167.48 33.79 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 288' ' ' PHE . . . . . 0.421 ' CZ ' ' H2 ' ' A' ' 2' ' ' ' A' . 1.4 m-85 -143.9 154.51 43.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.471 -1.605 . . . . 0.0 109.465 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 289' ' ' VAL . . . . . 0.773 ' HB ' HD11 ' C' ' 269' ' ' ILE . 0.7 OUTLIER -141.55 152.82 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 11.0 m -133.57 126.75 31.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.968 -1.083 . . . . 0.0 110.497 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 291' ' ' TYR . . . . . 0.46 ' CE2' ' CG2' ' C' ' 289' ' ' VAL . 49.8 m-85 -113.15 143.71 43.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.37 -50.84 71.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.298 -1.501 . . . . 0.0 109.064 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 16.6 t -91.29 171.19 9.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 294' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' C' ' 297' ' ' VAL . . . -105.29 -20.03 13.62 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 295' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 294' ' ' ALA . 91.5 m-20 -47.05 -39.63 13.28 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.43 -33.6 72.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 297' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' C' ' 294' ' ' ALA . 60.4 t -69.86 -63.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.06 -18.29 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.046 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 299' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' C' ' 297' ' ' VAL . 1.7 ttt85 -78.37 -57.39 3.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.485 -0.759 . . . . 0.0 109.004 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' C' ' 303' ' ' ASN . 3.3 p -65.76 -25.97 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 301' ' ' CYS . . . . . 0.437 ' C ' ' N ' ' C' ' 303' ' ' ASN . 33.5 m -44.77 -58.83 2.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.863 -1.148 . . . . 0.0 109.005 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 302' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' C' ' 301' ' ' CYS . 82.8 mt-30 -47.19 -23.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.011 . . . . 0.0 108.394 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' C' ' 300' ' ' VAL . 97.1 m-20 -100.16 70.75 1.56 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -68.93 -9.28 51.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.53 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 305' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' C' ' 314' ' ' GLU . 45.3 m-85 -137.53 122.26 18.69 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 0.0 108.832 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 306' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' C' ' 300' ' ' VAL . 54.2 mt -121.65 145.85 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.889 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -79.46 120.12 23.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 108.519 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 73.5 t80 -120.03 -179.1 3.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.641 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 33.0 ttpt -43.61 -30.13 0.57 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 310' ' ' ASP . . . . . 0.562 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 46.1 t0 -86.25 -154.23 0.21 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 311' ' ' ARG . . . . . 0.562 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 35.7 ptt180 -79.0 -48.11 15.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 109.041 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 312' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' C' ' 311' ' ' ARG . 6.5 ttmt -165.72 155.31 12.34 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' C' ' 250' ' ' ILE . 37.3 pt -131.2 157.68 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 314' ' ' GLU . . . . . 0.411 ' HG3' ' CE2' ' C' ' 305' ' ' PHE . 8.4 mp0 -110.43 152.54 26.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.959 . . . . 0.0 109.83 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.642 ' CG2' HD12 ' C' ' 245' ' ' ILE . 6.7 mm -119.38 142.26 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -145.93 144.23 30.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.192 -0.942 . . . . 0.0 108.859 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 317' ' ' ARG . . . . . 0.569 HH12 ' N ' ' C' ' 244' ' ' LYS . 20.9 tpt180 -70.64 135.51 48.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 318' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 319' ' ' GLU . . . -60.9 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 319' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' C' ' 317' ' ' ARG . 0.6 OUTLIER -44.64 -51.11 22.34 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 109.432 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 320' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' C' ' 319' ' ' GLU . 17.3 Cg_exo -64.35 135.8 48.07 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.887 1.725 . . . . 0.0 111.588 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 321' ' ' ARG . . . . . 0.438 HH21 ' HB2' ' C' ' 240' ' ' ASP . 80.2 ttt-85 -58.45 -38.33 77.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.966 . . . . 0.0 109.681 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 45.2 m80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.578 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.866 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.93 1 C5'-C4'-C3' 107.488 -5.342 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.866 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.437 1.889 2 C5'-C4'-C3' 107.291 -5.473 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 0.681 " O2'" " H4'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 P--O5' 1.61 1.67 1 C5'-C4'-C3' 105.886 -6.409 . 0.69 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.836 ' C6 ' ' CD1' ' C' ' 168' ' ' TRP . . . . . . . . 0 C2'--O2' 1.432 1.468 2 O4'-C1'-N19 113.325 5.125 . 0.069 2u . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.754 ' C2 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 O4'--C1' 1.446 2.676 1 C5'-C4'-C3' 108.748 -4.502 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 0.744 ' C5 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 P--O5' 1.616 2.327 1 C5'-C4'-C3' 107.07 -5.62 OUTLIER-EPSILON 0.644 1b . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 0.763 ' N3 ' ' CG ' ' C' ' 202' ' ' PHE . . . . . . . . 0 O4'--C1' 1.442 2.328 1 C5'-C4'-C3' 107.509 -5.327 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.723 " H4'" ' NH1' ' B' ' 95' ' ' ARG . . . . . . . . 0 O4'--C1' 1.439 2.112 2 C3'-C2'-C1' 105.638 4.598 . 0.01 6p . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 1.008 H5'' ' OH ' ' B' ' 69' ' ' TYR . . . . . . . . 0 P--O5' 1.613 2.044 2 O4'-C1'-N19 112.858 4.658 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 0.947 " H2'" ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.443 2.381 1 C5'-C4'-C3' 108.903 -4.398 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.947 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.442 2.309 1 C5'-C4'-C3' 106.131 -6.246 . 0.73 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.868 " H4'" ' NE ' ' C' ' 321' ' ' ARG . . . . . . . . 0 O4'--C4' 1.43 -1.918 1 C5'-C4'-C3' 106.961 -5.693 . 0.697 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.823 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 2.01 1 C5'-C4'-C3' 107.69 -5.206 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' B' ' 102' ' ' SER . 4.1 m-80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.34 147.03 87.2 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.46 2.107 . . . . 0.0 111.899 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.25 3.47 5.71 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.486 2.124 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.92 130.14 8.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.955 -1.091 . . . . 0.0 109.409 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.54 ' NH1' ' OD1' ' B' ' 76' ' ' ASP . 4.6 ttt85 -176.51 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -0.793 . . . . 0.0 109.249 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.69 HG12 ' H ' ' B' ' 102' ' ' SER . 1.6 p -140.85 165.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.1 t -124.9 144.64 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.723 ' CE1' ' C2 ' ' A' ' 9' ' ' ' A' . 5.7 m-85 -111.53 130.91 55.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' B' ' 72' ' ' ILE . 8.5 mp -115.98 105.33 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -103.21 -72.54 0.92 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.887 -1.149 . . . . 0.0 112.113 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.467 ' HG ' ' CB ' ' B' ' 94' ' ' SER . 8.5 t -68.85 86.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.332 . . . . 0.0 110.338 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' B' ' 30' ' ' LEU . 3.1 mp -147.38 126.09 6.23 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.73 165.96 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.721 1.614 . . . . 0.0 112.836 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -70.59 1.47 5.17 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.74 -34.28 77.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.77 112.26 19.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.103 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.5 p -107.2 -142.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.502 0.667 . . . . 0.0 110.891 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.63 -28.36 68.48 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.927 -1.108 . . . . 0.0 110.322 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.59 -53.98 16.24 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.078 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -68.84 -44.5 73.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.874 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' B' ' 44' ' ' ASP . 14.2 mm -59.79 -52.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.868 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 42' ' ' ILE . 0.7 OUTLIER -38.94 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.809 -0.557 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' B' ' 42' ' ' ILE . 97.4 m-20 -122.54 -23.71 5.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.658 -1.276 . . . . 0.0 110.552 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.739 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.0 tm? -59.25 -43.85 92.39 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.16 -1.588 . . . . 0.0 106.922 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.0 OUTLIER -82.14 -63.23 1.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.189 -0.944 . . . . 0.0 109.289 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.775 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.9 t -37.91 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.655 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.6 OUTLIER -51.81 67.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.441 1.115 . . . . 0.0 110.153 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.775 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.22 -34.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.278 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.66 -173.05 46.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.46 159.33 20.11 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 123.046 2.498 . . . . 0.0 112.535 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' B' ' 74' ' ' PHE . 20.8 t -129.4 145.96 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.558 HD11 ' HD2' ' B' ' 75' ' ' ARG . 43.3 mm -91.28 -67.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.054 . . . . 0.0 111.877 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.538 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 74.7 m-20 -117.72 146.28 43.86 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.079 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.576 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.6 OUTLIER -140.64 129.89 23.67 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.06 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.576 ' N ' HD23 ' B' ' 55' ' ' LEU . 8.8 mtmp? -143.29 147.92 35.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.884 -1.135 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 4.5 ttm -125.92 136.48 53.09 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' MET . . . . . 0.589 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -155.69 154.97 32.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.874 -1.141 . . . . 0.0 111.105 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.589 ' O ' ' SD ' ' B' ' 58' ' ' MET . 3.3 m-85 -111.43 176.4 5.04 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.616 -0.677 . . . . 0.0 110.167 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' B' ' 66' ' ' SER . 40.9 m-20 -114.24 84.9 9.77 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 0.0 110.901 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -60.82 -61.96 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.018 2.478 . . . . 0.0 113.136 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -81.62 -65.7 0.98 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.553 -0.717 . . . . 0.0 111.004 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.431 HG23 ' H ' ' B' ' 63' ' ' THR . 1.3 p -47.96 -45.13 30.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.113 -0.992 . . . . 0.0 109.135 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.92 12.21 81.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.649 ' NH2' ' C5 ' ' A' ' 10' ' ' ' U' . 78.5 mtm180 -59.52 -40.2 86.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.004 -1.292 . . . . 0.0 109.428 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.505 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -174.47 170.97 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.946 -1.096 . . . . 0.0 111.118 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 69' ' ' TYR . 37.9 mmtm -108.65 -68.09 0.93 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.266 -0.897 . . . . 0.0 110.437 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -60.32 68.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.138 0 O-C-N 120.595 -1.315 . . . . 0.0 111.571 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 1.008 ' OH ' H5'' ' A' ' 9' ' ' ' A' . 1.2 m-85 -106.96 125.82 51.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.688 -1.478 . . . . 0.0 109.18 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.21 140.0 32.19 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.499 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.803 ' CZ ' " H4'" ' A' ' 10' ' ' ' U' . 4.8 m-30 -106.5 123.56 48.27 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.736 ' CD1' HD13 ' B' ' 30' ' ' LEU . 3.4 mp -118.73 97.3 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.633 -0.667 . . . . 0.0 111.152 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.538 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 83.1 tt0 -84.48 131.06 34.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.437 -1.415 . . . . 0.0 110.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' B' ' 52' ' ' VAL . 6.6 m-85 -92.85 178.76 5.67 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.708 0.766 . . . . 0.0 111.056 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.558 ' HD2' HD11 ' B' ' 53' ' ' ILE . 10.4 tpt180 -52.16 -41.74 62.83 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.591 -0.693 . . . . 0.0 111.315 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.8 m-20 159.06 176.86 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.797 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.1 mp -36.63 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.816 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' B' ' 76' ' ' ASP . 50.1 mp0 -70.3 -74.74 0.13 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.389 -1.445 . . . . 0.0 108.459 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -61.78 -39.76 92.81 Favored 'General case' 0 C--O 1.195 -1.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' B' ' 26' ' ' ARG . 0.5 OUTLIER -64.07 -34.56 78.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.139 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -60.94 -61.72 2.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.485 -1.384 . . . . 0.0 107.746 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' B' ' 86' ' ' ASN . 23.3 t -62.77 -38.79 91.97 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.621 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.57 -64.83 1.08 Allowed 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 111.293 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' B' ' 99' ' ' CYS . 28.8 t -48.54 -41.03 11.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.655 -1.278 . . . . 0.0 108.538 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.57 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 61.7 ttm-85 -64.58 -49.14 72.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.938 -1.101 . . . . 0.0 109.237 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' B' ' 82' ' ' SER . 23.9 m120 -76.23 -46.39 28.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.23 -0.919 . . . . 0.0 109.907 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' B' ' 83' ' ' ALA . 3.7 mm? -86.8 15.91 5.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.46 -0.775 . . . . 0.0 110.44 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' B' ' 88' ' ' ASN . 0.5 OUTLIER -53.89 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.685 -1.26 . . . . 0.0 108.258 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.96 116.65 1.61 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -136.93 144.89 43.69 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.369 -1.665 . . . . 0.0 107.667 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -34.79 92.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.542 -0.724 . . . . 0.0 111.304 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 90' ' ' TYR . 61.2 tp -154.79 135.44 13.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.695 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.36 -162.39 10.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' SER . . . . . 0.467 ' CB ' ' HG ' ' B' ' 32' ' ' SER . 0.9 OUTLIER -88.0 -6.61 57.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.257 . . . . 0.0 109.344 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.723 ' NH1' " H4'" ' A' ' 8' ' ' ' A' . 37.8 ttm180 -134.56 160.28 38.55 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.502 ' O ' ' C ' ' B' ' 97' ' ' LEU . 57.1 m-85 -95.81 134.41 38.79 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.431 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.571 HD23 HD11 ' B' ' 30' ' ' LEU . 1.9 mp -31.76 150.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.408 ' HG2' ' C4 ' ' A' ' 8' ' ' ' A' . 1.3 mptp? -118.23 144.46 45.75 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' CYS . . . . . 0.558 ' O ' ' N1 ' ' A' ' 8' ' ' ' A' . 4.8 p -78.94 107.75 11.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.252 -0.905 . . . . 0.0 110.307 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -88.42 171.04 39.59 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.589 ' OH ' ' C6 ' ' A' ' 8' ' ' ' A' . 0.1 OUTLIER -156.15 92.82 1.37 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.1 -1.235 . . . . 0.0 108.066 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.69 ' H ' HG12 ' B' ' 27' ' ' VAL . 0.9 OUTLIER -27.22 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.778 0.799 . . . . 0.0 109.992 -178.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.43 ' N ' ' O ' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -133.24 -6.55 3.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.354 -177.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.14 -37.23 71.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.032 . . . . 0.0 109.631 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.439 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 156' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' C' ' 157' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 157' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' C' ' 156' ' ' LYS . 84.8 tt0 -57.96 -33.58 69.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 93.1 p -133.85 154.44 51.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.91 . . . . 0.0 109.727 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 6.9 m -78.19 66.67 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 108.742 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 16.3 tttt -108.29 89.41 2.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.551 -0.718 . . . . 0.0 110.418 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 161' ' ' MET . . . . . 0.505 ' SD ' ' CG2' ' C' ' 217' ' ' VAL . 14.0 mmm -64.31 140.63 58.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 110.501 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.754 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 5.6 t80 -103.76 132.76 49.71 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.51 ' O ' ' O2 ' ' A' ' 5' ' ' ' U' . 26.7 mm -114.02 128.01 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 164' ' ' GLY . . . . . 0.425 ' CA ' ' C2 ' ' A' ' 5' ' ' ' U' . . . -131.77 -173.68 13.41 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.347 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.96 22.23 2.87 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 166' ' ' LEU . . . . . 0.702 ' O ' ' H8 ' ' A' ' 4' ' ' ' A' . 3.0 mt -61.66 159.0 14.14 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.483 -1.01 . . . . 0.0 109.28 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.544 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 36.4 p-10 -80.31 167.3 20.42 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.174 -0.954 . . . . 0.0 108.851 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.836 ' CD1' ' C6 ' ' A' ' 4' ' ' ' A' . 0.5 OUTLIER -92.76 32.45 1.24 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.63 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.16 76.97 0.63 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.001 . . . . 0.0 110.332 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 170' ' ' THR . . . . . 0.408 ' HG1' ' CG ' ' C' ' 167' ' ' ASN . 84.7 m -150.7 147.46 27.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.961 -1.087 . . . . 0.0 110.078 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.13 172.51 6.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 172' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -69.66 -66.9 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.747 -1.221 . . . . 0.0 109.502 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 172' ' ' GLU . 57.4 t0 -43.94 -33.37 1.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.084 -1.01 . . . . 0.0 109.232 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -74.93 -49.49 20.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.125 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.57 -46.36 84.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.2 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 176' ' ' ARG . . . . . 0.559 ' CD ' HG11 ' C' ' 185' ' ' VAL . 21.9 ttp85 -63.23 -60.64 3.13 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.806 -1.184 . . . . 0.0 107.932 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 177' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' C' ' 176' ' ' ARG . 47.4 tp10 -41.94 -30.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.57 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 23.7 t80 -70.84 -53.85 13.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.038 -1.039 . . . . 0.0 108.826 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.81 ' O ' ' N ' ' C' ' 181' ' ' LYS . 72.5 m-85 -75.27 -62.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.35 -0.844 . . . . 0.0 110.192 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -41.61 2.79 0.01 OUTLIER Glycine 0 N--CA 1.503 3.154 0 O-C-N 120.555 -1.341 . . . . 0.0 112.381 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 181' ' ' LYS . . . . . 0.81 ' N ' ' O ' ' C' ' 179' ' ' PHE . 38.8 tttt -73.96 -15.1 61.12 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 182' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -77.46 -58.46 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.475 0.655 . . . . 0.0 110.017 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -156.61 -104.9 0.22 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 47.6 m -127.83 147.19 50.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.511 -0.994 . . . . 0.0 109.569 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.559 HG11 ' CD ' ' C' ' 176' ' ' ARG . 14.7 p -126.5 144.42 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' C' ' 208' ' ' GLU . 0.2 OUTLIER -91.06 -58.3 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.176 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 187' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' C' ' 206' ' ' SER . 43.8 t0 -156.86 160.76 39.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.814 HD23 ' H ' ' C' ' 188' ' ' LEU . 1.7 pt? -146.09 143.89 29.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.92 85.62 2.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.012 -1.055 . . . . 0.0 109.234 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.8 156.25 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 191' ' ' MET . . . . . 0.448 ' CB ' ' CZ ' ' C' ' 202' ' ' PHE . 6.3 tpp -142.31 55.84 1.45 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.022 -1.049 . . . . 0.0 110.486 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.74 117.5 15.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 108.887 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -135.42 80.36 45.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.383 -0.823 . . . . 0.0 109.906 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.16 -18.12 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.439 2.092 . . . . 0.0 110.914 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.72 ' O ' HG23 ' C' ' 196' ' ' THR . . . -65.5 -38.42 89.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 196' ' ' THR . . . . . 0.72 HG23 ' O ' ' C' ' 195' ' ' ALA . 5.8 p -165.81 -32.07 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.586 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 197' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 193' ' ' ASP . . . -102.64 100.31 1.95 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.398 -1.382 . . . . 0.0 109.842 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -103.26 133.77 47.78 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.453 -1.028 . . . . 0.0 109.557 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 199' ' ' SER . . . . . 0.629 ' O ' ' N1 ' ' A' ' 4' ' ' ' A' . 2.7 m -156.78 151.62 25.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 109.306 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.588 ' C ' ' O ' ' C' ' 199' ' ' SER . 94.0 mtt-85 -24.97 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 201' ' ' GLY . . . . . 0.446 ' HA3' ' C5 ' ' A' ' 4' ' ' ' A' . . . -80.9 120.58 5.18 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.151 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.763 ' CG ' ' N3 ' ' A' ' 7' ' ' ' U' . 50.8 p90 -165.03 164.66 20.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -140.86 125.5 2.85 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.582 -1.771 . . . . 0.0 110.41 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 204' ' ' PHE . . . . . 0.75 ' CE2' ' H5 ' ' A' ' 7' ' ' ' U' . 3.7 m-85 -89.98 65.65 6.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' C' ' 207' ' ' PHE . 0.7 OUTLIER -64.37 101.48 0.44 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.845 0.831 . . . . 0.0 112.606 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 206' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.3 OUTLIER -86.1 138.69 31.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.808 ' CE1' HD22 ' C' ' 205' ' ' LEU . 24.5 m-85 -118.05 144.01 45.94 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.537 -1.352 . . . . 0.0 109.694 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 208' ' ' GLU . . . . . 0.538 ' N ' ' OG1' ' C' ' 186' ' ' THR . 84.9 tt0 -68.36 -46.44 70.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -100.35 125.16 40.39 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.816 -1.178 . . . . 0.0 111.053 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 210' ' ' PRO . . . . . 0.904 ' O ' HG22 ' C' ' 213' ' ' VAL . 51.4 Cg_exo -45.74 -40.33 19.11 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.973 2.449 . . . . 0.0 114.223 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 97.8 p -61.34 -46.6 89.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.584 -1.322 . . . . 0.0 110.68 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.774 ' O ' HG23 ' C' ' 216' ' ' VAL . 29.6 m -39.33 -31.03 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 213' ' ' VAL . . . . . 0.904 HG22 ' O ' ' C' ' 210' ' ' PRO . 6.2 m -69.78 -34.52 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.21 . . . . 0.0 110.233 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 214' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' C' ' 218' ' ' LYS . 54.9 t0 -62.36 -49.17 76.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.32 -33.95 75.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 108.986 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.774 HG23 ' O ' ' C' ' 212' ' ' SER . 48.1 t -82.26 33.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.505 ' CG2' ' SD ' ' C' ' 161' ' ' MET . 21.1 t -154.58 -36.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.605 -0.684 . . . . 0.0 109.579 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.492 ' NZ ' ' OD1' ' C' ' 214' ' ' ASP . 2.2 ttmp? -92.67 23.87 3.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.644 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 219' ' ' THR . . . . . 0.796 ' O ' ' CE1' ' C' ' 221' ' ' HIS . 42.2 m -134.81 157.21 47.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -83.95 134.22 34.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 108.459 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.796 ' CE1' ' O ' ' C' ' 219' ' ' THR . 12.2 m80 -123.51 133.6 53.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.57 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -145.38 106.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 110.449 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' C' ' 178' ' ' TYR . 3.9 mm? -52.8 -65.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.635 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -126.26 24.15 6.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.23 15.07 42.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -80.93 -154.36 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -1.098 . . . . 0.0 108.51 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 227' ' ' VAL . . . . . 0.566 HG12 ' OE1' ' C' ' 273' ' ' GLN . 0.3 OUTLIER -132.32 97.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 228' ' ' ILE . . . . . 0.538 HD13 HD23 ' C' ' 223' ' ' LEU . 19.7 pt -107.56 153.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.622 -0.674 . . . . 0.0 109.579 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 229' ' ' ASP . . . . . 0.502 ' OD1' ' OD2' ' C' ' 271' ' ' ASP . 28.3 t0 -123.62 97.36 42.04 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.628 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 230' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -86.77 125.58 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.847 2.365 . . . . 0.0 111.928 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 231' ' ' LYS . . . . . 0.637 ' HG2' HD11 ' C' ' 234' ' ' ILE . 0.3 OUTLIER -145.82 142.39 28.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.99 . . . . 0.0 109.64 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' C' ' 233' ' ' ALA . 58.5 ttp180 -53.04 144.24 15.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 108.959 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 233' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -36.23 116.72 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 234' ' ' ILE . . . . . 0.73 ' H ' ' N6 ' ' A' ' 6' ' ' ' A' . 67.7 mt -99.25 134.95 20.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 0.0 109.486 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.42 149.61 62.94 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.125 1.883 . . . . 0.0 111.705 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -34.99 68.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.482 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.28 -45.57 80.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -71.23 -37.31 72.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 0.0 109.21 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.527 ' O ' ' OG1' ' C' ' 242' ' ' THR . 77.5 mt-30 -58.68 -35.27 72.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 108.727 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.53 -42.47 91.95 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.197 -0.939 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 241' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' C' ' 242' ' ' THR . 18.8 mttp -69.72 -51.79 31.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 242' ' ' THR . . . . . 0.537 ' C ' ' O ' ' C' ' 241' ' ' LYS . 0.1 OUTLIER -22.62 140.33 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.284 0.564 . . . . 0.0 111.403 -178.085 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -132.65 130.19 5.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 244' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' C' ' 318' ' ' ALA . 0.0 OUTLIER -132.27 138.61 47.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.971 -1.311 . . . . 0.0 110.406 178.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.419 ' CG2' HG13 ' C' ' 297' ' ' VAL . 2.5 pt -123.96 140.39 47.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.835 0.826 . . . . 0.0 108.906 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' C' ' 247' ' ' VAL . 10.8 t80 -70.85 158.23 36.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 247' ' ' VAL . . . . . 0.415 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 0.6 OUTLIER -138.27 133.88 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.852 . . . . 0.0 109.473 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.73 152.13 16.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.62 -29.16 12.78 Favored Glycine 0 N--CA 1.495 2.571 0 O-C-N 121.095 -1.238 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.402 HG22 ' CD2' ' C' ' 308' ' ' PHE . 1.2 pp -109.58 164.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.074 -1.251 . . . . 0.0 108.941 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 251' ' ' GLY . . . . . 0.65 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.71 -42.98 1.32 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 252' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 45.4 Cg_exo -56.16 -132.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.874 2.382 . . . . 0.0 112.378 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.79 -36.1 67.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -0.867 . . . . 0.0 110.575 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.531 ' CG1' ' OD2' ' C' ' 310' ' ' ASP . 13.7 m -55.92 127.46 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.0 109.47 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -90.65 160.66 38.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 256' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' C' ' 257' ' ' LYS . 17.0 Cg_endo -60.34 -26.26 82.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.97 2.447 . . . . 0.0 112.259 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 257' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' C' ' 256' ' ' PRO . 26.2 mtpp -45.32 -62.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 258' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.2 tp10 -60.9 -82.88 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.409 -0.917 . . . . 0.0 108.69 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 259' ' ' PHE . . . . . 0.606 ' C ' ' O ' ' C' ' 258' ' ' GLU . 1.1 t80 -10.98 -62.1 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 CA-C-O 121.438 0.637 . . . . 0.0 111.263 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 260' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 258' ' ' GLU . 87.7 tt0 -64.03 -48.53 75.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.27 -0.894 . . . . 0.0 109.523 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 261' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' C' ' 258' ' ' GLU . 0.0 OUTLIER -73.04 0.95 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 262' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' C' ' 264' ' ' SER . 0.7 OUTLIER -94.54 -74.24 0.55 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.496 ' O ' ' C ' ' C' ' 264' ' ' SER . 29.2 m-85 -42.19 -27.24 0.13 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.21 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.592 ' O ' ' N ' ' C' ' 266' ' ' TRP . 29.0 t -40.15 -41.64 1.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' C' ' 264' ' ' SER . 50.0 tt0 -39.79 -19.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.756 -0.59 . . . . 0.0 110.67 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.664 ' HE1' ' CG1' ' C' ' 300' ' ' VAL . 8.8 p90 -154.13 151.79 29.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.805 -1.185 . . . . 0.0 109.111 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 62.8 -172.4 10.44 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 268' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 3.4 t -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' C' ' 272' ' ' ALA . 5.0 mm -96.33 100.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.423 -1.311 . . . . 0.0 110.263 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 270' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 291' ' ' TYR . 1.4 mp -72.01 -57.71 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.634 -0.667 . . . . 0.0 110.372 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 271' ' ' ASP . . . . . 0.502 ' OD2' ' OD1' ' C' ' 229' ' ' ASP . 0.5 OUTLIER -129.61 106.53 8.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 272' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' C' ' 269' ' ' ILE . . . -120.87 142.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.903 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 273' ' ' GLN . . . . . 0.566 ' OE1' HG12 ' C' ' 227' ' ' VAL . 10.9 pt20 -171.53 136.75 1.0 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.637 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.536 HD13 ' HA2' ' C' ' 251' ' ' GLY . 3.6 pp -112.01 156.9 21.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 275' ' ' MET . . . . . 0.672 ' SD ' ' N ' ' C' ' 275' ' ' MET . 0.0 OUTLIER -99.4 168.67 9.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.717 -1.239 . . . . 0.0 109.533 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.621 ' O ' ' N ' ' C' ' 278' ' ' LYS . 1.6 pp -157.62 -178.37 7.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.924 . . . . 0.0 109.718 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 277' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' C' ' 283' ' ' SER . 55.7 t0 -64.96 44.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 109.047 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 278' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -48.5 -32.38 7.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 279' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 278' ' ' LYS . 6.8 m-20 -179.17 27.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 280' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' C' ' 280' ' ' THR . 0.0 OUTLIER -172.67 21.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.783 -1.198 . . . . 0.0 110.394 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 281' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' C' ' 277' ' ' ASP . . . 61.86 23.5 63.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' C' ' 284' ' ' ARG . 3.7 tp60 -50.65 -16.23 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -1.065 . . . . 0.0 109.076 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 283' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' C' ' 277' ' ' ASP . 0.3 OUTLIER -62.92 38.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.546 -0.721 . . . . 0.0 110.072 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 284' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' C' ' 282' ' ' GLN . 0.5 OUTLIER -46.61 -33.67 4.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.08 67.88 0.21 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.564 ' CE2' " H5'" ' A' ' 3' ' ' ' U' . 38.8 p90 -176.43 -171.23 0.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.88 -1.365 . . . . 0.0 109.604 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . 175.21 -165.54 36.61 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -142.13 154.87 45.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.296 -1.708 . . . . 0.0 108.978 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 289' ' ' VAL . . . . . 0.41 ' CG2' ' CE1' ' C' ' 291' ' ' TYR . 0.5 OUTLIER -131.42 145.64 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 290' ' ' THR . . . . . 0.467 ' O ' ' N ' ' C' ' 270' ' ' ILE . 32.3 m -133.05 123.67 26.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.509 -1.369 . . . . 0.0 109.997 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 291' ' ' TYR . . . . . 0.591 ' O ' HD13 ' C' ' 270' ' ' ILE . 33.4 m-85 -98.95 -80.27 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.293 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 292' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER 169.39 -56.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 O-C-N 120.631 -1.293 . . . . 0.0 108.009 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 293' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 58.6 p -93.82 172.66 8.11 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.17 -8.76 23.24 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.13 -52.4 65.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 108.618 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.52 95.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 108.485 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 297' ' ' VAL . . . . . 0.419 HG13 ' CG2' ' C' ' 245' ' ' ILE . 45.6 t -52.66 -57.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.186 -0.946 . . . . 0.0 108.611 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.07 -32.6 71.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.196 -0.94 . . . . 0.0 109.217 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.87 -62.07 2.08 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.664 ' CG1' ' HE1' ' C' ' 266' ' ' TRP . 0.2 OUTLIER -66.29 -31.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.497 -0.752 . . . . 0.0 110.203 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 301' ' ' CYS . . . . . 0.618 ' SG ' ' NH2' ' C' ' 317' ' ' ARG . 31.7 t -45.58 -52.13 11.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.674 -1.266 . . . . 0.0 108.817 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -50.88 -27.78 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.44 -0.788 . . . . 0.0 110.556 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' C' ' 303' ' ' ASN . 30.9 p30 -100.22 63.15 1.13 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.014 -1.054 . . . . 0.0 109.808 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 304' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' C' ' 303' ' ' ASN . 15.8 tttp -45.18 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.47 -1.394 . . . . 0.0 108.905 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 305' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' C' ' 314' ' ' GLU . 70.6 m-85 -67.28 127.83 34.11 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.32 -0.862 . . . . 0.0 109.497 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 306' ' ' ILE . . . . . 0.649 HG21 HD11 ' C' ' 315' ' ' ILE . 0.9 OUTLIER -135.92 154.19 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 108.949 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.0 128.6 33.47 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 34.3 t80 -118.07 173.62 6.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.511 -0.743 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.436 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.0 OUTLIER -56.11 -34.19 65.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.188 -0.945 . . . . 0.0 112.037 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 310' ' ' ASP . . . . . 0.531 ' OD2' ' CG1' ' C' ' 254' ' ' VAL . 15.6 m-20 -90.71 -71.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.734 -1.229 . . . . 0.0 109.942 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -148.06 -170.22 3.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 109.262 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -60.32 148.25 37.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.969 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.413 HG13 HG22 ' C' ' 306' ' ' ILE . 31.3 pt -132.27 153.74 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 314' ' ' GLU . . . . . 0.418 ' HG3' ' CE2' ' C' ' 305' ' ' PHE . 4.0 mp0 -111.44 110.17 20.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.003 -1.061 . . . . 0.0 110.842 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.649 HD11 HG21 ' C' ' 306' ' ' ILE . 59.6 mt -87.91 161.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.9 -1.125 . . . . 0.0 109.838 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 316' ' ' LYS . . . . . 0.422 ' N ' HG22 ' C' ' 315' ' ' ILE . 47.2 tttp -163.46 160.88 23.87 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.914 -1.116 . . . . 0.0 109.043 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 317' ' ' ARG . . . . . 0.618 ' NH2' ' SG ' ' C' ' 301' ' ' CYS . 62.5 mtt85 -71.76 146.25 48.22 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.699 -1.251 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 318' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' C' ' 244' ' ' LYS . . . -71.72 26.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 109.411 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 319' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' C' ' 317' ' ' ARG . 7.3 pt-20 -83.44 148.07 54.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.598 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.67 -27.0 45.52 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.413 2.075 . . . . 0.0 112.301 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 321' ' ' ARG . . . . . 0.868 ' NE ' " H4'" ' A' ' 12' ' ' ' A' . 75.0 ttt-85 -161.44 -70.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.467 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.536 ' N3 ' ' OE1' ' C' ' 314' ' ' GLU . . . . . . . . 0 O4'--C1' 1.44 2.208 1 C5'-C4'-C3' 107.625 -5.25 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.583 ' N6 ' ' O ' ' C' ' 319' ' ' GLU . . . . . . . . 0 O4'--C1' 1.438 2.001 1 C5'-C4'-C3' 108.042 -4.972 . 0.413 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 0.575 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.439 2.052 1 C5'-C4'-C3' 107.668 -5.221 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.716 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.44 2.151 1 C5'-C4'-C3' 107.278 -5.481 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.865 " H1'" ' O ' ' C' ' 201' ' ' GLY . . . . . . . . 0 O4'--C4' 1.424 -2.401 1 C3'-C2'-C1' 105.273 4.192 OUTLIER-DELTA 0.267 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 0.97 " H4'" " C5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.611 1.793 1 C5'-C4'-C3' 109.089 -4.274 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 0.97 " C5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.615 2.226 1 C5'-C4'-C3' 107.027 -5.649 . 0.225 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.481 " O2'" " O5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.433 1.605 1 C5'-C4'-C3' 106.564 -5.957 . 0.392 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.719 ' N3 ' ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 C2'--C1' 1.498 -2.984 2 O4'-C1'-N19 115.958 7.758 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 0.894 " H5'" ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 O4'--C4' 1.431 -1.844 2 C5'-C4'-C3' 107.549 -5.301 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 1.425 " H3'" ' N ' ' B' ' 69' ' ' TYR . . . . . . . . 1 O3'--C3' 1.494 5.087 1 C5'-C4'-C3' 108.97 -4.353 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 1.126 " H5'" ' O ' ' B' ' 67' ' ' LYS . . . . . . . . 2 P--O3' 1.706 8.226 2 O4'-C1'-N19 114.099 5.899 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.742 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.406 1 C5'-C4'-C3' 108.277 -4.816 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.734 ' N ' ' ND2' ' B' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.08 158.68 24.63 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.727 2.284 . . . . 0.0 112.208 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.47 20.2 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.848 2.365 . . . . 0.0 112.976 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.874 -1.141 . . . . 0.0 109.952 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.538 ' HE ' ' CB ' ' B' ' 103' ' ' SER . 5.3 ttp85 179.24 -45.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.636 HG22 ' HG3' ' B' ' 73' ' ' GLU . 10.3 t -122.56 155.02 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.637 HG22 HD13 ' B' ' 72' ' ' ILE . 0.2 OUTLIER -126.71 142.32 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.678 ' CE1' ' C2 ' ' A' ' 9' ' ' ' A' . 2.6 m-85 -114.98 141.81 47.47 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.072 -1.017 . . . . 0.0 110.547 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.605 ' HB3' HD11 ' B' ' 33' ' ' ILE . 1.7 mt -118.78 127.52 53.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.545 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -113.33 -50.39 0.54 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.639 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 9.7 p -88.76 115.38 26.26 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.743 -1.445 . . . . 0.0 107.731 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.609 HD12 ' C ' ' B' ' 32' ' ' SER . 4.2 mp -147.85 107.16 3.72 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.887 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' B' ' 36' ' ' ASP . 7.8 Cg_exo -63.01 159.23 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.629 1.553 . . . . 0.0 109.744 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.886 ' OH ' H5'' ' A' ' 12' ' ' ' A' . 6.2 m-30 -74.57 5.37 4.86 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 34' ' ' PRO . 27.0 t0 -62.03 -47.09 86.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.907 HE21 HD11 ' B' ' 92' ' ' LEU . 2.4 pm0 -120.12 109.13 15.08 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.872 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.545 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 45.8 p -100.14 -148.83 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.0 109.419 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.04 -26.39 67.59 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.14 -1.6 . . . . 0.0 110.902 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -73.17 -57.42 4.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.75 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' B' ' 36' ' ' ASP . 80.1 mt-30 -68.84 -44.17 73.97 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.972 -1.08 . . . . 0.0 109.231 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' B' ' 44' ' ' ASP . 2.4 mm -54.53 -54.77 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' B' ' 55' ' ' LEU . 45.6 tp -37.21 -19.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.9 t0 -123.86 -21.81 5.05 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.595 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.723 ' C ' HD13 ' B' ' 45' ' ' LEU . 3.2 tm? -62.97 -44.06 97.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.051 -1.656 . . . . 0.0 107.029 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' B' ' 48' ' ' ASN . 74.4 m -82.98 -65.45 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.155 -0.966 . . . . 0.0 108.739 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.839 ' O ' ' N ' ' B' ' 49' ' ' VAL . 4.6 t -37.24 -15.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.79 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.4 OUTLIER -50.23 56.45 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.483 1.135 . . . . 0.0 110.551 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.839 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.4 p 178.46 -34.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 121.426 -0.796 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.68 159.57 32.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' B' ' 52' ' ' VAL . 20.5 Cg_endo -65.24 86.47 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.525 2.15 . . . . 0.0 111.525 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.568 HG11 ' CG2' ' B' ' 72' ' ' ILE . 0.0 OUTLIER -40.09 153.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.633 0.73 . . . . 0.0 110.072 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' B' ' 73' ' ' GLU . 15.9 mm -77.05 -45.3 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.688 -0.632 . . . . 0.0 109.662 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' B' ' 53' ' ' ILE . 87.0 m-20 -146.89 152.68 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.362 -1.335 . . . . 0.0 111.678 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' B' ' 43' ' ' LEU . 42.5 tp -143.56 128.48 18.45 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -145.58 123.91 12.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.624 -1.297 . . . . 0.0 110.194 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 9.9 ttm -116.4 150.36 37.91 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.746 0.784 . . . . 0.0 111.138 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' MET . . . . . 1.09 ' C ' " H4'" ' A' ' 11' ' ' ' A' . 2.1 ttp -168.14 165.65 13.21 Favored 'General case' 0 C--O 1.282 2.781 0 O-C-N 121.383 -0.823 . . . . 0.0 109.498 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.823 ' HA ' " O3'" ' A' ' 11' ' ' ' A' . 0.0 OUTLIER -132.56 134.59 45.14 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 127.008 2.692 . . . . 0.0 110.214 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.597 ' H ' ' HA ' ' B' ' 67' ' ' LYS . 0.1 OUTLIER -42.05 105.39 0.4 Allowed Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 112.014 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -91.63 -66.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.796 2.331 . . . . 0.0 109.325 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -105.89 -25.45 12.13 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.583 ' OG1' ' C2 ' ' A' ' 11' ' ' ' A' . 80.5 p -46.41 -49.54 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' B' ' 60' ' ' ASP . . . 76.77 36.7 36.21 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.769 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.417 ' HB2' ' N1 ' ' A' ' 11' ' ' ' A' . 20.7 mtp180 -137.01 -76.92 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.718 -1.46 . . . . 0.0 110.142 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.797 ' O ' " H1'" ' A' ' 11' ' ' ' A' . 97.7 p -109.81 140.83 43.29 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.088 1.899 . . . . 0.0 111.538 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 1.126 ' O ' " H5'" ' A' ' 12' ' ' ' A' . 39.0 mttt -101.72 -5.49 24.89 Favored 'General case' 0 C--O 1.166 -3.332 0 CA-C-O 115.138 -2.363 . . . . 0.0 114.891 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 1.109 ' HA2' " O5'" ' A' ' 12' ' ' ' A' . . . -126.11 100.08 0.57 Allowed Glycine 1 N--CA 1.534 5.198 0 CA-C-N 123.356 2.798 . . . . 0.0 116.534 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 1.425 ' N ' " H3'" ' A' ' 11' ' ' ' A' . 3.1 m-85 -165.9 139.6 4.38 Favored 'General case' 0 N--CA 1.516 2.83 0 C-N-CA 115.329 -2.548 . . . . 0.0 114.127 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.68 142.99 28.43 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.134 -0.979 . . . . 0.0 110.973 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.894 ' CZ ' " H5'" ' A' ' 10' ' ' ' U' . 6.2 m-30 -107.83 132.86 52.98 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.183 0.992 . . . . 0.0 110.4 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.637 HD13 HG22 ' B' ' 28' ' ' VAL . 3.8 mp -115.27 146.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.636 ' HG3' HG22 ' B' ' 27' ' ' VAL . 83.9 tt0 -136.03 135.47 39.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.167 -1.583 . . . . 0.0 108.38 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.406 ' CZ ' HG13 ' B' ' 52' ' ' VAL . 13.3 m-85 -105.74 168.61 8.99 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.759 0.79 . . . . 0.0 110.845 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 47.6 ttp180 -53.75 -45.41 70.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.635 -0.666 . . . . 0.0 111.532 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.75 179.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.174 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.6 mm? -34.29 -24.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.851 -0.531 . . . . 0.0 111.142 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 91.9 mt-10 -71.05 -75.34 0.13 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.668 -1.27 . . . . 0.0 109.259 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.97 -41.56 98.14 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 84' ' ' VAL . 21.0 m -60.28 -37.54 80.8 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.836 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -61.1 -61.8 2.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.44 -1.413 . . . . 0.0 108.912 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.521 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 67.2 m -61.89 -43.24 99.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.723 0.773 . . . . 0.0 112.022 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.37 -64.93 1.05 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.427 -0.795 . . . . 0.0 111.031 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.442 ' O ' ' CA ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -50.63 -39.36 17.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.261 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.608 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 2.1 ttm-85 -66.86 -55.53 14.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.612 -1.305 . . . . 0.0 108.791 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' B' ' 82' ' ' SER . 46.9 m-80 -67.02 -43.91 81.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 109.68 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 83' ' ' ALA . 45.7 mt -105.6 41.67 1.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.411 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' B' ' 85' ' ' ARG . 0.0 OUTLIER -70.26 -75.16 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.98 117.88 1.73 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -139.87 147.54 40.8 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.549 -1.559 . . . . 0.0 107.819 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.592 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 4.2 mm100 -33.94 89.09 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.822 0.82 . . . . 0.0 111.184 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.907 HD11 HE21 ' B' ' 37' ' ' GLN . 51.3 tp -140.8 125.85 18.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.41 -157.05 4.01 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' SER . . . . . 0.606 ' N ' ' OG ' ' B' ' 32' ' ' SER . 2.3 p -83.36 -15.65 49.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.862 -1.376 . . . . 0.0 109.896 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.677 ' N ' ' OG ' ' B' ' 32' ' ' SER . 94.4 mtt-85 -131.23 155.87 46.35 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.8 m-85 -96.07 139.35 32.38 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.47 -0.769 . . . . 0.0 109.86 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.524 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -38.47 141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -114.2 147.53 38.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.112 -0.992 . . . . 0.0 109.867 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 17.9 p -88.02 115.61 25.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.679 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -108.52 177.23 20.59 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.469 ' O ' ' C ' ' B' ' 102' ' ' SER . 48.0 p90 -131.61 -17.57 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.555 -0.968 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.547 ' O ' HG21 ' B' ' 27' ' ' VAL . 8.3 t -38.02 99.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.108 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' SER . . . . . 0.538 ' CB ' ' HE ' ' B' ' 26' ' ' ARG . 60.0 p -93.91 159.17 15.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.436 ' CG ' ' H ' ' B' ' 105' ' ' SER . 39.2 t-20 -156.4 -137.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 0.0 109.284 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.436 ' H ' ' CG ' ' B' ' 104' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 157' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' C' ' 157' ' ' GLU . 0.0 OUTLIER -104.32 141.22 36.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.192 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 158' ' ' SER . . . . . 0.594 ' O ' ' N ' ' C' ' 160' ' ' LYS . 83.8 p -147.51 159.94 43.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.965 . . . . 0.0 109.553 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 159' ' ' CYS . . . . . 0.528 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 46.23 11.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.547 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 160' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' C' ' 158' ' ' SER . 14.5 tttp -94.75 137.82 33.36 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 161' ' ' MET . . . . . 0.693 ' SD ' ' N ' ' C' ' 162' ' ' PHE . 0.0 OUTLIER -114.9 152.58 32.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 108.986 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.711 ' CG ' ' C6 ' ' A' ' 6' ' ' ' A' . 55.2 t80 -119.4 72.94 0.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.607 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.749 HD12 HD21 ' C' ' 175' ' ' LEU . 54.5 mt -53.24 145.48 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.38 -177.43 15.98 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.772 ' H ' ' H3 ' ' A' ' 5' ' ' ' U' . . . 56.22 20.77 30.04 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 166' ' ' LEU . . . . . 0.567 ' O ' ' C8 ' ' A' ' 4' ' ' ' A' . 97.5 mt -60.97 163.7 5.63 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.364 -1.08 . . . . 0.0 108.776 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' C' ' 168' ' ' TRP . 11.5 p-10 -68.65 -75.71 0.1 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.056 -1.028 . . . . 0.0 108.918 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.725 ' HE1' HH21 ' C' ' 198' ' ' ARG . 0.1 OUTLIER 178.5 -24.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.872 -1.143 . . . . 0.0 109.784 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -133.01 91.46 2.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.975 . . . . 0.0 109.764 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 170' ' ' THR . . . . . 0.478 HG21 HD13 ' C' ' 175' ' ' LEU . 46.2 m -126.05 144.74 50.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.416 -0.803 . . . . 0.0 109.386 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.84 172.62 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.022 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 172' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' C' ' 176' ' ' ARG . 0.5 OUTLIER -75.14 -67.77 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.961 -1.087 . . . . 0.0 109.861 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -43.29 -33.45 0.99 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -74.92 -50.83 15.46 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 108.827 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.749 HD21 HD12 ' C' ' 163' ' ' ILE . 20.8 tp -52.67 -42.06 64.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.693 -0.63 . . . . 0.0 109.53 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 176' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' C' ' 179' ' ' PHE . 14.2 ptp180 -74.38 -57.3 4.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.511 -1.368 . . . . 0.0 108.866 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 177' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' C' ' 176' ' ' ARG . 54.0 mm-40 -37.71 -30.76 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.717 ' CD2' HD12 ' C' ' 223' ' ' LEU . 21.6 t80 -85.25 -39.85 17.29 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.103 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' C' ' 176' ' ' ARG . 22.6 m-85 -94.25 16.98 13.56 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.146 -0.971 . . . . 0.0 111.429 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.45 24.46 25.44 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 181' ' ' LYS . . . . . 0.696 ' NZ ' ' CZ ' ' C' ' 182' ' ' TYR . 3.6 ptmm? -104.52 16.41 26.15 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.35 -1.088 . . . . 0.0 108.814 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 182' ' ' TYR . . . . . 0.696 ' CZ ' ' NZ ' ' C' ' 181' ' ' LYS . 92.3 m-85 -119.21 -49.16 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.596 -0.69 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -164.88 -127.41 0.89 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 40.6 m -126.39 145.64 50.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.506 -0.996 . . . . 0.0 109.692 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.11 137.75 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.516 HG22 ' O ' ' C' ' 206' ' ' SER . 9.7 t -96.82 -37.0 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.81 -1.181 . . . . 0.0 110.111 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 187' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' C' ' 186' ' ' THR . 79.5 m-20 -149.0 149.17 30.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.938 . . . . 0.0 108.613 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.73 HD23 ' N ' ' C' ' 189' ' ' LYS . 7.7 tt -140.34 144.1 36.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.828 -1.17 . . . . 0.0 108.355 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 189' ' ' LYS . . . . . 0.73 ' N ' HD23 ' C' ' 188' ' ' LEU . 0.1 OUTLIER -126.08 129.95 50.13 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 190' ' ' ILE . . . . . 0.624 ' CD1' HD22 ' C' ' 175' ' ' LEU . 0.6 OUTLIER -147.75 121.47 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.789 -1.194 . . . . 0.0 108.778 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 191' ' ' MET . . . . . 0.559 ' SD ' ' O2 ' ' A' ' 7' ' ' ' U' . 4.3 ptp -176.2 158.18 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 108.765 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 192' ' ' LYS . . . . . 0.411 ' O ' ' OP1' ' A' ' 8' ' ' ' A' . 0.0 OUTLIER -164.56 -63.89 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.686 -1.259 . . . . 0.0 109.032 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.473 ' OD1' ' OG ' ' C' ' 199' ' ' SER . 0.2 OUTLIER -123.47 88.39 51.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.13 -20.86 8.26 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.356 2.037 . . . . 0.0 112.129 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.18 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.147 -0.971 . . . . 0.0 109.78 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 65.1 p -109.23 -8.66 15.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 197' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 81.22 15.64 76.27 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 198' ' ' ARG . . . . . 0.725 HH21 ' HE1' ' C' ' 168' ' ' TRP . 0.0 OUTLIER -97.68 73.22 2.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.258 . . . . 0.0 109.456 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 199' ' ' SER . . . . . 0.526 ' O ' ' C ' ' C' ' 200' ' ' ARG . 80.6 p -167.1 172.77 9.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' C' ' 199' ' ' SER . 0.0 OUTLIER -27.27 147.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.005 0.431 . . . . 0.0 110.137 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 201' ' ' GLY . . . . . 0.865 ' O ' " H1'" ' A' ' 5' ' ' ' U' . . . -131.5 158.82 22.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.661 ' CZ ' " H4'" ' A' ' 7' ' ' ' U' . 4.7 p90 -171.18 134.11 0.9 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.359 . . . . 0.0 108.614 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -112.12 132.95 11.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.09 114.13 27.17 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' C' ' 207' ' ' PHE . 0.5 OUTLIER -112.98 110.29 20.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.298 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 206' ' ' SER . . . . . 0.516 ' O ' HG22 ' C' ' 186' ' ' THR . 29.1 t -81.44 72.05 8.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.742 ' CZ ' HD13 ' C' ' 205' ' ' LEU . 27.3 m-85 -64.47 115.51 5.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.93 -38.43 90.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.18 108.74 30.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.006 -1.059 . . . . 0.0 110.44 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -52.1 -24.74 20.76 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.697 1.598 . . . . 0.0 112.5 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.507 ' O ' ' N ' ' C' ' 213' ' ' VAL . 22.9 t -66.95 -65.32 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.949 -1.094 . . . . 0.0 109.861 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.79 ' O ' HG23 ' C' ' 216' ' ' VAL . 51.0 m -40.75 -24.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.482 -0.761 . . . . 0.0 110.295 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 213' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' C' ' 211' ' ' SER . 95.0 t -69.13 -38.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 109.011 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 214' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.9 t0 -59.0 -49.41 77.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 110.094 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.08 -36.53 79.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.84 -1.162 . . . . 0.0 109.31 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.79 HG23 ' O ' ' C' ' 212' ' ' SER . 47.9 t -54.94 -47.91 75.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 110.024 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.13 -33.33 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -72.79 6.28 2.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 109.558 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 219' ' ' THR . . . . . 0.656 ' CG2' ' CE1' ' C' ' 221' ' ' HIS . 1.3 t -134.56 167.7 20.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.134 -0.979 . . . . 0.0 109.391 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -122.82 134.42 54.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.73 -0.606 . . . . 0.0 109.403 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.862 ' C ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -132.07 161.03 34.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.862 HD13 ' C ' ' C' ' 221' ' ' HIS . 0.4 OUTLIER -124.93 110.1 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 109.057 179.204 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.717 HD12 ' CD2' ' C' ' 178' ' ' TYR . 18.3 tp -75.14 -71.6 0.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 224' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 60.7 t0 -80.22 1.06 29.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.028 -1.045 . . . . 0.0 108.772 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.92 13.51 69.17 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' LYS . . . . . 0.702 ' HZ1' ' N ' ' C' ' 279' ' ' ASP . 0.0 OUTLIER -90.73 -83.28 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -1.075 . . . . 0.0 109.432 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 227' ' ' VAL . . . . . 0.587 HG22 ' O ' ' C' ' 227' ' ' VAL . 1.3 p 172.57 89.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.19 -0.944 . . . . 0.0 109.66 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 pt -94.63 152.02 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.396 -0.815 . . . . 0.0 110.34 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 229' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' C' ' 229' ' ' ASP . 0.0 OUTLIER -116.8 106.45 47.94 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 110.042 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 230' ' ' PRO . . . . . 0.44 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 42.7 Cg_endo -82.17 134.23 7.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.388 2.059 . . . . 0.0 111.819 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 231' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' C' ' 232' ' ' ARG . 11.8 ttmm -152.53 164.26 37.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.98 . . . . 0.0 109.673 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' C' ' 231' ' ' LYS . 56.7 ttm-85 -72.96 159.22 34.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 116.07 3.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.205 -0.934 . . . . 0.0 111.163 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 234' ' ' ILE . . . . . 0.628 ' O ' ' C6 ' ' A' ' 6' ' ' ' A' . 18.5 mt -156.91 91.67 2.45 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -40.15 137.78 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.601 1.534 . . . . 0.0 111.479 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.441 ' HG2' ' N7 ' ' A' ' 6' ' ' ' A' . 8.5 mmm-85 -55.69 -29.5 59.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.08 -45.13 79.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.65 -1.281 . . . . 0.0 108.663 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.88 -38.3 58.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' C' ' 242' ' ' THR . 4.2 tp-100 -57.92 -38.01 75.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.615 -0.678 . . . . 0.0 110.0 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -58.88 -22.59 59.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.867 . . . . 0.0 109.664 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 242' ' ' THR . . . . . 0.531 ' O ' ' O ' ' C' ' 291' ' ' TYR . 72.5 p -56.89 -36.67 70.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.13 3.22 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -138.58 138.15 37.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.025 -1.279 . . . . 0.0 110.855 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.746 HD12 ' CG2' ' C' ' 315' ' ' ILE . 3.8 pt -120.53 146.65 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.2 OUTLIER -86.54 160.37 18.98 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 247' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 28.4 t -134.11 131.17 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.56 -0.713 . . . . 0.0 109.092 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.01 147.53 18.51 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.51 5.25 79.14 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.553 HD11 ' HE2' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -111.12 133.06 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -1.058 . . . . 0.0 109.3 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 251' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.53 -36.35 2.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.727 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 252' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 32.0 Cg_exo -56.0 -30.0 76.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.397 2.064 . . . . 0.0 113.194 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -151.18 7.79 0.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.601 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.638 HG11 ' CE2' ' C' ' 308' ' ' PHE . 24.4 t -126.63 118.03 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 111.14 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.492 ' HA ' HD23 ' C' ' 274' ' ' LEU . 0.0 OUTLIER -102.26 169.79 7.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 256' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' C' ' 257' ' ' LYS . 0.0 OUTLIER -26.22 -50.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.312 2.675 . . . . 0.0 114.677 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 257' ' ' LYS . . . . . 0.498 ' O ' ' OE1' ' C' ' 261' ' ' GLU . 58.4 tttp -33.09 -84.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 258' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' C' ' 261' ' ' GLU . 27.4 tp10 -58.21 -76.79 0.04 OUTLIER 'General case' 0 C--O 1.194 -1.82 0 O-C-N 120.846 -1.159 . . . . 0.0 109.384 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 259' ' ' PHE . . . . . 0.632 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.0 t80 -12.16 -64.39 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 121.867 0.841 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 260' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' C' ' 258' ' ' GLU . 50.0 mt-10 -62.22 -49.39 75.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.96 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 261' ' ' GLU . . . . . 0.707 ' N ' ' O ' ' C' ' 258' ' ' GLU . 5.1 mp0 -71.27 2.79 4.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 262' ' ' PHE . . . . . 0.482 ' O ' ' CD ' ' C' ' 265' ' ' GLN . 6.1 t80 -98.21 -73.22 0.62 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.577 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 54.3 m-85 -50.52 -31.61 15.99 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.412 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.422 ' C ' ' O ' ' C' ' 263' ' ' PHE . 73.6 m -35.82 -38.34 0.12 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.605 -0.684 . . . . 0.0 112.445 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.482 ' CD ' ' O ' ' C' ' 262' ' ' PHE . 0.0 OUTLIER -54.75 -93.33 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.148 -1.595 . . . . 0.0 110.189 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.577 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -66.99 152.26 46.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.976 -1.078 . . . . 0.0 110.052 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 69.45 167.2 5.41 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 268' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 59.1 m -115.24 122.89 47.37 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' C' ' 272' ' ' ALA . 3.2 mp -104.87 107.91 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.43 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 270' ' ' ILE . . . . . 0.425 HD11 ' OD2' ' C' ' 292' ' ' ASP . 4.8 mm -77.15 -46.79 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 110.58 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -139.7 103.64 4.72 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.658 -1.276 . . . . 0.0 110.415 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 272' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' C' ' 269' ' ' ILE . . . -110.38 142.19 42.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.222 -0.924 . . . . 0.0 108.525 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -150.79 139.51 20.73 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.083 -1.447 . . . . 0.0 112.463 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 26.8 tp -122.96 141.24 52.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 275' ' ' MET . . . . . 0.863 ' C ' HD13 ' C' ' 276' ' ' LEU . 45.7 mmm -89.17 177.3 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.149 -1.595 . . . . 0.0 109.249 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 1.055 HD22 ' H ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -131.95 170.28 15.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.992 -1.067 . . . . 0.0 109.505 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 277' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 54.4 p30 -90.9 -11.48 39.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.424 -0.797 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 278' ' ' LYS . . . . . 0.625 ' C ' ' HZ1' ' C' ' 226' ' ' LYS . 19.8 tptm -62.46 -32.78 73.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 108.838 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 279' ' ' ASP . . . . . 0.702 ' N ' ' HZ1' ' C' ' 226' ' ' LYS . 34.2 p-10 -63.87 -44.38 93.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 280' ' ' THR . . . . . 0.655 HG22 ' C ' ' C' ' 279' ' ' ASP . 0.2 OUTLIER 177.34 5.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.099 -1.001 . . . . 0.0 110.172 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.08 57.0 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.557 ' HG2' HG23 ' C' ' 280' ' ' THR . 85.9 mm-40 -57.46 -34.24 68.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -1.197 . . . . 0.0 109.307 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 78.1 p -68.8 51.7 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.156 -0.965 . . . . 0.0 108.974 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 284' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' C' ' 282' ' ' GLN . 58.4 ttm-85 -49.59 -37.24 26.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 159.37 78.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.575 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 34.6 p90 -176.2 -174.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.271 . . . . 0.0 109.666 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -178.86 -170.97 41.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -147.97 152.26 37.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.22 -1.753 . . . . 0.0 108.877 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 94.2 t -130.6 145.61 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 15.5 m -128.55 130.45 47.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.814 -1.179 . . . . 0.0 110.453 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 291' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' C' ' 242' ' ' THR . 24.3 m-85 -113.37 153.33 28.72 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 292' ' ' ASP . . . . . 0.425 ' OD2' HD11 ' C' ' 270' ' ' ILE . 1.8 t0 -74.0 18.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.014 -1.054 . . . . 0.0 109.499 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 293' ' ' SER . . . . . 0.463 ' H ' ' C ' ' C' ' 291' ' ' TYR . 59.8 p -162.67 173.88 13.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.02 -7.99 15.27 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.27 -52.0 67.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.91 90.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.852 . . . . 0.0 108.768 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 297' ' ' VAL . . . . . 0.489 HG13 HG22 ' C' ' 245' ' ' ILE . 55.8 t -54.82 -57.38 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.23 -29.73 68.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -63.51 -63.75 1.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.124 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -63.71 -25.47 38.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.063 -1.023 . . . . 0.0 109.616 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 301' ' ' CYS . . . . . . . . . . . . . 45.3 t -45.18 -55.38 5.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 109.634 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 302' ' ' GLN . . . . . 0.585 ' NE2' ' OD1' ' C' ' 303' ' ' ASN . 0.0 OUTLIER -51.5 -24.98 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 108.051 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' C' ' 302' ' ' GLN . 97.1 m-20 -98.54 78.87 2.42 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -78.54 -8.97 59.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 110.48 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.06 120.19 19.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 108.952 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 306' ' ' ILE . . . . . 0.51 HD12 HD11 ' C' ' 315' ' ' ILE . 60.8 mt -123.96 154.88 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.802 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -90.08 116.07 27.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 108.704 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.638 ' CE2' HG11 ' C' ' 254' ' ' VAL . 7.4 t80 -121.0 179.48 4.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' C' ' 254' ' ' VAL . 35.7 mtmt -39.07 -62.72 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.005 -1.059 . . . . 0.0 110.881 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 310' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' C' ' 309' ' ' LYS . 93.0 m-20 -44.66 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.149 -0.97 . . . . 0.0 109.354 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -175.4 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -141.35 138.69 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 109.886 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.463 HD11 ' HB ' ' C' ' 306' ' ' ILE . 18.8 pt -126.27 151.43 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 314' ' ' GLU . . . . . 0.536 ' OE1' ' N3 ' ' A' ' 1' ' ' ' U' . 56.6 mt-10 -112.6 151.26 30.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.519 -0.738 . . . . 0.0 109.528 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.746 ' CG2' HD12 ' C' ' 245' ' ' ILE . 99.3 mt -125.84 154.72 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.514 -0.742 . . . . 0.0 109.126 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 316' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER 179.35 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.158 -1.589 . . . . 0.0 113.454 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 317' ' ' ARG . . . . . 0.616 ' O ' ' O ' ' C' ' 316' ' ' LYS . 77.8 mtm180 1.38 126.72 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.685 0 CA-C-O 121.778 0.799 . . . . 0.0 113.11 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 318' ' ' ALA . . . . . 0.414 ' N ' ' HA ' ' C' ' 245' ' ' ILE . . . -61.1 7.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.824 -1.173 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 319' ' ' GLU . . . . . 0.583 ' O ' ' N6 ' ' A' ' 2' ' ' ' A' . 3.8 mm-40 -57.44 154.01 25.54 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.952 . . . . 0.0 108.725 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -52.89 -85.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.252 1.968 . . . . 0.0 111.92 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 321' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -117.96 5.11 12.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 0.0 109.426 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 82.5 t60 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.523 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.916 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.932 1 C5'-C4'-C3' 107.802 -5.132 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.916 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.441 2.253 1 C5'-C4'-C3' 107.626 -5.249 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 0.46 " H5'" ' CE2' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.438 1.958 1 C5'-C4'-C3' 107.175 -5.55 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.714 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.438 2.012 1 C5'-C4'-C3' 106.757 -5.828 . 0.01 2u . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.775 ' H3 ' ' H ' ' C' ' 165' ' ' GLY . . . . . . . . 0 O4'--C4' 1.425 -2.306 1 C3'-C2'-C1' 105.512 4.458 OUTLIER-DELTA 0.348 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 1.045 " O4'" H5'' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O3'--C3' 1.454 2.187 2 O4'-C1'-N19 112.379 4.179 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 1.045 H5'' " O4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O3' 1.632 2.063 2 C5'-C4'-C3' 107.22 -5.52 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.757 ' OP2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.895 1 C5'-C4'-C3' 109.304 -4.131 . 0.817 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.919 " H4'" ' CE1' ' B' ' 69' ' ' TYR . . . . . . . . 0 P--O5' 1.611 1.829 2 C5'-C4'-C3' 108.335 -4.777 . 0.76 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 0.884 HO2' ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.439 2.045 2 C3'-C2'-C1' 106.222 5.247 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.884 ' H8 ' HO2' ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.438 1.996 1 C5'-C4'-C3' 106.165 -6.223 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.615 ' N6 ' ' SD ' ' B' ' 58' ' ' MET . . . . . . . . 0 O4'--C1' 1.433 1.603 1 C5'-C4'-C3' 106.607 -5.929 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.544 " O5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.861 1 C5'-C4'-C3' 107.573 -5.285 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' B' ' 23' ' ' PRO . 6.3 m120 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' B' ' 22' ' ' ASN . 5.8 Cg_exo -44.68 167.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.038 2.492 . . . . 0.0 112.188 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.86 2.78 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.989 2.46 . . . . 0.0 113.355 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 72.1 m -153.26 132.67 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.672 -1.267 . . . . 0.0 109.186 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.576 ' NE ' ' OD1' ' B' ' 76' ' ' ASP . 3.5 tpt180 -177.24 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.625 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' B' ' 100' ' ' GLY . 3.2 m -129.06 170.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.468 HG13 ' O ' ' B' ' 98' ' ' LYS . 3.8 t -127.2 143.25 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.705 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.708 ' CZ ' ' C2 ' ' A' ' 9' ' ' ' A' . 15.8 m-30 -110.5 122.4 47.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.269 -0.895 . . . . 0.0 108.973 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.568 ' C ' HD11 ' B' ' 33' ' ' ILE . 2.9 mm? -110.36 107.38 17.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.411 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -112.15 -16.03 9.36 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.485 ' CB ' ' H ' ' B' ' 95' ' ' ARG . 65.5 p -111.58 85.08 2.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 109.728 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.652 HD12 ' N ' ' B' ' 33' ' ' ILE . 0.8 OUTLIER -145.47 127.26 7.78 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' B' ' 36' ' ' ASP . 31.8 Cg_endo -72.89 151.65 51.09 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.255 1.303 . . . . 0.0 110.703 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -59.61 -0.11 0.16 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.105 -0.997 . . . . 0.0 109.045 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 34' ' ' PRO . 87.6 m-20 -64.28 -36.43 84.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.46 116.03 23.26 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.582 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.537 HG23 ' N ' ' B' ' 39' ' ' GLU . 9.9 t -111.92 -137.09 0.37 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.441 -0.787 . . . . 0.0 110.885 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.537 ' N ' HG23 ' B' ' 38' ' ' THR . 21.1 pt-20 -63.19 -28.93 70.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.658 -1.276 . . . . 0.0 110.743 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.62 -55.45 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.811 -1.18 . . . . 0.0 110.611 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -68.93 -43.7 74.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 111.064 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.558 ' O ' ' SG ' ' B' ' 46' ' ' CYS . 51.1 mm -63.44 -52.63 55.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 118.715 -1.194 . . . . 0.0 107.959 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' B' ' 39' ' ' GLU . 46.3 tp -39.71 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' B' ' 42' ' ' ILE . 24.7 t70 -124.97 -27.13 3.62 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.432 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.861 ' O ' HD12 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -58.68 -45.27 89.8 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.205 -1.559 . . . . 0.0 108.101 178.207 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.8 p -77.68 -60.78 2.23 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.815 -1.154 . . . . 0.0 107.982 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.834 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.3 p -37.33 -18.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.73 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' B' ' 46' ' ' CYS . 16.0 m-20 -47.75 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.405 0.622 . . . . 0.0 110.69 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.834 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.2 t 168.56 -32.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.23 165.24 37.65 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.236 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.87 91.48 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.047 2.498 . . . . 0.0 112.463 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.535 HG11 ' CG2' ' B' ' 72' ' ' ILE . 1.8 t -46.89 156.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 mm -100.4 -55.74 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.742 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 13.8 m-20 -118.3 127.85 54.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.314 -0.866 . . . . 0.0 111.317 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.91 130.14 48.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -139.79 125.39 19.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.808 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.8 tpt -105.93 129.4 54.08 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' MET . . . . . 0.659 ' HE1' ' C8 ' ' A' ' 11' ' ' ' A' . 0.0 OUTLIER -152.17 155.85 38.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.434 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.2 OUTLIER -113.03 179.93 3.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' B' ' 66' ' ' SER . 51.2 p-10 -102.75 74.52 0.18 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.15 -0.969 . . . . 0.0 110.75 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 28.6 Cg_endo -65.77 -60.1 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.966 1.777 . . . . 0.0 112.149 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.428 ' H ' ' H61' ' A' ' 11' ' ' ' A' . 30.9 tt0 -87.26 -50.01 6.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.936 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.534 HG21 ' C5 ' ' A' ' 10' ' ' ' U' . 30.3 p -57.47 -45.06 85.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.454 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.443 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 74.87 11.72 83.47 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.42 HH22 ' CZ ' ' C' ' 200' ' ' ARG . 10.8 mtp85 -66.02 -52.18 51.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.933 -1.334 . . . . 0.0 109.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.643 ' H ' ' HB3' ' B' ' 60' ' ' ASP . 8.0 t -156.02 145.24 20.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -0.988 . . . . 0.0 110.403 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -79.98 -5.87 56.5 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.735 -1.228 . . . . 0.0 109.465 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -127.94 88.52 0.33 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.093 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 0.919 ' CE1' " H4'" ' A' ' 9' ' ' ' A' . 1.5 m-85 -127.98 126.25 41.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.175 -1.191 . . . . 0.0 109.452 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.01 137.7 31.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.078 . . . . 0.0 110.088 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.802 ' CE1' " H5'" ' A' ' 10' ' ' ' U' . 4.9 m-30 -103.49 125.3 49.98 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.378 -0.827 . . . . 0.0 108.93 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.538 HD12 ' N ' ' B' ' 72' ' ' ILE . 3.7 mp -122.01 97.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.645 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 53.2 mt-10 -86.96 127.85 35.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.707 -1.246 . . . . 0.0 110.734 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -89.68 179.86 5.93 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.621 0.724 . . . . 0.0 110.579 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 0.1 OUTLIER -57.06 -42.45 80.59 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.593 -0.692 . . . . 0.0 110.374 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.662 ' O ' ' N ' ' B' ' 78' ' ' GLU . 4.2 m-20 158.76 177.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 0.0 109.018 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.758 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.6 OUTLIER -33.68 -24.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.919 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.662 ' N ' ' O ' ' B' ' 76' ' ' ASP . 10.6 mp0 -69.84 -73.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.387 -1.446 . . . . 0.0 108.891 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.9 m -62.97 -41.36 99.52 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.41 ' O ' HG23 ' B' ' 84' ' ' VAL . 1.3 m -59.6 -39.13 83.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.19 -0.943 . . . . 0.0 108.779 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -59.55 -61.21 2.79 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.141 0.972 . . . . 0.0 108.801 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.583 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 69.5 m -63.29 -39.7 95.31 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.579 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -79.6 -61.13 2.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.983 -1.073 . . . . 0.0 110.169 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.563 ' O ' ' CA ' ' B' ' 88' ' ' ASN . 26.7 t -51.19 -42.45 25.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.023 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -64.9 -56.57 12.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.411 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 82' ' ' SER . 8.7 m-80 -67.47 -43.8 80.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' B' ' 83' ' ' ALA . 51.0 mt -104.83 34.87 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.0 110.433 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.563 ' CA ' ' O ' ' B' ' 84' ' ' VAL . 0.2 OUTLIER -62.6 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.123 -0.986 . . . . 0.0 108.375 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.17 116.29 1.62 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -138.1 145.8 42.1 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.369 -1.665 . . . . 0.0 107.752 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 16.6 tp60 -30.9 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.668 -0.645 . . . . 0.0 111.286 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.564 HD22 HD21 ' B' ' 45' ' ' LEU . 11.3 tp -154.03 140.8 19.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.53 -171.63 0.1 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 47.2 p -67.94 -22.39 65.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' B' ' 92' ' ' LEU . 94.9 mtt180 -136.23 163.52 30.2 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.2 m-85 -93.04 141.68 28.13 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.257 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -37.4 136.99 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.468 ' O ' HG13 ' B' ' 28' ' ' VAL . 67.9 mmtt -108.4 147.77 31.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' CYS . . . . . 0.544 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 31.2 p -87.55 116.7 25.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' B' ' 27' ' ' VAL . . . -115.03 158.39 14.37 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.51 ' CB ' ' O ' ' B' ' 23' ' ' PRO . 1.8 p90 -136.97 113.87 10.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -1.113 . . . . 0.0 109.122 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 51.0 p -136.94 -84.41 0.34 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.253 -0.904 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 24.6 t -144.78 146.59 32.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.412 ' HB3' ' HE ' ' B' ' 26' ' ' ARG . 4.1 p-10 -113.07 17.14 19.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.468 -0.77 . . . . 0.0 109.281 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.625 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 65.2 tttt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -110.18 144.91 38.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 48.7 m -123.96 140.63 52.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 109.909 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 -1.98 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.79 140.08 32.7 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.015 -1.053 . . . . 0.0 108.936 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 24.8 ptm -123.32 155.61 36.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 109.345 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.717 ' CD2' ' C6 ' ' A' ' 6' ' ' ' A' . 72.1 t80 -111.29 77.95 1.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.709 HD11 HD13 ' C' ' 205' ' ' LEU . 60.8 mt -49.02 135.9 5.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 164' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' C' ' 229' ' ' ASP . . . -136.02 157.14 23.27 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.125 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.775 ' H ' ' H3 ' ' A' ' 5' ' ' ' U' . . . 76.02 20.65 77.43 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 166' ' ' LEU . . . . . 0.647 ' CB ' ' HZ1' ' C' ' 192' ' ' LYS . 83.0 mt -60.14 171.24 1.04 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.175 -1.191 . . . . 0.0 108.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.59 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 17.0 p30 -68.92 -79.95 0.05 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.017 -1.052 . . . . 0.0 109.309 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.714 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.0 OUTLIER 178.8 -24.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.78 -1.2 . . . . 0.0 110.192 179.201 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 169' ' ' ASP . . . . . 0.453 ' OD1' ' C ' ' C' ' 169' ' ' ASP . 19.6 t0 -135.03 93.53 3.02 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.016 -1.053 . . . . 0.0 110.623 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 170' ' ' THR . . . . . 0.586 ' H ' ' CD ' ' C' ' 192' ' ' LYS . 17.4 m -139.97 145.71 38.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.309 -0.869 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.82 167.21 10.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.951 -1.093 . . . . 0.0 109.348 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.28 -56.37 22.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -48.38 -40.82 26.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.996 -1.065 . . . . 0.0 110.818 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -74.85 -53.13 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 109.962 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.571 HD22 HD11 ' C' ' 190' ' ' ILE . 10.3 tp -53.02 -45.68 68.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 176' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' C' ' 177' ' ' GLU . 27.4 ttp180 -66.12 -60.28 2.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 177' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' C' ' 176' ' ' ARG . 61.3 mm-40 -40.97 -30.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.535 ' O ' ' NZ ' ' C' ' 181' ' ' LYS . 1.1 t80 -76.67 -48.68 18.22 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.354 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.863 ' O ' ' N ' ' C' ' 181' ' ' LYS . 24.5 m-85 -72.58 -58.46 3.35 Favored 'General case' 0 C--O 1.196 -1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -43.42 10.18 0.0 OUTLIER Glycine 0 N--CA 1.507 3.379 0 O-C-N 119.845 -1.785 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 181' ' ' LYS . . . . . 0.863 ' N ' ' O ' ' C' ' 179' ' ' PHE . 1.5 ttmp? -75.99 -18.35 59.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.726 -1.455 . . . . 0.0 107.689 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 182' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 3.2 m-85 -93.14 -58.73 2.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 109.708 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -144.54 -129.86 2.24 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 28.0 m -127.16 153.88 45.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.384 -1.068 . . . . 0.0 110.154 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.39 149.39 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.44 HG22 ' O ' ' C' ' 206' ' ' SER . 0.0 OUTLIER -90.02 -42.18 11.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.904 -1.123 . . . . 0.0 110.02 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -154.52 155.91 35.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.998 . . . . 0.0 109.319 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 1.059 HD12 ' N ' ' C' ' 189' ' ' LYS . 0.1 OUTLIER -147.15 139.62 24.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.652 -1.28 . . . . 0.0 107.809 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 189' ' ' LYS . . . . . 1.059 ' N ' HD12 ' C' ' 188' ' ' LEU . 5.9 tptp -127.61 133.85 49.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.878 -1.139 . . . . 0.0 109.64 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 190' ' ' ILE . . . . . 0.571 HD11 HD22 ' C' ' 175' ' ' LEU . 0.2 OUTLIER -127.62 156.24 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 108.521 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 4.0 tpp -139.84 42.3 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.022 -1.049 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 192' ' ' LYS . . . . . 0.647 ' HZ1' ' CB ' ' C' ' 166' ' ' LEU . 18.3 mttp -72.76 -163.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.982 -1.074 . . . . 0.0 109.432 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' C' ' 197' ' ' GLY . 0.9 OUTLIER -127.65 52.67 8.86 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.542 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 194' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 193' ' ' ASP . 83.9 Cg_endo -78.57 -4.42 14.11 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.823 2.349 . . . . 0.0 111.87 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.41 28.3 3.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.444 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 196' ' ' THR . . . . . 0.471 ' OG1' ' OD1' ' C' ' 193' ' ' ASP . 0.5 OUTLIER -153.37 -55.33 0.11 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.315 -0.866 . . . . 0.0 109.862 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 197' ' ' GLY . . . . . 0.58 ' N ' ' OD2' ' C' ' 193' ' ' ASP . . . 174.42 -100.94 0.15 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -136.08 136.83 40.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 109.488 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 199' ' ' SER . . . . . 0.515 ' O ' ' O ' ' C' ' 200' ' ' ARG . 9.3 t -153.36 170.61 20.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.263 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' C' ' 199' ' ' SER . 6.4 mmp_? -42.57 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 109.117 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 201' ' ' GLY . . . . . 0.435 ' HA2' ' HZ2' ' C' ' 192' ' ' LYS . . . -141.69 94.28 0.19 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.899 ' CZ ' " H4'" ' A' ' 7' ' ' ' U' . 21.0 p90 -137.94 167.78 21.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.36 136.13 8.19 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 119.061 -1.542 . . . . 0.0 109.66 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -105.43 102.88 12.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.709 HD13 HD11 ' C' ' 163' ' ' ILE . 0.5 OUTLIER -101.43 111.29 23.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.419 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 206' ' ' SER . . . . . 0.44 ' O ' HG22 ' C' ' 186' ' ' THR . 21.3 t -82.79 70.92 9.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.623 ' CE2' HD23 ' C' ' 205' ' ' LEU . 2.7 m-85 -60.01 117.98 5.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.63 -51.13 66.55 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.045 -1.035 . . . . 0.0 109.354 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' C' ' 211' ' ' SER . 50.5 mtpt -84.95 103.79 3.78 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.084 -1.01 . . . . 0.0 110.436 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.67 -15.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.823 1.682 . . . . 0.0 112.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.557 ' O ' ' N ' ' C' ' 213' ' ' VAL . 17.6 m -68.36 -69.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.855 -1.153 . . . . 0.0 109.898 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 211' ' ' SER . 0.0 OUTLIER -36.46 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.736 -0.603 . . . . 0.0 109.672 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 213' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' C' ' 211' ' ' SER . 88.4 t -65.63 -45.1 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 109.396 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 214' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -61.72 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.584 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.24 -39.33 86.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 108.965 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.696 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 15.2 t -64.85 -49.7 78.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.351 0.596 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.13 -31.17 52.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.585 -1.322 . . . . 0.0 109.488 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -81.12 -44.35 18.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.131 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 219' ' ' THR . . . . . 0.579 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 41.5 m -66.39 151.23 47.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.345 -0.847 . . . . 0.0 110.632 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -80.36 148.33 30.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.592 -0.692 . . . . 0.0 109.657 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.704 ' HB3' HD11 ' C' ' 228' ' ' ILE . 24.5 m-70 -132.84 132.74 42.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.222 -0.924 . . . . 0.0 110.623 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.2 86.61 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -55.15 -71.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 109.627 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 224' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 91.8 m-20 -96.2 7.64 45.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 109.126 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.52 12.28 61.3 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 226' ' ' LYS . . . . . 0.91 ' O ' HG13 ' C' ' 227' ' ' VAL . 0.4 OUTLIER -85.78 -86.06 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -1.089 . . . . 0.0 109.737 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 227' ' ' VAL . . . . . 0.91 HG13 ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 171.85 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.827 . . . . 0.0 109.641 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 228' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' C' ' 221' ' ' HIS . 15.4 pt -99.39 160.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.127 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 229' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' C' ' 164' ' ' GLY . 5.4 m-20 -126.76 102.17 25.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 111.016 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 230' ' ' PRO . . . . . 0.5 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 28.9 Cg_endo -83.28 137.29 8.17 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -164.05 168.66 18.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.912 -1.117 . . . . 0.0 109.804 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -58.64 156.07 11.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.986 . . . . 0.0 109.462 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 233' ' ' ALA . . . . . 0.4 ' O ' ' CG1' ' C' ' 234' ' ' ILE . . . -70.26 124.08 23.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 234' ' ' ILE . . . . . 0.629 ' O ' ' C6 ' ' A' ' 6' ' ' ' A' . 13.2 mt -158.71 108.92 1.62 Allowed Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.12 132.31 8.73 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.604 1.536 . . . . 0.0 111.82 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.438 ' NH2' ' H5 ' ' A' ' 5' ' ' ' U' . 5.3 tpp180 -55.47 -36.43 66.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.173 -0.955 . . . . 0.0 109.002 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 237' ' ' ASP . . . . . 0.406 ' OD1' ' CZ ' ' C' ' 321' ' ' ARG . 54.7 t0 -52.82 -40.89 63.69 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -70.17 -36.14 74.47 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.512 ' O ' ' OG1' ' C' ' 242' ' ' THR . 54.9 mm-40 -57.69 -38.48 75.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 108.896 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 240' ' ' ASP . . . . . 0.402 ' OD1' ' NZ ' ' C' ' 244' ' ' LYS . 87.2 m-20 -68.48 -37.67 80.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -60.94 -29.73 69.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 242' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 9.5 p -65.01 -21.71 66.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.968 -1.082 . . . . 0.0 110.09 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 110.35 102.66 2.72 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 244' ' ' LYS . . . . . 0.402 ' NZ ' ' OD1' ' C' ' 240' ' ' ASP . 4.3 ttpt -131.24 126.79 36.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.314 . . . . 0.0 110.223 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.489 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -113.86 141.82 28.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -87.33 164.9 16.0 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 247' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 58.8 t -136.69 131.53 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 248' ' ' GLY . . . . . 0.441 ' HA3' ' H3 ' ' A' ' 1' ' ' ' U' . . . -108.95 142.32 16.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 249' ' ' GLY . . . . . 0.637 ' O ' HG22 ' C' ' 313' ' ' ILE . . . 90.27 66.99 1.2 Allowed Glycine 0 N--CA 1.491 2.358 0 O-C-N 121.137 -1.214 . . . . 0.0 110.689 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' C' ' 285' ' ' GLY . 38.4 mm -114.2 133.82 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -1.19 . . . . 0.0 109.131 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.66 157.48 45.08 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.93 -22.82 55.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.823 2.349 . . . . 0.0 112.6 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -124.35 52.57 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.302 -0.874 . . . . 0.0 109.923 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.764 HG13 ' HG3' ' C' ' 309' ' ' LYS . 47.7 t -100.56 36.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' C' ' 254' ' ' VAL . 4.0 mtp85 -16.5 146.96 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.7 0 CA-C-O 121.384 0.611 . . . . 0.0 111.851 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 256' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' C' ' 257' ' ' LYS . 31.1 Cg_endo -57.95 -19.99 42.66 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.723 2.282 . . . . 0.0 113.048 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 257' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' C' ' 256' ' ' PRO . 54.0 tttm -46.51 -67.78 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 258' ' ' GLU . . . . . 0.744 ' O ' ' N ' ' C' ' 261' ' ' GLU . 23.8 mp0 -60.72 -91.46 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.71 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 259' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' C' ' 274' ' ' LEU . 56.7 t80 -6.1 -68.08 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 CA-C-O 121.179 0.514 . . . . 0.0 111.18 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 260' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 258' ' ' GLU . 83.4 tt0 -54.97 -48.02 73.78 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.617 0.723 . . . . 0.0 109.545 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 261' ' ' GLU . . . . . 0.744 ' N ' ' O ' ' C' ' 258' ' ' GLU . 82.1 tt0 -71.56 -45.04 63.41 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 262' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -49.84 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.61 -0.681 . . . . 0.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.528 ' O ' ' C ' ' C' ' 264' ' ' SER . 63.5 m-85 -45.3 -44.37 11.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.906 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.617 ' O ' ' N ' ' C' ' 266' ' ' TRP . 1.3 p -37.88 -36.64 0.2 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' C' ' 263' ' ' PHE . 23.4 tt0 -42.14 -9.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.946 -0.471 . . . . 0.0 111.872 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.617 ' N ' ' O ' ' C' ' 264' ' ' SER . 16.0 p90 -159.33 44.81 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.22 -1.55 . . . . 0.0 110.527 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 267' ' ' GLY . . . . . 0.448 ' O ' HD12 ' C' ' 269' ' ' ILE . . . 154.41 123.8 0.9 Allowed Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.294 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 27.8 m -56.78 140.4 47.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -1.153 . . . . 0.0 108.823 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.569 HG22 ' O ' ' C' ' 269' ' ' ILE . 1.1 mp -99.03 109.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 0.0 110.762 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.9 -50.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 109.877 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 271' ' ' ASP . . . . . 0.561 ' O ' ' C ' ' C' ' 272' ' ' ALA . 59.4 t0 -147.01 17.45 1.23 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.839 -1.163 . . . . 0.0 111.407 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 272' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' C' ' 271' ' ' ASP . . . -27.91 138.66 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.585 -0.697 . . . . 0.0 109.979 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -133.56 124.22 26.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.231 -0.918 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' C' ' 259' ' ' PHE . 1.4 tm? -121.43 129.37 52.95 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 275' ' ' MET . . . . . 0.765 ' N ' HD13 ' C' ' 274' ' ' LEU . 3.8 mmt -102.09 163.81 12.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.572 -1.33 . . . . 0.0 110.021 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.762 HD12 ' O ' ' C' ' 275' ' ' MET . 1.0 OUTLIER -144.07 -175.34 4.57 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.044 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -44.93 -86.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 109.689 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -107.77 -20.74 13.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 108.992 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 279' ' ' ASP . . . . . 0.753 ' O ' HG11 ' C' ' 227' ' ' VAL . 21.5 t70 -52.73 -26.94 15.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 280' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -143.37 -8.34 0.77 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.651 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.71 64.99 1.7 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' C' ' 276' ' ' LEU . 9.3 tp-100 -171.93 164.24 6.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -1.173 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 283' ' ' SER . . . . . 0.423 ' H ' ' H ' ' C' ' 284' ' ' ARG . 25.6 p -170.14 0.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.199 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 284' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' C' ' 283' ' ' SER . 46.7 mmt-85 -55.9 -31.2 62.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.373 -0.829 . . . . 0.0 109.661 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 285' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' C' ' 250' ' ' ILE . . . 106.81 20.64 8.72 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.184 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.46 ' CE2' " H5'" ' A' ' 3' ' ' ' U' . 26.8 p90 -109.84 175.81 5.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.068 -1.254 . . . . 0.0 110.203 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.49 -177.42 36.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -149.75 149.84 31.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.31 -1.7 . . . . 0.0 108.778 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 289' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' C' ' 291' ' ' TYR . 17.0 t -130.06 149.14 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 290' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 48.7 m -132.84 121.57 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.641 -1.287 . . . . 0.0 109.082 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 291' ' ' TYR . . . . . 0.507 ' CZ ' HG11 ' C' ' 289' ' ' VAL . 46.5 m-85 -116.22 137.4 52.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.204 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 292' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' C' ' 293' ' ' SER . 17.7 p-10 -62.35 -49.67 74.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 293' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 75.7 m -67.91 124.22 22.74 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -77.36 -27.05 52.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.086 -2.191 . . . . 0.0 105.086 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -51.46 -41.72 61.08 Favored 'General case' 0 C--O 1.206 -1.222 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.23 75.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.994 -1.066 . . . . 0.0 108.393 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 83.1 t -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.72 -29.56 53.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.66 -0.65 . . . . 0.0 109.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -71.69 -62.97 1.22 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -61.5 -24.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.628 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 301' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' C' ' 300' ' ' VAL . 1.3 m -43.98 -58.4 2.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -50.8 -26.86 6.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.081 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' C' ' 300' ' ' VAL . 34.1 t-20 -99.43 86.41 3.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 109.509 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 304' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' C' ' 314' ' ' GLU . 13.5 tttp -75.05 -84.31 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.695 -1.253 . . . . 0.0 108.561 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -58.74 127.62 33.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.198 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.1 tt -138.58 142.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.641 1.21 . . . . 0.0 110.18 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 307' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' C' ' 307' ' ' ASP . 47.3 p30 -68.65 142.13 55.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.866 0.841 . . . . 0.0 110.531 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.626 ' O ' ' N ' ' C' ' 310' ' ' ASP . 9.9 t80 -169.84 -174.07 1.74 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.764 ' HG3' HG13 ' C' ' 254' ' ' VAL . 37.0 mmtt -32.75 -30.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.556 -0.715 . . . . 0.0 110.217 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 310' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' C' ' 308' ' ' PHE . 92.6 m-20 -87.1 -84.74 0.18 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.07 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.015 -1.053 . . . . 0.0 110.556 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -168.75 49.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.988 -1.07 . . . . 0.0 109.342 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.637 HG22 ' O ' ' C' ' 249' ' ' GLY . 10.7 pt -49.92 138.55 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.766 0.793 . . . . 0.0 110.791 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 314' ' ' GLU . . . . . 0.55 ' HB3' ' HZ2' ' C' ' 304' ' ' LYS . 54.8 mt-10 -85.44 115.8 23.39 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.23 0.538 . . . . 0.0 110.527 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' C' ' 245' ' ' ILE . 83.8 mt -82.78 158.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 108.944 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 316' ' ' LYS . . . . . 0.413 ' N ' HG22 ' C' ' 315' ' ' ILE . 0.1 OUTLIER -166.58 165.95 16.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.511 -1.368 . . . . 0.0 109.659 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -78.8 140.45 38.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.625 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 318' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' C' ' 245' ' ' ILE . . . -70.79 -29.91 66.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.909 -1.119 . . . . 0.0 108.837 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 178.08 154.0 0.49 Allowed Pre-proline 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.29 136.8 27.27 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.078 1.852 . . . . 0.0 112.326 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 321' ' ' ARG . . . . . 0.406 ' CZ ' ' OD1' ' C' ' 237' ' ' ASP . 4.5 mtt-85 179.41 -29.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.199 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 17.7 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.569 179.809 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.708 " O2'" " H2'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.828 1 C5'-C4'-C3' 107.587 -5.275 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.765 " O2'" ' H6 ' ' A' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.115 1 C5'-C4'-C3' 108.023 -4.984 . 0.137 2z . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 0.786 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 P--O5' 1.613 1.966 1 C5'-C4'-C3' 108.214 -4.857 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.742 ' H8 ' ' O ' ' C' ' 166' ' ' LEU . . . . . . . . 0 O4'--C1' 1.439 2.044 1 C5'-C4'-C3' 106.623 -5.918 . 0.22 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.72 ' C2 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 O4'--C1' 1.446 2.67 0 C5'-C4'-C3' 109.622 -3.918 . 0.599 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 1.003 " C4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.616 2.252 1 C5'-C4'-C3' 108.64 -4.574 . 0.442 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 1.003 " H5'" " C4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.621 2.835 1 C5'-C4'-C3' 108.273 -4.818 . 0.195 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.643 ' N3 ' ' CD2' ' B' ' 29' ' ' TYR . . . . . . . . 0 O4'--C4' 1.428 -2.09 2 C5'-C4'-C3' 106.132 -6.245 OUTLIER-DELTA 0.303 2[ . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.921 " H1'" ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 P--O5' 1.612 1.899 2 C5'-C4'-C3' 108.737 -4.509 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 0.642 ' H6 ' " O5'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.614 2.088 1 C5'-C4'-C3' 108.234 -4.844 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.846 " O2'" ' H8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.925 1 C5'-C4'-C3' 106.937 -5.709 . 0.424 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.846 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.611 1.807 1 C5'-C4'-C3' 106.929 -5.714 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.516 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.927 1 C5'-C4'-C3' 107.571 -5.286 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.439 ' O ' ' CD2' ' B' ' 101' ' ' TYR . 6.6 Cg_exo -64.53 150.03 88.92 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.231 1.954 . . . . 0.0 112.303 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -85.09 26.35 0.65 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.559 2.173 . . . . 0.0 112.78 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.01 126.28 11.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.616 -1.303 . . . . 0.0 110.23 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -179.46 -49.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 109.24 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' B' ' 101' ' ' TYR . 3.0 p -125.04 154.91 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.832 0.825 . . . . 0.0 110.436 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.413 ' N ' HG22 ' B' ' 27' ' ' VAL . 3.0 t -108.06 139.52 29.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.693 ' CE2' ' C2 ' ' A' ' 9' ' ' ' A' . 5.1 m-85 -102.24 133.05 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.111 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' B' ' 72' ' ' ILE . 4.5 mp -116.96 121.28 40.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -114.61 -94.17 1.99 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.649 ' H ' ' NH1' ' B' ' 95' ' ' ARG . 2.7 p -69.04 110.7 4.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.75 -1.441 . . . . 0.0 110.36 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -160.74 127.37 2.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' B' ' 36' ' ' ASP . 51.7 Cg_endo -74.85 170.87 19.41 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.604 1.536 . . . . 0.0 112.61 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.589 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 3.8 m-30 -69.29 4.72 1.56 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.3 m-20 -60.26 -38.06 82.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.129 -0.982 . . . . 0.0 109.443 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.81 116.01 18.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 109.459 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.427 ' O ' HG12 ' B' ' 42' ' ' ILE . 82.2 p -113.02 -140.64 0.38 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.696 0.76 . . . . 0.0 111.631 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.401 ' CD ' ' C ' ' B' ' 39' ' ' GLU . 1.6 pp20? -61.46 -34.28 75.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.673 -1.267 . . . . 0.0 111.358 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -71.69 -53.95 11.87 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -44.1 79.56 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.385 -0.822 . . . . 0.0 110.189 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.584 ' O ' ' N ' ' B' ' 44' ' ' ASP . 30.6 mm -58.0 -51.62 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.808 HD13 ' O ' ' B' ' 43' ' ' LEU . 3.1 tm? -37.43 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' B' ' 42' ' ' ILE . 83.7 m-20 -124.7 -24.48 4.15 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.713 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.3 tm? -60.09 -41.18 91.94 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.214 -1.554 . . . . 0.0 107.472 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.621 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.4 m -87.65 -63.04 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.817 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.915 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.1 p -40.11 -19.96 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.779 -0.576 . . . . 0.0 109.896 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.671 ' O ' HG23 ' B' ' 49' ' ' VAL . 1.2 m-20 -42.69 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.117 0.96 . . . . 0.0 110.131 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.915 ' N ' ' O ' ' B' ' 47' ' ' SER . 0.9 OUTLIER 161.58 -28.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 47' ' ' SER . . . -169.37 123.16 1.06 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.424 -1.37 . . . . 0.0 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -48.14 100.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.579 1.52 . . . . 0.0 111.523 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.436 ' H ' HG13 ' B' ' 52' ' ' VAL . 0.8 OUTLIER -49.63 171.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.852 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.406 HD11 ' HG2' ' B' ' 75' ' ' ARG . 35.5 mm -107.47 -49.12 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 110.132 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.579 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 40.5 m-20 -118.35 139.17 51.76 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.103 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.558 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.6 OUTLIER -139.96 132.2 28.2 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.558 ' N ' HD23 ' B' ' 55' ' ' LEU . 21.4 tptp -137.26 121.5 18.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.045 -1.034 . . . . 0.0 109.678 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tpt -104.5 128.61 52.48 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.726 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' MET . . . . . 0.63 ' CE ' ' N7 ' ' A' ' 11' ' ' ' A' . 2.1 ttt -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.061 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.589 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 2.3 m-85 -104.11 -175.92 2.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' B' ' 66' ' ' SER . 49.8 m-20 -115.55 87.38 17.14 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.07 -1.019 . . . . 0.0 110.657 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.06 -60.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.485 2.123 . . . . 0.0 112.353 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' B' ' 63' ' ' THR . 14.8 tt0 -86.2 -62.1 1.59 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.446 HG23 ' H ' ' B' ' 63' ' ' THR . 5.2 p -45.24 -43.02 10.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.835 . . . . 0.0 108.91 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.41 18.26 76.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.547 ' CZ ' ' O4 ' ' A' ' 10' ' ' ' U' . 25.5 mmt85 -61.99 -42.02 98.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.979 -1.307 . . . . 0.0 109.516 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -179.86 179.15 0.58 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.978 -1.076 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -117.93 78.7 1.27 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.65 48.08 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 0.92 ' CE2' H5'' ' A' ' 9' ' ' ' A' . 3.9 m-30 -97.01 125.44 41.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.43 158.16 43.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 111.847 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.921 ' CZ ' " H1'" ' A' ' 9' ' ' ' A' . 5.7 m-85 -125.97 126.99 45.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.629 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.896 HD12 ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -118.06 98.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.724 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.579 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.8 tt0 -82.54 126.4 32.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.379 -1.451 . . . . 0.0 110.282 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -86.72 176.36 7.79 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.573 0.701 . . . . 0.0 110.038 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 58.3 mtp180 -56.63 -42.07 78.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.2 m-20 165.64 172.59 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.843 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.9 OUTLIER -38.07 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.062 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.1 mm-40 -74.43 -70.83 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.95 -1.094 . . . . 0.0 108.748 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 37.0 m -59.49 -45.02 92.89 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.66 -1.275 . . . . 0.0 107.691 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' B' ' 84' ' ' VAL . 8.6 t -62.68 -34.88 78.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 109.184 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.843 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -56.23 -59.36 5.05 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.124 -1.61 . . . . 0.0 107.231 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.457 ' O ' ' CG ' ' B' ' 86' ' ' ASN . 33.3 t -65.58 -38.95 91.0 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.501 ' N ' HG11 ' B' ' 49' ' ' VAL . . . -79.28 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.867 -1.146 . . . . 0.0 110.197 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -52.01 -42.91 35.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.861 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmt180 -66.82 -43.53 83.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.643 -1.911 . . . . 0.0 109.258 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.457 ' CG ' ' O ' ' B' ' 82' ' ' SER . 3.7 m-20 -68.59 -39.47 80.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 111.619 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.768 ' O ' HD11 ' B' ' 97' ' ' LEU . 7.9 mt -117.09 -4.05 11.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.927 -1.108 . . . . 0.0 111.254 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' B' ' 84' ' ' VAL . 0.0 OUTLIER -16.11 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.074 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.84 108.11 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -130.37 143.4 50.75 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.699 -1.471 . . . . 0.0 108.087 -179.258 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.568 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 16.7 tp60 -32.66 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.648 -0.658 . . . . 0.0 110.832 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 90' ' ' TYR . 5.3 tt -148.36 132.36 17.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.23 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.81 -157.94 1.58 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -21.18 52.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -1.125 . . . . 0.0 108.646 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.649 ' NH1' ' H ' ' B' ' 32' ' ' SER . 32.0 ttm105 -136.85 146.92 46.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 1.6 m-30 -93.1 143.92 25.77 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.511 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.768 HD11 ' O ' ' B' ' 87' ' ' LEU . 0.2 OUTLIER -46.68 157.69 0.14 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.174 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 147.97 42.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 109.888 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 17.2 p -77.2 121.46 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.412 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -135.89 174.56 21.32 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.515 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.505 ' HA ' HG12 ' B' ' 27' ' ' VAL . 7.1 t80 -147.69 125.25 11.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.571 -0.958 . . . . 0.0 109.784 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -137.84 101.64 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.651 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.04 127.73 0.16 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -113.35 137.44 51.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.481 -0.762 . . . . 0.0 109.289 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.503 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 5.9 tptm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -114.85 163.42 15.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.398 -0.813 . . . . 0.0 109.62 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 158' ' ' SER . . . . . 0.632 ' O ' ' N ' ' C' ' 160' ' ' LYS . 23.1 t -112.11 155.63 23.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.451 -0.781 . . . . 0.0 109.528 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 159' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' C' ' 213' ' ' VAL . 3.2 t -54.83 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 160' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' C' ' 158' ' ' SER . 11.3 tptp -88.21 136.17 33.1 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.611 0.72 . . . . 0.0 110.19 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 161' ' ' MET . . . . . 0.641 ' HE1' HG22 ' C' ' 217' ' ' VAL . 39.2 mmm -115.62 150.65 36.35 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.604 -0.685 . . . . 0.0 109.633 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.72 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 4.9 t80 -116.48 123.84 48.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.611 ' CG2' HD21 ' C' ' 166' ' ' LEU . 5.2 mm -105.1 133.61 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.09 171.19 21.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.555 ' O ' HG22 ' C' ' 228' ' ' ILE . . . 69.1 28.71 72.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 166' ' ' LEU . . . . . 0.742 ' O ' ' H8 ' ' A' ' 4' ' ' ' A' . 97.5 mt -77.2 150.69 35.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 110.536 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' C' ' 169' ' ' ASP . 0.4 OUTLIER -75.3 153.85 37.7 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.084 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.669 ' CH2' ' C2 ' ' A' ' 4' ' ' ' A' . 2.5 m0 -69.42 19.07 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.886 -1.134 . . . . 0.0 110.032 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 169' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' C' ' 167' ' ' ASN . 59.5 t0 -145.14 84.47 1.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.946 -1.096 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 170' ' ' THR . . . . . 0.583 ' OG1' ' NZ ' ' C' ' 192' ' ' LYS . 0.2 OUTLIER -146.61 119.96 8.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.17 158.55 15.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 0.0 109.465 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 172' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' C' ' 173' ' ' ASP . 87.9 mt-10 -61.7 -69.29 0.25 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.829 -1.169 . . . . 0.0 110.915 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' C' ' 172' ' ' GLU . 55.1 t0 -42.31 -36.61 1.3 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.684 -1.26 . . . . 0.0 109.818 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -47.85 14.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.412 -0.805 . . . . 0.0 109.69 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' C' ' 190' ' ' ILE . 7.6 tt -57.19 -42.26 80.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.034 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 176' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' C' ' 179' ' ' PHE . 70.8 ttp85 -67.34 -57.94 5.71 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 177' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' C' ' 176' ' ' ARG . 49.1 tp10 -39.75 -31.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.53 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 15.4 t80 -74.13 -49.39 23.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.725 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.891 ' O ' ' N ' ' C' ' 181' ' ' LYS . 28.9 m-85 -74.87 -62.94 1.37 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -39.43 4.19 0.0 OUTLIER Glycine 0 N--CA 1.508 3.457 0 O-C-N 120.345 -1.472 . . . . 0.0 112.38 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 181' ' ' LYS . . . . . 0.891 ' N ' ' O ' ' C' ' 179' ' ' PHE . 6.2 tttm -64.63 -28.57 69.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.779 -1.424 . . . . 0.0 107.839 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 182' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' C' ' 219' ' ' THR . 32.0 m-85 -78.39 -35.55 47.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.267 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.7 -126.1 0.88 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 41.3 m -129.28 154.92 46.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.61 HG12 ' CE1' ' C' ' 207' ' ' PHE . 1.1 m -120.44 159.7 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 108.978 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 186' ' ' THR . . . . . 0.492 ' O ' ' OD1' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -99.01 -43.92 6.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 110.248 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 187' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' C' ' 186' ' ' THR . 68.8 m-20 -151.93 147.57 26.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.833 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.737 HD23 ' C ' ' C' ' 188' ' ' LEU . 0.2 OUTLIER -141.73 146.21 35.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.934 -1.104 . . . . 0.0 108.486 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.3 123.2 29.5 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.978 -1.076 . . . . 0.0 109.88 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 190' ' ' ILE . . . . . 0.596 ' CD1' HD13 ' C' ' 175' ' ' LEU . 92.6 mt -134.75 121.63 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.478 -1.388 . . . . 0.0 108.169 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -114.66 44.49 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.865 0.841 . . . . 0.0 108.806 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 192' ' ' LYS . . . . . 0.583 ' NZ ' ' OG1' ' C' ' 170' ' ' THR . 4.5 ttmt -64.45 -162.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.428 ' H ' ' HG2' ' C' ' 192' ' ' LYS . 0.5 OUTLIER -134.25 66.64 71.57 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.767 -1.208 . . . . 0.0 110.696 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.35 -0.91 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.426 2.751 . . . . 0.0 110.889 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.36 15.86 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.343 0.592 . . . . 0.0 109.424 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.1 -59.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.2 -91.82 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -142.0 144.87 33.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.502 -0.999 . . . . 0.0 109.64 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 199' ' ' SER . . . . . 0.463 ' OG ' ' OP1' ' A' ' 8' ' ' ' A' . 42.2 t -161.86 160.58 28.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.48 ' O ' ' CD1' ' C' ' 202' ' ' PHE . 64.1 mmt-85 -47.75 114.38 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 109.122 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 201' ' ' GLY . . . . . 0.419 ' O ' " O4'" ' A' ' 5' ' ' ' U' . . . -83.42 113.05 3.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.603 ' CE1' " H4'" ' A' ' 7' ' ' ' U' . 16.0 p90 -141.31 153.27 45.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -1.163 . . . . 0.0 108.419 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -122.65 139.61 12.66 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.803 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -118.34 103.55 9.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.06 109.22 20.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.972 . . . . 0.0 111.016 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 206' ' ' SER . . . . . 0.527 ' HB2' ' HZ3' ' C' ' 160' ' ' LYS . 7.2 t -94.81 132.62 39.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' C' ' 185' ' ' VAL . 63.1 m-85 -116.21 143.43 45.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.924 -1.11 . . . . 0.0 109.559 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 208' ' ' GLU . . . . . 0.433 ' OE1' ' C ' ' C' ' 208' ' ' GLU . 1.7 tm-20 -68.15 -54.34 18.72 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.015 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' C' ' 210' ' ' PRO . 0.7 OUTLIER -91.16 108.22 26.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.968 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 210' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' C' ' 209' ' ' LYS . 2.2 Cg_endo -44.38 -20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.206 1.937 . . . . 0.0 113.683 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.574 ' O ' ' N ' ' C' ' 213' ' ' VAL . 11.3 t -61.83 -69.38 0.25 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.542 -1.349 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.679 ' O ' HG23 ' C' ' 216' ' ' VAL . 83.0 p -35.45 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.161 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 213' ' ' VAL . . . . . 0.595 HG21 ' SG ' ' C' ' 159' ' ' CYS . 0.4 OUTLIER -64.91 -37.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.0 109.229 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 214' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' C' ' 211' ' ' SER . 91.0 m-20 -63.68 -46.05 87.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 55.2 mp0 -68.76 -35.69 77.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.679 HG23 ' O ' ' C' ' 212' ' ' SER . 54.5 t -62.01 -52.62 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.641 HG22 ' HE1' ' C' ' 161' ' ' MET . 45.5 t -68.45 -38.79 79.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -73.31 -45.28 56.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.44 -0.788 . . . . 0.0 110.411 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 219' ' ' THR . . . . . 0.587 HG21 ' OH ' ' C' ' 182' ' ' TYR . 24.9 m -68.75 145.65 53.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.21 -0.931 . . . . 0.0 111.658 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -80.33 149.94 30.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.62 ' HB2' HD11 ' C' ' 228' ' ' ILE . 20.5 m-70 -127.68 132.19 49.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.53 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -142.56 103.21 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.326 -0.859 . . . . 0.0 109.678 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.516 ' N ' HD12 ' C' ' 223' ' ' LEU . 10.7 mp -73.02 -62.58 1.41 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.023 -1.048 . . . . 0.0 109.216 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -110.26 12.66 23.21 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 97.99 5.06 57.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -73.48 -171.61 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -1.084 . . . . 0.0 108.17 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.04 102.21 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 228' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' C' ' 221' ' ' HIS . 15.8 pt -102.13 151.55 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.478 -0.764 . . . . 0.0 108.955 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -119.27 107.27 41.65 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.354 -0.841 . . . . 0.0 110.888 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 230' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 95.9 Cg_endo -89.19 135.23 2.65 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 111.431 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 231' ' ' LYS . . . . . 0.584 ' NZ ' ' O4 ' ' A' ' 5' ' ' ' U' . 9.9 mtmp? -148.27 146.0 28.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.852 -1.155 . . . . 0.0 110.199 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' C' ' 233' ' ' ALA . 35.5 mtm105 -56.63 147.68 21.87 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 233' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.2 133.93 6.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.926 -1.109 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 234' ' ' ILE . . . . . 0.498 HD12 ' H62' ' A' ' 6' ' ' ' A' . 77.9 mt -109.86 124.15 34.36 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 109.667 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.15 142.42 4.07 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.939 1.759 . . . . 0.0 112.077 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.56 ' NH1' " O2'" ' A' ' 6' ' ' ' A' . 14.7 tpt180 -58.12 -43.68 87.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 110.688 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 237' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 29.7 p-10 -62.72 -39.26 93.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 238' ' ' GLU . . . . . 0.73 ' O ' HG23 ' C' ' 242' ' ' THR . 97.8 mt-10 -68.41 -41.84 79.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.692 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.615 ' NE2' ' N7 ' ' A' ' 6' ' ' ' A' . 4.5 tp-100 -65.44 -43.46 90.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.588 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -63.86 -41.57 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.887 . . . . 0.0 109.785 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -61.45 -47.18 86.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.746 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 242' ' ' THR . . . . . 0.73 HG23 ' O ' ' C' ' 238' ' ' GLU . 59.6 p -54.59 137.65 42.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.48 150.14 17.98 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -130.08 132.27 46.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -1.046 . . . . 0.0 109.983 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.949 HD13 ' O ' ' C' ' 245' ' ' ILE . 0.0 OUTLIER -121.15 156.59 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.572 -0.705 . . . . 0.0 109.148 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.684 ' CE2' ' C4 ' ' A' ' 2' ' ' ' A' . 0.0 OUTLIER -105.48 135.01 47.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.578 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.49 131.7 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.778 0.799 . . . . 0.0 110.082 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.69 145.93 16.21 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.34 64.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -129.73 154.85 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -1.076 . . . . 0.0 109.198 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 251' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 130.53 -39.6 1.78 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.629 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 252' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 87.6 Cg_exo -48.62 -120.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.612 2.208 . . . . 0.0 112.963 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -81.42 17.79 1.29 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' C' ' 308' ' ' PHE . 41.3 t -89.68 140.56 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.963 -1.086 . . . . 0.0 109.97 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -104.95 154.81 38.4 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.91 -24.89 74.2 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.157 1.905 . . . . 0.0 112.345 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -51.17 -64.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.714 -0.616 . . . . 0.0 109.697 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 258' ' ' GLU . . . . . 0.68 ' O ' ' N ' ' C' ' 261' ' ' GLU . 33.8 tt0 -61.16 -78.17 0.04 OUTLIER 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.176 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 259' ' ' PHE . . . . . 0.655 ' C ' ' O ' ' C' ' 258' ' ' GLU . 59.7 t80 -11.93 -65.74 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 121.52 0.676 . . . . 0.0 110.082 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 260' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' C' ' 258' ' ' GLU . 2.9 tm-20 -59.9 -45.73 91.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.574 -0.704 . . . . 0.0 110.799 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 261' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' C' ' 258' ' ' GLU . 63.2 mm-40 -71.89 -17.3 62.12 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.985 -1.072 . . . . 0.0 108.892 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 262' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' C' ' 263' ' ' PHE . 4.6 t80 -78.96 -80.52 0.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' C' ' 265' ' ' GLN . 31.0 m-85 -38.25 -42.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.235 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.615 ' N ' HD11 ' C' ' 269' ' ' ILE . 73.0 p -30.82 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.609 ' N ' ' O ' ' C' ' 263' ' ' PHE . 49.7 tt0 -45.26 -23.07 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.822 -0.549 . . . . 0.0 110.969 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.564 ' CZ2' ' CD2' ' C' ' 263' ' ' PHE . 8.2 p90 -151.58 151.1 31.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.644 -1.285 . . . . 0.0 109.246 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 82.08 176.3 51.12 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 268' ' ' THR . . . . . 0.511 ' O ' ' C ' ' C' ' 269' ' ' ILE . 43.1 p -115.35 19.61 15.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.733 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.615 HD11 ' N ' ' C' ' 264' ' ' SER . 0.0 OUTLIER -15.35 104.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 41.5 mm -83.4 -34.16 10.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -132.86 97.2 3.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -108.99 131.47 55.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.442 -0.786 . . . . 0.0 109.158 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -160.94 129.91 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.422 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.717 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.4 OUTLIER -97.12 157.89 15.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 275' ' ' MET . . . . . 0.708 ' O ' HD22 ' C' ' 276' ' ' LEU . 0.5 OUTLIER -93.76 168.19 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.316 -1.49 . . . . 0.0 109.336 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.708 HD22 ' O ' ' C' ' 275' ' ' MET . 0.2 OUTLIER -150.35 -155.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 277' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' C' ' 279' ' ' ASP . 77.2 m-20 -54.16 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.463 -0.773 . . . . 0.0 110.447 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 278' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' C' ' 278' ' ' LYS . 0.0 OUTLIER -49.46 -8.15 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.298 -0.876 . . . . 0.0 110.146 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 279' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 277' ' ' ASP . 85.3 m-20 -59.61 -66.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 110.073 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 131.89 43.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 56.53 -124.5 35.22 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.557 ' C ' ' H ' ' C' ' 284' ' ' ARG . 57.0 tt0 -146.95 147.2 30.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.235 -1.156 . . . . 0.0 110.136 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.23 21.73 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 284' ' ' ARG . . . . . 0.569 ' HD2' H5'' ' A' ' 2' ' ' ' A' . 0.1 OUTLIER -51.47 -33.3 30.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.664 -1.272 . . . . 0.0 108.016 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 285' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' C' ' 250' ' ' ILE . . . 117.34 69.62 0.4 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.786 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 32.6 p90 -162.18 175.01 12.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.609 . . . . 0.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -154.63 178.8 31.18 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.071 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 288' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' C' ' 246' ' ' PHE . 7.8 m-85 -142.41 157.13 45.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.722 -1.458 . . . . 0.0 108.929 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 289' ' ' VAL . . . . . 0.489 HG12 HD12 ' C' ' 245' ' ' ILE . 1.0 OUTLIER -149.12 148.46 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.714 -1.241 . . . . 0.0 108.904 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 12.6 m -129.46 130.94 46.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.05 -1.031 . . . . 0.0 111.101 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 291' ' ' TYR . . . . . 0.55 ' CE2' HG23 ' C' ' 269' ' ' ILE . 46.5 m-85 -112.88 142.5 45.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 292' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' C' ' 292' ' ' ASP . 56.6 p30 -75.79 13.03 0.9 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.437 -1.415 . . . . 0.0 107.544 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 293' ' ' SER . . . . . 0.516 ' H ' ' C ' ' C' ' 291' ' ' TYR . 1.8 m -131.04 112.02 12.54 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.49 76.16 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -50.6 -38.0 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.95 83.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 297' ' ' VAL . . . . . 0.448 HG22 ' CG2' ' C' ' 245' ' ' ILE . 59.5 t -59.31 -57.67 10.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.57 -19.13 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -77.11 -60.42 2.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.141 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.5 p -60.97 -20.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.146 -0.972 . . . . 0.0 109.039 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 301' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' C' ' 300' ' ' VAL . 0.0 OUTLIER -43.17 -58.54 2.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 108.867 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -49.82 -27.67 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' C' ' 300' ' ' VAL . 94.1 m-20 -99.94 68.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.21 -9.5 59.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.088 . . . . 0.0 109.94 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.76 125.06 32.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 306' ' ' ILE . . . . . 0.539 HD12 HD11 ' C' ' 315' ' ' ILE . 69.4 mt -132.67 145.5 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.0 111.099 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 307' ' ' ASP . . . . . 0.48 ' O ' ' OD1' ' C' ' 307' ' ' ASP . 3.3 p30 -81.53 94.81 6.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.577 ' HE2' HG11 ' C' ' 254' ' ' VAL . 36.7 t80 -104.26 -176.28 3.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' C' ' 308' ' ' PHE . 56.0 mttt -38.84 -32.77 0.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.787 -1.195 . . . . 0.0 109.691 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 310' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 44.1 t0 -95.13 -154.47 0.43 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 108.853 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 311' ' ' ARG . . . . . 0.65 ' O ' ' N ' ' C' ' 313' ' ' ILE . 17.3 ttp180 -79.66 -167.74 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 108.916 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 312' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' C' ' 311' ' ' ARG . 10.3 tptt -55.01 75.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.905 0.86 . . . . 0.0 109.672 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' C' ' 311' ' ' ARG . 3.6 pt -45.46 153.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.947 . . . . 0.0 108.896 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -107.3 155.22 20.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.478 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.539 HD11 HD12 ' C' ' 306' ' ' ILE . 77.8 mt -125.31 152.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -154.63 149.88 27.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.952 -1.093 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -67.33 145.46 55.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.085 -1.009 . . . . 0.0 109.333 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -78.08 13.45 1.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.905 -1.122 . . . . 0.0 109.116 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.51 151.57 77.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.8 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 320' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' C' ' 322' ' ' HIS . 50.4 Cg_endo -72.54 158.32 51.17 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.621 2.214 . . . . 0.0 112.061 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 321' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' C' ' 322' ' ' HIS . 60.0 ttt85 -62.99 68.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 322' ' ' HIS . . . . . 0.578 ' N ' ' O ' ' C' ' 320' ' ' PRO . 70.2 m80 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.938 -1.03 . . . . 0.0 109.588 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ' U' . . . . . 0.592 ' N3 ' ' OE1' ' C' ' 314' ' ' GLU . . . . . . . . 0 O4'--C1' 1.439 2.064 1 C5'-C4'-C3' 107.476 -5.349 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.95 " H4'" ' CD1' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.441 2.228 1 C5'-C4'-C3' 107.261 -5.493 . 0.544 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ' U' . . . . . 0.78 ' H6 ' HO2' ' A' ' 2' ' ' ' A' . . . . . . . . 0 P--O5' 1.612 1.876 1 C5'-C4'-C3' 107.88 -5.08 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.778 ' OP2' HG21 ' C' ' 280' ' ' THR . . . . . . . . 0 O4'--C1' 1.436 1.836 1 C5'-C4'-C3' 107.761 -5.159 . 0.112 4p . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ' U' . . . . . 0.708 ' C2 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 O4'--C4' 1.426 -2.249 0 C3'-C2'-C1' 104.883 3.758 . 0.696 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . 0.941 " H4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.62 2.671 1 C5'-C4'-C3' 108.485 -4.676 . 0.508 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . 0.941 " H5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.429 1 C5'-C4'-C3' 107.163 -5.558 . 0.238 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ' A' . . . . . 0.913 " H4'" ' NH2' ' B' ' 95' ' ' ARG . . . . . . . . 0 O4'--C1' 1.44 2.172 2 C5'-C4'-C3' 105.167 -6.889 . 0.449 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.743 ' N3 ' ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 C2'--C1' 1.51 -1.786 2 O4'-C1'-N19 114.196 5.996 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ' U' . . . . . 0.954 H5'' ' CZ ' ' B' ' 69' ' ' TYR . . . . . . . . 0 O4'--C1' 1.438 1.981 2 C5'-C4'-C3' 107.214 -5.524 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.909 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.612 1.905 1 C5'-C4'-C3' 107.524 -5.317 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.782 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 1.969 1 C5'-C4'-C3' 107.319 -5.454 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.512 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.883 1 C5'-C4'-C3' 107.462 -5.359 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.52 142.01 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.685 2.257 . . . . 0.0 111.986 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.15 12.08 1.61 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.424 2.083 . . . . 0.0 112.545 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -158.5 129.92 6.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.02 -1.05 . . . . 0.0 109.513 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.567 ' N ' ' OG ' ' B' ' 80' ' ' SER . 42.4 ttt-85 -177.48 -44.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.831 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -138.8 154.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.92 139.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.295 -0.878 . . . . 0.0 108.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.719 ' CZ ' ' N1 ' ' A' ' 9' ' ' ' A' . 2.0 m-30 -106.68 135.99 47.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 111.196 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.66 HD12 HD11 ' B' ' 72' ' ' ILE . 54.0 mt -110.21 119.27 38.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -78.52 -137.46 1.22 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.417 ' C ' HD12 ' B' ' 33' ' ' ILE . 23.2 p -69.42 122.42 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.65 -1.5 . . . . 0.0 109.673 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' B' ' 30' ' ' LEU . 1.2 mp -126.53 137.78 31.08 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.59 153.53 23.28 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.433 1.422 . . . . 0.0 112.526 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -72.39 -0.91 13.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 109.986 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.4 -35.81 78.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.026 . . . . 0.0 108.513 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.44 117.84 19.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.585 -0.697 . . . . 0.0 109.718 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.772 ' O ' HD13 ' B' ' 42' ' ' ILE . 82.1 p -111.42 -135.68 0.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.478 -0.764 . . . . 0.0 110.971 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -64.33 -32.42 74.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.029 -1.044 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.7 -54.44 27.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.184 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -68.11 -42.11 80.73 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.592 -0.693 . . . . 0.0 110.385 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.772 HD13 ' O ' ' B' ' 38' ' ' THR . 1.7 mp -61.1 -53.3 51.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.539 HD23 ' OD1' ' B' ' 44' ' ' ASP . 4.9 tt -39.58 -21.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.554 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.539 ' OD1' HD23 ' B' ' 43' ' ' LEU . 91.5 m-20 -125.45 -24.24 3.95 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.732 -1.23 . . . . 0.0 110.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.709 ' C ' HD13 ' B' ' 45' ' ' LEU . 2.9 tm? -57.22 -39.02 74.64 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.108 -1.62 . . . . 0.0 106.877 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' B' ' 48' ' ' ASN . 85.4 m -83.26 -63.42 1.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.799 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.1 m -37.16 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.775 -0.578 . . . . 0.0 110.119 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' B' ' 46' ' ' CYS . 12.4 m-20 -48.09 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.525 0.678 . . . . 0.0 111.112 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.799 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.1 t 174.5 -31.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.19 -174.63 46.89 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.6 158.87 15.01 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.143 2.562 . . . . 0.0 113.028 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.602 HG21 ' OG ' ' B' ' 47' ' ' SER . 23.2 t -128.76 145.26 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.712 HG22 ' OD1' ' B' ' 54' ' ' ASN . 45.6 mm -90.56 -66.49 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 112.011 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.712 ' OD1' HG22 ' B' ' 53' ' ' ILE . 64.0 m-20 -117.86 139.72 50.71 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.598 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.15 127.63 38.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -138.02 129.89 28.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.673 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' MET . . . . . 0.626 ' N ' ' H61' ' A' ' 12' ' ' ' A' . 0.8 OUTLIER -133.25 144.68 49.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.591 0.71 . . . . 0.0 110.379 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 58' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -172.07 170.76 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.491 -0.756 . . . . 0.0 109.134 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 59' ' ' PHE . . . . . 0.51 ' O ' ' SD ' ' B' ' 58' ' ' MET . 0.1 OUTLIER -116.12 -166.93 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.0 109.21 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' B' ' 64' ' ' GLY . 6.6 t0 -105.03 73.98 0.24 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.184 -0.948 . . . . 0.0 110.622 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.41 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 5.9 Cg_endo -57.09 -31.33 89.98 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.04 1.827 . . . . 0.0 112.404 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -63.09 -37.76 88.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.599 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.431 HG23 ' H ' ' B' ' 65' ' ' ARG . 0.2 OUTLIER -140.97 -32.8 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 110.206 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 60' ' ' ASP . . . 99.5 -1.34 57.08 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.431 ' H ' HG23 ' B' ' 63' ' ' THR . 99.1 mtt180 -58.51 -40.79 83.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.848 -1.384 . . . . 0.0 109.606 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.529 ' H ' ' HB2' ' B' ' 60' ' ' ASP . 0.5 OUTLIER -89.6 116.24 27.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.102 -0.999 . . . . 0.0 108.709 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.89 -72.58 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.734 -0.604 . . . . 0.0 109.638 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -123.01 95.74 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' TYR . . . . . 0.954 ' CZ ' H5'' ' A' ' 10' ' ' ' U' . 0.8 OUTLIER -108.67 130.61 55.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.473 -1.016 . . . . 0.0 109.126 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.73 24.38 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.834 -1.146 . . . . 0.0 112.193 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.743 ' CZ ' ' N3 ' ' A' ' 9' ' ' ' A' . 12.7 m-30 -115.32 129.4 56.59 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.882 0.849 . . . . 0.0 109.782 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ILE . . . . . 0.747 HD12 ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -120.25 102.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.121 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.573 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.5 mt-10 -83.95 131.42 34.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.573 -1.33 . . . . 0.0 110.472 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' B' ' 52' ' ' VAL . 7.2 m-85 -93.66 178.24 5.75 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.474 0.654 . . . . 0.0 110.176 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 50.4 ttt180 -52.71 -44.3 66.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 110.216 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 158.58 -177.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.754 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.3 mp -35.52 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.683 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.4 tt0 -70.06 -75.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.548 -1.345 . . . . 0.0 109.227 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -62.31 -40.26 95.74 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.978 ' O ' HG22 ' B' ' 84' ' ' VAL . 34.0 t -61.64 -39.6 91.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.055 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -57.44 -60.86 3.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 21.5 t -63.07 -35.05 78.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.905 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.748 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -73.51 -67.71 0.56 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 0.0 110.411 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.978 HG22 ' O ' ' B' ' 80' ' ' SER . 26.2 m -53.59 -37.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.506 -1.371 . . . . 0.0 110.077 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 10.2 mmt180 -62.9 -43.35 99.02 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.559 -1.338 . . . . 0.0 107.898 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -84.0 -45.97 12.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.641 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.748 ' N ' ' O ' ' B' ' 83' ' ' ALA . 0.4 OUTLIER -125.18 84.06 2.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.36 -0.838 . . . . 0.0 110.315 -179.371 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.4 OUTLIER -110.47 -68.46 0.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' B' ' 88' ' ' ASN . . . -127.66 108.1 0.92 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -139.42 147.55 41.57 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.468 -1.607 . . . . 0.0 108.843 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.3 tp-100 -31.32 89.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.556 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 90' ' ' TYR . 60.0 tp -148.89 135.22 19.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.09 -1.006 . . . . 0.0 109.531 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 45.86 -168.74 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 36.7 m -64.83 -25.18 67.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.492 -1.004 . . . . 0.0 110.345 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.913 ' NH2' " H4'" ' A' ' 8' ' ' ' A' . 1.1 mmm180 -131.3 160.67 34.27 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.213 -0.929 . . . . 0.0 109.2 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' PHE . . . . . 0.45 ' HB3' ' N ' ' B' ' 90' ' ' TYR . 6.8 m-85 -95.18 138.89 32.27 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.624 -0.673 . . . . 0.0 110.148 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LEU . . . . . 0.629 HD23 ' H ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -43.89 157.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.67 159.84 38.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 109.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' CYS . . . . . 0.578 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.5 OUTLIER -110.49 129.14 55.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.393 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.4 -165.8 13.59 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.531 -1.318 . . . . 0.0 110.824 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.526 ' N ' ' OH ' ' B' ' 29' ' ' TYR . 30.2 p90 -130.53 171.29 13.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.635 -0.92 . . . . 0.0 109.452 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' B' ' 102' ' ' SER . 5.8 t 179.79 27.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 109.964 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 28.1 t -137.48 141.2 41.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 109.395 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -118.86 -17.8 9.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.496 -0.752 . . . . 0.0 109.596 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.439 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 157' ' ' GLU . . . . . 0.42 ' N ' ' OE1' ' C' ' 157' ' ' GLU . 58.4 mp0 -106.84 154.7 20.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.794 . . . . 0.0 109.445 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 158' ' ' SER . . . . . 0.53 ' C ' ' SG ' ' C' ' 159' ' ' CYS . 23.9 t -142.06 162.01 36.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 109.716 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 159' ' ' CYS . . . . . 0.53 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 61.84 14.45 6.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.321 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 160' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 13.4 tttp -102.28 99.24 9.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 161' ' ' MET . . . . . 0.618 ' HE2' HD13 ' C' ' 163' ' ' ILE . 3.4 mmm -71.24 151.89 43.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 110.027 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 162' ' ' PHE . . . . . 0.708 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 25.6 t80 -126.37 78.3 1.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 163' ' ' ILE . . . . . 0.936 HD11 HD12 ' C' ' 205' ' ' LEU . 4.1 mm -49.94 137.25 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 164' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 166' ' ' LEU . . . -140.18 172.32 23.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.06 11.44 0.12 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 166' ' ' LEU . . . . . 0.636 ' HA ' HG22 ' C' ' 228' ' ' ILE . 1.2 pp -62.27 163.96 7.68 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.929 . . . . 0.0 109.353 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 167' ' ' ASN . . . . . 0.633 ' O ' HD12 ' C' ' 166' ' ' LEU . 29.9 t30 -68.68 123.99 22.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.935 -1.103 . . . . 0.0 109.503 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 168' ' ' TRP . . . . . 0.63 ' CH2' ' C4 ' ' A' ' 4' ' ' ' A' . 3.8 m-90 -37.74 -33.24 0.07 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.784 -0.572 . . . . 0.0 110.437 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 169' ' ' ASP . . . . . 0.457 ' H ' ' ND2' ' C' ' 167' ' ' ASN . 23.6 t70 -101.33 99.21 9.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.949 -1.095 . . . . 0.0 111.112 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 3.0 m -157.19 116.12 3.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.26 -0.9 . . . . 0.0 109.314 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 171' ' ' THR . . . . . 0.538 ' O ' ' OD1' ' C' ' 174' ' ' ASN . 0.0 OUTLIER -75.5 173.89 10.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.783 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 172' ' ' GLU . . . . . 0.673 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -75.47 -71.92 0.34 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.348 -0.845 . . . . 0.0 110.252 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' C' ' 176' ' ' ARG . 91.5 m-20 -38.34 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 174' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' C' ' 175' ' ' LEU . 29.6 p-10 -36.1 -44.83 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.709 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.623 ' CD2' HD11 ' C' ' 205' ' ' LEU . 5.3 tt -54.79 -46.39 74.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 176' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' C' ' 178' ' ' TYR . 60.9 ttp85 -72.15 -60.34 2.28 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.009 -1.057 . . . . 0.0 108.72 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 177' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' C' ' 176' ' ' ARG . 78.1 mm-40 -40.06 -22.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.067 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 178' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' C' ' 176' ' ' ARG . 16.3 t80 -95.24 -36.57 11.38 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.729 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 179' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' C' ' 176' ' ' ARG . 12.6 m-85 -90.02 12.59 17.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.094 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 180' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' C' ' 182' ' ' TYR . . . -61.28 -55.87 26.81 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.035 -1.041 . . . . 0.0 111.174 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.82 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.765 -1.433 . . . . 0.0 112.048 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 182' ' ' TYR . . . . . 0.596 ' H ' ' C ' ' C' ' 180' ' ' GLY . 22.3 m-85 -107.48 -3.93 18.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.999 -1.063 . . . . 0.0 109.567 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.87 -165.34 27.3 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 184' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' C' ' 208' ' ' GLU . 0.1 OUTLIER -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.286 . . . . 0.0 108.522 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.543 HG22 ' CE1' ' C' ' 207' ' ' PHE . 22.7 t -104.29 129.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -51.42 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.962 . . . . 0.0 109.414 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 187' ' ' ASP . . . . . 0.454 ' H ' ' HB2' ' C' ' 206' ' ' SER . 21.1 t70 -149.84 160.91 43.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp -157.62 143.05 17.13 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.22 -1.55 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 189' ' ' LYS . . . . . 0.456 ' H ' ' HB2' ' C' ' 204' ' ' PHE . 43.8 mttm -117.14 161.25 19.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.142 -0.974 . . . . 0.0 108.774 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 176.78 104.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 191' ' ' MET . . . . . 0.552 ' O ' ' C ' ' C' ' 192' ' ' LYS . 12.9 mtm -122.4 80.04 1.68 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 110.885 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 192' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' C' ' 191' ' ' MET . 41.5 mttp -24.07 -83.66 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 193' ' ' ASP . . . . . 0.406 ' HB3' ' N ' ' C' ' 199' ' ' SER . 3.8 p-10 -153.26 152.5 27.87 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.963 . . . . 0.0 109.233 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.55 -57.64 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.166 1.911 . . . . 0.0 112.303 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.48 ' O ' ' C ' ' C' ' 196' ' ' THR . . . -175.53 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 109.071 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 196' ' ' THR . . . . . 0.48 ' C ' ' O ' ' C' ' 195' ' ' ALA . 37.3 p -28.44 -72.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.84 -55.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 198' ' ' ARG . . . . . 0.622 ' CZ ' ' CZ2' ' C' ' 168' ' ' TRP . 18.2 ptt180 -169.33 158.75 8.32 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 199' ' ' SER . . . . . 0.552 ' O ' ' N ' ' C' ' 201' ' ' GLY . 90.3 p -156.42 170.3 22.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.0 -1.063 . . . . 0.0 109.417 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 200' ' ' ARG . . . . . 0.684 ' CB ' " H4'" ' A' ' 5' ' ' ' U' . 0.0 OUTLIER -26.56 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.436 0.636 . . . . 0.0 110.735 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 201' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.33 109.35 2.78 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.588 ' HB3' " H1'" ' A' ' 5' ' ' ' U' . 13.0 p90 -129.56 166.67 19.24 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.785 -0.832 . . . . 0.0 108.783 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -137.65 130.02 4.9 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.171 -1.49 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 204' ' ' PHE . . . . . 0.456 ' HB2' ' H ' ' C' ' 189' ' ' LYS . 61.6 m-85 -104.08 115.55 30.62 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.607 -1.525 . . . . 0.0 107.596 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.936 HD12 HD11 ' C' ' 163' ' ' ILE . 3.5 mt -115.32 97.02 5.95 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.838 0.828 . . . . 0.0 109.967 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 206' ' ' SER . . . . . 0.454 ' HB2' ' H ' ' C' ' 187' ' ' ASP . 2.4 m -69.31 80.6 0.36 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.284 0.564 . . . . 0.0 109.651 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 207' ' ' PHE . . . . . 0.65 ' O ' ' O ' ' C' ' 208' ' ' GLU . 44.2 m-85 -79.56 123.6 27.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 110.943 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 208' ' ' GLU . . . . . 0.65 ' O ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -36.59 -103.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.617 ' H ' ' CG ' ' C' ' 208' ' ' GLU . 9.4 ptmt -51.39 160.6 0.93 Allowed Pre-proline 0 C--N 1.298 -1.665 0 O-C-N 119.744 -1.847 . . . . 0.0 108.326 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 210' ' ' PRO . . . . . 0.698 ' O ' HG22 ' C' ' 213' ' ' VAL . 8.6 Cg_endo -94.85 14.07 1.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.614 2.209 . . . . 0.0 112.478 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 211' ' ' SER . . . . . 0.586 ' O ' ' N ' ' C' ' 214' ' ' ASP . 60.0 p -82.64 -51.16 7.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 212' ' ' SER . . . . . 0.852 ' O ' HG23 ' C' ' 216' ' ' VAL . 60.6 p -39.58 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.47 -0.769 . . . . 0.0 109.317 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 213' ' ' VAL . . . . . 0.698 HG22 ' O ' ' C' ' 210' ' ' PRO . 4.1 m -66.28 -37.96 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.962 -1.086 . . . . 0.0 108.31 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 214' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' C' ' 211' ' ' SER . 89.9 m-20 -65.19 -49.83 68.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.3 -39.74 94.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 108.68 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 216' ' ' VAL . . . . . 0.852 HG23 ' O ' ' C' ' 212' ' ' SER . 47.7 t -56.49 -49.18 78.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.96 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.489 HG23 ' O ' ' C' ' 230' ' ' PRO . 13.1 p -82.83 -31.45 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.868 -1.145 . . . . 0.0 111.264 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -74.17 12.87 0.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.933 -1.104 . . . . 0.0 109.697 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 219' ' ' THR . . . . . 0.411 ' H ' ' C ' ' C' ' 217' ' ' VAL . 15.8 m -131.28 142.58 50.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.349 -0.844 . . . . 0.0 108.885 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -107.23 67.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 108.973 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' HIS . . . . . 0.831 ' CD2' ' H ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -55.54 163.95 1.16 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.706 -0.621 . . . . 0.0 109.95 -179.168 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.426 HG22 ' C ' ' C' ' 225' ' ' GLY . 0.2 OUTLIER -142.14 74.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.902 0.858 . . . . 0.0 108.789 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -49.08 -71.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.233 -0.917 . . . . 0.0 110.67 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 224' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 58.3 t0 -89.81 12.19 17.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.75 -1.219 . . . . 0.0 109.606 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 225' ' ' GLY . . . . . 0.426 ' C ' HG22 ' C' ' 222' ' ' ILE . . . 81.01 17.12 73.06 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 226' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' C' ' 222' ' ' ILE . 27.3 mmtp -95.16 -153.94 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 227' ' ' VAL . . . . . 0.513 HG22 ' O ' ' C' ' 227' ' ' VAL . 2.0 p -122.4 90.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.071 -1.018 . . . . 0.0 109.921 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 228' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' C' ' 166' ' ' LEU . 34.0 pt -84.97 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -114.63 96.61 44.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.362 -0.837 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 230' ' ' PRO . . . . . 0.534 ' HB2' HG12 ' C' ' 216' ' ' VAL . 1.7 Cg_endo -74.65 125.67 9.67 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.384 2.056 . . . . 0.0 111.704 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.64 134.3 35.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 109.767 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.432 ' HD3' HG21 ' C' ' 213' ' ' VAL . 69.0 ttp85 -62.73 148.84 45.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.322 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 233' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' C' ' 160' ' ' LYS . . . -46.91 139.86 5.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.992 . . . . 0.0 109.196 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 28.6 mt -121.84 127.51 25.97 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.52 -0.737 . . . . 0.0 109.491 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.84 147.78 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.874 1.716 . . . . 0.0 112.276 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -58.66 -38.43 78.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.86 -41.42 74.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 109.134 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 238' ' ' GLU . . . . . 0.688 ' O ' HG23 ' C' ' 242' ' ' THR . 9.1 mp0 -71.79 -39.91 69.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.912 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 239' ' ' GLN . . . . . 0.496 ' OE1' ' C8 ' ' A' ' 6' ' ' ' A' . 4.4 tt0 -58.98 -43.68 91.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.17 -41.89 76.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 241' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' C' ' 242' ' ' THR . 16.0 ttmm -61.08 -45.38 94.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.124 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 242' ' ' THR . . . . . 0.688 HG23 ' O ' ' C' ' 238' ' ' GLU . 50.0 p -40.63 139.28 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.148 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.67 143.35 17.78 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 244' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' C' ' 290' ' ' THR . 16.7 tptp -118.71 130.26 55.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.86 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 245' ' ' ILE . . . . . 0.641 HD11 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -120.57 143.43 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 246' ' ' PHE . . . . . 0.519 ' CD2' ' N3 ' ' A' ' 2' ' ' ' A' . 6.9 t80 -104.14 128.57 51.81 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.48 0.657 . . . . 0.0 109.975 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 247' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' C' ' 263' ' ' PHE . 14.1 t -100.63 133.07 45.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.951 0.881 . . . . 0.0 110.392 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.64 158.32 14.4 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.07 83.0 0.2 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.063 -1.257 . . . . 0.0 110.542 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 250' ' ' ILE . . . . . 0.546 HG21 HD22 ' C' ' 274' ' ' LEU . 3.7 mm -127.37 127.86 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -1.108 . . . . 0.0 108.855 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 251' ' ' GLY . . . . . 0.454 ' O ' HG23 ' C' ' 254' ' ' VAL . . . -52.61 111.87 1.83 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.92 -20.86 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.802 1.668 . . . . 0.0 111.66 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -96.52 16.17 19.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.479 -0.763 . . . . 0.0 109.265 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 254' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 251' ' ' GLY . 48.8 t -97.86 135.62 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.96 163.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 108.964 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.36 -25.89 80.8 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.653 2.235 . . . . 0.0 112.09 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -50.03 -62.74 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.233 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 258' ' ' GLU . . . . . 0.626 ' O ' ' N ' ' C' ' 261' ' ' GLU . 77.3 mm-40 -60.43 -74.18 0.08 Allowed 'General case' 0 C--O 1.194 -1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 108.51 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 259' ' ' PHE . . . . . 0.722 ' CZ ' HG13 ' C' ' 289' ' ' VAL . 89.1 t80 -16.82 -67.51 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.889 0.852 . . . . 0.0 111.045 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 260' ' ' GLU . . . . . 0.449 ' O ' HD11 ' C' ' 269' ' ' ILE . 93.6 mt-10 -61.24 -44.65 96.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 109.51 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 261' ' ' GLU . . . . . 0.626 ' N ' ' O ' ' C' ' 258' ' ' GLU . 35.5 tp10 -68.37 -7.68 33.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 262' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' C' ' 263' ' ' PHE . 13.9 t80 -92.76 -76.45 0.46 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 263' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' C' ' 247' ' ' VAL . 82.4 m-85 -45.74 -33.57 3.1 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.093 -1.443 . . . . 0.0 109.466 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 264' ' ' SER . . . . . 0.429 ' C ' ' O ' ' C' ' 263' ' ' PHE . 48.1 p -34.6 -37.5 0.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.942 -0.474 . . . . 0.0 111.786 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 265' ' ' GLN . . . . . 0.546 ' C ' ' H ' ' C' ' 267' ' ' GLY . 0.2 OUTLIER -58.52 -95.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.19 -1.569 . . . . 0.0 110.118 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 266' ' ' TRP . . . . . 0.679 ' CD1' ' O ' ' C' ' 266' ' ' TRP . 0.6 OUTLIER -69.92 19.25 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.025 -1.047 . . . . 0.0 109.38 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 267' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' C' ' 265' ' ' GLN . . . -136.17 128.16 4.45 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 268' ' ' THR . . . . . 0.528 ' O ' ' C ' ' C' ' 269' ' ' ILE . 58.1 p -85.5 6.6 26.27 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.365 -1.079 . . . . 0.0 109.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 269' ' ' ILE . . . . . 0.761 HG23 ' CE1' ' C' ' 291' ' ' TYR . 5.4 pt -14.67 96.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 122.451 1.119 . . . . 0.0 113.865 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.85 -35.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -135.94 94.87 3.12 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 272' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -137.81 172.05 13.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 273' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 7.7 tt0 164.99 156.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.563 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 274' ' ' LEU . . . . . 0.546 HD22 HG21 ' C' ' 250' ' ' ILE . 16.3 tp -97.0 140.63 31.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 275' ' ' MET . . . . . 0.503 ' H ' HD12 ' C' ' 274' ' ' LEU . 1.7 mpp? -90.4 156.33 18.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.564 -1.335 . . . . 0.0 108.686 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.67 -169.22 3.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.125 -0.984 . . . . 0.0 109.397 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 277' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 36.8 p-10 -61.84 -38.38 88.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 278' ' ' LYS . . . . . 0.583 ' N ' ' OD1' ' C' ' 277' ' ' ASP . 13.3 tttp -63.29 -42.8 99.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 279' ' ' ASP . . . . . 0.412 ' O ' ' N1 ' ' A' ' 4' ' ' ' A' . 87.3 m-20 -66.76 -61.03 2.17 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.114 -0.991 . . . . 0.0 109.243 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 280' ' ' THR . . . . . 0.778 HG21 ' OP2' ' A' ' 4' ' ' ' A' . 0.7 OUTLIER 178.74 129.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.1 -118.78 5.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 282' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.3 tt0 -166.37 150.33 7.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.311 . . . . 0.0 111.009 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 4.5 t -62.17 66.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 110.213 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 284' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' C' ' 282' ' ' GLN . 72.3 mtt85 -55.77 -22.28 23.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 137.73 12.81 0.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.95 ' CD1' " H4'" ' A' ' 2' ' ' ' A' . 32.4 p90 -106.5 165.09 11.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 110.534 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.71 178.99 37.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -134.61 154.44 51.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.441 -1.623 . . . . 0.0 109.725 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 289' ' ' VAL . . . . . 0.722 HG13 ' CZ ' ' C' ' 259' ' ' PHE . 0.0 OUTLIER -148.01 138.04 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.365 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 290' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' C' ' 269' ' ' ILE . 10.1 m -123.0 126.0 46.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.96 -1.088 . . . . 0.0 109.943 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 291' ' ' TYR . . . . . 0.761 ' CE1' HG23 ' C' ' 269' ' ' ILE . 41.0 m-85 -113.55 133.09 55.45 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 292' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' C' ' 293' ' ' SER . 25.9 p-10 -53.02 -46.22 68.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.625 -1.297 . . . . 0.0 108.767 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 293' ' ' SER . . . . . 0.567 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 67.3 m -88.15 164.75 15.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.11 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 294' ' ' ALA . . . . . 0.406 ' O ' ' CG1' ' C' ' 297' ' ' VAL . . . -102.83 -22.38 13.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -50.08 -38.51 38.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.005 -1.06 . . . . 0.0 108.535 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.69 31.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 297' ' ' VAL . . . . . 0.575 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 1.4 p -54.99 -54.95 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.339 -1.476 . . . . 0.0 108.242 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 298' ' ' ASP . . . . . 0.456 ' H ' HG13 ' C' ' 297' ' ' VAL . 92.4 m-20 -57.84 -19.5 29.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.895 -1.128 . . . . 0.0 109.606 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -76.9 -58.37 3.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 108.877 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 300' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' C' ' 303' ' ' ASN . 7.2 p -68.11 -25.22 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 301' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 65.6 m -43.9 -52.07 7.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.115 -0.991 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -50.92 -22.21 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 303' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' C' ' 300' ' ' VAL . 20.1 t-20 -100.13 65.76 1.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.0 109.446 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 304' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' C' ' 303' ' ' ASN . 55.7 tttp -46.17 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.688 -1.257 . . . . 0.0 108.753 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 305' ' ' PHE . . . . . 0.644 ' CE1' ' CG ' ' C' ' 314' ' ' GLU . 90.9 m-85 -76.79 133.93 39.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.5 mt -130.39 148.34 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.369 -0.832 . . . . 0.0 109.019 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 307' ' ' ASP . . . . . 0.543 ' OD1' ' NZ ' ' C' ' 312' ' ' LYS . 78.1 m-20 -76.66 123.97 26.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 108.608 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 308' ' ' PHE . . . . . 0.579 ' O ' ' N ' ' C' ' 310' ' ' ASP . 52.6 t80 -123.44 173.16 8.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -0.873 . . . . 0.0 109.345 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 309' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -40.45 -23.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 310' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 308' ' ' PHE . 46.0 t0 -94.23 -154.5 0.42 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 311' ' ' ARG . . . . . 0.563 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 87.8 mtt180 -79.0 -55.71 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 312' ' ' LYS . . . . . 0.543 ' NZ ' ' OD1' ' C' ' 307' ' ' ASP . 24.9 tptt -157.37 147.04 20.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.176 -0.953 . . . . 0.0 109.183 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 313' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' C' ' 308' ' ' PHE . 41.7 pt -129.85 147.64 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.877 . . . . 0.0 109.229 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 314' ' ' GLU . . . . . 0.644 ' CG ' ' CE1' ' C' ' 305' ' ' PHE . 85.2 mt-10 -99.43 144.31 28.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 315' ' ' ILE . . . . . 0.641 ' CG2' HD11 ' C' ' 245' ' ' ILE . 36.2 mt -118.39 147.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.909 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -155.58 148.23 24.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.001 . . . . 0.0 108.976 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 317' ' ' ARG . . . . . 0.441 ' NH1' ' CB ' ' C' ' 317' ' ' ARG . 5.7 ptm85 -68.77 152.49 45.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.948 -1.095 . . . . 0.0 109.579 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.57 93.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 109.109 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 319' ' ' GLU . . . . . 0.472 ' O ' ' C ' ' C' ' 320' ' ' PRO . 3.2 mm-40 -128.28 74.57 79.54 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.632 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 320' ' ' PRO . . . . . 0.472 ' C ' ' O ' ' C' ' 319' ' ' GLU . 98.9 Cg_exo -26.09 -67.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.984 2.456 . . . . 0.0 112.955 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 321' ' ' ARG . . . . . 0.477 ' O ' ' OXT' ' C' ' 322' ' ' HIS . 36.6 mmm-85 -122.85 89.85 3.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.328 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 322' ' ' HIS . . . . . 0.477 ' OXT' ' O ' ' C' ' 321' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.74 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.424 0.63 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.28 175.2 3.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.956 2.437 . . . . 0.0 111.827 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.36 -2.88 9.37 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.825 2.35 . . . . 0.0 113.117 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' B' ' 77' ' ' LEU . 60.0 p -156.77 136.98 12.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.908 -1.12 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -179.12 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.529 0.68 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' B' ' 73' ' ' GLU . 2.4 t -128.05 163.48 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.891 . . . . 0.0 109.953 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.44 136.63 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 108.404 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.459 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 10.3 m-30 -106.78 119.49 39.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.017 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' B' ' 33' ' ' ILE . 1.7 mm? -106.61 105.45 15.48 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -107.03 -72.79 0.81 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.84 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.497 ' HB3' ' H ' ' B' ' 95' ' ' ARG . 7.8 t -69.2 82.71 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.929 -1.336 . . . . 0.0 110.014 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' B' ' 30' ' ' LEU . 3.7 mp -144.94 121.29 6.09 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' B' ' 36' ' ' ASP . 30.0 Cg_endo -69.72 164.35 34.83 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.515 1.477 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -59.73 2.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.589 -0.694 . . . . 0.0 109.468 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' B' ' 34' ' ' PRO . 89.3 m-20 -63.99 -39.16 93.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.23 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.548 ' OE1' HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -124.4 113.98 18.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.581 -0.699 . . . . 0.0 109.158 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.4 p -110.05 -139.88 0.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 111.2 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.43 ' C ' ' CD ' ' B' ' 39' ' ' GLU . 0.5 OUTLIER -63.02 -29.45 70.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.962 -1.086 . . . . 0.0 110.794 -178.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -71.18 -54.39 11.18 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.343 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -49.05 64.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' B' ' 44' ' ' ASP . 24.1 mm -55.33 -52.58 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 42' ' ' ILE . 42.0 tp -37.6 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.839 -0.538 . . . . 0.0 110.846 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.604 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 88.8 m-20 -123.5 -24.75 4.51 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.585 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.749 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.2 tm? -57.64 -39.44 76.98 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 119.905 -1.747 . . . . 0.0 106.612 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.623 ' O ' ' N ' ' B' ' 48' ' ' ASN . 0.8 OUTLIER -84.48 -63.68 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.801 . . . . 0.0 109.289 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.758 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.7 t -38.8 -21.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.797 -0.564 . . . . 0.0 109.798 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.623 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.36 68.9 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.893 0.854 . . . . 0.0 110.511 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.758 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.51 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.804 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.36 -155.7 19.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.75 159.83 38.24 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.325 2.016 . . . . 0.0 112.327 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.821 HG12 ' H ' ' B' ' 53' ' ' ILE . 3.0 t -120.92 -152.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.821 ' H ' HG12 ' B' ' 52' ' ' VAL . 31.8 mm -151.91 -64.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.827 -1.171 . . . . 0.0 109.577 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.555 ' OD1' HG22 ' B' ' 53' ' ' ILE . 71.6 m-20 -126.65 146.56 50.14 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.645 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.575 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.5 OUTLIER -139.37 130.69 26.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.575 ' N ' HD23 ' B' ' 55' ' ' LEU . 61.3 mttp -137.08 144.59 43.2 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 108.827 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.91 135.24 39.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.5 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -158.39 166.88 31.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.416 -0.802 . . . . 0.0 109.202 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.442 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.1 OUTLIER -122.06 -168.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.559 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 25.2 p-10 -101.1 73.88 0.11 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 112.508 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.442 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 28.6 Cg_endo -67.68 -36.65 18.46 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.623 1.549 . . . . 0.0 111.222 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -101.99 -59.91 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.517 -0.74 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 75.5 p -48.7 -40.72 29.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.419 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' B' ' 60' ' ' ASP . . . 73.67 26.81 68.62 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.559 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 32.1 mtp180 -131.8 -68.01 0.66 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -1.115 . . . . 0.0 110.216 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' B' ' 60' ' ' ASP . 0.0 OUTLIER -50.01 120.39 4.36 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.832 0.825 . . . . 0.0 110.791 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.32 -74.61 0.43 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.066 -1.021 . . . . 0.0 108.699 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -115.69 94.7 0.67 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.52 130.49 55.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.039 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' B' ' 56' ' ' LYS . . . -142.41 138.86 31.41 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.356 -0.937 . . . . 0.0 109.574 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.496 ' C ' HD12 ' B' ' 72' ' ' ILE . 4.2 m-30 -105.68 122.98 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.905 HD12 ' N ' ' B' ' 72' ' ' ILE . 1.6 mp -118.17 98.81 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.294 -0.879 . . . . 0.0 111.485 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.709 ' HA ' HG13 ' B' ' 27' ' ' VAL . 83.8 tt0 -83.11 133.14 35.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.495 -1.378 . . . . 0.0 110.91 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.39 174.87 6.92 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.629 0.728 . . . . 0.0 110.996 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 11.7 ttt-85 -53.2 -42.36 66.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.708 -0.62 . . . . 0.0 110.967 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.5 m-20 160.7 179.19 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.777 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 9.3 mt -38.09 -22.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.856 -0.528 . . . . 0.0 109.63 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.7 mt-10 -70.23 -73.3 0.17 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.215 1.007 . . . . 0.0 109.324 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m -61.73 -40.93 96.84 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.824 -1.173 . . . . 0.0 108.297 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.3 m -62.54 -35.67 80.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.193 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.777 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -59.64 -56.66 19.09 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.598 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 70.2 m -65.25 -35.95 82.61 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.955 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.607 ' HB2' HG11 ' B' ' 49' ' ' VAL . . . -80.43 -61.86 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 110.9 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.583 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 41.5 t -56.16 -40.61 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.03 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' B' ' 81' ' ' ALA . 0.0 OUTLIER -68.14 -51.55 44.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.021 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' B' ' 82' ' ' SER . 81.4 m-20 -67.52 -44.21 78.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.633 ' O ' HD12 ' B' ' 87' ' ' LEU . 1.7 pp -139.98 121.45 15.1 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.129 -0.982 . . . . 0.0 110.15 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 84' ' ' VAL . 1.4 p30 -143.89 -56.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.11 104.35 0.77 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -138.11 146.39 42.81 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.537 -1.566 . . . . 0.0 108.255 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . 0.556 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.1 tp-100 -33.72 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.508 -0.745 . . . . 0.0 111.217 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.548 HD11 ' OE1' ' B' ' 37' ' ' GLN . 62.5 tp -146.19 126.16 13.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.69 -147.62 48.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . 0.418 ' CB ' ' OG ' ' B' ' 32' ' ' SER . 0.2 OUTLIER -92.36 -18.87 22.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.054 -1.263 . . . . 0.0 109.537 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' B' ' 92' ' ' LEU . 60.2 mtp180 -131.02 161.19 32.53 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.458 ' O ' ' C ' ' B' ' 97' ' ' LEU . 8.9 m-85 -94.57 137.41 33.73 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.2 -0.937 . . . . 0.0 110.072 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.574 ' H ' HD23 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -40.44 145.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -109.74 151.98 26.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 11.0 p -77.37 108.46 10.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.471 -0.768 . . . . 0.0 109.214 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -87.0 173.17 44.6 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 54.8 p90 -152.15 -32.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -1.065 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . 0.62 ' O ' HG21 ' B' ' 27' ' ' VAL . 74.3 m -37.01 143.33 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.35 -0.844 . . . . 0.0 110.666 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . 0.561 ' CB ' ' HE ' ' C' ' 232' ' ' ARG . 32.9 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.327 0.584 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.8 OUTLIER 170.36 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . 0.585 ' NZ ' ' NZ ' ' C' ' 189' ' ' LYS . 12.1 ttmm -83.7 140.22 32.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.036 -1.04 . . . . 0.0 108.275 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 2.4 ptm -125.78 169.92 12.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.952 -1.092 . . . . 0.0 109.323 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -121.5 80.8 1.72 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.567 -0.708 . . . . 0.0 109.693 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . 0.404 ' H ' HG12 ' C' ' 163' ' ' ILE . 1.7 mm -50.29 131.98 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.88 156.36 22.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.39 28.42 61.78 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.41 142.32 53.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.52 -0.988 . . . . 0.0 109.768 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' C' ' 169' ' ' ASP . 47.5 t30 -69.27 140.89 54.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . 0.493 ' O ' ' OD1' ' C' ' 169' ' ' ASP . 7.5 m0 -63.63 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.069 -1.019 . . . . 0.0 110.307 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' C' ' 167' ' ' ASN . 57.4 m-20 -157.66 64.95 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.938 -1.102 . . . . 0.0 109.825 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 34.0 m -134.16 153.3 51.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.133 -0.98 . . . . 0.0 110.688 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.97 167.71 11.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.495 -0.753 . . . . 0.0 109.117 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.69 -67.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.754 -1.216 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -47.23 -36.13 8.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.034 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . 0.444 ' OD1' ' C ' ' C' ' 174' ' ' ASN . 1.6 t30 -69.74 -52.21 27.44 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.445 ' HB2' HD12 ' C' ' 190' ' ' ILE . 12.4 tp -55.46 -41.84 73.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' C' ' 177' ' ' GLU . 25.4 ttp85 -66.12 -60.43 2.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.103 -0.998 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -44.76 -31.35 1.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.231 -0.918 . . . . 0.0 108.783 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.715 ' CD2' HD12 ' C' ' 223' ' ' LEU . 21.8 t80 -76.01 -49.58 17.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.739 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.781 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.4 m-85 -72.16 -49.37 36.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.309 -0.869 . . . . 0.0 111.664 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.21 23.91 0.01 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 119.568 -1.958 . . . . 0.0 112.405 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . 0.781 ' N ' ' O ' ' C' ' 179' ' ' PHE . 4.9 ttpm? -90.24 -13.85 34.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.89 -1.359 . . . . 0.0 107.614 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . 0.609 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 32.0 m-85 -91.08 -62.69 1.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.4 -125.22 2.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 27.4 m -122.89 145.61 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -1.0 . . . . 0.0 109.86 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.409 HG21 HD11 ' C' ' 205' ' ' LEU . 14.2 p -127.66 142.61 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.424 HG23 ' N ' ' C' ' 187' ' ' ASP . 9.7 t -97.1 -37.47 10.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 110.337 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' C' ' 206' ' ' SER . 42.9 t0 -165.08 160.39 18.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.986 -1.071 . . . . 0.0 110.202 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.36 147.71 22.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . 0.585 ' NZ ' ' NZ ' ' C' ' 160' ' ' LYS . 23.6 mttp -114.86 90.85 3.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 110.175 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' C' ' 175' ' ' LEU . 10.3 tt -84.79 142.35 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . 0.533 ' O ' ' C ' ' C' ' 192' ' ' LYS . 0.0 OUTLIER -98.85 -47.56 5.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.188 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' C' ' 191' ' ' MET . 0.1 OUTLIER -30.8 124.53 0.19 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.636 0.732 . . . . 0.0 110.214 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.438 ' CG ' ' OG1' ' C' ' 196' ' ' THR . 15.7 t0 -134.45 87.16 33.13 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.13 -22.62 75.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.312 2.008 . . . . 0.0 111.389 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.41 -52.51 15.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.627 -0.67 . . . . 0.0 109.894 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' C' ' 193' ' ' ASP . 3.0 p -70.61 -35.9 73.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 109.78 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 153.9 -76.22 0.22 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -168.65 155.1 7.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -1.18 . . . . 0.0 110.171 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . 0.428 ' O ' ' C ' ' C' ' 200' ' ' ARG . 23.0 t -151.68 168.73 24.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' C' ' 199' ' ' SER . 14.1 mmp_? -46.44 143.52 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.937 -1.102 . . . . 0.0 108.286 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.27 91.25 1.42 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.121 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' C' ' 202' ' ' PHE . 25.1 p90 -152.25 167.17 29.47 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.38 130.99 3.32 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 118.149 -1.977 . . . . 0.0 110.766 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.14 120.7 29.74 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 119.992 -1.887 . . . . 0.0 107.271 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.409 HD11 HG21 ' C' ' 185' ' ' VAL . 0.1 OUTLIER -108.33 104.79 14.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 109.148 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.4 OUTLIER -80.44 73.08 7.35 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.543 0.687 . . . . 0.0 109.606 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' C' ' 216' ' ' VAL . 10.3 m-85 -67.95 114.74 6.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.981 -1.074 . . . . 0.0 109.408 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.75 -48.03 83.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 108.947 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' C' ' 211' ' ' SER . 1.8 mtmp? -84.36 101.3 1.41 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.992 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -39.38 -23.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 121.871 1.714 . . . . 0.0 112.704 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.473 ' N ' ' O ' ' C' ' 209' ' ' LYS . 17.9 t -62.26 -57.1 12.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.013 -1.054 . . . . 0.0 110.585 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.751 ' O ' HG23 ' C' ' 216' ' ' VAL . 24.7 m -41.51 -34.91 0.62 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.29 -0.881 . . . . 0.0 109.53 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . 0.611 ' O ' HG12 ' C' ' 217' ' ' VAL . 86.6 t -65.97 -43.02 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' C' ' 211' ' ' SER . 61.8 t0 -60.83 -50.64 72.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 0.0 110.506 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' C' ' 219' ' ' THR . 19.7 pt-20 -73.63 -31.83 63.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.967 -1.083 . . . . 0.0 109.972 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.751 HG23 ' O ' ' C' ' 212' ' ' SER . 22.6 t -61.48 -50.99 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.747 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.611 HG12 ' O ' ' C' ' 213' ' ' VAL . 8.5 p -74.02 -29.9 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.511 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -85.01 17.48 2.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.495 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' C' ' 215' ' ' GLU . 32.0 m -136.43 147.3 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.921 -1.112 . . . . 0.0 109.46 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -102.63 136.33 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.248 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.705 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -139.82 167.65 21.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.858 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.0 107.2 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.825 . . . . 0.0 108.899 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.715 HD12 ' CD2' ' C' ' 178' ' ' TYR . 1.0 OUTLIER -73.43 -71.96 0.29 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 109.796 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . 0.574 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 60.2 t0 -84.95 0.45 51.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.039 -1.038 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.03 13.23 72.21 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . 0.866 ' O ' HG13 ' C' ' 227' ' ' VAL . 1.2 tpmt? -90.09 -78.76 0.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -1.019 . . . . 0.0 109.325 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . 0.866 HG13 ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 174.75 109.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.251 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . 0.416 HD13 HG21 ' C' ' 228' ' ' ILE . 17.9 pt -113.96 148.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.706 -0.621 . . . . 0.0 110.132 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.43 96.68 38.36 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.441 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 46.8 Cg_endo -85.4 125.31 2.93 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.564 2.176 . . . . 0.0 112.028 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -141.18 143.05 34.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.699 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.561 ' HE ' ' CB ' ' C' ' 158' ' ' SER . 75.1 ttt-85 -57.45 153.96 11.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 108.591 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -44.31 137.57 3.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 108.856 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.92 135.99 22.51 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.406 -0.809 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.24 139.19 16.39 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.809 1.672 . . . . 0.0 112.125 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.25 -44.58 88.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.518 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 34.0 p-10 -63.31 -38.65 91.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 109.856 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . 0.676 ' O ' HG23 ' C' ' 242' ' ' THR . 48.6 tp10 -66.0 -40.34 91.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.399 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . 0.467 ' O ' ' OG1' ' C' ' 242' ' ' THR . 14.3 tt0 -62.31 -43.91 97.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.1 -39.24 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.049 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -63.32 -39.53 94.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.936 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . 0.7 HG22 ' HA ' ' C' ' 292' ' ' ASP . 66.9 p -50.76 141.65 12.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.851 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.09 160.5 14.74 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . 0.623 ' O ' ' HB2' ' C' ' 318' ' ' ALA . 22.9 tttt -136.37 133.39 36.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.243 . . . . 0.0 110.45 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.505 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -119.61 147.57 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.51 -0.744 . . . . 0.0 109.463 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 4.7 t80 -103.0 130.42 50.09 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 10.1 t -100.14 134.97 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.784 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 249' ' ' GLY . . . -105.89 155.85 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 248' ' ' GLY . . . 59.66 141.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.458 ' CG1' HG11 ' C' ' 254' ' ' VAL . 2.7 tp -162.5 164.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.427 -1.043 . . . . 0.0 109.158 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . 0.428 ' O ' HG23 ' C' ' 250' ' ' ILE . . . -54.82 155.03 8.86 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.81 -28.78 86.99 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.548 2.166 . . . . 0.0 112.119 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.69 73.98 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' C' ' 308' ' ' PHE . 8.5 p -111.05 134.58 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.638 0.732 . . . . 0.0 109.932 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -96.32 157.05 36.19 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -57.74 -21.75 49.49 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.593 2.196 . . . . 0.0 111.859 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -51.98 -63.66 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.605 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . 0.731 ' O ' ' N ' ' C' ' 261' ' ' GLU . 76.0 mm-40 -58.21 -88.11 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . 0.619 ' C ' ' O ' ' C' ' 258' ' ' GLU . 36.9 t80 -9.59 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.309 0.576 . . . . 0.0 111.449 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' C' ' 258' ' ' GLU . 96.9 mt-10 -56.71 -44.29 81.43 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.07 -1.019 . . . . 0.0 109.404 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . 0.731 ' N ' ' O ' ' C' ' 258' ' ' GLU . 76.3 mm-40 -69.44 -40.28 77.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . 0.417 ' O ' ' CG ' ' C' ' 265' ' ' GLN . 70.3 t80 -49.37 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.505 -0.747 . . . . 0.0 109.363 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.471 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 93.5 m-85 -55.39 -32.12 62.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.576 -1.328 . . . . 0.0 110.465 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.423 ' C ' ' O ' ' C' ' 263' ' ' PHE . 13.0 t -38.29 -38.32 0.35 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.822 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' C' ' 264' ' ' SER . 0.2 OUTLIER -52.11 -95.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.322 -1.486 . . . . 0.0 109.9 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.471 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -63.56 152.55 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.29 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 52.96 103.2 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 60.5 m -49.9 138.47 15.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.245 . . . . 0.0 107.785 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.619 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -99.63 104.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.103 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.5 -50.29 35.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.8 -1.187 . . . . 0.0 109.189 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' C' ' 290' ' ' THR . 57.4 t0 -142.36 98.05 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 109.611 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -128.25 166.39 18.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 109.419 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.1 OUTLIER 167.26 162.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.214 1.007 . . . . 0.0 111.367 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 5.9 tp -99.82 144.24 29.1 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . 0.752 ' O ' HD22 ' C' ' 276' ' ' LEU . 23.0 mmm -92.01 160.02 15.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.195 -1.566 . . . . 0.0 108.304 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.752 HD22 ' O ' ' C' ' 275' ' ' MET . 0.3 OUTLIER -143.28 153.3 42.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' C' ' 281' ' ' GLY . 0.0 OUTLIER -49.73 -31.89 12.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 108.619 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . 0.51 ' O ' ' NZ ' ' C' ' 226' ' ' LYS . 57.4 tttp -54.99 -40.46 70.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.366 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' C' ' 275' ' ' MET . 91.3 m-20 -60.9 -37.4 82.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.35 -39.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.777 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' C' ' 277' ' ' ASP . . . 125.63 30.64 0.88 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' C' ' 284' ' ' ARG . 60.8 mm-40 -119.4 42.72 2.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.352 -1.087 . . . . 0.0 110.13 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . 0.467 ' O ' ' OG ' ' C' ' 283' ' ' SER . 6.6 t -62.51 39.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.247 -0.908 . . . . 0.0 110.032 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . 0.606 ' N ' ' O ' ' C' ' 282' ' ' GLN . 68.2 mtp85 -55.87 -34.17 65.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -0.974 . . . . 0.0 109.44 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.85 79.55 0.38 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' C' ' 282' ' ' GLN . 0.0 OUTLIER -146.75 -176.02 5.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.578 -1.542 . . . . 0.0 111.984 -178.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -157.89 164.65 33.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -138.06 151.02 47.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.951 -1.323 . . . . 0.0 108.55 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -146.29 141.97 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.433 -1.417 . . . . 0.0 108.389 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 23.9 m -130.12 129.24 43.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.044 -1.035 . . . . 0.0 109.988 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.98 156.0 27.04 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . 0.7 ' HA ' HG22 ' C' ' 242' ' ' THR . 54.2 p30 -79.95 15.54 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.733 -1.23 . . . . 0.0 109.714 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 22.7 t -158.76 168.57 26.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.195 -0.94 . . . . 0.0 108.985 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.05 -12.05 20.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -57.31 -48.32 79.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.469 -0.769 . . . . 0.0 109.162 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.22 88.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.047 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.08 -57.74 6.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.22 -30.23 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' C' ' 302' ' ' GLN . 59.2 ttm-85 -63.86 -64.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.44 -0.787 . . . . 0.0 109.325 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.439 ' HB ' ' HE1' ' C' ' 266' ' ' TRP . 9.0 p -65.54 -23.0 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.415 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . 0.498 ' SG ' ' NH1' ' C' ' 317' ' ' ARG . 45.0 t -48.24 -57.32 6.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.062 -1.024 . . . . 0.0 109.706 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' C' ' 299' ' ' ARG . 3.9 pt20 -49.45 -22.33 1.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.109 . . . . 0.0 108.515 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' C' ' 300' ' ' VAL . 92.4 m-20 -99.67 69.73 1.62 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.9 -82.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.672 -1.268 . . . . 0.0 108.869 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -69.63 126.6 30.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.162 -0.961 . . . . 0.0 109.493 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 59.6 mt -120.22 145.45 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.37 114.69 11.87 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' C' ' 309' ' ' LYS . 22.1 t80 -114.59 -178.08 3.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.578 ' C ' ' O ' ' C' ' 308' ' ' PHE . 73.8 mttt -19.75 -82.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 0.0 111.998 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' C' ' 311' ' ' ARG . 47.6 p30 -127.97 -16.41 4.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 110.201 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . 0.429 ' N ' ' OD1' ' C' ' 310' ' ' ASP . 40.1 mtp180 -121.2 125.81 48.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -52.77 164.96 0.31 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.43 -0.793 . . . . 0.0 109.398 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.59 122.85 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.83 103.79 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 0.0 109.68 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.505 ' CG2' HD12 ' C' ' 245' ' ' ILE . 5.6 mm -72.53 146.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.014 -1.054 . . . . 0.0 110.046 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -154.04 152.39 30.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . 0.705 ' CD ' ' H ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER -59.73 149.69 30.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 108.998 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' C' ' 244' ' ' LYS . . . -50.77 -25.32 4.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.899 -1.126 . . . . 0.0 108.921 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 179.232 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.57 ' O ' ' CG ' ' B' ' 101' ' ' TYR . 16.1 Cg_exo -63.05 -176.92 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.819 2.346 . . . . 0.0 111.84 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 23' ' ' PRO . 71.0 Cg_endo -86.9 25.79 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.91 2.407 . . . . 0.0 112.811 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.58 107.22 2.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.907 -1.121 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.475 ' CA ' ' OG ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -162.74 -40.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' B' ' 28' ' ' VAL . 1.2 p -139.56 158.0 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.664 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.436 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.9 t -108.59 134.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 9.1 m-30 -99.51 117.08 33.12 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.603 0.716 . . . . 0.0 109.682 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.73 HD11 HD23 ' B' ' 97' ' ' LEU . 1.1 mm? -101.98 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' B' ' 33' ' ' ILE . . . -146.75 -53.84 0.02 OUTLIER Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.986 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 27.6 t -69.5 30.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -1.21 . . . . 0.0 109.981 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.642 HD12 ' N ' ' B' ' 33' ' ' ILE . 4.9 mp -108.71 136.37 19.98 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -87.64 -176.01 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.743 1.629 . . . . 0.0 111.444 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.606 ' OH ' ' CG ' ' B' ' 59' ' ' PHE . 3.0 m-30 -67.1 0.45 2.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.73 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.577 ' CB ' HE22 ' B' ' 37' ' ' GLN . 62.7 m-20 -67.08 -45.27 77.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.964 -1.085 . . . . 0.0 108.968 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.577 HE22 ' CB ' ' B' ' 36' ' ' ASP . 11.8 mp0 -107.25 100.32 9.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.236 -0.915 . . . . 0.0 109.09 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -98.57 -153.95 0.45 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.651 -0.656 . . . . 0.0 110.079 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 40.2 tt0 -57.22 -26.29 60.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.141 -0.974 . . . . 0.0 109.884 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.7 -56.84 6.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.507 -0.746 . . . . 0.0 110.997 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.27 -41.63 80.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.948 . . . . 0.0 111.479 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.4 ' N ' HD13 ' B' ' 42' ' ' ILE . 6.0 mm -63.19 -52.28 60.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' B' ' 47' ' ' SER . 32.4 tp -58.5 -36.63 74.08 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -55.34 -74.77 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.416 1.103 . . . . 0.0 109.979 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -45.63 90.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.089 -177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' B' ' 48' ' ' ASN . 96.6 m -61.59 -68.67 0.3 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.003 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 87.7 p -33.39 -31.41 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.0 OUTLIER -78.37 -43.35 27.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.976 -1.078 . . . . 0.0 109.431 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.638 HG21 HD11 ' B' ' 87' ' ' LEU . 13.2 t -43.4 -56.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.564 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.9 -158.79 11.63 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.938 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' B' ' 52' ' ' VAL . 57.9 Cg_endo -79.9 82.08 2.59 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.798 2.332 . . . . 0.0 112.788 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.556 ' O ' ' O ' ' B' ' 51' ' ' PRO . 0.3 OUTLIER -51.08 -166.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.49 ' H ' HG12 ' B' ' 52' ' ' VAL . 0.7 OUTLIER -160.09 -57.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.594 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 78.6 m-20 -117.91 132.64 56.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.428 HD12 ' N ' ' B' ' 56' ' ' LYS . 16.9 tp -133.0 126.36 31.77 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.428 ' N ' HD12 ' B' ' 55' ' ' LEU . 59.4 mttp -138.7 138.0 37.33 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.068 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' B' ' 70' ' ' ALA . 1.8 tpt -127.9 134.32 49.35 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . 0.599 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.1 OUTLIER -153.66 150.13 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 109.87 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.606 ' CG ' ' OH ' ' B' ' 35' ' ' TYR . 4.0 m-85 -106.33 -177.54 3.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.345 -0.847 . . . . 0.0 109.555 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.643 ' CG ' ' H ' ' B' ' 66' ' ' SER . 13.6 m-20 -103.98 71.89 0.17 Allowed Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.908 -1.12 . . . . 0.0 111.939 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 17.0 Cg_exo -49.22 -65.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.239 1.959 . . . . 0.0 112.88 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -85.2 -54.14 4.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.429 -0.794 . . . . 0.0 110.255 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.42 ' C ' ' H ' ' B' ' 65' ' ' ARG . 62.4 p -51.99 -38.4 56.6 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.224 -0.923 . . . . 0.0 108.751 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' B' ' 60' ' ' ASP . . . 60.73 3.24 3.05 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' B' ' 63' ' ' THR . 83.0 mtt85 -65.83 -37.8 87.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.387 -1.067 . . . . 0.0 111.138 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.643 ' H ' ' CG ' ' B' ' 60' ' ' ASP . 0.8 OUTLIER -155.4 150.12 26.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.379 -1.451 . . . . 0.0 112.305 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -115.98 77.97 1.14 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.65 54.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' B' ' 66' ' ' SER . 2.5 m-85 -104.48 127.33 52.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 108.602 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.693 ' HB2' ' SD ' ' B' ' 57' ' ' MET . . . -144.35 145.85 32.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.441 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -124.77 129.63 50.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 109.775 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.49 108.67 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.701 -0.799 . . . . 0.0 111.701 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.594 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 31.9 tt0 -92.9 134.12 35.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.352 -1.468 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -96.66 171.63 8.41 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.858 0.837 . . . . 0.0 110.415 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' B' ' 76' ' ' ASP . 4.0 tpt180 -42.88 -40.84 3.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.785 -0.572 . . . . 0.0 112.322 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' B' ' 78' ' ' GLU . 17.8 t70 166.61 -177.73 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.35 0.595 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.791 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.0 mm? -39.58 -21.88 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.072 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.2 mm-40 -70.59 -74.42 0.14 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.753 -1.217 . . . . 0.0 109.096 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 29.8 m -60.87 -41.89 96.86 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.55 ' O ' HG23 ' B' ' 84' ' ' VAL . 0.1 OUTLIER -62.35 -29.93 70.81 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.076 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.791 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -67.23 -60.91 2.21 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.947 -1.095 . . . . 0.0 108.461 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.589 ' O ' ' OD1' ' B' ' 86' ' ' ASN . 59.0 m -61.51 -45.77 92.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.452 -0.78 . . . . 0.0 110.792 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.566 ' CB ' HG11 ' B' ' 49' ' ' VAL . . . -68.46 -67.31 0.48 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.62 HG12 ' ND2' ' B' ' 88' ' ' ASN . 16.1 t -49.73 -31.77 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.8 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.582 ' HE ' ' C ' ' B' ' 81' ' ' ALA . 76.2 mtm180 -65.0 -52.44 56.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 109.559 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.589 ' OD1' ' O ' ' B' ' 82' ' ' SER . 0.0 OUTLIER -75.08 -42.8 56.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 117.973 -1.491 . . . . 0.0 108.183 178.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.638 HD11 HG21 ' B' ' 49' ' ' VAL . 17.1 mt -79.63 -2.08 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 110.185 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.62 ' ND2' HG12 ' B' ' 84' ' ' VAL . 0.5 OUTLIER -48.51 -82.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.55 114.9 1.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.989 ' CE1' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -139.71 149.76 44.03 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 119.936 1.868 . . . . 0.0 110.821 -179.169 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -47.87 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.102 -1.624 . . . . 0.0 110.044 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -154.71 113.09 3.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.247 -0.908 . . . . 0.0 108.627 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.55 -171.83 36.86 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 44.9 m -79.44 -14.74 58.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.899 -1.353 . . . . 0.0 109.929 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.435 ' N ' ' OG ' ' B' ' 32' ' ' SER . 14.8 ttm180 -146.78 163.64 35.36 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.3 m-85 -93.41 127.36 39.0 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.867 -1.146 . . . . 0.0 110.502 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.989 HD11 ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -41.37 156.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.383 0.611 . . . . 0.0 109.482 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -111.27 149.23 31.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.568 -0.708 . . . . 0.0 110.124 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' OD1' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -75.07 113.69 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.777 -0.577 . . . . 0.0 109.64 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -111.21 161.81 12.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' B' ' 23' ' ' PRO . 5.2 p90 -148.37 108.46 4.07 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.479 -1.013 . . . . 0.0 109.21 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 29.6 t -144.72 128.56 17.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.274 -0.891 . . . . 0.0 109.272 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.1 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . 0.41 ' SG ' ' CG2' ' C' ' 213' ' ' VAL . 8.6 t -116.04 87.32 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.057 0.932 . . . . 0.0 109.527 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -94.63 148.88 21.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . 0.56 ' SD ' HG21 ' C' ' 216' ' ' VAL . 0.1 OUTLIER -115.72 170.7 8.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.998 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -128.81 68.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . 0.907 HG22 HD21 ' C' ' 166' ' ' LEU . 8.2 mm -57.26 129.39 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.79 -173.9 13.26 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' C' ' 227' ' ' VAL . . . 53.94 27.23 36.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . 0.907 HD21 HG22 ' C' ' 163' ' ' ILE . 4.1 mm? -59.73 161.93 5.76 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.353 -1.087 . . . . 0.0 108.559 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' C' ' 168' ' ' TRP . 3.2 p30 -68.2 -71.84 0.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . 0.559 ' N ' ' OD1' ' C' ' 167' ' ' ASN . 0.1 OUTLIER 178.56 -32.97 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.884 -1.135 . . . . 0.0 109.636 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.29 96.96 3.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 11.9 m -129.21 141.94 51.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.872 . . . . 0.0 108.958 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . 0.58 ' OG1' ' ND2' ' C' ' 174' ' ' ASN . 0.2 OUTLIER -92.56 156.59 17.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 109.594 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.81 -63.92 1.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.275 -0.891 . . . . 0.0 110.526 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.55 -33.53 22.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.929 -1.107 . . . . 0.0 109.696 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . 0.58 ' ND2' ' OG1' ' C' ' 171' ' ' THR . 87.9 m-20 -70.45 -50.84 34.12 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.911 0.863 . . . . 0.0 108.68 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' C' ' 190' ' ' ILE . 0.6 OUTLIER -59.77 -37.76 79.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.655 -0.653 . . . . 0.0 110.011 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -69.4 -60.74 2.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.48 -28.1 4.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.329 -0.857 . . . . 0.0 108.816 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' C' ' 178' ' ' TYR . 18.6 t80 -70.08 -53.61 16.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.922 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.763 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.6 m-85 -72.87 -41.87 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.608 -0.683 . . . . 0.0 112.501 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.77 30.01 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 119.347 -2.096 . . . . 0.0 111.431 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . 0.763 ' N ' ' O ' ' C' ' 179' ' ' PHE . 28.5 ttmt -94.01 -12.27 29.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 44.0 m-85 -99.77 -50.7 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.405 0.622 . . . . 0.0 109.744 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -143.66 -130.89 2.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 39.7 m -122.76 141.25 52.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -1.064 . . . . 0.0 109.567 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.498 HG22 ' CE1' ' C' ' 207' ' ' PHE . 59.7 t -117.96 135.34 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.409 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.422 HG22 ' H ' ' C' ' 186' ' ' THR . 0.6 OUTLIER -95.19 -41.52 9.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.921 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -160.1 158.0 29.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 109.657 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.885 HD12 ' N ' ' C' ' 189' ' ' LYS . 0.6 OUTLIER -139.97 140.38 36.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . 0.885 ' N ' HD12 ' C' ' 188' ' ' LEU . 0.2 OUTLIER -105.74 92.51 4.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.175 . . . . 0.0 110.2 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . 0.629 ' CD1' HD12 ' C' ' 175' ' ' LEU . 1.8 tt -117.13 145.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 13.0 ptp -154.19 61.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 109.986 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -68.22 171.86 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.998 -1.064 . . . . 0.0 109.614 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -52.51 124.71 34.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 108.962 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.98 -4.82 15.98 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.153 1.902 . . . . 0.0 112.706 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.67 -85.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 32.5 p -98.69 -12.57 20.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 110.018 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 79.84 18.96 71.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -96.13 74.72 2.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.298 . . . . 0.0 110.176 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . 0.571 ' O ' ' O ' ' C' ' 200' ' ' ARG . 37.0 m -167.31 171.64 10.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.576 ' NE ' ' C ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -34.98 162.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 110.128 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.06 108.29 0.36 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.53 ' CE2' ' NH2' ' C' ' 200' ' ' ARG . 7.8 p90 -130.41 158.1 40.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -1.097 . . . . 0.0 109.377 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.16 116.96 1.54 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.747 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.07 82.72 6.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.716 -1.461 . . . . 0.0 107.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.5 mt -70.59 104.14 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.935 . . . . 0.0 111.621 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.0 t -76.75 76.34 3.39 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.498 ' CE1' HG22 ' C' ' 185' ' ' VAL . 2.6 m-85 -64.5 122.84 17.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.526 -0.734 . . . . 0.0 110.459 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.19 -47.12 71.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.163 -0.961 . . . . 0.0 109.397 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -93.96 118.5 67.27 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.802 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . 0.674 ' O ' HG12 ' C' ' 213' ' ' VAL . 2.4 Cg_endo -62.14 -2.25 2.91 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.516 ' O ' ' N ' ' C' ' 213' ' ' VAL . 18.6 t -74.53 -70.44 0.4 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.707 -1.246 . . . . 0.0 109.877 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.432 ' C ' ' O ' ' C' ' 211' ' ' SER . 28.2 t -39.28 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.5 -0.75 . . . . 0.0 109.96 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . 0.674 HG12 ' O ' ' C' ' 210' ' ' PRO . 0.5 OUTLIER -61.99 -20.18 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.765 -1.209 . . . . 0.0 110.106 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.97 -45.09 9.94 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.045 0.926 . . . . 0.0 108.863 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . 0.5 ' OE2' ' OG1' ' C' ' 219' ' ' THR . 48.7 tp10 -70.92 -27.85 64.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.79 -0.569 . . . . 0.0 109.849 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.56 HG21 ' SD ' ' C' ' 161' ' ' MET . 3.3 p -61.41 -49.11 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.541 ' N ' HG13 ' C' ' 216' ' ' VAL . 14.4 p -78.27 -40.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.94 -1.1 . . . . 0.0 109.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . 0.481 ' N ' HG13 ' C' ' 217' ' ' VAL . 42.0 tptt -59.4 -48.67 80.75 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.441 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . 0.5 ' OG1' ' OE2' ' C' ' 215' ' ' GLU . 28.6 m -79.06 155.07 28.95 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.738 0.78 . . . . 0.0 110.898 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -112.07 138.45 48.71 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.809 ' O ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -136.44 163.19 31.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . 0.809 HD13 ' O ' ' C' ' 221' ' ' HIS . 1.0 OUTLIER -132.26 119.47 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.416 ' HA ' ' CE2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -50.51 -72.28 0.05 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -126.22 20.7 7.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 109.171 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.42 8.94 58.26 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . 0.689 ' NZ ' ' NZ ' ' C' ' 278' ' ' LYS . 2.1 tpmt? -87.58 -76.8 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.368 -1.077 . . . . 0.0 109.188 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' C' ' 165' ' ' GLY . 1.2 t 169.13 135.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.385 -0.822 . . . . 0.0 109.629 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 17.9 pt -139.62 159.18 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.625 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.79 98.05 12.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 109.088 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.458 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 83.8 Cg_endo -87.94 123.33 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.964 2.442 . . . . 0.0 113.252 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -141.61 139.1 33.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.054 . . . . 0.0 109.6 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' C' ' 233' ' ' ALA . 70.7 ttt180 -66.54 151.46 47.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.081 . . . . 0.0 109.868 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.64 138.17 4.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' C' ' 232' ' ' ARG . 3.4 mt -134.74 119.09 13.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.924 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -45.94 156.03 0.51 Allowed 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.037 1.825 . . . . 0.0 111.551 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.447 ' CZ ' HE22 ' C' ' 239' ' ' GLN . 0.3 OUTLIER -60.16 -45.62 92.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 0.0 110.485 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.13 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -70.42 -39.51 74.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.89 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . 0.447 HE22 ' CZ ' ' C' ' 236' ' ' ARG . 6.7 tt0 -58.45 -39.46 79.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.06 -36.71 84.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.975 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . 0.515 ' O ' ' C ' ' C' ' 242' ' ' THR . 19.4 tttt -56.77 -65.71 0.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . 0.515 ' C ' ' O ' ' C' ' 241' ' ' LYS . 39.9 p -33.04 145.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.779 -0.575 . . . . 0.0 110.074 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -131.38 147.32 18.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 130.58 27.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -1.205 . . . . 0.0 109.832 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.584 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -123.42 152.59 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.701 0.762 . . . . 0.0 109.679 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -108.16 136.09 48.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.675 -0.641 . . . . 0.0 109.329 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . 0.595 HG11 HD12 ' C' ' 313' ' ' ILE . 9.7 t -109.6 144.26 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.551 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 168.1 14.45 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . 0.582 ' O ' ' NH1' ' C' ' 311' ' ' ARG . . . 88.65 17.54 56.53 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 121.107 -1.231 . . . . 0.0 110.349 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.73 ' CG2' HG11 ' C' ' 254' ' ' VAL . 4.6 mt -116.04 136.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -1.053 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . 0.715 ' O ' HG12 ' C' ' 254' ' ' VAL . . . -108.67 178.15 20.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.96 -20.41 38.68 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.623 2.215 . . . . 0.0 112.379 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -56.1 -35.7 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.906 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.73 HG11 ' CG2' ' C' ' 250' ' ' ILE . 2.8 p -76.78 148.01 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.161 -0.962 . . . . 0.0 109.584 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -106.18 158.31 32.85 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.51 -21.31 61.28 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.455 2.103 . . . . 0.0 111.276 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -62.71 -54.76 34.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.04 -43.24 95.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -56.29 -59.67 4.61 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 109.936 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' C' ' 264' ' ' SER . 84.5 tt0 -60.66 -49.16 78.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . 0.453 ' C ' ' HG ' ' C' ' 264' ' ' SER . 47.4 tp10 -57.98 -22.56 49.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 0.0 108.75 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . 0.476 ' O ' ' OE1' ' C' ' 265' ' ' GLN . 67.6 t80 -81.25 -79.73 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.537 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 91.4 m-85 -52.61 -33.61 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.023 -1.048 . . . . 0.0 110.162 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.58 ' HA ' HD13 ' C' ' 269' ' ' ILE . 2.7 p -35.59 -38.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 111.996 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.62 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 1.8 pt20 -57.09 -90.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.422 -1.424 . . . . 0.0 110.339 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.62 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.7 OUTLIER -67.47 150.93 48.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.548 -1.345 . . . . 0.0 110.203 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . 0.405 ' O ' HD12 ' C' ' 269' ' ' ILE . . . 59.43 95.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 47.6 m -48.05 137.11 10.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.878 -1.366 . . . . 0.0 108.232 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.711 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -94.65 96.93 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 111.059 -178.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' C' ' 292' ' ' ASP . 6.4 mm -67.93 -39.57 81.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.449 -1.407 . . . . 0.0 108.497 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.59 92.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.439 -0.788 . . . . 0.0 109.506 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -123.42 172.33 8.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 109.888 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.0 OUTLIER 169.29 160.11 0.05 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.167 0.984 . . . . 0.0 111.277 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' C' ' 275' ' ' MET . 0.1 OUTLIER -107.7 152.59 24.12 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . 0.443 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 0.0 OUTLIER -87.78 -179.12 6.21 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.492 -1.38 . . . . 0.0 109.858 -178.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.583 ' N ' ' OG1' ' C' ' 280' ' ' THR . 0.9 OUTLIER -153.21 -160.47 1.13 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.999 -1.063 . . . . 0.0 110.259 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' C' ' 283' ' ' SER . 1.2 m-20 -61.79 -85.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.281 -0.887 . . . . 0.0 111.58 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . 0.689 ' NZ ' ' NZ ' ' C' ' 226' ' ' LYS . 11.3 tptp -103.69 -32.11 9.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 109.805 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.54 -39.03 75.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 75.6 p -151.14 132.33 14.45 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.688 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.84 -127.95 28.72 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' C' ' 283' ' ' SER . 96.3 mt-30 -141.53 147.26 37.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -1.078 . . . . 0.0 110.987 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . 0.595 ' O ' ' N ' ' C' ' 285' ' ' GLY . 0.0 OUTLIER -16.57 -52.22 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.106 -177.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' C' ' 282' ' ' GLN . 97.3 mtt180 -69.21 47.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' C' ' 283' ' ' SER . . . -40.36 102.46 0.02 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' C' ' 286' ' ' PHE . 0.0 OUTLIER -67.42 -163.73 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -130.21 149.92 19.03 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.923 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -139.39 151.61 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 2.3 t -147.77 143.24 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.735 -1.228 . . . . 0.0 108.501 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 24.4 m -129.7 125.32 35.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.106 -0.996 . . . . 0.0 108.974 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -115.94 144.79 43.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . 0.469 ' HB2' HD11 ' C' ' 270' ' ' ILE . 11.4 t70 -57.17 -50.2 73.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.658 -1.276 . . . . 0.0 109.149 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 72.9 m -98.02 178.95 4.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.27 -11.73 14.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -51.18 -44.38 61.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.0 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.85 . . . . 0.0 109.088 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . 0.553 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 59.4 t -60.16 -60.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -57.48 -28.18 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -64.29 -62.93 1.3 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.79 -28.17 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.798 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 67.5 m -45.78 -55.78 6.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 0.0 108.853 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' C' ' 301' ' ' CYS . 15.8 mm100 -47.63 -25.05 1.04 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' C' ' 300' ' ' VAL . 82.7 m-20 -98.98 72.66 1.91 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -65.74 -12.29 52.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.821 -1.174 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -132.0 122.75 26.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.831 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . 0.573 HD12 HD11 ' C' ' 315' ' ' ILE . 46.7 mt -119.93 147.41 23.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 307' ' ' ASP . 47.3 p30 -69.79 159.43 33.6 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 109.012 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.745 ' O ' ' O ' ' C' ' 309' ' ' LYS . 13.9 t80 -167.31 -171.46 1.72 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.745 ' O ' ' O ' ' C' ' 308' ' ' PHE . 68.2 mttt -42.27 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.107 0.956 . . . . 0.0 110.937 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 310' ' ' ASP . 44.6 p30 -61.14 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.375 -1.453 . . . . 0.0 110.912 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' C' ' 309' ' ' LYS . 0.3 OUTLIER -166.75 112.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.979 -1.075 . . . . 0.0 109.641 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.49 168.94 0.5 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . 0.595 HD12 HG11 ' C' ' 247' ' ' VAL . 48.4 pt -133.25 157.21 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 109.937 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . 0.46 ' O ' HG13 ' C' ' 247' ' ' VAL . 64.4 mt-10 -112.2 157.0 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.352 -0.842 . . . . 0.0 109.133 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' C' ' 245' ' ' ILE . 5.7 mm -120.6 142.48 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -156.52 155.14 31.45 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -60.72 143.45 54.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.026 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.58 61.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.322 -0.862 . . . . 0.0 109.383 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 109.774 -179.473 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.449 ' HD2' HH21 ' B' ' 26' ' ' ARG . 30.5 Cg_endo -67.78 157.15 63.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.715 2.277 . . . . 0.0 112.067 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.86 -5.67 16.14 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.927 2.418 . . . . 0.0 112.832 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 75.5 m -148.5 130.23 15.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 109.669 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.449 HH21 ' HD2' ' B' ' 23' ' ' PRO . 23.3 ttp85 179.05 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.51 HG22 ' HG2' ' B' ' 73' ' ' GLU . 76.5 t -116.07 151.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.592 -0.693 . . . . 0.0 109.637 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.4 ' N ' HG12 ' B' ' 27' ' ' VAL . 10.8 t -103.49 131.84 51.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' B' ' 100' ' ' GLY . 3.2 m-85 -102.2 116.93 33.68 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.816 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.49 HD13 ' CD1' ' B' ' 72' ' ' ILE . 4.7 mp -102.71 129.19 49.25 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -106.12 -112.15 3.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.456 ' OG ' ' CG ' ' B' ' 95' ' ' ARG . 10.4 p -70.08 131.0 43.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -1.219 . . . . 0.0 109.331 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.447 HD12 ' O ' ' B' ' 32' ' ' SER . 0.5 OUTLIER -163.42 132.88 3.08 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' B' ' 36' ' ' ASP . 14.8 Cg_endo -60.74 146.6 97.04 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.259 1.306 . . . . 0.0 112.162 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -62.98 3.66 0.22 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' B' ' 34' ' ' PRO . 93.0 m-20 -57.65 -37.77 73.92 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.362 -0.836 . . . . 0.0 108.913 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -119.27 113.23 20.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.769 . . . . 0.0 110.176 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.508 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 67.4 p -106.76 -141.18 0.37 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 0.0 109.88 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.79 -31.39 71.59 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.798 -1.189 . . . . 0.0 111.092 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -73.45 -58.55 3.23 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' B' ' 37' ' ' GLN . 15.4 mt-30 -67.55 -38.51 84.26 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.781 -1.2 . . . . 0.0 109.721 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' B' ' 44' ' ' ASP . 5.7 mm -61.07 -52.66 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' B' ' 42' ' ' ILE . 54.3 tp -37.81 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.151 -0.343 . . . . 0.0 110.826 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' B' ' 42' ' ' ILE . 90.7 m-20 -125.11 -24.76 3.95 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.732 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.783 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.0 tm? -59.77 -39.95 86.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.014 -1.679 . . . . 0.0 106.898 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.653 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.5 m -85.86 -63.81 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 109.065 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.823 ' O ' ' N ' ' B' ' 49' ' ' VAL . 2.5 p -40.03 -15.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.777 -0.577 . . . . 0.0 110.535 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.72 64.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.289 1.042 . . . . 0.0 109.986 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.823 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.4 p 169.89 -33.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.16 160.02 33.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.67 93.56 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.47 2.113 . . . . 0.0 111.731 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -45.67 165.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 109.4 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.424 HD11 ' HG2' ' B' ' 75' ' ' ARG . 40.5 mm -99.38 -47.46 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.25 -0.906 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.487 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 79.5 m-20 -126.54 142.37 51.56 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.49 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 24.9 tp -130.8 129.65 42.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -138.09 134.65 34.94 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.109 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.687 ' SD ' ' HB2' ' B' ' 70' ' ' ALA . 4.7 tpp -126.54 132.51 51.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.734 -0.603 . . . . 0.0 109.445 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 75.2 mtm -151.77 155.96 39.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.472 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.451 ' O ' ' HD3' ' B' ' 61' ' ' PRO . 0.0 OUTLIER -117.86 -177.07 3.17 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 41.1 p-10 -100.7 102.28 18.71 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 110.933 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 37.3 Cg_endo -89.36 -59.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.429 2.086 . . . . 0.0 110.738 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -81.49 -50.23 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.512 -0.743 . . . . 0.0 109.048 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 48.0 p -57.64 -44.35 85.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 109.522 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.441 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 70.03 24.63 76.38 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.539 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 46.4 mmm-85 -118.38 -68.23 0.93 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -1.104 . . . . 0.0 110.277 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD1' ' B' ' 69' ' ' TYR . 0.2 OUTLIER -58.52 118.88 6.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 110.343 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -79.88 -74.25 0.31 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 108.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -117.41 80.54 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . 0.534 ' CD1' ' CB ' ' B' ' 66' ' ' SER . 4.9 m-85 -92.38 132.13 36.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.012 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.687 ' HB2' ' SD ' ' B' ' 57' ' ' MET . . . -143.0 141.18 31.31 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' B' ' 71' ' ' PHE . 2.8 m-85 -114.88 122.92 47.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 109.229 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.49 ' CD1' HD13 ' B' ' 30' ' ' LEU . 3.3 mp -116.69 102.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.866 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.51 ' HG2' HG22 ' B' ' 27' ' ' VAL . 46.5 mt-10 -80.48 128.37 33.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.789 -1.194 . . . . 0.0 111.123 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -93.54 174.22 7.3 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.68 0.752 . . . . 0.0 110.793 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 81.4 mtt-85 -50.5 -41.32 53.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.717 -0.614 . . . . 0.0 110.56 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.77 178.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.821 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -39.81 -19.0 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.566 -0.709 . . . . 0.0 110.392 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.1 tt0 -71.74 -74.69 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.69 -1.256 . . . . 0.0 108.733 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 43.3 m -60.37 -40.5 91.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -34.64 76.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.501 -0.749 . . . . 0.0 109.282 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -61.77 -59.82 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 24.5 t -64.74 -36.83 85.57 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.72 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.09 -64.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 109.988 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' B' ' 88' ' ' ASN . 35.0 t -51.75 -39.29 23.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.018 -1.051 . . . . 0.0 109.627 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.462 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmp_? -69.28 -48.52 61.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.885 -1.134 . . . . 0.0 109.697 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.88 -48.0 15.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.057 . . . . 0.0 109.669 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' B' ' 83' ' ' ALA . 59.4 mt -93.85 27.91 2.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -54.91 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.454 ' HA2' HD12 ' B' ' 97' ' ' LEU . . . -137.48 121.04 2.19 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -136.27 142.67 43.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.513 -1.58 . . . . 0.0 108.796 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . 0.597 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -27.25 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.609 0.719 . . . . 0.0 111.06 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.7 tt -151.44 128.23 10.92 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.696 -0.627 . . . . 0.0 109.309 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' B' ' 92' ' ' LEU . . . 46.36 -175.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 37.4 t -66.02 -17.15 64.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.008 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.456 ' CG ' ' OG ' ' B' ' 32' ' ' SER . 24.5 mmt180 -134.67 149.81 50.56 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.133 -0.98 . . . . 0.0 109.58 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.9 m-85 -103.5 142.77 33.7 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.293 0.568 . . . . 0.0 110.388 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -39.93 151.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -134.87 170.05 16.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.262 -0.899 . . . . 0.0 110.2 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 2.3 p -73.33 -176.08 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.355 -0.841 . . . . 0.0 109.245 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' B' ' 29' ' ' TYR . . . 160.3 177.14 33.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.614 ' O ' ' N ' ' B' ' 103' ' ' SER . 21.8 p90 -149.15 -3.08 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.053 -1.263 . . . . 0.0 111.065 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' B' ' 102' ' ' SER . 0.1 OUTLIER -35.57 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.227 -0.921 . . . . 0.0 110.602 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.614 ' N ' ' O ' ' B' ' 101' ' ' TYR . 17.2 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 120.981 -1.075 . . . . 0.0 109.509 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 99.9 p . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . 0.592 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER 170.35 -26.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -80.97 139.08 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . 0.71 ' SD ' HG11 ' C' ' 216' ' ' VAL . 2.3 ttp -121.32 165.57 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -138.36 77.93 1.65 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.497 -0.752 . . . . 0.0 110.192 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . 0.708 HG22 HD11 ' C' ' 166' ' ' LEU . 49.6 mt -54.19 141.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -137.04 168.51 24.3 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.464 ' H ' ' NH2' ' C' ' 200' ' ' ARG . . . 66.72 31.35 78.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . 0.708 HD11 HG22 ' C' ' 163' ' ' ILE . 7.6 mp -68.26 172.25 6.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 108.046 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' C' ' 168' ' ' TRP . 1.6 t-20 -67.79 -73.23 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.929 -1.107 . . . . 0.0 108.421 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . 0.472 ' N ' ' OD1' ' C' ' 167' ' ' ASN . 0.0 OUTLIER 178.72 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.32 178.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . 0.458 ' OD1' ' CD ' ' C' ' 192' ' ' LYS . 68.5 t0 -135.73 92.34 2.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.892 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 86.6 m -125.8 143.53 51.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.459 -0.775 . . . . 0.0 109.2 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 172.7 8.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.602 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . 0.787 ' OE1' HG23 ' C' ' 190' ' ' ILE . 0.0 OUTLIER -79.06 -71.27 0.45 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.924 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' C' ' 174' ' ' ASN . 90.0 m-20 -40.24 -72.37 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . 0.543 ' C ' ' O ' ' C' ' 173' ' ' ASP . 0.1 OUTLIER -34.7 -44.57 0.22 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.614 HD12 HD13 ' C' ' 190' ' ' ILE . 0.5 OUTLIER -55.98 -57.97 9.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 109.779 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' C' ' 178' ' ' TYR . 7.4 ptm180 -67.28 -54.11 23.81 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . 0.513 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -38.51 -30.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.108 -0.995 . . . . 0.0 108.394 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.534 ' CD2' HD12 ' C' ' 223' ' ' LEU . 20.4 t80 -86.94 -40.19 15.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 110.143 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' C' ' 176' ' ' ARG . 25.8 m-85 -90.94 16.75 8.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.139 -0.976 . . . . 0.0 111.149 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.36 25.74 24.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -102.77 10.87 38.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . 0.488 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 90.3 m-85 -109.62 -77.0 0.6 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.19 -122.09 2.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 38.9 m -124.17 139.94 53.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.556 -0.967 . . . . 0.0 109.416 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.523 HG23 HH21 ' C' ' 176' ' ' ARG . 35.8 m -112.17 139.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.467 HG23 ' N ' ' C' ' 187' ' ' ASP . 11.1 t -105.2 -38.08 6.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.05 -1.031 . . . . 0.0 110.116 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . 0.467 ' N ' HG23 ' C' ' 186' ' ' THR . 17.5 t70 -163.43 166.17 23.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.628 ' N ' HD23 ' C' ' 188' ' ' LEU . 1.8 pt? -161.59 150.8 16.15 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 0.0 108.921 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -124.0 141.66 51.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 109.091 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . 0.787 HG23 ' OE1' ' C' ' 172' ' ' GLU . 1.1 tt -166.61 107.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.059 -1.026 . . . . 0.0 108.392 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . 0.477 ' O ' ' C ' ' C' ' 192' ' ' LYS . 5.2 ptp -115.83 71.45 0.78 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' C' ' 191' ' ' MET . 4.0 pttt -39.25 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.287 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' C' ' 195' ' ' ALA . 4.8 t0 -147.58 106.53 3.77 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -48.31 -5.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' C' ' 193' ' ' ASP . . . -103.47 -85.61 0.45 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . 0.535 HG23 ' N ' ' C' ' 197' ' ' GLY . 10.2 t -103.46 -41.57 5.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 109.764 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . 0.535 ' N ' HG23 ' C' ' 196' ' ' THR . . . 127.35 13.43 2.87 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . 0.425 ' H ' HG23 ' C' ' 196' ' ' THR . 1.6 mmm180 -98.27 86.92 3.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 109.711 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . 0.624 ' O ' ' N ' ' C' ' 201' ' ' GLY . 42.7 t -161.48 149.23 15.06 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' C' ' 201' ' ' GLY . 47.2 tpt85 -42.53 90.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.14 138.15 21.53 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.538 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.443 ' CD2' ' O ' ' C' ' 200' ' ' ARG . 1.1 p90 -138.84 169.47 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -130.78 130.61 6.18 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.142 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -107.33 95.97 6.08 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.4 ' HG ' ' CZ ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -93.02 106.38 18.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -178.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.5 t -77.48 77.35 4.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.395 -0.816 . . . . 0.0 109.531 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.592 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 34.5 m-85 -71.69 107.52 4.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 109.927 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.73 -39.8 81.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -85.25 105.09 5.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.744 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.08 -28.73 20.07 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.744 1.629 . . . . 0.0 112.997 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.545 ' O ' ' N ' ' C' ' 213' ' ' VAL . 83.9 p -68.18 -57.76 5.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.986 -1.072 . . . . 0.0 110.383 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.891 ' O ' HG23 ' C' ' 216' ' ' VAL . 91.2 p -40.81 -22.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.862 . . . . 0.0 109.955 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 211' ' ' SER . 97.1 t -70.4 -37.78 71.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 108.939 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.8 t0 -57.91 -48.86 78.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 109.813 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.13 -36.83 77.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.894 -1.129 . . . . 0.0 109.611 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.891 HG23 ' O ' ' C' ' 212' ' ' SER . 84.2 t -56.14 -46.85 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.767 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.424 HG23 ' N ' ' C' ' 218' ' ' LYS . 25.2 m -78.13 -36.79 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.027 . . . . 0.0 110.102 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . 0.424 ' N ' HG23 ' C' ' 217' ' ' VAL . 3.0 tmtm? -67.14 -50.55 60.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 0.0 109.868 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -73.04 144.85 46.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.688 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -98.66 138.28 36.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.695 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -136.46 150.24 48.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.99 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.57 89.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.534 HD12 ' CD2' ' C' ' 178' ' ' TYR . 27.0 tp -58.44 -56.68 19.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.697 -0.627 . . . . 0.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.46 13.9 29.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.087 -1.008 . . . . 0.0 108.598 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 75.54 26.69 64.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.589 -2.205 . . . . 0.0 107.589 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . 0.465 ' HD3' HD22 ' C' ' 167' ' ' ASN . 0.1 OUTLIER -101.9 -154.25 0.48 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . 0.532 ' O ' HG12 ' C' ' 227' ' ' VAL . 12.6 t -121.41 94.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 109.329 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' C' ' 166' ' ' LEU . 30.1 pt -105.27 149.59 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.396 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' C' ' 231' ' ' LYS . 0.4 OUTLIER -124.17 100.17 36.48 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 0.0 109.813 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.401 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 16.6 Cg_endo -74.87 131.11 14.07 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.981 1.787 . . . . 0.0 111.244 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' C' ' 229' ' ' ASP . 19.4 mttm -149.91 151.08 32.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -62.07 149.09 42.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.72 . . . . 0.0 109.265 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.72 29.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.045 . . . . 0.0 109.123 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.11 116.68 32.46 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.32 159.05 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.237 1.958 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.729 ' N ' ' HE ' ' C' ' 236' ' ' ARG . 0.2 OUTLIER -57.44 -52.14 66.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.414 -0.804 . . . . 0.0 110.343 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' C' ' 241' ' ' LYS . 90.9 m-20 -61.44 -41.68 97.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.12 -39.55 95.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.692 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -62.83 -41.36 99.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.974 -1.079 . . . . 0.0 108.613 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.85 -22.31 31.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.788 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' C' ' 237' ' ' ASP . 48.9 tttm -54.64 -16.81 2.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 0.0 110.302 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 10.2 p -102.36 162.6 12.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.893 -1.129 . . . . 0.0 109.449 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.87 154.08 17.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -129.92 126.61 38.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.056 -1.261 . . . . 0.0 109.972 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.502 HD11 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -117.33 138.55 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.765 0.793 . . . . 0.0 108.895 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.4 OUTLIER -80.56 161.28 24.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.458 0.647 . . . . 0.0 109.51 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . 0.546 ' N ' ' CD1' ' C' ' 246' ' ' PHE . 39.8 t -134.85 132.69 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.66 152.4 18.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 61.73 120.17 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.592 HD11 ' O ' ' C' ' 286' ' ' PHE . 0.0 OUTLIER -151.87 165.82 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -1.096 . . . . 0.0 108.743 179.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -47.07 145.71 4.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.31 -49.38 10.34 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.906 1.737 . . . . 0.0 112.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -122.14 33.87 5.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.741 . . . . 0.0 109.387 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.5 HG11 ' HB ' ' C' ' 250' ' ' ILE . 2.5 p -44.97 141.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -110.71 158.37 35.79 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.24 -30.66 81.81 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.35 2.033 . . . . 0.0 111.169 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -51.56 -62.64 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . 0.704 ' O ' ' N ' ' C' ' 261' ' ' GLU . 0.0 OUTLIER -62.57 -87.71 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . 0.631 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.3 t80 -9.03 -70.39 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 121.441 0.639 . . . . 0.0 110.942 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' C' ' 272' ' ' ALA . 85.0 tt0 -56.06 -44.14 78.59 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.271 0.558 . . . . 0.0 110.39 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . 0.704 ' N ' ' O ' ' C' ' 258' ' ' GLU . 46.4 tp10 -68.53 -41.93 79.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' C' ' 263' ' ' PHE . 42.1 t80 -54.69 -77.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.924 -0.485 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.611 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 61.3 m-85 -42.04 -48.77 4.69 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.706 -1.246 . . . . 0.0 110.24 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.0 OUTLIER -35.26 -37.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' C' ' 263' ' ' PHE . 1.7 pp0? -55.86 -7.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.0 113.246 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.611 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.2 p90 -146.35 -53.42 0.25 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.86 -1.775 . . . . 0.0 111.318 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . 0.597 ' N ' ' CD1' ' C' ' 266' ' ' TRP . . . -83.83 -178.52 51.82 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . 0.56 ' O ' ' C ' ' C' ' 269' ' ' ILE . 34.1 p -102.19 9.5 40.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.924 -1.339 . . . . 0.0 111.706 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.996 HG23 ' CE1' ' C' ' 291' ' ' TYR . 0.9 OUTLIER -16.45 104.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.264 0.938 . . . . 0.0 112.98 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.6 mm -92.74 -33.11 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' C' ' 272' ' ' ALA . 88.0 m-20 -115.19 17.72 16.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.42 -0.8 . . . . 0.0 110.457 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . 0.731 ' HB2' ' HB ' ' C' ' 269' ' ' ILE . . . -25.92 130.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.998 -0.438 . . . . 0.0 110.275 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' C' ' 288' ' ' PHE . 14.0 pt20 -152.52 132.5 13.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.695 -1.253 . . . . 0.0 111.64 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.941 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.3 OUTLIER -126.58 152.46 46.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . 0.44 ' C ' ' OG ' ' C' ' 283' ' ' SER . 17.8 mmt -88.54 168.44 12.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.651 -1.281 . . . . 0.0 109.872 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.957 ' H ' HD12 ' C' ' 276' ' ' LEU . 0.0 OUTLIER -144.59 176.98 9.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.788 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -78.71 -35.78 44.39 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 110.39 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -56.31 -36.43 68.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.062 -1.024 . . . . 0.0 109.789 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -53.55 -52.43 59.73 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.668 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . 0.41 ' H ' ' H ' ' C' ' 281' ' ' GLY . 1.1 t 178.83 0.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' C' ' 283' ' ' SER . . . 102.47 9.07 42.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.41 ' O ' ' CE2' ' C' ' 286' ' ' PHE . 50.7 mm-40 -77.42 23.27 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -1.03 . . . . 0.0 109.958 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . 0.532 ' OG ' ' CA ' ' C' ' 276' ' ' LEU . 3.0 m -107.44 59.07 0.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.434 -0.792 . . . . 0.0 109.798 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.77 -27.69 19.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 108.618 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 143.29 17.37 0.25 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.592 ' O ' HD11 ' C' ' 250' ' ' ILE . 46.1 p90 -108.55 176.77 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.42 178.17 39.1 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . 0.402 ' O ' ' O ' ' C' ' 273' ' ' GLN . 73.7 m-85 -147.55 156.31 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.325 -1.691 . . . . 0.0 109.676 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . 0.412 ' HB ' HG22 ' C' ' 269' ' ' ILE . 1.7 m -140.51 152.11 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.042 -1.036 . . . . 0.0 108.626 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.65 120.09 28.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . 0.996 ' CE1' HG23 ' C' ' 269' ' ' ILE . 93.9 m-85 -109.18 136.69 48.25 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.82 -50.67 72.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.592 -1.317 . . . . 0.0 109.381 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 75.4 m -93.54 169.38 10.39 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.309 -0.869 . . . . 0.0 108.89 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -103.54 -9.81 18.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.67 -46.24 74.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.01 76.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.807 . . . . 0.0 109.049 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . 0.419 ' O ' HG12 ' C' ' 300' ' ' VAL . 67.9 t -62.53 -61.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -56.11 -29.17 60.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 109.135 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -62.94 -60.8 2.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.59 HG23 ' OD1' ' C' ' 303' ' ' ASN . 14.4 p -63.06 -27.89 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.647 -0.658 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . 0.496 ' C ' ' O ' ' C' ' 300' ' ' VAL . 65.1 m -45.27 -49.37 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -46.13 -32.83 3.14 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.872 -0.518 . . . . 0.0 109.654 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.766 ' ND2' ' O ' ' C' ' 303' ' ' ASN . 1.0 OUTLIER -101.5 81.77 2.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -72.62 -14.98 61.73 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.64 -1.913 . . . . 0.0 108.739 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -126.05 122.28 35.38 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . 0.623 HD11 HD21 ' C' ' 303' ' ' ASN . 82.7 mt -117.18 149.87 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.13 96.69 10.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.624 ' O ' ' C ' ' C' ' 309' ' ' LYS . 34.7 t80 -104.32 -176.65 3.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.776 ' O ' ' N ' ' C' ' 311' ' ' ARG . 71.2 mttt -25.26 133.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' C' ' 309' ' ' LYS . 23.8 t70 -17.79 69.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.405 0.622 . . . . 0.0 112.057 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . 0.776 ' N ' ' O ' ' C' ' 309' ' ' LYS . 54.1 ttm-85 177.98 109.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 153.12 4.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.064 . . . . 0.0 108.742 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.88 153.31 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.104 -0.997 . . . . 0.0 108.972 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -116.04 121.41 42.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 109.791 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.502 ' CG2' HD11 ' C' ' 245' ' ' ILE . 2.0 mm -88.84 154.9 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -160.96 159.94 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.165 -0.959 . . . . 0.0 108.421 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -71.92 150.75 43.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.81 -1.181 . . . . 0.0 109.175 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.24 -0.7 10.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.842 -1.161 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.778 . . . . 0.0 109.929 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.59 ' OD1' ' CE2' ' B' ' 101' ' ' TYR . 2.4 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.464 0.649 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.01 154.47 70.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.936 2.424 . . . . 0.0 112.255 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.24 3.39 4.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.719 2.28 . . . . 0.0 112.315 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -154.3 133.42 12.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.93 . . . . 0.0 109.276 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -43.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.0 109.333 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' B' ' 100' ' ' GLY . 2.7 t -119.81 151.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' B' ' 98' ' ' LYS . 9.0 p -142.44 134.41 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.66 -1.275 . . . . 0.0 107.994 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -129.36 155.57 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 110.475 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.62 ' HB3' HD11 ' B' ' 33' ' ' ILE . 3.4 mp -121.24 147.93 44.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.537 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -123.39 -45.13 0.29 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.413 ' C ' HD12 ' B' ' 33' ' ' ILE . 0.7 OUTLIER -92.04 87.51 6.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.964 -1.315 . . . . 0.0 109.706 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.635 HD12 ' N ' ' B' ' 33' ' ' ILE . 3.4 mp -143.44 126.81 9.08 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 108.886 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' B' ' 36' ' ' ASP . 39.3 Cg_endo -73.43 155.85 50.44 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.451 1.434 . . . . 0.0 111.583 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.449 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 8.2 m-85 -60.24 5.85 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 109.621 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.2 m-20 -61.51 -41.93 98.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.048 -1.032 . . . . 0.0 108.584 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.757 HE22 HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -125.4 112.04 15.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.39 -0.819 . . . . 0.0 109.57 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.408 ' O ' HG12 ' B' ' 42' ' ' ILE . 69.3 p -107.45 -143.19 0.38 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.379 -0.826 . . . . 0.0 110.963 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 21.7 pt-20 -65.97 -29.19 69.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.815 -1.178 . . . . 0.0 110.955 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -64.0 -54.78 28.91 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.882 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.568 HE21 ' CD ' ' B' ' 37' ' ' GLN . 6.0 tt0 -69.52 -48.11 61.6 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 110.359 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' B' ' 44' ' ' ASP . 6.5 mm -56.76 -54.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' B' ' 55' ' ' LEU . 41.4 tp -36.9 -20.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.2 t0 -124.02 -22.22 4.88 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.178 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.728 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.4 tm? -61.6 -37.59 84.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.165 -1.584 . . . . 0.0 107.94 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' B' ' 48' ' ' ASN . 86.6 m -92.77 -63.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.95 -1.093 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.412 ' C ' ' O ' ' B' ' 46' ' ' CYS . 17.6 t -37.76 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.806 -0.559 . . . . 0.0 110.788 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' B' ' 49' ' ' VAL . 5.9 p30 -71.38 -59.05 2.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.784 -1.198 . . . . 0.0 109.844 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' B' ' 48' ' ' ASN . 0.9 OUTLIER -42.37 -51.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.714 -0.616 . . . . 0.0 110.207 -178.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.507 ' N ' HG12 ' B' ' 49' ' ' VAL . . . -157.22 167.63 33.94 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.21 131.06 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.905 1.737 . . . . 0.0 111.495 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.624 HG13 ' H ' ' B' ' 53' ' ' ILE . 0.9 OUTLIER -99.66 -172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.328 -0.857 . . . . 0.0 108.998 -178.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.624 ' H ' HG13 ' B' ' 52' ' ' VAL . 24.0 mm -142.86 -44.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 86.8 m-20 -149.52 155.53 40.5 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.662 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' B' ' 43' ' ' LEU . 56.8 tp -146.61 130.23 16.94 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.444 ' CG ' ' SD ' ' B' ' 58' ' ' MET . 43.1 tptt -145.81 116.54 7.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.671 -1.268 . . . . 0.0 110.143 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.46 130.41 35.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 109.297 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . 0.447 ' O ' ' O ' ' B' ' 69' ' ' TYR . 2.3 mpp? -141.3 144.18 34.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.112 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.449 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 14.0 m-85 -98.89 -179.15 4.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.513 ' OD1' ' CG2' ' B' ' 63' ' ' THR . 0.4 OUTLIER -117.1 69.86 5.24 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.497 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -68.17 -61.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.916 2.411 . . . . 0.0 113.281 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -64.08 -40.94 97.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -0.829 . . . . 0.0 110.818 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.513 ' CG2' ' OD1' ' B' ' 60' ' ' ASP . 7.8 p -70.84 -43.38 68.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.69 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.61 -2.45 85.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -1.08 . . . . 0.0 110.016 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' B' ' 60' ' ' ASP . 0.1 OUTLIER -177.24 -161.94 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.927 -1.108 . . . . 0.0 111.11 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' B' ' 60' ' ' ASP . 29.8 mttm -144.62 38.15 1.23 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 109.913 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.27 63.3 0.5 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.88 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . 0.468 ' CE2' ' OD2' ' B' ' 60' ' ' ASP . 66.4 m-85 -116.8 123.57 47.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.279 -1.13 . . . . 0.0 109.498 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 135.9 36.59 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.296 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.79 125.35 50.89 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.516 0.674 . . . . 0.0 111.549 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.87 153.01 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 81.7 tt0 -133.48 136.51 45.16 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.424 ' HD1' ' HG ' ' B' ' 79' ' ' SER . 12.0 m-85 -103.0 169.76 8.37 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.035 0.921 . . . . 0.0 111.583 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 51.6 ttt85 -55.52 -42.37 74.45 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.841 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 159.64 -176.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.502 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.789 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.8 mm? -38.77 -21.73 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.852 -0.53 . . . . 0.0 110.313 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.3 mt-10 -70.28 -79.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . 0.424 ' HG ' ' HD1' ' B' ' 74' ' ' PHE . 13.9 t -62.57 -36.62 83.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.5 t -62.82 -37.75 88.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -60.31 -58.16 9.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.409 -1.432 . . . . 0.0 108.534 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.3 t -64.58 -34.19 77.68 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.415 0.626 . . . . 0.0 111.995 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -84.23 -58.26 2.83 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.932 -1.105 . . . . 0.0 110.596 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.709 HG13 ' CB ' ' B' ' 99' ' ' CYS . 58.7 t -53.59 -40.74 43.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 120.331 -1.481 . . . . 0.0 108.561 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -69.63 -46.9 65.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.826 -1.171 . . . . 0.0 109.782 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' B' ' 88' ' ' ASN . 73.7 m-20 -88.07 -59.48 2.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.851 -1.155 . . . . 0.0 109.006 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.69 ' N ' ' O ' ' B' ' 83' ' ' ALA . 11.8 tp -73.85 32.11 0.08 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -71.85 -73.07 0.2 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.029 -1.044 . . . . 0.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' B' ' 97' ' ' LEU . . . -137.07 120.96 2.22 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -138.43 141.1 39.54 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.45 -1.617 . . . . 0.0 107.294 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.8 mm-40 -31.16 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.781 0.8 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.757 HD11 HE22 ' B' ' 37' ' ' GLN . 20.8 tp -152.16 117.78 5.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.42 -168.9 48.0 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -11.94 59.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.028 -1.278 . . . . 0.0 108.872 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' B' ' 92' ' ' LEU . 0.1 OUTLIER -134.44 155.24 50.68 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' B' ' 97' ' ' LEU . 6.8 m-85 -97.09 134.17 40.78 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.27 -0.894 . . . . 0.0 109.207 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -29.21 136.91 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.505 0.669 . . . . 0.0 111.084 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.739 ' O ' HG23 ' B' ' 28' ' ' VAL . 1.5 mmtt -112.76 126.81 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 109.054 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . 0.709 ' CB ' HG13 ' B' ' 84' ' ' VAL . 14.7 p -89.27 129.96 35.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 111.168 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -130.8 -168.16 12.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.59 ' CE2' ' OD1' ' B' ' 22' ' ' ASN . 38.5 p90 -137.49 161.36 36.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.682 -0.893 . . . . 0.0 109.076 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . 0.472 ' HB3' HG21 ' B' ' 27' ' ' VAL . 26.9 t -179.24 92.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.438 -0.789 . . . . 0.0 108.945 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 -179.54 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . 0.502 ' C ' ' H ' ' C' ' 160' ' ' LYS . 28.2 t . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . 0.409 ' CB ' ' O ' ' C' ' 209' ' ' LYS . 27.4 p -72.42 28.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.741 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' C' ' 158' ' ' SER . 38.7 tttt -104.51 134.81 47.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.545 -0.722 . . . . 0.0 109.997 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 8.3 ptm -118.26 159.26 23.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -0.842 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' C' ' 202' ' ' PHE . 44.3 t80 -122.83 77.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 110.29 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . 0.478 ' CD1' HD21 ' C' ' 175' ' ' LEU . 0.6 OUTLIER -50.11 140.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -139.11 166.66 25.39 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' C' ' 227' ' ' VAL . . . 53.91 24.51 27.15 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . 0.749 ' HA ' HG22 ' C' ' 228' ' ' ILE . 1.7 pp -75.06 162.37 28.61 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.362 -1.081 . . . . 0.0 110.653 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.635 ' N ' HD12 ' C' ' 166' ' ' LEU . 63.5 t30 -75.29 123.98 26.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.025 -1.047 . . . . 0.0 109.528 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' C' ' 167' ' ' ASN . 3.2 m0 -37.52 -39.28 0.3 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 111.054 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.7 84.41 7.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.694 -1.253 . . . . 0.0 110.94 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . 0.405 ' O ' ' CD1' ' C' ' 190' ' ' ILE . 57.9 m -146.18 133.82 21.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.991 . . . . 0.0 109.368 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . 0.445 ' O ' ' C ' ' C' ' 172' ' ' GLU . 1.4 m -124.33 138.92 54.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.343 -0.848 . . . . 0.0 109.128 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . 0.566 ' HB3' HD13 ' C' ' 188' ' ' LEU . 0.5 OUTLIER -39.38 -72.99 0.05 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.138 -0.976 . . . . 0.0 110.744 -178.171 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' C' ' 172' ' ' GLU . 53.9 t0 -38.68 -39.46 0.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.542 -0.724 . . . . 0.0 110.139 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -76.51 -44.22 36.05 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' C' ' 172' ' ' GLU . 0.9 OUTLIER -53.1 -54.05 41.27 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' C' ' 179' ' ' PHE . 5.6 ptm180 -68.81 -55.54 10.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.43 -1.308 . . . . 0.0 108.534 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' C' ' 176' ' ' ARG . 84.6 tt0 -35.94 -33.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.559 ' CG ' HD12 ' C' ' 223' ' ' LEU . 21.1 t80 -91.93 -31.14 15.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.724 . . . . 0.0 110.564 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' C' ' 176' ' ' ARG . 6.0 m-85 -95.49 15.92 18.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.84 -1.163 . . . . 0.0 110.832 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.67 29.57 2.63 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.57 22.79 12.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -1.079 . . . . 0.0 109.195 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . 0.603 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 99.2 m-85 -127.91 -3.84 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.486 -0.759 . . . . 0.0 109.628 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 151.33 -126.19 2.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 2.9 t -131.58 149.7 52.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -1.077 . . . . 0.0 108.844 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.557 HG11 HD23 ' C' ' 188' ' ' LEU . 86.0 t -103.25 134.42 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.915 . . . . 0.0 109.663 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 53.0 p -122.3 -29.51 4.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.378 -0.826 . . . . 0.0 110.562 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -153.9 150.51 28.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 109.62 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.831 ' O ' HD12 ' C' ' 188' ' ' LEU . 1.2 pp -171.93 154.84 3.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.588 -1.32 . . . . 0.0 110.111 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -140.35 118.52 11.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 108.337 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' C' ' 170' ' ' THR . 0.0 OUTLIER -141.11 148.66 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.777 -1.202 . . . . 0.0 110.33 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 9.8 mtt -121.63 174.13 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 140.05 1.13 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.523 -1.361 . . . . 0.0 109.118 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' C' ' 193' ' ' ASP . 0.0 OUTLIER -74.9 143.46 78.02 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.069 -1.019 . . . . 0.0 110.045 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' C' ' 195' ' ' ALA . 60.3 Cg_endo -75.74 -40.73 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.946 1.764 . . . . 0.0 110.994 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' C' ' 194' ' ' PRO . . . 178.93 -39.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.566 -0.709 . . . . 0.0 109.771 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 50.1 p -123.4 5.44 9.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' C' ' 198' ' ' ARG . . . -105.03 42.64 1.85 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' C' ' 197' ' ' GLY . 49.6 mtm180 -41.91 133.73 2.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -1.109 . . . . 0.0 109.63 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . . . . . . . . . 23.0 t -154.67 167.04 31.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.55 ' N ' ' NE ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -59.94 92.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . 0.493 ' O ' ' CD2' ' C' ' 166' ' ' LEU . . . -83.11 93.13 1.68 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 8.7 p90 -109.14 154.54 22.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -115.6 134.09 11.31 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.522 -1.799 . . . . 0.0 110.087 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -114.14 91.44 3.63 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.485 HD12 HD22 ' C' ' 175' ' ' LEU . 0.8 OUTLIER -100.23 111.87 24.17 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.175 -0.953 . . . . 0.0 110.442 -177.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 7.7 t -106.61 135.6 47.85 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -104.43 -121.41 0.21 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -141.05 -14.25 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.188 -1.57 . . . . 0.0 108.867 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 7.6 mtmp? -130.0 170.45 10.98 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -97.66 -11.82 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.638 2.225 . . . . 0.0 112.481 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.587 ' O ' ' N ' ' C' ' 213' ' ' VAL . 15.1 m -68.58 -61.64 1.74 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.924 -1.11 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.489 ' O ' HG23 ' C' ' 216' ' ' VAL . 42.8 m -40.64 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -0.763 . . . . 0.0 109.873 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' C' ' 211' ' ' SER . 84.0 t -73.64 -35.79 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.754 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -63.83 -49.32 73.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.75 . . . . 0.0 110.409 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . 0.65 ' CD ' ' H ' ' C' ' 215' ' ' GLU . 0.0 OUTLIER -69.04 -42.7 76.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.797 -1.189 . . . . 0.0 108.674 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.489 HG23 ' O ' ' C' ' 212' ' ' SER . 4.8 t -51.55 -47.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.7 -36.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -77.93 8.95 3.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.786 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 18.0 m -129.38 142.95 50.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.879 . . . . 0.0 108.762 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.95 136.27 45.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.904 ' C ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -131.18 153.01 49.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.726 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . 0.904 HD13 ' C ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -117.62 86.85 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.672 0.748 . . . . 0.0 109.102 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' C' ' 178' ' ' TYR . 1.1 tp -57.27 -66.75 0.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.855 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -96.05 8.31 44.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.665 -1.272 . . . . 0.0 109.401 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 81.95 14.88 76.4 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . 0.677 ' HB2' ' HZ2' ' C' ' 226' ' ' LYS . 0.0 OUTLIER -95.69 -154.39 0.43 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' C' ' 165' ' ' GLY . 7.6 t -115.07 95.91 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' C' ' 166' ' ' LEU . 26.3 pt -105.65 136.94 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.78 108.44 53.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.798 . . . . 0.0 109.612 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.466 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 37.2 Cg_endo -81.7 137.33 10.03 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.968 1.779 . . . . 0.0 111.939 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -145.99 159.52 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 234' ' ' ILE . 26.8 ptt-85 -87.61 152.14 22.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.04 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -49.15 99.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 108.761 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' C' ' 232' ' ' ARG . 4.4 mt -90.76 127.44 52.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.03 149.36 2.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.062 1.841 . . . . 0.0 112.55 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -57.33 -45.83 83.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -59.41 -41.73 90.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 108.704 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . 0.518 ' O ' HG23 ' C' ' 242' ' ' THR . 75.9 mm-40 -66.3 -36.39 82.83 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.434 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . 0.497 ' O ' ' OG1' ' C' ' 242' ' ' THR . 30.5 tp60 -61.19 -44.82 96.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -73.0 -41.2 64.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.362 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -72.28 -13.93 61.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 111.805 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . 0.518 HG23 ' O ' ' C' ' 238' ' ' GLU . 0.9 OUTLIER -47.64 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.525 -1.359 . . . . 0.0 110.284 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 107.66 108.76 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -140.72 134.33 30.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.715 -1.462 . . . . 0.0 110.6 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.696 HD12 ' CG2' ' C' ' 315' ' ' ILE . 1.2 pt -126.16 159.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 109.875 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -106.93 131.19 54.29 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.46 132.25 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.652 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.19 148.75 18.26 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.39 72.53 0.87 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.224 -1.162 . . . . 0.0 111.223 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' C' ' 251' ' ' GLY . 19.6 mt -118.34 145.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -1.057 . . . . 0.0 109.096 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . 0.584 ' O ' HG12 ' C' ' 254' ' ' VAL . . . -42.66 126.88 4.74 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.29 -40.76 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.822 1.681 . . . . 0.0 112.207 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' C' ' 254' ' ' VAL . 90.5 m-20 -95.17 6.31 49.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.376 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.596 HG22 ' N ' ' C' ' 255' ' ' ARG . 10.7 p -42.26 165.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.88 . . . . 0.0 109.982 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . 0.596 ' N ' HG22 ' C' ' 254' ' ' VAL . 14.4 mtt180 -137.3 156.76 75.12 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.0 109.052 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.14 -28.14 48.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.467 2.111 . . . . 0.0 111.913 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -52.13 -64.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . 0.718 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.0 tp10 -59.77 -83.2 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.727 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . 0.608 ' C ' ' O ' ' C' ' 258' ' ' GLU . 75.9 t80 -12.67 -70.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.207 0.527 . . . . 0.0 111.45 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.31 -41.77 72.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.431 -0.793 . . . . 0.0 109.691 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . 0.718 ' N ' ' O ' ' C' ' 258' ' ' GLU . 44.3 tp10 -67.46 -46.69 72.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . 0.636 ' O ' ' HG2' ' C' ' 265' ' ' GLN . 60.3 t80 -49.68 -72.32 0.05 Allowed 'General case' 0 C--O 1.193 -1.907 0 O-C-N 121.573 -0.705 . . . . 0.0 110.512 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' C' ' 265' ' ' GLN . 88.4 m-85 -53.59 -45.1 69.89 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.044 -1.035 . . . . 0.0 112.083 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.502 ' C ' ' O ' ' C' ' 263' ' ' PHE . 0.3 OUTLIER -24.07 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' C' ' 262' ' ' PHE . 1.0 OUTLIER -48.41 -100.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.762 -1.212 . . . . 0.0 111.042 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.504 ' H ' ' HG3' ' C' ' 265' ' ' GLN . 1.7 p90 -60.77 148.71 38.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 51.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 86.2 m -49.77 141.71 9.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.289 . . . . 0.0 108.558 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.61 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -95.41 106.71 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.986 -1.071 . . . . 0.0 110.753 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . 0.475 HG22 ' N ' ' C' ' 271' ' ' ASP . 0.6 OUTLIER -70.13 -55.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.705 -1.247 . . . . 0.0 108.862 179.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . 0.475 ' N ' HG22 ' C' ' 270' ' ' ILE . 59.4 t0 -141.25 102.43 4.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' C' ' 273' ' ' GLN . . . -131.71 157.36 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' C' ' 272' ' ' ALA . 14.6 pt20 168.69 173.31 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.685 1.231 . . . . 0.0 111.796 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.505 HD22 HG13 ' C' ' 254' ' ' VAL . 10.4 tp -95.12 148.36 22.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 96.8 mmm -97.71 -172.55 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.448 -1.407 . . . . 0.0 110.933 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 175.29 88.56 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' C' ' 280' ' ' THR . 83.0 m-20 -84.34 47.5 1.35 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' C' ' 277' ' ' ASP . 15.6 pttp -40.41 -33.22 0.24 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -58.41 -37.12 74.68 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.356 -0.937 . . . . 0.0 108.484 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . 0.597 ' N ' ' O ' ' C' ' 277' ' ' ASP . 0.4 OUTLIER -141.73 -79.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . 0.57 ' N ' ' OG1' ' C' ' 280' ' ' THR . . . -65.27 -165.34 1.26 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.0 tt0 -167.09 158.59 12.34 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.338 -1.095 . . . . 0.0 109.828 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . 0.427 ' N ' ' HG2' ' C' ' 282' ' ' GLN . 1.0 OUTLIER -61.17 67.59 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.203 0.525 . . . . 0.0 109.774 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' C' ' 282' ' ' GLN . 60.8 ttm-85 -50.07 -24.74 2.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.86 22.93 0.26 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.408 ' C ' HD12 ' C' ' 250' ' ' ILE . 23.0 p90 -111.36 173.36 6.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 110.668 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.93 36.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' C' ' 246' ' ' PHE . 21.8 m-85 -143.1 158.45 43.6 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.417 -1.637 . . . . 0.0 109.189 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 19.8 t -141.59 143.94 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.81 -1.181 . . . . 0.0 108.253 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . 0.453 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 18.6 m -130.97 128.71 40.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.869 -1.144 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . 0.517 ' O ' ' O ' ' C' ' 242' ' ' THR . 42.0 m-85 -114.42 143.64 44.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER -62.48 -48.56 79.08 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . 0.543 ' N ' ' CG ' ' C' ' 292' ' ' ASP . 12.4 m -73.93 132.93 42.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -76.33 -32.7 58.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -50.95 -38.48 50.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.702 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.44 -46.09 83.97 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . 0.45 HG13 ' CG2' ' C' ' 245' ' ' ILE . 40.5 t -56.99 -56.56 14.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -54.5 -21.39 9.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.585 -0.697 . . . . 0.0 109.79 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -75.07 -60.82 2.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.96 -27.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 109.684 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' C' ' 300' ' ' VAL . 26.8 t -43.74 -57.2 3.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.124 -0.985 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -51.71 -24.09 5.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 108.914 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' C' ' 300' ' ' VAL . 89.1 m-20 -99.55 91.39 4.87 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -75.95 -84.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.558 -1.339 . . . . 0.0 109.218 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' C' ' 313' ' ' ILE . 80.2 m-85 -66.59 124.93 24.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 79.8 mt -125.04 139.78 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.42 -0.8 . . . . 0.0 109.305 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -64.62 129.91 41.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.913 . . . . 0.0 109.741 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 87.8 t80 -137.31 171.41 14.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 0.0 110.713 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 31.7 ttmt -32.35 -71.18 0.06 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.115 0.483 . . . . 0.0 111.265 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.16 -71.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.49 -166.36 2.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.079 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -56.37 157.97 4.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.365 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . 0.513 ' O ' ' CG1' ' C' ' 313' ' ' ILE . 2.1 pt -131.85 121.77 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.26 106.9 7.01 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.2 -0.938 . . . . 0.0 110.02 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.696 ' CG2' HD12 ' C' ' 245' ' ' ILE . 2.8 mm -79.71 154.0 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.047 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -157.27 157.49 34.32 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.836 -1.165 . . . . 0.0 109.01 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -67.65 143.88 55.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.668 -1.27 . . . . 0.0 109.254 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -84.92 44.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.006 -1.059 . . . . 0.0 109.939 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.423 HD22 ' HB2' ' B' ' 101' ' ' TYR . 4.9 m120 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.512 ' CB ' ' CD ' ' B' ' 24' ' ' PRO . 26.5 Cg_exo -57.92 -172.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.881 2.387 . . . . 0.0 111.877 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.543 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 52.4 Cg_endo -89.32 23.4 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.02 2.48 . . . . 0.0 112.163 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.29 120.59 5.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.101 -1.0 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.49 ' N ' ' OG ' ' B' ' 80' ' ' SER . 4.3 ttt85 -179.28 -45.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.59 HG11 ' O ' ' B' ' 102' ' ' SER . 2.0 p -139.0 158.61 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.081 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.587 HG13 HD13 ' B' ' 72' ' ' ILE . 7.1 p -120.98 142.16 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.459 ' CZ ' ' HA3' ' B' ' 100' ' ' GLY . 2.9 m-30 -105.32 141.48 36.75 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.467 ' CD1' HD12 ' B' ' 42' ' ' ILE . 7.0 mt -129.26 117.21 20.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.478 -0.764 . . . . 0.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.52 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -132.95 -23.54 0.77 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.652 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -91.65 71.79 5.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.847 -1.384 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.577 HD12 ' N ' ' B' ' 33' ' ' ILE . 1.2 mp -145.74 125.18 6.81 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 109.829 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.585 ' C ' ' H ' ' B' ' 36' ' ' ASP . 29.7 Cg_endo -73.83 163.0 38.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.07 1.18 . . . . 0.0 109.935 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.451 ' OH ' ' CB ' ' B' ' 59' ' ' PHE . 4.7 m-85 -55.71 3.45 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 109.887 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' B' ' 34' ' ' PRO . 85.5 m-20 -66.17 -45.03 82.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.905 -1.122 . . . . 0.0 109.575 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.4 107.52 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -102.45 -153.25 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.466 -0.771 . . . . 0.0 111.53 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.43 ' N ' ' SD ' ' B' ' 57' ' ' MET . 1.1 pp20? -58.2 -23.69 56.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.69 -54.7 12.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.37 -38.76 88.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 110.845 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' B' ' 30' ' ' LEU . 24.7 mm -60.2 -51.53 71.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.8 -37.31 73.53 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.495 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 24.0 t70 -55.73 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.909 1.338 . . . . 0.0 109.377 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.637 HD21 ' CE2' ' B' ' 90' ' ' TYR . 14.4 tp -52.1 -48.84 64.54 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.417 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' B' ' 49' ' ' VAL . 94.9 m -60.26 -68.07 0.33 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.138 -0.976 . . . . 0.0 109.044 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.502 ' C ' ' H ' ' B' ' 49' ' ' VAL . 85.1 p -31.72 -33.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.979 0.419 . . . . 0.0 110.576 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' B' ' 46' ' ' CYS . 72.9 m-80 -67.25 5.73 0.68 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.948 -1.095 . . . . 0.0 109.234 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 1.048 HG11 ' HB2' ' B' ' 83' ' ' ALA . 65.9 t -111.67 -55.06 4.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' B' ' 52' ' ' VAL . . . 174.63 154.24 10.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 52' ' ' VAL . 51.4 Cg_exo -44.76 80.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.308 2.006 . . . . 0.0 112.194 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' B' ' 50' ' ' GLY . 0.8 OUTLIER -39.37 157.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.828 . . . . 0.0 109.61 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' B' ' 75' ' ' ARG . 16.7 mm -87.56 -60.76 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.193 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.588 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 73.7 m-20 -119.86 126.12 50.18 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.104 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -125.35 126.37 44.93 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -140.81 118.63 11.75 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.017 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' B' ' 39' ' ' GLU . 0.1 OUTLIER -113.41 143.81 43.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.255 0.55 . . . . 0.0 109.901 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . 0.559 ' C ' ' SD ' ' B' ' 58' ' ' MET . 0.0 OUTLIER -161.54 157.18 24.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.603 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -129.88 149.24 51.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.517 ' HB3' ' N ' ' B' ' 66' ' ' SER . 4.7 p30 -42.87 98.04 0.16 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 111.383 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 42.3 Cg_endo -92.5 -17.58 0.83 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 122.807 2.338 . . . . 0.0 111.54 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -87.42 -65.93 0.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 111.267 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 -34.71 9.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.181 -0.949 . . . . 0.0 111.367 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.465 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 108.07 30.41 3.94 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.043 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.461 ' C ' ' OD2' ' B' ' 60' ' ' ASP . 81.1 mtp180 -93.88 -71.0 0.68 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.297 . . . . 0.0 110.3 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' B' ' 60' ' ' ASP . 25.8 t -43.68 121.92 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -86.86 5.32 37.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.184 -0.948 . . . . 0.0 109.024 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.21 88.89 0.1 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . 0.463 ' CD1' ' HA2' ' B' ' 31' ' ' GLY . 1.9 m-85 -105.7 133.33 50.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.53 -0.983 . . . . 0.0 109.782 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.84 146.03 26.9 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.947 -1.095 . . . . 0.0 112.536 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.434 ' C ' HD12 ' B' ' 72' ' ' ILE . 10.4 m-85 -114.51 130.11 56.72 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.705 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.929 HD12 ' N ' ' B' ' 72' ' ' ILE . 1.1 mp -121.93 102.33 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.35 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.588 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 29.4 mt-10 -93.05 136.71 33.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.252 -1.53 . . . . 0.0 110.244 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -98.32 176.53 5.67 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.853 0.835 . . . . 0.0 111.366 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 5.5 ttp180 -48.3 -42.01 29.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.858 -0.526 . . . . 0.0 111.42 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' B' ' 78' ' ' GLU . 3.5 m-20 156.62 -175.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.729 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.5 mm? -37.48 -23.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.655 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.8 mm-40 -70.24 -75.98 0.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.862 -1.149 . . . . 0.0 109.822 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 52.0 m -63.54 -40.59 97.41 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' B' ' 26' ' ' ARG . 25.7 t -58.92 -34.9 72.25 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -65.87 -61.29 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.676 -1.265 . . . . 0.0 109.031 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.602 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 22.0 t -60.21 -42.56 95.42 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.27 -0.894 . . . . 0.0 111.395 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 1.048 ' HB2' HG11 ' B' ' 49' ' ' VAL . . . -76.54 -65.66 0.9 Allowed 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.551 -0.718 . . . . 0.0 111.771 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -52.94 -37.84 27.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.296 -1.362 . . . . 0.0 109.212 -176.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.416 ' HA ' HD22 ' B' ' 88' ' ' ASN . 71.7 mtp85 -67.87 -47.47 68.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.365 -1.459 . . . . 0.0 108.382 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' B' ' 82' ' ' SER . 91.2 m-20 -67.5 -42.74 82.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.056 -1.028 . . . . 0.0 109.27 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.484 HD11 HG21 ' B' ' 49' ' ' VAL . 7.3 mt -106.35 28.72 7.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.333 -0.855 . . . . 0.0 110.084 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.69 ' O ' HD13 ' B' ' 97' ' ' LEU . 1.2 m-20 -61.51 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.82 -1.175 . . . . 0.0 109.188 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.68 107.77 0.86 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 1.051 ' CE1' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -134.1 148.81 51.05 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 119.677 1.739 . . . . 0.0 110.917 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -46.25 91.59 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 119.876 -1.765 . . . . 0.0 108.456 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.1 tt -153.2 104.81 2.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.85 -175.39 43.47 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -67.12 -27.36 67.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.248 . . . . 0.0 109.617 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt85 -135.95 163.95 29.09 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.453 ' O ' ' C ' ' B' ' 97' ' ' LEU . 2.3 m-85 -92.69 133.99 35.47 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.31 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 1.051 HD11 ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -38.94 152.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.263 0.554 . . . . 0.0 109.562 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -108.46 146.84 32.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 109.268 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . 0.571 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.0 OUTLIER -91.9 124.78 36.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 109.781 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' B' ' 29' ' ' TYR . . . -137.17 -175.5 13.85 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.375 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 4.3 p90 -120.82 6.15 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -1.051 . . . . 0.0 110.562 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . 0.59 ' O ' HG11 ' B' ' 27' ' ' VAL . 0.6 OUTLIER -39.92 125.05 1.87 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 0.0 109.913 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.241 179.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 1.0 OUTLIER -175.41 39.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.425 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 15.0 tttt -100.4 102.89 14.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . 0.554 ' SD ' HG11 ' C' ' 216' ' ' VAL . 71.3 mtp -87.23 133.04 33.71 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.701 -1.199 . . . . 0.0 111.144 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' C' ' 202' ' ' PHE . 76.9 t80 -104.77 90.69 3.56 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' C' ' 166' ' ' LEU . 5.6 mm -59.99 127.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' C' ' 165' ' ' GLY . . . -130.34 -177.2 14.75 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' C' ' 164' ' ' GLY . . . 42.84 41.1 4.33 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' C' ' 163' ' ' ILE . 13.5 mt -83.96 170.84 13.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -1.041 . . . . 0.0 109.725 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.478 ' O ' ' OD1' ' C' ' 167' ' ' ASN . 39.9 p-10 -85.45 140.21 30.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -48.95 -27.85 3.43 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.676 -1.265 . . . . 0.0 110.018 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . 0.444 ' O ' ' ND2' ' C' ' 167' ' ' ASN . 58.3 t0 -90.49 102.43 15.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.978 -1.076 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 33.0 m -147.2 144.51 28.98 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.46 173.5 6.38 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.222 -0.924 . . . . 0.0 109.142 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' C' ' 192' ' ' LYS . 11.5 mp0 -84.18 -77.04 0.28 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.799 -1.188 . . . . 0.0 109.587 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' C' ' 176' ' ' ARG . 49.5 t0 -49.08 -55.45 12.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.629 -1.295 . . . . 0.0 108.388 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' C' ' 173' ' ' ASP . 64.2 t30 -43.23 -53.18 5.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.93 -35.19 70.75 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.215 -0.928 . . . . 0.0 108.994 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' C' ' 178' ' ' TYR . 67.5 ttp85 -70.98 -63.52 1.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 108.904 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' C' ' 176' ' ' ARG . 77.3 mm-40 -43.78 -25.91 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.563 ' CE2' HD23 ' C' ' 223' ' ' LEU . 34.1 t80 -76.37 -47.05 24.69 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.557 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 176' ' ' ARG . 26.2 m-85 -95.7 15.85 18.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.257 -0.902 . . . . 0.0 111.655 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.17 14.44 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -106.13 9.73 32.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -1.077 . . . . 0.0 108.228 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 19.8 m-85 -121.61 -4.25 9.27 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 144.12 -134.69 5.86 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -126.69 145.65 50.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -1.041 . . . . 0.0 109.297 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' C' ' 188' ' ' LEU . 0.6 OUTLIER -99.76 134.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.413 ' N ' ' O ' ' C' ' 206' ' ' SER . 0.1 OUTLIER -78.52 -61.47 2.0 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.985 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . 0.589 ' OD2' ' NZ ' ' C' ' 189' ' ' LYS . 0.3 OUTLIER -121.22 84.79 2.29 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.329 1.061 . . . . 0.0 112.021 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.71 ' O ' HD23 ' C' ' 188' ' ' LEU . 7.1 tt -81.28 107.03 13.73 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . 0.589 ' NZ ' ' OD2' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -121.31 96.13 4.96 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.22 -0.925 . . . . 0.0 110.893 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . 0.562 ' O ' ' SD ' ' C' ' 191' ' ' MET . 0.0 OUTLIER -107.8 141.13 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' C' ' 190' ' ' ILE . 10.7 mmt -125.33 78.99 1.77 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.059 -1.026 . . . . 0.0 110.647 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' C' ' 172' ' ' GLU . 26.1 pttm -79.52 153.77 29.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.107 -0.995 . . . . 0.0 109.305 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 11.9 t0 -52.68 114.69 6.05 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.038 -1.039 . . . . 0.0 108.699 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.01 -21.54 4.02 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.827 1.685 . . . . 0.0 112.661 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -80.18 -86.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.24 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 45.5 p -109.35 -28.63 8.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.212 -0.93 . . . . 0.0 109.677 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . 0.527 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 122.28 17.63 3.59 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -90.79 58.47 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.072 -1.252 . . . . 0.0 109.519 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . 0.477 ' O ' ' C ' ' C' ' 200' ' ' ARG . 39.4 t -142.99 169.83 16.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' C' ' 199' ' ' SER . 19.3 mmt180 -37.06 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.92 92.29 1.49 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.302 -1.427 . . . . 0.0 109.861 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.458 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 48.5 p90 -125.9 155.65 40.92 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.512 -0.993 . . . . 0.0 108.611 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.93 123.11 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.957 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -93.25 86.44 5.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.843 -1.387 . . . . 0.0 107.981 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.433 HD12 HD11 ' C' ' 163' ' ' ILE . 33.2 mt -87.49 85.27 7.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.727 -1.233 . . . . 0.0 110.321 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . 0.553 ' CB ' ' H ' ' C' ' 187' ' ' ASP . 0.1 OUTLIER -65.47 85.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.596 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.527 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 14.5 m-85 -68.08 122.3 17.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.155 -0.966 . . . . 0.0 110.917 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.87 -50.32 36.44 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.788 -0.57 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -83.56 115.19 58.22 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 110.86 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.58 -38.22 44.53 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.186 1.924 . . . . 0.0 112.799 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 86.1 p -64.53 -49.95 69.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.854 ' O ' HG23 ' C' ' 216' ' ' VAL . 22.6 t -43.56 -33.21 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 109.224 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.17 -40.44 85.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.168 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' C' ' 211' ' ' SER . 57.6 t0 -59.68 -51.14 71.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.505 -0.747 . . . . 0.0 110.665 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' C' ' 219' ' ' THR . 5.5 pt-20 -68.17 -33.37 74.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.854 HG23 ' O ' ' C' ' 212' ' ' SER . 55.8 t -58.97 -47.99 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.009 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.441 HG12 ' O ' ' C' ' 214' ' ' ASP . 8.8 p -71.48 -30.04 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.1 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -89.71 21.53 3.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 109.742 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . 0.578 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 41.3 m -129.82 149.43 51.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' C' ' 221' ' ' HIS . 13.1 tt0 -75.92 -177.85 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.125 -0.985 . . . . 0.0 109.392 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.781 ' HB3' HD11 ' C' ' 228' ' ' ILE . 55.3 m-70 -158.28 130.52 6.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 110.3 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . 0.517 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 24.6 mt -153.35 80.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.737 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.563 HD23 ' CE2' ' C' ' 178' ' ' TYR . 16.5 mt -51.43 -71.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.735 -1.228 . . . . 0.0 109.54 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -101.51 -55.77 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 108.855 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 159.9 30.9 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . 0.911 ' NZ ' HG23 ' C' ' 280' ' ' THR . 0.0 OUTLIER -94.1 -76.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.107 -1.231 . . . . 0.0 108.601 178.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . 0.865 HG23 ' O ' ' C' ' 226' ' ' LYS . 2.1 t 155.39 90.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' C' ' 221' ' ' HIS . 23.2 pt -94.2 152.05 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.34 96.41 44.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.543 -0.723 . . . . 0.0 110.768 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.508 ' CG ' ' CD2' ' C' ' 221' ' ' HIS . 18.9 Cg_endo -81.82 121.51 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.709 2.273 . . . . 0.0 111.645 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -142.52 148.26 37.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 0.0 110.127 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.52 159.36 0.51 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' C' ' 160' ' ' LYS . . . -57.5 144.28 37.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . 0.402 HG22 ' N ' ' C' ' 239' ' ' GLN . 38.4 mt -132.6 91.15 31.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.486 -0.759 . . . . 0.0 109.418 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.42 161.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.11 1.873 . . . . 0.0 111.742 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' C' ' 236' ' ' ARG . 0.0 OUTLIER -51.57 -49.2 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.975 . . . . 0.0 111.312 -178.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -59.66 -43.28 94.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.845 -1.159 . . . . 0.0 109.824 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -68.36 -36.91 79.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.131 -0.98 . . . . 0.0 110.001 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . 0.402 ' N ' HG22 ' C' ' 234' ' ' ILE . 35.0 tt0 -61.17 -41.46 96.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.171 -0.956 . . . . 0.0 108.838 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.3 -25.03 31.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.473 -0.767 . . . . 0.0 109.599 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -51.2 -16.11 0.45 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.692 . . . . 0.0 110.432 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 13.9 p -106.38 159.69 15.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.918 -1.113 . . . . 0.0 109.231 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -115.41 154.87 16.67 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . 0.569 ' N ' HH12 ' C' ' 317' ' ' ARG . 0.0 OUTLIER -140.05 147.28 40.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.268 . . . . 0.0 111.235 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.642 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -129.68 154.44 40.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.729 0.776 . . . . 0.0 109.142 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 2.0 t80 -102.19 128.19 48.81 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.75 143.64 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 110.368 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.9 154.21 16.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.0 56.26 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 120.939 -1.33 . . . . 0.0 111.209 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' C' ' 286' ' ' PHE . 1.5 pp -111.26 137.69 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.903 -1.351 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . 0.657 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 157.81 -37.8 0.54 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 50.0 Cg_exo -54.06 -127.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.512 2.142 . . . . 0.0 112.22 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -69.86 19.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 109.681 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' C' ' 252' ' ' PRO . 1.3 m -93.19 137.3 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.918 -1.114 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . 0.633 ' CD ' ' N ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -103.45 163.07 18.19 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . 0.477 ' HB3' HD22 ' C' ' 274' ' ' LEU . 29.6 Cg_endo -63.59 -21.43 70.41 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.46 2.107 . . . . 0.0 111.372 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -62.25 -58.57 7.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.655 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.59 -41.72 86.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' C' ' 263' ' ' PHE . 29.0 t80 -52.6 -63.18 1.23 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.93 -43.43 98.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.911 -0.493 . . . . 0.0 110.28 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.97 -18.83 64.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.093 -1.005 . . . . 0.0 108.979 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . 0.606 ' O ' ' NE2' ' C' ' 265' ' ' GLN . 33.8 t80 -88.95 -77.75 0.37 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.234 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.575 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 43.2 m-85 -43.5 -36.26 1.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.928 -1.107 . . . . 0.0 109.494 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.499 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.8 t -30.72 -40.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.325 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.635 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 0.0 OUTLIER -60.76 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.429 -1.419 . . . . 0.0 110.981 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.635 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.2 OUTLIER -60.15 147.83 38.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.397 -1.439 . . . . 0.0 109.402 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' C' ' 269' ' ' ILE . . . 58.91 86.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . 0.506 ' O ' ' C ' ' C' ' 269' ' ' ILE . 3.8 t -53.59 43.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.483 -1.01 . . . . 0.0 113.625 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.773 HD11 ' HB ' ' C' ' 289' ' ' VAL . 1.7 tt -13.77 111.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.9 mm -87.2 -33.95 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.439 -1.413 . . . . 0.0 107.81 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.04 99.1 5.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' C' ' 269' ' ' ILE . . . -108.32 132.78 53.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.321 -0.862 . . . . 0.0 109.371 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -160.59 123.56 3.34 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 117.919 -1.512 . . . . 0.0 112.081 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.961 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.2 OUTLIER -100.63 155.08 18.08 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' C' ' 280' ' ' THR . 20.8 mmt -90.08 161.24 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.398 . . . . 0.0 109.619 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' C' ' 280' ' ' THR . 1.0 OUTLIER -126.62 -165.41 1.45 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.494 0.664 . . . . 0.0 109.689 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' C' ' 277' ' ' ASP . 53.5 p30 -97.98 -9.97 25.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.448 -0.782 . . . . 0.0 109.339 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . 0.504 ' HG2' HD23 ' C' ' 276' ' ' LEU . 49.9 mmtt -60.6 -54.6 43.38 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . 0.806 ' N ' ' HZ1' ' C' ' 226' ' ' LYS . 0.2 OUTLIER 177.51 -6.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.598 -0.689 . . . . 0.0 110.895 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . 0.911 HG23 ' NZ ' ' C' ' 226' ' ' LYS . 42.8 p -64.88 -3.14 3.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.446 -1.409 . . . . 0.0 108.708 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' C' ' 279' ' ' ASP . . . 155.04 -119.48 0.93 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.583 ' C ' ' H ' ' C' ' 284' ' ' ARG . 55.9 mt-30 -147.1 129.09 15.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 109.881 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 51.5 p -66.01 15.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 109.518 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . 0.583 ' H ' ' C ' ' C' ' 282' ' ' GLN . 10.1 tpp85 -49.86 -38.15 34.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.86 70.52 0.06 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.448 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' C' ' 250' ' ' ILE . 22.3 p90 -170.58 179.31 3.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.173 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -174.21 -167.48 33.79 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -143.9 154.51 43.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.471 -1.605 . . . . 0.0 109.465 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . 0.773 ' HB ' HD11 ' C' ' 269' ' ' ILE . 0.7 OUTLIER -141.55 152.82 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 11.0 m -133.57 126.75 31.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.968 -1.083 . . . . 0.0 110.497 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . 0.46 ' CE2' ' CG2' ' C' ' 289' ' ' VAL . 49.8 m-85 -113.15 143.71 43.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.37 -50.84 71.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.298 -1.501 . . . . 0.0 109.064 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 16.6 t -91.29 171.19 9.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' C' ' 297' ' ' VAL . . . -105.29 -20.03 13.62 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 294' ' ' ALA . 91.5 m-20 -47.05 -39.63 13.28 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.43 -33.6 72.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' C' ' 294' ' ' ALA . 60.4 t -69.86 -63.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.06 -18.29 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.046 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' C' ' 297' ' ' VAL . 1.7 ttt85 -78.37 -57.39 3.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.485 -0.759 . . . . 0.0 109.004 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' C' ' 303' ' ' ASN . 3.3 p -65.76 -25.97 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . 0.437 ' C ' ' N ' ' C' ' 303' ' ' ASN . 33.5 m -44.77 -58.83 2.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.863 -1.148 . . . . 0.0 109.005 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' C' ' 301' ' ' CYS . 26.3 mt-30 -47.19 -23.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.011 . . . . 0.0 108.394 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' C' ' 300' ' ' VAL . 97.1 m-20 -100.16 70.75 1.56 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -68.93 -9.28 51.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.53 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' C' ' 314' ' ' GLU . 45.3 m-85 -137.53 122.26 18.69 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 0.0 108.832 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' C' ' 300' ' ' VAL . 54.2 mt -121.65 145.85 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.889 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -79.46 120.12 23.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 108.519 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 73.5 t80 -120.03 -179.1 3.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.641 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 33.0 ttpt -43.61 -30.13 0.57 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . 0.562 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 46.1 t0 -86.25 -154.23 0.21 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . 0.562 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 35.7 ptt180 -79.0 -48.11 15.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 109.041 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' C' ' 311' ' ' ARG . 6.5 ttmt -165.72 155.31 12.34 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' C' ' 250' ' ' ILE . 37.3 pt -131.2 157.68 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . 0.411 ' HG3' ' CE2' ' C' ' 305' ' ' PHE . 8.4 mp0 -110.43 152.54 26.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.959 . . . . 0.0 109.83 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.642 ' CG2' HD12 ' C' ' 245' ' ' ILE . 6.7 mm -119.38 142.26 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -145.93 144.23 30.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.192 -0.942 . . . . 0.0 108.859 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . 0.569 HH12 ' N ' ' C' ' 244' ' ' LYS . 20.9 tpt180 -70.64 135.51 48.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 319' ' ' GLU . . . -60.9 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' C' ' 317' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 109.432 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' B' ' 102' ' ' SER . 2.0 m120 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' B' ' 22' ' ' ASN . 23.4 Cg_endo -65.34 147.03 87.2 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.46 2.107 . . . . 0.0 111.899 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.25 3.47 5.71 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.486 2.124 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.92 130.14 8.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.955 -1.091 . . . . 0.0 109.409 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.54 ' NH1' ' OD1' ' B' ' 76' ' ' ASP . 4.6 ttt85 -176.51 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -0.793 . . . . 0.0 109.249 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.69 HG12 ' H ' ' B' ' 102' ' ' SER . 1.6 p -140.85 165.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.1 t -124.9 144.64 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.498 ' C ' HD12 ' B' ' 30' ' ' LEU . 5.7 m-85 -111.53 130.91 55.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' B' ' 72' ' ' ILE . 8.5 mp -115.98 105.33 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -103.21 -72.54 0.92 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.887 -1.149 . . . . 0.0 112.113 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.467 ' HG ' ' CB ' ' B' ' 94' ' ' SER . 8.5 t -68.85 86.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.332 . . . . 0.0 110.338 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' B' ' 30' ' ' LEU . 3.1 mp -147.38 126.09 6.23 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.73 165.96 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.721 1.614 . . . . 0.0 112.836 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -70.59 1.47 5.17 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.74 -34.28 77.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.455 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -118.77 112.26 19.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.103 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.5 p -107.2 -142.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.502 0.667 . . . . 0.0 110.891 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.63 -28.36 68.48 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.927 -1.108 . . . . 0.0 110.322 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.59 -53.98 16.24 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.078 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.2 OUTLIER -68.84 -44.5 73.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.874 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' B' ' 44' ' ' ASP . 14.2 mm -59.79 -52.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.868 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 42' ' ' ILE . 0.7 OUTLIER -38.94 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.809 -0.557 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' B' ' 42' ' ' ILE . 97.4 m-20 -122.54 -23.71 5.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.658 -1.276 . . . . 0.0 110.552 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.739 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.0 tm? -59.25 -43.85 92.39 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.16 -1.588 . . . . 0.0 106.922 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.0 OUTLIER -82.14 -63.23 1.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.189 -0.944 . . . . 0.0 109.289 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.775 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.9 t -37.91 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.655 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.6 OUTLIER -51.81 67.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.441 1.115 . . . . 0.0 110.153 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.775 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.22 -34.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.278 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.66 -173.05 46.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.46 159.33 20.11 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 123.046 2.498 . . . . 0.0 112.535 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' B' ' 74' ' ' PHE . 20.8 t -129.4 145.96 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.558 HD11 ' HD2' ' B' ' 75' ' ' ARG . 43.3 mm -91.28 -67.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.054 . . . . 0.0 111.877 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.538 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 74.7 m-20 -117.72 146.28 43.86 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.079 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.576 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.6 OUTLIER -140.64 129.89 23.67 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.576 ' N ' HD23 ' B' ' 55' ' ' LEU . 8.8 mtmp? -143.29 147.92 35.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.884 -1.135 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 4.5 ttm -125.92 136.48 53.09 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . 0.589 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -155.69 154.97 32.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.874 -1.141 . . . . 0.0 111.105 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.589 ' O ' ' SD ' ' B' ' 58' ' ' MET . 3.3 m-85 -111.43 176.4 5.04 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.616 -0.677 . . . . 0.0 110.167 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' B' ' 66' ' ' SER . 40.9 m-20 -114.24 84.9 9.77 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 0.0 110.901 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -60.82 -61.96 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.018 2.478 . . . . 0.0 113.136 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -81.62 -65.7 0.98 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.553 -0.717 . . . . 0.0 111.004 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.431 HG23 ' H ' ' B' ' 63' ' ' THR . 1.3 p -47.96 -45.13 30.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.113 -0.992 . . . . 0.0 109.135 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.92 12.21 81.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.498 HH12 HH22 ' C' ' 200' ' ' ARG . 78.5 mtm180 -59.52 -40.2 86.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.004 -1.292 . . . . 0.0 109.428 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.505 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -174.47 170.97 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.946 -1.096 . . . . 0.0 111.118 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 69' ' ' TYR . 37.9 mmtm -108.65 -68.09 0.93 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.266 -0.897 . . . . 0.0 110.437 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -60.32 68.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.138 0 O-C-N 120.595 -1.315 . . . . 0.0 111.571 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . 0.561 ' N ' ' O ' ' B' ' 67' ' ' LYS . 1.2 m-85 -106.96 125.82 51.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.688 -1.478 . . . . 0.0 109.18 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.21 140.0 32.19 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.499 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -106.5 123.56 48.27 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.736 ' CD1' HD13 ' B' ' 30' ' ' LEU . 3.4 mp -118.73 97.3 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.633 -0.667 . . . . 0.0 111.152 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.538 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 83.1 tt0 -84.48 131.06 34.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.437 -1.415 . . . . 0.0 110.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' B' ' 52' ' ' VAL . 6.6 m-85 -92.85 178.76 5.67 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.708 0.766 . . . . 0.0 111.056 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.558 ' HD2' HD11 ' B' ' 53' ' ' ILE . 10.4 tpt180 -52.16 -41.74 62.83 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.591 -0.693 . . . . 0.0 111.315 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.8 m-20 159.06 176.86 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.797 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.1 mp -36.63 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.816 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' B' ' 76' ' ' ASP . 50.1 mp0 -70.3 -74.74 0.13 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.389 -1.445 . . . . 0.0 108.459 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -61.78 -39.76 92.81 Favored 'General case' 0 C--O 1.195 -1.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' B' ' 26' ' ' ARG . 0.5 OUTLIER -64.07 -34.56 78.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.139 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -60.94 -61.72 2.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.485 -1.384 . . . . 0.0 107.746 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.591 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 23.3 t -62.77 -38.79 91.97 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.621 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.57 -64.83 1.08 Allowed 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 111.293 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' B' ' 99' ' ' CYS . 28.8 t -48.54 -41.03 11.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.655 -1.278 . . . . 0.0 108.538 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.57 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 61.7 ttm-85 -64.58 -49.14 72.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.938 -1.101 . . . . 0.0 109.237 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' B' ' 82' ' ' SER . 86.5 m-20 -76.23 -46.39 28.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.23 -0.919 . . . . 0.0 109.907 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' B' ' 83' ' ' ALA . 3.7 mm? -86.8 15.91 5.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.46 -0.775 . . . . 0.0 110.44 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' B' ' 88' ' ' ASN . 0.5 OUTLIER -53.89 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.685 -1.26 . . . . 0.0 108.258 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.96 116.65 1.61 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -136.93 144.89 43.69 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.369 -1.665 . . . . 0.0 107.667 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -34.79 92.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.542 -0.724 . . . . 0.0 111.304 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 90' ' ' TYR . 61.2 tp -154.79 135.44 13.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.695 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.36 -162.39 10.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . 0.467 ' CB ' ' HG ' ' B' ' 32' ' ' SER . 0.9 OUTLIER -88.0 -6.61 57.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.257 . . . . 0.0 109.344 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' B' ' 92' ' ' LEU . 37.8 ttm180 -134.56 160.28 38.55 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.502 ' O ' ' C ' ' B' ' 97' ' ' LEU . 57.1 m-85 -95.81 134.41 38.79 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.431 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.571 HD23 HD11 ' B' ' 30' ' ' LEU . 1.9 mp -31.76 150.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -118.23 144.46 45.75 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . 0.478 ' HA ' HG13 ' B' ' 84' ' ' VAL . 4.8 p -78.94 107.75 11.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.252 -0.905 . . . . 0.0 110.307 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -88.42 171.04 39.59 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.588 ' CD1' ' N ' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -156.15 92.82 1.37 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.1 -1.235 . . . . 0.0 108.066 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . 0.69 ' H ' HG12 ' B' ' 27' ' ' VAL . 0.9 OUTLIER -27.22 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.778 0.799 . . . . 0.0 109.992 -178.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.43 ' N ' ' O ' ' B' ' 101' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.52 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.354 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 93.1 p . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.341 0.591 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 6.9 m -78.19 66.67 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 108.742 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 16.3 tttt -108.29 89.41 2.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.551 -0.718 . . . . 0.0 110.418 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . 0.505 ' SD ' ' CG2' ' C' ' 217' ' ' VAL . 14.0 mmm -64.31 140.63 58.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 110.501 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -103.76 132.76 49.71 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . . . . . . . . . 26.7 mm -114.02 128.01 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -131.77 -173.68 13.41 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.347 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.96 22.23 2.87 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' C' ' 202' ' ' PHE . 3.0 mt -61.66 159.0 14.14 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.483 -1.01 . . . . 0.0 109.28 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.449 ' OD1' ' C ' ' C' ' 167' ' ' ASN . 36.4 p-10 -80.31 167.3 20.42 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.174 -0.954 . . . . 0.0 108.851 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -92.76 32.45 1.24 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.63 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.16 76.97 0.63 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.001 . . . . 0.0 110.332 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . 0.408 ' HG1' ' CG ' ' C' ' 167' ' ' ASN . 84.7 m -150.7 147.46 27.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.961 -1.087 . . . . 0.0 110.078 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . 0.554 ' OG1' ' ND2' ' C' ' 174' ' ' ASN . 0.2 OUTLIER -106.13 172.51 6.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -69.66 -66.9 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.747 -1.221 . . . . 0.0 109.502 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 172' ' ' GLU . 57.4 t0 -43.94 -33.37 1.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.084 -1.01 . . . . 0.0 109.232 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . 0.554 ' ND2' ' OG1' ' C' ' 171' ' ' THR . 87.2 m-20 -74.93 -49.49 20.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.125 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.57 -46.36 84.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.2 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . 0.559 ' CD ' HG11 ' C' ' 185' ' ' VAL . 21.9 ttp85 -63.23 -60.64 3.13 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.806 -1.184 . . . . 0.0 107.932 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' C' ' 176' ' ' ARG . 47.4 tp10 -41.94 -30.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.57 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 23.7 t80 -70.84 -53.85 13.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.038 -1.039 . . . . 0.0 108.826 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.81 ' O ' ' N ' ' C' ' 181' ' ' LYS . 72.5 m-85 -75.27 -62.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.35 -0.844 . . . . 0.0 110.192 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -41.61 2.79 0.01 OUTLIER Glycine 0 N--CA 1.503 3.154 0 O-C-N 120.555 -1.341 . . . . 0.0 112.381 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . 0.81 ' N ' ' O ' ' C' ' 179' ' ' PHE . 38.8 tttt -73.96 -15.1 61.12 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -77.46 -58.46 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.475 0.655 . . . . 0.0 110.017 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -156.61 -104.9 0.22 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 47.6 m -127.83 147.19 50.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.511 -0.994 . . . . 0.0 109.569 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.559 HG11 ' CD ' ' C' ' 176' ' ' ARG . 14.7 p -126.5 144.42 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' C' ' 208' ' ' GLU . 0.2 OUTLIER -91.06 -58.3 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.176 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' C' ' 206' ' ' SER . 43.8 t0 -156.86 160.76 39.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.814 HD23 ' H ' ' C' ' 188' ' ' LEU . 1.7 pt? -146.09 143.89 29.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.92 85.62 2.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.012 -1.055 . . . . 0.0 109.234 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.8 156.25 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . 0.448 ' CB ' ' CZ ' ' C' ' 202' ' ' PHE . 6.3 tpp -142.31 55.84 1.45 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.022 -1.049 . . . . 0.0 110.486 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.74 117.5 15.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 108.887 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -135.42 80.36 45.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.383 -0.823 . . . . 0.0 109.906 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.16 -18.12 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.439 2.092 . . . . 0.0 110.914 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.72 ' O ' HG23 ' C' ' 196' ' ' THR . . . -65.5 -38.42 89.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . 0.72 HG23 ' O ' ' C' ' 195' ' ' ALA . 5.8 p -165.81 -32.07 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.586 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 193' ' ' ASP . . . -102.64 100.31 1.95 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.398 -1.382 . . . . 0.0 109.842 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -103.26 133.77 47.78 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.453 -1.028 . . . . 0.0 109.557 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . 0.588 ' O ' ' C ' ' C' ' 200' ' ' ARG . 2.7 m -156.78 151.62 25.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 109.306 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.588 ' C ' ' O ' ' C' ' 199' ' ' SER . 94.0 mtt-85 -24.97 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.9 120.58 5.18 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.151 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.623 ' HA ' HD12 ' C' ' 166' ' ' LEU . 50.8 p90 -165.03 164.66 20.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -140.86 125.5 2.85 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.582 -1.771 . . . . 0.0 110.41 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . 0.422 ' CD1' ' NZ ' ' C' ' 160' ' ' LYS . 3.7 m-85 -89.98 65.65 6.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' C' ' 207' ' ' PHE . 0.7 OUTLIER -64.37 101.48 0.44 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.845 0.831 . . . . 0.0 112.606 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.3 OUTLIER -86.1 138.69 31.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.808 ' CE1' HD22 ' C' ' 205' ' ' LEU . 24.5 m-85 -118.05 144.01 45.94 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.537 -1.352 . . . . 0.0 109.694 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . 0.538 ' N ' ' OG1' ' C' ' 186' ' ' THR . 84.9 tt0 -68.36 -46.44 70.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -100.35 125.16 40.39 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.816 -1.178 . . . . 0.0 111.053 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . 0.904 ' O ' HG22 ' C' ' 213' ' ' VAL . 51.4 Cg_exo -45.74 -40.33 19.11 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.973 2.449 . . . . 0.0 114.223 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 97.8 p -61.34 -46.6 89.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.584 -1.322 . . . . 0.0 110.68 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.774 ' O ' HG23 ' C' ' 216' ' ' VAL . 29.6 m -39.33 -31.03 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . 0.904 HG22 ' O ' ' C' ' 210' ' ' PRO . 6.2 m -69.78 -34.52 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.21 . . . . 0.0 110.233 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' C' ' 218' ' ' LYS . 54.9 t0 -62.36 -49.17 76.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.32 -33.95 75.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 108.986 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.774 HG23 ' O ' ' C' ' 212' ' ' SER . 48.1 t -82.26 33.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.505 ' CG2' ' SD ' ' C' ' 161' ' ' MET . 21.1 t -154.58 -36.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.605 -0.684 . . . . 0.0 109.579 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . 0.492 ' NZ ' ' OD1' ' C' ' 214' ' ' ASP . 2.2 ttmp? -92.67 23.87 3.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.644 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . 0.597 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 42.2 m -134.81 157.21 47.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -83.95 134.22 34.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 108.459 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' C' ' 219' ' ' THR . 18.4 m-70 -123.51 133.6 53.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . 0.57 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -145.38 106.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 110.449 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' C' ' 178' ' ' TYR . 3.9 mm? -52.8 -65.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.635 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -126.26 24.15 6.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.23 15.07 42.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -80.93 -154.36 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -1.098 . . . . 0.0 108.51 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . 0.566 HG12 ' OE1' ' C' ' 273' ' ' GLN . 0.3 OUTLIER -132.32 97.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . 0.538 HD13 HD23 ' C' ' 223' ' ' LEU . 19.7 pt -107.56 153.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.622 -0.674 . . . . 0.0 109.579 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . 0.502 ' OD1' ' OD2' ' C' ' 271' ' ' ASP . 28.3 t0 -123.62 97.36 42.04 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.628 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 56.9 Cg_endo -86.77 125.58 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.847 2.365 . . . . 0.0 111.928 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . 0.637 ' HG2' HD11 ' C' ' 234' ' ' ILE . 0.3 OUTLIER -145.82 142.39 28.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.99 . . . . 0.0 109.64 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' C' ' 233' ' ' ALA . 58.5 ttp180 -53.04 144.24 15.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 108.959 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -36.23 116.72 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . 0.637 HD11 ' HG2' ' C' ' 231' ' ' LYS . 67.7 mt -99.25 134.95 20.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 0.0 109.486 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.42 149.61 62.94 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.125 1.883 . . . . 0.0 111.705 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -34.99 68.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.482 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.28 -45.57 80.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -71.23 -37.31 72.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 0.0 109.21 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . 0.527 ' O ' ' OG1' ' C' ' 242' ' ' THR . 77.5 mt-30 -58.68 -35.27 72.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 108.727 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.53 -42.47 91.95 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.197 -0.939 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' C' ' 242' ' ' THR . 18.8 mttp -69.72 -51.79 31.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . 0.537 ' C ' ' O ' ' C' ' 241' ' ' LYS . 0.1 OUTLIER -22.62 140.33 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.284 0.564 . . . . 0.0 111.403 -178.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -132.65 130.19 5.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' C' ' 318' ' ' ALA . 0.0 OUTLIER -132.27 138.61 47.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.971 -1.311 . . . . 0.0 110.406 178.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.419 ' CG2' HG13 ' C' ' 297' ' ' VAL . 2.5 pt -123.96 140.39 47.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.835 0.826 . . . . 0.0 108.906 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' C' ' 247' ' ' VAL . 10.8 t80 -70.85 158.23 36.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . 0.415 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 0.6 OUTLIER -138.27 133.88 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.852 . . . . 0.0 109.473 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.73 152.13 16.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.62 -29.16 12.78 Favored Glycine 0 N--CA 1.495 2.571 0 O-C-N 121.095 -1.238 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.402 HG22 ' CD2' ' C' ' 308' ' ' PHE . 1.2 pp -109.58 164.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.074 -1.251 . . . . 0.0 108.941 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . 0.65 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.71 -42.98 1.32 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 45.4 Cg_exo -56.16 -132.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.874 2.382 . . . . 0.0 112.378 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.79 -36.1 67.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -0.867 . . . . 0.0 110.575 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.531 ' CG1' ' OD2' ' C' ' 310' ' ' ASP . 13.7 m -55.92 127.46 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.0 109.47 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -90.65 160.66 38.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' C' ' 257' ' ' LYS . 17.0 Cg_endo -60.34 -26.26 82.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.97 2.447 . . . . 0.0 112.259 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' C' ' 256' ' ' PRO . 26.2 mtpp -45.32 -62.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.2 tp10 -60.9 -82.88 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.409 -0.917 . . . . 0.0 108.69 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . 0.606 ' C ' ' O ' ' C' ' 258' ' ' GLU . 1.1 t80 -10.98 -62.1 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 CA-C-O 121.438 0.637 . . . . 0.0 111.263 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 258' ' ' GLU . 87.7 tt0 -64.03 -48.53 75.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.27 -0.894 . . . . 0.0 109.523 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' C' ' 258' ' ' GLU . 0.0 OUTLIER -73.04 0.95 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' C' ' 264' ' ' SER . 0.7 OUTLIER -94.54 -74.24 0.55 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.496 ' O ' ' C ' ' C' ' 264' ' ' SER . 29.2 m-85 -42.19 -27.24 0.13 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.21 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.592 ' O ' ' N ' ' C' ' 266' ' ' TRP . 29.0 t -40.15 -41.64 1.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' C' ' 264' ' ' SER . 6.3 tt0 -39.79 -19.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.756 -0.59 . . . . 0.0 110.67 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.664 ' HE1' ' CG1' ' C' ' 300' ' ' VAL . 8.8 p90 -154.13 151.79 29.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.805 -1.185 . . . . 0.0 109.111 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 62.8 -172.4 10.44 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 3.4 t -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' C' ' 272' ' ' ALA . 5.0 mm -96.33 100.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.423 -1.311 . . . . 0.0 110.263 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 291' ' ' TYR . 1.4 mp -72.01 -57.71 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.634 -0.667 . . . . 0.0 110.372 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . 0.502 ' OD2' ' OD1' ' C' ' 229' ' ' ASP . 0.5 OUTLIER -129.61 106.53 8.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' C' ' 269' ' ' ILE . . . -120.87 142.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.903 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . 0.566 ' OE1' HG12 ' C' ' 227' ' ' VAL . 10.9 pt20 -171.53 136.75 1.0 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.637 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.536 HD13 ' HA2' ' C' ' 251' ' ' GLY . 3.6 pp -112.01 156.9 21.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . 0.672 ' SD ' ' N ' ' C' ' 275' ' ' MET . 0.0 OUTLIER -99.4 168.67 9.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.717 -1.239 . . . . 0.0 109.533 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.621 ' O ' ' N ' ' C' ' 278' ' ' LYS . 1.6 pp -157.62 -178.37 7.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.924 . . . . 0.0 109.718 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' C' ' 283' ' ' SER . 55.7 t0 -64.96 44.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 109.047 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -48.5 -32.38 7.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 278' ' ' LYS . 6.8 m-20 -179.17 27.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' C' ' 280' ' ' THR . 0.0 OUTLIER -172.67 21.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.783 -1.198 . . . . 0.0 110.394 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' C' ' 277' ' ' ASP . . . 61.86 23.5 63.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' C' ' 284' ' ' ARG . 3.7 tp60 -50.65 -16.23 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -1.065 . . . . 0.0 109.076 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' C' ' 277' ' ' ASP . 0.3 OUTLIER -62.92 38.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.546 -0.721 . . . . 0.0 110.072 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' C' ' 282' ' ' GLN . 0.5 OUTLIER -46.61 -33.67 4.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.08 67.88 0.21 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.408 ' HB2' ' CZ ' ' C' ' 246' ' ' PHE . 38.8 p90 -176.43 -171.23 0.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.88 -1.365 . . . . 0.0 109.604 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . 175.21 -165.54 36.61 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -142.13 154.87 45.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.296 -1.708 . . . . 0.0 108.978 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . 0.41 ' CG2' ' CE1' ' C' ' 291' ' ' TYR . 0.5 OUTLIER -131.42 145.64 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . 0.467 ' O ' ' N ' ' C' ' 270' ' ' ILE . 32.3 m -133.05 123.67 26.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.509 -1.369 . . . . 0.0 109.997 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . 0.591 ' O ' HD13 ' C' ' 270' ' ' ILE . 33.4 m-85 -98.95 -80.27 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.293 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER 169.39 -56.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 O-C-N 120.631 -1.293 . . . . 0.0 108.009 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 58.6 p -93.82 172.66 8.11 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.17 -8.76 23.24 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.13 -52.4 65.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 108.618 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.52 95.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 108.485 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . 0.419 HG13 ' CG2' ' C' ' 245' ' ' ILE . 45.6 t -52.66 -57.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.186 -0.946 . . . . 0.0 108.611 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.07 -32.6 71.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.196 -0.94 . . . . 0.0 109.217 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.87 -62.07 2.08 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.664 ' CG1' ' HE1' ' C' ' 266' ' ' TRP . 0.2 OUTLIER -66.29 -31.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.497 -0.752 . . . . 0.0 110.203 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . 0.618 ' SG ' ' NH2' ' C' ' 317' ' ' ARG . 31.7 t -45.58 -52.13 11.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.674 -1.266 . . . . 0.0 108.817 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -50.88 -27.78 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.44 -0.788 . . . . 0.0 110.556 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' C' ' 303' ' ' ASN . 30.9 p30 -100.22 63.15 1.13 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.014 -1.054 . . . . 0.0 109.808 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' C' ' 303' ' ' ASN . 15.8 tttp -45.18 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.47 -1.394 . . . . 0.0 108.905 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' C' ' 314' ' ' GLU . 70.6 m-85 -67.28 127.83 34.11 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.32 -0.862 . . . . 0.0 109.497 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . 0.649 HG21 HD11 ' C' ' 315' ' ' ILE . 0.9 OUTLIER -135.92 154.19 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 108.949 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.0 128.6 33.47 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 34.3 t80 -118.07 173.62 6.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.511 -0.743 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.436 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.0 OUTLIER -56.11 -34.19 65.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.188 -0.945 . . . . 0.0 112.037 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . 0.531 ' OD2' ' CG1' ' C' ' 254' ' ' VAL . 15.6 m-20 -90.71 -71.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.734 -1.229 . . . . 0.0 109.942 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -148.06 -170.22 3.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 109.262 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -60.32 148.25 37.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.969 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . 0.413 HG13 HG22 ' C' ' 306' ' ' ILE . 31.3 pt -132.27 153.74 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . 0.418 ' HG3' ' CE2' ' C' ' 305' ' ' PHE . 4.0 mp0 -111.44 110.17 20.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.003 -1.061 . . . . 0.0 110.842 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.649 HD11 HG21 ' C' ' 306' ' ' ILE . 59.6 mt -87.91 161.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.9 -1.125 . . . . 0.0 109.838 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . 0.422 ' N ' HG22 ' C' ' 315' ' ' ILE . 47.2 tttp -163.46 160.88 23.87 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.914 -1.116 . . . . 0.0 109.043 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . 0.618 ' NH2' ' SG ' ' C' ' 301' ' ' CYS . 62.5 mtt85 -71.76 146.25 48.22 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.699 -1.251 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' C' ' 244' ' ' LYS . . . -71.72 26.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 109.411 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' C' ' 317' ' ' ARG . 7.3 pt-20 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.598 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' B' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.08 158.68 24.63 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.727 2.284 . . . . 0.0 112.208 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.47 20.2 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.848 2.365 . . . . 0.0 112.976 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.874 -1.141 . . . . 0.0 109.952 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.538 ' HE ' ' CB ' ' B' ' 103' ' ' SER . 5.3 ttp85 179.24 -45.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.636 HG22 ' HG3' ' B' ' 73' ' ' GLU . 10.3 t -122.56 155.02 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.637 HG22 HD13 ' B' ' 72' ' ' ILE . 0.2 OUTLIER -126.71 142.32 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.471 ' CZ ' ' HA3' ' B' ' 100' ' ' GLY . 2.6 m-85 -114.98 141.81 47.47 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.072 -1.017 . . . . 0.0 110.547 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.605 ' HB3' HD11 ' B' ' 33' ' ' ILE . 1.7 mt -118.78 127.52 53.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.545 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -113.33 -50.39 0.54 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.639 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 9.7 p -88.76 115.38 26.26 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.743 -1.445 . . . . 0.0 107.731 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.609 HD12 ' C ' ' B' ' 32' ' ' SER . 4.2 mp -147.85 107.16 3.72 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.887 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' B' ' 36' ' ' ASP . 7.8 Cg_exo -63.01 159.23 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.629 1.553 . . . . 0.0 109.744 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' B' ' 35' ' ' TYR . 6.2 m-30 -74.57 5.37 4.86 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 34' ' ' PRO . 27.0 t0 -62.03 -47.09 86.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.59 ' N ' HE21 ' B' ' 37' ' ' GLN . 0.0 OUTLIER -120.12 109.13 15.08 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.872 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.545 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 45.8 p -100.14 -148.83 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.0 109.419 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.04 -26.39 67.59 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.14 -1.6 . . . . 0.0 110.902 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -73.17 -57.42 4.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.75 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.511 HE21 ' HB3' ' B' ' 37' ' ' GLN . 25.1 mt-30 -68.84 -44.17 73.97 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.972 -1.08 . . . . 0.0 109.231 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' B' ' 44' ' ' ASP . 2.4 mm -54.53 -54.77 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' B' ' 55' ' ' LEU . 45.6 tp -37.21 -19.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.9 t0 -123.86 -21.81 5.05 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.595 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.723 ' C ' HD13 ' B' ' 45' ' ' LEU . 3.2 tm? -62.97 -44.06 97.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.051 -1.656 . . . . 0.0 107.029 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' B' ' 48' ' ' ASN . 74.4 m -82.98 -65.45 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.155 -0.966 . . . . 0.0 108.739 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.839 ' O ' ' N ' ' B' ' 49' ' ' VAL . 4.6 t -37.24 -15.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.79 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.4 OUTLIER -50.23 56.45 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.483 1.135 . . . . 0.0 110.551 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.839 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.4 p 178.46 -34.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 121.426 -0.796 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.68 159.57 32.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' B' ' 52' ' ' VAL . 20.5 Cg_endo -65.24 86.47 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.525 2.15 . . . . 0.0 111.525 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.568 HG11 ' CG2' ' B' ' 72' ' ' ILE . 0.0 OUTLIER -40.09 153.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.633 0.73 . . . . 0.0 110.072 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' B' ' 73' ' ' GLU . 15.9 mm -77.05 -45.3 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.688 -0.632 . . . . 0.0 109.662 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' B' ' 53' ' ' ILE . 87.0 m-20 -146.89 152.68 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.362 -1.335 . . . . 0.0 111.678 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' B' ' 43' ' ' LEU . 42.5 tp -143.56 128.48 18.45 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -145.58 123.91 12.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.624 -1.297 . . . . 0.0 110.194 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 9.9 ttm -116.4 150.36 37.91 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.746 0.784 . . . . 0.0 111.138 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . 0.59 ' CG ' ' N ' ' B' ' 59' ' ' PHE . 2.1 ttp -168.14 165.65 13.21 Favored 'General case' 0 C--O 1.282 2.781 0 O-C-N 121.383 -0.823 . . . . 0.0 109.498 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.681 ' CD1' ' N ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -132.56 134.59 45.14 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 127.008 2.692 . . . . 0.0 110.214 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.597 ' H ' ' HA ' ' B' ' 67' ' ' LYS . 0.1 OUTLIER -42.05 105.39 0.4 Allowed Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 112.014 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -91.63 -66.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.796 2.331 . . . . 0.0 109.325 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -105.89 -25.45 12.13 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 80.5 p -46.41 -49.54 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' B' ' 60' ' ' ASP . . . 76.77 36.7 36.21 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.769 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -137.01 -76.92 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.718 -1.46 . . . . 0.0 110.142 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' B' ' 60' ' ' ASP . 97.7 p -109.81 140.83 43.29 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.088 1.899 . . . . 0.0 111.538 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.597 ' HA ' ' H ' ' B' ' 60' ' ' ASP . 39.0 mttt -101.72 -5.49 24.89 Favored 'General case' 0 C--O 1.166 -3.332 0 CA-C-O 115.138 -2.363 . . . . 0.0 114.891 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . 0.597 ' O ' ' CD2' ' B' ' 69' ' ' TYR . . . -126.11 100.08 0.57 Allowed Glycine 1 N--CA 1.534 5.198 0 CA-C-N 123.356 2.798 . . . . 0.0 116.534 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . 0.597 ' CD2' ' O ' ' B' ' 68' ' ' GLY . 3.1 m-85 -165.9 139.6 4.38 Favored 'General case' 0 N--CA 1.516 2.83 0 C-N-CA 115.329 -2.548 . . . . 0.0 114.127 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.68 142.99 28.43 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.134 -0.979 . . . . 0.0 110.973 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -107.83 132.86 52.98 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.183 0.992 . . . . 0.0 110.4 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.637 HD13 HG22 ' B' ' 28' ' ' VAL . 3.8 mp -115.27 146.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.636 ' HG3' HG22 ' B' ' 27' ' ' VAL . 83.9 tt0 -136.03 135.47 39.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.167 -1.583 . . . . 0.0 108.38 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.406 ' CZ ' HG13 ' B' ' 52' ' ' VAL . 13.3 m-85 -105.74 168.61 8.99 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.759 0.79 . . . . 0.0 110.845 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 47.6 ttp180 -53.75 -45.41 70.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.635 -0.666 . . . . 0.0 111.532 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.75 179.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.174 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.6 mm? -34.29 -24.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.851 -0.531 . . . . 0.0 111.142 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 91.9 mt-10 -71.05 -75.34 0.13 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.668 -1.27 . . . . 0.0 109.259 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.97 -41.56 98.14 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 84' ' ' VAL . 21.0 m -60.28 -37.54 80.8 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.836 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -61.1 -61.8 2.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.44 -1.413 . . . . 0.0 108.912 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.521 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 67.2 m -61.89 -43.24 99.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.723 0.773 . . . . 0.0 112.022 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.37 -64.93 1.05 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.427 -0.795 . . . . 0.0 111.031 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.442 ' O ' ' CA ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -50.63 -39.36 17.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.261 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.608 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 2.1 ttm-85 -66.86 -55.53 14.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.612 -1.305 . . . . 0.0 108.791 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' B' ' 82' ' ' SER . 46.9 m-80 -67.02 -43.91 81.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 109.68 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 83' ' ' ALA . 45.7 mt -105.6 41.67 1.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.411 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' B' ' 85' ' ' ARG . 0.0 OUTLIER -70.26 -75.16 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.98 117.88 1.73 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -139.87 147.54 40.8 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.549 -1.559 . . . . 0.0 107.819 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . 0.592 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.3 mm-40 -33.94 89.09 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.822 0.82 . . . . 0.0 111.184 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' B' ' 90' ' ' TYR . 51.3 tp -140.8 125.85 18.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.41 -157.05 4.01 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . 0.606 ' N ' ' OG ' ' B' ' 32' ' ' SER . 2.3 p -83.36 -15.65 49.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.862 -1.376 . . . . 0.0 109.896 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.677 ' N ' ' OG ' ' B' ' 32' ' ' SER . 94.4 mtt-85 -131.23 155.87 46.35 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.8 m-85 -96.07 139.35 32.38 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.47 -0.769 . . . . 0.0 109.86 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.524 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -38.47 141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -114.2 147.53 38.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.112 -0.992 . . . . 0.0 109.867 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 17.9 p -88.02 115.61 25.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.679 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -108.52 177.23 20.59 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.469 ' O ' ' C ' ' B' ' 102' ' ' SER . 48.0 p90 -131.61 -17.57 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.555 -0.968 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . 0.547 ' O ' HG21 ' B' ' 27' ' ' VAL . 8.3 t -38.02 99.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.108 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . 0.538 ' CB ' ' HE ' ' B' ' 26' ' ' ARG . 60.0 p . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . 0.594 ' O ' ' N ' ' C' ' 160' ' ' LYS . 83.8 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.248 0.547 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . 0.528 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 46.23 11.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.547 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' C' ' 158' ' ' SER . 14.5 tttp -94.75 137.82 33.36 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . 0.693 ' SD ' ' N ' ' C' ' 162' ' ' PHE . 0.0 OUTLIER -114.9 152.58 32.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 108.986 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . 0.693 ' N ' ' SD ' ' C' ' 161' ' ' MET . 55.2 t80 -119.4 72.94 0.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.607 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . 0.749 HD12 HD21 ' C' ' 175' ' ' LEU . 54.5 mt -53.24 145.48 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.38 -177.43 15.98 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 56.22 20.77 30.04 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . 0.52 HD21 ' CG2' ' C' ' 163' ' ' ILE . 97.5 mt -60.97 163.7 5.63 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.364 -1.08 . . . . 0.0 108.776 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' C' ' 168' ' ' TRP . 11.5 p-10 -68.65 -75.71 0.1 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.056 -1.028 . . . . 0.0 108.918 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . 0.725 ' HE1' HH21 ' C' ' 198' ' ' ARG . 0.1 OUTLIER 178.5 -24.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.872 -1.143 . . . . 0.0 109.784 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -133.01 91.46 2.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.975 . . . . 0.0 109.764 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . 0.478 HG21 HD13 ' C' ' 175' ' ' LEU . 46.2 m -126.05 144.74 50.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.416 -0.803 . . . . 0.0 109.386 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.84 172.62 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.022 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' C' ' 176' ' ' ARG . 0.5 OUTLIER -75.14 -67.77 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.961 -1.087 . . . . 0.0 109.861 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -43.29 -33.45 0.99 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -74.92 -50.83 15.46 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 108.827 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.749 HD21 HD12 ' C' ' 163' ' ' ILE . 20.8 tp -52.67 -42.06 64.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.693 -0.63 . . . . 0.0 109.53 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' C' ' 179' ' ' PHE . 14.2 ptp180 -74.38 -57.3 4.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.511 -1.368 . . . . 0.0 108.866 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' C' ' 176' ' ' ARG . 54.0 mm-40 -37.71 -30.76 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.717 ' CD2' HD12 ' C' ' 223' ' ' LEU . 21.6 t80 -85.25 -39.85 17.29 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.103 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' C' ' 176' ' ' ARG . 22.6 m-85 -94.25 16.98 13.56 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.146 -0.971 . . . . 0.0 111.429 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.45 24.46 25.44 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . 0.696 ' NZ ' ' CZ ' ' C' ' 182' ' ' TYR . 3.6 ptmm? -104.52 16.41 26.15 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.35 -1.088 . . . . 0.0 108.814 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . 0.696 ' CZ ' ' NZ ' ' C' ' 181' ' ' LYS . 92.3 m-85 -119.21 -49.16 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.596 -0.69 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -164.88 -127.41 0.89 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 40.6 m -126.39 145.64 50.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.506 -0.996 . . . . 0.0 109.692 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.11 137.75 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.516 HG22 ' O ' ' C' ' 206' ' ' SER . 9.7 t -96.82 -37.0 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.81 -1.181 . . . . 0.0 110.111 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' C' ' 186' ' ' THR . 79.5 m-20 -149.0 149.17 30.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.938 . . . . 0.0 108.613 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.73 HD23 ' N ' ' C' ' 189' ' ' LYS . 7.7 tt -140.34 144.1 36.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.828 -1.17 . . . . 0.0 108.355 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . 0.73 ' N ' HD23 ' C' ' 188' ' ' LEU . 0.1 OUTLIER -126.08 129.95 50.13 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . 0.624 ' CD1' HD22 ' C' ' 175' ' ' LEU . 0.6 OUTLIER -147.75 121.47 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.789 -1.194 . . . . 0.0 108.778 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . 0.555 ' O ' ' CZ ' ' C' ' 202' ' ' PHE . 4.3 ptp -176.2 158.18 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 108.765 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.56 -63.89 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.686 -1.259 . . . . 0.0 109.032 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.473 ' OD1' ' OG ' ' C' ' 199' ' ' SER . 0.2 OUTLIER -123.47 88.39 51.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.13 -20.86 8.26 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.356 2.037 . . . . 0.0 112.129 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.18 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.147 -0.971 . . . . 0.0 109.78 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 65.1 p -109.23 -8.66 15.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 81.22 15.64 76.27 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . 0.725 HH21 ' HE1' ' C' ' 168' ' ' TRP . 0.0 OUTLIER -97.68 73.22 2.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.258 . . . . 0.0 109.456 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . 0.526 ' O ' ' C ' ' C' ' 200' ' ' ARG . 80.6 p -167.1 172.77 9.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' C' ' 199' ' ' SER . 0.0 OUTLIER -27.27 147.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.005 0.431 . . . . 0.0 110.137 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.5 158.82 22.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.555 ' CZ ' ' O ' ' C' ' 191' ' ' MET . 4.7 p90 -171.18 134.11 0.9 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.359 . . . . 0.0 108.614 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -112.12 132.95 11.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.09 114.13 27.17 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' C' ' 207' ' ' PHE . 0.5 OUTLIER -112.98 110.29 20.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.298 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . 0.516 ' O ' HG22 ' C' ' 186' ' ' THR . 29.1 t -81.44 72.05 8.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.742 ' CZ ' HD13 ' C' ' 205' ' ' LEU . 27.3 m-85 -64.47 115.51 5.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.93 -38.43 90.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.18 108.74 30.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.006 -1.059 . . . . 0.0 110.44 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -52.1 -24.74 20.76 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.697 1.598 . . . . 0.0 112.5 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.507 ' O ' ' N ' ' C' ' 213' ' ' VAL . 22.9 t -66.95 -65.32 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.949 -1.094 . . . . 0.0 109.861 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.79 ' O ' HG23 ' C' ' 216' ' ' VAL . 51.0 m -40.75 -24.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.482 -0.761 . . . . 0.0 110.295 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' C' ' 211' ' ' SER . 95.0 t -69.13 -38.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 109.011 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.9 t0 -59.0 -49.41 77.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 110.094 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.08 -36.53 79.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.84 -1.162 . . . . 0.0 109.31 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.79 HG23 ' O ' ' C' ' 212' ' ' SER . 47.9 t -54.94 -47.91 75.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 110.024 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.13 -33.33 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -72.79 6.28 2.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 109.558 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . 0.656 ' CG2' ' CE1' ' C' ' 221' ' ' HIS . 1.3 t -134.56 167.7 20.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.134 -0.979 . . . . 0.0 109.391 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -122.82 134.42 54.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.73 -0.606 . . . . 0.0 109.403 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.862 ' C ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -132.07 161.03 34.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . 0.862 HD13 ' C ' ' C' ' 221' ' ' HIS . 0.4 OUTLIER -124.93 110.1 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 109.057 179.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.717 HD12 ' CD2' ' C' ' 178' ' ' TYR . 18.3 tp -75.14 -71.6 0.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 60.7 t0 -80.22 1.06 29.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.028 -1.045 . . . . 0.0 108.772 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.92 13.51 69.17 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . 0.702 ' HZ1' ' N ' ' C' ' 279' ' ' ASP . 0.0 OUTLIER -90.73 -83.28 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -1.075 . . . . 0.0 109.432 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . 0.587 HG22 ' O ' ' C' ' 227' ' ' VAL . 1.3 p 172.57 89.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.19 -0.944 . . . . 0.0 109.66 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 pt -94.63 152.02 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.396 -0.815 . . . . 0.0 110.34 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' C' ' 229' ' ' ASP . 0.0 OUTLIER -116.8 106.45 47.94 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 110.042 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.44 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 42.7 Cg_endo -82.17 134.23 7.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.388 2.059 . . . . 0.0 111.819 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' C' ' 232' ' ' ARG . 11.8 ttmm -152.53 164.26 37.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.98 . . . . 0.0 109.673 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' C' ' 231' ' ' LYS . 56.7 ttm-85 -72.96 159.22 34.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 116.07 3.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.205 -0.934 . . . . 0.0 111.163 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . 0.417 HD13 HG21 ' C' ' 234' ' ' ILE . 18.5 mt -156.91 91.67 2.45 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -40.15 137.78 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.601 1.534 . . . . 0.0 111.479 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -55.69 -29.5 59.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.08 -45.13 79.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.65 -1.281 . . . . 0.0 108.663 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.88 -38.3 58.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' C' ' 242' ' ' THR . 4.2 tp-100 -57.92 -38.01 75.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.615 -0.678 . . . . 0.0 110.0 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -58.88 -22.59 59.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.867 . . . . 0.0 109.664 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . 0.531 ' O ' ' O ' ' C' ' 291' ' ' TYR . 72.5 p -56.89 -36.67 70.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.13 3.22 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -138.58 138.15 37.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.025 -1.279 . . . . 0.0 110.855 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.746 HD12 ' CG2' ' C' ' 315' ' ' ILE . 3.8 pt -120.53 146.65 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.2 OUTLIER -86.54 160.37 18.98 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 28.4 t -134.11 131.17 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.56 -0.713 . . . . 0.0 109.092 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.01 147.53 18.51 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.51 5.25 79.14 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.553 HD11 ' HE2' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -111.12 133.06 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -1.058 . . . . 0.0 109.3 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.53 -36.35 2.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.727 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 32.0 Cg_exo -56.0 -30.0 76.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.397 2.064 . . . . 0.0 113.194 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -151.18 7.79 0.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.601 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.638 HG11 ' CE2' ' C' ' 308' ' ' PHE . 24.4 t -126.63 118.03 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 111.14 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . 0.492 ' HA ' HD23 ' C' ' 274' ' ' LEU . 0.0 OUTLIER -102.26 169.79 7.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' C' ' 257' ' ' LYS . 0.0 OUTLIER -26.22 -50.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.312 2.675 . . . . 0.0 114.677 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . 0.498 ' O ' ' OE1' ' C' ' 261' ' ' GLU . 58.4 tttp -33.09 -84.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' C' ' 261' ' ' GLU . 27.4 tp10 -58.21 -76.79 0.04 OUTLIER 'General case' 0 C--O 1.194 -1.82 0 O-C-N 120.846 -1.159 . . . . 0.0 109.384 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . 0.632 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.0 t80 -12.16 -64.39 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 121.867 0.841 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' C' ' 258' ' ' GLU . 50.0 mt-10 -62.22 -49.39 75.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.96 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . 0.707 ' N ' ' O ' ' C' ' 258' ' ' GLU . 5.1 mp0 -71.27 2.79 4.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . 0.482 ' O ' ' CD ' ' C' ' 265' ' ' GLN . 6.1 t80 -98.21 -73.22 0.62 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.577 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 54.3 m-85 -50.52 -31.61 15.99 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.412 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.422 ' C ' ' O ' ' C' ' 263' ' ' PHE . 73.6 m -35.82 -38.34 0.12 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.605 -0.684 . . . . 0.0 112.445 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.482 ' CD ' ' O ' ' C' ' 262' ' ' PHE . 0.0 OUTLIER -54.75 -93.33 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.148 -1.595 . . . . 0.0 110.189 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.577 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -66.99 152.26 46.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.976 -1.078 . . . . 0.0 110.052 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 69.45 167.2 5.41 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 59.1 m -115.24 122.89 47.37 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' C' ' 272' ' ' ALA . 3.2 mp -104.87 107.91 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.43 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . 0.425 HD11 ' OD2' ' C' ' 292' ' ' ASP . 4.8 mm -77.15 -46.79 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 110.58 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -139.7 103.64 4.72 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.658 -1.276 . . . . 0.0 110.415 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' C' ' 269' ' ' ILE . . . -110.38 142.19 42.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.222 -0.924 . . . . 0.0 108.525 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -150.79 139.51 20.73 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.083 -1.447 . . . . 0.0 112.463 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 26.8 tp -122.96 141.24 52.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . 0.863 ' C ' HD13 ' C' ' 276' ' ' LEU . 45.7 mmm -89.17 177.3 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.149 -1.595 . . . . 0.0 109.249 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 1.055 HD22 ' H ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -131.95 170.28 15.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.992 -1.067 . . . . 0.0 109.505 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 54.4 p30 -90.9 -11.48 39.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.424 -0.797 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . 0.625 ' C ' ' HZ1' ' C' ' 226' ' ' LYS . 19.8 tptm -62.46 -32.78 73.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 108.838 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . 0.702 ' N ' ' HZ1' ' C' ' 226' ' ' LYS . 34.2 p-10 -63.87 -44.38 93.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . 0.655 HG22 ' C ' ' C' ' 279' ' ' ASP . 0.2 OUTLIER 177.34 5.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.099 -1.001 . . . . 0.0 110.172 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.08 57.0 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.557 ' HG2' HG23 ' C' ' 280' ' ' THR . 19.4 mm100 -57.46 -34.24 68.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -1.197 . . . . 0.0 109.307 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 78.1 p -68.8 51.7 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.156 -0.965 . . . . 0.0 108.974 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' C' ' 282' ' ' GLN . 58.4 ttm-85 -49.59 -37.24 26.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 159.37 78.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.562 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 34.6 p90 -176.2 -174.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.271 . . . . 0.0 109.666 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -178.86 -170.97 41.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -147.97 152.26 37.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.22 -1.753 . . . . 0.0 108.877 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 94.2 t -130.6 145.61 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 15.5 m -128.55 130.45 47.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.814 -1.179 . . . . 0.0 110.453 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' C' ' 242' ' ' THR . 24.3 m-85 -113.37 153.33 28.72 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . 0.425 ' OD2' HD11 ' C' ' 270' ' ' ILE . 1.8 t0 -74.0 18.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.014 -1.054 . . . . 0.0 109.499 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . 0.463 ' H ' ' C ' ' C' ' 291' ' ' TYR . 59.8 p -162.67 173.88 13.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.02 -7.99 15.27 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.27 -52.0 67.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.91 90.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.852 . . . . 0.0 108.768 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . 0.489 HG13 HG22 ' C' ' 245' ' ' ILE . 55.8 t -54.82 -57.38 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.23 -29.73 68.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -63.51 -63.75 1.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.124 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -63.71 -25.47 38.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.063 -1.023 . . . . 0.0 109.616 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . . . . . . . . . 45.3 t -45.18 -55.38 5.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 109.634 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . 0.585 ' NE2' ' OD1' ' C' ' 303' ' ' ASN . 0.0 OUTLIER -51.5 -24.98 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 108.051 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' C' ' 302' ' ' GLN . 97.1 m-20 -98.54 78.87 2.42 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -78.54 -8.97 59.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 110.48 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.06 120.19 19.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 108.952 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . 0.51 HD12 HD11 ' C' ' 315' ' ' ILE . 60.8 mt -123.96 154.88 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.802 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -90.08 116.07 27.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 108.704 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.638 ' CE2' HG11 ' C' ' 254' ' ' VAL . 7.4 t80 -121.0 179.48 4.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' C' ' 254' ' ' VAL . 35.7 mtmt -39.07 -62.72 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.005 -1.059 . . . . 0.0 110.881 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' C' ' 309' ' ' LYS . 93.0 m-20 -44.66 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.149 -0.97 . . . . 0.0 109.354 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -175.4 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -141.35 138.69 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 109.886 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . 0.463 HD11 ' HB ' ' C' ' 306' ' ' ILE . 18.8 pt -126.27 151.43 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -112.6 151.26 30.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.519 -0.738 . . . . 0.0 109.528 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.746 ' CG2' HD12 ' C' ' 245' ' ' ILE . 99.3 mt -125.84 154.72 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.514 -0.742 . . . . 0.0 109.126 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER 179.35 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.158 -1.589 . . . . 0.0 113.454 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . 0.616 ' O ' ' O ' ' C' ' 316' ' ' LYS . 77.8 mtm180 1.38 126.72 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.685 0 CA-C-O 121.778 0.799 . . . . 0.0 113.11 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . 0.414 ' N ' ' HA ' ' C' ' 245' ' ' ILE . . . -61.1 7.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.824 -1.173 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' C' ' 317' ' ' ARG . 3.8 mm-40 . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.952 . . . . 0.0 108.725 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' B' ' 23' ' ' PRO . 6.3 m120 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' B' ' 22' ' ' ASN . 5.8 Cg_exo -44.68 167.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.038 2.492 . . . . 0.0 112.188 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.86 2.78 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.989 2.46 . . . . 0.0 113.355 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 72.1 m -153.26 132.67 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.672 -1.267 . . . . 0.0 109.186 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.576 ' NE ' ' OD1' ' B' ' 76' ' ' ASP . 3.5 tpt180 -177.24 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.625 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' B' ' 100' ' ' GLY . 3.2 m -129.06 170.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.468 HG13 ' O ' ' B' ' 98' ' ' LYS . 3.8 t -127.2 143.25 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.705 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -110.5 122.4 47.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.269 -0.895 . . . . 0.0 108.973 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.568 ' C ' HD11 ' B' ' 33' ' ' ILE . 2.9 mm? -110.36 107.38 17.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.411 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -112.15 -16.03 9.36 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.485 ' CB ' ' H ' ' B' ' 95' ' ' ARG . 65.5 p -111.58 85.08 2.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 109.728 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.652 HD12 ' N ' ' B' ' 33' ' ' ILE . 0.8 OUTLIER -145.47 127.26 7.78 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' B' ' 36' ' ' ASP . 31.8 Cg_endo -72.89 151.65 51.09 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.255 1.303 . . . . 0.0 110.703 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -59.61 -0.11 0.16 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.105 -0.997 . . . . 0.0 109.045 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 34' ' ' PRO . 87.6 m-20 -64.28 -36.43 84.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.46 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -122.46 116.03 23.26 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.582 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.537 HG23 ' N ' ' B' ' 39' ' ' GLU . 9.9 t -111.92 -137.09 0.37 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.441 -0.787 . . . . 0.0 110.885 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.537 ' N ' HG23 ' B' ' 38' ' ' THR . 21.1 pt-20 -63.19 -28.93 70.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.658 -1.276 . . . . 0.0 110.743 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.62 -55.45 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.811 -1.18 . . . . 0.0 110.611 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.46 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -68.93 -43.7 74.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 111.064 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.558 ' O ' ' SG ' ' B' ' 46' ' ' CYS . 51.1 mm -63.44 -52.63 55.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 118.715 -1.194 . . . . 0.0 107.959 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' B' ' 39' ' ' GLU . 46.3 tp -39.71 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.625 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 24.7 t70 -124.97 -27.13 3.62 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.432 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.861 ' O ' HD12 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -58.68 -45.27 89.8 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.205 -1.559 . . . . 0.0 108.101 178.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.8 p -77.68 -60.78 2.23 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.815 -1.154 . . . . 0.0 107.982 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.834 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.3 p -37.33 -18.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.73 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' B' ' 46' ' ' CYS . 1.4 m120 -47.75 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.405 0.622 . . . . 0.0 110.69 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.834 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.2 t 168.56 -32.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.23 165.24 37.65 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.236 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.87 91.48 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.047 2.498 . . . . 0.0 112.463 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.535 HG11 ' CG2' ' B' ' 72' ' ' ILE . 1.8 t -46.89 156.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 mm -100.4 -55.74 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.742 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 13.8 m-20 -118.3 127.85 54.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.314 -0.866 . . . . 0.0 111.317 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.91 130.14 48.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -139.79 125.39 19.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.808 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.8 tpt -105.93 129.4 54.08 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.17 155.85 38.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.434 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.2 OUTLIER -113.03 179.93 3.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' B' ' 66' ' ' SER . 51.2 p-10 -102.75 74.52 0.18 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.15 -0.969 . . . . 0.0 110.75 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 28.6 Cg_endo -65.77 -60.1 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.966 1.777 . . . . 0.0 112.149 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.26 -50.01 6.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.936 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p -57.47 -45.06 85.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.454 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.443 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 74.87 11.72 83.47 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.42 HH22 ' CZ ' ' C' ' 200' ' ' ARG . 10.8 mtp85 -66.02 -52.18 51.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.933 -1.334 . . . . 0.0 109.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.643 ' H ' ' HB3' ' B' ' 60' ' ' ASP . 8.0 t -156.02 145.24 20.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -0.988 . . . . 0.0 110.403 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -79.98 -5.87 56.5 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.735 -1.228 . . . . 0.0 109.465 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -127.94 88.52 0.33 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.093 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . 0.411 ' CD1' ' HA2' ' B' ' 31' ' ' GLY . 1.5 m-85 -127.98 126.25 41.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.175 -1.191 . . . . 0.0 109.452 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.01 137.7 31.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.078 . . . . 0.0 110.088 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -103.49 125.3 49.98 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.378 -0.827 . . . . 0.0 108.93 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.538 HD12 ' N ' ' B' ' 72' ' ' ILE . 3.7 mp -122.01 97.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.645 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 53.2 mt-10 -86.96 127.85 35.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.707 -1.246 . . . . 0.0 110.734 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -89.68 179.86 5.93 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.621 0.724 . . . . 0.0 110.579 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 0.1 OUTLIER -57.06 -42.45 80.59 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.593 -0.692 . . . . 0.0 110.374 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.662 ' O ' ' N ' ' B' ' 78' ' ' GLU . 4.2 m-20 158.76 177.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 0.0 109.018 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.758 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.6 OUTLIER -33.68 -24.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.919 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.662 ' N ' ' O ' ' B' ' 76' ' ' ASP . 10.6 mp0 -69.84 -73.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.387 -1.446 . . . . 0.0 108.891 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.9 m -62.97 -41.36 99.52 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.41 ' O ' HG23 ' B' ' 84' ' ' VAL . 1.3 m -59.6 -39.13 83.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.19 -0.943 . . . . 0.0 108.779 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -59.55 -61.21 2.79 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.141 0.972 . . . . 0.0 108.801 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.583 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 69.5 m -63.29 -39.7 95.31 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.579 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -79.6 -61.13 2.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.983 -1.073 . . . . 0.0 110.169 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.653 HG12 ' ND2' ' B' ' 88' ' ' ASN . 26.7 t -51.19 -42.45 25.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.023 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.476 ' HA ' HD22 ' B' ' 88' ' ' ASN . 23.3 ttm180 -64.9 -56.57 12.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.411 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 82' ' ' SER . 8.7 m-80 -67.47 -43.8 80.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' B' ' 83' ' ' ALA . 51.0 mt -104.83 34.87 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.0 110.433 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.653 ' ND2' HG12 ' B' ' 84' ' ' VAL . 0.5 OUTLIER -62.6 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.123 -0.986 . . . . 0.0 108.375 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.17 116.29 1.62 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -138.1 145.8 42.1 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.369 -1.665 . . . . 0.0 107.752 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.0 OUTLIER -30.9 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.668 -0.645 . . . . 0.0 111.286 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.564 HD22 HD21 ' B' ' 45' ' ' LEU . 11.3 tp -154.03 140.8 19.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.53 -171.63 0.1 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 47.2 p -67.94 -22.39 65.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' B' ' 92' ' ' LEU . 94.9 mtt180 -136.23 163.52 30.2 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.2 m-85 -93.04 141.68 28.13 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.257 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -37.4 136.99 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.468 ' O ' HG13 ' B' ' 28' ' ' VAL . 67.9 mmtt -108.4 147.77 31.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . 0.544 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 31.2 p -87.55 116.7 25.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' B' ' 27' ' ' VAL . . . -115.03 158.39 14.37 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.51 ' CB ' ' O ' ' B' ' 23' ' ' PRO . 1.8 p90 -136.97 113.87 10.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -1.113 . . . . 0.0 109.122 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 51.0 p -136.94 -84.41 0.34 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.253 -0.904 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.648 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.42 0.629 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 -1.98 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.79 140.08 32.7 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.015 -1.053 . . . . 0.0 108.936 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 24.8 ptm -123.32 155.61 36.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 109.345 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . 0.415 ' O ' ' C ' ' C' ' 163' ' ' ILE . 72.1 t80 -111.29 77.95 1.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . 0.709 HD11 HD13 ' C' ' 205' ' ' LEU . 60.8 mt -49.02 135.9 5.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' C' ' 229' ' ' ASP . . . -136.02 157.14 23.27 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.125 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.02 20.65 77.43 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . 0.647 ' CB ' ' HZ1' ' C' ' 192' ' ' LYS . 83.0 mt -60.14 171.24 1.04 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.175 -1.191 . . . . 0.0 108.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.55 ' CG ' ' H ' ' C' ' 168' ' ' TRP . 17.0 p30 -68.92 -79.95 0.05 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.017 -1.052 . . . . 0.0 109.309 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . 0.55 ' H ' ' CG ' ' C' ' 167' ' ' ASN . 0.0 OUTLIER 178.8 -24.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.78 -1.2 . . . . 0.0 110.192 179.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . 0.453 ' OD1' ' C ' ' C' ' 169' ' ' ASP . 19.6 t0 -135.03 93.53 3.02 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.016 -1.053 . . . . 0.0 110.623 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . 0.586 ' H ' ' CD ' ' C' ' 192' ' ' LYS . 17.4 m -139.97 145.71 38.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.309 -0.869 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.82 167.21 10.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.951 -1.093 . . . . 0.0 109.348 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.28 -56.37 22.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -48.38 -40.82 26.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.996 -1.065 . . . . 0.0 110.818 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -74.85 -53.13 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 109.962 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.571 HD22 HD11 ' C' ' 190' ' ' ILE . 10.3 tp -53.02 -45.68 68.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' C' ' 177' ' ' GLU . 27.4 ttp180 -66.12 -60.28 2.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' C' ' 176' ' ' ARG . 61.3 mm-40 -40.97 -30.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.535 ' O ' ' NZ ' ' C' ' 181' ' ' LYS . 1.1 t80 -76.67 -48.68 18.22 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.354 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.863 ' O ' ' N ' ' C' ' 181' ' ' LYS . 24.5 m-85 -72.58 -58.46 3.35 Favored 'General case' 0 C--O 1.196 -1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -43.42 10.18 0.0 OUTLIER Glycine 0 N--CA 1.507 3.379 0 O-C-N 119.845 -1.785 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . 0.863 ' N ' ' O ' ' C' ' 179' ' ' PHE . 1.5 ttmp? -75.99 -18.35 59.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.726 -1.455 . . . . 0.0 107.689 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 3.2 m-85 -93.14 -58.73 2.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 109.708 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -144.54 -129.86 2.24 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 28.0 m -127.16 153.88 45.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.384 -1.068 . . . . 0.0 110.154 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.39 149.39 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.44 HG22 ' O ' ' C' ' 206' ' ' SER . 0.0 OUTLIER -90.02 -42.18 11.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.904 -1.123 . . . . 0.0 110.02 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -154.52 155.91 35.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.998 . . . . 0.0 109.319 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 1.059 HD12 ' N ' ' C' ' 189' ' ' LYS . 0.1 OUTLIER -147.15 139.62 24.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.652 -1.28 . . . . 0.0 107.809 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . 1.059 ' N ' HD12 ' C' ' 188' ' ' LEU . 5.9 tptp -127.61 133.85 49.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.878 -1.139 . . . . 0.0 109.64 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . 0.571 HD11 HD22 ' C' ' 175' ' ' LEU . 0.2 OUTLIER -127.62 156.24 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 108.521 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 4.0 tpp -139.84 42.3 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.022 -1.049 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . 0.647 ' HZ1' ' CB ' ' C' ' 166' ' ' LEU . 18.3 mttp -72.76 -163.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.982 -1.074 . . . . 0.0 109.432 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' C' ' 197' ' ' GLY . 0.9 OUTLIER -127.65 52.67 8.86 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.542 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 193' ' ' ASP . 83.9 Cg_endo -78.57 -4.42 14.11 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.823 2.349 . . . . 0.0 111.87 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.41 28.3 3.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.444 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . 0.471 ' OG1' ' OD1' ' C' ' 193' ' ' ASP . 0.5 OUTLIER -153.37 -55.33 0.11 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.315 -0.866 . . . . 0.0 109.862 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . 0.58 ' N ' ' OD2' ' C' ' 193' ' ' ASP . . . 174.42 -100.94 0.15 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -136.08 136.83 40.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 109.488 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . 0.515 ' O ' ' O ' ' C' ' 200' ' ' ARG . 9.3 t -153.36 170.61 20.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.263 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' C' ' 199' ' ' SER . 6.4 mmp_? -42.57 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 109.117 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . 0.435 ' HA2' ' HZ2' ' C' ' 192' ' ' LYS . . . -141.69 94.28 0.19 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.487 ' CA ' HD12 ' C' ' 166' ' ' LEU . 21.0 p90 -137.94 167.78 21.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.36 136.13 8.19 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 119.061 -1.542 . . . . 0.0 109.66 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -105.43 102.88 12.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.709 HD13 HD11 ' C' ' 163' ' ' ILE . 0.5 OUTLIER -101.43 111.29 23.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.419 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . 0.44 ' O ' HG22 ' C' ' 186' ' ' THR . 21.3 t -82.79 70.92 9.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.623 ' CE2' HD23 ' C' ' 205' ' ' LEU . 2.7 m-85 -60.01 117.98 5.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.63 -51.13 66.55 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.045 -1.035 . . . . 0.0 109.354 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' C' ' 211' ' ' SER . 50.5 mtpt -84.95 103.79 3.78 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.084 -1.01 . . . . 0.0 110.436 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.67 -15.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.823 1.682 . . . . 0.0 112.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.557 ' O ' ' N ' ' C' ' 213' ' ' VAL . 17.6 m -68.36 -69.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.855 -1.153 . . . . 0.0 109.898 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 211' ' ' SER . 0.0 OUTLIER -36.46 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.736 -0.603 . . . . 0.0 109.672 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' C' ' 211' ' ' SER . 88.4 t -65.63 -45.1 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 109.396 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -61.72 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.584 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.24 -39.33 86.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 108.965 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.696 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 15.2 t -64.85 -49.7 78.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.351 0.596 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.13 -31.17 52.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.585 -1.322 . . . . 0.0 109.488 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -81.12 -44.35 18.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.131 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . 0.579 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 41.5 m -66.39 151.23 47.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.345 -0.847 . . . . 0.0 110.632 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -80.36 148.33 30.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.592 -0.692 . . . . 0.0 109.657 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.704 ' HB3' HD11 ' C' ' 228' ' ' ILE . 24.5 m-70 -132.84 132.74 42.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.222 -0.924 . . . . 0.0 110.623 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.2 86.61 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -55.15 -71.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 109.627 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 91.8 m-20 -96.2 7.64 45.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 109.126 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.52 12.28 61.3 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . 0.91 ' O ' HG13 ' C' ' 227' ' ' VAL . 0.4 OUTLIER -85.78 -86.06 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -1.089 . . . . 0.0 109.737 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . 0.91 HG13 ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 171.85 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.827 . . . . 0.0 109.641 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' C' ' 221' ' ' HIS . 15.4 pt -99.39 160.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.127 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' C' ' 164' ' ' GLY . 5.4 m-20 -126.76 102.17 25.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 111.016 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.5 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 28.9 Cg_endo -83.28 137.29 8.17 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -164.05 168.66 18.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.912 -1.117 . . . . 0.0 109.804 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -58.64 156.07 11.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.986 . . . . 0.0 109.462 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . 0.4 ' O ' ' CG1' ' C' ' 234' ' ' ILE . . . -70.26 124.08 23.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . 0.479 ' HB ' HE21 ' C' ' 239' ' ' GLN . 13.2 mt -158.71 108.92 1.62 Allowed Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.12 132.31 8.73 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.604 1.536 . . . . 0.0 111.82 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -55.47 -36.43 66.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.173 -0.955 . . . . 0.0 109.002 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -52.82 -40.89 63.69 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -70.17 -36.14 74.47 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . 0.512 ' O ' ' OG1' ' C' ' 242' ' ' THR . 54.9 mm-40 -57.69 -38.48 75.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 108.896 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . 0.402 ' OD1' ' NZ ' ' C' ' 244' ' ' LYS . 87.2 m-20 -68.48 -37.67 80.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -60.94 -29.73 69.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 9.5 p -65.01 -21.71 66.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.968 -1.082 . . . . 0.0 110.09 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 110.35 102.66 2.72 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . 0.402 ' NZ ' ' OD1' ' C' ' 240' ' ' ASP . 4.3 ttpt -131.24 126.79 36.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.314 . . . . 0.0 110.223 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.489 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -113.86 141.82 28.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -87.33 164.9 16.0 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 58.8 t -136.69 131.53 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.95 142.32 16.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . 0.637 ' O ' HG22 ' C' ' 313' ' ' ILE . . . 90.27 66.99 1.2 Allowed Glycine 0 N--CA 1.491 2.358 0 O-C-N 121.137 -1.214 . . . . 0.0 110.689 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' C' ' 285' ' ' GLY . 38.4 mm -114.2 133.82 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -1.19 . . . . 0.0 109.131 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.66 157.48 45.08 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.93 -22.82 55.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.823 2.349 . . . . 0.0 112.6 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -124.35 52.57 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.302 -0.874 . . . . 0.0 109.923 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.764 HG13 ' HG3' ' C' ' 309' ' ' LYS . 47.7 t -100.56 36.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' C' ' 254' ' ' VAL . 4.0 mtp85 -16.5 146.96 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.7 0 CA-C-O 121.384 0.611 . . . . 0.0 111.851 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' C' ' 257' ' ' LYS . 31.1 Cg_endo -57.95 -19.99 42.66 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.723 2.282 . . . . 0.0 113.048 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' C' ' 256' ' ' PRO . 54.0 tttm -46.51 -67.78 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . 0.744 ' O ' ' N ' ' C' ' 261' ' ' GLU . 23.8 mp0 -60.72 -91.46 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.71 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' C' ' 274' ' ' LEU . 56.7 t80 -6.1 -68.08 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 CA-C-O 121.179 0.514 . . . . 0.0 111.18 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 258' ' ' GLU . 83.4 tt0 -54.97 -48.02 73.78 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.617 0.723 . . . . 0.0 109.545 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . 0.744 ' N ' ' O ' ' C' ' 258' ' ' GLU . 82.1 tt0 -71.56 -45.04 63.41 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -49.84 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.61 -0.681 . . . . 0.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.528 ' O ' ' C ' ' C' ' 264' ' ' SER . 63.5 m-85 -45.3 -44.37 11.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.906 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.617 ' O ' ' N ' ' C' ' 266' ' ' TRP . 1.3 p -37.88 -36.64 0.2 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' C' ' 263' ' ' PHE . 23.4 tt0 -42.14 -9.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.946 -0.471 . . . . 0.0 111.872 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.617 ' N ' ' O ' ' C' ' 264' ' ' SER . 16.0 p90 -159.33 44.81 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.22 -1.55 . . . . 0.0 110.527 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . 0.448 ' O ' HD12 ' C' ' 269' ' ' ILE . . . 154.41 123.8 0.9 Allowed Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.294 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 27.8 m -56.78 140.4 47.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -1.153 . . . . 0.0 108.823 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.569 HG22 ' O ' ' C' ' 269' ' ' ILE . 1.1 mp -99.03 109.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 0.0 110.762 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.9 -50.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 109.877 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . 0.561 ' O ' ' C ' ' C' ' 272' ' ' ALA . 59.4 t0 -147.01 17.45 1.23 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.839 -1.163 . . . . 0.0 111.407 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' C' ' 271' ' ' ASP . . . -27.91 138.66 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.585 -0.697 . . . . 0.0 109.979 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -133.56 124.22 26.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.231 -0.918 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' C' ' 259' ' ' PHE . 1.4 tm? -121.43 129.37 52.95 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . 0.765 ' N ' HD13 ' C' ' 274' ' ' LEU . 3.8 mmt -102.09 163.81 12.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.572 -1.33 . . . . 0.0 110.021 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.762 HD12 ' O ' ' C' ' 275' ' ' MET . 1.0 OUTLIER -144.07 -175.34 4.57 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.044 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -44.93 -86.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 109.689 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -107.77 -20.74 13.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 108.992 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . 0.753 ' O ' HG11 ' C' ' 227' ' ' VAL . 21.5 t70 -52.73 -26.94 15.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -143.37 -8.34 0.77 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.651 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.71 64.99 1.7 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' C' ' 276' ' ' LEU . 9.3 tp-100 -171.93 164.24 6.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -1.173 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . 0.423 ' H ' ' H ' ' C' ' 284' ' ' ARG . 25.6 p -170.14 0.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.199 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' C' ' 283' ' ' SER . 46.7 mmt-85 -55.9 -31.2 62.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.373 -0.829 . . . . 0.0 109.661 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' C' ' 250' ' ' ILE . . . 106.81 20.64 8.72 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.184 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' C' ' 286' ' ' PHE . 26.8 p90 -109.84 175.81 5.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.068 -1.254 . . . . 0.0 110.203 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.49 -177.42 36.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -149.75 149.84 31.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.31 -1.7 . . . . 0.0 108.778 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' C' ' 291' ' ' TYR . 17.0 t -130.06 149.14 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 48.7 m -132.84 121.57 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.641 -1.287 . . . . 0.0 109.082 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . 0.507 ' CZ ' HG11 ' C' ' 289' ' ' VAL . 46.5 m-85 -116.22 137.4 52.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.204 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' C' ' 293' ' ' SER . 17.7 p-10 -62.35 -49.67 74.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 75.7 m -67.91 124.22 22.74 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -77.36 -27.05 52.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.086 -2.191 . . . . 0.0 105.086 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -51.46 -41.72 61.08 Favored 'General case' 0 C--O 1.206 -1.222 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.23 75.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.994 -1.066 . . . . 0.0 108.393 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 83.1 t -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.72 -29.56 53.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.66 -0.65 . . . . 0.0 109.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -71.69 -62.97 1.22 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -61.5 -24.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.628 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' C' ' 300' ' ' VAL . 1.3 m -43.98 -58.4 2.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -50.8 -26.86 6.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.081 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' C' ' 300' ' ' VAL . 34.1 t-20 -99.43 86.41 3.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 109.509 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' C' ' 314' ' ' GLU . 13.5 tttp -75.05 -84.31 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.695 -1.253 . . . . 0.0 108.561 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -58.74 127.62 33.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.198 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.1 tt -138.58 142.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.641 1.21 . . . . 0.0 110.18 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' C' ' 307' ' ' ASP . 47.3 p30 -68.65 142.13 55.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.866 0.841 . . . . 0.0 110.531 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.626 ' O ' ' N ' ' C' ' 310' ' ' ASP . 9.9 t80 -169.84 -174.07 1.74 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.764 ' HG3' HG13 ' C' ' 254' ' ' VAL . 37.0 mmtt -32.75 -30.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.556 -0.715 . . . . 0.0 110.217 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' C' ' 308' ' ' PHE . 92.6 m-20 -87.1 -84.74 0.18 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.07 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.015 -1.053 . . . . 0.0 110.556 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -168.75 49.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.988 -1.07 . . . . 0.0 109.342 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . 0.637 HG22 ' O ' ' C' ' 249' ' ' GLY . 10.7 pt -49.92 138.55 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.766 0.793 . . . . 0.0 110.791 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . 0.55 ' HB3' ' HZ2' ' C' ' 304' ' ' LYS . 54.8 mt-10 -85.44 115.8 23.39 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.23 0.538 . . . . 0.0 110.527 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' C' ' 245' ' ' ILE . 83.8 mt -82.78 158.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 108.944 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . 0.413 ' N ' HG22 ' C' ' 315' ' ' ILE . 0.1 OUTLIER -166.58 165.95 16.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.511 -1.368 . . . . 0.0 109.659 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -78.8 140.45 38.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.625 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' C' ' 245' ' ' ILE . . . -70.79 -29.91 66.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.909 -1.119 . . . . 0.0 108.837 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 -179.842 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . 0.439 ' O ' ' CD2' ' B' ' 101' ' ' TYR . 6.6 Cg_exo -64.53 150.03 88.92 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.231 1.954 . . . . 0.0 112.303 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -85.09 26.35 0.65 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.559 2.173 . . . . 0.0 112.78 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.01 126.28 11.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.616 -1.303 . . . . 0.0 110.23 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -179.46 -49.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 109.24 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' B' ' 101' ' ' TYR . 3.0 p -125.04 154.91 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.832 0.825 . . . . 0.0 110.436 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.413 ' N ' HG22 ' B' ' 27' ' ' VAL . 3.0 t -108.06 139.52 29.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.412 ' CE1' ' HA3' ' B' ' 100' ' ' GLY . 5.1 m-85 -102.24 133.05 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.111 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' B' ' 72' ' ' ILE . 4.5 mp -116.96 121.28 40.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -114.61 -94.17 1.99 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.649 ' H ' ' NH1' ' B' ' 95' ' ' ARG . 2.7 p -69.04 110.7 4.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.75 -1.441 . . . . 0.0 110.36 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -160.74 127.37 2.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' B' ' 36' ' ' ASP . 51.7 Cg_endo -74.85 170.87 19.41 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.604 1.536 . . . . 0.0 112.61 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.589 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 3.8 m-30 -69.29 4.72 1.56 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.3 m-20 -60.26 -38.06 82.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.129 -0.982 . . . . 0.0 109.443 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -129.81 116.01 18.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 109.459 -179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.427 ' O ' HG12 ' B' ' 42' ' ' ILE . 82.2 p -113.02 -140.64 0.38 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.696 0.76 . . . . 0.0 111.631 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.401 ' CD ' ' C ' ' B' ' 39' ' ' GLU . 1.6 pp20? -61.46 -34.28 75.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.673 -1.267 . . . . 0.0 111.358 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -71.69 -53.95 11.87 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -67.43 -44.1 79.56 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.385 -0.822 . . . . 0.0 110.189 -178.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.584 ' O ' ' N ' ' B' ' 44' ' ' ASP . 30.6 mm -58.0 -51.62 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.808 HD13 ' O ' ' B' ' 43' ' ' LEU . 3.1 tm? -37.43 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' B' ' 42' ' ' ILE . 83.7 m-20 -124.7 -24.48 4.15 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.713 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.3 tm? -60.09 -41.18 91.94 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.214 -1.554 . . . . 0.0 107.472 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.621 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.4 m -87.65 -63.04 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.817 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.915 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.1 p -40.11 -19.96 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.779 -0.576 . . . . 0.0 109.896 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.671 ' O ' HG23 ' B' ' 49' ' ' VAL . 0.3 OUTLIER -42.69 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.117 0.96 . . . . 0.0 110.131 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.915 ' N ' ' O ' ' B' ' 47' ' ' SER . 0.9 OUTLIER 161.58 -28.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 47' ' ' SER . . . -169.37 123.16 1.06 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.424 -1.37 . . . . 0.0 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -48.14 100.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.579 1.52 . . . . 0.0 111.523 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.436 ' H ' HG13 ' B' ' 52' ' ' VAL . 0.8 OUTLIER -49.63 171.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.852 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.406 HD11 ' HG2' ' B' ' 75' ' ' ARG . 35.5 mm -107.47 -49.12 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 110.132 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.579 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 40.5 m-20 -118.35 139.17 51.76 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.103 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.558 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.6 OUTLIER -139.96 132.2 28.2 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.558 ' N ' HD23 ' B' ' 55' ' ' LEU . 21.4 tptp -137.26 121.5 18.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.045 -1.034 . . . . 0.0 109.678 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tpt -104.5 128.61 52.48 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.726 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . . . . . . . . . 2.1 ttt -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.061 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.589 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 2.3 m-85 -104.11 -175.92 2.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' B' ' 66' ' ' SER . 49.8 m-20 -115.55 87.38 17.14 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.07 -1.019 . . . . 0.0 110.657 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.06 -60.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.485 2.123 . . . . 0.0 112.353 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' B' ' 63' ' ' THR . 3.4 tt0 -86.2 -62.1 1.59 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.446 HG23 ' H ' ' B' ' 63' ' ' THR . 5.2 p -45.24 -43.02 10.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.835 . . . . 0.0 108.91 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.41 18.26 76.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -61.99 -42.02 98.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.979 -1.307 . . . . 0.0 109.516 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -179.86 179.15 0.58 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.978 -1.076 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -117.93 78.7 1.27 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.65 48.08 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . 0.413 ' CD1' ' HA2' ' B' ' 31' ' ' GLY . 3.9 m-30 -97.01 125.44 41.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.43 158.16 43.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 111.847 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.537 ' C ' HD12 ' B' ' 72' ' ' ILE . 5.7 m-85 -125.97 126.99 45.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.629 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.896 HD12 ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -118.06 98.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.724 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.579 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.8 tt0 -82.54 126.4 32.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.379 -1.451 . . . . 0.0 110.282 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -86.72 176.36 7.79 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.573 0.701 . . . . 0.0 110.038 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 58.3 mtp180 -56.63 -42.07 78.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.2 m-20 165.64 172.59 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.843 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.9 OUTLIER -38.07 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.062 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.1 mm-40 -74.43 -70.83 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.95 -1.094 . . . . 0.0 108.748 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 37.0 m -59.49 -45.02 92.89 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.66 -1.275 . . . . 0.0 107.691 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' B' ' 84' ' ' VAL . 8.6 t -62.68 -34.88 78.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 109.184 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.843 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -56.23 -59.36 5.05 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.124 -1.61 . . . . 0.0 107.231 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.502 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 33.3 t -65.58 -38.95 91.0 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.501 ' N ' HG11 ' B' ' 49' ' ' VAL . . . -79.28 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.867 -1.146 . . . . 0.0 110.197 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -52.01 -42.91 35.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.861 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmt180 -66.82 -43.53 83.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.643 -1.911 . . . . 0.0 109.258 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.636 ' N ' HD22 ' B' ' 86' ' ' ASN . 0.8 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 111.619 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.768 ' O ' HD11 ' B' ' 97' ' ' LEU . 7.9 mt -117.09 -4.05 11.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.927 -1.108 . . . . 0.0 111.254 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' B' ' 84' ' ' VAL . 0.0 OUTLIER -16.11 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.074 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.84 108.11 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -130.37 143.4 50.75 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.699 -1.471 . . . . 0.0 108.087 -179.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . 0.568 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.0 OUTLIER -32.66 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.648 -0.658 . . . . 0.0 110.832 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 90' ' ' TYR . 5.3 tt -148.36 132.36 17.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.23 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.81 -157.94 1.58 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -21.18 52.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -1.125 . . . . 0.0 108.646 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.649 ' NH1' ' H ' ' B' ' 32' ' ' SER . 32.0 ttm105 -136.85 146.92 46.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 1.6 m-30 -93.1 143.92 25.77 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.511 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.768 HD11 ' O ' ' B' ' 87' ' ' LEU . 0.2 OUTLIER -46.68 157.69 0.14 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.174 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 147.97 42.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 109.888 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 17.2 p -77.2 121.46 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.412 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -135.89 174.56 21.32 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.515 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.505 ' HA ' HG12 ' B' ' 27' ' ' VAL . 7.1 t80 -147.69 125.25 11.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.571 -0.958 . . . . 0.0 109.784 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -137.84 101.64 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.651 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . 0.632 ' O ' ' N ' ' C' ' 160' ' ' LYS . 23.1 t . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' C' ' 213' ' ' VAL . 3.2 t -54.83 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' C' ' 158' ' ' SER . 11.3 tptp -88.21 136.17 33.1 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.611 0.72 . . . . 0.0 110.19 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . 0.641 ' HE1' HG22 ' C' ' 217' ' ' VAL . 39.2 mmm -115.62 150.65 36.35 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.604 -0.685 . . . . 0.0 109.633 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -116.48 123.84 48.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . 0.611 ' CG2' HD21 ' C' ' 166' ' ' LEU . 5.2 mm -105.1 133.61 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.09 171.19 21.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.555 ' O ' HG22 ' C' ' 228' ' ' ILE . . . 69.1 28.71 72.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . 0.611 HD21 ' CG2' ' C' ' 163' ' ' ILE . 97.5 mt -77.2 150.69 35.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 110.536 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' C' ' 169' ' ' ASP . 0.4 OUTLIER -75.3 153.85 37.7 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -69.42 19.07 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.886 -1.134 . . . . 0.0 110.032 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' C' ' 167' ' ' ASN . 59.5 t0 -145.14 84.47 1.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.946 -1.096 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . 0.583 ' OG1' ' NZ ' ' C' ' 192' ' ' LYS . 0.2 OUTLIER -146.61 119.96 8.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.17 158.55 15.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 0.0 109.465 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' C' ' 173' ' ' ASP . 87.9 mt-10 -61.7 -69.29 0.25 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.829 -1.169 . . . . 0.0 110.915 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' C' ' 172' ' ' GLU . 55.1 t0 -42.31 -36.61 1.3 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.684 -1.26 . . . . 0.0 109.818 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -80.02 -47.85 14.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.412 -0.805 . . . . 0.0 109.69 179.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' C' ' 190' ' ' ILE . 7.6 tt -57.19 -42.26 80.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.034 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' C' ' 179' ' ' PHE . 70.8 ttp85 -67.34 -57.94 5.71 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' C' ' 176' ' ' ARG . 49.1 tp10 -39.75 -31.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.53 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 15.4 t80 -74.13 -49.39 23.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.725 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.891 ' O ' ' N ' ' C' ' 181' ' ' LYS . 28.9 m-85 -74.87 -62.94 1.37 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -39.43 4.19 0.0 OUTLIER Glycine 0 N--CA 1.508 3.457 0 O-C-N 120.345 -1.472 . . . . 0.0 112.38 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . 0.891 ' N ' ' O ' ' C' ' 179' ' ' PHE . 6.2 tttm -64.63 -28.57 69.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.779 -1.424 . . . . 0.0 107.839 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' C' ' 219' ' ' THR . 32.0 m-85 -78.39 -35.55 47.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.267 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.7 -126.1 0.88 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 41.3 m -129.28 154.92 46.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.61 HG12 ' CE1' ' C' ' 207' ' ' PHE . 1.1 m -120.44 159.7 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 108.978 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . 0.492 ' O ' ' OD1' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -99.01 -43.92 6.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 110.248 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' C' ' 186' ' ' THR . 68.8 m-20 -151.93 147.57 26.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.833 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.737 HD23 ' C ' ' C' ' 188' ' ' LEU . 0.2 OUTLIER -141.73 146.21 35.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.934 -1.104 . . . . 0.0 108.486 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.3 123.2 29.5 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.978 -1.076 . . . . 0.0 109.88 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . 0.596 ' CD1' HD13 ' C' ' 175' ' ' LEU . 92.6 mt -134.75 121.63 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.478 -1.388 . . . . 0.0 108.169 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -114.66 44.49 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.865 0.841 . . . . 0.0 108.806 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . 0.583 ' NZ ' ' OG1' ' C' ' 170' ' ' THR . 4.5 ttmt -64.45 -162.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.428 ' H ' ' HG2' ' C' ' 192' ' ' LYS . 0.5 OUTLIER -134.25 66.64 71.57 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.767 -1.208 . . . . 0.0 110.696 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.35 -0.91 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.426 2.751 . . . . 0.0 110.889 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.36 15.86 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.343 0.592 . . . . 0.0 109.424 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.1 -59.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.2 -91.82 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -142.0 144.87 33.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.502 -0.999 . . . . 0.0 109.64 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . . . . . . . . . 42.2 t -161.86 160.58 28.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.48 ' O ' ' CD1' ' C' ' 202' ' ' PHE . 64.1 mmt-85 -47.75 114.38 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 109.122 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.42 113.05 3.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' C' ' 200' ' ' ARG . 16.0 p90 -141.31 153.27 45.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -1.163 . . . . 0.0 108.419 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -122.65 139.61 12.66 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.803 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -118.34 103.55 9.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.06 109.22 20.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.972 . . . . 0.0 111.016 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . 0.527 ' HB2' ' HZ3' ' C' ' 160' ' ' LYS . 7.2 t -94.81 132.62 39.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' C' ' 185' ' ' VAL . 63.1 m-85 -116.21 143.43 45.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.924 -1.11 . . . . 0.0 109.559 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . 0.433 ' OE1' ' C ' ' C' ' 208' ' ' GLU . 1.7 tm-20 -68.15 -54.34 18.72 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.015 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' C' ' 210' ' ' PRO . 0.7 OUTLIER -91.16 108.22 26.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.968 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' C' ' 209' ' ' LYS . 2.2 Cg_endo -44.38 -20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.206 1.937 . . . . 0.0 113.683 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.574 ' O ' ' N ' ' C' ' 213' ' ' VAL . 11.3 t -61.83 -69.38 0.25 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.542 -1.349 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.679 ' O ' HG23 ' C' ' 216' ' ' VAL . 83.0 p -35.45 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.161 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . 0.595 HG21 ' SG ' ' C' ' 159' ' ' CYS . 0.4 OUTLIER -64.91 -37.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.0 109.229 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' C' ' 211' ' ' SER . 91.0 m-20 -63.68 -46.05 87.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 55.2 mp0 -68.76 -35.69 77.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.679 HG23 ' O ' ' C' ' 212' ' ' SER . 54.5 t -62.01 -52.62 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.641 HG22 ' HE1' ' C' ' 161' ' ' MET . 45.5 t -68.45 -38.79 79.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -73.31 -45.28 56.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.44 -0.788 . . . . 0.0 110.411 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . 0.587 HG21 ' OH ' ' C' ' 182' ' ' TYR . 24.9 m -68.75 145.65 53.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.21 -0.931 . . . . 0.0 111.658 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -80.33 149.94 30.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.62 ' HB2' HD11 ' C' ' 228' ' ' ILE . 20.5 m-70 -127.68 132.19 49.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . 0.53 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -142.56 103.21 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.326 -0.859 . . . . 0.0 109.678 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.516 ' N ' HD12 ' C' ' 223' ' ' LEU . 10.7 mp -73.02 -62.58 1.41 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.023 -1.048 . . . . 0.0 109.216 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -110.26 12.66 23.21 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 97.99 5.06 57.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -73.48 -171.61 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -1.084 . . . . 0.0 108.17 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.04 102.21 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' C' ' 221' ' ' HIS . 15.8 pt -102.13 151.55 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.478 -0.764 . . . . 0.0 108.955 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -119.27 107.27 41.65 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.354 -0.841 . . . . 0.0 110.888 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 95.9 Cg_endo -89.19 135.23 2.65 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 111.431 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -148.27 146.0 28.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.852 -1.155 . . . . 0.0 110.199 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' C' ' 233' ' ' ALA . 35.5 mtm105 -56.63 147.68 21.87 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.2 133.93 6.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.926 -1.109 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.86 124.15 34.36 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 109.667 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.15 142.42 4.07 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.939 1.759 . . . . 0.0 112.077 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -58.12 -43.68 87.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 110.688 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 29.7 p-10 -62.72 -39.26 93.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . 0.73 ' O ' HG23 ' C' ' 242' ' ' THR . 97.8 mt-10 -68.41 -41.84 79.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.692 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -65.44 -43.46 90.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.588 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -63.86 -41.57 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.887 . . . . 0.0 109.785 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -61.45 -47.18 86.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.746 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . 0.73 HG23 ' O ' ' C' ' 238' ' ' GLU . 59.6 p -54.59 137.65 42.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.48 150.14 17.98 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -130.08 132.27 46.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -1.046 . . . . 0.0 109.983 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.949 HD13 ' O ' ' C' ' 245' ' ' ILE . 0.0 OUTLIER -121.15 156.59 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.572 -0.705 . . . . 0.0 109.148 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -105.48 135.01 47.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.578 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.49 131.7 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.778 0.799 . . . . 0.0 110.082 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.69 145.93 16.21 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.34 64.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -129.73 154.85 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -1.076 . . . . 0.0 109.198 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 130.53 -39.6 1.78 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.629 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 87.6 Cg_exo -48.62 -120.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.612 2.208 . . . . 0.0 112.963 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -81.42 17.79 1.29 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' C' ' 308' ' ' PHE . 41.3 t -89.68 140.56 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.963 -1.086 . . . . 0.0 109.97 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -104.95 154.81 38.4 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.91 -24.89 74.2 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.157 1.905 . . . . 0.0 112.345 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -51.17 -64.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.714 -0.616 . . . . 0.0 109.697 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . 0.68 ' O ' ' N ' ' C' ' 261' ' ' GLU . 33.8 tt0 -61.16 -78.17 0.04 OUTLIER 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.176 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . 0.655 ' C ' ' O ' ' C' ' 258' ' ' GLU . 59.7 t80 -11.93 -65.74 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 121.52 0.676 . . . . 0.0 110.082 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' C' ' 258' ' ' GLU . 2.9 tm-20 -59.9 -45.73 91.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.574 -0.704 . . . . 0.0 110.799 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' C' ' 258' ' ' GLU . 63.2 mm-40 -71.89 -17.3 62.12 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.985 -1.072 . . . . 0.0 108.892 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' C' ' 263' ' ' PHE . 4.6 t80 -78.96 -80.52 0.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' C' ' 265' ' ' GLN . 31.0 m-85 -38.25 -42.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.235 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.615 ' N ' HD11 ' C' ' 269' ' ' ILE . 73.0 p -30.82 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.609 ' N ' ' O ' ' C' ' 263' ' ' PHE . 6.4 tt0 -45.26 -23.07 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.822 -0.549 . . . . 0.0 110.969 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.564 ' CZ2' ' CD2' ' C' ' 263' ' ' PHE . 8.2 p90 -151.58 151.1 31.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.644 -1.285 . . . . 0.0 109.246 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 82.08 176.3 51.12 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . 0.511 ' O ' ' C ' ' C' ' 269' ' ' ILE . 43.1 p -115.35 19.61 15.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.733 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.615 HD11 ' N ' ' C' ' 264' ' ' SER . 0.0 OUTLIER -15.35 104.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 41.5 mm -83.4 -34.16 10.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -132.86 97.2 3.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -108.99 131.47 55.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.442 -0.786 . . . . 0.0 109.158 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -160.94 129.91 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.422 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.717 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.4 OUTLIER -97.12 157.89 15.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . 0.708 ' O ' HD22 ' C' ' 276' ' ' LEU . 0.5 OUTLIER -93.76 168.19 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.316 -1.49 . . . . 0.0 109.336 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.708 HD22 ' O ' ' C' ' 275' ' ' MET . 0.2 OUTLIER -150.35 -155.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' C' ' 279' ' ' ASP . 77.2 m-20 -54.16 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.463 -0.773 . . . . 0.0 110.447 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' C' ' 278' ' ' LYS . 0.0 OUTLIER -49.46 -8.15 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.298 -0.876 . . . . 0.0 110.146 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 277' ' ' ASP . 85.3 m-20 -59.61 -66.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 110.073 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 131.89 43.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 56.53 -124.5 35.22 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.557 ' C ' ' H ' ' C' ' 284' ' ' ARG . 6.9 tt0 -146.95 147.2 30.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.235 -1.156 . . . . 0.0 110.136 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.23 21.73 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' C' ' 282' ' ' GLN . 0.1 OUTLIER -51.47 -33.3 30.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.664 -1.272 . . . . 0.0 108.016 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' C' ' 250' ' ' ILE . . . 117.34 69.62 0.4 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' C' ' 250' ' ' ILE . 32.6 p90 -162.18 175.01 12.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.609 . . . . 0.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -154.63 178.8 31.18 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.071 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' C' ' 246' ' ' PHE . 7.8 m-85 -142.41 157.13 45.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.722 -1.458 . . . . 0.0 108.929 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . 0.489 HG12 HD12 ' C' ' 245' ' ' ILE . 1.0 OUTLIER -149.12 148.46 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.714 -1.241 . . . . 0.0 108.904 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 12.6 m -129.46 130.94 46.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.05 -1.031 . . . . 0.0 111.101 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . 0.55 ' CE2' HG23 ' C' ' 269' ' ' ILE . 46.5 m-85 -112.88 142.5 45.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' C' ' 292' ' ' ASP . 56.6 p30 -75.79 13.03 0.9 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.437 -1.415 . . . . 0.0 107.544 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . 0.516 ' H ' ' C ' ' C' ' 291' ' ' TYR . 1.8 m -131.04 112.02 12.54 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.49 76.16 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -50.6 -38.0 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.95 83.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . 0.448 HG22 ' CG2' ' C' ' 245' ' ' ILE . 59.5 t -59.31 -57.67 10.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.57 -19.13 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -77.11 -60.42 2.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.141 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.5 p -60.97 -20.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.146 -0.972 . . . . 0.0 109.039 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' C' ' 300' ' ' VAL . 0.0 OUTLIER -43.17 -58.54 2.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 108.867 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -49.82 -27.67 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' C' ' 300' ' ' VAL . 94.1 m-20 -99.94 68.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.21 -9.5 59.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.088 . . . . 0.0 109.94 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.76 125.06 32.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . 0.539 HD12 HD11 ' C' ' 315' ' ' ILE . 69.4 mt -132.67 145.5 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.0 111.099 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . 0.48 ' O ' ' OD1' ' C' ' 307' ' ' ASP . 3.3 p30 -81.53 94.81 6.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.577 ' HE2' HG11 ' C' ' 254' ' ' VAL . 36.7 t80 -104.26 -176.28 3.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' C' ' 308' ' ' PHE . 56.0 mttt -38.84 -32.77 0.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.787 -1.195 . . . . 0.0 109.691 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 44.1 t0 -95.13 -154.47 0.43 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 108.853 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . 0.65 ' O ' ' N ' ' C' ' 313' ' ' ILE . 17.3 ttp180 -79.66 -167.74 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 108.916 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' C' ' 311' ' ' ARG . 10.3 tptt -55.01 75.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.905 0.86 . . . . 0.0 109.672 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' C' ' 311' ' ' ARG . 3.6 pt -45.46 153.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.947 . . . . 0.0 108.896 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -107.3 155.22 20.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.478 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.539 HD11 HD12 ' C' ' 306' ' ' ILE . 77.8 mt -125.31 152.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -154.63 149.88 27.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.952 -1.093 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -67.33 145.46 55.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.085 -1.009 . . . . 0.0 109.333 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -78.08 13.45 1.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.905 -1.122 . . . . 0.0 109.116 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.8 -179.534 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.453 ' ND2' ' CD2' ' B' ' 101' ' ' TYR . 1.1 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.52 142.01 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.685 2.257 . . . . 0.0 111.986 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.15 12.08 1.61 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.424 2.083 . . . . 0.0 112.545 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -158.5 129.92 6.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.02 -1.05 . . . . 0.0 109.513 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.567 ' N ' ' OG ' ' B' ' 80' ' ' SER . 42.4 ttt-85 -177.48 -44.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.831 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -138.8 154.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.92 139.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.295 -0.878 . . . . 0.0 108.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' B' ' 101' ' ' TYR . 2.0 m-30 -106.68 135.99 47.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 111.196 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.66 HD12 HD11 ' B' ' 72' ' ' ILE . 54.0 mt -110.21 119.27 38.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -78.52 -137.46 1.22 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 0.417 ' C ' HD12 ' B' ' 33' ' ' ILE . 23.2 p -69.42 122.42 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.65 -1.5 . . . . 0.0 109.673 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' B' ' 30' ' ' LEU . 1.2 mp -126.53 137.78 31.08 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.59 153.53 23.28 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.433 1.422 . . . . 0.0 112.526 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -72.39 -0.91 13.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 109.986 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.4 -35.81 78.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.026 . . . . 0.0 108.513 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.448 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -131.44 117.84 19.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.585 -0.697 . . . . 0.0 109.718 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.772 ' O ' HD13 ' B' ' 42' ' ' ILE . 82.1 p -111.42 -135.68 0.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.478 -0.764 . . . . 0.0 110.971 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -64.33 -32.42 74.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.029 -1.044 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.7 -54.44 27.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.184 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -68.11 -42.11 80.73 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.592 -0.693 . . . . 0.0 110.385 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.772 HD13 ' O ' ' B' ' 38' ' ' THR . 1.7 mp -61.1 -53.3 51.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.539 HD23 ' OD1' ' B' ' 44' ' ' ASP . 4.9 tt -39.58 -21.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.554 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.596 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 91.5 m-20 -125.45 -24.24 3.95 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.732 -1.23 . . . . 0.0 110.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.709 ' C ' HD13 ' B' ' 45' ' ' LEU . 2.9 tm? -57.22 -39.02 74.64 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.108 -1.62 . . . . 0.0 106.877 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' B' ' 48' ' ' ASN . 85.4 m -83.26 -63.42 1.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.799 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.1 m -37.16 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.775 -0.578 . . . . 0.0 110.119 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' B' ' 46' ' ' CYS . 1.2 m120 -48.09 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.525 0.678 . . . . 0.0 111.112 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.799 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.1 t 174.5 -31.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.19 -174.63 46.89 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.6 158.87 15.01 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.143 2.562 . . . . 0.0 113.028 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.602 HG21 ' OG ' ' B' ' 47' ' ' SER . 23.2 t -128.76 145.26 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.712 HG22 ' OD1' ' B' ' 54' ' ' ASN . 45.6 mm -90.56 -66.49 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 112.011 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.712 ' OD1' HG22 ' B' ' 53' ' ' ILE . 64.0 m-20 -117.86 139.72 50.71 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.598 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.15 127.63 38.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -138.02 129.89 28.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.673 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' MET . . . . . 0.417 ' SD ' ' C ' ' B' ' 38' ' ' THR . 0.8 OUTLIER -133.25 144.68 49.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.591 0.71 . . . . 0.0 110.379 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -172.07 170.76 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.491 -0.756 . . . . 0.0 109.134 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' PHE . . . . . 0.51 ' O ' ' SD ' ' B' ' 58' ' ' MET . 0.1 OUTLIER -116.12 -166.93 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.0 109.21 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' B' ' 64' ' ' GLY . 6.6 t0 -105.03 73.98 0.24 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.184 -0.948 . . . . 0.0 110.622 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.41 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 5.9 Cg_endo -57.09 -31.33 89.98 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.04 1.827 . . . . 0.0 112.404 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -63.09 -37.76 88.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.599 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.431 HG23 ' H ' ' B' ' 65' ' ' ARG . 0.2 OUTLIER -140.97 -32.8 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 110.206 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 60' ' ' ASP . . . 99.5 -1.34 57.08 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.431 ' H ' HG23 ' B' ' 63' ' ' THR . 99.1 mtt180 -58.51 -40.79 83.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.848 -1.384 . . . . 0.0 109.606 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.529 ' H ' ' HB2' ' B' ' 60' ' ' ASP . 0.5 OUTLIER -89.6 116.24 27.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.102 -0.999 . . . . 0.0 108.709 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.89 -72.58 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.734 -0.604 . . . . 0.0 109.638 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -123.01 95.74 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' TYR . . . . . 0.711 ' OH ' ' CZ ' ' B' ' 71' ' ' PHE . 0.8 OUTLIER -108.67 130.61 55.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.473 -1.016 . . . . 0.0 109.126 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.73 24.38 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.834 -1.146 . . . . 0.0 112.193 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.711 ' CZ ' ' OH ' ' B' ' 69' ' ' TYR . 12.7 m-30 -115.32 129.4 56.59 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.882 0.849 . . . . 0.0 109.782 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ILE . . . . . 0.747 HD12 ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -120.25 102.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.121 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.573 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.5 mt-10 -83.95 131.42 34.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.573 -1.33 . . . . 0.0 110.472 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' B' ' 52' ' ' VAL . 7.2 m-85 -93.66 178.24 5.75 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.474 0.654 . . . . 0.0 110.176 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 50.4 ttt180 -52.71 -44.3 66.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 110.216 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 158.58 -177.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.754 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.3 mp -35.52 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.683 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.4 tt0 -70.06 -75.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.548 -1.345 . . . . 0.0 109.227 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -62.31 -40.26 95.74 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.978 ' O ' HG22 ' B' ' 84' ' ' VAL . 34.0 t -61.64 -39.6 91.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.055 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -57.44 -60.86 3.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' SER . . . . . 0.473 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 21.5 t -63.07 -35.05 78.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.905 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.748 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -73.51 -67.71 0.56 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 0.0 110.411 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.978 HG22 ' O ' ' B' ' 80' ' ' SER . 26.2 m -53.59 -37.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.506 -1.371 . . . . 0.0 110.077 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 10.2 mmt180 -62.9 -43.35 99.02 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.559 -1.338 . . . . 0.0 107.898 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' B' ' 82' ' ' SER . 87.0 m-20 -84.0 -45.97 12.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.641 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.748 ' N ' ' O ' ' B' ' 83' ' ' ALA . 0.4 OUTLIER -125.18 84.06 2.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.36 -0.838 . . . . 0.0 110.315 -179.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.4 OUTLIER -110.47 -68.46 0.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' B' ' 88' ' ' ASN . . . -127.66 108.1 0.92 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -139.42 147.55 41.57 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.468 -1.607 . . . . 0.0 108.843 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.6 tp60 -31.32 89.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.556 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 90' ' ' TYR . 60.0 tp -148.89 135.22 19.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.09 -1.006 . . . . 0.0 109.531 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 45.86 -168.74 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 36.7 m -64.83 -25.18 67.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.492 -1.004 . . . . 0.0 110.345 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.531 ' O ' ' O ' ' B' ' 92' ' ' LEU . 1.1 mmm180 -131.3 160.67 34.27 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.213 -0.929 . . . . 0.0 109.2 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' PHE . . . . . 0.45 ' HB3' ' N ' ' B' ' 90' ' ' TYR . 6.8 m-85 -95.18 138.89 32.27 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.624 -0.673 . . . . 0.0 110.148 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LEU . . . . . 0.629 HD23 ' H ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -43.89 157.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.67 159.84 38.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 109.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' CYS . . . . . 0.578 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.5 OUTLIER -110.49 129.14 55.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.393 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.4 -165.8 13.59 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.531 -1.318 . . . . 0.0 110.824 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.526 ' N ' ' OH ' ' B' ' 29' ' ' TYR . 30.2 p90 -130.53 171.29 13.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.635 -0.92 . . . . 0.0 109.452 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' B' ' 102' ' ' SER . 5.8 t 179.79 27.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 109.964 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 109.395 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 158' ' ' SER . . . . . 0.53 ' C ' ' SG ' ' C' ' 159' ' ' CYS . 23.9 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.343 0.592 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 159' ' ' CYS . . . . . 0.53 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 61.84 14.45 6.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.321 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 160' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 13.4 tttp -102.28 99.24 9.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 161' ' ' MET . . . . . 0.618 ' HE2' HD13 ' C' ' 163' ' ' ILE . 3.4 mmm -71.24 151.89 43.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 110.027 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 162' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' C' ' 202' ' ' PHE . 25.6 t80 -126.37 78.3 1.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 163' ' ' ILE . . . . . 0.936 HD11 HD12 ' C' ' 205' ' ' LEU . 4.1 mm -49.94 137.25 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 166' ' ' LEU . . . -140.18 172.32 23.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.06 11.44 0.12 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 166' ' ' LEU . . . . . 0.636 ' HA ' HG22 ' C' ' 228' ' ' ILE . 1.2 pp -62.27 163.96 7.68 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.929 . . . . 0.0 109.353 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 167' ' ' ASN . . . . . 0.633 ' O ' HD12 ' C' ' 166' ' ' LEU . 22.5 t-20 -68.68 123.99 22.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.935 -1.103 . . . . 0.0 109.503 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 168' ' ' TRP . . . . . 0.622 ' CZ2' ' CZ ' ' C' ' 198' ' ' ARG . 3.8 m-90 -37.74 -33.24 0.07 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.784 -0.572 . . . . 0.0 110.437 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 169' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' C' ' 167' ' ' ASN . 23.6 t70 -101.33 99.21 9.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.949 -1.095 . . . . 0.0 111.112 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 3.0 m -157.19 116.12 3.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.26 -0.9 . . . . 0.0 109.314 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 171' ' ' THR . . . . . 0.538 ' O ' ' OD1' ' C' ' 174' ' ' ASN . 0.0 OUTLIER -75.5 173.89 10.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.783 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 172' ' ' GLU . . . . . 0.673 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -75.47 -71.92 0.34 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.348 -0.845 . . . . 0.0 110.252 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' C' ' 176' ' ' ARG . 91.5 m-20 -38.34 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 174' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' C' ' 175' ' ' LEU . 29.6 p-10 -36.1 -44.83 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.709 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.623 ' CD2' HD11 ' C' ' 205' ' ' LEU . 5.3 tt -54.79 -46.39 74.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 176' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' C' ' 178' ' ' TYR . 60.9 ttp85 -72.15 -60.34 2.28 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.009 -1.057 . . . . 0.0 108.72 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 177' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' C' ' 176' ' ' ARG . 78.1 mm-40 -40.06 -22.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.067 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 178' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' C' ' 176' ' ' ARG . 16.3 t80 -95.24 -36.57 11.38 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.729 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 179' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' C' ' 176' ' ' ARG . 12.6 m-85 -90.02 12.59 17.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.094 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 180' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' C' ' 182' ' ' TYR . . . -61.28 -55.87 26.81 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.035 -1.041 . . . . 0.0 111.174 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.82 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.765 -1.433 . . . . 0.0 112.048 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 182' ' ' TYR . . . . . 0.596 ' H ' ' C ' ' C' ' 180' ' ' GLY . 22.3 m-85 -107.48 -3.93 18.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.999 -1.063 . . . . 0.0 109.567 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.87 -165.34 27.3 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 184' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' C' ' 208' ' ' GLU . 0.1 OUTLIER -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.286 . . . . 0.0 108.522 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.543 HG22 ' CE1' ' C' ' 207' ' ' PHE . 22.7 t -104.29 129.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -51.42 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.962 . . . . 0.0 109.414 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 187' ' ' ASP . . . . . 0.454 ' H ' ' HB2' ' C' ' 206' ' ' SER . 21.1 t70 -149.84 160.91 43.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp -157.62 143.05 17.13 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.22 -1.55 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 189' ' ' LYS . . . . . 0.456 ' H ' ' HB2' ' C' ' 204' ' ' PHE . 43.8 mttm -117.14 161.25 19.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.142 -0.974 . . . . 0.0 108.774 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 176.78 104.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 191' ' ' MET . . . . . 0.552 ' O ' ' C ' ' C' ' 192' ' ' LYS . 12.9 mtm -122.4 80.04 1.68 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 110.885 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 192' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' C' ' 191' ' ' MET . 41.5 mttp -24.07 -83.66 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 193' ' ' ASP . . . . . 0.406 ' HB3' ' N ' ' C' ' 199' ' ' SER . 3.8 p-10 -153.26 152.5 27.87 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.963 . . . . 0.0 109.233 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.55 -57.64 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.166 1.911 . . . . 0.0 112.303 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.48 ' O ' ' C ' ' C' ' 196' ' ' THR . . . -175.53 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 109.071 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . 0.48 ' C ' ' O ' ' C' ' 195' ' ' ALA . 37.3 p -28.44 -72.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.84 -55.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 198' ' ' ARG . . . . . 0.622 ' CZ ' ' CZ2' ' C' ' 168' ' ' TRP . 18.2 ptt180 -169.33 158.75 8.32 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 199' ' ' SER . . . . . 0.552 ' O ' ' N ' ' C' ' 201' ' ' GLY . 90.3 p -156.42 170.3 22.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.0 -1.063 . . . . 0.0 109.417 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 200' ' ' ARG . . . . . 0.545 ' C ' ' O ' ' C' ' 199' ' ' SER . 0.0 OUTLIER -26.56 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.436 0.636 . . . . 0.0 110.735 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 201' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.33 109.35 2.78 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.466 ' CD2' ' O ' ' C' ' 200' ' ' ARG . 13.0 p90 -129.56 166.67 19.24 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.785 -0.832 . . . . 0.0 108.783 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -137.65 130.02 4.9 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.171 -1.49 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 204' ' ' PHE . . . . . 0.456 ' HB2' ' H ' ' C' ' 189' ' ' LYS . 61.6 m-85 -104.08 115.55 30.62 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.607 -1.525 . . . . 0.0 107.596 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.936 HD12 HD11 ' C' ' 163' ' ' ILE . 3.5 mt -115.32 97.02 5.95 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.838 0.828 . . . . 0.0 109.967 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 206' ' ' SER . . . . . 0.454 ' HB2' ' H ' ' C' ' 187' ' ' ASP . 2.4 m -69.31 80.6 0.36 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.284 0.564 . . . . 0.0 109.651 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . 0.65 ' O ' ' O ' ' C' ' 208' ' ' GLU . 44.2 m-85 -79.56 123.6 27.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 110.943 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 208' ' ' GLU . . . . . 0.65 ' O ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -36.59 -103.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.617 ' H ' ' CG ' ' C' ' 208' ' ' GLU . 9.4 ptmt -51.39 160.6 0.93 Allowed Pre-proline 0 C--N 1.298 -1.665 0 O-C-N 119.744 -1.847 . . . . 0.0 108.326 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 210' ' ' PRO . . . . . 0.698 ' O ' HG22 ' C' ' 213' ' ' VAL . 8.6 Cg_endo -94.85 14.07 1.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.614 2.209 . . . . 0.0 112.478 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 211' ' ' SER . . . . . 0.586 ' O ' ' N ' ' C' ' 214' ' ' ASP . 60.0 p -82.64 -51.16 7.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . 0.852 ' O ' HG23 ' C' ' 216' ' ' VAL . 60.6 p -39.58 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.47 -0.769 . . . . 0.0 109.317 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 213' ' ' VAL . . . . . 0.698 HG22 ' O ' ' C' ' 210' ' ' PRO . 4.1 m -66.28 -37.96 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.962 -1.086 . . . . 0.0 108.31 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 214' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' C' ' 211' ' ' SER . 89.9 m-20 -65.19 -49.83 68.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.3 -39.74 94.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 108.68 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' VAL . . . . . 0.852 HG23 ' O ' ' C' ' 212' ' ' SER . 47.7 t -56.49 -49.18 78.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.96 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.489 HG23 ' O ' ' C' ' 230' ' ' PRO . 13.1 p -82.83 -31.45 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.868 -1.145 . . . . 0.0 111.264 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -74.17 12.87 0.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.933 -1.104 . . . . 0.0 109.697 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . 0.411 ' H ' ' C ' ' C' ' 217' ' ' VAL . 15.8 m -131.28 142.58 50.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.349 -0.844 . . . . 0.0 108.885 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -107.23 67.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 108.973 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 221' ' ' HIS . . . . . 0.831 ' CD2' ' H ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -55.54 163.95 1.16 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.706 -0.621 . . . . 0.0 109.95 -179.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 222' ' ' ILE . . . . . 0.426 HG22 ' C ' ' C' ' 225' ' ' GLY . 0.2 OUTLIER -142.14 74.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.902 0.858 . . . . 0.0 108.789 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 223' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -49.08 -71.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.233 -0.917 . . . . 0.0 110.67 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 224' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 58.3 t0 -89.81 12.19 17.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.75 -1.219 . . . . 0.0 109.606 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 225' ' ' GLY . . . . . 0.426 ' C ' HG22 ' C' ' 222' ' ' ILE . . . 81.01 17.12 73.06 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 226' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' C' ' 222' ' ' ILE . 27.3 mmtp -95.16 -153.94 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . 0.513 HG22 ' O ' ' C' ' 227' ' ' VAL . 2.0 p -122.4 90.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.071 -1.018 . . . . 0.0 109.921 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 228' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' C' ' 166' ' ' LEU . 34.0 pt -84.97 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -114.63 96.61 44.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.362 -0.837 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 230' ' ' PRO . . . . . 0.534 ' HB2' HG12 ' C' ' 216' ' ' VAL . 1.7 Cg_endo -74.65 125.67 9.67 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.384 2.056 . . . . 0.0 111.704 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.64 134.3 35.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 109.767 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.432 ' HD3' HG21 ' C' ' 213' ' ' VAL . 69.0 ttp85 -62.73 148.84 45.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.322 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' C' ' 160' ' ' LYS . . . -46.91 139.86 5.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.992 . . . . 0.0 109.196 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 28.6 mt -121.84 127.51 25.97 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.52 -0.737 . . . . 0.0 109.491 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.84 147.78 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.874 1.716 . . . . 0.0 112.276 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -58.66 -38.43 78.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.86 -41.42 74.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 109.134 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 238' ' ' GLU . . . . . 0.688 ' O ' HG23 ' C' ' 242' ' ' THR . 9.1 mp0 -71.79 -39.91 69.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.912 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 239' ' ' GLN . . . . . 0.456 ' O ' ' OG1' ' C' ' 242' ' ' THR . 9.2 tt0 -58.98 -43.68 91.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.17 -41.89 76.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 241' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' C' ' 242' ' ' THR . 16.0 ttmm -61.08 -45.38 94.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.124 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 242' ' ' THR . . . . . 0.688 HG23 ' O ' ' C' ' 238' ' ' GLU . 50.0 p -40.63 139.28 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.148 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.67 143.35 17.78 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 244' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' C' ' 290' ' ' THR . 16.7 tptp -118.71 130.26 55.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.86 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 245' ' ' ILE . . . . . 0.641 HD11 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -120.57 143.43 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 246' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -104.14 128.57 51.81 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.48 0.657 . . . . 0.0 109.975 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 247' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' C' ' 263' ' ' PHE . 14.1 t -100.63 133.07 45.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.951 0.881 . . . . 0.0 110.392 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.64 158.32 14.4 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.07 83.0 0.2 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.063 -1.257 . . . . 0.0 110.542 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 250' ' ' ILE . . . . . 0.546 HG21 HD22 ' C' ' 274' ' ' LEU . 3.7 mm -127.37 127.86 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -1.108 . . . . 0.0 108.855 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 251' ' ' GLY . . . . . 0.454 ' O ' HG23 ' C' ' 254' ' ' VAL . . . -52.61 111.87 1.83 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.92 -20.86 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.802 1.668 . . . . 0.0 111.66 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -96.52 16.17 19.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.479 -0.763 . . . . 0.0 109.265 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 254' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 251' ' ' GLY . 48.8 t -97.86 135.62 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.96 163.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 108.964 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.36 -25.89 80.8 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.653 2.235 . . . . 0.0 112.09 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -50.03 -62.74 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.233 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 258' ' ' GLU . . . . . 0.626 ' O ' ' N ' ' C' ' 261' ' ' GLU . 77.3 mm-40 -60.43 -74.18 0.08 Allowed 'General case' 0 C--O 1.194 -1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 108.51 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 259' ' ' PHE . . . . . 0.722 ' CZ ' HG13 ' C' ' 289' ' ' VAL . 89.1 t80 -16.82 -67.51 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.889 0.852 . . . . 0.0 111.045 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 260' ' ' GLU . . . . . 0.449 ' O ' HD11 ' C' ' 269' ' ' ILE . 93.6 mt-10 -61.24 -44.65 96.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 109.51 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 261' ' ' GLU . . . . . 0.626 ' N ' ' O ' ' C' ' 258' ' ' GLU . 35.5 tp10 -68.37 -7.68 33.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 262' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' C' ' 263' ' ' PHE . 13.9 t80 -92.76 -76.45 0.46 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 263' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' C' ' 247' ' ' VAL . 82.4 m-85 -45.74 -33.57 3.1 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.093 -1.443 . . . . 0.0 109.466 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 264' ' ' SER . . . . . 0.429 ' C ' ' O ' ' C' ' 263' ' ' PHE . 48.1 p -34.6 -37.5 0.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.942 -0.474 . . . . 0.0 111.786 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 265' ' ' GLN . . . . . 0.546 ' C ' ' H ' ' C' ' 267' ' ' GLY . 0.2 OUTLIER -58.52 -95.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.19 -1.569 . . . . 0.0 110.118 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 266' ' ' TRP . . . . . 0.679 ' CD1' ' O ' ' C' ' 266' ' ' TRP . 0.6 OUTLIER -69.92 19.25 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.025 -1.047 . . . . 0.0 109.38 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 267' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' C' ' 265' ' ' GLN . . . -136.17 128.16 4.45 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 268' ' ' THR . . . . . 0.528 ' O ' ' C ' ' C' ' 269' ' ' ILE . 58.1 p -85.5 6.6 26.27 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.365 -1.079 . . . . 0.0 109.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 269' ' ' ILE . . . . . 0.761 HG23 ' CE1' ' C' ' 291' ' ' TYR . 5.4 pt -14.67 96.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 122.451 1.119 . . . . 0.0 113.865 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.85 -35.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -135.94 94.87 3.12 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 272' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -137.81 172.05 13.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 273' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 7.7 tt0 164.99 156.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.563 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 274' ' ' LEU . . . . . 0.546 HD22 HG21 ' C' ' 250' ' ' ILE . 16.3 tp -97.0 140.63 31.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 275' ' ' MET . . . . . 0.503 ' H ' HD12 ' C' ' 274' ' ' LEU . 1.7 mpp? -90.4 156.33 18.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.564 -1.335 . . . . 0.0 108.686 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.67 -169.22 3.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.125 -0.984 . . . . 0.0 109.397 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 277' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 36.8 p-10 -61.84 -38.38 88.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 278' ' ' LYS . . . . . 0.583 ' N ' ' OD1' ' C' ' 277' ' ' ASP . 13.3 tttp -63.29 -42.8 99.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -66.76 -61.03 2.17 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.114 -0.991 . . . . 0.0 109.243 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 178.74 129.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.1 -118.78 5.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 282' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.3 tt0 -166.37 150.33 7.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.311 . . . . 0.0 111.009 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 4.5 t -62.17 66.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 110.213 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 284' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' C' ' 282' ' ' GLN . 72.3 mtt85 -55.77 -22.28 23.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 137.73 12.81 0.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 32.4 p90 -106.5 165.09 11.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 110.534 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.71 178.99 37.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -134.61 154.44 51.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.441 -1.623 . . . . 0.0 109.725 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 289' ' ' VAL . . . . . 0.722 HG13 ' CZ ' ' C' ' 259' ' ' PHE . 0.0 OUTLIER -148.01 138.04 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 290' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' C' ' 269' ' ' ILE . 10.1 m -123.0 126.0 46.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.96 -1.088 . . . . 0.0 109.943 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 291' ' ' TYR . . . . . 0.761 ' CE1' HG23 ' C' ' 269' ' ' ILE . 41.0 m-85 -113.55 133.09 55.45 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 292' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' C' ' 293' ' ' SER . 25.9 p-10 -53.02 -46.22 68.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.625 -1.297 . . . . 0.0 108.767 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 293' ' ' SER . . . . . 0.567 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 67.3 m -88.15 164.75 15.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.11 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 294' ' ' ALA . . . . . 0.406 ' O ' ' CG1' ' C' ' 297' ' ' VAL . . . -102.83 -22.38 13.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -50.08 -38.51 38.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.005 -1.06 . . . . 0.0 108.535 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.69 31.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 297' ' ' VAL . . . . . 0.575 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 1.4 p -54.99 -54.95 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.339 -1.476 . . . . 0.0 108.242 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 298' ' ' ASP . . . . . 0.456 ' H ' HG13 ' C' ' 297' ' ' VAL . 92.4 m-20 -57.84 -19.5 29.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.895 -1.128 . . . . 0.0 109.606 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -76.9 -58.37 3.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 108.877 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 300' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' C' ' 303' ' ' ASN . 7.2 p -68.11 -25.22 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 301' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 65.6 m -43.9 -52.07 7.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.115 -0.991 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -50.92 -22.21 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 303' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' C' ' 300' ' ' VAL . 20.1 t-20 -100.13 65.76 1.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.0 109.446 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 304' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' C' ' 303' ' ' ASN . 55.7 tttp -46.17 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.688 -1.257 . . . . 0.0 108.753 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 305' ' ' PHE . . . . . 0.644 ' CE1' ' CG ' ' C' ' 314' ' ' GLU . 90.9 m-85 -76.79 133.93 39.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.5 mt -130.39 148.34 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.369 -0.832 . . . . 0.0 109.019 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 307' ' ' ASP . . . . . 0.543 ' OD1' ' NZ ' ' C' ' 312' ' ' LYS . 78.1 m-20 -76.66 123.97 26.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 108.608 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 308' ' ' PHE . . . . . 0.579 ' O ' ' N ' ' C' ' 310' ' ' ASP . 52.6 t80 -123.44 173.16 8.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -0.873 . . . . 0.0 109.345 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 309' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -40.45 -23.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 310' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 308' ' ' PHE . 46.0 t0 -94.23 -154.5 0.42 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 311' ' ' ARG . . . . . 0.563 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 87.8 mtt180 -79.0 -55.71 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 312' ' ' LYS . . . . . 0.543 ' NZ ' ' OD1' ' C' ' 307' ' ' ASP . 24.9 tptt -157.37 147.04 20.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.176 -0.953 . . . . 0.0 109.183 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 313' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' C' ' 308' ' ' PHE . 41.7 pt -129.85 147.64 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.877 . . . . 0.0 109.229 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 314' ' ' GLU . . . . . 0.644 ' CG ' ' CE1' ' C' ' 305' ' ' PHE . 85.2 mt-10 -99.43 144.31 28.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 315' ' ' ILE . . . . . 0.641 ' CG2' HD11 ' C' ' 245' ' ' ILE . 36.2 mt -118.39 147.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.909 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -155.58 148.23 24.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.001 . . . . 0.0 108.976 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 317' ' ' ARG . . . . . 0.441 ' NH1' ' CB ' ' C' ' 317' ' ' ARG . 5.7 ptm85 -68.77 152.49 45.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.948 -1.095 . . . . 0.0 109.579 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.57 93.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 109.109 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.632 -179.554 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.896 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.921 1 C5'-C4'-C3' 107.702 -5.199 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.896 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.444 2.529 1 C5'-C4'-C3' 108.209 -4.861 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 0.697 " O2'" H5'' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.435 1.787 1 C5'-C4'-C3' 108.002 -4.999 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.73 ' C4 ' ' CZ2' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.443 2.4 1 C5'-C4'-C3' 106.622 -5.919 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.668 ' O4 ' ' N ' ' C' ' 165' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.782 1 C3'-C2'-C1' 105.598 4.553 OUTLIER-DELTA 0.552 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 1.003 " H4'" " C5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.61 1.667 2 C5'-C4'-C3' 109.396 -4.07 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 1.003 " C5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.421 1 C5'-C4'-C3' 107.809 -5.127 . 0.186 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.606 ' OP2' " H4'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.705 1 C5'-C4'-C3' 107.937 -5.042 . 0.524 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.888 " H4'" ' CE2' ' B' ' 69' ' ' TYR . . . . . . . . 0 O4'--C4' 1.423 -2.498 0 C5'-C4'-C3' 110.168 -3.555 . 0.661 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 0.876 " H2'" ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 C5'-C4'-C3' 109.551 -3.966 . 0.432 7a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.876 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.611 1.779 1 C5'-C4'-C3' 107.851 -5.099 . 0.929 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.855 ' H8 ' HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 1.96 1 C5'-C4'-C3' 107.258 -5.495 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.517 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.891 1 C5'-C4'-C3' 107.59 -5.273 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.424 0.63 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.28 175.2 3.48 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.956 2.437 . . . . 0.0 111.827 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -85.36 -2.88 9.37 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.825 2.35 . . . . 0.0 113.117 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' B' ' 77' ' ' LEU . 60.0 p -156.77 136.98 12.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.908 -1.12 . . . . 0.0 109.767 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -179.12 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.529 0.68 . . . . 0.0 109.368 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' B' ' 73' ' ' GLU . 2.4 t -128.05 163.48 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -0.891 . . . . 0.0 109.953 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.44 136.63 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.159 -0.963 . . . . 0.0 108.404 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.696 ' CZ ' ' C2 ' ' A' ' 9' ' ' ' A' . 10.3 m-30 -106.78 119.49 39.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.89 . . . . 0.0 109.017 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' B' ' 33' ' ' ILE . 1.7 mm? -106.61 105.45 15.48 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -107.03 -72.79 0.81 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.84 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.497 ' HB3' ' H ' ' B' ' 95' ' ' ARG . 7.8 t -69.2 82.71 0.35 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.929 -1.336 . . . . 0.0 110.014 -178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' B' ' 30' ' ' LEU . 3.7 mp -144.94 121.29 6.09 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' B' ' 36' ' ' ASP . 30.0 Cg_endo -69.72 164.35 34.83 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.515 1.477 . . . . 0.0 112.666 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -59.73 2.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.589 -0.694 . . . . 0.0 109.468 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' B' ' 34' ' ' PRO . 89.3 m-20 -63.99 -39.16 93.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.175 -0.953 . . . . 0.0 109.23 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.548 ' OE1' HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -124.4 113.98 18.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.581 -0.699 . . . . 0.0 109.158 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.4 p -110.05 -139.88 0.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 111.2 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.43 ' CD ' ' C ' ' B' ' 39' ' ' GLU . 0.5 OUTLIER -63.02 -29.45 70.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.962 -1.086 . . . . 0.0 110.794 -178.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -71.18 -54.39 11.18 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.343 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -49.05 64.07 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' B' ' 44' ' ' ASP . 24.1 mm -55.33 -52.58 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 42' ' ' ILE . 42.0 tp -37.6 -21.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.839 -0.538 . . . . 0.0 110.846 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.604 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 88.8 m-20 -123.5 -24.75 4.51 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.585 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.749 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.2 tm? -57.64 -39.44 76.98 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 119.905 -1.747 . . . . 0.0 106.612 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.623 ' O ' ' N ' ' B' ' 48' ' ' ASN . 0.8 OUTLIER -84.48 -63.68 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.801 . . . . 0.0 109.289 179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.758 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.7 t -38.8 -21.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.797 -0.564 . . . . 0.0 109.798 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.623 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.36 68.9 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.893 0.854 . . . . 0.0 110.511 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.758 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.51 -32.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.804 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.36 -155.7 19.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.75 159.83 38.24 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.325 2.016 . . . . 0.0 112.327 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.821 HG12 ' H ' ' B' ' 53' ' ' ILE . 3.0 t -120.92 -152.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.821 ' H ' HG12 ' B' ' 52' ' ' VAL . 31.8 mm -151.91 -64.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.827 -1.171 . . . . 0.0 109.577 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.555 ' OD1' HG22 ' B' ' 53' ' ' ILE . 71.6 m-20 -126.65 146.56 50.14 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.645 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.575 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.5 OUTLIER -139.37 130.69 26.83 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.575 ' N ' HD23 ' B' ' 55' ' ' LEU . 61.3 mttp -137.08 144.59 43.2 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 108.827 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.91 135.24 39.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.606 -0.684 . . . . 0.0 109.5 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 0.533 ' CE ' ' C2 ' ' A' ' 10' ' ' ' U' . 3.8 mpp? -158.39 166.88 31.18 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.416 -0.802 . . . . 0.0 109.202 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.442 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.1 OUTLIER -122.06 -168.63 1.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.559 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 25.2 p-10 -101.1 73.88 0.11 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 112.508 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.559 ' HD2' H5'' ' A' ' 11' ' ' ' A' . 28.6 Cg_endo -67.68 -36.65 18.46 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.623 1.549 . . . . 0.0 111.222 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -101.99 -59.91 1.62 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.517 -0.74 . . . . 0.0 109.695 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 75.5 p -48.7 -40.72 29.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.289 -0.882 . . . . 0.0 109.419 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' B' ' 60' ' ' ASP . . . 73.67 26.81 68.62 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.559 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 32.1 mtp180 -131.8 -68.01 0.66 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -1.115 . . . . 0.0 110.216 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.598 ' CB ' " H4'" ' A' ' 10' ' ' ' U' . 0.0 OUTLIER -50.01 120.39 4.36 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.832 0.825 . . . . 0.0 110.791 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.32 -74.61 0.43 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.066 -1.021 . . . . 0.0 108.699 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -115.69 94.7 0.67 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 0.888 ' CE2' " H4'" ' A' ' 9' ' ' ' A' . 2.0 m-85 -112.52 130.49 55.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -1.158 . . . . 0.0 110.039 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' B' ' 56' ' ' LYS . . . -142.41 138.86 31.41 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.356 -0.937 . . . . 0.0 109.574 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.721 ' CZ ' ' N3 ' ' A' ' 9' ' ' ' A' . 4.2 m-30 -105.68 122.98 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.905 HD12 ' N ' ' B' ' 72' ' ' ILE . 1.6 mp -118.17 98.81 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.294 -0.879 . . . . 0.0 111.485 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.709 ' HA ' HG13 ' B' ' 27' ' ' VAL . 83.8 tt0 -83.11 133.14 35.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.495 -1.378 . . . . 0.0 110.91 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.39 174.87 6.92 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.629 0.728 . . . . 0.0 110.996 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 11.7 ttt-85 -53.2 -42.36 66.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.708 -0.62 . . . . 0.0 110.967 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.5 m-20 160.7 179.19 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.777 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 9.3 mt -38.09 -22.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.856 -0.528 . . . . 0.0 109.63 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.7 mt-10 -70.23 -73.3 0.17 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.215 1.007 . . . . 0.0 109.324 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m -61.73 -40.93 96.84 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.824 -1.173 . . . . 0.0 108.297 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 40.3 m -62.54 -35.67 80.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.193 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.777 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -59.64 -56.66 19.09 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.598 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 70.2 m -65.25 -35.95 82.61 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.955 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.607 ' HB2' HG11 ' B' ' 49' ' ' VAL . . . -80.43 -61.86 1.85 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.038 -1.039 . . . . 0.0 110.9 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.583 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 41.5 t -56.16 -40.61 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.03 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' B' ' 81' ' ' ALA . 0.0 OUTLIER -68.14 -51.55 44.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.708 -1.245 . . . . 0.0 109.021 179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' B' ' 82' ' ' SER . 81.4 m-20 -67.52 -44.21 78.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.174 -0.953 . . . . 0.0 109.602 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.633 ' O ' HD12 ' B' ' 87' ' ' LEU . 1.7 pp -139.98 121.45 15.1 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.129 -0.982 . . . . 0.0 110.15 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 84' ' ' VAL . 1.4 p30 -143.89 -56.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.11 104.35 0.77 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -138.11 146.39 42.81 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 120.537 -1.566 . . . . 0.0 108.255 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.556 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.1 tp-100 -33.72 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.508 -0.745 . . . . 0.0 111.217 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.548 HD11 ' OE1' ' B' ' 37' ' ' GLN . 62.5 tp -146.19 126.16 13.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.57 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.69 -147.62 48.05 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . 0.418 ' CB ' ' OG ' ' B' ' 32' ' ' SER . 0.2 OUTLIER -92.36 -18.87 22.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.054 -1.263 . . . . 0.0 109.537 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' B' ' 92' ' ' LEU . 60.2 mtp180 -131.02 161.19 32.53 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.458 ' O ' ' C ' ' B' ' 97' ' ' LEU . 8.9 m-85 -94.57 137.41 33.73 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.2 -0.937 . . . . 0.0 110.072 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.574 HD23 ' H ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -40.44 145.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -109.74 151.98 26.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.935 . . . . 0.0 110.218 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 11.0 p -77.37 108.46 10.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.471 -0.768 . . . . 0.0 109.214 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -87.0 173.17 44.6 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 54.8 p90 -152.15 -32.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -1.065 . . . . 0.0 110.466 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.778 ' HG ' ' H61' ' A' ' 9' ' ' ' A' . 74.3 m -37.01 143.33 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.35 -0.844 . . . . 0.0 110.666 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 16.5 t -133.9 141.03 47.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -108.8 124.95 51.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.355 -0.84 . . . . 0.0 109.44 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.464 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 28.4 mttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.252 0.548 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . 0.537 ' O ' ' NH2' ' C' ' 232' ' ' ARG . 97.0 mt-10 -62.44 -34.82 77.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 109.805 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . 0.561 ' CB ' ' HE ' ' C' ' 232' ' ' ARG . 32.9 t -138.7 140.61 38.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 109.979 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . 0.519 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.8 OUTLIER 170.36 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . 0.585 ' NZ ' ' NZ ' ' C' ' 189' ' ' LYS . 12.1 ttmm -83.7 140.22 32.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.036 -1.04 . . . . 0.0 108.275 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 2.4 ptm -125.78 169.92 12.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.952 -1.092 . . . . 0.0 109.323 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.692 ' CZ ' ' C8 ' ' A' ' 6' ' ' ' A' . 54.0 t80 -121.5 80.8 1.72 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.567 -0.708 . . . . 0.0 109.693 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.404 ' H ' HG12 ' C' ' 163' ' ' ILE . 1.7 mm -50.29 131.98 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.88 156.36 22.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.668 ' N ' ' O4 ' ' A' ' 5' ' ' ' U' . . . 75.39 28.42 61.78 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.41 142.32 53.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.52 -0.988 . . . . 0.0 109.768 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' C' ' 169' ' ' ASP . 47.5 t30 -69.27 140.89 54.47 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.73 ' CZ2' ' C4 ' ' A' ' 4' ' ' ' A' . 7.5 m0 -63.63 35.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.069 -1.019 . . . . 0.0 110.307 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' C' ' 167' ' ' ASN . 57.4 m-20 -157.66 64.95 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.938 -1.102 . . . . 0.0 109.825 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 34.0 m -134.16 153.3 51.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.133 -0.98 . . . . 0.0 110.688 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.97 167.71 11.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.495 -0.753 . . . . 0.0 109.117 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.69 -67.57 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.754 -1.216 . . . . 0.0 109.679 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -47.23 -36.13 8.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.034 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . 0.444 ' OD1' ' C ' ' C' ' 174' ' ' ASN . 1.6 t30 -69.74 -52.21 27.44 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.445 ' HB2' HD12 ' C' ' 190' ' ' ILE . 12.4 tp -55.46 -41.84 73.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' C' ' 177' ' ' GLU . 25.4 ttp85 -66.12 -60.43 2.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.103 -0.998 . . . . 0.0 109.345 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -44.76 -31.35 1.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.231 -0.918 . . . . 0.0 108.783 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.715 ' CD2' HD12 ' C' ' 223' ' ' LEU . 21.8 t80 -76.01 -49.58 17.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.0 109.739 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.781 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.4 m-85 -72.16 -49.37 36.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.309 -0.869 . . . . 0.0 111.664 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.21 23.91 0.01 OUTLIER Glycine 0 N--CA 1.503 3.112 0 O-C-N 119.568 -1.958 . . . . 0.0 112.405 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . 0.781 ' N ' ' O ' ' C' ' 179' ' ' PHE . 4.9 ttpm? -90.24 -13.85 34.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.89 -1.359 . . . . 0.0 107.614 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . 0.609 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 32.0 m-85 -91.08 -62.69 1.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.4 -125.22 2.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 27.4 m -122.89 145.61 48.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -1.0 . . . . 0.0 109.86 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.409 HG21 HD11 ' C' ' 205' ' ' LEU . 14.2 p -127.66 142.61 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.424 HG23 ' N ' ' C' ' 187' ' ' ASP . 9.7 t -97.1 -37.47 10.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 110.337 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . 0.455 ' O ' ' CB ' ' C' ' 206' ' ' SER . 42.9 t0 -165.08 160.39 18.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.986 -1.071 . . . . 0.0 110.202 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.36 147.71 22.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . 0.585 ' NZ ' ' NZ ' ' C' ' 160' ' ' LYS . 23.6 mttp -114.86 90.85 3.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.843 -1.161 . . . . 0.0 110.175 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' C' ' 175' ' ' LEU . 10.3 tt -84.79 142.35 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 109.037 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . 0.556 ' HE1' ' C2 ' ' A' ' 7' ' ' ' U' . 0.0 OUTLIER -98.85 -47.56 5.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.238 -0.914 . . . . 0.0 110.188 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' C' ' 191' ' ' MET . 0.1 OUTLIER -30.8 124.53 0.19 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.636 0.732 . . . . 0.0 110.214 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.438 ' CG ' ' OG1' ' C' ' 196' ' ' THR . 15.7 t0 -134.45 87.16 33.13 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.13 -22.62 75.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.312 2.008 . . . . 0.0 111.389 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.41 -52.51 15.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.627 -0.67 . . . . 0.0 109.894 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . 0.438 ' OG1' ' CG ' ' C' ' 193' ' ' ASP . 3.0 p -70.61 -35.9 73.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 109.78 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 153.9 -76.22 0.22 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -168.65 155.1 7.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.194 -1.18 . . . . 0.0 110.171 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . 0.428 ' O ' ' C ' ' C' ' 200' ' ' ARG . 23.0 t -151.68 168.73 24.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' C' ' 199' ' ' SER . 14.1 mmp_? -46.44 143.52 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.937 -1.102 . . . . 0.0 108.286 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . 0.555 ' O ' ' O2 ' ' A' ' 5' ' ' ' U' . . . -94.27 91.25 1.42 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.121 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' C' ' 202' ' ' PHE . 25.1 p90 -152.25 167.17 29.47 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.38 130.99 3.32 Favored Glycine 0 N--CA 1.487 2.056 0 C-N-CA 118.149 -1.977 . . . . 0.0 110.766 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -88.14 120.7 29.74 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 119.992 -1.887 . . . . 0.0 107.271 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.409 HD11 HG21 ' C' ' 185' ' ' VAL . 0.1 OUTLIER -108.33 104.79 14.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 109.148 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.4 OUTLIER -80.44 73.08 7.35 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.543 0.687 . . . . 0.0 109.606 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' C' ' 216' ' ' VAL . 10.3 m-85 -67.95 114.74 6.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.981 -1.074 . . . . 0.0 109.408 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.75 -48.03 83.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 108.947 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' C' ' 211' ' ' SER . 1.8 mtmp? -84.36 101.3 1.41 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.992 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -39.38 -23.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.487 1.127 0 C-N-CA 121.871 1.714 . . . . 0.0 112.704 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.473 ' N ' ' O ' ' C' ' 209' ' ' LYS . 17.9 t -62.26 -57.1 12.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.013 -1.054 . . . . 0.0 110.585 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.751 ' O ' HG23 ' C' ' 216' ' ' VAL . 24.7 m -41.51 -34.91 0.62 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.29 -0.881 . . . . 0.0 109.53 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . 0.611 ' O ' HG12 ' C' ' 217' ' ' VAL . 86.6 t -65.97 -43.02 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' C' ' 211' ' ' SER . 61.8 t0 -60.83 -50.64 72.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 0.0 110.506 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' C' ' 219' ' ' THR . 19.7 pt-20 -73.63 -31.83 63.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.967 -1.083 . . . . 0.0 109.972 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.751 HG23 ' O ' ' C' ' 212' ' ' SER . 22.6 t -61.48 -50.99 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 109.747 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.611 HG12 ' O ' ' C' ' 213' ' ' VAL . 8.5 p -74.02 -29.9 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.511 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -85.01 17.48 2.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.495 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' C' ' 215' ' ' GLU . 32.0 m -136.43 147.3 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.921 -1.112 . . . . 0.0 109.46 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -102.63 136.33 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.248 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.705 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -139.82 167.65 21.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.133 -0.98 . . . . 0.0 109.858 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.0 107.2 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.825 . . . . 0.0 108.899 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.715 HD12 ' CD2' ' C' ' 178' ' ' TYR . 1.0 OUTLIER -73.43 -71.96 0.29 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 109.796 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . 0.574 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 60.2 t0 -84.95 0.45 51.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.039 -1.038 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.03 13.23 72.21 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . 0.866 ' O ' HG13 ' C' ' 227' ' ' VAL . 1.2 tpmt? -90.09 -78.76 0.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.468 -1.019 . . . . 0.0 109.325 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . 0.866 HG13 ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 174.75 109.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.251 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . 0.416 HD13 HG21 ' C' ' 228' ' ' ILE . 17.9 pt -113.96 148.46 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.706 -0.621 . . . . 0.0 110.132 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.43 96.68 38.36 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.441 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 46.8 Cg_endo -85.4 125.31 2.93 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.564 2.176 . . . . 0.0 112.028 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -141.18 143.05 34.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.18 -0.95 . . . . 0.0 109.699 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.561 ' HE ' ' CB ' ' C' ' 158' ' ' SER . 75.1 ttt-85 -57.45 153.96 11.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 108.591 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -44.31 137.57 3.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 108.856 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . 0.439 HD12 ' H62' ' A' ' 6' ' ' ' A' . 55.5 mt -114.92 135.99 22.51 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.406 -0.809 . . . . 0.0 109.811 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.24 139.19 16.39 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.809 1.672 . . . . 0.0 112.125 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.25 -44.58 88.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.518 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 34.0 p-10 -63.31 -38.65 91.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 109.856 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . 0.676 ' O ' HG23 ' C' ' 242' ' ' THR . 48.6 tp10 -66.0 -40.34 91.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.399 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.656 ' NE2' ' C8 ' ' A' ' 6' ' ' ' A' . 14.3 tt0 -62.31 -43.91 97.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -66.1 -39.24 89.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 110.049 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -63.32 -39.53 94.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.936 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . 0.7 HG22 ' HA ' ' C' ' 292' ' ' ASP . 66.9 p -50.76 141.65 12.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.851 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.09 160.5 14.74 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . 0.623 ' O ' ' HB2' ' C' ' 318' ' ' ALA . 22.9 tttt -136.37 133.39 36.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.243 . . . . 0.0 110.45 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.505 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -119.61 147.57 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.51 -0.744 . . . . 0.0 109.463 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 4.7 t80 -103.0 130.42 50.09 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 10.1 t -100.14 134.97 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.398 -0.814 . . . . 0.0 109.784 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 249' ' ' GLY . . . -105.89 155.85 16.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' C' ' 248' ' ' GLY . . . 59.66 141.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.458 ' CG1' HG11 ' C' ' 254' ' ' VAL . 2.7 tp -162.5 164.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.427 -1.043 . . . . 0.0 109.158 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . 0.428 ' O ' HG23 ' C' ' 250' ' ' ILE . . . -54.82 155.03 8.86 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.81 -28.78 86.99 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.548 2.166 . . . . 0.0 112.119 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.69 73.98 1.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' C' ' 308' ' ' PHE . 8.5 p -111.05 134.58 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.638 0.732 . . . . 0.0 109.932 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -96.32 157.05 36.19 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -57.74 -21.75 49.49 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.593 2.196 . . . . 0.0 111.859 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -51.98 -63.66 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 108.605 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . 0.731 ' O ' ' N ' ' C' ' 261' ' ' GLU . 76.0 mm-40 -58.21 -88.11 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . 0.619 ' C ' ' O ' ' C' ' 258' ' ' GLU . 36.9 t80 -9.59 -66.66 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.309 0.576 . . . . 0.0 111.449 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' C' ' 258' ' ' GLU . 96.9 mt-10 -56.71 -44.29 81.43 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.07 -1.019 . . . . 0.0 109.404 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . 0.731 ' N ' ' O ' ' C' ' 258' ' ' GLU . 76.3 mm-40 -69.44 -40.28 77.3 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . 0.417 ' O ' ' CG ' ' C' ' 265' ' ' GLN . 70.3 t80 -49.37 -75.64 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.505 -0.747 . . . . 0.0 109.363 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.471 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 93.5 m-85 -55.39 -32.12 62.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.576 -1.328 . . . . 0.0 110.465 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.423 ' C ' ' O ' ' C' ' 263' ' ' PHE . 13.0 t -38.29 -38.32 0.35 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.822 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' C' ' 264' ' ' SER . 0.2 OUTLIER -52.11 -95.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.322 -1.486 . . . . 0.0 109.9 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.471 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -63.56 152.55 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.29 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 52.96 103.2 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 60.5 m -49.9 138.47 15.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.084 -1.245 . . . . 0.0 107.785 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.619 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -99.63 104.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.103 -178.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 1.5 mp -72.5 -50.29 35.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.8 -1.187 . . . . 0.0 109.189 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' C' ' 290' ' ' THR . 57.4 t0 -142.36 98.05 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 109.611 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -128.25 166.39 18.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 109.419 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.1 OUTLIER 167.26 162.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.214 1.007 . . . . 0.0 111.367 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 5.9 tp -99.82 144.24 29.1 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . 0.752 ' O ' HD22 ' C' ' 276' ' ' LEU . 23.0 mmm -92.01 160.02 15.44 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.195 -1.566 . . . . 0.0 108.304 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.752 HD22 ' O ' ' C' ' 275' ' ' MET . 0.3 OUTLIER -143.28 153.3 42.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' C' ' 281' ' ' GLY . 0.0 OUTLIER -49.73 -31.89 12.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 108.619 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . 0.51 ' O ' ' NZ ' ' C' ' 226' ' ' LYS . 57.4 tttp -54.99 -40.46 70.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.45 -0.781 . . . . 0.0 109.366 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . 0.556 ' OD2' ' SD ' ' C' ' 275' ' ' MET . 91.3 m-20 -60.9 -37.4 82.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.35 -39.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.777 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' C' ' 277' ' ' ASP . . . 125.63 30.64 0.88 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' C' ' 284' ' ' ARG . 60.8 mm-40 -119.4 42.72 2.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.352 -1.087 . . . . 0.0 110.13 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . 0.467 ' O ' ' OG ' ' C' ' 283' ' ' SER . 6.6 t -62.51 39.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.247 -0.908 . . . . 0.0 110.032 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . 0.606 ' N ' ' O ' ' C' ' 282' ' ' GLN . 68.2 mtp85 -55.87 -34.17 65.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -0.974 . . . . 0.0 109.44 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.85 79.55 0.38 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.585 ' CZ ' ' O ' ' C' ' 282' ' ' GLN . 0.0 OUTLIER -146.75 -176.02 5.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.578 -1.542 . . . . 0.0 111.984 -178.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -157.89 164.65 33.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . 0.455 ' CZ ' " O4'" ' A' ' 3' ' ' ' U' . 64.8 m-85 -138.06 151.02 47.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.951 -1.323 . . . . 0.0 108.55 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -146.29 141.97 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.433 -1.417 . . . . 0.0 108.389 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 23.9 m -130.12 129.24 43.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.044 -1.035 . . . . 0.0 109.988 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.98 156.0 27.04 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . 0.7 ' HA ' HG22 ' C' ' 242' ' ' THR . 54.2 p30 -79.95 15.54 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.733 -1.23 . . . . 0.0 109.714 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 22.7 t -158.76 168.57 26.48 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.195 -0.94 . . . . 0.0 108.985 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.05 -12.05 20.03 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -57.31 -48.32 79.23 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.469 -0.769 . . . . 0.0 109.162 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.22 88.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.047 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.08 -57.74 6.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.22 -30.23 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.276 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' C' ' 302' ' ' GLN . 59.2 ttm-85 -63.86 -64.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.44 -0.787 . . . . 0.0 109.325 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.439 ' HB ' ' HE1' ' C' ' 266' ' ' TRP . 9.0 p -65.54 -23.0 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.415 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . 0.498 ' SG ' ' NH1' ' C' ' 317' ' ' ARG . 45.0 t -48.24 -57.32 6.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.062 -1.024 . . . . 0.0 109.706 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' C' ' 299' ' ' ARG . 3.9 pt20 -49.45 -22.33 1.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.925 -1.109 . . . . 0.0 108.515 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' C' ' 300' ' ' VAL . 92.4 m-20 -99.67 69.73 1.62 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.9 -82.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.672 -1.268 . . . . 0.0 108.869 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -69.63 126.6 30.24 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.162 -0.961 . . . . 0.0 109.493 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 59.6 mt -120.22 145.45 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.37 114.69 11.87 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.466 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.578 ' O ' ' C ' ' C' ' 309' ' ' LYS . 22.1 t80 -114.59 -178.08 3.28 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.578 ' C ' ' O ' ' C' ' 308' ' ' PHE . 73.8 mttt -19.75 -82.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.865 -0.522 . . . . 0.0 111.998 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' C' ' 311' ' ' ARG . 47.6 p30 -127.97 -16.41 4.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 110.201 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . 0.429 ' N ' ' OD1' ' C' ' 310' ' ' ASP . 40.1 mtp180 -121.2 125.81 48.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -52.77 164.96 0.31 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.43 -0.793 . . . . 0.0 109.398 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 17.8 pt -126.59 122.85 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.83 103.79 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 0.0 109.68 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.505 ' CG2' HD12 ' C' ' 245' ' ' ILE . 5.6 mm -72.53 146.18 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.014 -1.054 . . . . 0.0 110.046 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -154.04 152.39 30.44 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . 0.705 ' CD ' ' H ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER -59.73 149.69 30.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 108.998 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' C' ' 244' ' ' LYS . . . -50.77 -25.32 4.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.899 -1.126 . . . . 0.0 108.921 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . 0.485 ' OE1' ' O4 ' ' A' ' 3' ' ' ' U' . 2.0 mt-10 179.13 -51.05 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 110.135 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . 0.466 ' HD2' ' H ' ' C' ' 319' ' ' GLU . 55.3 Cg_exo -49.05 103.32 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.272 1.981 . . . . 0.0 112.419 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -60.1 -35.08 74.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.407 -0.808 . . . . 0.0 109.479 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 10.8 t60 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.463 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.493 ' H6 ' " H2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.441 2.235 1 C5'-C4'-C3' 107.8 -5.133 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.796 " O2'" ' H6 ' ' A' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.054 1 C5'-C4'-C3' 108.197 -4.869 . 0.742 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 1.059 " O2'" " H5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 P--O5' 1.612 1.904 2 O4'-C1'-N19 113.422 5.222 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 1.059 " H5'" " O2'" ' A' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.442 2.332 1 C5'-C4'-C3' 108.866 -4.423 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.717 ' C2 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 O4'--C1' 1.446 2.682 1 C5'-C4'-C3' 108.895 -4.403 . 0.634 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 1.055 " H4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.429 -1.998 1 C5'-C4'-C3' 108.068 -4.955 . 0.642 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 1.055 " H5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.618 2.55 1 C5'-C4'-C3' 106.183 -6.211 . 0.137 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.637 ' OP2' " H4'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.443 2.423 1 C5'-C4'-C3' 108.042 -4.972 . 0.459 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.923 H5'' ' CZ ' ' B' ' 69' ' ' TYR . . . . . . . . 0 P--O5' 1.611 1.78 2 C5'-C4'-C3' 108.347 -4.769 . 0.585 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 0.899 HO2' ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 1.994 2 C5'-C4'-C3' 107.94 -5.04 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.899 ' H8 ' HO2' ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.431 -1.796 1 C5'-C4'-C3' 105.751 -6.5 . 0.075 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.678 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.95 1 C5'-C4'-C3' 107.426 -5.383 . 0.052 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.518 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.844 1 C5'-C4'-C3' 107.61 -5.26 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.57 ' O ' ' CG ' ' B' ' 101' ' ' TYR . 16.1 Cg_exo -63.05 -176.92 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.819 2.346 . . . . 0.0 111.84 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 23' ' ' PRO . 71.0 Cg_endo -86.9 25.79 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.91 2.407 . . . . 0.0 112.811 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.58 107.22 2.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.907 -1.121 . . . . 0.0 110.521 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.475 ' CA ' ' OG ' ' B' ' 80' ' ' SER . 0.1 OUTLIER -162.74 -40.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' B' ' 28' ' ' VAL . 1.2 p -139.56 158.0 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.664 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.436 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.9 t -108.59 134.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.625 ' CZ ' ' N1 ' ' A' ' 9' ' ' ' A' . 9.1 m-30 -99.51 117.08 33.12 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.603 0.716 . . . . 0.0 109.682 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.73 HD11 HD23 ' B' ' 97' ' ' LEU . 1.1 mm? -101.98 129.19 48.21 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' B' ' 33' ' ' ILE . . . -146.75 -53.84 0.02 OUTLIER Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.127 -1.511 . . . . 0.0 110.986 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 27.6 t -69.5 30.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -1.21 . . . . 0.0 109.981 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.642 HD12 ' N ' ' B' ' 33' ' ' ILE . 4.9 mp -108.71 136.37 19.98 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -87.64 -176.01 1.62 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.743 1.629 . . . . 0.0 111.444 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.606 ' OH ' ' CG ' ' B' ' 59' ' ' PHE . 3.0 m-30 -67.1 0.45 2.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.73 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.577 ' CB ' HE22 ' B' ' 37' ' ' GLN . 62.7 m-20 -67.08 -45.27 77.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.964 -1.085 . . . . 0.0 108.968 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.577 HE22 ' CB ' ' B' ' 36' ' ' ASP . 11.8 mp0 -107.25 100.32 9.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.236 -0.915 . . . . 0.0 109.09 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -98.57 -153.95 0.45 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.651 -0.656 . . . . 0.0 110.079 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 40.2 tt0 -57.22 -26.29 60.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.141 -0.974 . . . . 0.0 109.884 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.7 -56.84 6.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.507 -0.746 . . . . 0.0 110.997 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.27 -41.63 80.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.948 . . . . 0.0 111.479 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.4 ' N ' HD13 ' B' ' 42' ' ' ILE . 6.0 mm -63.19 -52.28 60.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' B' ' 47' ' ' SER . 32.4 tp -58.5 -36.63 74.08 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -55.34 -74.77 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.416 1.103 . . . . 0.0 109.979 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -45.63 90.02 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.089 -177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' B' ' 48' ' ' ASN . 96.6 m -61.59 -68.67 0.3 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.003 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 87.7 p -33.39 -31.41 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.004 0.43 . . . . 0.0 110.628 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.0 OUTLIER -78.37 -43.35 27.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.976 -1.078 . . . . 0.0 109.431 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.638 HG21 HD11 ' B' ' 87' ' ' LEU . 13.2 t -43.4 -56.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.564 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.9 -158.79 11.63 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.938 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.556 ' O ' ' O ' ' B' ' 52' ' ' VAL . 57.9 Cg_endo -79.9 82.08 2.59 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.798 2.332 . . . . 0.0 112.788 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.556 ' O ' ' O ' ' B' ' 51' ' ' PRO . 0.3 OUTLIER -51.08 -166.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.49 ' H ' HG12 ' B' ' 52' ' ' VAL . 0.7 OUTLIER -160.09 -57.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.594 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 78.6 m-20 -117.91 132.64 56.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.225 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.428 HD12 ' N ' ' B' ' 56' ' ' LYS . 16.9 tp -133.0 126.36 31.77 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.428 ' N ' HD12 ' B' ' 55' ' ' LEU . 59.4 mttp -138.7 138.0 37.33 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.068 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' B' ' 70' ' ' ALA . 1.8 tpt -127.9 134.32 49.35 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 0.6 ' CE ' ' N7 ' ' A' ' 11' ' ' ' A' . 0.1 OUTLIER -153.66 150.13 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.011 -1.056 . . . . 0.0 109.87 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.606 ' CG ' ' OH ' ' B' ' 35' ' ' TYR . 4.0 m-85 -106.33 -177.54 3.39 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.345 -0.847 . . . . 0.0 109.555 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.643 ' CG ' ' H ' ' B' ' 66' ' ' SER . 13.6 m-20 -103.98 71.89 0.17 Allowed Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 120.908 -1.12 . . . . 0.0 111.939 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 17.0 Cg_exo -49.22 -65.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.239 1.959 . . . . 0.0 112.88 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -85.2 -54.14 4.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.429 -0.794 . . . . 0.0 110.255 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.42 ' C ' ' H ' ' B' ' 65' ' ' ARG . 62.4 p -51.99 -38.4 56.6 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.224 -0.923 . . . . 0.0 108.751 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' B' ' 60' ' ' ASP . . . 60.73 3.24 3.05 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' B' ' 63' ' ' THR . 83.0 mtt85 -65.83 -37.8 87.18 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.387 -1.067 . . . . 0.0 111.138 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.643 ' H ' ' CG ' ' B' ' 60' ' ' ASP . 0.8 OUTLIER -155.4 150.12 26.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.379 -1.451 . . . . 0.0 112.305 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -115.98 77.97 1.14 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.349 -0.844 . . . . 0.0 108.976 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.65 54.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 0.923 ' CZ ' H5'' ' A' ' 9' ' ' ' A' . 2.5 m-85 -104.48 127.33 52.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 108.602 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.693 ' HB2' ' SD ' ' B' ' 57' ' ' MET . . . -144.35 145.85 32.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.441 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.814 ' CZ ' " H1'" ' A' ' 9' ' ' ' A' . 6.6 m-85 -124.77 129.63 50.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.49 108.67 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.701 -0.799 . . . . 0.0 111.701 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.594 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 31.9 tt0 -92.9 134.12 35.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.352 -1.468 . . . . 0.0 110.78 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -96.66 171.63 8.41 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.858 0.837 . . . . 0.0 110.415 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' B' ' 76' ' ' ASP . 4.0 tpt180 -42.88 -40.84 3.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.785 -0.572 . . . . 0.0 112.322 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' B' ' 78' ' ' GLU . 17.8 t70 166.61 -177.73 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.35 0.595 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.791 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.0 mm? -39.58 -21.88 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.072 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.2 mm-40 -70.59 -74.42 0.14 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.753 -1.217 . . . . 0.0 109.096 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 29.8 m -60.87 -41.89 96.86 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.55 ' O ' HG23 ' B' ' 84' ' ' VAL . 0.1 OUTLIER -62.35 -29.93 70.81 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.076 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.791 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -67.23 -60.91 2.21 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.947 -1.095 . . . . 0.0 108.461 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.589 ' O ' ' OD1' ' B' ' 86' ' ' ASN . 59.0 m -61.51 -45.77 92.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.452 -0.78 . . . . 0.0 110.792 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.566 ' CB ' HG11 ' B' ' 49' ' ' VAL . . . -68.46 -67.31 0.48 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.62 HG12 ' ND2' ' B' ' 88' ' ' ASN . 16.1 t -49.73 -31.77 6.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.8 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.582 ' HE ' ' C ' ' B' ' 81' ' ' ALA . 76.2 mtm180 -65.0 -52.44 56.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.945 -1.097 . . . . 0.0 109.559 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.589 ' OD1' ' O ' ' B' ' 82' ' ' SER . 0.0 OUTLIER -75.08 -42.8 56.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 117.973 -1.491 . . . . 0.0 108.183 178.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.638 HD11 HG21 ' B' ' 49' ' ' VAL . 17.1 mt -79.63 -2.08 41.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.429 -0.794 . . . . 0.0 110.185 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.62 ' ND2' HG12 ' B' ' 84' ' ' VAL . 0.5 OUTLIER -48.51 -82.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.55 114.9 1.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.096 -2.002 . . . . 0.0 108.096 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.989 ' CE1' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -139.71 149.76 44.03 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 119.936 1.868 . . . . 0.0 110.821 -179.169 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -47.87 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.102 -1.624 . . . . 0.0 110.044 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -154.71 113.09 3.53 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.247 -0.908 . . . . 0.0 108.627 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.55 -171.83 36.86 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 44.9 m -79.44 -14.74 58.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.899 -1.353 . . . . 0.0 109.929 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.435 ' N ' ' OG ' ' B' ' 32' ' ' SER . 14.8 ttm180 -146.78 163.64 35.36 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.3 m-85 -93.41 127.36 39.0 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.867 -1.146 . . . . 0.0 110.502 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.989 HD11 ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -41.37 156.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.383 0.611 . . . . 0.0 109.482 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.51 ' HE3' " H1'" ' A' ' 8' ' ' ' A' . 9.7 mtmm -111.27 149.23 31.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.568 -0.708 . . . . 0.0 110.124 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' OD1' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -75.07 113.69 12.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.777 -0.577 . . . . 0.0 109.64 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -111.21 161.81 12.67 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' B' ' 23' ' ' PRO . 5.2 p90 -148.37 108.46 4.07 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.479 -1.013 . . . . 0.0 109.21 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 29.6 t -144.72 128.56 17.35 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.274 -0.891 . . . . 0.0 109.272 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 11.3 t 179.61 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.1 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.04 -52.74 64.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.853 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 109.412 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.28 134.86 46.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.467 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 30.3 t -158.73 155.14 27.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.901 . . . . 0.0 109.194 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . 0.41 ' SG ' ' CG2' ' C' ' 213' ' ' VAL . 8.6 t -116.04 87.32 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.057 0.932 . . . . 0.0 109.527 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -94.63 148.88 21.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . 0.56 ' SD ' HG21 ' C' ' 216' ' ' VAL . 0.1 OUTLIER -115.72 170.7 8.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.998 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.717 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 10.5 t80 -128.81 68.86 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.907 HG22 HD21 ' C' ' 166' ' ' LEU . 8.2 mm -57.26 129.39 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . 0.408 ' HA3' ' C2 ' ' A' ' 5' ' ' ' U' . . . -134.79 -173.9 13.26 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' C' ' 227' ' ' VAL . . . 53.94 27.23 36.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . 0.907 HD21 HG22 ' C' ' 163' ' ' ILE . 4.1 mm? -59.73 161.93 5.76 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.353 -1.087 . . . . 0.0 108.559 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.609 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 3.2 p30 -68.2 -71.84 0.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.697 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.1 OUTLIER 178.56 -32.97 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.884 -1.135 . . . . 0.0 109.636 177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.29 96.96 3.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 11.9 m -129.21 141.94 51.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.872 . . . . 0.0 108.958 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . 0.58 ' OG1' ' ND2' ' C' ' 174' ' ' ASN . 0.2 OUTLIER -92.56 156.59 17.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 109.594 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.81 -63.92 1.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.275 -0.891 . . . . 0.0 110.526 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.55 -33.53 22.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.929 -1.107 . . . . 0.0 109.696 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . 0.58 ' ND2' ' OG1' ' C' ' 171' ' ' THR . 87.9 m-20 -70.45 -50.84 34.12 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.911 0.863 . . . . 0.0 108.68 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' C' ' 190' ' ' ILE . 0.6 OUTLIER -59.77 -37.76 79.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.655 -0.653 . . . . 0.0 110.011 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -69.4 -60.74 2.14 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.48 -28.1 4.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.329 -0.857 . . . . 0.0 108.816 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' C' ' 178' ' ' TYR . 18.6 t80 -70.08 -53.61 16.68 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.922 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.763 ' O ' ' N ' ' C' ' 181' ' ' LYS . 13.6 m-85 -72.87 -41.87 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.608 -0.683 . . . . 0.0 112.501 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.77 30.01 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 119.347 -2.096 . . . . 0.0 111.431 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . 0.763 ' N ' ' O ' ' C' ' 179' ' ' PHE . 28.5 ttmt -94.01 -12.27 29.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 44.0 m-85 -99.77 -50.7 3.95 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.405 0.622 . . . . 0.0 109.744 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -143.66 -130.89 2.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 39.7 m -122.76 141.25 52.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -1.064 . . . . 0.0 109.567 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.498 HG22 ' CE1' ' C' ' 207' ' ' PHE . 59.7 t -117.96 135.34 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.409 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.422 HG22 ' H ' ' C' ' 186' ' ' THR . 0.6 OUTLIER -95.19 -41.52 9.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.921 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -160.1 158.0 29.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 109.657 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.885 HD12 ' N ' ' C' ' 189' ' ' LYS . 0.6 OUTLIER -139.97 140.38 36.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . 0.885 ' N ' HD12 ' C' ' 188' ' ' LEU . 0.2 OUTLIER -105.74 92.51 4.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.819 -1.175 . . . . 0.0 110.2 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . 0.629 ' CD1' HD12 ' C' ' 175' ' ' LEU . 1.8 tt -117.13 145.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . 0.442 ' SD ' " H1'" ' A' ' 7' ' ' ' U' . 13.0 ptp -154.19 61.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 109.986 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -68.22 171.86 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.998 -1.064 . . . . 0.0 109.614 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -52.51 124.71 34.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.013 . . . . 0.0 108.962 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.98 -4.82 15.98 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.153 1.902 . . . . 0.0 112.706 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -100.67 -85.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.152 -0.968 . . . . 0.0 110.22 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 32.5 p -98.69 -12.57 20.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 110.018 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 79.84 18.96 71.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -96.13 74.72 2.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.994 -1.298 . . . . 0.0 110.176 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . 0.571 ' O ' ' O ' ' C' ' 200' ' ' ARG . 37.0 m -167.31 171.64 10.48 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.576 ' NE ' ' C ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -34.98 162.44 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 110.128 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.06 108.29 0.36 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.53 ' CE2' ' NH2' ' C' ' 200' ' ' ARG . 7.8 p90 -130.41 158.1 40.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -1.097 . . . . 0.0 109.377 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.16 116.96 1.54 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.747 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -90.07 82.72 6.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.716 -1.461 . . . . 0.0 107.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.5 mt -70.59 104.14 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.935 . . . . 0.0 111.621 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.0 t -76.75 76.34 3.39 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.498 ' CE1' HG22 ' C' ' 185' ' ' VAL . 2.6 m-85 -64.5 122.84 17.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.526 -0.734 . . . . 0.0 110.459 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.19 -47.12 71.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.163 -0.961 . . . . 0.0 109.397 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -93.96 118.5 67.27 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.802 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . 0.674 ' O ' HG12 ' C' ' 213' ' ' VAL . 2.4 Cg_endo -62.14 -2.25 2.91 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 121.867 1.711 . . . . 0.0 113.044 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.516 ' O ' ' N ' ' C' ' 213' ' ' VAL . 18.6 t -74.53 -70.44 0.4 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.707 -1.246 . . . . 0.0 109.877 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.432 ' C ' ' O ' ' C' ' 211' ' ' SER . 28.2 t -39.28 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.5 -0.75 . . . . 0.0 109.96 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . 0.674 HG12 ' O ' ' C' ' 210' ' ' PRO . 0.5 OUTLIER -61.99 -20.18 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.765 -1.209 . . . . 0.0 110.106 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.97 -45.09 9.94 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.045 0.926 . . . . 0.0 108.863 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . 0.5 ' OE2' ' OG1' ' C' ' 219' ' ' THR . 48.7 tp10 -70.92 -27.85 64.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.79 -0.569 . . . . 0.0 109.849 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.56 HG21 ' SD ' ' C' ' 161' ' ' MET . 3.3 p -61.41 -49.11 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.244 -0.91 . . . . 0.0 110.153 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.541 ' N ' HG13 ' C' ' 216' ' ' VAL . 14.4 p -78.27 -40.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.94 -1.1 . . . . 0.0 109.114 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.481 ' N ' HG13 ' C' ' 217' ' ' VAL . 42.0 tptt -59.4 -48.67 80.75 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.441 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . 0.5 ' OG1' ' OE2' ' C' ' 215' ' ' GLU . 28.6 m -79.06 155.07 28.95 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.738 0.78 . . . . 0.0 110.898 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -112.07 138.45 48.71 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.809 ' O ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -136.44 163.19 31.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.809 HD13 ' O ' ' C' ' 221' ' ' HIS . 1.0 OUTLIER -132.26 119.47 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.416 ' HA ' ' CE2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -50.51 -72.28 0.05 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.176 -0.952 . . . . 0.0 110.287 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -126.22 20.7 7.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 109.171 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.42 8.94 58.26 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . 0.689 ' NZ ' ' NZ ' ' C' ' 278' ' ' LYS . 2.1 tpmt? -87.58 -76.8 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.368 -1.077 . . . . 0.0 109.188 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' C' ' 165' ' ' GLY . 1.2 t 169.13 135.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.385 -0.822 . . . . 0.0 109.629 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 17.9 pt -139.62 159.18 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 109.625 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.79 98.05 12.24 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 109.088 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.458 ' HG3' ' NE2' ' C' ' 221' ' ' HIS . 83.8 Cg_endo -87.94 123.33 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.964 2.442 . . . . 0.0 113.252 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -141.61 139.1 33.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.054 . . . . 0.0 109.6 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' C' ' 233' ' ' ALA . 70.7 ttt180 -66.54 151.46 47.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.97 -1.081 . . . . 0.0 109.868 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.64 138.17 4.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' C' ' 232' ' ' ARG . 3.4 mt -134.74 119.09 13.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.904 . . . . 0.0 109.924 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -45.94 156.03 0.51 Allowed 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 122.037 1.825 . . . . 0.0 111.551 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.644 HH22 " C2'" ' A' ' 6' ' ' ' A' . 0.3 OUTLIER -60.16 -45.62 92.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 0.0 110.485 -179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.13 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 109.864 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -70.42 -39.51 74.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.89 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.447 HE22 ' CZ ' ' C' ' 236' ' ' ARG . 6.7 tt0 -58.45 -39.46 79.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -63.06 -36.71 84.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.491 -0.756 . . . . 0.0 109.975 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . 0.515 ' O ' ' C ' ' C' ' 242' ' ' THR . 19.4 tttt -56.77 -65.71 0.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . 0.515 ' C ' ' O ' ' C' ' 241' ' ' LYS . 39.9 p -33.04 145.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.779 -0.575 . . . . 0.0 110.074 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -131.38 147.32 18.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.05 130.58 27.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -1.205 . . . . 0.0 109.832 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.584 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -123.42 152.59 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.701 0.762 . . . . 0.0 109.679 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.69 ' CD2' ' C6 ' ' A' ' 2' ' ' ' A' . 0.0 OUTLIER -108.16 136.09 48.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.675 -0.641 . . . . 0.0 109.329 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . 0.595 HG11 HD12 ' C' ' 313' ' ' ILE . 9.7 t -109.6 144.26 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.551 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 168.1 14.45 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . 0.582 ' O ' ' NH1' ' C' ' 311' ' ' ARG . . . 88.65 17.54 56.53 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 121.107 -1.231 . . . . 0.0 110.349 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.73 ' CG2' HG11 ' C' ' 254' ' ' VAL . 4.6 mt -116.04 136.34 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -1.053 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . 0.715 ' O ' HG12 ' C' ' 254' ' ' VAL . . . -108.67 178.15 20.87 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.96 -20.41 38.68 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.623 2.215 . . . . 0.0 112.379 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -56.1 -35.7 67.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.906 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.73 HG11 ' CG2' ' C' ' 250' ' ' ILE . 2.8 p -76.78 148.01 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.161 -0.962 . . . . 0.0 109.584 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -106.18 158.31 32.85 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.51 -21.31 61.28 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.455 2.103 . . . . 0.0 111.276 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -62.71 -54.76 34.41 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.04 -43.24 95.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.474 -0.766 . . . . 0.0 109.272 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -56.29 -59.67 4.61 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.107 -0.996 . . . . 0.0 109.936 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' C' ' 264' ' ' SER . 84.5 tt0 -60.66 -49.16 78.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 109.498 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . 0.453 ' C ' ' HG ' ' C' ' 264' ' ' SER . 47.4 tp10 -57.98 -22.56 49.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 0.0 108.75 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . 0.476 ' O ' ' OE1' ' C' ' 265' ' ' GLN . 67.6 t80 -81.25 -79.73 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.537 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 91.4 m-85 -52.61 -33.61 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.023 -1.048 . . . . 0.0 110.162 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.58 ' HA ' HD13 ' C' ' 269' ' ' ILE . 2.7 p -35.59 -38.68 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 111.996 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.62 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 1.8 pt20 -57.09 -90.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.422 -1.424 . . . . 0.0 110.339 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.62 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.7 OUTLIER -67.47 150.93 48.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.548 -1.345 . . . . 0.0 110.203 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . 0.405 ' O ' HD12 ' C' ' 269' ' ' ILE . . . 59.43 95.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 47.6 m -48.05 137.11 10.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.878 -1.366 . . . . 0.0 108.232 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.711 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -94.65 96.93 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 111.059 -178.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' C' ' 292' ' ' ASP . 6.4 mm -67.93 -39.57 81.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.449 -1.407 . . . . 0.0 108.497 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.59 92.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.439 -0.788 . . . . 0.0 109.506 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -123.42 172.33 8.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 109.888 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 0.0 OUTLIER 169.29 160.11 0.05 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.167 0.984 . . . . 0.0 111.277 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' C' ' 275' ' ' MET . 0.1 OUTLIER -107.7 152.59 24.12 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . 0.443 ' O ' ' CD1' ' C' ' 274' ' ' LEU . 0.0 OUTLIER -87.78 -179.12 6.21 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.492 -1.38 . . . . 0.0 109.858 -178.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.583 ' N ' ' OG1' ' C' ' 280' ' ' THR . 0.9 OUTLIER -153.21 -160.47 1.13 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.999 -1.063 . . . . 0.0 110.259 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' C' ' 283' ' ' SER . 1.2 m-20 -61.79 -85.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.281 -0.887 . . . . 0.0 111.58 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . 0.689 ' NZ ' ' NZ ' ' C' ' 226' ' ' LYS . 11.3 tptp -103.69 -32.11 9.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 109.805 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.54 -39.03 75.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 75.6 p -151.14 132.33 14.45 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.688 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.84 -127.95 28.72 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.559 ' O ' ' C ' ' C' ' 283' ' ' SER . 96.3 mt-30 -141.53 147.26 37.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.367 -1.078 . . . . 0.0 110.987 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . 0.595 ' O ' ' N ' ' C' ' 285' ' ' GLY . 0.0 OUTLIER -16.57 -52.22 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.106 -177.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' C' ' 282' ' ' GLN . 97.3 mtt180 -69.21 47.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' C' ' 283' ' ' SER . . . -40.36 102.46 0.02 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.67 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 0.0 OUTLIER -67.42 -163.73 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -130.21 149.92 19.03 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.229 -1.463 . . . . 0.0 110.923 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . 0.446 ' CZ ' ' H2 ' ' A' ' 2' ' ' ' A' . 2.0 m-85 -139.39 151.61 46.44 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 2.3 t -147.77 143.24 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.735 -1.228 . . . . 0.0 108.501 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 24.4 m -129.7 125.32 35.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.106 -0.996 . . . . 0.0 108.974 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -115.94 144.79 43.57 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . 0.469 ' HB2' HD11 ' C' ' 270' ' ' ILE . 11.4 t70 -57.17 -50.2 73.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.658 -1.276 . . . . 0.0 109.149 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 72.9 m -98.02 178.95 4.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.194 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.27 -11.73 14.85 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -51.18 -44.38 61.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.0 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.85 . . . . 0.0 109.088 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . 0.553 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 59.4 t -60.16 -60.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -57.48 -28.18 63.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -64.29 -62.93 1.3 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.79 -28.17 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.798 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 67.5 m -45.78 -55.78 6.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 0.0 108.853 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' C' ' 301' ' ' CYS . 15.8 mm100 -47.63 -25.05 1.04 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' C' ' 300' ' ' VAL . 82.7 m-20 -98.98 72.66 1.91 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -65.74 -12.29 52.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.821 -1.174 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -132.0 122.75 26.04 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.168 -0.957 . . . . 0.0 108.831 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . 0.573 HD12 HD11 ' C' ' 315' ' ' ILE . 46.7 mt -119.93 147.41 23.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 307' ' ' ASP . 47.3 p30 -69.79 159.43 33.6 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 109.012 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.745 ' O ' ' O ' ' C' ' 309' ' ' LYS . 13.9 t80 -167.31 -171.46 1.72 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.745 ' O ' ' O ' ' C' ' 308' ' ' PHE . 68.2 mttt -42.27 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.107 0.956 . . . . 0.0 110.937 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . 0.448 ' OD1' ' C ' ' C' ' 310' ' ' ASP . 44.6 p30 -61.14 35.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.375 -1.453 . . . . 0.0 110.912 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' C' ' 309' ' ' LYS . 0.3 OUTLIER -166.75 112.5 0.79 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.979 -1.075 . . . . 0.0 109.641 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.49 168.94 0.5 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.595 HD12 HG11 ' C' ' 247' ' ' VAL . 48.4 pt -133.25 157.21 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.24 -0.913 . . . . 0.0 109.937 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . 0.46 ' O ' HG13 ' C' ' 247' ' ' VAL . 64.4 mt-10 -112.2 157.0 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.352 -0.842 . . . . 0.0 109.133 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' C' ' 245' ' ' ILE . 5.7 mm -120.6 142.48 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -156.52 155.14 31.45 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . 0.69 ' CZ ' HH22 ' C' ' 321' ' ' ARG . 37.4 mtp180 -60.72 143.45 54.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.85 -1.156 . . . . 0.0 110.026 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.65 -12.58 61.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.322 -0.862 . . . . 0.0 109.383 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . 0.404 ' O ' ' NH1' ' C' ' 321' ' ' ARG . 7.8 mm-40 -128.75 85.82 59.2 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 109.774 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -56.03 142.57 85.37 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.424 2.083 . . . . 0.0 111.965 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . 0.69 HH22 ' CZ ' ' C' ' 317' ' ' ARG . 90.8 mtm-85 -151.86 108.07 3.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.088 -1.007 . . . . 0.0 109.248 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 20.8 p80 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.42 179.956 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.886 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.83 1 C5'-C4'-C3' 107.655 -5.23 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.886 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.442 2.335 1 C5'-C4'-C3' 107.808 -5.128 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 0.726 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.436 1.84 1 C5'-C4'-C3' 108.193 -4.872 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.68 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.44 2.201 1 C5'-C4'-C3' 107.085 -5.61 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.818 " H5'" ' CD ' ' C' ' 200' ' ' ARG . . . . . . . . 0 O4'--C1' 1.441 2.286 0 C5'-C4'-C3' 109.876 -3.749 . 0.464 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 1.047 " O4'" H5'' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.051 1 O4'-C1'-N19 112.245 4.045 OUTLIER-EPSILON 0.087 1b . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 1.047 H5'' " O4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.616 2.27 2 C5'-C4'-C3' 106.639 -5.908 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.873 ' OP2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.448 2.852 1 C5'-C4'-C3' 109.181 -4.213 . 0.791 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.958 " H2'" ' C6 ' ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.464 1 C5'-C4'-C3' 109.446 -4.036 . 0.759 &a . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 0.958 ' C6 ' " H2'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 2.0 1 C5'-C4'-C3' 107.655 -5.23 . 0.766 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.878 " O2'" ' H8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.435 1.712 1 C5'-C4'-C3' 106.774 -5.818 . 0.13 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.878 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.611 1.843 1 C5'-C4'-C3' 107.128 -5.582 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.849 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 2.011 1 C5'-C4'-C3' 107.49 -5.34 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.449 ' HD2' HH21 ' B' ' 26' ' ' ARG . 30.5 Cg_endo -67.78 157.15 63.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.715 2.277 . . . . 0.0 112.067 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.86 -5.67 16.14 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.927 2.418 . . . . 0.0 112.832 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 75.5 m -148.5 130.23 15.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 109.669 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.449 HH21 ' HD2' ' B' ' 23' ' ' PRO . 23.3 ttp85 179.05 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.51 HG22 ' HG2' ' B' ' 73' ' ' GLU . 76.5 t -116.07 151.52 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.592 -0.693 . . . . 0.0 109.637 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.4 ' N ' HG12 ' B' ' 27' ' ' VAL . 10.8 t -103.49 131.84 51.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.699 ' CD2' ' H2 ' ' A' ' 8' ' ' ' A' . 3.2 m-85 -102.2 116.93 33.68 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.816 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.49 HD13 ' CD1' ' B' ' 72' ' ' ILE . 4.7 mp -102.71 129.19 49.25 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -106.12 -112.15 3.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.456 ' OG ' ' CG ' ' B' ' 95' ' ' ARG . 10.4 p -70.08 131.0 43.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -1.219 . . . . 0.0 109.331 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.447 HD12 ' O ' ' B' ' 32' ' ' SER . 0.5 OUTLIER -163.42 132.88 3.08 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' B' ' 36' ' ' ASP . 14.8 Cg_endo -60.74 146.6 97.04 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.259 1.306 . . . . 0.0 112.162 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -62.98 3.66 0.22 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' B' ' 34' ' ' PRO . 93.0 m-20 -57.65 -37.77 73.92 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.362 -0.836 . . . . 0.0 108.913 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -119.27 113.23 20.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.469 -0.769 . . . . 0.0 110.176 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.508 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 67.4 p -106.76 -141.18 0.37 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 0.0 109.88 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -61.79 -31.39 71.59 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.798 -1.189 . . . . 0.0 111.092 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -73.45 -58.55 3.23 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.962 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' B' ' 37' ' ' GLN . 15.4 mt-30 -67.55 -38.51 84.26 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.781 -1.2 . . . . 0.0 109.721 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' B' ' 44' ' ' ASP . 5.7 mm -61.07 -52.66 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' B' ' 42' ' ' ILE . 54.3 tp -37.81 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.151 -0.343 . . . . 0.0 110.826 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' B' ' 42' ' ' ILE . 90.7 m-20 -125.11 -24.76 3.95 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.732 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.783 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.0 tm? -59.77 -39.95 86.59 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.014 -1.679 . . . . 0.0 106.898 178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.653 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.5 m -85.86 -63.81 1.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.296 -0.877 . . . . 0.0 109.065 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.823 ' O ' ' N ' ' B' ' 49' ' ' VAL . 2.5 p -40.03 -15.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.777 -0.577 . . . . 0.0 110.535 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.7 OUTLIER -50.72 64.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 122.289 1.042 . . . . 0.0 109.986 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.823 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.4 p 169.89 -33.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.16 160.02 33.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.67 93.56 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.47 2.113 . . . . 0.0 111.731 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -45.67 165.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 109.4 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.424 HD11 ' HG2' ' B' ' 75' ' ' ARG . 40.5 mm -99.38 -47.46 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.25 -0.906 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.487 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 79.5 m-20 -126.54 142.37 51.56 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.49 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 24.9 tp -130.8 129.65 42.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.227 -0.921 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.485 ' NZ ' ' C4 ' ' A' ' 11' ' ' ' A' . 11.3 tptm -138.09 134.65 34.94 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.109 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.687 ' SD ' ' HB2' ' B' ' 70' ' ' ALA . 4.7 tpp -126.54 132.51 51.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.734 -0.603 . . . . 0.0 109.445 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 0.629 ' SD ' ' C8 ' ' A' ' 11' ' ' ' A' . 75.2 mtm -151.77 155.96 39.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.472 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.451 ' O ' ' HD3' ' B' ' 61' ' ' PRO . 0.0 OUTLIER -117.86 -177.07 3.17 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.539 ' OD2' ' N ' ' B' ' 65' ' ' ARG . 41.1 p-10 -100.7 102.28 18.71 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 110.933 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 37.3 Cg_endo -89.36 -59.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.429 2.086 . . . . 0.0 110.738 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -81.49 -50.23 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.512 -0.743 . . . . 0.0 109.048 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 48.0 p -57.64 -44.35 85.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 109.522 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.441 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 70.03 24.63 76.38 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.539 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 46.4 mmm-85 -118.38 -68.23 0.93 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -1.104 . . . . 0.0 110.277 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.534 ' CB ' ' CD1' ' B' ' 69' ' ' TYR . 0.2 OUTLIER -58.52 118.88 6.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 110.343 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -79.88 -74.25 0.31 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.036 -1.04 . . . . 0.0 108.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -117.41 80.54 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 0.842 ' CE2' " H4'" ' A' ' 9' ' ' ' A' . 4.9 m-85 -92.38 132.13 36.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.012 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.687 ' HB2' ' SD ' ' B' ' 57' ' ' MET . . . -143.0 141.18 31.31 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.683 ' CE1' ' N3 ' ' A' ' 9' ' ' ' A' . 2.8 m-85 -114.88 122.92 47.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 109.229 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.49 ' CD1' HD13 ' B' ' 30' ' ' LEU . 3.3 mp -116.69 102.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.866 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.51 ' HG2' HG22 ' B' ' 27' ' ' VAL . 46.5 mt-10 -80.48 128.37 33.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.789 -1.194 . . . . 0.0 111.123 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -93.54 174.22 7.3 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.68 0.752 . . . . 0.0 110.793 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 81.4 mtt-85 -50.5 -41.32 53.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.717 -0.614 . . . . 0.0 110.56 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.77 178.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.821 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.8 OUTLIER -39.81 -19.0 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.665 0 O-C-N 121.566 -0.709 . . . . 0.0 110.392 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.1 tt0 -71.74 -74.69 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.69 -1.256 . . . . 0.0 108.733 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 43.3 m -60.37 -40.5 91.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -34.64 76.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.501 -0.749 . . . . 0.0 109.282 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -61.77 -59.82 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 24.5 t -64.74 -36.83 85.57 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.72 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.09 -64.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.149 -0.969 . . . . 0.0 109.988 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' B' ' 88' ' ' ASN . 35.0 t -51.75 -39.29 23.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.018 -1.051 . . . . 0.0 109.627 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.462 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmp_? -69.28 -48.52 61.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.885 -1.134 . . . . 0.0 109.697 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.88 -48.0 15.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.057 . . . . 0.0 109.669 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' B' ' 83' ' ' ALA . 59.4 mt -93.85 27.91 2.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -54.91 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.454 ' HA2' HD12 ' B' ' 97' ' ' LEU . . . -137.48 121.04 2.19 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -136.27 142.67 43.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.513 -1.58 . . . . 0.0 108.796 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.597 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.9 OUTLIER -27.25 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.609 0.719 . . . . 0.0 111.06 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.7 tt -151.44 128.23 10.92 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.696 -0.627 . . . . 0.0 109.309 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' B' ' 92' ' ' LEU . . . 46.36 -175.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 37.4 t -66.02 -17.15 64.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -1.157 . . . . 0.0 110.008 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.456 ' CG ' ' OG ' ' B' ' 32' ' ' SER . 24.5 mmt180 -134.67 149.81 50.56 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.133 -0.98 . . . . 0.0 109.58 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.467 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.9 m-85 -103.5 142.77 33.7 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.293 0.568 . . . . 0.0 110.388 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -39.93 151.29 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -134.87 170.05 16.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.262 -0.899 . . . . 0.0 110.2 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 2.3 p -73.33 -176.08 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.355 -0.841 . . . . 0.0 109.245 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' B' ' 29' ' ' TYR . . . 160.3 177.14 33.13 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.614 ' O ' ' N ' ' B' ' 103' ' ' SER . 21.8 p90 -149.15 -3.08 0.44 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.053 -1.263 . . . . 0.0 111.065 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' B' ' 102' ' ' SER . 0.1 OUTLIER -35.57 88.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.227 -0.921 . . . . 0.0 110.602 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.614 ' N ' ' O ' ' B' ' 101' ' ' TYR . 17.2 t -58.37 -38.64 77.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.981 -1.075 . . . . 0.0 109.509 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -130.78 131.97 45.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.452 -0.78 . . . . 0.0 109.478 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.468 ' C ' ' N6 ' ' A' ' 11' ' ' ' A' . 22.3 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.464 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 52.6 pttt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.21 0.529 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -102.83 59.3 0.78 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 109.626 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 99.9 p -119.99 142.0 49.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 108.903 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . 0.592 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER 170.35 -26.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -0.95 . . . . 0.0 109.303 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -80.97 139.08 36.02 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . 0.71 ' SD ' HG11 ' C' ' 216' ' ' VAL . 2.3 ttp -121.32 165.57 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.688 ' CD2' ' C6 ' ' A' ' 6' ' ' ' A' . 50.9 t80 -138.36 77.93 1.65 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.497 -0.752 . . . . 0.0 110.192 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.708 HG22 HD11 ' C' ' 166' ' ' LEU . 49.6 mt -54.19 141.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -137.04 168.51 24.3 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.464 ' H ' ' NH2' ' C' ' 200' ' ' ARG . . . 66.72 31.35 78.18 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . 0.708 HD11 HG22 ' C' ' 163' ' ' ILE . 7.6 mp -68.26 172.25 6.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 108.046 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.594 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 1.6 t-20 -67.79 -73.23 0.15 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.929 -1.107 . . . . 0.0 108.421 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.68 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.0 OUTLIER 178.72 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.32 178.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . 0.458 ' OD1' ' CD ' ' C' ' 192' ' ' LYS . 68.5 t0 -135.73 92.34 2.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.892 . . . . 0.0 109.644 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 86.6 m -125.8 143.53 51.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.459 -0.775 . . . . 0.0 109.2 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 172.7 8.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 109.602 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . 0.787 ' OE1' HG23 ' C' ' 190' ' ' ILE . 0.0 OUTLIER -79.06 -71.27 0.45 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.924 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' C' ' 174' ' ' ASN . 90.0 m-20 -40.24 -72.37 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . 0.543 ' C ' ' O ' ' C' ' 173' ' ' ASP . 0.1 OUTLIER -34.7 -44.57 0.22 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.614 HD12 HD13 ' C' ' 190' ' ' ILE . 0.5 OUTLIER -55.98 -57.97 9.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.054 -1.029 . . . . 0.0 109.779 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' C' ' 178' ' ' TYR . 7.4 ptm180 -67.28 -54.11 23.81 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.097 -1.441 . . . . 0.0 108.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . 0.513 ' C ' ' O ' ' C' ' 176' ' ' ARG . 83.7 tt0 -38.51 -30.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.108 -0.995 . . . . 0.0 108.394 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.534 ' CD2' HD12 ' C' ' 223' ' ' LEU . 20.4 t80 -86.94 -40.19 15.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 110.143 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' C' ' 176' ' ' ARG . 25.8 m-85 -90.94 16.75 8.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.139 -0.976 . . . . 0.0 111.149 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.36 25.74 24.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -102.77 10.87 38.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.163 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . 0.488 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 90.3 m-85 -109.62 -77.0 0.6 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.484 -0.76 . . . . 0.0 109.956 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -127.19 -122.09 2.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 38.9 m -124.17 139.94 53.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.556 -0.967 . . . . 0.0 109.416 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.523 HG23 HH21 ' C' ' 176' ' ' ARG . 35.8 m -112.17 139.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.467 HG23 ' N ' ' C' ' 187' ' ' ASP . 11.1 t -105.2 -38.08 6.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.05 -1.031 . . . . 0.0 110.116 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . 0.467 ' N ' HG23 ' C' ' 186' ' ' THR . 17.5 t70 -163.43 166.17 23.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.628 ' N ' HD23 ' C' ' 188' ' ' LEU . 1.8 pt? -161.59 150.8 16.15 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 0.0 108.921 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -124.0 141.66 51.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 109.091 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . 0.787 HG23 ' OE1' ' C' ' 172' ' ' GLU . 1.1 tt -166.61 107.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.059 -1.026 . . . . 0.0 108.392 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . 0.666 ' SD ' ' C2 ' ' A' ' 7' ' ' ' U' . 5.2 ptp -115.83 71.45 0.78 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' C' ' 191' ' ' MET . 4.0 pttt -39.25 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.287 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' C' ' 195' ' ' ALA . 4.8 t0 -147.58 106.53 3.77 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -48.31 -5.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 112.527 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' C' ' 193' ' ' ASP . . . -103.47 -85.61 0.45 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 0.0 110.048 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . 0.535 HG23 ' N ' ' C' ' 197' ' ' GLY . 10.2 t -103.46 -41.57 5.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 109.764 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . 0.535 ' N ' HG23 ' C' ' 196' ' ' THR . . . 127.35 13.43 2.87 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . 0.425 ' H ' HG23 ' C' ' 196' ' ' THR . 1.6 mmm180 -98.27 86.92 3.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 109.711 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . 0.624 ' O ' ' N ' ' C' ' 201' ' ' GLY . 42.7 t -161.48 149.23 15.06 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.818 ' CD ' " H5'" ' A' ' 5' ' ' ' U' . 47.2 tpt85 -42.53 90.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.14 138.15 21.53 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.538 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.53 ' CZ ' " H1'" ' A' ' 7' ' ' ' U' . 1.1 p90 -138.84 169.47 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -130.78 130.61 6.18 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.142 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . 0.407 ' HZ ' " H5'" ' A' ' 7' ' ' ' U' . 48.7 m-85 -107.33 95.97 6.08 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.4 ' HG ' ' CZ ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -93.02 106.38 18.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -178.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 3.5 t -77.48 77.35 4.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.395 -0.816 . . . . 0.0 109.531 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.592 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 34.5 m-85 -71.69 107.52 4.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.297 -0.877 . . . . 0.0 109.927 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.73 -39.8 81.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -85.25 105.09 5.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.744 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -50.08 -28.73 20.07 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.744 1.629 . . . . 0.0 112.997 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.545 ' O ' ' N ' ' C' ' 213' ' ' VAL . 83.9 p -68.18 -57.76 5.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.986 -1.072 . . . . 0.0 110.383 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.891 ' O ' HG23 ' C' ' 216' ' ' VAL . 91.2 p -40.81 -22.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.862 . . . . 0.0 109.955 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 211' ' ' SER . 97.1 t -70.4 -37.78 71.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 108.939 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.8 t0 -57.91 -48.86 78.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 109.813 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.13 -36.83 77.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.894 -1.129 . . . . 0.0 109.611 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.891 HG23 ' O ' ' C' ' 212' ' ' SER . 84.2 t -56.14 -46.85 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.767 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.424 HG23 ' N ' ' C' ' 218' ' ' LYS . 25.2 m -78.13 -36.79 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.027 . . . . 0.0 110.102 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.424 ' N ' HG23 ' C' ' 217' ' ' VAL . 3.0 tmtm? -67.14 -50.55 60.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.958 . . . . 0.0 109.868 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 16.9 m -73.04 144.85 46.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.259 -0.901 . . . . 0.0 110.688 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -98.66 138.28 36.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.695 ' N ' ' CD2' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -136.46 150.24 48.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.99 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.57 89.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.534 HD12 ' CD2' ' C' ' 178' ' ' TYR . 27.0 tp -58.44 -56.68 19.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.697 -0.627 . . . . 0.0 111.17 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -105.46 13.9 29.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.087 -1.008 . . . . 0.0 108.598 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 75.54 26.69 64.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 107.589 -2.205 . . . . 0.0 107.589 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . 0.465 ' HD3' HD22 ' C' ' 167' ' ' ASN . 0.1 OUTLIER -101.9 -154.25 0.48 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . 0.532 ' O ' HG12 ' C' ' 227' ' ' VAL . 12.6 t -121.41 94.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.556 -0.715 . . . . 0.0 109.329 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' C' ' 166' ' ' LEU . 30.1 pt -105.27 149.59 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 109.396 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' C' ' 231' ' ' LYS . 0.4 OUTLIER -124.17 100.17 36.48 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 0.0 109.813 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.401 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 16.6 Cg_endo -74.87 131.11 14.07 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.981 1.787 . . . . 0.0 111.244 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' C' ' 229' ' ' ASP . 19.4 mttm -149.91 151.08 32.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -62.07 149.09 42.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.72 . . . . 0.0 109.265 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -53.92 140.72 29.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.045 . . . . 0.0 109.123 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mt -120.11 116.68 32.46 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.32 159.05 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.237 1.958 . . . . 0.0 112.579 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.729 ' N ' ' HE ' ' C' ' 236' ' ' ARG . 0.2 OUTLIER -57.44 -52.14 66.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.414 -0.804 . . . . 0.0 110.343 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' C' ' 241' ' ' LYS . 90.9 m-20 -61.44 -41.68 97.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.244 -0.91 . . . . 0.0 109.384 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.12 -39.55 95.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 109.692 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.68 ' NE2' ' N7 ' ' A' ' 6' ' ' ' A' . 8.4 tp-100 -62.83 -41.36 99.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.974 -1.079 . . . . 0.0 108.613 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.85 -22.31 31.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.788 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' C' ' 237' ' ' ASP . 48.9 tttm -54.64 -16.81 2.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 0.0 110.302 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 10.2 p -102.36 162.6 12.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.893 -1.129 . . . . 0.0 109.449 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -112.87 154.08 17.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -129.92 126.61 38.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.056 -1.261 . . . . 0.0 109.972 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.502 HD11 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -117.33 138.55 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 121.765 0.793 . . . . 0.0 108.895 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.4 OUTLIER -80.56 161.28 24.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.458 0.647 . . . . 0.0 109.51 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . 0.546 ' N ' ' CD1' ' C' ' 246' ' ' PHE . 39.8 t -134.85 132.69 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.66 152.4 18.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 61.73 120.17 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.592 HD11 ' O ' ' C' ' 286' ' ' PHE . 0.0 OUTLIER -151.87 165.82 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -1.096 . . . . 0.0 108.743 179.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -47.07 145.71 4.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.31 -49.38 10.34 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.906 1.737 . . . . 0.0 112.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -122.14 33.87 5.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.741 . . . . 0.0 109.387 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.5 HG11 ' HB ' ' C' ' 250' ' ' ILE . 2.5 p -44.97 141.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -110.71 158.37 35.79 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.24 -30.66 81.81 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.35 2.033 . . . . 0.0 111.169 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -51.56 -62.64 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . 0.704 ' O ' ' N ' ' C' ' 261' ' ' GLU . 0.0 OUTLIER -62.57 -87.71 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . 0.631 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.3 t80 -9.03 -70.39 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 CA-C-O 121.441 0.639 . . . . 0.0 110.942 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . 0.556 ' HG3' ' HB3' ' C' ' 272' ' ' ALA . 85.0 tt0 -56.06 -44.14 78.59 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.271 0.558 . . . . 0.0 110.39 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . 0.704 ' N ' ' O ' ' C' ' 258' ' ' GLU . 46.4 tp10 -68.53 -41.93 79.2 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' C' ' 263' ' ' PHE . 42.1 t80 -54.69 -77.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.924 -0.485 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.611 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 61.3 m-85 -42.04 -48.77 4.69 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.706 -1.246 . . . . 0.0 110.24 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.0 OUTLIER -35.26 -37.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -178.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' C' ' 263' ' ' PHE . 1.7 pp0? -55.86 -7.35 0.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.0 113.246 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.611 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.2 p90 -146.35 -53.42 0.25 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 119.86 -1.775 . . . . 0.0 111.318 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . 0.597 ' N ' ' CD1' ' C' ' 266' ' ' TRP . . . -83.83 -178.52 51.82 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . 0.56 ' O ' ' C ' ' C' ' 269' ' ' ILE . 34.1 p -102.19 9.5 40.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.924 -1.339 . . . . 0.0 111.706 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.996 HG23 ' CE1' ' C' ' 291' ' ' TYR . 0.9 OUTLIER -16.45 104.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.264 0.938 . . . . 0.0 112.98 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.6 mm -92.74 -33.11 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . 0.551 ' O ' ' C ' ' C' ' 272' ' ' ALA . 88.0 m-20 -115.19 17.72 16.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.42 -0.8 . . . . 0.0 110.457 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . 0.731 ' HB2' ' HB ' ' C' ' 269' ' ' ILE . . . -25.92 130.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 O-C-N 121.998 -0.438 . . . . 0.0 110.275 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' C' ' 288' ' ' PHE . 14.0 pt20 -152.52 132.5 13.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.695 -1.253 . . . . 0.0 111.64 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.941 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.3 OUTLIER -126.58 152.46 46.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . 0.471 ' CE ' ' OP1' ' A' ' 4' ' ' ' A' . 17.8 mmt -88.54 168.44 12.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.651 -1.281 . . . . 0.0 109.872 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.957 ' H ' HD12 ' C' ' 276' ' ' LEU . 0.0 OUTLIER -144.59 176.98 9.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.788 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -78.71 -35.78 44.39 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 0.0 110.39 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -56.31 -36.43 68.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.062 -1.024 . . . . 0.0 109.789 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . 0.478 ' OD1' ' N6 ' ' A' ' 4' ' ' ' A' . 53.3 t0 -53.55 -52.43 59.73 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.668 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . 0.41 ' H ' ' H ' ' C' ' 281' ' ' GLY . 1.1 t 178.83 0.2 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' C' ' 283' ' ' SER . . . 102.47 9.07 42.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.459 ' OE1' ' OP1' ' A' ' 3' ' ' ' U' . 50.7 mm-40 -77.42 23.27 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -1.03 . . . . 0.0 109.958 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . 0.532 ' OG ' ' CA ' ' C' ' 276' ' ' LEU . 3.0 m -107.44 59.07 0.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.434 -0.792 . . . . 0.0 109.798 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.77 -27.69 19.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 108.618 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 143.29 17.37 0.25 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.726 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 46.1 p90 -108.55 176.77 5.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.42 178.17 39.1 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . 0.414 ' CE1' " O4'" ' A' ' 3' ' ' ' U' . 73.7 m-85 -147.55 156.31 42.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.325 -1.691 . . . . 0.0 109.676 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . 0.412 ' HB ' HG22 ' C' ' 269' ' ' ILE . 1.7 m -140.51 152.11 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.042 -1.036 . . . . 0.0 108.626 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.65 120.09 28.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . 0.996 ' CE1' HG23 ' C' ' 269' ' ' ILE . 93.9 m-85 -109.18 136.69 48.25 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -59.82 -50.67 72.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.592 -1.317 . . . . 0.0 109.381 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 75.4 m -93.54 169.38 10.39 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.309 -0.869 . . . . 0.0 108.89 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -103.54 -9.81 18.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.67 -46.24 74.01 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.01 76.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.807 . . . . 0.0 109.049 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . 0.419 ' O ' HG12 ' C' ' 300' ' ' VAL . 67.9 t -62.53 -61.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -56.11 -29.17 60.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 109.135 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -62.94 -60.8 2.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.59 HG23 ' OD1' ' C' ' 303' ' ' ASN . 14.4 p -63.06 -27.89 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.647 -0.658 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . 0.496 ' C ' ' O ' ' C' ' 300' ' ' VAL . 65.1 m -45.27 -49.37 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -46.13 -32.83 3.14 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.872 -0.518 . . . . 0.0 109.654 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.766 ' ND2' ' O ' ' C' ' 303' ' ' ASN . 1.0 OUTLIER -101.5 81.77 2.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -72.62 -14.98 61.73 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.64 -1.913 . . . . 0.0 108.739 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -126.05 122.28 35.38 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . 0.623 HD11 HD21 ' C' ' 303' ' ' ASN . 82.7 mt -117.18 149.87 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.13 96.69 10.79 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.624 ' O ' ' C ' ' C' ' 309' ' ' LYS . 34.7 t80 -104.32 -176.65 3.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.776 ' O ' ' N ' ' C' ' 311' ' ' ARG . 71.2 mttt -25.26 133.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' C' ' 309' ' ' LYS . 23.8 t70 -17.79 69.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.405 0.622 . . . . 0.0 112.057 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . 0.776 ' N ' ' O ' ' C' ' 309' ' ' LYS . 54.1 ttm-85 177.98 109.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 153.12 4.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.997 -1.064 . . . . 0.0 108.742 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.88 153.31 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.104 -0.997 . . . . 0.0 108.972 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -116.04 121.41 42.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.839 . . . . 0.0 109.791 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.502 ' CG2' HD11 ' C' ' 245' ' ' ILE . 2.0 mm -88.84 154.9 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.196 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -160.96 159.94 30.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.165 -0.959 . . . . 0.0 108.421 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -71.92 150.75 43.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.81 -1.181 . . . . 0.0 109.175 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.24 -0.7 10.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.842 -1.161 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.86 85.23 9.25 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.778 . . . . 0.0 109.929 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . 0.467 ' CG ' ' H61' ' A' ' 2' ' ' ' A' . 31.7 Cg_exo -54.94 137.75 76.54 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.463 2.109 . . . . 0.0 111.988 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . 0.444 ' O ' ' CB ' ' C' ' 322' ' ' HIS . 58.3 ttt85 -58.39 -38.37 77.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.66 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . 0.474 ' NE2' ' C5 ' ' A' ' 12' ' ' ' A' . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.478 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.855 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.957 1 C5'-C4'-C3' 107.627 -5.249 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.855 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.084 2 C5'-C4'-C3' 107.353 -5.432 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 0.682 " H3'" ' OD2' ' C' ' 277' ' ' ASP . . . . . . . . 0 O4'--C1' 1.433 1.601 1 C5'-C4'-C3' 106.607 -5.929 . 0.581 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.717 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.439 2.107 1 C5'-C4'-C3' 107.039 -5.641 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.68 ' O4 ' ' N ' ' C' ' 165' ' ' GLY . . . . . . . . 0 O4'--C4' 1.42 -2.776 2 C3'-C2'-C1' 105.446 4.384 . 0.541 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 1.023 " C4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.611 1.85 1 C5'-C4'-C3' 107.489 -5.341 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 1.023 " H5'" " C4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.618 2.543 1 C5'-C4'-C3' 107.4 -5.4 . 0.241 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.692 ' OP2' " H4'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.447 2.748 1 C5'-C4'-C3' 107.282 -5.479 . 0.41 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.735 ' C4 ' ' CE2' ' B' ' 29' ' ' TYR . . . . . . . . 0 O4'--C4' 1.417 -2.983 0 C5'-C4'-C3' 109.759 -3.828 . 0.789 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 0.824 " H1'" ' CE ' ' B' ' 58' ' ' MET . . . . . . . . 0 O4'--C1' 1.442 2.295 1 C5'-C4'-C3' 108.609 -4.594 . 0.527 &a . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.922 " O2'" ' H8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 P--O5' 1.612 1.934 2 C5'-C4'-C3' 107.987 -5.009 . 0.503 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.922 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.614 2.06 1 C5'-C4'-C3' 107.37 -5.42 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.508 " O5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 1.965 1 C5'-C4'-C3' 107.442 -5.372 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.59 ' OD1' ' CE2' ' B' ' 101' ' ' TYR . 2.4 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.464 0.649 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -69.01 154.47 70.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.936 2.424 . . . . 0.0 112.255 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.24 3.39 4.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.719 2.28 . . . . 0.0 112.315 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -154.3 133.42 12.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.93 . . . . 0.0 109.276 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -43.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.0 109.333 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' B' ' 100' ' ' GLY . 2.7 t -119.81 151.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' B' ' 98' ' ' LYS . 9.0 p -142.44 134.41 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.66 -1.275 . . . . 0.0 107.994 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.735 ' CE2' ' C4 ' ' A' ' 9' ' ' ' A' . 0.1 OUTLIER -129.36 155.57 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 110.475 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.62 ' HB3' HD11 ' B' ' 33' ' ' ILE . 3.4 mp -121.24 147.93 44.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.537 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -123.39 -45.13 0.29 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.864 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.413 ' C ' HD12 ' B' ' 33' ' ' ILE . 0.7 OUTLIER -92.04 87.51 6.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.964 -1.315 . . . . 0.0 109.706 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.635 HD12 ' N ' ' B' ' 33' ' ' ILE . 3.4 mp -143.44 126.81 9.08 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 108.886 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' B' ' 36' ' ' ASP . 39.3 Cg_endo -73.43 155.85 50.44 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.451 1.434 . . . . 0.0 111.583 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.449 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 8.2 m-85 -60.24 5.85 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 109.621 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.2 m-20 -61.51 -41.93 98.04 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.048 -1.032 . . . . 0.0 108.584 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.757 HE22 HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -125.4 112.04 15.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.39 -0.819 . . . . 0.0 109.57 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.408 ' O ' HG12 ' B' ' 42' ' ' ILE . 69.3 p -107.45 -143.19 0.38 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.379 -0.826 . . . . 0.0 110.963 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' B' ' 43' ' ' LEU . 21.7 pt-20 -65.97 -29.19 69.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.815 -1.178 . . . . 0.0 110.955 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -64.0 -54.78 28.91 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.882 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.568 HE21 ' CD ' ' B' ' 37' ' ' GLN . 6.0 tt0 -69.52 -48.11 61.6 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 110.359 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' B' ' 44' ' ' ASP . 6.5 mm -56.76 -54.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.479 ' HA ' HD22 ' B' ' 55' ' ' LEU . 41.4 tp -36.9 -20.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.766 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.2 t0 -124.02 -22.22 4.88 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.178 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.728 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.4 tm? -61.6 -37.59 84.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.165 -1.584 . . . . 0.0 107.94 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' B' ' 48' ' ' ASN . 86.6 m -92.77 -63.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.95 -1.093 . . . . 0.0 109.382 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.412 ' C ' ' O ' ' B' ' 46' ' ' CYS . 17.6 t -37.76 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.806 -0.559 . . . . 0.0 110.788 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' B' ' 49' ' ' VAL . 5.9 p30 -71.38 -59.05 2.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.784 -1.198 . . . . 0.0 109.844 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' B' ' 48' ' ' ASN . 0.9 OUTLIER -42.37 -51.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.714 -0.616 . . . . 0.0 110.207 -178.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.507 ' N ' HG12 ' B' ' 49' ' ' VAL . . . -157.22 167.63 33.94 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.21 131.06 21.72 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.905 1.737 . . . . 0.0 111.495 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.624 HG13 ' H ' ' B' ' 53' ' ' ILE . 0.9 OUTLIER -99.66 -172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.328 -0.857 . . . . 0.0 108.998 -178.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.624 ' H ' HG13 ' B' ' 52' ' ' VAL . 24.0 mm -142.86 -44.29 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 86.8 m-20 -149.52 155.53 40.5 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.523 -1.271 . . . . 0.0 111.662 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' B' ' 43' ' ' LEU . 56.8 tp -146.61 130.23 16.94 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.444 ' CG ' ' SD ' ' B' ' 58' ' ' MET . 43.1 tptt -145.81 116.54 7.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.671 -1.268 . . . . 0.0 110.143 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.46 130.41 35.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 109.297 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 0.824 ' CE ' " H1'" ' A' ' 10' ' ' ' U' . 2.3 mpp? -141.3 144.18 34.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.112 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.449 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 14.0 m-85 -98.89 -179.15 4.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.822 ' CG ' H5'' ' A' ' 10' ' ' ' U' . 0.4 OUTLIER -117.1 69.86 5.24 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.497 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -68.17 -61.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.916 2.411 . . . . 0.0 113.281 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -64.08 -40.94 97.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.373 -0.829 . . . . 0.0 110.818 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.513 ' CG2' ' OD1' ' B' ' 60' ' ' ASP . 7.8 p -70.84 -43.38 68.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.69 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.61 -2.45 85.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -1.08 . . . . 0.0 110.016 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' B' ' 60' ' ' ASP . 0.1 OUTLIER -177.24 -161.94 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.927 -1.108 . . . . 0.0 111.11 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' B' ' 60' ' ' ASP . 29.8 mttm -144.62 38.15 1.23 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.082 -1.011 . . . . 0.0 109.913 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -143.27 63.3 0.5 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.88 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 0.705 ' CE1' " H4'" ' A' ' 9' ' ' ' A' . 66.4 m-85 -116.8 123.57 47.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.279 -1.13 . . . . 0.0 109.498 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 135.9 36.59 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.296 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.73 ' CE2' ' C2 ' ' A' ' 9' ' ' ' A' . 3.5 m-85 -106.79 125.35 50.89 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.516 0.674 . . . . 0.0 111.549 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.87 153.01 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 81.7 tt0 -133.48 136.51 45.16 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.424 ' HD1' ' HG ' ' B' ' 79' ' ' SER . 12.0 m-85 -103.0 169.76 8.37 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.035 0.921 . . . . 0.0 111.583 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 51.6 ttt85 -55.52 -42.37 74.45 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.841 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 159.64 -176.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.502 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.789 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.8 mm? -38.77 -21.73 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.579 0 O-C-N 121.852 -0.53 . . . . 0.0 110.313 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' B' ' 76' ' ' ASP . 92.3 mt-10 -70.28 -79.04 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.858 -1.151 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . 0.424 ' HG ' ' HD1' ' B' ' 74' ' ' PHE . 13.9 t -62.57 -36.62 83.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 25.5 t -62.82 -37.75 88.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -60.31 -58.16 9.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.409 -1.432 . . . . 0.0 108.534 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 23.3 t -64.58 -34.19 77.68 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.415 0.626 . . . . 0.0 111.995 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -84.23 -58.26 2.83 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.932 -1.105 . . . . 0.0 110.596 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.709 HG13 ' CB ' ' B' ' 99' ' ' CYS . 58.7 t -53.59 -40.74 43.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 120.331 -1.481 . . . . 0.0 108.561 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -69.63 -46.9 65.16 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.826 -1.171 . . . . 0.0 109.782 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' B' ' 88' ' ' ASN . 73.7 m-20 -88.07 -59.48 2.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.851 -1.155 . . . . 0.0 109.006 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.69 ' N ' ' O ' ' B' ' 83' ' ' ALA . 11.8 tp -73.85 32.11 0.08 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.1 OUTLIER -71.85 -73.07 0.2 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.029 -1.044 . . . . 0.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' B' ' 97' ' ' LEU . . . -137.07 120.96 2.22 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER -138.43 141.1 39.54 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.45 -1.617 . . . . 0.0 107.294 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.8 mm-40 -31.16 89.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.781 0.8 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.757 HD11 HE22 ' B' ' 37' ' ' GLN . 20.8 tp -152.16 117.78 5.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.42 -168.9 48.0 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -11.94 59.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.028 -1.278 . . . . 0.0 108.872 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.536 ' NH2' " H4'" ' A' ' 8' ' ' ' A' . 0.1 OUTLIER -134.44 155.24 50.68 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' B' ' 97' ' ' LEU . 6.8 m-85 -97.09 134.17 40.78 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.27 -0.894 . . . . 0.0 109.207 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' B' ' 96' ' ' PHE . 0.0 OUTLIER -29.21 136.91 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.505 0.669 . . . . 0.0 111.084 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.739 ' O ' HG23 ' B' ' 28' ' ' VAL . 1.5 mmtt -112.76 126.81 55.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.448 -0.783 . . . . 0.0 109.054 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . 0.709 ' CB ' HG13 ' B' ' 84' ' ' VAL . 14.7 p -89.27 129.96 35.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 111.168 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -130.8 -168.16 12.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.59 ' CE2' ' OD1' ' B' ' 22' ' ' ASN . 38.5 p90 -137.49 161.36 36.58 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.682 -0.893 . . . . 0.0 109.076 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.472 ' HB3' HG21 ' B' ' 27' ' ' VAL . 26.9 t -179.24 92.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.438 -0.789 . . . . 0.0 108.945 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 60.7 p -151.91 168.44 25.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' B' ' 104' ' ' ASN . 33.3 p-10 -125.71 -178.06 4.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.473 -0.767 . . . . 0.0 109.653 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.616 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 6.9 tptt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.92 140.23 32.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 109.58 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . 0.502 ' C ' ' H ' ' C' ' 160' ' ' LYS . 28.2 t -111.93 142.49 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.475 -0.766 . . . . 0.0 109.336 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . 0.409 ' CB ' ' O ' ' C' ' 209' ' ' LYS . 27.4 p -72.42 28.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.741 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' C' ' 158' ' ' SER . 38.7 tttt -104.51 134.81 47.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.545 -0.722 . . . . 0.0 109.997 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 8.3 ptm -118.26 159.26 23.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -0.842 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.437 ' CG ' ' C2 ' ' A' ' 6' ' ' ' A' . 44.3 t80 -122.83 77.98 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.727 . . . . 0.0 110.29 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.478 ' CD1' HD21 ' C' ' 175' ' ' LEU . 0.6 OUTLIER -50.11 140.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . 0.497 ' HA2' ' C5 ' ' A' ' 5' ' ' ' U' . . . -139.11 166.66 25.39 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.68 ' N ' ' O4 ' ' A' ' 5' ' ' ' U' . . . 53.91 24.51 27.15 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . 0.749 ' HA ' HG22 ' C' ' 228' ' ' ILE . 1.7 pp -75.06 162.37 28.61 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.362 -1.081 . . . . 0.0 110.653 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.635 ' N ' HD12 ' C' ' 166' ' ' LEU . 63.5 t30 -75.29 123.98 26.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.025 -1.047 . . . . 0.0 109.528 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.717 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 3.2 m0 -37.52 -39.28 0.3 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 111.054 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -82.7 84.41 7.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.694 -1.253 . . . . 0.0 110.94 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . 0.405 ' O ' ' CD1' ' C' ' 190' ' ' ILE . 57.9 m -146.18 133.82 21.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.991 . . . . 0.0 109.368 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . 0.445 ' O ' ' C ' ' C' ' 172' ' ' GLU . 1.4 m -124.33 138.92 54.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.343 -0.848 . . . . 0.0 109.128 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . 0.566 ' HB3' HD13 ' C' ' 188' ' ' LEU . 0.5 OUTLIER -39.38 -72.99 0.05 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.138 -0.976 . . . . 0.0 110.744 -178.171 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' C' ' 172' ' ' GLU . 53.9 t0 -38.68 -39.46 0.5 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.542 -0.724 . . . . 0.0 110.139 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -76.51 -44.22 36.05 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' C' ' 172' ' ' GLU . 0.9 OUTLIER -53.1 -54.05 41.27 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' C' ' 179' ' ' PHE . 5.6 ptm180 -68.81 -55.54 10.88 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.43 -1.308 . . . . 0.0 108.534 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' C' ' 176' ' ' ARG . 84.6 tt0 -35.94 -33.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.559 ' CG ' HD12 ' C' ' 223' ' ' LEU . 21.1 t80 -91.93 -31.14 15.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.541 -0.724 . . . . 0.0 110.564 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' C' ' 176' ' ' ARG . 6.0 m-85 -95.49 15.92 18.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.84 -1.163 . . . . 0.0 110.832 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.67 29.57 2.63 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.57 22.79 12.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -1.079 . . . . 0.0 109.195 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . 0.603 ' OH ' ' ND1' ' C' ' 221' ' ' HIS . 99.2 m-85 -127.91 -3.84 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.486 -0.759 . . . . 0.0 109.628 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 151.33 -126.19 2.04 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 2.9 t -131.58 149.7 52.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -1.077 . . . . 0.0 108.844 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.557 HG11 HD23 ' C' ' 188' ' ' LEU . 86.0 t -103.25 134.42 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.915 . . . . 0.0 109.663 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 53.0 p -122.3 -29.51 4.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.378 -0.826 . . . . 0.0 110.562 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -153.9 150.51 28.44 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 109.62 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.831 ' O ' HD12 ' C' ' 188' ' ' LEU . 1.2 pp -171.93 154.84 3.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.588 -1.32 . . . . 0.0 110.111 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -140.35 118.52 11.99 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 108.337 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' C' ' 170' ' ' THR . 0.0 OUTLIER -141.11 148.66 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.777 -1.202 . . . . 0.0 110.33 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 9.8 mtt -121.63 174.13 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 140.05 1.13 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.523 -1.361 . . . . 0.0 109.118 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.498 ' O ' ' OD1' ' C' ' 193' ' ' ASP . 0.0 OUTLIER -74.9 143.46 78.02 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.069 -1.019 . . . . 0.0 110.045 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' C' ' 195' ' ' ALA . 60.3 Cg_endo -75.74 -40.73 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.946 1.764 . . . . 0.0 110.994 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' C' ' 194' ' ' PRO . . . 178.93 -39.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.566 -0.709 . . . . 0.0 109.771 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 50.1 p -123.4 5.44 9.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' C' ' 198' ' ' ARG . . . -105.03 42.64 1.85 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' C' ' 197' ' ' GLY . 49.6 mtm180 -41.91 133.73 2.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -1.109 . . . . 0.0 109.63 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . . . . . . . . . 23.0 t -154.67 167.04 31.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.55 ' NE ' ' N ' ' C' ' 200' ' ' ARG . 0.0 OUTLIER -59.94 92.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 109.942 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . 0.679 ' O ' ' N3 ' ' A' ' 5' ' ' ' U' . . . -83.11 93.13 1.68 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 8.7 p90 -109.14 154.54 22.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -115.6 134.09 11.31 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.522 -1.799 . . . . 0.0 110.087 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -114.14 91.44 3.63 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.485 HD12 HD22 ' C' ' 175' ' ' LEU . 0.8 OUTLIER -100.23 111.87 24.17 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.175 -0.953 . . . . 0.0 110.442 -177.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . . . . . . . . . 7.7 t -106.61 135.6 47.85 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -104.43 -121.41 0.21 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -141.05 -14.25 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.188 -1.57 . . . . 0.0 108.867 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 159' ' ' CYS . 7.6 mtmp? -130.0 170.45 10.98 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -97.66 -11.82 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.638 2.225 . . . . 0.0 112.481 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.587 ' O ' ' N ' ' C' ' 213' ' ' VAL . 15.1 m -68.58 -61.64 1.74 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.924 -1.11 . . . . 0.0 109.314 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.489 ' O ' HG23 ' C' ' 216' ' ' VAL . 42.8 m -40.64 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -0.763 . . . . 0.0 109.873 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' C' ' 211' ' ' SER . 84.0 t -73.64 -35.79 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.094 -1.004 . . . . 0.0 108.754 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -63.83 -49.32 73.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.501 -0.75 . . . . 0.0 110.409 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . 0.65 ' CD ' ' H ' ' C' ' 215' ' ' GLU . 0.0 OUTLIER -69.04 -42.7 76.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.797 -1.189 . . . . 0.0 108.674 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.489 HG23 ' O ' ' C' ' 212' ' ' SER . 4.8 t -51.55 -47.26 37.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.7 -36.13 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -77.93 8.95 3.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 109.786 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 18.0 m -129.38 142.95 50.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.879 . . . . 0.0 108.762 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -105.95 136.27 45.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.357 -0.839 . . . . 0.0 109.199 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.904 ' C ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -131.18 153.01 49.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.726 -179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.904 HD13 ' C ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -117.62 86.85 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.672 0.748 . . . . 0.0 109.102 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' C' ' 178' ' ' TYR . 1.1 tp -57.27 -66.75 0.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.331 -0.855 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -96.05 8.31 44.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.665 -1.272 . . . . 0.0 109.401 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 81.95 14.88 76.4 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . 0.677 ' HB2' ' HZ2' ' C' ' 226' ' ' LYS . 0.0 OUTLIER -95.69 -154.39 0.43 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' C' ' 165' ' ' GLY . 7.6 t -115.07 95.91 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' C' ' 166' ' ' LEU . 26.3 pt -105.65 136.94 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.983 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -112.78 108.44 53.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.798 . . . . 0.0 109.612 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.466 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 37.2 Cg_endo -81.7 137.33 10.03 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.968 1.779 . . . . 0.0 111.939 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -145.99 159.52 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' C' ' 234' ' ' ILE . 26.8 ptt-85 -87.61 152.14 22.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.04 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -49.15 99.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.892 -1.13 . . . . 0.0 108.761 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . 0.451 HD12 ' H61' ' A' ' 6' ' ' ' A' . 4.4 mt -90.76 127.44 52.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -46.03 149.36 2.35 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.062 1.841 . . . . 0.0 112.55 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -57.33 -45.83 83.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.504 -0.747 . . . . 0.0 110.133 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -59.41 -41.73 90.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 108.704 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . 0.518 ' O ' HG23 ' C' ' 242' ' ' THR . 75.9 mm-40 -66.3 -36.39 82.83 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.434 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.544 ' CD ' ' N7 ' ' A' ' 6' ' ' ' A' . 30.5 tp60 -61.19 -44.82 96.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.255 -0.903 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -73.0 -41.2 64.52 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.362 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -72.28 -13.93 61.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.508 -0.745 . . . . 0.0 111.805 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . 0.518 HG23 ' O ' ' C' ' 238' ' ' GLU . 0.9 OUTLIER -47.64 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.525 -1.359 . . . . 0.0 110.284 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 107.66 108.76 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -140.72 134.33 30.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.715 -1.462 . . . . 0.0 110.6 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.696 HD12 ' CG2' ' C' ' 315' ' ' ILE . 1.2 pt -126.16 159.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 109.875 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.717 ' CE2' ' C4 ' ' A' ' 2' ' ' ' A' . 0.0 OUTLIER -106.93 131.19 54.29 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.46 132.25 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.631 -0.668 . . . . 0.0 109.652 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.19 148.75 18.26 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . 0.852 ' H ' ' H3 ' ' A' ' 1' ' ' ' U' . . . 70.39 72.53 0.87 Allowed Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.224 -1.162 . . . . 0.0 111.223 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' C' ' 251' ' ' GLY . 19.6 mt -118.34 145.38 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -1.057 . . . . 0.0 109.096 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . 0.584 ' O ' HG12 ' C' ' 254' ' ' VAL . . . -42.66 126.88 4.74 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.29 -40.76 43.36 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.822 1.681 . . . . 0.0 112.207 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' C' ' 254' ' ' VAL . 90.5 m-20 -95.17 6.31 49.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.376 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.596 HG22 ' N ' ' C' ' 255' ' ' ARG . 10.7 p -42.26 165.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.291 -0.88 . . . . 0.0 109.982 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.596 ' N ' HG22 ' C' ' 254' ' ' VAL . 14.4 mtt180 -137.3 156.76 75.12 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.0 109.052 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.14 -28.14 48.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.467 2.111 . . . . 0.0 111.913 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -52.13 -64.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . 0.718 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.0 tp10 -59.77 -83.2 0.01 OUTLIER 'General case' 0 C--O 1.196 -1.727 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . 0.608 ' C ' ' O ' ' C' ' 258' ' ' GLU . 75.9 t80 -12.67 -70.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.207 0.527 . . . . 0.0 111.45 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.31 -41.77 72.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.431 -0.793 . . . . 0.0 109.691 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . 0.718 ' N ' ' O ' ' C' ' 258' ' ' GLU . 44.3 tp10 -67.46 -46.69 72.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . 0.636 ' O ' ' HG2' ' C' ' 265' ' ' GLN . 60.3 t80 -49.68 -72.32 0.05 Allowed 'General case' 0 C--O 1.193 -1.907 0 O-C-N 121.573 -0.705 . . . . 0.0 110.512 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' C' ' 265' ' ' GLN . 88.4 m-85 -53.59 -45.1 69.89 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.044 -1.035 . . . . 0.0 112.083 -176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.502 ' C ' ' O ' ' C' ' 263' ' ' PHE . 0.3 OUTLIER -24.07 -36.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' C' ' 262' ' ' PHE . 1.0 OUTLIER -48.41 -100.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.762 -1.212 . . . . 0.0 111.042 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.504 ' H ' ' HG3' ' C' ' 265' ' ' GLN . 1.7 p90 -60.77 148.71 38.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 266' ' ' TRP . . . 51.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 86.2 m -49.77 141.71 9.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.289 . . . . 0.0 108.558 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.61 HG22 ' O ' ' C' ' 269' ' ' ILE . 0.9 OUTLIER -95.41 106.71 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.986 -1.071 . . . . 0.0 110.753 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . 0.475 HG22 ' N ' ' C' ' 271' ' ' ASP . 0.6 OUTLIER -70.13 -55.92 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.705 -1.247 . . . . 0.0 108.862 179.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . 0.475 ' N ' HG22 ' C' ' 270' ' ' ILE . 59.4 t0 -141.25 102.43 4.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' C' ' 273' ' ' GLN . . . -131.71 157.36 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' C' ' 272' ' ' ALA . 14.6 pt20 168.69 173.31 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.685 1.231 . . . . 0.0 111.796 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.505 HD22 HG13 ' C' ' 254' ' ' VAL . 10.4 tp -95.12 148.36 22.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . . . . . . . . . 96.8 mmm -97.71 -172.55 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.448 -1.407 . . . . 0.0 110.933 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 175.29 88.56 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . 0.682 ' OD2' " H3'" ' A' ' 3' ' ' ' U' . 83.0 m-20 -84.34 47.5 1.35 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' C' ' 277' ' ' ASP . 15.6 pttp -40.41 -33.22 0.24 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -58.41 -37.12 74.68 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.356 -0.937 . . . . 0.0 108.484 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . 0.597 ' N ' ' O ' ' C' ' 277' ' ' ASP . 0.4 OUTLIER -141.73 -79.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . 0.57 ' N ' ' OG1' ' C' ' 280' ' ' THR . . . -65.27 -165.34 1.26 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.0 tt0 -167.09 158.59 12.34 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.338 -1.095 . . . . 0.0 109.828 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . 0.427 ' N ' ' HG2' ' C' ' 282' ' ' GLN . 1.0 OUTLIER -61.17 67.59 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.203 0.525 . . . . 0.0 109.774 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' C' ' 282' ' ' GLN . 60.8 ttm-85 -50.07 -24.74 2.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 140.86 22.93 0.26 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.571 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 23.0 p90 -111.36 173.36 6.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 110.668 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.3 179.93 36.42 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' C' ' 246' ' ' PHE . 21.8 m-85 -143.1 158.45 43.6 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.417 -1.637 . . . . 0.0 109.189 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 19.8 t -141.59 143.94 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.81 -1.181 . . . . 0.0 108.253 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . 0.453 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 18.6 m -130.97 128.71 40.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.869 -1.144 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . 0.517 ' O ' ' O ' ' C' ' 242' ' ' THR . 42.0 m-85 -114.42 143.64 44.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.519 -0.738 . . . . 0.0 109.381 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . 0.543 ' CG ' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER -62.48 -48.56 79.08 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . 0.543 ' N ' ' CG ' ' C' ' 292' ' ' ASP . 12.4 m -73.93 132.93 42.95 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -76.33 -32.7 58.83 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -50.95 -38.48 50.82 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.702 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.44 -46.09 83.97 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . 0.45 HG13 ' CG2' ' C' ' 245' ' ' ILE . 40.5 t -56.99 -56.56 14.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -54.5 -21.39 9.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.585 -0.697 . . . . 0.0 109.79 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -75.07 -60.82 2.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.9 p -64.96 -27.58 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 109.684 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' C' ' 300' ' ' VAL . 26.8 t -43.74 -57.2 3.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.124 -0.985 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -51.71 -24.09 5.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 108.914 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' C' ' 300' ' ' VAL . 89.1 m-20 -99.55 91.39 4.87 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -75.95 -84.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.558 -1.339 . . . . 0.0 109.218 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' C' ' 313' ' ' ILE . 80.2 m-85 -66.59 124.93 24.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 0.0 110.193 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 79.8 mt -125.04 139.78 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.42 -0.8 . . . . 0.0 109.305 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -64.62 129.91 41.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.24 -0.913 . . . . 0.0 109.741 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 87.8 t80 -137.31 171.41 14.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 0.0 110.713 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.561 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 31.7 ttmt -32.35 -71.18 0.06 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.115 0.483 . . . . 0.0 111.265 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.16 -71.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.49 -166.36 2.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.854 . . . . 0.0 109.079 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -56.37 157.97 4.61 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.159 -0.963 . . . . 0.0 109.365 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.513 ' O ' ' CG1' ' C' ' 313' ' ' ILE . 2.1 pt -131.85 121.77 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.26 106.9 7.01 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.2 -0.938 . . . . 0.0 110.02 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.696 ' CG2' HD12 ' C' ' 245' ' ' ILE . 2.8 mm -79.71 154.0 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.047 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -157.27 157.49 34.32 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.836 -1.165 . . . . 0.0 109.01 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -67.65 143.88 55.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.668 -1.27 . . . . 0.0 109.254 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -84.92 44.7 1.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.006 -1.059 . . . . 0.0 109.939 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' C' ' 320' ' ' PRO . 0.3 OUTLIER -127.31 55.25 14.75 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.864 . . . . 0.0 109.761 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 319' ' ' GLU . 54.1 Cg_endo -70.95 -63.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.873 2.382 . . . . 0.0 112.393 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -104.99 0.75 28.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.467 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.558 -179.474 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.761 " H4'" ' NH1' ' C' ' 284' ' ' ARG . . . . . . . . 0 O4'--C1' 1.439 2.079 1 C5'-C4'-C3' 107.807 -5.129 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.884 " H4'" ' CE1' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.444 2.519 1 C5'-C4'-C3' 108.327 -4.782 . 0.616 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 0.607 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 P--O5' 1.613 2.033 1 C5'-C4'-C3' 108.666 -4.556 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.712 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.445 2.571 1 C5'-C4'-C3' 107.442 -5.372 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.69 ' N3 ' ' O ' ' C' ' 201' ' ' GLY . . . . . . . . 0 O4'--C4' 1.421 -2.66 2 C3'-C2'-C1' 105.701 4.668 . 0.754 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 1.034 " H4'" " C5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.432 -1.773 1 C5'-C4'-C3' 108.535 -4.643 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 1.034 " C5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.616 2.301 1 C5'-C4'-C3' 107.232 -5.512 . 0.214 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.569 " O2'" " O5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.444 2.535 1 C5'-C4'-C3' 106.118 -6.255 . 0.621 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.764 ' N3 ' ' CE1' ' B' ' 71' ' ' PHE . . . . . . . . 0 C2'--C1' 1.498 -3.009 3 O4'-C1'-N19 116.428 8.228 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 1.142 " H5'" ' CE1' ' B' ' 71' ' ' PHE . . . . . . . . 0 P--O5' 1.627 3.386 0 O5'-C5'-C4' 115.605 3.86 . 0.021 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.893 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.614 2.066 2 C5'-C4'-C3' 108.244 -4.837 . 0.719 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.816 " O2'" ' H6 ' ' A' ' 13' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.431 -1.837 1 C5'-C4'-C3' 106.054 -6.297 . 0.523 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.816 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.439 2.053 1 C5'-C4'-C3' 107.585 -5.277 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.423 HD22 ' HB2' ' B' ' 101' ' ' TYR . 4.9 m120 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.512 ' CB ' ' CD ' ' B' ' 24' ' ' PRO . 26.5 Cg_exo -57.92 -172.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.881 2.387 . . . . 0.0 111.877 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.543 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 52.4 Cg_endo -89.32 23.4 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.02 2.48 . . . . 0.0 112.163 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.29 120.59 5.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.101 -1.0 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.49 ' N ' ' OG ' ' B' ' 80' ' ' SER . 4.3 ttt85 -179.28 -45.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.59 HG11 ' O ' ' B' ' 102' ' ' SER . 2.0 p -139.0 158.61 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.081 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.587 HG13 HD13 ' B' ' 72' ' ' ILE . 7.1 p -120.98 142.16 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.74 ' CZ ' ' C2 ' ' A' ' 9' ' ' ' A' . 2.9 m-30 -105.32 141.48 36.75 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.512 ' O ' ' P ' ' A' ' 10' ' ' ' U' . 7.0 mt -129.26 117.21 20.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.478 -0.764 . . . . 0.0 110.562 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.52 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -132.95 -23.54 0.77 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.652 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m -91.65 71.79 5.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.847 -1.384 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.577 HD12 ' N ' ' B' ' 33' ' ' ILE . 1.2 mp -145.74 125.18 6.81 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 109.829 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.585 ' C ' ' H ' ' B' ' 36' ' ' ASP . 29.7 Cg_endo -73.83 163.0 38.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.07 1.18 . . . . 0.0 109.935 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.451 ' OH ' ' CB ' ' B' ' 59' ' ' PHE . 4.7 m-85 -55.71 3.45 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 109.887 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' B' ' 34' ' ' PRO . 85.5 m-20 -66.17 -45.03 82.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.905 -1.122 . . . . 0.0 109.575 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.4 107.52 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -102.45 -153.25 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.466 -0.771 . . . . 0.0 111.53 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.43 ' N ' ' SD ' ' B' ' 57' ' ' MET . 1.1 pp20? -58.2 -23.69 56.51 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.057 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.69 -54.7 12.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.803 . . . . 0.0 109.941 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.37 -38.76 88.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 110.845 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' B' ' 30' ' ' LEU . 24.7 mm -60.2 -51.53 71.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.8 -37.31 73.53 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.495 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 24.0 t70 -55.73 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.909 1.338 . . . . 0.0 109.377 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.637 HD21 ' CE2' ' B' ' 90' ' ' TYR . 14.4 tp -52.1 -48.84 64.54 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.417 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.616 ' O ' ' N ' ' B' ' 49' ' ' VAL . 94.9 m -60.26 -68.07 0.33 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.138 -0.976 . . . . 0.0 109.044 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.502 ' C ' ' H ' ' B' ' 49' ' ' VAL . 85.1 p -31.72 -33.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.979 0.419 . . . . 0.0 110.576 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' B' ' 46' ' ' CYS . 72.9 m-80 -67.25 5.73 0.68 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.948 -1.095 . . . . 0.0 109.234 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 1.048 HG11 ' HB2' ' B' ' 83' ' ' ALA . 65.9 t -111.67 -55.06 4.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' B' ' 52' ' ' VAL . . . 174.63 154.24 10.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 52' ' ' VAL . 51.4 Cg_exo -44.76 80.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.308 2.006 . . . . 0.0 112.194 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' B' ' 50' ' ' GLY . 0.8 OUTLIER -39.37 157.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.828 . . . . 0.0 109.61 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' B' ' 75' ' ' ARG . 16.7 mm -87.56 -60.76 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 110.193 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.588 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 73.7 m-20 -119.86 126.12 50.18 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.104 -177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -125.35 126.37 44.93 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -140.81 118.63 11.75 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.017 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.543 ' O ' ' N6 ' ' A' ' 12' ' ' ' A' . 0.1 OUTLIER -113.41 143.81 43.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.255 0.55 . . . . 0.0 109.901 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 0.616 ' CE ' ' C8 ' ' A' ' 11' ' ' ' A' . 0.0 OUTLIER -161.54 157.18 24.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.603 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -129.88 149.24 51.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.517 ' HB3' ' N ' ' B' ' 66' ' ' SER . 4.7 p30 -42.87 98.04 0.16 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 111.383 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' B' ' 59' ' ' PHE . 42.3 Cg_endo -92.5 -17.58 0.83 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 122.807 2.338 . . . . 0.0 111.54 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -87.42 -65.93 0.96 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.765 . . . . 0.0 111.267 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 -34.71 9.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.181 -0.949 . . . . 0.0 111.367 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.465 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 108.07 30.41 3.94 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.043 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.461 ' C ' ' OD2' ' B' ' 60' ' ' ASP . 81.1 mtp180 -93.88 -71.0 0.68 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.297 . . . . 0.0 110.3 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' B' ' 60' ' ' ASP . 25.8 t -43.68 121.92 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -86.86 5.32 37.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.184 -0.948 . . . . 0.0 109.024 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.21 88.89 0.1 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 0.772 ' CG ' ' OP2' ' A' ' 10' ' ' ' U' . 1.9 m-85 -105.7 133.33 50.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.53 -0.983 . . . . 0.0 109.782 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.597 ' N ' ' OP1' ' A' ' 10' ' ' ' U' . . . -149.84 146.03 26.9 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.947 -1.095 . . . . 0.0 112.536 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 1.142 ' CE1' " H5'" ' A' ' 10' ' ' ' U' . 10.4 m-85 -114.51 130.11 56.72 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.705 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.929 HD12 ' N ' ' B' ' 72' ' ' ILE . 1.1 mp -121.93 102.33 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.35 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.588 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 29.4 mt-10 -93.05 136.71 33.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.252 -1.53 . . . . 0.0 110.244 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -98.32 176.53 5.67 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.853 0.835 . . . . 0.0 111.366 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 5.5 ttp180 -48.3 -42.01 29.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.858 -0.526 . . . . 0.0 111.42 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' B' ' 78' ' ' GLU . 3.5 m-20 156.62 -175.93 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.729 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.5 mm? -37.48 -23.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 110.655 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.8 mm-40 -70.24 -75.98 0.11 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.862 -1.149 . . . . 0.0 109.822 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 52.0 m -63.54 -40.59 97.41 Favored 'General case' 0 C--O 1.195 -1.785 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' B' ' 26' ' ' ARG . 25.7 t -58.92 -34.9 72.25 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -65.87 -61.29 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.676 -1.265 . . . . 0.0 109.031 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.602 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 22.0 t -60.21 -42.56 95.42 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.27 -0.894 . . . . 0.0 111.395 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 1.048 ' HB2' HG11 ' B' ' 49' ' ' VAL . . . -76.54 -65.66 0.9 Allowed 'General case' 0 C--N 1.292 -1.913 0 O-C-N 121.551 -0.718 . . . . 0.0 111.771 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -52.94 -37.84 27.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 118.296 -1.362 . . . . 0.0 109.212 -176.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.416 ' HA ' HD22 ' B' ' 88' ' ' ASN . 71.7 mtp85 -67.87 -47.47 68.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.365 -1.459 . . . . 0.0 108.382 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' B' ' 82' ' ' SER . 91.2 m-20 -67.5 -42.74 82.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.056 -1.028 . . . . 0.0 109.27 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.484 HD11 HG21 ' B' ' 49' ' ' VAL . 7.3 mt -106.35 28.72 7.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.333 -0.855 . . . . 0.0 110.084 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.69 ' O ' HD13 ' B' ' 97' ' ' LEU . 1.2 m-20 -61.51 -79.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.82 -1.175 . . . . 0.0 109.188 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.68 107.77 0.86 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 1.051 ' CE1' HD11 ' B' ' 97' ' ' LEU . 0.0 OUTLIER -134.1 148.81 51.05 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 119.677 1.739 . . . . 0.0 110.917 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -46.25 91.59 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 119.876 -1.765 . . . . 0.0 108.456 -179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' B' ' 90' ' ' TYR . 6.1 tt -153.2 104.81 2.83 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.85 -175.39 43.47 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 20.9 m -67.12 -27.36 67.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.248 . . . . 0.0 109.617 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 61.8 mtt85 -135.95 163.95 29.09 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.453 ' O ' ' C ' ' B' ' 97' ' ' LEU . 2.3 m-85 -92.69 133.99 35.47 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.31 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 1.051 HD11 ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -38.94 152.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.263 0.554 . . . . 0.0 109.562 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -108.46 146.84 32.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 109.268 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . 0.571 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.0 OUTLIER -91.9 124.78 36.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 109.781 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' B' ' 29' ' ' TYR . . . -137.17 -175.5 13.85 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.375 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' B' ' 102' ' ' SER . 4.3 p90 -120.82 6.15 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -1.051 . . . . 0.0 110.562 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.59 ' O ' HG11 ' B' ' 27' ' ' VAL . 0.6 OUTLIER -39.92 125.05 1.87 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.147 -0.971 . . . . 0.0 109.913 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 41.4 t -174.7 79.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.241 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -106.67 122.34 46.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 109.429 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.412 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 15.4 pttp . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -99.8 125.89 45.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.368 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m -134.95 150.01 50.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.563 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' C' ' 207' ' ' PHE . 1.0 OUTLIER -175.41 39.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.425 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 15.0 tttt -100.4 102.89 14.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.6 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . 0.554 ' SD ' HG11 ' C' ' 216' ' ' VAL . 71.3 mtp -87.23 133.04 33.71 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.701 -1.199 . . . . 0.0 111.144 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.677 ' CZ ' ' C8 ' ' A' ' 6' ' ' ' A' . 76.9 t80 -104.77 90.69 3.56 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.557 ' HB ' HD11 ' C' ' 166' ' ' LEU . 5.6 mm -59.99 127.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . 0.438 ' HA2' ' C4 ' ' A' ' 5' ' ' ' U' . . . -130.34 -177.2 14.75 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.687 ' N ' ' O4 ' ' A' ' 5' ' ' ' U' . . . 42.84 41.1 4.33 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' C' ' 163' ' ' ILE . 13.5 mt -83.96 170.84 13.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.431 -1.041 . . . . 0.0 109.725 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.478 ' O ' ' OD1' ' C' ' 167' ' ' ASN . 39.9 p-10 -85.45 140.21 30.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.712 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 2.1 m0 -48.95 -27.85 3.43 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.676 -1.265 . . . . 0.0 110.018 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . 0.444 ' O ' ' ND2' ' C' ' 167' ' ' ASN . 58.3 t0 -90.49 102.43 15.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.978 -1.076 . . . . 0.0 110.988 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 33.0 m -147.2 144.51 28.98 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.46 173.5 6.38 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.222 -0.924 . . . . 0.0 109.142 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . 0.467 ' OE2' ' NZ ' ' C' ' 192' ' ' LYS . 11.5 mp0 -84.18 -77.04 0.28 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.799 -1.188 . . . . 0.0 109.587 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' C' ' 176' ' ' ARG . 49.5 t0 -49.08 -55.45 12.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.629 -1.295 . . . . 0.0 108.388 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' C' ' 173' ' ' ASP . 64.2 t30 -43.23 -53.18 5.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.93 -35.19 70.75 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.215 -0.928 . . . . 0.0 108.994 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' C' ' 178' ' ' TYR . 67.5 ttp85 -70.98 -63.52 1.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 108.904 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' C' ' 176' ' ' ARG . 77.3 mm-40 -43.78 -25.91 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.563 ' CE2' HD23 ' C' ' 223' ' ' LEU . 34.1 t80 -76.37 -47.05 24.69 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.557 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 176' ' ' ARG . 26.2 m-85 -95.7 15.85 18.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.257 -0.902 . . . . 0.0 111.655 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.17 14.44 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -106.13 9.73 32.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -1.077 . . . . 0.0 108.228 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 19.8 m-85 -121.61 -4.25 9.27 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 144.12 -134.69 5.86 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -126.69 145.65 50.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -1.041 . . . . 0.0 109.297 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' C' ' 188' ' ' LEU . 0.6 OUTLIER -99.76 134.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.413 ' N ' ' O ' ' C' ' 206' ' ' SER . 0.1 OUTLIER -78.52 -61.47 2.0 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.124 -0.985 . . . . 0.0 110.985 -178.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . 0.589 ' OD2' ' NZ ' ' C' ' 189' ' ' LYS . 0.3 OUTLIER -121.22 84.79 2.29 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.329 1.061 . . . . 0.0 112.021 -178.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.71 ' O ' HD23 ' C' ' 188' ' ' LEU . 7.1 tt -81.28 107.03 13.73 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . 0.589 ' NZ ' ' OD2' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -121.31 96.13 4.96 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.22 -0.925 . . . . 0.0 110.893 -179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . 0.562 ' O ' ' SD ' ' C' ' 191' ' ' MET . 0.0 OUTLIER -107.8 141.13 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . 0.562 ' SD ' ' O ' ' C' ' 190' ' ' ILE . 10.7 mmt -125.33 78.99 1.77 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.059 -1.026 . . . . 0.0 110.647 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . 0.467 ' NZ ' ' OE2' ' C' ' 172' ' ' GLU . 26.1 pttm -79.52 153.77 29.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.107 -0.995 . . . . 0.0 109.305 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' C' ' 197' ' ' GLY . 11.9 t0 -52.68 114.69 6.05 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.038 -1.039 . . . . 0.0 108.699 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.01 -21.54 4.02 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.827 1.685 . . . . 0.0 112.661 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -80.18 -86.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.24 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 45.5 p -109.35 -28.63 8.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.212 -0.93 . . . . 0.0 109.677 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . 0.527 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 122.28 17.63 3.59 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -90.79 58.47 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.072 -1.252 . . . . 0.0 109.519 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . 0.477 ' O ' ' C ' ' C' ' 200' ' ' ARG . 39.4 t -142.99 169.83 16.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' C' ' 199' ' ' SER . 19.3 mmt180 -37.06 102.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . 0.69 ' O ' ' N3 ' ' A' ' 5' ' ' ' U' . . . -94.92 92.29 1.49 Allowed Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.302 -1.427 . . . . 0.0 109.861 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.458 ' HB2' ' CE1' ' C' ' 162' ' ' PHE . 48.5 p90 -125.9 155.65 40.92 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.512 -0.993 . . . . 0.0 108.611 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -127.93 123.11 4.34 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.957 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -93.25 86.44 5.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.843 -1.387 . . . . 0.0 107.981 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.433 HD12 HD11 ' C' ' 163' ' ' ILE . 33.2 mt -87.49 85.27 7.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.727 -1.233 . . . . 0.0 110.321 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . 0.553 ' CB ' ' H ' ' C' ' 187' ' ' ASP . 0.1 OUTLIER -65.47 85.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.596 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.527 ' O ' ' SG ' ' C' ' 159' ' ' CYS . 14.5 m-85 -68.08 122.3 17.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.155 -0.966 . . . . 0.0 110.917 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.87 -50.32 36.44 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.788 -0.57 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -83.56 115.19 58.22 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 110.86 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.58 -38.22 44.53 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.186 1.924 . . . . 0.0 112.799 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 86.1 p -64.53 -49.95 69.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.854 ' O ' HG23 ' C' ' 216' ' ' VAL . 22.6 t -43.56 -33.21 1.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 109.224 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.17 -40.44 85.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.168 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' C' ' 211' ' ' SER . 57.6 t0 -59.68 -51.14 71.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.505 -0.747 . . . . 0.0 110.665 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' C' ' 219' ' ' THR . 5.5 pt-20 -68.17 -33.37 74.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.854 HG23 ' O ' ' C' ' 212' ' ' SER . 55.8 t -58.97 -47.99 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.009 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.441 HG12 ' O ' ' C' ' 214' ' ' ASP . 8.8 p -71.48 -30.04 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.1 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -89.71 21.53 3.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 109.742 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . 0.578 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 41.3 m -129.82 149.43 51.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . 0.583 ' O ' ' CG ' ' C' ' 221' ' ' HIS . 13.1 tt0 -75.92 -177.85 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.125 -0.985 . . . . 0.0 109.392 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.781 ' HB3' HD11 ' C' ' 228' ' ' ILE . 55.3 m-70 -158.28 130.52 6.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.495 -0.753 . . . . 0.0 110.3 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.517 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 24.6 mt -153.35 80.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.344 -0.847 . . . . 0.0 108.737 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.563 HD23 ' CE2' ' C' ' 178' ' ' TYR . 16.5 mt -51.43 -71.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.735 -1.228 . . . . 0.0 109.54 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -101.51 -55.77 2.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 108.855 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 159.9 30.9 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . 0.911 ' NZ ' HG23 ' C' ' 280' ' ' THR . 0.0 OUTLIER -94.1 -76.88 0.47 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.107 -1.231 . . . . 0.0 108.601 178.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . 0.865 HG23 ' O ' ' C' ' 226' ' ' LYS . 2.1 t 155.39 90.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' C' ' 221' ' ' HIS . 23.2 pt -94.2 152.05 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.325 -0.859 . . . . 0.0 110.143 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.34 96.41 44.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.543 -0.723 . . . . 0.0 110.768 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.508 ' CG ' ' CD2' ' C' ' 221' ' ' HIS . 18.9 Cg_endo -81.82 121.51 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.709 2.273 . . . . 0.0 111.645 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -142.52 148.26 37.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.061 -1.024 . . . . 0.0 110.127 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -50.52 159.36 0.51 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.346 -0.846 . . . . 0.0 109.725 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' C' ' 160' ' ' LYS . . . -57.5 144.28 37.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . 0.402 HG22 ' N ' ' C' ' 239' ' ' GLN . 38.4 mt -132.6 91.15 31.07 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.486 -0.759 . . . . 0.0 109.418 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -43.42 161.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.11 1.873 . . . . 0.0 111.742 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.665 ' NH2' ' P ' ' A' ' 6' ' ' ' A' . 0.0 OUTLIER -51.57 -49.2 62.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.975 . . . . 0.0 111.312 -178.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -59.66 -43.28 94.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.845 -1.159 . . . . 0.0 109.824 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -68.36 -36.91 79.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.131 -0.98 . . . . 0.0 110.001 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.402 ' N ' HG22 ' C' ' 234' ' ' ILE . 35.0 tt0 -61.17 -41.46 96.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.171 -0.956 . . . . 0.0 108.838 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . 0.438 ' HB2' HH21 ' C' ' 321' ' ' ARG . 22.9 t70 -83.3 -25.03 31.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.473 -0.767 . . . . 0.0 109.599 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -51.2 -16.11 0.45 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.592 -0.692 . . . . 0.0 110.432 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . . . . . . . . . 13.9 p -106.38 159.69 15.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.918 -1.113 . . . . 0.0 109.231 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -115.41 154.87 16.67 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . 0.569 ' N ' HH12 ' C' ' 317' ' ' ARG . 0.0 OUTLIER -140.05 147.28 40.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.268 . . . . 0.0 111.235 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.642 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -129.68 154.44 40.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.729 0.776 . . . . 0.0 109.142 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.635 ' CD2' ' N3 ' ' A' ' 2' ' ' ' A' . 2.0 t80 -102.19 128.19 48.81 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.75 143.64 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.799 . . . . 0.0 110.368 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.9 154.21 16.47 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.0 56.26 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 120.939 -1.33 . . . . 0.0 111.209 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' C' ' 286' ' ' PHE . 1.5 pp -111.26 137.69 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.903 -1.351 . . . . 0.0 109.497 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . 0.657 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 157.81 -37.8 0.54 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 50.0 Cg_exo -54.06 -127.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.512 2.142 . . . . 0.0 112.22 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -69.86 19.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 109.681 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' C' ' 252' ' ' PRO . 1.3 m -93.19 137.3 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.918 -1.114 . . . . 0.0 109.588 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.633 ' CD ' ' N ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -103.45 163.07 18.19 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . 0.477 ' HB3' HD22 ' C' ' 274' ' ' LEU . 29.6 Cg_endo -63.59 -21.43 70.41 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.46 2.107 . . . . 0.0 111.372 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -62.25 -58.57 7.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.499 -0.751 . . . . 0.0 109.655 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.59 -41.72 86.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . 0.461 ' CE1' ' CE1' ' C' ' 263' ' ' PHE . 29.0 t80 -52.6 -63.18 1.23 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.93 -43.43 98.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.911 -0.493 . . . . 0.0 110.28 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.97 -18.83 64.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.093 -1.005 . . . . 0.0 108.979 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . 0.606 ' O ' ' NE2' ' C' ' 265' ' ' GLN . 33.8 t80 -88.95 -77.75 0.37 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.234 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.575 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 43.2 m-85 -43.5 -36.26 1.97 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.928 -1.107 . . . . 0.0 109.494 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.499 ' C ' ' O ' ' C' ' 263' ' ' PHE . 1.8 t -30.72 -40.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.325 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.635 ' CG ' ' H ' ' C' ' 266' ' ' TRP . 0.0 OUTLIER -60.76 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.429 -1.419 . . . . 0.0 110.981 -178.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.635 ' H ' ' CG ' ' C' ' 265' ' ' GLN . 0.2 OUTLIER -60.15 147.83 38.26 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.397 -1.439 . . . . 0.0 109.402 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' C' ' 269' ' ' ILE . . . 58.91 86.13 0.03 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . 0.506 ' O ' ' C ' ' C' ' 269' ' ' ILE . 3.8 t -53.59 43.69 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.483 -1.01 . . . . 0.0 113.625 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.773 HD11 ' HB ' ' C' ' 289' ' ' VAL . 1.7 tt -13.77 111.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.9 mm -87.2 -33.95 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.439 -1.413 . . . . 0.0 107.81 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.04 99.1 5.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' C' ' 269' ' ' ILE . . . -108.32 132.78 53.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.321 -0.862 . . . . 0.0 109.371 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -160.59 123.56 3.34 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 117.919 -1.512 . . . . 0.0 112.081 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.961 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.2 OUTLIER -100.63 155.08 18.08 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' C' ' 280' ' ' THR . 20.8 mmt -90.08 161.24 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.398 . . . . 0.0 109.619 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' C' ' 280' ' ' THR . 1.0 OUTLIER -126.62 -165.41 1.45 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.494 0.664 . . . . 0.0 109.689 -179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' C' ' 277' ' ' ASP . 53.5 p30 -97.98 -9.97 25.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.448 -0.782 . . . . 0.0 109.339 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . 0.504 ' HG2' HD23 ' C' ' 276' ' ' LEU . 49.9 mmtt -60.6 -54.6 43.38 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . 0.806 ' N ' ' HZ1' ' C' ' 226' ' ' LYS . 0.2 OUTLIER 177.51 -6.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.598 -0.689 . . . . 0.0 110.895 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . 0.911 HG23 ' NZ ' ' C' ' 226' ' ' LYS . 42.8 p -64.88 -3.14 3.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.446 -1.409 . . . . 0.0 108.708 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' C' ' 279' ' ' ASP . . . 155.04 -119.48 0.93 Allowed Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.583 ' C ' ' H ' ' C' ' 284' ' ' ARG . 55.9 mt-30 -147.1 129.09 15.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -1.143 . . . . 0.0 109.881 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 51.5 p -66.01 15.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 109.518 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . 0.761 ' NH1' " H4'" ' A' ' 1' ' ' ' U' . 10.1 tpp85 -49.86 -38.15 34.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.86 70.52 0.06 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.448 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.884 ' CE1' " H4'" ' A' ' 2' ' ' ' A' . 22.3 p90 -170.58 179.31 3.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.34 . . . . 0.0 110.173 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -174.21 -167.48 33.79 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . 0.421 ' CZ ' ' H2 ' ' A' ' 2' ' ' ' A' . 1.4 m-85 -143.9 154.51 43.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.471 -1.605 . . . . 0.0 109.465 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . 0.773 ' HB ' HD11 ' C' ' 269' ' ' ILE . 0.7 OUTLIER -141.55 152.82 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 11.0 m -133.57 126.75 31.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.968 -1.083 . . . . 0.0 110.497 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . 0.46 ' CE2' ' CG2' ' C' ' 289' ' ' VAL . 49.8 m-85 -113.15 143.71 43.9 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.37 -50.84 71.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.298 -1.501 . . . . 0.0 109.064 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . . . . . . . . . 16.6 t -91.29 171.19 9.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.836 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' C' ' 297' ' ' VAL . . . -105.29 -20.03 13.62 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 294' ' ' ALA . 91.5 m-20 -47.05 -39.63 13.28 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.43 -33.6 72.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' C' ' 294' ' ' ALA . 60.4 t -69.86 -63.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -52.06 -18.29 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.027 -1.046 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' C' ' 297' ' ' VAL . 1.7 ttt85 -78.37 -57.39 3.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.485 -0.759 . . . . 0.0 109.004 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' C' ' 303' ' ' ASN . 3.3 p -65.76 -25.97 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . 0.437 ' C ' ' N ' ' C' ' 303' ' ' ASN . 33.5 m -44.77 -58.83 2.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.863 -1.148 . . . . 0.0 109.005 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' C' ' 301' ' ' CYS . 26.3 mt-30 -47.19 -23.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.083 -1.011 . . . . 0.0 108.394 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' C' ' 300' ' ' VAL . 97.1 m-20 -100.16 70.75 1.56 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -68.93 -9.28 51.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 109.53 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' C' ' 314' ' ' GLU . 45.3 m-85 -137.53 122.26 18.69 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.163 -0.961 . . . . 0.0 108.832 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . 0.407 HD11 ' CG2' ' C' ' 300' ' ' VAL . 54.2 mt -121.65 145.85 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.889 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -79.46 120.12 23.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 108.519 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.641 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 73.5 t80 -120.03 -179.1 3.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 110.126 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.641 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 33.0 ttpt -43.61 -30.13 0.57 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . 0.562 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 46.1 t0 -86.25 -154.23 0.21 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . 0.562 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 35.7 ptt180 -79.0 -48.11 15.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 109.041 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . 0.505 ' N ' ' CG ' ' C' ' 311' ' ' ARG . 6.5 ttmt -165.72 155.31 12.34 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' C' ' 250' ' ' ILE . 37.3 pt -131.2 157.68 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . 0.411 ' HG3' ' CE2' ' C' ' 305' ' ' PHE . 8.4 mp0 -110.43 152.54 26.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.959 . . . . 0.0 109.83 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.642 ' CG2' HD12 ' C' ' 245' ' ' ILE . 6.7 mm -119.38 142.26 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -145.93 144.23 30.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.192 -0.942 . . . . 0.0 108.859 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . 0.569 HH12 ' N ' ' C' ' 244' ' ' LYS . 20.9 tpt180 -70.64 135.51 48.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 319' ' ' GLU . . . -60.9 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' C' ' 317' ' ' ARG . 0.6 OUTLIER -44.64 -51.11 22.34 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.956 -1.09 . . . . 0.0 109.432 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' C' ' 319' ' ' GLU . 17.3 Cg_exo -64.35 135.8 48.07 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.887 1.725 . . . . 0.0 111.588 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . 0.438 HH21 ' HB2' ' C' ' 240' ' ' ASP . 80.2 ttt-85 -58.45 -38.33 77.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -0.966 . . . . 0.0 109.681 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 45.2 m80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.578 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.866 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.93 1 C5'-C4'-C3' 107.488 -5.342 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.866 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.437 1.889 2 C5'-C4'-C3' 107.291 -5.473 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 0.681 " O2'" " H4'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 P--O5' 1.61 1.67 1 C5'-C4'-C3' 105.886 -6.409 . 0.69 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.836 ' C6 ' ' CD1' ' C' ' 168' ' ' TRP . . . . . . . . 0 C2'--O2' 1.432 1.468 2 O4'-C1'-N19 113.325 5.125 . 0.069 2u . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.754 ' C2 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 O4'--C1' 1.446 2.676 1 C5'-C4'-C3' 108.748 -4.502 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 0.744 ' C5 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 P--O5' 1.616 2.327 1 C5'-C4'-C3' 107.07 -5.62 OUTLIER-EPSILON 0.644 1b . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 0.763 ' N3 ' ' CG ' ' C' ' 202' ' ' PHE . . . . . . . . 0 O4'--C1' 1.442 2.328 1 C5'-C4'-C3' 107.509 -5.327 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.723 " H4'" ' NH1' ' B' ' 95' ' ' ARG . . . . . . . . 0 O4'--C1' 1.439 2.112 2 C3'-C2'-C1' 105.638 4.598 . 0.01 6p . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 1.008 H5'' ' OH ' ' B' ' 69' ' ' TYR . . . . . . . . 0 P--O5' 1.613 2.044 2 O4'-C1'-N19 112.858 4.658 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 0.947 " H2'" ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.443 2.381 1 C5'-C4'-C3' 108.903 -4.398 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.947 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.442 2.309 1 C5'-C4'-C3' 106.131 -6.246 . 0.73 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.868 " H4'" ' NE ' ' C' ' 321' ' ' ARG . . . . . . . . 0 O4'--C4' 1.43 -1.918 1 C5'-C4'-C3' 106.961 -5.693 . 0.697 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.823 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.438 2.01 1 C5'-C4'-C3' 107.69 -5.206 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' B' ' 102' ' ' SER . 2.0 m120 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' B' ' 22' ' ' ASN . 23.4 Cg_endo -65.34 147.03 87.2 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.46 2.107 . . . . 0.0 111.899 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.25 3.47 5.71 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.486 2.124 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.92 130.14 8.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.955 -1.091 . . . . 0.0 109.409 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.54 ' NH1' ' OD1' ' B' ' 76' ' ' ASP . 4.6 ttt85 -176.51 -33.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -0.793 . . . . 0.0 109.249 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.69 HG12 ' H ' ' B' ' 102' ' ' SER . 1.6 p -140.85 165.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 2.1 t -124.9 144.64 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.723 ' CE1' ' C2 ' ' A' ' 9' ' ' ' A' . 5.7 m-85 -111.53 130.91 55.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.251 -0.906 . . . . 0.0 109.465 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.736 HD13 ' CD1' ' B' ' 72' ' ' ILE . 8.5 mp -115.98 105.33 12.52 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -103.21 -72.54 0.92 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.887 -1.149 . . . . 0.0 112.113 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.467 ' HG ' ' CB ' ' B' ' 94' ' ' SER . 8.5 t -68.85 86.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.332 . . . . 0.0 110.338 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' B' ' 30' ' ' LEU . 3.1 mp -147.38 126.09 6.23 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.73 165.96 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.721 1.614 . . . . 0.0 112.836 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' B' ' 35' ' ' TYR . 0.3 OUTLIER -70.59 1.47 5.17 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.74 -34.28 77.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.455 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -118.77 112.26 19.51 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.103 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 81.5 p -107.2 -142.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.502 0.667 . . . . 0.0 110.891 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.63 -28.36 68.48 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.927 -1.108 . . . . 0.0 110.322 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.59 -53.98 16.24 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.078 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.2 OUTLIER -68.84 -44.5 73.29 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.874 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' B' ' 44' ' ' ASP . 14.2 mm -59.79 -52.65 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.868 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 42' ' ' ILE . 0.7 OUTLIER -38.94 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.809 -0.557 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' B' ' 42' ' ' ILE . 97.4 m-20 -122.54 -23.71 5.11 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.658 -1.276 . . . . 0.0 110.552 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.739 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.0 tm? -59.25 -43.85 92.39 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.16 -1.588 . . . . 0.0 106.922 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.655 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.0 OUTLIER -82.14 -63.23 1.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.189 -0.944 . . . . 0.0 109.289 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.775 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.9 t -37.91 -19.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.655 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.6 OUTLIER -51.81 67.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.441 1.115 . . . . 0.0 110.153 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.775 ' N ' ' O ' ' B' ' 47' ' ' SER . 2.0 p 172.22 -34.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.278 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.66 -173.05 46.01 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -58.46 159.33 20.11 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 123.046 2.498 . . . . 0.0 112.535 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' B' ' 74' ' ' PHE . 20.8 t -129.4 145.96 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.558 HD11 ' HD2' ' B' ' 75' ' ' ARG . 43.3 mm -91.28 -67.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.013 -1.054 . . . . 0.0 111.877 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.538 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 74.7 m-20 -117.72 146.28 43.86 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.079 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.576 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.6 OUTLIER -140.64 129.89 23.67 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.576 ' N ' HD23 ' B' ' 55' ' ' LEU . 8.8 mtmp? -143.29 147.92 35.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.884 -1.135 . . . . 0.0 109.741 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 4.5 ttm -125.92 136.48 53.09 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 0.589 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -155.69 154.97 32.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.874 -1.141 . . . . 0.0 111.105 -179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.589 ' O ' ' SD ' ' B' ' 58' ' ' MET . 3.3 m-85 -111.43 176.4 5.04 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.616 -0.677 . . . . 0.0 110.167 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' B' ' 66' ' ' SER . 40.9 m-20 -114.24 84.9 9.77 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 0.0 110.901 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -60.82 -61.96 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.018 2.478 . . . . 0.0 113.136 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -81.62 -65.7 0.98 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.553 -0.717 . . . . 0.0 111.004 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.431 HG23 ' H ' ' B' ' 63' ' ' THR . 1.3 p -47.96 -45.13 30.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.113 -0.992 . . . . 0.0 109.135 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.92 12.21 81.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.649 ' NH2' ' C5 ' ' A' ' 10' ' ' ' U' . 78.5 mtm180 -59.52 -40.2 86.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.004 -1.292 . . . . 0.0 109.428 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.505 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -174.47 170.97 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.946 -1.096 . . . . 0.0 111.118 179.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' B' ' 69' ' ' TYR . 37.9 mmtm -108.65 -68.09 0.93 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.266 -0.897 . . . . 0.0 110.437 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -60.32 68.56 0.01 OUTLIER Glycine 0 N--CA 1.488 2.138 0 O-C-N 120.595 -1.315 . . . . 0.0 111.571 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 1.008 ' OH ' H5'' ' A' ' 9' ' ' ' A' . 1.2 m-85 -106.96 125.82 51.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.688 -1.478 . . . . 0.0 109.18 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.21 140.0 32.19 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.499 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.803 ' CZ ' " H4'" ' A' ' 10' ' ' ' U' . 4.8 m-30 -106.5 123.56 48.27 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.736 ' CD1' HD13 ' B' ' 30' ' ' LEU . 3.4 mp -118.73 97.3 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.633 -0.667 . . . . 0.0 111.152 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.538 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 83.1 tt0 -84.48 131.06 34.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.437 -1.415 . . . . 0.0 110.583 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' B' ' 52' ' ' VAL . 6.6 m-85 -92.85 178.76 5.67 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.708 0.766 . . . . 0.0 111.056 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.558 ' HD2' HD11 ' B' ' 53' ' ' ILE . 10.4 tpt180 -52.16 -41.74 62.83 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.591 -0.693 . . . . 0.0 111.315 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.8 m-20 159.06 176.86 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.797 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.1 mp -36.63 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.816 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' B' ' 76' ' ' ASP . 50.1 mp0 -70.3 -74.74 0.13 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.389 -1.445 . . . . 0.0 108.459 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -61.78 -39.76 92.81 Favored 'General case' 0 C--O 1.195 -1.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.427 ' OG ' ' C ' ' B' ' 26' ' ' ARG . 0.5 OUTLIER -64.07 -34.56 78.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 109.139 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -60.94 -61.72 2.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.485 -1.384 . . . . 0.0 107.746 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.591 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 23.3 t -62.77 -38.79 91.97 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.621 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.57 -64.83 1.08 Allowed 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.33 -0.856 . . . . 0.0 111.293 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' B' ' 99' ' ' CYS . 28.8 t -48.54 -41.03 11.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 120.655 -1.278 . . . . 0.0 108.538 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.57 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 61.7 ttm-85 -64.58 -49.14 72.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.938 -1.101 . . . . 0.0 109.237 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' B' ' 82' ' ' SER . 86.5 m-20 -76.23 -46.39 28.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.23 -0.919 . . . . 0.0 109.907 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' B' ' 83' ' ' ALA . 3.7 mm? -86.8 15.91 5.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.46 -0.775 . . . . 0.0 110.44 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.576 ' OD1' ' N ' ' B' ' 88' ' ' ASN . 0.5 OUTLIER -53.89 -81.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.685 -1.26 . . . . 0.0 108.258 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.96 116.65 1.61 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -136.93 144.89 43.69 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.369 -1.665 . . . . 0.0 107.667 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 0.0 OUTLIER -34.79 92.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.542 -0.724 . . . . 0.0 111.304 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 90' ' ' TYR . 61.2 tp -154.79 135.44 13.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.695 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.36 -162.39 10.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . 0.467 ' CB ' ' HG ' ' B' ' 32' ' ' SER . 0.9 OUTLIER -88.0 -6.61 57.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.062 -1.257 . . . . 0.0 109.344 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.723 ' NH1' " H4'" ' A' ' 8' ' ' ' A' . 37.8 ttm180 -134.56 160.28 38.55 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.502 ' O ' ' C ' ' B' ' 97' ' ' LEU . 57.1 m-85 -95.81 134.41 38.79 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.431 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.571 HD23 HD11 ' B' ' 30' ' ' LEU . 1.9 mp -31.76 150.19 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.408 ' HG2' ' C4 ' ' A' ' 8' ' ' ' A' . 1.3 mptp? -118.23 144.46 45.75 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . 0.558 ' O ' ' N1 ' ' A' ' 8' ' ' ' A' . 4.8 p -78.94 107.75 11.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.252 -0.905 . . . . 0.0 110.307 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -88.42 171.04 39.59 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.589 ' OH ' ' C6 ' ' A' ' 8' ' ' ' A' . 0.1 OUTLIER -156.15 92.82 1.37 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.1 -1.235 . . . . 0.0 108.066 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.69 ' H ' HG12 ' B' ' 27' ' ' VAL . 0.9 OUTLIER -27.22 98.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.778 0.799 . . . . 0.0 109.992 -178.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.43 ' N ' ' O ' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -133.24 -6.55 3.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.354 -177.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.14 -37.23 71.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.032 . . . . 0.0 109.631 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.439 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' C' ' 157' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' C' ' 156' ' ' LYS . 84.8 tt0 -57.96 -33.58 69.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.878 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 93.1 p -133.85 154.44 51.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.91 . . . . 0.0 109.727 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 6.9 m -78.19 66.67 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 108.742 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 16.3 tttt -108.29 89.41 2.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.551 -0.718 . . . . 0.0 110.418 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . 0.505 ' SD ' ' CG2' ' C' ' 217' ' ' VAL . 14.0 mmm -64.31 140.63 58.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 110.501 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.754 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 5.6 t80 -103.76 132.76 49.71 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.51 ' O ' ' O2 ' ' A' ' 5' ' ' ' U' . 26.7 mm -114.02 128.01 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . 0.425 ' CA ' ' C2 ' ' A' ' 5' ' ' ' U' . . . -131.77 -173.68 13.41 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.347 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.96 22.23 2.87 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.486 -1.845 . . . . 0.0 108.486 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . 0.702 ' O ' ' H8 ' ' A' ' 4' ' ' ' A' . 3.0 mt -61.66 159.0 14.14 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.483 -1.01 . . . . 0.0 109.28 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.544 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 36.4 p-10 -80.31 167.3 20.42 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.174 -0.954 . . . . 0.0 108.851 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.836 ' CD1' ' C6 ' ' A' ' 4' ' ' ' A' . 0.5 OUTLIER -92.76 32.45 1.24 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.63 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -160.16 76.97 0.63 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.099 -1.001 . . . . 0.0 110.332 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . 0.408 ' HG1' ' CG ' ' C' ' 167' ' ' ASN . 84.7 m -150.7 147.46 27.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.961 -1.087 . . . . 0.0 110.078 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . 0.554 ' OG1' ' ND2' ' C' ' 174' ' ' ASN . 0.2 OUTLIER -106.13 172.51 6.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -69.66 -66.9 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.747 -1.221 . . . . 0.0 109.502 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' C' ' 172' ' ' GLU . 57.4 t0 -43.94 -33.37 1.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.084 -1.01 . . . . 0.0 109.232 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . 0.554 ' ND2' ' OG1' ' C' ' 171' ' ' THR . 87.2 m-20 -74.93 -49.49 20.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.125 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.57 -46.36 84.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.2 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . 0.559 ' CD ' HG11 ' C' ' 185' ' ' VAL . 21.9 ttp85 -63.23 -60.64 3.13 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.806 -1.184 . . . . 0.0 107.932 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' C' ' 176' ' ' ARG . 47.4 tp10 -41.94 -30.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.57 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 23.7 t80 -70.84 -53.85 13.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.038 -1.039 . . . . 0.0 108.826 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.81 ' O ' ' N ' ' C' ' 181' ' ' LYS . 72.5 m-85 -75.27 -62.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.35 -0.844 . . . . 0.0 110.192 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -41.61 2.79 0.01 OUTLIER Glycine 0 N--CA 1.503 3.154 0 O-C-N 120.555 -1.341 . . . . 0.0 112.381 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . 0.81 ' N ' ' O ' ' C' ' 179' ' ' PHE . 38.8 tttt -73.96 -15.1 61.12 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -77.46 -58.46 3.26 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.475 0.655 . . . . 0.0 110.017 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -156.61 -104.9 0.22 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 47.6 m -127.83 147.19 50.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.511 -0.994 . . . . 0.0 109.569 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.559 HG11 ' CD ' ' C' ' 176' ' ' ARG . 14.7 p -126.5 144.42 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' C' ' 208' ' ' GLU . 0.2 OUTLIER -91.06 -58.3 2.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.176 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' C' ' 206' ' ' SER . 43.8 t0 -156.86 160.76 39.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.491 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.814 HD23 ' H ' ' C' ' 188' ' ' LEU . 1.7 pt? -146.09 143.89 29.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.92 85.62 2.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.012 -1.055 . . . . 0.0 109.234 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.8 156.25 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . 0.448 ' CB ' ' CZ ' ' C' ' 202' ' ' PHE . 6.3 tpp -142.31 55.84 1.45 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.022 -1.049 . . . . 0.0 110.486 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.74 117.5 15.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 108.887 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' C' ' 197' ' ' GLY . 0.5 OUTLIER -135.42 80.36 45.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.383 -0.823 . . . . 0.0 109.906 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -57.16 -18.12 28.23 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.439 2.092 . . . . 0.0 110.914 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.72 ' O ' HG23 ' C' ' 196' ' ' THR . . . -65.5 -38.42 89.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . 0.72 HG23 ' O ' ' C' ' 195' ' ' ALA . 5.8 p -165.81 -32.07 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.467 -0.771 . . . . 0.0 109.586 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 193' ' ' ASP . . . -102.64 100.31 1.95 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.398 -1.382 . . . . 0.0 109.842 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -103.26 133.77 47.78 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.453 -1.028 . . . . 0.0 109.557 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . 0.629 ' O ' ' N1 ' ' A' ' 4' ' ' ' A' . 2.7 m -156.78 151.62 25.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 109.306 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.588 ' C ' ' O ' ' C' ' 199' ' ' SER . 94.0 mtt-85 -24.97 132.34 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . 0.446 ' HA3' ' C5 ' ' A' ' 4' ' ' ' A' . . . -80.9 120.58 5.18 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.151 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.763 ' CG ' ' N3 ' ' A' ' 7' ' ' ' U' . 50.8 p90 -165.03 164.66 20.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -140.86 125.5 2.85 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.582 -1.771 . . . . 0.0 110.41 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . 0.75 ' CE2' ' H5 ' ' A' ' 7' ' ' ' U' . 3.7 m-85 -89.98 65.65 6.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' C' ' 207' ' ' PHE . 0.7 OUTLIER -64.37 101.48 0.44 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.845 0.831 . . . . 0.0 112.606 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' C' ' 187' ' ' ASP . 0.3 OUTLIER -86.1 138.69 31.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.808 ' CE1' HD22 ' C' ' 205' ' ' LEU . 24.5 m-85 -118.05 144.01 45.94 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.537 -1.352 . . . . 0.0 109.694 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . 0.538 ' N ' ' OG1' ' C' ' 186' ' ' THR . 84.9 tt0 -68.36 -46.44 70.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.206 -0.934 . . . . 0.0 109.925 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -100.35 125.16 40.39 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.816 -1.178 . . . . 0.0 111.053 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . 0.904 ' O ' HG22 ' C' ' 213' ' ' VAL . 51.4 Cg_exo -45.74 -40.33 19.11 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.973 2.449 . . . . 0.0 114.223 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.459 ' O ' ' N ' ' C' ' 214' ' ' ASP . 97.8 p -61.34 -46.6 89.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.584 -1.322 . . . . 0.0 110.68 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.774 ' O ' HG23 ' C' ' 216' ' ' VAL . 29.6 m -39.33 -31.03 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . 0.904 HG22 ' O ' ' C' ' 210' ' ' PRO . 6.2 m -69.78 -34.52 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.21 . . . . 0.0 110.233 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' C' ' 218' ' ' LYS . 54.9 t0 -62.36 -49.17 76.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.32 -33.95 75.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 108.986 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.774 HG23 ' O ' ' C' ' 212' ' ' SER . 48.1 t -82.26 33.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.505 ' CG2' ' SD ' ' C' ' 161' ' ' MET . 21.1 t -154.58 -36.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.605 -0.684 . . . . 0.0 109.579 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.492 ' NZ ' ' OD1' ' C' ' 214' ' ' ASP . 2.2 ttmp? -92.67 23.87 3.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.644 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . 0.597 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 42.2 m -134.81 157.21 47.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.289 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -83.95 134.22 34.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 108.459 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' C' ' 219' ' ' THR . 18.4 m-70 -123.51 133.6 53.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.57 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -145.38 106.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 110.449 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' C' ' 178' ' ' TYR . 3.9 mm? -52.8 -65.0 0.63 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.359 -0.838 . . . . 0.0 109.635 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -126.26 24.15 6.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.347 -0.846 . . . . 0.0 109.38 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.23 15.07 42.77 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -80.93 -154.36 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -1.098 . . . . 0.0 108.51 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . 0.566 HG12 ' OE1' ' C' ' 273' ' ' GLN . 0.3 OUTLIER -132.32 97.6 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . 0.538 HD13 HD23 ' C' ' 223' ' ' LEU . 19.7 pt -107.56 153.19 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.622 -0.674 . . . . 0.0 109.579 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . 0.502 ' OD1' ' OD2' ' C' ' 271' ' ' ASP . 28.3 t0 -123.62 97.36 42.04 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.551 -0.718 . . . . 0.0 110.628 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.454 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 56.9 Cg_endo -86.77 125.58 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.847 2.365 . . . . 0.0 111.928 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . 0.637 ' HG2' HD11 ' C' ' 234' ' ' ILE . 0.3 OUTLIER -145.82 142.39 28.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.99 . . . . 0.0 109.64 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' C' ' 233' ' ' ALA . 58.5 ttp180 -53.04 144.24 15.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.024 -1.047 . . . . 0.0 108.959 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -36.23 116.72 0.42 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.439 -0.788 . . . . 0.0 109.892 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . 0.73 ' H ' ' N6 ' ' A' ' 6' ' ' ' A' . 67.7 mt -99.25 134.95 20.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 0.0 109.486 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.42 149.61 62.94 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.125 1.883 . . . . 0.0 111.705 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -34.99 68.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.482 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.28 -45.57 80.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 0.0 109.589 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -71.23 -37.31 72.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 0.0 109.21 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.527 ' O ' ' OG1' ' C' ' 242' ' ' THR . 77.5 mt-30 -58.68 -35.27 72.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 108.727 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -65.53 -42.47 91.95 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.197 -0.939 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' C' ' 242' ' ' THR . 18.8 mttp -69.72 -51.79 31.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.0 110.446 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . 0.537 ' C ' ' O ' ' C' ' 241' ' ' LYS . 0.1 OUTLIER -22.62 140.33 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.284 0.564 . . . . 0.0 111.403 -178.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -132.65 130.19 5.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' C' ' 318' ' ' ALA . 0.0 OUTLIER -132.27 138.61 47.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.971 -1.311 . . . . 0.0 110.406 178.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.419 ' CG2' HG13 ' C' ' 297' ' ' VAL . 2.5 pt -123.96 140.39 47.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.835 0.826 . . . . 0.0 108.906 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' C' ' 247' ' ' VAL . 10.8 t80 -70.85 158.23 36.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . 0.415 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 0.6 OUTLIER -138.27 133.88 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.852 . . . . 0.0 109.473 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -120.73 152.13 16.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.62 -29.16 12.78 Favored Glycine 0 N--CA 1.495 2.571 0 O-C-N 121.095 -1.238 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.402 HG22 ' CD2' ' C' ' 308' ' ' PHE . 1.2 pp -109.58 164.64 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.074 -1.251 . . . . 0.0 108.941 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . 0.65 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.71 -42.98 1.32 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.974 -1.651 . . . . 0.0 108.974 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 45.4 Cg_exo -56.16 -132.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.874 2.382 . . . . 0.0 112.378 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.79 -36.1 67.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.312 -0.867 . . . . 0.0 110.575 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.531 ' CG1' ' OD2' ' C' ' 310' ' ' ASP . 13.7 m -55.92 127.46 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.948 -1.095 . . . . 0.0 109.47 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' C' ' 255' ' ' ARG . 0.0 OUTLIER -90.65 160.66 38.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' C' ' 257' ' ' LYS . 17.0 Cg_endo -60.34 -26.26 82.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.97 2.447 . . . . 0.0 112.259 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' C' ' 256' ' ' PRO . 26.2 mtpp -45.32 -62.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' C' ' 261' ' ' GLU . 50.2 tp10 -60.9 -82.88 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.409 -0.917 . . . . 0.0 108.69 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . 0.606 ' C ' ' O ' ' C' ' 258' ' ' GLU . 1.1 t80 -10.98 -62.1 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.568 0 CA-C-O 121.438 0.637 . . . . 0.0 111.263 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 258' ' ' GLU . 87.7 tt0 -64.03 -48.53 75.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.27 -0.894 . . . . 0.0 109.523 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' C' ' 258' ' ' GLU . 0.0 OUTLIER -73.04 0.95 9.97 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' C' ' 264' ' ' SER . 0.7 OUTLIER -94.54 -74.24 0.55 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.496 ' O ' ' C ' ' C' ' 264' ' ' SER . 29.2 m-85 -42.19 -27.24 0.13 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.21 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.592 ' O ' ' N ' ' C' ' 266' ' ' TRP . 29.0 t -40.15 -41.64 1.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' C' ' 264' ' ' SER . 6.3 tt0 -39.79 -19.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.756 -0.59 . . . . 0.0 110.67 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.664 ' HE1' ' CG1' ' C' ' 300' ' ' VAL . 8.8 p90 -154.13 151.79 29.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.805 -1.185 . . . . 0.0 109.111 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 62.8 -172.4 10.44 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 3.4 t -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' C' ' 272' ' ' ALA . 5.0 mm -96.33 100.26 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.423 -1.311 . . . . 0.0 110.263 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . 0.591 HD13 ' O ' ' C' ' 291' ' ' TYR . 1.4 mp -72.01 -57.71 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.634 -0.667 . . . . 0.0 110.372 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . 0.502 ' OD2' ' OD1' ' C' ' 229' ' ' ASP . 0.5 OUTLIER -129.61 106.53 8.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' C' ' 269' ' ' ILE . . . -120.87 142.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.903 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . 0.566 ' OE1' HG12 ' C' ' 227' ' ' VAL . 10.9 pt20 -171.53 136.75 1.0 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.637 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.536 HD13 ' HA2' ' C' ' 251' ' ' GLY . 3.6 pp -112.01 156.9 21.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . 0.672 ' SD ' ' N ' ' C' ' 275' ' ' MET . 0.0 OUTLIER -99.4 168.67 9.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.717 -1.239 . . . . 0.0 109.533 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.621 ' O ' ' N ' ' C' ' 278' ' ' LYS . 1.6 pp -157.62 -178.37 7.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -0.924 . . . . 0.0 109.718 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' C' ' 283' ' ' SER . 55.7 t0 -64.96 44.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 109.047 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -48.5 -32.38 7.82 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . 0.463 ' CG ' ' O ' ' C' ' 278' ' ' LYS . 6.8 m-20 -179.17 27.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' C' ' 280' ' ' THR . 0.0 OUTLIER -172.67 21.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.783 -1.198 . . . . 0.0 110.394 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' C' ' 277' ' ' ASP . . . 61.86 23.5 63.5 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' C' ' 284' ' ' ARG . 3.7 tp60 -50.65 -16.23 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -1.065 . . . . 0.0 109.076 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' C' ' 277' ' ' ASP . 0.3 OUTLIER -62.92 38.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.546 -0.721 . . . . 0.0 110.072 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' C' ' 282' ' ' GLN . 0.5 OUTLIER -46.61 -33.67 4.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.909 -1.119 . . . . 0.0 108.196 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.08 67.88 0.21 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.564 ' CE2' " H5'" ' A' ' 3' ' ' ' U' . 38.8 p90 -176.43 -171.23 0.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.88 -1.365 . . . . 0.0 109.604 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . 175.21 -165.54 36.61 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -142.13 154.87 45.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.296 -1.708 . . . . 0.0 108.978 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . 0.41 ' CG2' ' CE1' ' C' ' 291' ' ' TYR . 0.5 OUTLIER -131.42 145.64 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . 0.467 ' O ' ' N ' ' C' ' 270' ' ' ILE . 32.3 m -133.05 123.67 26.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.509 -1.369 . . . . 0.0 109.997 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . 0.591 ' O ' HD13 ' C' ' 270' ' ' ILE . 33.4 m-85 -98.95 -80.27 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.293 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' C' ' 293' ' ' SER . 0.0 OUTLIER 169.39 -56.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.062 0 O-C-N 120.631 -1.293 . . . . 0.0 108.009 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 58.6 p -93.82 172.66 8.11 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -100.17 -8.76 23.24 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.891 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.13 -52.4 65.04 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 108.618 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.52 95.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 108.485 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . 0.419 HG13 ' CG2' ' C' ' 245' ' ' ILE . 45.6 t -52.66 -57.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.186 -0.946 . . . . 0.0 108.611 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.07 -32.6 71.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.196 -0.94 . . . . 0.0 109.217 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.87 -62.07 2.08 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.664 ' CG1' ' HE1' ' C' ' 266' ' ' TRP . 0.2 OUTLIER -66.29 -31.42 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.497 -0.752 . . . . 0.0 110.203 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . 0.618 ' SG ' ' NH2' ' C' ' 317' ' ' ARG . 31.7 t -45.58 -52.13 11.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.674 -1.266 . . . . 0.0 108.817 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -50.88 -27.78 8.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.44 -0.788 . . . . 0.0 110.556 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' C' ' 303' ' ' ASN . 30.9 p30 -100.22 63.15 1.13 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.014 -1.054 . . . . 0.0 109.808 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' C' ' 303' ' ' ASN . 15.8 tttp -45.18 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.47 -1.394 . . . . 0.0 108.905 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' C' ' 314' ' ' GLU . 70.6 m-85 -67.28 127.83 34.11 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.32 -0.862 . . . . 0.0 109.497 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . 0.649 HG21 HD11 ' C' ' 315' ' ' ILE . 0.9 OUTLIER -135.92 154.19 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.348 -0.845 . . . . 0.0 108.949 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.0 128.6 33.47 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.194 -0.941 . . . . 0.0 110.605 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' C' ' 309' ' ' LYS . 34.3 t80 -118.07 173.62 6.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.511 -0.743 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.436 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.0 OUTLIER -56.11 -34.19 65.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.188 -0.945 . . . . 0.0 112.037 -177.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . 0.531 ' OD2' ' CG1' ' C' ' 254' ' ' VAL . 15.6 m-20 -90.71 -71.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.734 -1.229 . . . . 0.0 109.942 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -148.06 -170.22 3.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 109.262 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -60.32 148.25 37.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 108.969 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.413 HG13 HG22 ' C' ' 306' ' ' ILE . 31.3 pt -132.27 153.74 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . 0.418 ' HG3' ' CE2' ' C' ' 305' ' ' PHE . 4.0 mp0 -111.44 110.17 20.49 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.003 -1.061 . . . . 0.0 110.842 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.649 HD11 HG21 ' C' ' 306' ' ' ILE . 59.6 mt -87.91 161.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.9 -1.125 . . . . 0.0 109.838 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . 0.422 ' N ' HG22 ' C' ' 315' ' ' ILE . 47.2 tttp -163.46 160.88 23.87 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.914 -1.116 . . . . 0.0 109.043 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . 0.618 ' NH2' ' SG ' ' C' ' 301' ' ' CYS . 62.5 mtt85 -71.76 146.25 48.22 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.699 -1.251 . . . . 0.0 109.418 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' C' ' 244' ' ' LYS . . . -71.72 26.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.827 -1.171 . . . . 0.0 109.411 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' C' ' 317' ' ' ARG . 7.3 pt-20 -83.44 148.07 54.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.598 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.67 -27.0 45.52 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.413 2.075 . . . . 0.0 112.301 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . 0.868 ' NE ' " H4'" ' A' ' 12' ' ' ' A' . 75.0 ttt-85 -161.44 -70.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.467 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.536 ' N3 ' ' OE1' ' C' ' 314' ' ' GLU . . . . . . . . 0 O4'--C1' 1.44 2.208 1 C5'-C4'-C3' 107.625 -5.25 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.583 ' N6 ' ' O ' ' C' ' 319' ' ' GLU . . . . . . . . 0 O4'--C1' 1.438 2.001 1 C5'-C4'-C3' 108.042 -4.972 . 0.413 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 0.575 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.439 2.052 1 C5'-C4'-C3' 107.668 -5.221 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.716 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.44 2.151 1 C5'-C4'-C3' 107.278 -5.481 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.865 " H1'" ' O ' ' C' ' 201' ' ' GLY . . . . . . . . 0 O4'--C4' 1.424 -2.401 1 C3'-C2'-C1' 105.273 4.192 OUTLIER-DELTA 0.267 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 0.97 " H4'" " C5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.611 1.793 1 C5'-C4'-C3' 109.089 -4.274 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 0.97 " C5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.615 2.226 1 C5'-C4'-C3' 107.027 -5.649 . 0.225 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.481 " O2'" " O5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.433 1.605 1 C5'-C4'-C3' 106.564 -5.957 . 0.392 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.719 ' N3 ' ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 C2'--C1' 1.498 -2.984 2 O4'-C1'-N19 115.958 7.758 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 0.894 " H5'" ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 O4'--C4' 1.431 -1.844 2 C5'-C4'-C3' 107.549 -5.301 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 1.425 " H3'" ' N ' ' B' ' 69' ' ' TYR . . . . . . . . 1 O3'--C3' 1.494 5.087 1 C5'-C4'-C3' 108.97 -4.353 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 1.126 " H5'" ' O ' ' B' ' 67' ' ' LYS . . . . . . . . 2 P--O3' 1.706 8.226 2 O4'-C1'-N19 114.099 5.899 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.742 ' H6 ' " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.406 1 C5'-C4'-C3' 108.277 -4.816 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' B' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.08 158.68 24.63 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.727 2.284 . . . . 0.0 112.208 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.47 20.2 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.848 2.365 . . . . 0.0 112.976 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.874 -1.141 . . . . 0.0 109.952 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.538 ' HE ' ' CB ' ' B' ' 103' ' ' SER . 5.3 ttp85 179.24 -45.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.636 HG22 ' HG3' ' B' ' 73' ' ' GLU . 10.3 t -122.56 155.02 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.637 HG22 HD13 ' B' ' 72' ' ' ILE . 0.2 OUTLIER -126.71 142.32 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.678 ' CE1' ' C2 ' ' A' ' 9' ' ' ' A' . 2.6 m-85 -114.98 141.81 47.47 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.072 -1.017 . . . . 0.0 110.547 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.605 ' HB3' HD11 ' B' ' 33' ' ' ILE . 1.7 mt -118.78 127.52 53.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.545 ' C ' HD12 ' B' ' 33' ' ' ILE . . . -113.33 -50.39 0.54 Allowed Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.639 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.677 ' OG ' ' N ' ' B' ' 95' ' ' ARG . 9.7 p -88.76 115.38 26.26 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.743 -1.445 . . . . 0.0 107.731 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.609 HD12 ' C ' ' B' ' 32' ' ' SER . 4.2 mp -147.85 107.16 3.72 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 118.87 -1.132 . . . . 0.0 111.887 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' B' ' 36' ' ' ASP . 7.8 Cg_exo -63.01 159.23 39.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.629 1.553 . . . . 0.0 109.744 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.886 ' OH ' H5'' ' A' ' 12' ' ' ' A' . 6.2 m-30 -74.57 5.37 4.86 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 34' ' ' PRO . 27.0 t0 -62.03 -47.09 86.29 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.59 ' N ' HE21 ' B' ' 37' ' ' GLN . 0.0 OUTLIER -120.12 109.13 15.08 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.872 178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.545 ' O ' ' CG1' ' B' ' 42' ' ' ILE . 45.8 p -100.14 -148.83 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.0 109.419 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.04 -26.39 67.59 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.14 -1.6 . . . . 0.0 110.902 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -73.17 -57.42 4.04 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.75 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.511 HE21 ' HB3' ' B' ' 37' ' ' GLN . 25.1 mt-30 -68.84 -44.17 73.97 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.972 -1.08 . . . . 0.0 109.231 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' B' ' 44' ' ' ASP . 2.4 mm -54.53 -54.77 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' B' ' 55' ' ' LEU . 45.6 tp -37.21 -19.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.872 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.627 ' N ' ' O ' ' B' ' 42' ' ' ILE . 59.9 t0 -123.86 -21.81 5.05 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.595 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.723 ' C ' HD13 ' B' ' 45' ' ' LEU . 3.2 tm? -62.97 -44.06 97.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.051 -1.656 . . . . 0.0 107.029 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.695 ' O ' ' N ' ' B' ' 48' ' ' ASN . 74.4 m -82.98 -65.45 1.01 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.155 -0.966 . . . . 0.0 108.739 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.839 ' O ' ' N ' ' B' ' 49' ' ' VAL . 4.6 t -37.24 -15.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.79 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' B' ' 46' ' ' CYS . 0.4 OUTLIER -50.23 56.45 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.483 1.135 . . . . 0.0 110.551 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.839 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.4 p 178.46 -34.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 121.426 -0.796 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.68 159.57 32.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' B' ' 52' ' ' VAL . 20.5 Cg_endo -65.24 86.47 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.525 2.15 . . . . 0.0 111.525 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.568 HG11 ' CG2' ' B' ' 72' ' ' ILE . 0.0 OUTLIER -40.09 153.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.633 0.73 . . . . 0.0 110.072 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.53 ' N ' ' O ' ' B' ' 73' ' ' GLU . 15.9 mm -77.05 -45.3 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.688 -0.632 . . . . 0.0 109.662 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' B' ' 53' ' ' ILE . 87.0 m-20 -146.89 152.68 39.09 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 118.362 -1.335 . . . . 0.0 111.678 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' B' ' 43' ' ' LEU . 42.5 tp -143.56 128.48 18.45 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -145.58 123.91 12.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.624 -1.297 . . . . 0.0 110.194 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 9.9 ttm -116.4 150.36 37.91 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.746 0.784 . . . . 0.0 111.138 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 1.09 ' C ' " H4'" ' A' ' 11' ' ' ' A' . 2.1 ttp -168.14 165.65 13.21 Favored 'General case' 0 C--O 1.282 2.781 0 O-C-N 121.383 -0.823 . . . . 0.0 109.498 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.823 ' HA ' " O3'" ' A' ' 11' ' ' ' A' . 0.0 OUTLIER -132.56 134.59 45.14 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 127.008 2.692 . . . . 0.0 110.214 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.597 ' H ' ' HA ' ' B' ' 67' ' ' LYS . 0.1 OUTLIER -42.05 105.39 0.4 Allowed Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 112.014 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -91.63 -66.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.796 2.331 . . . . 0.0 109.325 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -105.89 -25.45 12.13 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.583 ' OG1' ' C2 ' ' A' ' 11' ' ' ' A' . 80.5 p -46.41 -49.54 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' B' ' 60' ' ' ASP . . . 76.77 36.7 36.21 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.769 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.417 ' HB2' ' N1 ' ' A' ' 11' ' ' ' A' . 20.7 mtp180 -137.01 -76.92 0.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.718 -1.46 . . . . 0.0 110.142 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.797 ' O ' " H1'" ' A' ' 11' ' ' ' A' . 97.7 p -109.81 140.83 43.29 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.088 1.899 . . . . 0.0 111.538 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 1.126 ' O ' " H5'" ' A' ' 12' ' ' ' A' . 39.0 mttt -101.72 -5.49 24.89 Favored 'General case' 0 C--O 1.166 -3.332 0 CA-C-O 115.138 -2.363 . . . . 0.0 114.891 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 1.109 ' HA2' " O5'" ' A' ' 12' ' ' ' A' . . . -126.11 100.08 0.57 Allowed Glycine 1 N--CA 1.534 5.198 0 CA-C-N 123.356 2.798 . . . . 0.0 116.534 -177.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 1.425 ' N ' " H3'" ' A' ' 11' ' ' ' A' . 3.1 m-85 -165.9 139.6 4.38 Favored 'General case' 0 N--CA 1.516 2.83 0 C-N-CA 115.329 -2.548 . . . . 0.0 114.127 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.68 142.99 28.43 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.134 -0.979 . . . . 0.0 110.973 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.894 ' CZ ' " H5'" ' A' ' 10' ' ' ' U' . 6.2 m-30 -107.83 132.86 52.98 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.183 0.992 . . . . 0.0 110.4 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.637 HD13 HG22 ' B' ' 28' ' ' VAL . 3.8 mp -115.27 146.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.636 ' HG3' HG22 ' B' ' 27' ' ' VAL . 83.9 tt0 -136.03 135.47 39.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.167 -1.583 . . . . 0.0 108.38 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.406 ' CZ ' HG13 ' B' ' 52' ' ' VAL . 13.3 m-85 -105.74 168.61 8.99 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.759 0.79 . . . . 0.0 110.845 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 47.6 ttp180 -53.75 -45.41 70.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.635 -0.666 . . . . 0.0 111.532 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.3 m-20 161.75 179.88 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.174 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 3.6 mm? -34.29 -24.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.851 -0.531 . . . . 0.0 111.142 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 91.9 mt-10 -71.05 -75.34 0.13 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.668 -1.27 . . . . 0.0 109.259 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.97 -41.56 98.14 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 84' ' ' VAL . 21.0 m -60.28 -37.54 80.8 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.836 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -61.1 -61.8 2.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.44 -1.413 . . . . 0.0 108.912 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.521 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 67.2 m -61.89 -43.24 99.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.723 0.773 . . . . 0.0 112.022 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -78.37 -64.93 1.05 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.427 -0.795 . . . . 0.0 111.031 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.442 ' O ' ' CA ' ' B' ' 88' ' ' ASN . 0.4 OUTLIER -50.63 -39.36 17.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 120.851 -1.156 . . . . 0.0 109.261 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.608 ' O ' ' ND2' ' B' ' 88' ' ' ASN . 2.1 ttm-85 -66.86 -55.53 14.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.612 -1.305 . . . . 0.0 108.791 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' B' ' 82' ' ' SER . 46.9 m-80 -67.02 -43.91 81.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 109.68 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 83' ' ' ALA . 45.7 mt -105.6 41.67 1.35 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 110.411 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' B' ' 85' ' ' ARG . 0.0 OUTLIER -70.26 -75.16 0.12 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.98 117.88 1.73 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -139.87 147.54 40.8 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.549 -1.559 . . . . 0.0 107.819 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.592 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.3 mm-40 -33.94 89.09 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.822 0.82 . . . . 0.0 111.184 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' B' ' 90' ' ' TYR . 51.3 tp -140.8 125.85 18.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.41 -157.05 4.01 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . 0.606 ' N ' ' OG ' ' B' ' 32' ' ' SER . 2.3 p -83.36 -15.65 49.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.862 -1.376 . . . . 0.0 109.896 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.677 ' N ' ' OG ' ' B' ' 32' ' ' SER . 94.4 mtt-85 -131.23 155.87 46.35 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.8 m-85 -96.07 139.35 32.38 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.47 -0.769 . . . . 0.0 109.86 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.524 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -38.47 141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -114.2 147.53 38.78 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.112 -0.992 . . . . 0.0 109.867 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . . . . . . . . . 17.9 p -88.02 115.61 25.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.954 . . . . 0.0 109.679 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' B' ' 27' ' ' VAL . . . -108.52 177.23 20.59 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.469 ' O ' ' C ' ' B' ' 102' ' ' SER . 48.0 p90 -131.61 -17.57 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.555 -0.968 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.547 ' O ' HG21 ' B' ' 27' ' ' VAL . 8.3 t -38.02 99.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.403 -0.811 . . . . 0.0 110.108 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . 0.538 ' CB ' ' HE ' ' B' ' 26' ' ' ARG . 60.0 p -93.91 159.17 15.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.436 ' CG ' ' H ' ' B' ' 105' ' ' SER . 39.2 t-20 -156.4 -137.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 0.0 109.284 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.436 ' H ' ' CG ' ' B' ' 104' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' C' ' 157' ' ' GLU . 0.0 OUTLIER -104.32 141.22 36.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 109.192 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . 0.594 ' O ' ' N ' ' C' ' 160' ' ' LYS . 83.8 p -147.51 159.94 43.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.965 . . . . 0.0 109.553 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . 0.528 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 46.23 11.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.547 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' C' ' 158' ' ' SER . 14.5 tttp -94.75 137.82 33.36 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . 0.693 ' SD ' ' N ' ' C' ' 162' ' ' PHE . 0.0 OUTLIER -114.9 152.58 32.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 108.986 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.711 ' CG ' ' C6 ' ' A' ' 6' ' ' ' A' . 55.2 t80 -119.4 72.94 0.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.607 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.749 HD12 HD21 ' C' ' 175' ' ' LEU . 54.5 mt -53.24 145.48 3.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.38 -177.43 15.98 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.772 ' H ' ' H3 ' ' A' ' 5' ' ' ' U' . . . 56.22 20.77 30.04 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . 0.567 ' O ' ' C8 ' ' A' ' 4' ' ' ' A' . 97.5 mt -60.97 163.7 5.63 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.364 -1.08 . . . . 0.0 108.776 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.591 ' O ' ' CG ' ' C' ' 168' ' ' TRP . 11.5 p-10 -68.65 -75.71 0.1 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.056 -1.028 . . . . 0.0 108.918 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.725 ' HE1' HH21 ' C' ' 198' ' ' ARG . 0.1 OUTLIER 178.5 -24.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.872 -1.143 . . . . 0.0 109.784 178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -133.01 91.46 2.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.139 -0.975 . . . . 0.0 109.764 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . 0.478 HG21 HD13 ' C' ' 175' ' ' LEU . 46.2 m -126.05 144.74 50.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.416 -0.803 . . . . 0.0 109.386 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.84 172.62 6.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.022 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' C' ' 176' ' ' ARG . 0.5 OUTLIER -75.14 -67.77 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.961 -1.087 . . . . 0.0 109.861 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -43.29 -33.45 0.99 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -74.92 -50.83 15.46 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 108.827 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.749 HD21 HD12 ' C' ' 163' ' ' ILE . 20.8 tp -52.67 -42.06 64.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.693 -0.63 . . . . 0.0 109.53 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' C' ' 179' ' ' PHE . 14.2 ptp180 -74.38 -57.3 4.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.511 -1.368 . . . . 0.0 108.866 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' C' ' 176' ' ' ARG . 54.0 mm-40 -37.71 -30.76 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.717 ' CD2' HD12 ' C' ' 223' ' ' LEU . 21.6 t80 -85.25 -39.85 17.29 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.103 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' C' ' 176' ' ' ARG . 22.6 m-85 -94.25 16.98 13.56 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.146 -0.971 . . . . 0.0 111.429 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.45 24.46 25.44 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . 0.696 ' NZ ' ' CZ ' ' C' ' 182' ' ' TYR . 3.6 ptmm? -104.52 16.41 26.15 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.35 -1.088 . . . . 0.0 108.814 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . 0.696 ' CZ ' ' NZ ' ' C' ' 181' ' ' LYS . 92.3 m-85 -119.21 -49.16 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.596 -0.69 . . . . 0.0 109.397 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -164.88 -127.41 0.89 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 40.6 m -126.39 145.64 50.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.506 -0.996 . . . . 0.0 109.692 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.11 137.75 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.516 HG22 ' O ' ' C' ' 206' ' ' SER . 9.7 t -96.82 -37.0 10.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.81 -1.181 . . . . 0.0 110.111 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' C' ' 186' ' ' THR . 79.5 m-20 -149.0 149.17 30.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.938 . . . . 0.0 108.613 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.73 HD23 ' N ' ' C' ' 189' ' ' LYS . 7.7 tt -140.34 144.1 36.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.828 -1.17 . . . . 0.0 108.355 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . 0.73 ' N ' HD23 ' C' ' 188' ' ' LEU . 0.1 OUTLIER -126.08 129.95 50.13 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . 0.624 ' CD1' HD22 ' C' ' 175' ' ' LEU . 0.6 OUTLIER -147.75 121.47 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.789 -1.194 . . . . 0.0 108.778 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . 0.559 ' SD ' ' O2 ' ' A' ' 7' ' ' ' U' . 4.3 ptp -176.2 158.18 1.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 108.765 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . 0.411 ' O ' ' OP1' ' A' ' 8' ' ' ' A' . 0.0 OUTLIER -164.56 -63.89 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.686 -1.259 . . . . 0.0 109.032 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.473 ' OD1' ' OG ' ' C' ' 199' ' ' SER . 0.2 OUTLIER -123.47 88.39 51.66 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.13 -20.86 8.26 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.356 2.037 . . . . 0.0 112.129 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.18 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.147 -0.971 . . . . 0.0 109.78 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 65.1 p -109.23 -8.66 15.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' C' ' 193' ' ' ASP . . . 81.22 15.64 76.27 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . 0.725 HH21 ' HE1' ' C' ' 168' ' ' TRP . 0.0 OUTLIER -97.68 73.22 2.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.061 -1.258 . . . . 0.0 109.456 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . 0.526 ' O ' ' C ' ' C' ' 200' ' ' ARG . 80.6 p -167.1 172.77 9.74 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.526 ' C ' ' O ' ' C' ' 199' ' ' SER . 0.0 OUTLIER -27.27 147.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.005 0.431 . . . . 0.0 110.137 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . 0.865 ' O ' " H1'" ' A' ' 5' ' ' ' U' . . . -131.5 158.82 22.94 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.661 ' CZ ' " H4'" ' A' ' 7' ' ' ' U' . 4.7 p90 -171.18 134.11 0.9 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.359 . . . . 0.0 108.614 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -112.12 132.95 11.11 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.09 114.13 27.17 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.742 HD13 ' CZ ' ' C' ' 207' ' ' PHE . 0.5 OUTLIER -112.98 110.29 20.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.298 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . 0.516 ' O ' HG22 ' C' ' 186' ' ' THR . 29.1 t -81.44 72.05 8.46 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.742 ' CZ ' HD13 ' C' ' 205' ' ' LEU . 27.3 m-85 -64.47 115.51 5.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.139 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.93 -38.43 90.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.18 108.74 30.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.006 -1.059 . . . . 0.0 110.44 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -52.1 -24.74 20.76 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.697 1.598 . . . . 0.0 112.5 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.507 ' O ' ' N ' ' C' ' 213' ' ' VAL . 22.9 t -66.95 -65.32 0.7 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.949 -1.094 . . . . 0.0 109.861 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.79 ' O ' HG23 ' C' ' 216' ' ' VAL . 51.0 m -40.75 -24.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.482 -0.761 . . . . 0.0 110.295 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' C' ' 211' ' ' SER . 95.0 t -69.13 -38.23 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 109.011 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' C' ' 211' ' ' SER . 54.9 t0 -59.0 -49.41 77.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.465 -0.772 . . . . 0.0 110.094 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -68.08 -36.53 79.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.84 -1.162 . . . . 0.0 109.31 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.79 HG23 ' O ' ' C' ' 212' ' ' SER . 47.9 t -54.94 -47.91 75.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 110.024 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.13 -33.33 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -72.79 6.28 2.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 109.558 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . 0.656 ' CG2' ' CE1' ' C' ' 221' ' ' HIS . 1.3 t -134.56 167.7 20.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.134 -0.979 . . . . 0.0 109.391 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -122.82 134.42 54.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.73 -0.606 . . . . 0.0 109.403 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.862 ' C ' HD13 ' C' ' 222' ' ' ILE . 0.0 OUTLIER -132.07 161.03 34.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.862 HD13 ' C ' ' C' ' 221' ' ' HIS . 0.4 OUTLIER -124.93 110.1 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 109.057 179.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.717 HD12 ' CD2' ' C' ' 178' ' ' TYR . 18.3 tp -75.14 -71.6 0.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 60.7 t0 -80.22 1.06 29.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.028 -1.045 . . . . 0.0 108.772 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 85.92 13.51 69.17 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . 0.702 ' HZ1' ' N ' ' C' ' 279' ' ' ASP . 0.0 OUTLIER -90.73 -83.28 0.27 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -1.075 . . . . 0.0 109.432 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . 0.587 HG22 ' O ' ' C' ' 227' ' ' VAL . 1.3 p 172.57 89.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.19 -0.944 . . . . 0.0 109.66 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . . . . . . . . . 42.3 pt -94.63 152.02 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.396 -0.815 . . . . 0.0 110.34 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' C' ' 229' ' ' ASP . 0.0 OUTLIER -116.8 106.45 47.94 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 110.042 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.44 ' HG3' ' HE2' ' C' ' 221' ' ' HIS . 42.7 Cg_endo -82.17 134.23 7.95 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.388 2.059 . . . . 0.0 111.819 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' C' ' 232' ' ' ARG . 11.8 ttmm -152.53 164.26 37.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.131 -0.98 . . . . 0.0 109.673 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' C' ' 231' ' ' LYS . 56.7 ttm-85 -72.96 159.22 34.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.022 -1.049 . . . . 0.0 109.602 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 116.07 3.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.205 -0.934 . . . . 0.0 111.163 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . 0.628 ' O ' ' C6 ' ' A' ' 6' ' ' ' A' . 18.5 mt -156.91 91.67 2.45 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -40.15 137.78 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.601 1.534 . . . . 0.0 111.479 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.441 ' HG2' ' N7 ' ' A' ' 6' ' ' ' A' . 8.5 mmm-85 -55.69 -29.5 59.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.08 -45.13 79.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.65 -1.281 . . . . 0.0 108.663 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -75.88 -38.3 58.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.063 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' C' ' 242' ' ' THR . 4.2 tp-100 -57.92 -38.01 75.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.14 -39.2 93.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.615 -0.678 . . . . 0.0 110.0 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -58.88 -22.59 59.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.867 . . . . 0.0 109.664 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . 0.531 ' O ' ' O ' ' C' ' 291' ' ' TYR . 72.5 p -56.89 -36.67 70.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.27 -0.894 . . . . 0.0 109.656 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 113.08 114.13 3.22 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 108.521 -1.831 . . . . 0.0 108.521 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -138.58 138.15 37.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.025 -1.279 . . . . 0.0 110.855 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.746 HD12 ' CG2' ' C' ' 315' ' ' ILE . 3.8 pt -120.53 146.65 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.2 OUTLIER -86.54 160.37 18.98 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 28.4 t -134.11 131.17 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.56 -0.713 . . . . 0.0 109.092 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.01 147.53 18.51 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.51 5.25 79.14 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.553 HD11 ' HE2' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -111.12 133.06 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -1.058 . . . . 0.0 109.3 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 132.53 -36.35 2.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.727 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 32.0 Cg_exo -56.0 -30.0 76.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.397 2.064 . . . . 0.0 113.194 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -151.18 7.79 0.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.601 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.638 HG11 ' CE2' ' C' ' 308' ' ' PHE . 24.4 t -126.63 118.03 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 111.14 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.492 ' HA ' HD23 ' C' ' 274' ' ' LEU . 0.0 OUTLIER -102.26 169.79 7.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' C' ' 257' ' ' LYS . 0.0 OUTLIER -26.22 -50.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.312 2.675 . . . . 0.0 114.677 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . 0.498 ' O ' ' OE1' ' C' ' 261' ' ' GLU . 58.4 tttp -33.09 -84.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.57 -0.706 . . . . 0.0 111.113 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . 0.707 ' O ' ' N ' ' C' ' 261' ' ' GLU . 27.4 tp10 -58.21 -76.79 0.04 OUTLIER 'General case' 0 C--O 1.194 -1.82 0 O-C-N 120.846 -1.159 . . . . 0.0 109.384 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . 0.632 ' C ' ' O ' ' C' ' 258' ' ' GLU . 52.0 t80 -12.16 -64.39 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 121.867 0.841 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' C' ' 258' ' ' GLU . 50.0 mt-10 -62.22 -49.39 75.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 108.96 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . 0.707 ' N ' ' O ' ' C' ' 258' ' ' GLU . 5.1 mp0 -71.27 2.79 4.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . 0.482 ' O ' ' CD ' ' C' ' 265' ' ' GLN . 6.1 t80 -98.21 -73.22 0.62 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.577 ' CD2' ' CH2' ' C' ' 266' ' ' TRP . 54.3 m-85 -50.52 -31.61 15.99 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.455 -1.298 . . . . 0.0 109.412 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.422 ' C ' ' O ' ' C' ' 263' ' ' PHE . 73.6 m -35.82 -38.34 0.12 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.605 -0.684 . . . . 0.0 112.445 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.482 ' CD ' ' O ' ' C' ' 262' ' ' PHE . 0.0 OUTLIER -54.75 -93.33 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.148 -1.595 . . . . 0.0 110.189 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.577 ' CH2' ' CD2' ' C' ' 263' ' ' PHE . 1.7 p90 -66.99 152.26 46.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.976 -1.078 . . . . 0.0 110.052 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 69.45 167.2 5.41 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' C' ' 291' ' ' TYR . 59.1 m -115.24 122.89 47.37 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' C' ' 272' ' ' ALA . 3.2 mp -104.87 107.91 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.077 -1.049 . . . . 0.0 112.43 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . 0.425 HD11 ' OD2' ' C' ' 292' ' ' ASP . 4.8 mm -77.15 -46.79 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 110.58 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -139.7 103.64 4.72 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.658 -1.276 . . . . 0.0 110.415 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' C' ' 269' ' ' ILE . . . -110.38 142.19 42.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.222 -0.924 . . . . 0.0 108.525 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -150.79 139.51 20.73 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.083 -1.447 . . . . 0.0 112.463 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' C' ' 286' ' ' PHE . 26.8 tp -122.96 141.24 52.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . 0.863 ' C ' HD13 ' C' ' 276' ' ' LEU . 45.7 mmm -89.17 177.3 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.149 -1.595 . . . . 0.0 109.249 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 1.055 HD22 ' H ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -131.95 170.28 15.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.992 -1.067 . . . . 0.0 109.505 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 54.4 p30 -90.9 -11.48 39.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.424 -0.797 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . 0.625 ' C ' ' HZ1' ' C' ' 226' ' ' LYS . 19.8 tptm -62.46 -32.78 73.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 108.838 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . 0.702 ' N ' ' HZ1' ' C' ' 226' ' ' LYS . 34.2 p-10 -63.87 -44.38 93.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.039 -1.038 . . . . 0.0 109.475 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . 0.655 HG22 ' C ' ' C' ' 279' ' ' ASP . 0.2 OUTLIER 177.34 5.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.099 -1.001 . . . . 0.0 110.172 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.08 57.0 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.557 ' HG2' HG23 ' C' ' 280' ' ' THR . 19.4 mm100 -57.46 -34.24 68.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -1.197 . . . . 0.0 109.307 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 78.1 p -68.8 51.7 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.156 -0.965 . . . . 0.0 108.974 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' C' ' 282' ' ' GLN . 58.4 ttm-85 -49.59 -37.24 26.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 159.37 78.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.575 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 34.6 p90 -176.2 -174.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.271 . . . . 0.0 109.666 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -178.86 -170.97 41.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -147.97 152.26 37.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.22 -1.753 . . . . 0.0 108.877 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . . . . . . . . . 94.2 t -130.6 145.61 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 15.5 m -128.55 130.45 47.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.814 -1.179 . . . . 0.0 110.453 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' C' ' 242' ' ' THR . 24.3 m-85 -113.37 153.33 28.72 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . 0.425 ' OD2' HD11 ' C' ' 270' ' ' ILE . 1.8 t0 -74.0 18.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.014 -1.054 . . . . 0.0 109.499 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . 0.463 ' H ' ' C ' ' C' ' 291' ' ' TYR . 59.8 p -162.67 173.88 13.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -109.02 -7.99 15.27 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.27 -52.0 67.41 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.91 90.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.336 -0.852 . . . . 0.0 108.768 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . 0.489 HG13 HG22 ' C' ' 245' ' ' ILE . 55.8 t -54.82 -57.38 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.23 -29.73 68.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 109.493 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -63.51 -63.75 1.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.124 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -63.71 -25.47 38.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.063 -1.023 . . . . 0.0 109.616 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . . . . . . . . . 45.3 t -45.18 -55.38 5.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 109.634 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . 0.585 ' NE2' ' OD1' ' C' ' 303' ' ' ASN . 0.0 OUTLIER -51.5 -24.98 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 108.051 179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' C' ' 302' ' ' GLN . 97.1 m-20 -98.54 78.87 2.42 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -78.54 -8.97 59.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 110.48 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.06 120.19 19.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.375 -0.828 . . . . 0.0 108.952 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . 0.51 HD12 HD11 ' C' ' 315' ' ' ILE . 60.8 mt -123.96 154.88 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.802 . . . . 0.0 109.848 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -90.08 116.07 27.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 108.704 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.638 ' CE2' HG11 ' C' ' 254' ' ' VAL . 7.4 t80 -121.0 179.48 4.36 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' C' ' 254' ' ' VAL . 35.7 mtmt -39.07 -62.72 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.005 -1.059 . . . . 0.0 110.881 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' C' ' 309' ' ' LYS . 93.0 m-20 -44.66 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.149 -0.97 . . . . 0.0 109.354 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -175.4 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -141.35 138.69 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.52 -0.738 . . . . 0.0 109.886 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.463 HD11 ' HB ' ' C' ' 306' ' ' ILE . 18.8 pt -126.27 151.43 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . 0.536 ' OE1' ' N3 ' ' A' ' 1' ' ' ' U' . 56.6 mt-10 -112.6 151.26 30.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.519 -0.738 . . . . 0.0 109.528 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.746 ' CG2' HD12 ' C' ' 245' ' ' ILE . 99.3 mt -125.84 154.72 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.514 -0.742 . . . . 0.0 109.126 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' C' ' 317' ' ' ARG . 0.0 OUTLIER 179.35 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.158 -1.589 . . . . 0.0 113.454 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . 0.616 ' O ' ' O ' ' C' ' 316' ' ' LYS . 77.8 mtm180 1.38 126.72 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.685 0 CA-C-O 121.778 0.799 . . . . 0.0 113.11 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . 0.414 ' N ' ' HA ' ' C' ' 245' ' ' ILE . . . -61.1 7.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.824 -1.173 . . . . 0.0 110.014 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . 0.583 ' O ' ' N6 ' ' A' ' 2' ' ' ' A' . 3.8 mm-40 -57.44 154.01 25.54 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.176 -0.952 . . . . 0.0 108.725 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -52.89 -85.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.252 1.968 . . . . 0.0 111.92 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -117.96 5.11 12.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 0.0 109.426 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 82.5 t60 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.523 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.916 " O2'" ' H8 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.932 1 C5'-C4'-C3' 107.802 -5.132 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.916 ' H8 ' " O2'" ' A' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.441 2.253 1 C5'-C4'-C3' 107.626 -5.249 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 0.46 " H5'" ' CE2' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.438 1.958 1 C5'-C4'-C3' 107.175 -5.55 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.714 ' C6 ' ' CZ3' ' C' ' 168' ' ' TRP . . . . . . . . 0 O4'--C1' 1.438 2.012 1 C5'-C4'-C3' 106.757 -5.828 . 0.01 2u . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.775 ' H3 ' ' H ' ' C' ' 165' ' ' GLY . . . . . . . . 0 O4'--C4' 1.425 -2.306 1 C3'-C2'-C1' 105.512 4.458 OUTLIER-DELTA 0.348 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 1.045 " O4'" H5'' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O3'--C3' 1.454 2.187 2 O4'-C1'-N19 112.379 4.179 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 1.045 H5'' " O4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O3' 1.632 2.063 2 C5'-C4'-C3' 107.22 -5.52 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.757 ' OP2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.895 1 C5'-C4'-C3' 109.304 -4.131 . 0.817 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.919 " H4'" ' CE1' ' B' ' 69' ' ' TYR . . . . . . . . 0 P--O5' 1.611 1.829 2 C5'-C4'-C3' 108.335 -4.777 . 0.76 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 0.884 HO2' ' H8 ' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.439 2.045 2 C3'-C2'-C1' 106.222 5.247 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.884 ' H8 ' HO2' ' A' ' 10' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.438 1.996 1 C5'-C4'-C3' 106.165 -6.223 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.615 ' N6 ' ' SD ' ' B' ' 58' ' ' MET . . . . . . . . 0 O4'--C1' 1.433 1.603 1 C5'-C4'-C3' 106.607 -5.929 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.544 " O5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.861 1 C5'-C4'-C3' 107.573 -5.285 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' B' ' 23' ' ' PRO . 6.3 m120 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' B' ' 22' ' ' ASN . 5.8 Cg_exo -44.68 167.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.038 2.492 . . . . 0.0 112.188 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.86 2.78 5.01 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.989 2.46 . . . . 0.0 113.355 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 72.1 m -153.26 132.67 12.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.672 -1.267 . . . . 0.0 109.186 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.576 ' NE ' ' OD1' ' B' ' 76' ' ' ASP . 3.5 tpt180 -177.24 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.625 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' B' ' 100' ' ' GLY . 3.2 m -129.06 170.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.468 HG13 ' O ' ' B' ' 98' ' ' LYS . 3.8 t -127.2 143.25 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 109.705 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.708 ' CZ ' ' C2 ' ' A' ' 9' ' ' ' A' . 15.8 m-30 -110.5 122.4 47.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.269 -0.895 . . . . 0.0 108.973 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.568 ' C ' HD11 ' B' ' 33' ' ' ILE . 2.9 mm? -110.36 107.38 17.07 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.411 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -112.15 -16.03 9.36 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.485 ' CB ' ' H ' ' B' ' 95' ' ' ARG . 65.5 p -111.58 85.08 2.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 109.728 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.652 HD12 ' N ' ' B' ' 33' ' ' ILE . 0.8 OUTLIER -145.47 127.26 7.78 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' B' ' 36' ' ' ASP . 31.8 Cg_endo -72.89 151.65 51.09 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.255 1.303 . . . . 0.0 110.703 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -59.61 -0.11 0.16 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.105 -0.997 . . . . 0.0 109.045 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' B' ' 34' ' ' PRO . 87.6 m-20 -64.28 -36.43 84.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.46 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -122.46 116.03 23.26 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.582 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.537 HG23 ' N ' ' B' ' 39' ' ' GLU . 9.9 t -111.92 -137.09 0.37 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.441 -0.787 . . . . 0.0 110.885 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.537 ' N ' HG23 ' B' ' 38' ' ' THR . 21.1 pt-20 -63.19 -28.93 70.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.658 -1.276 . . . . 0.0 110.743 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.62 -55.45 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.811 -1.18 . . . . 0.0 110.611 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.46 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -68.93 -43.7 74.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 111.064 -178.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.558 ' O ' ' SG ' ' B' ' 46' ' ' CYS . 51.1 mm -63.44 -52.63 55.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 118.715 -1.194 . . . . 0.0 107.959 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' B' ' 39' ' ' GLU . 46.3 tp -39.71 -22.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.625 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 24.7 t70 -124.97 -27.13 3.62 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.432 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.861 ' O ' HD12 ' B' ' 45' ' ' LEU . 0.3 OUTLIER -58.68 -45.27 89.8 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.205 -1.559 . . . . 0.0 108.101 178.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.69 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.8 p -77.68 -60.78 2.23 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.815 -1.154 . . . . 0.0 107.982 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.834 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.3 p -37.33 -18.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.73 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' B' ' 46' ' ' CYS . 1.4 m120 -47.75 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.405 0.622 . . . . 0.0 110.69 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.834 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.2 t 168.56 -32.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.23 165.24 37.65 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.236 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.87 91.48 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.047 2.498 . . . . 0.0 112.463 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.535 HG11 ' CG2' ' B' ' 72' ' ' ILE . 1.8 t -46.89 156.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.367 -0.833 . . . . 0.0 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 26.7 mm -100.4 -55.74 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.742 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 13.8 m-20 -118.3 127.85 54.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.314 -0.866 . . . . 0.0 111.317 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.91 130.14 48.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -139.79 125.39 19.27 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.808 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.8 tpt -105.93 129.4 54.08 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 0.659 ' HE1' ' C8 ' ' A' ' 11' ' ' ' A' . 0.0 OUTLIER -152.17 155.85 38.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.434 ' O ' ' CD ' ' B' ' 61' ' ' PRO . 0.2 OUTLIER -113.03 179.93 3.82 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' B' ' 66' ' ' SER . 51.2 p-10 -102.75 74.52 0.18 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.15 -0.969 . . . . 0.0 110.75 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 28.6 Cg_endo -65.77 -60.1 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.966 1.777 . . . . 0.0 112.149 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.428 ' H ' ' H61' ' A' ' 11' ' ' ' A' . 30.9 tt0 -87.26 -50.01 6.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.936 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.534 HG21 ' C5 ' ' A' ' 10' ' ' ' U' . 30.3 p -57.47 -45.06 85.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.454 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.443 ' C ' ' OD2' ' B' ' 60' ' ' ASP . . . 74.87 11.72 83.47 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.42 HH22 ' CZ ' ' C' ' 200' ' ' ARG . 10.8 mtp85 -66.02 -52.18 51.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.933 -1.334 . . . . 0.0 109.877 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.643 ' H ' ' HB3' ' B' ' 60' ' ' ASP . 8.0 t -156.02 145.24 20.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.12 -0.988 . . . . 0.0 110.403 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -79.98 -5.87 56.5 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.735 -1.228 . . . . 0.0 109.465 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -127.94 88.52 0.33 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.093 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 0.919 ' CE1' " H4'" ' A' ' 9' ' ' ' A' . 1.5 m-85 -127.98 126.25 41.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.175 -1.191 . . . . 0.0 109.452 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.01 137.7 31.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.975 -1.078 . . . . 0.0 110.088 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.802 ' CE1' " H5'" ' A' ' 10' ' ' ' U' . 4.9 m-30 -103.49 125.3 49.98 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.378 -0.827 . . . . 0.0 108.93 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.538 HD12 ' N ' ' B' ' 72' ' ' ILE . 3.7 mp -122.01 97.76 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.645 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 53.2 mt-10 -86.96 127.85 35.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.707 -1.246 . . . . 0.0 110.734 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -89.68 179.86 5.93 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.621 0.724 . . . . 0.0 110.579 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 0.1 OUTLIER -57.06 -42.45 80.59 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.593 -0.692 . . . . 0.0 110.374 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.662 ' O ' ' N ' ' B' ' 78' ' ' GLU . 4.2 m-20 158.76 177.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.176 -0.952 . . . . 0.0 109.018 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.758 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.6 OUTLIER -33.68 -24.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.919 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.662 ' N ' ' O ' ' B' ' 76' ' ' ASP . 10.6 mp0 -69.84 -73.85 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.387 -1.446 . . . . 0.0 108.891 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 13.9 m -62.97 -41.36 99.52 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.41 ' O ' HG23 ' B' ' 84' ' ' VAL . 1.3 m -59.6 -39.13 83.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.19 -0.943 . . . . 0.0 108.779 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -59.55 -61.21 2.79 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.141 0.972 . . . . 0.0 108.801 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.583 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 69.5 m -63.29 -39.7 95.31 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.579 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -79.6 -61.13 2.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.983 -1.073 . . . . 0.0 110.169 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.653 HG12 ' ND2' ' B' ' 88' ' ' ASN . 26.7 t -51.19 -42.45 25.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.023 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.476 ' HA ' HD22 ' B' ' 88' ' ' ASN . 23.3 ttm180 -64.9 -56.57 12.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.411 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 82' ' ' SER . 8.7 m-80 -67.47 -43.8 80.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 109.849 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' B' ' 83' ' ' ALA . 51.0 mt -104.83 34.87 2.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.0 110.433 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.653 ' ND2' HG12 ' B' ' 84' ' ' VAL . 0.5 OUTLIER -62.6 -78.81 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.123 -0.986 . . . . 0.0 108.375 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -134.17 116.29 1.62 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.0 OUTLIER -138.1 145.8 42.1 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.369 -1.665 . . . . 0.0 107.752 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.0 OUTLIER -30.9 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.668 -0.645 . . . . 0.0 111.286 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.564 HD22 HD21 ' B' ' 45' ' ' LEU . 11.3 tp -154.03 140.8 19.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.53 -171.63 0.1 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 47.2 p -67.94 -22.39 65.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' B' ' 92' ' ' LEU . 94.9 mtt180 -136.23 163.52 30.2 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' B' ' 97' ' ' LEU . 4.2 m-85 -93.04 141.68 28.13 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.257 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' B' ' 88' ' ' ASN . 0.0 OUTLIER -37.4 136.99 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.468 ' O ' HG13 ' B' ' 28' ' ' VAL . 67.9 mmtt -108.4 147.77 31.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . 0.544 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 31.2 p -87.55 116.7 25.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' B' ' 27' ' ' VAL . . . -115.03 158.39 14.37 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.51 ' CB ' ' O ' ' B' ' 23' ' ' PRO . 1.8 p90 -136.97 113.87 10.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.308 -1.113 . . . . 0.0 109.122 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 51.0 p -136.94 -84.41 0.34 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.253 -0.904 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 24.6 t -144.78 146.59 32.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.412 ' HB3' ' HE ' ' B' ' 26' ' ' ARG . 4.1 p-10 -113.07 17.14 19.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.468 -0.77 . . . . 0.0 109.281 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.625 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 65.2 tttt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -110.18 144.91 38.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 109.361 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 48.7 m -123.96 140.63 52.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 109.909 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.11 -1.98 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.992 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.79 140.08 32.7 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.015 -1.053 . . . . 0.0 108.936 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . . . . . . . . . 24.8 ptm -123.32 155.61 36.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 109.345 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.717 ' CD2' ' C6 ' ' A' ' 6' ' ' ' A' . 72.1 t80 -111.29 77.95 1.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.709 HD11 HD13 ' C' ' 205' ' ' LEU . 60.8 mt -49.02 135.9 5.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' C' ' 229' ' ' ASP . . . -136.02 157.14 23.27 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.125 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.775 ' H ' ' H3 ' ' A' ' 5' ' ' ' U' . . . 76.02 20.65 77.43 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . 0.647 ' CB ' ' HZ1' ' C' ' 192' ' ' LYS . 83.0 mt -60.14 171.24 1.04 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.175 -1.191 . . . . 0.0 108.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.59 ' O ' ' N7 ' ' A' ' 4' ' ' ' A' . 17.0 p30 -68.92 -79.95 0.05 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.017 -1.052 . . . . 0.0 109.309 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.714 ' CZ3' ' C6 ' ' A' ' 4' ' ' ' A' . 0.0 OUTLIER 178.8 -24.24 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.78 -1.2 . . . . 0.0 110.192 179.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . 0.453 ' OD1' ' C ' ' C' ' 169' ' ' ASP . 19.6 t0 -135.03 93.53 3.02 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.016 -1.053 . . . . 0.0 110.623 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . 0.586 ' H ' ' CD ' ' C' ' 192' ' ' LYS . 17.4 m -139.97 145.71 38.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.309 -0.869 . . . . 0.0 109.207 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.82 167.21 10.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.951 -1.093 . . . . 0.0 109.348 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.28 -56.37 22.32 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -48.38 -40.82 26.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.996 -1.065 . . . . 0.0 110.818 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -74.85 -53.13 9.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 109.962 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.571 HD22 HD11 ' C' ' 190' ' ' ILE . 10.3 tp -53.02 -45.68 68.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' C' ' 177' ' ' GLU . 27.4 ttp180 -66.12 -60.28 2.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' C' ' 176' ' ' ARG . 61.3 mm-40 -40.97 -30.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.535 ' O ' ' NZ ' ' C' ' 181' ' ' LYS . 1.1 t80 -76.67 -48.68 18.22 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.354 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.863 ' O ' ' N ' ' C' ' 181' ' ' LYS . 24.5 m-85 -72.58 -58.46 3.35 Favored 'General case' 0 C--O 1.196 -1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -43.42 10.18 0.0 OUTLIER Glycine 0 N--CA 1.507 3.379 0 O-C-N 119.845 -1.785 . . . . 0.0 112.574 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . 0.863 ' N ' ' O ' ' C' ' 179' ' ' PHE . 1.5 ttmp? -75.99 -18.35 59.33 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.726 -1.455 . . . . 0.0 107.689 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' C' ' 182' ' ' TYR . 3.2 m-85 -93.14 -58.73 2.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.361 -0.837 . . . . 0.0 109.708 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -144.54 -129.86 2.24 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 28.0 m -127.16 153.88 45.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.384 -1.068 . . . . 0.0 110.154 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.39 149.39 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.44 HG22 ' O ' ' C' ' 206' ' ' SER . 0.0 OUTLIER -90.02 -42.18 11.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.904 -1.123 . . . . 0.0 110.02 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -154.52 155.91 35.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.998 . . . . 0.0 109.319 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 1.059 HD12 ' N ' ' C' ' 189' ' ' LYS . 0.1 OUTLIER -147.15 139.62 24.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.652 -1.28 . . . . 0.0 107.809 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . 1.059 ' N ' HD12 ' C' ' 188' ' ' LEU . 5.9 tptp -127.61 133.85 49.69 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.878 -1.139 . . . . 0.0 109.64 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . 0.571 HD11 HD22 ' C' ' 175' ' ' LEU . 0.2 OUTLIER -127.62 156.24 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 108.521 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 4.0 tpp -139.84 42.3 1.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.022 -1.049 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . 0.647 ' HZ1' ' CB ' ' C' ' 166' ' ' LEU . 18.3 mttp -72.76 -163.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.982 -1.074 . . . . 0.0 109.432 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' C' ' 197' ' ' GLY . 0.9 OUTLIER -127.65 52.67 8.86 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.542 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 193' ' ' ASP . 83.9 Cg_endo -78.57 -4.42 14.11 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.823 2.349 . . . . 0.0 111.87 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.41 28.3 3.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.447 -0.783 . . . . 0.0 109.444 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . 0.471 ' OG1' ' OD1' ' C' ' 193' ' ' ASP . 0.5 OUTLIER -153.37 -55.33 0.11 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.315 -0.866 . . . . 0.0 109.862 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . 0.58 ' N ' ' OD2' ' C' ' 193' ' ' ASP . . . 174.42 -100.94 0.15 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -136.08 136.83 40.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 109.488 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . 0.515 ' O ' ' O ' ' C' ' 200' ' ' ARG . 9.3 t -153.36 170.61 20.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.263 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' C' ' 199' ' ' SER . 6.4 mmp_? -42.57 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 109.117 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . 0.435 ' HA2' ' HZ2' ' C' ' 192' ' ' LYS . . . -141.69 94.28 0.19 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.899 ' CZ ' " H4'" ' A' ' 7' ' ' ' U' . 21.0 p90 -137.94 167.78 21.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -136.36 136.13 8.19 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 119.061 -1.542 . . . . 0.0 109.66 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -105.43 102.88 12.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.709 HD13 HD11 ' C' ' 163' ' ' ILE . 0.5 OUTLIER -101.43 111.29 23.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.419 -178.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . 0.44 ' O ' HG22 ' C' ' 186' ' ' THR . 21.3 t -82.79 70.92 9.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.623 ' CE2' HD23 ' C' ' 205' ' ' LEU . 2.7 m-85 -60.01 117.98 5.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.375 -0.828 . . . . 0.0 109.492 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.63 -51.13 66.55 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.045 -1.035 . . . . 0.0 109.354 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' C' ' 211' ' ' SER . 50.5 mtpt -84.95 103.79 3.78 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.084 -1.01 . . . . 0.0 110.436 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.67 -15.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.823 1.682 . . . . 0.0 112.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.557 ' O ' ' N ' ' C' ' 213' ' ' VAL . 17.6 m -68.36 -69.49 0.32 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.855 -1.153 . . . . 0.0 109.898 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.487 ' C ' ' O ' ' C' ' 211' ' ' SER . 0.0 OUTLIER -36.46 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.736 -0.603 . . . . 0.0 109.672 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' C' ' 211' ' ' SER . 88.4 t -65.63 -45.1 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 109.396 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' C' ' 211' ' ' SER . 90.5 m-20 -61.72 -46.57 89.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.584 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.24 -39.33 86.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 108.965 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.696 ' O ' ' NE2' ' C' ' 221' ' ' HIS . 15.2 t -64.85 -49.7 78.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.351 0.596 . . . . 0.0 109.66 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.13 -31.17 52.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.585 -1.322 . . . . 0.0 109.488 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -81.12 -44.35 18.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.487 -0.758 . . . . 0.0 110.131 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . 0.579 ' O ' ' CD2' ' C' ' 221' ' ' HIS . 41.5 m -66.39 151.23 47.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.345 -0.847 . . . . 0.0 110.632 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -80.36 148.33 30.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.592 -0.692 . . . . 0.0 109.657 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.704 ' HB3' HD11 ' C' ' 228' ' ' ILE . 24.5 m-70 -132.84 132.74 42.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.222 -0.924 . . . . 0.0 110.623 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.2 86.61 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -55.15 -71.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 109.627 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' C' ' 167' ' ' ASN . 91.8 m-20 -96.2 7.64 45.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 0.0 109.126 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.52 12.28 61.3 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . 0.91 ' O ' HG13 ' C' ' 227' ' ' VAL . 0.4 OUTLIER -85.78 -86.06 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.349 -1.089 . . . . 0.0 109.737 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . 0.91 HG13 ' O ' ' C' ' 226' ' ' LYS . 0.0 OUTLIER 171.85 95.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.827 . . . . 0.0 109.641 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' C' ' 221' ' ' HIS . 15.4 pt -99.39 160.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.124 -0.985 . . . . 0.0 109.127 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' C' ' 164' ' ' GLY . 5.4 m-20 -126.76 102.17 25.78 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 111.016 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.5 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 28.9 Cg_endo -83.28 137.29 8.17 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -164.05 168.66 18.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.912 -1.117 . . . . 0.0 109.804 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -58.64 156.07 11.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.986 . . . . 0.0 109.462 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . 0.4 ' O ' ' CG1' ' C' ' 234' ' ' ILE . . . -70.26 124.08 23.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . 0.629 ' O ' ' C6 ' ' A' ' 6' ' ' ' A' . 13.2 mt -158.71 108.92 1.62 Allowed Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.12 132.31 8.73 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.604 1.536 . . . . 0.0 111.82 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.438 ' NH2' ' H5 ' ' A' ' 5' ' ' ' U' . 5.3 tpp180 -55.47 -36.43 66.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.173 -0.955 . . . . 0.0 109.002 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . 0.406 ' OD1' ' CZ ' ' C' ' 321' ' ' ARG . 54.7 t0 -52.82 -40.89 63.69 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -70.17 -36.14 74.47 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.512 ' O ' ' OG1' ' C' ' 242' ' ' THR . 54.9 mm-40 -57.69 -38.48 75.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 108.896 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . 0.402 ' OD1' ' NZ ' ' C' ' 244' ' ' LYS . 87.2 m-20 -68.48 -37.67 80.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.724 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -60.94 -29.73 69.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' C' ' 239' ' ' GLN . 9.5 p -65.01 -21.71 66.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.968 -1.082 . . . . 0.0 110.09 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . 110.35 102.66 2.72 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . 0.402 ' NZ ' ' OD1' ' C' ' 240' ' ' ASP . 4.3 ttpt -131.24 126.79 36.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.314 . . . . 0.0 110.223 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.489 HD12 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -113.86 141.82 28.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' C' ' 246' ' ' PHE . 0.0 OUTLIER -87.33 164.9 16.0 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' C' ' 246' ' ' PHE . 58.8 t -136.69 131.53 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . 0.441 ' HA3' ' H3 ' ' A' ' 1' ' ' ' U' . . . -108.95 142.32 16.1 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . 0.637 ' O ' HG22 ' C' ' 313' ' ' ILE . . . 90.27 66.99 1.2 Allowed Glycine 0 N--CA 1.491 2.358 0 O-C-N 121.137 -1.214 . . . . 0.0 110.689 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' C' ' 285' ' ' GLY . 38.4 mm -114.2 133.82 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.177 -1.19 . . . . 0.0 109.131 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.66 157.48 45.08 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.93 -22.82 55.29 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.823 2.349 . . . . 0.0 112.6 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -124.35 52.57 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.302 -0.874 . . . . 0.0 109.923 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.764 HG13 ' HG3' ' C' ' 309' ' ' LYS . 47.7 t -100.56 36.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.073 -1.017 . . . . 0.0 110.725 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' C' ' 254' ' ' VAL . 4.0 mtp85 -16.5 146.96 0.0 OUTLIER Pre-proline 0 N--CA 1.513 2.7 0 CA-C-O 121.384 0.611 . . . . 0.0 111.851 -177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' C' ' 257' ' ' LYS . 31.1 Cg_endo -57.95 -19.99 42.66 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.723 2.282 . . . . 0.0 113.048 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' C' ' 256' ' ' PRO . 54.0 tttm -46.51 -67.78 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . 0.744 ' O ' ' N ' ' C' ' 261' ' ' GLU . 23.8 mp0 -60.72 -91.46 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.71 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' C' ' 274' ' ' LEU . 56.7 t80 -6.1 -68.08 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 CA-C-O 121.179 0.514 . . . . 0.0 111.18 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 258' ' ' GLU . 83.4 tt0 -54.97 -48.02 73.78 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.617 0.723 . . . . 0.0 109.545 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . 0.744 ' N ' ' O ' ' C' ' 258' ' ' GLU . 82.1 tt0 -71.56 -45.04 63.41 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -49.84 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.61 -0.681 . . . . 0.0 110.827 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.528 ' O ' ' C ' ' C' ' 264' ' ' SER . 63.5 m-85 -45.3 -44.37 11.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.906 -177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.617 ' O ' ' N ' ' C' ' 266' ' ' TRP . 1.3 p -37.88 -36.64 0.2 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' C' ' 263' ' ' PHE . 23.4 tt0 -42.14 -9.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.946 -0.471 . . . . 0.0 111.872 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.617 ' N ' ' O ' ' C' ' 264' ' ' SER . 16.0 p90 -159.33 44.81 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.22 -1.55 . . . . 0.0 110.527 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . 0.448 ' O ' HD12 ' C' ' 269' ' ' ILE . . . 154.41 123.8 0.9 Allowed Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.294 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . . . . . . . . . 27.8 m -56.78 140.4 47.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -1.153 . . . . 0.0 108.823 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.569 HG22 ' O ' ' C' ' 269' ' ' ILE . 1.1 mp -99.03 109.66 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.16 -0.963 . . . . 0.0 110.762 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.9 -50.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 109.877 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . 0.561 ' O ' ' C ' ' C' ' 272' ' ' ALA . 59.4 t0 -147.01 17.45 1.23 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.839 -1.163 . . . . 0.0 111.407 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' C' ' 271' ' ' ASP . . . -27.91 138.66 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.585 -0.697 . . . . 0.0 109.979 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -133.56 124.22 26.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.231 -0.918 . . . . 0.0 111.013 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' C' ' 259' ' ' PHE . 1.4 tm? -121.43 129.37 52.95 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . 0.765 ' N ' HD13 ' C' ' 274' ' ' LEU . 3.8 mmt -102.09 163.81 12.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.572 -1.33 . . . . 0.0 110.021 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.762 HD12 ' O ' ' C' ' 275' ' ' MET . 1.0 OUTLIER -144.07 -175.34 4.57 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.044 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -44.93 -86.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.572 -0.705 . . . . 0.0 109.689 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -107.77 -20.74 13.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 108.992 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . 0.753 ' O ' HG11 ' C' ' 227' ' ' VAL . 21.5 t70 -52.73 -26.94 15.59 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . 0.607 ' OG1' ' N ' ' C' ' 276' ' ' LEU . 0.0 OUTLIER -143.37 -8.34 0.77 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.514 -0.741 . . . . 0.0 109.651 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.71 64.99 1.7 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' C' ' 276' ' ' LEU . 9.3 tp-100 -171.93 164.24 6.3 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.206 -1.173 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . 0.423 ' H ' ' H ' ' C' ' 284' ' ' ARG . 25.6 p -170.14 0.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.199 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' C' ' 283' ' ' SER . 46.7 mmt-85 -55.9 -31.2 62.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.373 -0.829 . . . . 0.0 109.661 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' C' ' 250' ' ' ILE . . . 106.81 20.64 8.72 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.184 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.46 ' CE2' " H5'" ' A' ' 3' ' ' ' U' . 26.8 p90 -109.84 175.81 5.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.068 -1.254 . . . . 0.0 110.203 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -163.49 -177.42 36.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -149.75 149.84 31.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.31 -1.7 . . . . 0.0 108.778 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' C' ' 291' ' ' TYR . 17.0 t -130.06 149.14 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' C' ' 271' ' ' ASP . 48.7 m -132.84 121.57 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.641 -1.287 . . . . 0.0 109.082 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . 0.507 ' CZ ' HG11 ' C' ' 289' ' ' VAL . 46.5 m-85 -116.22 137.4 52.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.204 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' C' ' 293' ' ' SER . 17.7 p-10 -62.35 -49.67 74.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 75.7 m -67.91 124.22 22.74 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -77.36 -27.05 52.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.086 -2.191 . . . . 0.0 105.086 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -51.46 -41.72 61.08 Favored 'General case' 0 C--O 1.206 -1.222 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.23 75.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.994 -1.066 . . . . 0.0 108.393 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . . . . . . . . . 83.1 t -54.76 -55.41 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -54.72 -29.56 53.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.66 -0.65 . . . . 0.0 109.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -71.69 -62.97 1.22 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.579 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' C' ' 303' ' ' ASN . 4.2 p -61.5 -24.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.628 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' C' ' 300' ' ' VAL . 1.3 m -43.98 -58.4 2.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.121 -0.987 . . . . 0.0 109.162 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -50.8 -26.86 6.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.081 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' C' ' 300' ' ' VAL . 34.1 t-20 -99.43 86.41 3.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 109.509 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' C' ' 314' ' ' GLU . 13.5 tttp -75.05 -84.31 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.695 -1.253 . . . . 0.0 108.561 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -58.74 127.62 33.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.198 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.1 tt -138.58 142.18 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.641 1.21 . . . . 0.0 110.18 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' C' ' 307' ' ' ASP . 47.3 p30 -68.65 142.13 55.17 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.866 0.841 . . . . 0.0 110.531 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.626 ' O ' ' N ' ' C' ' 310' ' ' ASP . 9.9 t80 -169.84 -174.07 1.74 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.764 ' HG3' HG13 ' C' ' 254' ' ' VAL . 37.0 mmtt -32.75 -30.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.556 -0.715 . . . . 0.0 110.217 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' C' ' 308' ' ' PHE . 92.6 m-20 -87.1 -84.74 0.18 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.3 -0.875 . . . . 0.0 109.543 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.07 -29.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.015 -1.053 . . . . 0.0 110.556 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -168.75 49.79 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.988 -1.07 . . . . 0.0 109.342 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.637 HG22 ' O ' ' C' ' 249' ' ' GLY . 10.7 pt -49.92 138.55 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.766 0.793 . . . . 0.0 110.791 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . 0.55 ' HB3' ' HZ2' ' C' ' 304' ' ' LYS . 54.8 mt-10 -85.44 115.8 23.39 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.23 0.538 . . . . 0.0 110.527 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.489 ' CG2' HD12 ' C' ' 245' ' ' ILE . 83.8 mt -82.78 158.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.075 -1.016 . . . . 0.0 108.944 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . 0.413 ' N ' HG22 ' C' ' 315' ' ' ILE . 0.1 OUTLIER -166.58 165.95 16.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.511 -1.368 . . . . 0.0 109.659 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -78.8 140.45 38.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.625 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' C' ' 245' ' ' ILE . . . -70.79 -29.91 66.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.909 -1.119 . . . . 0.0 108.837 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 178.08 154.0 0.49 Allowed Pre-proline 0 C--N 1.296 -1.754 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.29 136.8 27.27 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.078 1.852 . . . . 0.0 112.326 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . 0.406 ' CZ ' ' OD1' ' C' ' 237' ' ' ASP . 4.5 mtt-85 179.41 -29.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.199 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . . . . . . . . . 17.7 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.569 179.809 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.708 " O2'" " H2'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.436 1.828 1 C5'-C4'-C3' 107.587 -5.275 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.765 " O2'" ' H6 ' ' A' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C1' 1.439 2.115 1 C5'-C4'-C3' 108.023 -4.984 . 0.137 2z . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 0.786 " H5'" ' CZ ' ' C' ' 286' ' ' PHE . . . . . . . . 0 P--O5' 1.613 1.966 1 C5'-C4'-C3' 108.214 -4.857 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.742 ' H8 ' ' O ' ' C' ' 166' ' ' LEU . . . . . . . . 0 O4'--C1' 1.439 2.044 1 C5'-C4'-C3' 106.623 -5.918 . 0.22 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.72 ' C2 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 O4'--C1' 1.446 2.67 0 C5'-C4'-C3' 109.622 -3.918 . 0.599 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 1.003 " C4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.616 2.252 1 C5'-C4'-C3' 108.64 -4.574 . 0.442 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 1.003 " H5'" " C4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.621 2.835 1 C5'-C4'-C3' 108.273 -4.818 . 0.195 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.643 ' N3 ' ' CD2' ' B' ' 29' ' ' TYR . . . . . . . . 0 O4'--C4' 1.428 -2.09 2 C5'-C4'-C3' 106.132 -6.245 OUTLIER-DELTA 0.303 2[ . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.921 " H1'" ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 P--O5' 1.612 1.899 2 C5'-C4'-C3' 108.737 -4.509 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 0.642 ' H6 ' " O5'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.614 2.088 1 C5'-C4'-C3' 108.234 -4.844 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.846 " O2'" ' H8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.925 1 C5'-C4'-C3' 106.937 -5.709 . 0.424 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.846 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.611 1.807 1 C5'-C4'-C3' 106.929 -5.714 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.516 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.927 1 C5'-C4'-C3' 107.571 -5.286 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.439 ' O ' ' CD2' ' B' ' 101' ' ' TYR . 6.6 Cg_exo -64.53 150.03 88.92 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.231 1.954 . . . . 0.0 112.303 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -85.09 26.35 0.65 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.559 2.173 . . . . 0.0 112.78 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.01 126.28 11.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.616 -1.303 . . . . 0.0 110.23 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -179.46 -49.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 109.24 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' B' ' 101' ' ' TYR . 3.0 p -125.04 154.91 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.832 0.825 . . . . 0.0 110.436 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.413 ' N ' HG22 ' B' ' 27' ' ' VAL . 3.0 t -108.06 139.52 29.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.693 ' CE2' ' C2 ' ' A' ' 9' ' ' ' A' . 5.1 m-85 -102.24 133.05 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.111 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' B' ' 72' ' ' ILE . 4.5 mp -116.96 121.28 40.95 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' B' ' 69' ' ' TYR . . . -114.61 -94.17 1.99 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.649 ' H ' ' NH1' ' B' ' 95' ' ' ARG . 2.7 p -69.04 110.7 4.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.75 -1.441 . . . . 0.0 110.36 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -160.74 127.37 2.5 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' B' ' 36' ' ' ASP . 51.7 Cg_endo -74.85 170.87 19.41 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.604 1.536 . . . . 0.0 112.61 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.589 ' OH ' ' CD1' ' B' ' 59' ' ' PHE . 3.8 m-30 -69.29 4.72 1.56 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.55 -0.719 . . . . 0.0 109.527 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' B' ' 34' ' ' PRO . 90.3 m-20 -60.26 -38.06 82.34 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.129 -0.982 . . . . 0.0 109.443 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -129.81 116.01 18.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 109.459 -179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.427 ' O ' HG12 ' B' ' 42' ' ' ILE . 82.2 p -113.02 -140.64 0.38 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.696 0.76 . . . . 0.0 111.631 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.401 ' CD ' ' C ' ' B' ' 39' ' ' GLU . 1.6 pp20? -61.46 -34.28 75.17 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.673 -1.267 . . . . 0.0 111.358 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -71.69 -53.95 11.87 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -67.43 -44.1 79.56 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.385 -0.822 . . . . 0.0 110.189 -178.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.584 ' O ' ' N ' ' B' ' 44' ' ' ASP . 30.6 mm -58.0 -51.62 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.808 HD13 ' O ' ' B' ' 43' ' ' LEU . 3.1 tm? -37.43 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.484 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' B' ' 42' ' ' ILE . 83.7 m-20 -124.7 -24.48 4.15 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.713 HD13 ' O ' ' B' ' 45' ' ' LEU . 3.3 tm? -60.09 -41.18 91.94 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.214 -1.554 . . . . 0.0 107.472 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.621 ' O ' ' N ' ' B' ' 48' ' ' ASN . 1.4 m -87.65 -63.04 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.817 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.915 ' O ' ' N ' ' B' ' 49' ' ' VAL . 1.1 p -40.11 -19.96 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.779 -0.576 . . . . 0.0 109.896 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.671 ' O ' HG23 ' B' ' 49' ' ' VAL . 0.3 OUTLIER -42.69 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.117 0.96 . . . . 0.0 110.131 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.915 ' N ' ' O ' ' B' ' 47' ' ' SER . 0.9 OUTLIER 161.58 -28.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 47' ' ' SER . . . -169.37 123.16 1.06 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.424 -1.37 . . . . 0.0 109.941 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -48.14 100.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.579 1.52 . . . . 0.0 111.523 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.436 ' H ' HG13 ' B' ' 52' ' ' VAL . 0.8 OUTLIER -49.63 171.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.372 -0.83 . . . . 0.0 109.852 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.406 HD11 ' HG2' ' B' ' 75' ' ' ARG . 35.5 mm -107.47 -49.12 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 110.132 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.579 ' ND2' ' OE1' ' B' ' 73' ' ' GLU . 40.5 m-20 -118.35 139.17 51.76 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.103 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.558 HD23 ' N ' ' B' ' 56' ' ' LYS . 0.6 OUTLIER -139.96 132.2 28.2 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.558 ' N ' HD23 ' B' ' 55' ' ' LEU . 21.4 tptp -137.26 121.5 18.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.045 -1.034 . . . . 0.0 109.678 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 3.3 tpt -104.5 128.61 52.48 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.726 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 0.63 ' CE ' ' N7 ' ' A' ' 11' ' ' ' A' . 2.1 ttt -149.32 148.9 30.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.061 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.589 ' CD1' ' OH ' ' B' ' 35' ' ' TYR . 2.3 m-85 -104.11 -175.92 2.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.589 ' OD2' ' N ' ' B' ' 66' ' ' SER . 49.8 m-20 -115.55 87.38 17.14 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.07 -1.019 . . . . 0.0 110.657 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.06 -60.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.485 2.123 . . . . 0.0 112.353 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' B' ' 63' ' ' THR . 3.4 tt0 -86.2 -62.1 1.59 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.205 -0.934 . . . . 0.0 109.708 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.446 HG23 ' H ' ' B' ' 63' ' ' THR . 5.2 p -45.24 -43.02 10.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.835 . . . . 0.0 108.91 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.41 18.26 76.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.547 ' CZ ' ' O4 ' ' A' ' 10' ' ' ' U' . 25.5 mmt85 -61.99 -42.02 98.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.979 -1.307 . . . . 0.0 109.516 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.589 ' N ' ' OD2' ' B' ' 60' ' ' ASP . 0.2 OUTLIER -179.86 179.15 0.58 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.978 -1.076 . . . . 0.0 110.782 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -117.93 78.7 1.27 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 152.65 48.08 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 0.92 ' CE2' H5'' ' A' ' 9' ' ' ' A' . 3.9 m-30 -97.01 125.44 41.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.43 158.16 43.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 111.847 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.921 ' CZ ' " H1'" ' A' ' 9' ' ' ' A' . 5.7 m-85 -125.97 126.99 45.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.468 -0.77 . . . . 0.0 109.629 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.896 HD12 ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -118.06 98.7 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.724 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.579 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.8 tt0 -82.54 126.4 32.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.379 -1.451 . . . . 0.0 110.282 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -86.72 176.36 7.79 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.573 0.701 . . . . 0.0 110.038 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 58.3 mtp180 -56.63 -42.07 78.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.481 -0.762 . . . . 0.0 109.888 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' B' ' 78' ' ' GLU . 1.2 m-20 165.64 172.59 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.843 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 0.9 OUTLIER -38.07 -19.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.062 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.653 ' N ' ' O ' ' B' ' 76' ' ' ASP . 77.1 mm-40 -74.43 -70.83 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.95 -1.094 . . . . 0.0 108.748 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 37.0 m -59.49 -45.02 92.89 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.66 -1.275 . . . . 0.0 107.691 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' B' ' 84' ' ' VAL . 8.6 t -62.68 -34.88 78.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 109.184 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.843 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -56.23 -59.36 5.05 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.124 -1.61 . . . . 0.0 107.231 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.502 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 33.3 t -65.58 -38.95 91.0 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.501 ' N ' HG11 ' B' ' 49' ' ' VAL . . . -79.28 -62.9 1.55 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.867 -1.146 . . . . 0.0 110.197 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' B' ' 88' ' ' ASN . 0.6 OUTLIER -52.01 -42.91 35.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.015 -1.074 . . . . 0.0 108.861 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 4.0 mmt180 -66.82 -43.53 83.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.643 -1.911 . . . . 0.0 109.258 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.636 ' N ' HD22 ' B' ' 86' ' ' ASN . 0.8 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 111.619 -178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.768 ' O ' HD11 ' B' ' 97' ' ' LEU . 7.9 mt -117.09 -4.05 11.49 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.927 -1.108 . . . . 0.0 111.254 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' B' ' 84' ' ' VAL . 0.0 OUTLIER -16.11 -80.18 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.074 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.84 108.11 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -130.37 143.4 50.75 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 120.699 -1.471 . . . . 0.0 108.087 -179.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.568 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 1.0 OUTLIER -32.66 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.648 -0.658 . . . . 0.0 110.832 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 90' ' ' TYR . 5.3 tt -148.36 132.36 17.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.23 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 49.81 -157.94 1.58 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -21.18 52.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -1.125 . . . . 0.0 108.646 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.649 ' NH1' ' H ' ' B' ' 32' ' ' SER . 32.0 ttm105 -136.85 146.92 46.17 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' B' ' 96' ' ' PHE . 1.6 m-30 -93.1 143.92 25.77 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.511 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.768 HD11 ' O ' ' B' ' 87' ' ' LEU . 0.2 OUTLIER -46.68 157.69 0.14 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.174 -179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 147.97 42.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 109.888 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 17.2 p -77.2 121.46 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.412 ' HA3' ' CE1' ' B' ' 29' ' ' TYR . . . -135.89 174.56 21.32 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.515 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.505 ' HA ' HG12 ' B' ' 27' ' ' VAL . 7.1 t80 -147.69 125.25 11.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.571 -0.958 . . . . 0.0 109.784 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -137.84 101.64 4.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.651 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.04 127.73 0.16 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.348 -0.845 . . . . 0.0 109.66 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -113.35 137.44 51.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.481 -0.762 . . . . 0.0 109.289 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.503 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 5.9 tptm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -114.85 163.42 15.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.398 -0.813 . . . . 0.0 109.62 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . 0.632 ' O ' ' N ' ' C' ' 160' ' ' LYS . 23.1 t -112.11 155.63 23.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.451 -0.781 . . . . 0.0 109.528 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' C' ' 213' ' ' VAL . 3.2 t -54.83 77.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.595 -0.69 . . . . 0.0 109.332 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' C' ' 158' ' ' SER . 11.3 tptp -88.21 136.17 33.1 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.611 0.72 . . . . 0.0 110.19 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . 0.641 ' HE1' HG22 ' C' ' 217' ' ' VAL . 39.2 mmm -115.62 150.65 36.35 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.604 -0.685 . . . . 0.0 109.633 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.72 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 4.9 t80 -116.48 123.84 48.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.611 ' CG2' HD21 ' C' ' 166' ' ' LEU . 5.2 mm -105.1 133.61 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.09 171.19 21.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.555 ' O ' HG22 ' C' ' 228' ' ' ILE . . . 69.1 28.71 72.62 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . 0.742 ' O ' ' H8 ' ' A' ' 4' ' ' ' A' . 97.5 mt -77.2 150.69 35.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 110.536 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' C' ' 169' ' ' ASP . 0.4 OUTLIER -75.3 153.85 37.7 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.669 ' CH2' ' C2 ' ' A' ' 4' ' ' ' A' . 2.5 m0 -69.42 19.07 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.886 -1.134 . . . . 0.0 110.032 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' C' ' 167' ' ' ASN . 59.5 t0 -145.14 84.47 1.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.946 -1.096 . . . . 0.0 110.692 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . 0.583 ' OG1' ' NZ ' ' C' ' 192' ' ' LYS . 0.2 OUTLIER -146.61 119.96 8.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.17 158.55 15.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 0.0 109.465 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' C' ' 173' ' ' ASP . 87.9 mt-10 -61.7 -69.29 0.25 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.829 -1.169 . . . . 0.0 110.915 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' C' ' 172' ' ' GLU . 55.1 t0 -42.31 -36.61 1.3 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.684 -1.26 . . . . 0.0 109.818 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -80.02 -47.85 14.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.412 -0.805 . . . . 0.0 109.69 179.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' C' ' 190' ' ' ILE . 7.6 tt -57.19 -42.26 80.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.034 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' C' ' 179' ' ' PHE . 70.8 ttp85 -67.34 -57.94 5.71 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' C' ' 176' ' ' ARG . 49.1 tp10 -39.75 -31.43 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.53 ' OH ' ' N ' ' C' ' 222' ' ' ILE . 15.4 t80 -74.13 -49.39 23.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.535 -0.866 . . . . 0.0 108.725 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.891 ' O ' ' N ' ' C' ' 181' ' ' LYS . 28.9 m-85 -74.87 -62.94 1.37 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . . . . . . . . . . . -39.43 4.19 0.0 OUTLIER Glycine 0 N--CA 1.508 3.457 0 O-C-N 120.345 -1.472 . . . . 0.0 112.38 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . 0.891 ' N ' ' O ' ' C' ' 179' ' ' PHE . 6.2 tttm -64.63 -28.57 69.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.779 -1.424 . . . . 0.0 107.839 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' C' ' 219' ' ' THR . 32.0 m-85 -78.39 -35.55 47.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.267 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.7 -126.1 0.88 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . . . . . . . . . 41.3 m -129.28 154.92 46.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.61 HG12 ' CE1' ' C' ' 207' ' ' PHE . 1.1 m -120.44 159.7 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 108.978 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . 0.492 ' O ' ' OD1' ' C' ' 187' ' ' ASP . 0.0 OUTLIER -99.01 -43.92 6.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 110.248 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' C' ' 186' ' ' THR . 68.8 m-20 -151.93 147.57 26.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.833 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.737 HD23 ' C ' ' C' ' 188' ' ' LEU . 0.2 OUTLIER -141.73 146.21 35.76 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.934 -1.104 . . . . 0.0 108.486 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.3 123.2 29.5 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.978 -1.076 . . . . 0.0 109.88 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . 0.596 ' CD1' HD13 ' C' ' 175' ' ' LEU . 92.6 mt -134.75 121.63 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.478 -1.388 . . . . 0.0 108.169 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -114.66 44.49 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.865 0.841 . . . . 0.0 108.806 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . 0.583 ' NZ ' ' OG1' ' C' ' 170' ' ' THR . 4.5 ttmt -64.45 -162.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.428 ' H ' ' HG2' ' C' ' 192' ' ' LYS . 0.5 OUTLIER -134.25 66.64 71.57 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.767 -1.208 . . . . 0.0 110.696 179.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -95.35 -0.91 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.426 2.751 . . . . 0.0 110.889 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.36 15.86 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.343 0.592 . . . . 0.0 109.424 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.1 -59.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . 175.2 -91.82 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . . . . . . . . . 53.1 mmt-85 -142.0 144.87 33.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.502 -0.999 . . . . 0.0 109.64 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . 0.463 ' OG ' ' OP1' ' A' ' 8' ' ' ' A' . 42.2 t -161.86 160.58 28.23 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.48 ' O ' ' CD1' ' C' ' 202' ' ' PHE . 64.1 mmt-85 -47.75 114.38 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 109.122 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . 0.419 ' O ' " O4'" ' A' ' 5' ' ' ' U' . . . -83.42 113.05 3.63 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.603 ' CE1' " H4'" ' A' ' 7' ' ' ' U' . 16.0 p90 -141.31 153.27 45.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.223 -1.163 . . . . 0.0 108.419 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -122.65 139.61 12.66 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.803 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -118.34 103.55 9.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 1.6 mt -109.06 109.22 20.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.972 . . . . 0.0 111.016 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . 0.527 ' HB2' ' HZ3' ' C' ' 160' ' ' LYS . 7.2 t -94.81 132.62 39.41 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' C' ' 185' ' ' VAL . 63.1 m-85 -116.21 143.43 45.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.924 -1.11 . . . . 0.0 109.559 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . 0.433 ' OE1' ' C ' ' C' ' 208' ' ' GLU . 1.7 tm-20 -68.15 -54.34 18.72 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.015 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' C' ' 210' ' ' PRO . 0.7 OUTLIER -91.16 108.22 26.9 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.968 -178.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' C' ' 209' ' ' LYS . 2.2 Cg_endo -44.38 -20.72 0.34 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.206 1.937 . . . . 0.0 113.683 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.574 ' O ' ' N ' ' C' ' 213' ' ' VAL . 11.3 t -61.83 -69.38 0.25 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.542 -1.349 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.679 ' O ' HG23 ' C' ' 216' ' ' VAL . 83.0 p -35.45 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.751 -0.593 . . . . 0.0 110.161 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . 0.595 HG21 ' SG ' ' C' ' 159' ' ' CYS . 0.4 OUTLIER -64.91 -37.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.0 109.229 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' C' ' 211' ' ' SER . 91.0 m-20 -63.68 -46.05 87.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 109.475 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 55.2 mp0 -68.76 -35.69 77.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.679 HG23 ' O ' ' C' ' 212' ' ' SER . 54.5 t -62.01 -52.62 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.384 -0.822 . . . . 0.0 109.811 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.641 HG22 ' HE1' ' C' ' 161' ' ' MET . 45.5 t -68.45 -38.79 79.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -73.31 -45.28 56.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.44 -0.788 . . . . 0.0 110.411 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . 0.587 HG21 ' OH ' ' C' ' 182' ' ' TYR . 24.9 m -68.75 145.65 53.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.21 -0.931 . . . . 0.0 111.658 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -80.33 149.94 30.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.62 ' HB2' HD11 ' C' ' 228' ' ' ILE . 20.5 m-70 -127.68 132.19 49.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.293 -0.88 . . . . 0.0 110.313 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.53 ' N ' ' OH ' ' C' ' 178' ' ' TYR . 0.0 OUTLIER -142.56 103.21 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.326 -0.859 . . . . 0.0 109.678 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.516 ' N ' HD12 ' C' ' 223' ' ' LEU . 10.7 mp -73.02 -62.58 1.41 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.023 -1.048 . . . . 0.0 109.216 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -110.26 12.66 23.21 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . 97.99 5.06 57.53 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -73.48 -171.61 1.03 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.357 -1.084 . . . . 0.0 108.17 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.04 102.21 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.546 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' C' ' 221' ' ' HIS . 15.8 pt -102.13 151.55 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.478 -0.764 . . . . 0.0 108.955 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -119.27 107.27 41.65 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.354 -0.841 . . . . 0.0 110.888 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' C' ' 221' ' ' HIS . 95.9 Cg_endo -89.19 135.23 2.65 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.756 2.304 . . . . 0.0 111.431 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . 0.584 ' NZ ' ' O4 ' ' A' ' 5' ' ' ' U' . 9.9 mtmp? -148.27 146.0 28.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.852 -1.155 . . . . 0.0 110.199 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' C' ' 233' ' ' ALA . 35.5 mtm105 -56.63 147.68 21.87 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' C' ' 232' ' ' ARG . . . -45.2 133.93 6.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.926 -1.109 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . 0.498 HD12 ' H62' ' A' ' 6' ' ' ' A' . 77.9 mt -109.86 124.15 34.36 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 109.667 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.15 142.42 4.07 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.939 1.759 . . . . 0.0 112.077 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.56 ' NH1' " O2'" ' A' ' 6' ' ' ' A' . 14.7 tpt180 -58.12 -43.68 87.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 110.688 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' C' ' 238' ' ' GLU . 29.7 p-10 -62.72 -39.26 93.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . 0.73 ' O ' HG23 ' C' ' 242' ' ' THR . 97.8 mt-10 -68.41 -41.84 79.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.103 -0.998 . . . . 0.0 109.692 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.615 ' NE2' ' N7 ' ' A' ' 6' ' ' ' A' . 4.5 tp-100 -65.44 -43.46 90.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.588 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -63.86 -41.57 97.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.887 . . . . 0.0 109.785 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -61.45 -47.18 86.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.746 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . 0.73 HG23 ' O ' ' C' ' 238' ' ' GLU . 59.6 p -54.59 137.65 42.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 109.72 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.48 150.14 17.98 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -130.08 132.27 46.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -1.046 . . . . 0.0 109.983 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.949 HD13 ' O ' ' C' ' 245' ' ' ILE . 0.0 OUTLIER -121.15 156.59 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.572 -0.705 . . . . 0.0 109.148 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.684 ' CE2' ' C4 ' ' A' ' 2' ' ' ' A' . 0.0 OUTLIER -105.48 135.01 47.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.578 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.49 131.7 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.778 0.799 . . . . 0.0 110.082 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.69 145.93 16.21 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.34 64.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -129.73 154.85 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.371 -1.076 . . . . 0.0 109.198 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' C' ' 252' ' ' PRO . . . 130.53 -39.6 1.78 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.629 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' C' ' 251' ' ' GLY . 87.6 Cg_exo -48.62 -120.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.612 2.208 . . . . 0.0 112.963 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -81.42 17.79 1.29 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' C' ' 308' ' ' PHE . 41.3 t -89.68 140.56 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.963 -1.086 . . . . 0.0 109.97 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -104.95 154.81 38.4 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.91 -24.89 74.2 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.157 1.905 . . . . 0.0 112.345 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -51.17 -64.65 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.714 -0.616 . . . . 0.0 109.697 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . 0.68 ' O ' ' N ' ' C' ' 261' ' ' GLU . 33.8 tt0 -61.16 -78.17 0.04 OUTLIER 'General case' 0 C--O 1.195 -1.81 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.176 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . 0.655 ' C ' ' O ' ' C' ' 258' ' ' GLU . 59.7 t80 -11.93 -65.74 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 121.52 0.676 . . . . 0.0 110.082 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' C' ' 258' ' ' GLU . 2.9 tm-20 -59.9 -45.73 91.61 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.574 -0.704 . . . . 0.0 110.799 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' C' ' 258' ' ' GLU . 63.2 mm-40 -71.89 -17.3 62.12 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.985 -1.072 . . . . 0.0 108.892 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' C' ' 263' ' ' PHE . 4.6 t80 -78.96 -80.52 0.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' C' ' 265' ' ' GLN . 31.0 m-85 -38.25 -42.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.235 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.615 ' N ' HD11 ' C' ' 269' ' ' ILE . 73.0 p -30.82 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.609 ' N ' ' O ' ' C' ' 263' ' ' PHE . 6.4 tt0 -45.26 -23.07 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.822 -0.549 . . . . 0.0 110.969 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.564 ' CZ2' ' CD2' ' C' ' 263' ' ' PHE . 8.2 p90 -151.58 151.1 31.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.644 -1.285 . . . . 0.0 109.246 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . . . . . . . . . . . 82.08 176.3 51.12 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . 0.511 ' O ' ' C ' ' C' ' 269' ' ' ILE . 43.1 p -115.35 19.61 15.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.733 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.615 HD11 ' N ' ' C' ' 264' ' ' SER . 0.0 OUTLIER -15.35 104.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 41.5 mm -83.4 -34.16 10.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -132.86 97.2 3.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . . . . . . . . . . . -108.99 131.47 55.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.442 -0.786 . . . . 0.0 109.158 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -160.94 129.91 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.118 -1.433 . . . . 0.0 112.422 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.717 ' O ' HD23 ' C' ' 274' ' ' LEU . 0.4 OUTLIER -97.12 157.89 15.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . 0.708 ' O ' HD22 ' C' ' 276' ' ' LEU . 0.5 OUTLIER -93.76 168.19 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.316 -1.49 . . . . 0.0 109.336 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.708 HD22 ' O ' ' C' ' 275' ' ' MET . 0.2 OUTLIER -150.35 -155.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' C' ' 279' ' ' ASP . 77.2 m-20 -54.16 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.463 -0.773 . . . . 0.0 110.447 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . 0.531 ' N ' ' CD ' ' C' ' 278' ' ' LYS . 0.0 OUTLIER -49.46 -8.15 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.298 -0.876 . . . . 0.0 110.146 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' C' ' 277' ' ' ASP . 85.3 m-20 -59.61 -66.9 0.44 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 110.073 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.4 131.89 43.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 56.53 -124.5 35.22 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.557 ' C ' ' H ' ' C' ' 284' ' ' ARG . 6.9 tt0 -146.95 147.2 30.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.235 -1.156 . . . . 0.0 110.136 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.23 21.73 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . 0.569 ' HD2' H5'' ' A' ' 2' ' ' ' A' . 0.1 OUTLIER -51.47 -33.3 30.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.664 -1.272 . . . . 0.0 108.016 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' C' ' 250' ' ' ILE . . . 117.34 69.62 0.4 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.786 ' CZ ' " H5'" ' A' ' 3' ' ' ' U' . 32.6 p90 -162.18 175.01 12.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.464 -1.609 . . . . 0.0 110.205 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -154.63 178.8 31.18 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.071 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' C' ' 246' ' ' PHE . 7.8 m-85 -142.41 157.13 45.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.722 -1.458 . . . . 0.0 108.929 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . 0.489 HG12 HD12 ' C' ' 245' ' ' ILE . 1.0 OUTLIER -149.12 148.46 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.714 -1.241 . . . . 0.0 108.904 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . . . . . . . . . 12.6 m -129.46 130.94 46.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.05 -1.031 . . . . 0.0 111.101 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . 0.55 ' CE2' HG23 ' C' ' 269' ' ' ILE . 46.5 m-85 -112.88 142.5 45.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' C' ' 292' ' ' ASP . 56.6 p30 -75.79 13.03 0.9 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.437 -1.415 . . . . 0.0 107.544 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . 0.516 ' H ' ' C ' ' C' ' 291' ' ' TYR . 1.8 m -131.04 112.02 12.54 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.49 76.16 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -50.6 -38.0 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -57.18 -43.95 83.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . 0.448 HG22 ' CG2' ' C' ' 245' ' ' ILE . 59.5 t -59.31 -57.67 10.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -56.57 -19.13 14.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -77.11 -60.42 2.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 109.141 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' C' ' 303' ' ' ASN . 8.5 p -60.97 -20.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.146 -0.972 . . . . 0.0 109.039 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . 0.445 ' C ' ' O ' ' C' ' 300' ' ' VAL . 0.0 OUTLIER -43.17 -58.54 2.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 0.0 108.867 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -49.82 -27.67 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' C' ' 300' ' ' VAL . 94.1 m-20 -99.94 68.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.21 -9.5 59.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.088 . . . . 0.0 109.94 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.76 125.06 32.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . 0.539 HD12 HD11 ' C' ' 315' ' ' ILE . 69.4 mt -132.67 145.5 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.169 -0.957 . . . . 0.0 111.099 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . 0.48 ' O ' ' OD1' ' C' ' 307' ' ' ASP . 3.3 p30 -81.53 94.81 6.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 108.945 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.577 ' HE2' HG11 ' C' ' 254' ' ' VAL . 36.7 t80 -104.26 -176.28 3.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' C' ' 308' ' ' PHE . 56.0 mttt -38.84 -32.77 0.09 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.787 -1.195 . . . . 0.0 109.691 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' C' ' 311' ' ' ARG . 44.1 t0 -95.13 -154.47 0.43 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.358 -0.839 . . . . 0.0 108.853 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . 0.65 ' O ' ' N ' ' C' ' 313' ' ' ILE . 17.3 ttp180 -79.66 -167.74 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 108.916 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' C' ' 311' ' ' ARG . 10.3 tptt -55.01 75.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.905 0.86 . . . . 0.0 109.672 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' C' ' 311' ' ' ARG . 3.6 pt -45.46 153.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.186 -0.947 . . . . 0.0 108.896 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -107.3 155.22 20.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.478 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.539 HD11 HD12 ' C' ' 306' ' ' ILE . 77.8 mt -125.31 152.37 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -154.63 149.88 27.08 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.952 -1.093 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -67.33 145.46 55.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.085 -1.009 . . . . 0.0 109.333 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -78.08 13.45 1.44 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.905 -1.122 . . . . 0.0 109.116 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.51 151.57 77.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.421 -0.799 . . . . 0.0 109.8 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' C' ' 322' ' ' HIS . 50.4 Cg_endo -72.54 158.32 51.17 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.621 2.214 . . . . 0.0 112.061 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' C' ' 322' ' ' HIS . 60.0 ttt85 -62.99 68.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . 0.578 ' N ' ' O ' ' C' ' 320' ' ' PRO . 70.2 m80 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.938 -1.03 . . . . 0.0 109.588 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ' U' . . . . . 0.592 ' N3 ' ' OE1' ' C' ' 314' ' ' GLU . . . . . . . . 0 O4'--C1' 1.439 2.064 1 C5'-C4'-C3' 107.476 -5.349 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.95 " H4'" ' CD1' ' C' ' 286' ' ' PHE . . . . . . . . 0 O4'--C1' 1.441 2.228 1 C5'-C4'-C3' 107.261 -5.493 . 0.544 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ' U' . . . . . 0.78 ' H6 ' HO2' ' A' ' 2' ' ' ' A' . . . . . . . . 0 P--O5' 1.612 1.876 1 C5'-C4'-C3' 107.88 -5.08 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.778 ' OP2' HG21 ' C' ' 280' ' ' THR . . . . . . . . 0 O4'--C1' 1.436 1.836 1 C5'-C4'-C3' 107.761 -5.159 . 0.112 4p . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ' U' . . . . . 0.708 ' C2 ' ' CE2' ' C' ' 162' ' ' PHE . . . . . . . . 0 O4'--C4' 1.426 -2.249 0 C3'-C2'-C1' 104.883 3.758 . 0.696 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . 0.941 " H4'" " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 P--O5' 1.62 2.671 1 C5'-C4'-C3' 108.485 -4.676 . 0.508 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . 0.941 " H5'" " H4'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.429 1 C5'-C4'-C3' 107.163 -5.558 . 0.238 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ' A' . . . . . 0.913 " H4'" ' NH2' ' B' ' 95' ' ' ARG . . . . . . . . 0 O4'--C1' 1.44 2.172 2 C5'-C4'-C3' 105.167 -6.889 . 0.449 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.743 ' N3 ' ' CZ ' ' B' ' 71' ' ' PHE . . . . . . . . 0 C2'--C1' 1.51 -1.786 2 O4'-C1'-N19 114.196 5.996 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ' U' . . . . . 0.954 H5'' ' CZ ' ' B' ' 69' ' ' TYR . . . . . . . . 0 O4'--C1' 1.438 1.981 2 C5'-C4'-C3' 107.214 -5.524 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.909 ' H8 ' " H2'" ' A' ' 10' ' ' ' U' . . . . . . . . 0 P--O5' 1.612 1.905 1 C5'-C4'-C3' 107.524 -5.317 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.782 ' H8 ' " O2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 P--O5' 1.613 1.969 1 C5'-C4'-C3' 107.319 -5.454 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.512 " C5'" " O2'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C1' 1.437 1.883 1 C5'-C4'-C3' 107.462 -5.359 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.453 ' ND2' ' CD2' ' B' ' 101' ' ' TYR . 1.1 m120 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.52 142.01 69.71 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.685 2.257 . . . . 0.0 111.986 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.15 12.08 1.61 Allowed 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.424 2.083 . . . . 0.0 112.545 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -158.5 129.92 6.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.02 -1.05 . . . . 0.0 109.513 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.567 ' N ' ' OG ' ' B' ' 80' ' ' SER . 42.4 ttt-85 -177.48 -44.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.371 -0.831 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -138.8 154.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.92 139.92 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.295 -0.878 . . . . 0.0 108.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.719 ' CZ ' ' N1 ' ' A' ' 9' ' ' ' A' . 2.0 m-30 -106.68 135.99 47.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 111.196 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.66 HD12 HD11 ' B' ' 72' ' ' ILE . 54.0 mt -110.21 119.27 38.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 68' ' ' GLY . . . -78.52 -137.46 1.22 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.417 ' C ' HD12 ' B' ' 33' ' ' ILE . 23.2 p -69.42 122.42 18.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.65 -1.5 . . . . 0.0 109.673 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' B' ' 30' ' ' LEU . 1.2 mp -126.53 137.78 31.08 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -54.59 153.53 23.28 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.433 1.422 . . . . 0.0 112.526 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -72.39 -0.91 13.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 109.986 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -61.4 -35.81 78.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.026 . . . . 0.0 108.513 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.448 ' HB3' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -131.44 117.84 19.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.585 -0.697 . . . . 0.0 109.718 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.772 ' O ' HD13 ' B' ' 42' ' ' ILE . 82.1 p -111.42 -135.68 0.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.478 -0.764 . . . . 0.0 110.971 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -64.33 -32.42 74.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.029 -1.044 . . . . 0.0 110.402 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.7 -54.44 27.4 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.184 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -68.11 -42.11 80.73 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.592 -0.693 . . . . 0.0 110.385 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.772 HD13 ' O ' ' B' ' 38' ' ' THR . 1.7 mp -61.1 -53.3 51.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.539 HD23 ' OD1' ' B' ' 44' ' ' ASP . 4.9 tt -39.58 -21.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.554 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.596 ' O ' ' ND2' ' B' ' 48' ' ' ASN . 91.5 m-20 -125.45 -24.24 3.95 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.732 -1.23 . . . . 0.0 110.446 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.709 ' C ' HD13 ' B' ' 45' ' ' LEU . 2.9 tm? -57.22 -39.02 74.64 Favored 'General case' 0 C--N 1.292 -1.913 0 O-C-N 120.108 -1.62 . . . . 0.0 106.877 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' CYS . . . . . 0.675 ' O ' ' N ' ' B' ' 48' ' ' ASN . 85.4 m -83.26 -63.42 1.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.799 ' O ' ' N ' ' B' ' 49' ' ' VAL . 3.1 m -37.16 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.775 -0.578 . . . . 0.0 110.119 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' B' ' 46' ' ' CYS . 1.2 m120 -48.09 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 CA-C-O 121.525 0.678 . . . . 0.0 111.112 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.799 ' N ' ' O ' ' B' ' 47' ' ' SER . 1.1 t 174.5 -31.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.19 -174.63 46.89 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.6 158.87 15.01 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.143 2.562 . . . . 0.0 113.028 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.602 HG21 ' OG ' ' B' ' 47' ' ' SER . 23.2 t -128.76 145.26 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.712 HG22 ' OD1' ' B' ' 54' ' ' ASN . 45.6 mm -90.56 -66.49 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.162 -0.961 . . . . 0.0 112.011 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.712 ' OD1' HG22 ' B' ' 53' ' ' ILE . 64.0 m-20 -117.86 139.72 50.71 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.598 -176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 22.0 tp -131.15 127.63 38.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -138.02 129.89 28.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.127 -0.983 . . . . 0.0 109.673 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . 0.626 ' N ' ' H61' ' A' ' 12' ' ' ' A' . 0.8 OUTLIER -133.25 144.68 49.91 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.591 0.71 . . . . 0.0 110.379 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' B' ' 59' ' ' PHE . 0.0 OUTLIER -172.07 170.76 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.491 -0.756 . . . . 0.0 109.134 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' PHE . . . . . 0.51 ' O ' ' SD ' ' B' ' 58' ' ' MET . 0.1 OUTLIER -116.12 -166.93 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.429 -0.794 . . . . 0.0 109.21 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' B' ' 64' ' ' GLY . 6.6 t0 -105.03 73.98 0.24 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.184 -0.948 . . . . 0.0 110.622 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.41 ' CD ' ' O ' ' B' ' 59' ' ' PHE . 5.9 Cg_endo -57.09 -31.33 89.98 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.04 1.827 . . . . 0.0 112.404 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -63.09 -37.76 88.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.599 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.431 HG23 ' H ' ' B' ' 65' ' ' ARG . 0.2 OUTLIER -140.97 -32.8 0.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.977 -1.077 . . . . 0.0 110.206 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 60' ' ' ASP . . . 99.5 -1.34 57.08 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.431 ' H ' HG23 ' B' ' 63' ' ' THR . 99.1 mtt180 -58.51 -40.79 83.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.848 -1.384 . . . . 0.0 109.606 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.529 ' H ' ' HB2' ' B' ' 60' ' ' ASP . 0.5 OUTLIER -89.6 116.24 27.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.102 -0.999 . . . . 0.0 108.709 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.89 -72.58 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.734 -0.604 . . . . 0.0 109.638 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' B' ' 31' ' ' GLY . . . -123.01 95.74 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' TYR . . . . . 0.954 ' CZ ' H5'' ' A' ' 10' ' ' ' U' . 0.8 OUTLIER -108.67 130.61 55.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.473 -1.016 . . . . 0.0 109.126 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.73 24.38 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.834 -1.146 . . . . 0.0 112.193 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.743 ' CZ ' ' N3 ' ' A' ' 9' ' ' ' A' . 12.7 m-30 -115.32 129.4 56.59 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-O 121.882 0.849 . . . . 0.0 109.782 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . 0.747 HD12 ' N ' ' B' ' 72' ' ' ILE . 2.2 mp -120.25 102.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.121 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.573 ' OE1' ' ND2' ' B' ' 54' ' ' ASN . 80.5 mt-10 -83.95 131.42 34.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.573 -1.33 . . . . 0.0 110.472 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' B' ' 52' ' ' VAL . 7.2 m-85 -93.66 178.24 5.75 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.474 0.654 . . . . 0.0 110.176 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' B' ' 76' ' ' ASP . 50.4 ttt180 -52.71 -44.3 66.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.383 -0.823 . . . . 0.0 110.216 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' B' ' 78' ' ' GLU . 2.0 m-20 158.58 -177.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.754 ' O ' ' HB2' ' B' ' 81' ' ' ALA . 2.3 mp -35.52 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.683 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 76' ' ' ASP . 84.4 tt0 -70.06 -75.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.548 -1.345 . . . . 0.0 109.227 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' SER . . . . . . . . . . . . . 31.6 p -62.31 -40.26 95.74 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.978 ' O ' HG22 ' B' ' 84' ' ' VAL . 34.0 t -61.64 -39.6 91.9 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.055 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' B' ' 77' ' ' LEU . . . -57.44 -60.86 3.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.473 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 21.5 t -63.07 -35.05 78.97 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.905 -178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.748 ' O ' ' N ' ' B' ' 87' ' ' LEU . . . -73.51 -67.71 0.56 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.841 -1.162 . . . . 0.0 110.411 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.978 HG22 ' O ' ' B' ' 80' ' ' SER . 26.2 m -53.59 -37.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.506 -1.371 . . . . 0.0 110.077 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' B' ' 81' ' ' ALA . 10.2 mmt180 -62.9 -43.35 99.02 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.559 -1.338 . . . . 0.0 107.898 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' B' ' 82' ' ' SER . 87.0 m-20 -84.0 -45.97 12.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.641 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.748 ' N ' ' O ' ' B' ' 83' ' ' ALA . 0.4 OUTLIER -125.18 84.06 2.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.36 -0.838 . . . . 0.0 110.315 -179.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' B' ' 97' ' ' LEU . 0.4 OUTLIER -110.47 -68.46 0.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' B' ' 88' ' ' ASN . . . -127.66 108.1 0.92 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' B' ' 91' ' ' GLN . 0.1 OUTLIER -139.42 147.55 41.57 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.468 -1.607 . . . . 0.0 108.843 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . 0.585 ' O ' ' CE1' ' B' ' 90' ' ' TYR . 2.6 tp60 -31.32 89.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.556 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' B' ' 90' ' ' TYR . 60.0 tp -148.89 135.22 19.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.09 -1.006 . . . . 0.0 109.531 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLY . . . . . . . . . . . . . . . 45.86 -168.74 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' SER . . . . . . . . . . . . . 36.7 m -64.83 -25.18 67.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.492 -1.004 . . . . 0.0 110.345 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.913 ' NH2' " H4'" ' A' ' 8' ' ' ' A' . 1.1 mmm180 -131.3 160.67 34.27 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.213 -0.929 . . . . 0.0 109.2 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' PHE . . . . . 0.45 ' HB3' ' N ' ' B' ' 90' ' ' TYR . 6.8 m-85 -95.18 138.89 32.27 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.624 -0.673 . . . . 0.0 110.148 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LEU . . . . . 0.629 HD23 ' H ' ' B' ' 97' ' ' LEU . 0.0 OUTLIER -43.89 157.91 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.67 159.84 38.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 109.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' CYS . . . . . 0.578 ' O ' ' SG ' ' B' ' 99' ' ' CYS . 0.5 OUTLIER -110.49 129.14 55.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 110.393 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.4 -165.8 13.59 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.531 -1.318 . . . . 0.0 110.824 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.526 ' N ' ' OH ' ' B' ' 29' ' ' TYR . 30.2 p90 -130.53 171.29 13.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.635 -0.92 . . . . 0.0 109.452 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' B' ' 102' ' ' SER . 5.8 t 179.79 27.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 109.964 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 28.1 t -137.48 141.2 41.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 109.395 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.541 ' C ' HD22 ' B' ' 104' ' ' ASN . 0.2 OUTLIER -118.86 -17.8 9.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.496 -0.752 . . . . 0.0 109.596 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.439 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 156' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 157' ' ' GLU . . . . . 0.42 ' N ' ' OE1' ' C' ' 157' ' ' GLU . 58.4 mp0 -106.84 154.7 20.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.794 . . . . 0.0 109.445 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . 0.53 ' C ' ' SG ' ' C' ' 159' ' ' CYS . 23.9 t -142.06 162.01 36.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 109.716 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 159' ' ' CYS . . . . . 0.53 ' SG ' ' C ' ' C' ' 158' ' ' SER . 0.0 OUTLIER 61.84 14.45 6.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.321 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 160' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' C' ' 233' ' ' ALA . 13.4 tttp -102.28 99.24 9.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 161' ' ' MET . . . . . 0.618 ' HE2' HD13 ' C' ' 163' ' ' ILE . 3.4 mmm -71.24 151.89 43.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 110.027 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 162' ' ' PHE . . . . . 0.708 ' CE2' ' C2 ' ' A' ' 5' ' ' ' U' . 25.6 t80 -126.37 78.3 1.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 163' ' ' ILE . . . . . 0.936 HD11 HD12 ' C' ' 205' ' ' LEU . 4.1 mm -49.94 137.25 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' C' ' 166' ' ' LEU . . . -140.18 172.32 23.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 48.06 11.44 0.12 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 166' ' ' LEU . . . . . 0.636 ' HA ' HG22 ' C' ' 228' ' ' ILE . 1.2 pp -62.27 163.96 7.68 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.929 . . . . 0.0 109.353 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 167' ' ' ASN . . . . . 0.633 ' O ' HD12 ' C' ' 166' ' ' LEU . 22.5 t-20 -68.68 123.99 22.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.935 -1.103 . . . . 0.0 109.503 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 168' ' ' TRP . . . . . 0.63 ' CH2' ' C4 ' ' A' ' 4' ' ' ' A' . 3.8 m-90 -37.74 -33.24 0.07 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.784 -0.572 . . . . 0.0 110.437 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 169' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' C' ' 167' ' ' ASN . 23.6 t70 -101.33 99.21 9.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.949 -1.095 . . . . 0.0 111.112 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 3.0 m -157.19 116.12 3.31 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.26 -0.9 . . . . 0.0 109.314 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 171' ' ' THR . . . . . 0.538 ' O ' ' OD1' ' C' ' 174' ' ' ASN . 0.0 OUTLIER -75.5 173.89 10.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.783 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 172' ' ' GLU . . . . . 0.673 ' CD ' ' H ' ' C' ' 172' ' ' GLU . 0.0 OUTLIER -75.47 -71.92 0.34 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.348 -0.845 . . . . 0.0 110.252 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' C' ' 176' ' ' ARG . 91.5 m-20 -38.34 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 174' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' C' ' 175' ' ' LEU . 29.6 p-10 -36.1 -44.83 0.4 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.709 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.623 ' CD2' HD11 ' C' ' 205' ' ' LEU . 5.3 tt -54.79 -46.39 74.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 176' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' C' ' 178' ' ' TYR . 60.9 ttp85 -72.15 -60.34 2.28 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.009 -1.057 . . . . 0.0 108.72 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 177' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' C' ' 176' ' ' ARG . 78.1 mm-40 -40.06 -22.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.067 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 178' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' C' ' 176' ' ' ARG . 16.3 t80 -95.24 -36.57 11.38 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.729 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 179' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' C' ' 176' ' ' ARG . 12.6 m-85 -90.02 12.59 17.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.094 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 180' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' C' ' 182' ' ' TYR . . . -61.28 -55.87 26.81 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.035 -1.041 . . . . 0.0 111.174 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 181' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.82 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.765 -1.433 . . . . 0.0 112.048 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 182' ' ' TYR . . . . . 0.596 ' H ' ' C ' ' C' ' 180' ' ' GLY . 22.3 m-85 -107.48 -3.93 18.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.999 -1.063 . . . . 0.0 109.567 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.87 -165.34 27.3 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 184' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' C' ' 208' ' ' GLU . 0.1 OUTLIER -98.91 135.2 40.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.013 -1.286 . . . . 0.0 108.522 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.543 HG22 ' CE1' ' C' ' 207' ' ' PHE . 22.7 t -104.29 129.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 186' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -51.42 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.16 -0.962 . . . . 0.0 109.414 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 187' ' ' ASP . . . . . 0.454 ' H ' ' HB2' ' C' ' 206' ' ' SER . 21.1 t70 -149.84 160.91 43.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp -157.62 143.05 17.13 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.22 -1.55 . . . . 0.0 108.659 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 189' ' ' LYS . . . . . 0.456 ' H ' ' HB2' ' C' ' 204' ' ' PHE . 43.8 mttm -117.14 161.25 19.74 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.142 -0.974 . . . . 0.0 108.774 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 176.78 104.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 191' ' ' MET . . . . . 0.552 ' O ' ' C ' ' C' ' 192' ' ' LYS . 12.9 mtm -122.4 80.04 1.68 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 110.885 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 192' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' C' ' 191' ' ' MET . 41.5 mttp -24.07 -83.66 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 193' ' ' ASP . . . . . 0.406 ' HB3' ' N ' ' C' ' 199' ' ' SER . 3.8 p-10 -153.26 152.5 27.87 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.963 . . . . 0.0 109.233 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 194' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.55 -57.64 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.166 1.911 . . . . 0.0 112.303 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.48 ' O ' ' C ' ' C' ' 196' ' ' THR . . . -175.53 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 109.071 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . 0.48 ' C ' ' O ' ' C' ' 195' ' ' ALA . 37.3 p -28.44 -72.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.7 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 197' ' ' GLY . . . . . . . . . . . . . . . -160.84 -55.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 198' ' ' ARG . . . . . 0.622 ' CZ ' ' CZ2' ' C' ' 168' ' ' TRP . 18.2 ptt180 -169.33 158.75 8.32 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 199' ' ' SER . . . . . 0.552 ' O ' ' N ' ' C' ' 201' ' ' GLY . 90.3 p -156.42 170.3 22.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.0 -1.063 . . . . 0.0 109.417 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 200' ' ' ARG . . . . . 0.684 ' CB ' " H4'" ' A' ' 5' ' ' ' U' . 0.0 OUTLIER -26.56 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.436 0.636 . . . . 0.0 110.735 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 201' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' C' ' 199' ' ' SER . . . -77.33 109.35 2.78 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.588 ' HB3' " H1'" ' A' ' 5' ' ' ' U' . 13.0 p90 -129.56 166.67 19.24 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.785 -0.832 . . . . 0.0 108.783 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 203' ' ' GLY . . . . . . . . . . . . . . . -137.65 130.02 4.9 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.171 -1.49 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 204' ' ' PHE . . . . . 0.456 ' HB2' ' H ' ' C' ' 189' ' ' LYS . 61.6 m-85 -104.08 115.55 30.62 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.607 -1.525 . . . . 0.0 107.596 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.936 HD12 HD11 ' C' ' 163' ' ' ILE . 3.5 mt -115.32 97.02 5.95 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.838 0.828 . . . . 0.0 109.967 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 206' ' ' SER . . . . . 0.454 ' HB2' ' H ' ' C' ' 187' ' ' ASP . 2.4 m -69.31 80.6 0.36 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.284 0.564 . . . . 0.0 109.651 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . 0.65 ' O ' ' O ' ' C' ' 208' ' ' GLU . 44.2 m-85 -79.56 123.6 27.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.165 -0.96 . . . . 0.0 110.943 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 208' ' ' GLU . . . . . 0.65 ' O ' ' O ' ' C' ' 207' ' ' PHE . 0.0 OUTLIER -36.59 -103.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.617 ' H ' ' CG ' ' C' ' 208' ' ' GLU . 9.4 ptmt -51.39 160.6 0.93 Allowed Pre-proline 0 C--N 1.298 -1.665 0 O-C-N 119.744 -1.847 . . . . 0.0 108.326 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' PRO . . . . . 0.698 ' O ' HG22 ' C' ' 213' ' ' VAL . 8.6 Cg_endo -94.85 14.07 1.32 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.614 2.209 . . . . 0.0 112.478 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' SER . . . . . 0.586 ' O ' ' N ' ' C' ' 214' ' ' ASP . 60.0 p -82.64 -51.16 7.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . 0.852 ' O ' HG23 ' C' ' 216' ' ' VAL . 60.6 p -39.58 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.47 -0.769 . . . . 0.0 109.317 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' VAL . . . . . 0.698 HG22 ' O ' ' C' ' 210' ' ' PRO . 4.1 m -66.28 -37.96 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.962 -1.086 . . . . 0.0 108.31 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' C' ' 211' ' ' SER . 89.9 m-20 -65.19 -49.83 68.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.3 -39.74 94.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 108.68 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' VAL . . . . . 0.852 HG23 ' O ' ' C' ' 212' ' ' SER . 47.7 t -56.49 -49.18 78.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.96 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.489 HG23 ' O ' ' C' ' 230' ' ' PRO . 13.1 p -82.83 -31.45 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.868 -1.145 . . . . 0.0 111.264 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -74.17 12.87 0.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.933 -1.104 . . . . 0.0 109.697 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . 0.411 ' H ' ' C ' ' C' ' 217' ' ' VAL . 15.8 m -131.28 142.58 50.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.349 -0.844 . . . . 0.0 108.885 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -107.23 67.34 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 108.973 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' HIS . . . . . 0.831 ' CD2' ' H ' ' C' ' 221' ' ' HIS . 0.0 OUTLIER -55.54 163.95 1.16 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.706 -0.621 . . . . 0.0 109.95 -179.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.426 HG22 ' C ' ' C' ' 225' ' ' GLY . 0.2 OUTLIER -142.14 74.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.902 0.858 . . . . 0.0 108.789 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' C' ' 178' ' ' TYR . 0.1 OUTLIER -49.08 -71.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.233 -0.917 . . . . 0.0 110.67 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' C' ' 224' ' ' ASP . 58.3 t0 -89.81 12.19 17.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.75 -1.219 . . . . 0.0 109.606 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . 0.426 ' C ' HG22 ' C' ' 222' ' ' ILE . . . 81.01 17.12 73.06 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' C' ' 222' ' ' ILE . 27.3 mmtp -95.16 -153.94 0.41 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . 0.513 HG22 ' O ' ' C' ' 227' ' ' VAL . 2.0 p -122.4 90.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.071 -1.018 . . . . 0.0 109.921 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' C' ' 166' ' ' LEU . 34.0 pt -84.97 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -114.63 96.61 44.37 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.362 -0.837 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 230' ' ' PRO . . . . . 0.534 ' HB2' HG12 ' C' ' 216' ' ' VAL . 1.7 Cg_endo -74.65 125.67 9.67 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.384 2.056 . . . . 0.0 111.704 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.64 134.3 35.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 109.767 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.432 ' HD3' HG21 ' C' ' 213' ' ' VAL . 69.0 ttp85 -62.73 148.84 45.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 109.322 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' C' ' 160' ' ' LYS . . . -46.91 139.86 5.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.992 . . . . 0.0 109.196 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 28.6 mt -121.84 127.51 25.97 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.52 -0.737 . . . . 0.0 109.491 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 235' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.84 147.78 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.874 1.716 . . . . 0.0 112.276 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -58.66 -38.43 78.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.409 -0.807 . . . . 0.0 110.635 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 237' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.86 -41.42 74.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 109.134 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 238' ' ' GLU . . . . . 0.688 ' O ' HG23 ' C' ' 242' ' ' THR . 9.1 mp0 -71.79 -39.91 69.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.912 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 239' ' ' GLN . . . . . 0.643 ' NE2' ' C8 ' ' A' ' 6' ' ' ' A' . 9.2 tt0 -58.98 -43.68 91.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 240' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -69.17 -41.89 76.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 241' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' C' ' 242' ' ' THR . 16.0 ttmm -61.08 -45.38 94.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.939 . . . . 0.0 110.124 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 242' ' ' THR . . . . . 0.688 HG23 ' O ' ' C' ' 238' ' ' GLU . 50.0 p -40.63 139.28 0.83 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.148 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.67 143.35 17.78 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 244' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' C' ' 290' ' ' THR . 16.7 tptp -118.71 130.26 55.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 109.86 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 245' ' ' ILE . . . . . 0.641 HD11 ' CG2' ' C' ' 315' ' ' ILE . 0.1 OUTLIER -120.57 143.43 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 246' ' ' PHE . . . . . 0.519 ' CD2' ' N3 ' ' A' ' 2' ' ' ' A' . 6.9 t80 -104.14 128.57 51.81 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.48 0.657 . . . . 0.0 109.975 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 247' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' C' ' 263' ' ' PHE . 14.1 t -100.63 133.07 45.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.951 0.881 . . . . 0.0 110.392 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 248' ' ' GLY . . . . . . . . . . . . . . . -111.64 158.32 14.4 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.07 83.0 0.2 Allowed Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.063 -1.257 . . . . 0.0 110.542 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 250' ' ' ILE . . . . . 0.546 HG21 HD22 ' C' ' 274' ' ' LEU . 3.7 mm -127.37 127.86 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -1.108 . . . . 0.0 108.855 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 251' ' ' GLY . . . . . 0.454 ' O ' HG23 ' C' ' 254' ' ' VAL . . . -52.61 111.87 1.83 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 252' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.92 -20.86 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.802 1.668 . . . . 0.0 111.66 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 253' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -96.52 16.17 19.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.479 -0.763 . . . . 0.0 109.265 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 254' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 251' ' ' GLY . 48.8 t -97.86 135.62 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.96 163.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.0 108.964 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 256' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.36 -25.89 80.8 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.653 2.235 . . . . 0.0 112.09 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 257' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -50.03 -62.74 1.4 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.519 -0.738 . . . . 0.0 109.233 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 258' ' ' GLU . . . . . 0.626 ' O ' ' N ' ' C' ' 261' ' ' GLU . 77.3 mm-40 -60.43 -74.18 0.08 Allowed 'General case' 0 C--O 1.194 -1.855 0 O-C-N 121.175 -0.953 . . . . 0.0 108.51 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 259' ' ' PHE . . . . . 0.722 ' CZ ' HG13 ' C' ' 289' ' ' VAL . 89.1 t80 -16.82 -67.51 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.889 0.852 . . . . 0.0 111.045 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 260' ' ' GLU . . . . . 0.449 ' O ' HD11 ' C' ' 269' ' ' ILE . 93.6 mt-10 -61.24 -44.65 96.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.359 -0.838 . . . . 0.0 109.51 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 261' ' ' GLU . . . . . 0.626 ' N ' ' O ' ' C' ' 258' ' ' GLU . 35.5 tp10 -68.37 -7.68 33.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 262' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' C' ' 263' ' ' PHE . 13.9 t80 -92.76 -76.45 0.46 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 263' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' C' ' 247' ' ' VAL . 82.4 m-85 -45.74 -33.57 3.1 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.093 -1.443 . . . . 0.0 109.466 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 264' ' ' SER . . . . . 0.429 ' C ' ' O ' ' C' ' 263' ' ' PHE . 48.1 p -34.6 -37.5 0.06 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.942 -0.474 . . . . 0.0 111.786 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 265' ' ' GLN . . . . . 0.546 ' C ' ' H ' ' C' ' 267' ' ' GLY . 0.2 OUTLIER -58.52 -95.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.19 -1.569 . . . . 0.0 110.118 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 266' ' ' TRP . . . . . 0.679 ' CD1' ' O ' ' C' ' 266' ' ' TRP . 0.6 OUTLIER -69.92 19.25 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.025 -1.047 . . . . 0.0 109.38 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 267' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' C' ' 265' ' ' GLN . . . -136.17 128.16 4.45 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 268' ' ' THR . . . . . 0.528 ' O ' ' C ' ' C' ' 269' ' ' ILE . 58.1 p -85.5 6.6 26.27 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.365 -1.079 . . . . 0.0 109.747 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 269' ' ' ILE . . . . . 0.761 HG23 ' CE1' ' C' ' 291' ' ' TYR . 5.4 pt -14.67 96.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 122.451 1.119 . . . . 0.0 113.865 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 270' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.85 -35.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 271' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -135.94 94.87 3.12 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 272' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' C' ' 273' ' ' GLN . . . -137.81 172.05 13.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 273' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' C' ' 272' ' ' ALA . 7.7 tt0 164.99 156.86 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.563 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 274' ' ' LEU . . . . . 0.546 HD22 HG21 ' C' ' 250' ' ' ILE . 16.3 tp -97.0 140.63 31.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 275' ' ' MET . . . . . 0.503 ' H ' HD12 ' C' ' 274' ' ' LEU . 1.7 mpp? -90.4 156.33 18.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.564 -1.335 . . . . 0.0 108.686 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.67 -169.22 3.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.125 -0.984 . . . . 0.0 109.397 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 277' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' C' ' 278' ' ' LYS . 36.8 p-10 -61.84 -38.38 88.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.239 -0.913 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 278' ' ' LYS . . . . . 0.583 ' N ' ' OD1' ' C' ' 277' ' ' ASP . 13.3 tttp -63.29 -42.8 99.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 279' ' ' ASP . . . . . 0.412 ' O ' ' N1 ' ' A' ' 4' ' ' ' A' . 87.3 m-20 -66.76 -61.03 2.17 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.114 -0.991 . . . . 0.0 109.243 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 280' ' ' THR . . . . . 0.778 HG21 ' OP2' ' A' ' 4' ' ' ' A' . 0.7 OUTLIER 178.74 129.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 281' ' ' GLY . . . . . . . . . . . . . . . 76.1 -118.78 5.45 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 282' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' C' ' 284' ' ' ARG . 32.3 tt0 -166.37 150.33 7.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.972 -1.311 . . . . 0.0 111.009 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 283' ' ' SER . . . . . . . . . . . . . 4.5 t -62.17 66.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 110.213 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 284' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' C' ' 282' ' ' GLN . 72.3 mtt85 -55.77 -22.28 23.43 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 137.73 12.81 0.87 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.95 ' CD1' " H4'" ' A' ' 2' ' ' ' A' . 32.4 p90 -106.5 165.09 11.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 110.534 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 287' ' ' GLY . . . . . . . . . . . . . . . -161.71 178.99 37.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 288' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -134.61 154.44 51.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.441 -1.623 . . . . 0.0 109.725 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 289' ' ' VAL . . . . . 0.722 HG13 ' CZ ' ' C' ' 259' ' ' PHE . 0.0 OUTLIER -148.01 138.04 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 177.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 290' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' C' ' 269' ' ' ILE . 10.1 m -123.0 126.0 46.32 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.96 -1.088 . . . . 0.0 109.943 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 291' ' ' TYR . . . . . 0.761 ' CE1' HG23 ' C' ' 269' ' ' ILE . 41.0 m-85 -113.55 133.09 55.45 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 292' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' C' ' 293' ' ' SER . 25.9 p-10 -53.02 -46.22 68.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.625 -1.297 . . . . 0.0 108.767 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 293' ' ' SER . . . . . 0.567 ' N ' ' OD1' ' C' ' 292' ' ' ASP . 67.3 m -88.15 164.75 15.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.11 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 294' ' ' ALA . . . . . 0.406 ' O ' ' CG1' ' C' ' 297' ' ' VAL . . . -102.83 -22.38 13.89 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 295' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -50.08 -38.51 38.66 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.005 -1.06 . . . . 0.0 108.535 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.47 -55.69 31.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 297' ' ' VAL . . . . . 0.575 ' O ' ' SG ' ' C' ' 301' ' ' CYS . 1.4 p -54.99 -54.95 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.339 -1.476 . . . . 0.0 108.242 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 298' ' ' ASP . . . . . 0.456 ' H ' HG13 ' C' ' 297' ' ' VAL . 92.4 m-20 -57.84 -19.5 29.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.895 -1.128 . . . . 0.0 109.606 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 299' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -76.9 -58.37 3.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.433 -0.792 . . . . 0.0 108.877 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 300' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' C' ' 303' ' ' ASN . 7.2 p -68.11 -25.22 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 301' ' ' CYS . . . . . 0.575 ' SG ' ' O ' ' C' ' 297' ' ' VAL . 65.6 m -43.9 -52.07 7.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.115 -0.991 . . . . 0.0 108.766 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 302' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -50.92 -22.21 2.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.091 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 303' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' C' ' 300' ' ' VAL . 20.1 t-20 -100.13 65.76 1.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.0 109.446 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 304' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' C' ' 303' ' ' ASN . 55.7 tttp -46.17 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.688 -1.257 . . . . 0.0 108.753 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 305' ' ' PHE . . . . . 0.644 ' CE1' ' CG ' ' C' ' 314' ' ' GLU . 90.9 m-85 -76.79 133.93 39.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 306' ' ' ILE . . . . . . . . . . . . . 1.5 mt -130.39 148.34 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.369 -0.832 . . . . 0.0 109.019 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 307' ' ' ASP . . . . . 0.543 ' OD1' ' NZ ' ' C' ' 312' ' ' LYS . 78.1 m-20 -76.66 123.97 26.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.057 -1.027 . . . . 0.0 108.608 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 308' ' ' PHE . . . . . 0.579 ' O ' ' N ' ' C' ' 310' ' ' ASP . 52.6 t80 -123.44 173.16 8.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -0.873 . . . . 0.0 109.345 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 309' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' C' ' 308' ' ' PHE . 0.3 OUTLIER -40.45 -23.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 310' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 308' ' ' PHE . 46.0 t0 -94.23 -154.5 0.42 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 311' ' ' ARG . . . . . 0.563 ' H ' ' CG ' ' C' ' 310' ' ' ASP . 87.8 mtt180 -79.0 -55.71 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 312' ' ' LYS . . . . . 0.543 ' NZ ' ' OD1' ' C' ' 307' ' ' ASP . 24.9 tptt -157.37 147.04 20.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.176 -0.953 . . . . 0.0 109.183 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 313' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' C' ' 308' ' ' PHE . 41.7 pt -129.85 147.64 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.877 . . . . 0.0 109.229 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 314' ' ' GLU . . . . . 0.644 ' CG ' ' CE1' ' C' ' 305' ' ' PHE . 85.2 mt-10 -99.43 144.31 28.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.473 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 315' ' ' ILE . . . . . 0.641 ' CG2' HD11 ' C' ' 245' ' ' ILE . 36.2 mt -118.39 147.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.909 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 316' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -155.58 148.23 24.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.001 . . . . 0.0 108.976 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 317' ' ' ARG . . . . . 0.441 ' NH1' ' CB ' ' C' ' 317' ' ' ARG . 5.7 ptm85 -68.77 152.49 45.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.948 -1.095 . . . . 0.0 109.579 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.57 93.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.196 -0.94 . . . . 0.0 109.109 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 319' ' ' GLU . . . . . 0.472 ' O ' ' C ' ' C' ' 320' ' ' PRO . 3.2 mm-40 -128.28 74.57 79.54 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.632 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 320' ' ' PRO . . . . . 0.472 ' C ' ' O ' ' C' ' 319' ' ' GLU . 98.9 Cg_exo -26.09 -67.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 122.984 2.456 . . . . 0.0 112.955 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 321' ' ' ARG . . . . . 0.477 ' O ' ' OXT' ' C' ' 322' ' ' HIS . 36.6 mmm-85 -122.85 89.85 3.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.328 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 322' ' ' HIS . . . . . 0.477 ' OXT' ' O ' ' C' ' 321' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.74 179.9 . . . . . . . . 2 2 . 1 stop_ save_